<SEC-DOCUMENT>0001193125-14-400994.txt : 20141106
<SEC-HEADER>0001193125-14-400994.hdr.sgml : 20141106
<ACCEPTANCE-DATETIME>20141106160710
ACCESSION NUMBER:		0001193125-14-400994
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		10
CONFORMED PERIOD OF REPORT:	20140930
FILED AS OF DATE:		20141106
DATE AS OF CHANGE:		20141106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HERON THERAPEUTICS, INC. /DE/
		CENTRAL INDEX KEY:			0000818033
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				942875566
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33221
		FILM NUMBER:		141200698

	BUSINESS ADDRESS:	
		STREET 1:		123 SAGINAW DRIVE
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063
		BUSINESS PHONE:		6503662626

	MAIL ADDRESS:	
		STREET 1:		123 SAGINAW DRIVE
		STREET 2:		123 SAGINAW DRIVE
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AP PHARMA INC /DE/
		DATE OF NAME CHANGE:	20010511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED POLYMER SYSTEMS INC /DE/
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>d817679d10q.htm
<DESCRIPTION>10-Q
<TEXT>
<HTML><HEAD>
<TITLE>10-Q</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, DC 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 10-Q
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(Mark One) </B></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"><B>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934 </B></TD></TR></TABLE>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the quarterly period ended September&nbsp;30, 2014 </B></P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OR </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"><B>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934 </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the transition period from
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> to
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission file number: 001-33221 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>HERON
THERAPEUTICS, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>94-2875566</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>123 Saginaw Drive</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Redwood City, CA</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>94063</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (650)&nbsp;366-2626 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant: (1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark
whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule&nbsp;405 of Regulation&nbsp;S-T (&#167;232.405 of this chapter) during
the preceding 12&nbsp;months (or for such shorter period that the registrant was required to submit and post such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in Rule 12b-2 of the Exchange Act. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Non-accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;(Do not check if a smaller reporting company)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of shares of the registrant&#146;s common stock, par value $0.01 per share, outstanding as of October&nbsp;29,&nbsp;2014 was 29,180,099. </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HERON THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM 10-Q </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE
QUARTERLY PERIOD ENDED SEPTEMBER 30, 2014 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">PART I. FINANCIAL INFORMATION</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">ITEM&nbsp;1.</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_1">Condensed Financial Statements &#151; Unaudited</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_2">Condensed Balance Sheets as of September&nbsp;30, 2014 and December&nbsp;31, 2013</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">1</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_3">Condensed Statements of Operations for the three and nine months ended September&nbsp;30, 2014 and 2013</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">2</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_4">Condensed Statements of Cash Flows for the nine months ended September&nbsp;30, 2014 and 2013</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">3</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_5">Notes to Condensed Financial Statements</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">4</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">ITEM&nbsp;2.</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_6">Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">11</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">ITEM&nbsp;3.</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_7">Quantitative and Qualitative Disclosures About Market Risk</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">16</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">ITEM&nbsp;4.</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_8">Controls and Procedures</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">16</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24" COLSPAN="5"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">PART II. OTHER INFORMATION</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">ITEM&nbsp;1.</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_9">Legal Proceedings</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">16</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">ITEM&nbsp;1A.</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_10">Risk Factors</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">16</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">ITEM&nbsp;2.</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_11">Unregistered Sales of Equity Securities and Use of Proceeds</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">32</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">ITEM&nbsp;3.</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_12">Defaults Upon Senior Securities</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">32</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">ITEM&nbsp;4.</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_13">Mine Safety Disclosures</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">32</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">ITEM&nbsp;5.</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_14">Other Information</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">32</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">ITEM&nbsp;6.</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><A HREF="#tx817679_15">Exhibits</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">33</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><A HREF="#tx817679_16">SIGNATURES</A></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">34</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>PART&nbsp;I.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="tx817679_1"></A>FINANCIAL INFORMATION </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;1.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>CONDENSED FINANCIAL STATEMENTS </B>&#151;<B> UNAUDITED </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HERON THERAPEUTICS, INC.
</B></P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx817679_2"></A>Condensed Balance Sheets </B></P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(in thousands) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">September&nbsp;30,<br>2014</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">December&nbsp;31,<br>2013</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">(Unaudited)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">(Note 2)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>ASSETS</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">86,212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">72,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,910</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other long-term assets</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">92,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>LIABILITIES AND STOCKHOLDERS&#146; EQUITY</U></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,264</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued clinical liabilities</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued payroll and employee-related liabilities</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,601</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other accrued expenses</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible notes payable to related parties, net of discount</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; equity:</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional paid-in capital</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">375,329</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">307,578</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(294,613</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(238,870</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; equity</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities and stockholders&#146; equity</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">92,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See accompanying notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HERON THERAPEUTICS, INC. </B></P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx817679_3"></A>Condensed Statements of Operations </B></P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(in
thousands, except per share amounts) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Three Months Ended<br>September&nbsp;30,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Nine Months Ended<br>September&nbsp;30,</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2014</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2013</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2014</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2013</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,216</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40,929</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,664</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,626</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18,953</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,664</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,066</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(40,626</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other expense</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(241</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(209</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(677</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(614</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(19,194</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(12,873</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(55,743</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(41,240</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per share</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.66</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.84</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2.17</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2.69</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares used in computing basic and diluted net loss per share</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,004</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,679</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See accompanying notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HERON THERAPEUTICS, INC. </B></P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx817679_4"></A>Condensed Statements of Cash Flows </B></P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(in
thousands) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Nine Months Ended<br>September&nbsp;30,</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2014</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2013</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(55,743</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(41,240</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used for operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">389</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,809</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of debt discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,392</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(202</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">514</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued clinical liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">302</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued payroll and employee-related liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used for operating activities</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,425</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31,136</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investing activities:</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of property and equipment</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(417</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,518</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used for investing activities</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(417</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,518</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing activities:</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from warrant exercises</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from purchases under the Employee Stock Purchase Plan</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from stock option exercises</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net proceeds from sale of common stock and pre-funded warrants</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,916</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase (decrease) in cash</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,909</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash at beginning of period</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,506</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash at end of period</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">86,212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See accompanying notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HERON THERAPUETICS, INC. </B></P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx817679_5"></A>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Business</B> </TD></TR></TABLE>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) (the &#147;Company,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our&#148;) is a
biotechnology company using its proprietary technology and innovative efforts to develop products to address unmet medical needs. Our proprietary Biochronomer<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> polymer-based drug delivery
platform is designed to improve the therapeutic profile of injectable pharmaceuticals by extending the duration of action of known active ingredients. Our product development program also focuses on identifying new delivery methods and formulations
utilizing known compounds that may expand or extend the therapeutic effort, or eliminate the drawbacks of current therapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our lead investigational
product candidate, APF530, which we intend to market as SUSTOL<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (granisetron injection, extended release), subject to regulatory approval, is being developed for the prevention of both acute-
and delayed-onset chemotherapy induced nausea and vomiting (&#147;CINV&#148;). In 2014, we initiated a Phase 3 clinical study with APF530 for the prevention of delayed-onset CINV in patients receiving highly emetogenic chemotherapy (&#147;HEC
study&#148;). One of the most debilitating side effects of cancer chemotherapy, CINV is a leading cause of premature discontinuation of treatment. There is only one injectable 5-HT<SUB STYLE="font-size:85%; vertical-align:bottom">3</SUB> receptor
antagonist approved for the prevention of delayed-onset CINV in patients receiving moderately emetogenic chemotherapy; none are approved for delayed-onset CINV in patients receiving highly emetogenic chemotherapy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SUSTOL contains the 5-HT<SUB STYLE="font-size:85%; vertical-align:bottom">3</SUB> receptor antagonist granisetron formulated in the Company&#146;s proprietary
Biochronomer polymer-based drug delivery platform, which has been shown in clinical studies to maintain therapeutic drug levels of SUSTOL for up to five days with a single subcutaneous injection. Currently available intravenous and oral formulations
of granisetron are approved only for the prevention of acute-onset CINV. Granisetron was selected for SUSTOL because it is widely prescribed by physicians based on a well-established record of safety and efficacy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2009, we filed the original New Drug Application (&#147;NDA&#148;) with the U.S. Food and Drug Administration (&#147;FDA&#148;) seeking approval for
SUSTOL for the prevention of acute-onset CINV in patients receiving both moderately and highly emetogenic chemotherapy and delayed-onset CINV in patients receiving moderately emetogenic chemotherapy. The FDA issued a Complete Response Letter
(&#147;CRL&#148;) for the SUSTOL NDA in March 2010. In September 2012, we resubmitted our NDA for SUSTOL and, in March 2013, we received a second CRL, which identified several remaining issues that need to be addressed prior to approval of the
SUSTOL NDA. We believe that we have substantially addressed those issues raised in the March 2013 CRL. We are anticipating completing enrollment of our ongoing HEC study in the first quarter of 2015. We intend to include the results of the study in
the resubmission of the SUSTOL NDA, which we anticipate filing shortly thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Biochronomer technology, on which SUSTOL and certain of our other
product candidates are based, consists of bioerodible polymers designed to release drugs over a defined period of time. The results of over 100 <I>in vivo</I> and <I>in vitro</I> studies demonstrate that our Biochronomer technology is potentially
applicable to a range of therapeutic areas, including prevention of CINV, pain management and control of inflammation, among others. We have also completed comprehensive animal and human toxicology studies that have established that our Biochronomer
polymers are well tolerated. Furthermore, our Biochronomer technology can be designed to deliver drugs over periods varying from days to potentially multiple weeks. As part of our product development efforts, we are researching the potential use of
our Biochronomer technology with other drugs for the clinical development of other drug candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2013, we initiated a program to expand
our pipeline of sustained-release products, including a new program targeting pain management. Our lead product candidate for this program is HTX-011, a combination of local anesthetic bupivacaine and the anti-inflammatory meloxicam in a formulation
utilizing our proprietary Biochronomer polymer-based drug delivery platform. We are in the process of commencing a Phase 1 study in Europe to examine the product candidate in human </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
candidates. As of 2012, approximately 25 million<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> procedures associated with post-operative pain were conducted in the U.S. In addition,
post-operative pain market sales were approximately $3.1&nbsp;billion<SUP STYLE="font-size:85%; vertical-align:top">2</SUP> in 2012. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2014, we
announced our product development program for HTX-019. The investigational product HTX-019 is a proprietary intravenous formulation of aprepitant, a substance P/neurokinin-1 (NK<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>) receptor
antagonist used in combination with a 5-HT<SUB STYLE="font-size:85%; vertical-align:bottom">3</SUB> for the prevention of CINV. HTX-019 does not contain polysorbate 80. By eliminating the use of surfactant polysorbate 80, HTX-019 may reduce the
hypersensitivity reactions observed with fosaprepitant formulations containing this component. At present, there is only one intravenous NK<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> receptor antagonist approved in the U.S. for the
prevention of CINV. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2014, we changed our name from A.P. Pharma, Inc. to Heron Therapeutics, Inc. Effective January&nbsp;13,&nbsp;2014, we
effected a 1-for-20 reverse split of our outstanding common stock (&#147;Reverse Stock Split&#148;) (See Note 5). All historical share and per share amounts have been adjusted to reflect the Reverse Stock Split. All stock options, common stock
underlying convertible notes and warrants outstanding were adjusted to give effect to the Reverse Stock Split. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have incurred significant operating losses and negative cash flows from operations and we have an accumulated deficit of $294.6 million as of
September&nbsp;30, 2014. Since 2011, we completed a total of five rounds of equity and/or debt financings, which provided us with cash of approximately $194.3 million, net of issuance costs, to fund operations (see Notes 4 and 5). As of
September&nbsp;30, 2014, we had cash on hand of $86.2 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that our current working capital is sufficient to fund operations into 2015,
including pursuing regulatory approval to market SUSTOL, and beginning human clinical studies relative to our HTX-011 and HTX-019 development programs. In the event we were to pursue clinical product development in other areas, potentially acquire
other strategic assets, or begin to make significant investments in preparing for commercialization of SUSTOL, we would need to raise additional capital. If we are unable to obtain sufficient financing on acceptable terms or otherwise, we may be
required to reduce or defer our activities. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Basis of Presentation</B> </TD></TR></TABLE>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in
the United States (&#147;GAAP&#148;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete
financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended
September&nbsp;30,&nbsp;2014 are not necessarily indicative of the results that may be expected for other quarters or the year ending December&nbsp;31, 2014. The condensed balance sheet at December&nbsp;31, 2013 has been derived from the audited
financial statements as of that date, but does not include all of the information and disclosures required by GAAP. The presentation of prior year amounts was reclassified to conform to the current year presentation. For more complete financial
information, these unaudited condensed financial statements and the notes thereto should be read in conjunction with the audited financial statements included in the Company&#146;s Annual Report on Form&nbsp;10-K for the fiscal year ended
December&nbsp;31, 2013 filed with the Securities and Exchange Commission (&#147;SEC&#148;) on March&nbsp;7,&nbsp;2014. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Accounting Policies</B> </TD></TR></TABLE>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of Estimates </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of
condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.
We evaluate our estimates on an </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Custom Research Project by Design Resources completed in 2013. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Decision Resources, Acute Pain, December 2012. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ongoing basis, including those related to clinical trial accruals, income taxes and stock-based compensation. We base our estimates on historical experience and on assumptions that we believe to
be reasonable under the circumstances, the results of which form the basis of making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these
estimates under different assumptions or conditions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We had cash of $86.2 million and $72.3 million at September&nbsp;30, 2014 and December&nbsp;31, 2013, respectively. We did not hold any cash equivalents or
investment securities as of both dates. Our bank accounts have been placed under a control agreement in accordance with the Senior Secured Convertible Notes (see Note 4). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Earnings Per Share </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Basic earnings per share
(&#147;EPS&#148;) is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration of common share equivalents. Diluted EPS is computed by dividing the net loss by the
weighted-average number of common shares and common share equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, stock options, warrants and common stock underlying convertible notes are
considered to be common stock equivalents and are only included in the calculation of diluted EPS when their effect is dilutive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because we have incurred
a net loss for all periods presented in the unaudited condensed statements of operations, outstanding stock options, warrants and common stock underlying convertible notes are not included in the computation of net loss per share because their
effect would be anti-dilutive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table includes the number of outstanding stock options, warrants and common stock underlying convertible
notes not included in the computation as of the dates shown below (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="84%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of&nbsp;September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,456</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock underlying convertible notes outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,578</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Comprehensive Income (Loss) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Our
comprehensive net loss for all periods presented was comprised solely of our net loss and there were no other changes in equity from non-owner sources. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Accounting Pronouncements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2014, the
Financial Accounting Standards Board (&#147;FASB&#148;) issued Accounting Standards Update (&#147;ASU&#148;) No.&nbsp;2014-15, <I>Presentation of Financial Statements &#150; Going Concern (Subtopic 205-40)</I> (&#147;ASU 2014-15&#148;). ASU 2014-15
requires management to assess an entity&#146;s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1)&nbsp;provide a definition of
the term substantial doubt, (2)&nbsp;require an evaluation every reporting period including interim periods, (3)&nbsp;provide principles for considering the mitigating effect of management&#146;s plans, (4)&nbsp;require certain disclosures when
substantial doubt is alleviated as a result of consideration of management&#146;s plans, (5)&nbsp;require an express statement and other disclosures when substantial doubt is not alleviated, and (6)&nbsp;require an assessment for a period of one
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
year after the date that the financial statements are issued (or available to be issued). The amendments in ASU 2014-15 are effective for the annual period ending after December&nbsp;15, 2016,
and for annual periods and interim periods thereafter. Early adoption is permitted. We plan to adopt the provisions on ASU 2014-15 in 2016. We do not expect the adoption of this ASU to have a material impact on our results of operations or financial
condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2014, FASB issued ASU No.&nbsp;2014-12, <I>Compensation &#150; Stock Compensation (Topic 718)</I> (&#147;ASU 2014-12&#148;). ASU
2014-12 requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for annual periods and interim periods within those annual
periods beginning after December&nbsp;15, 2015. Earlier adoption is permitted. The amendments in ASU 2014-12 may either be applied (a)&nbsp;prospectively to all awards granted or modified after the effective date or (b)&nbsp;retrospectively to all
awards with performance targets that are outstanding as of the beginning of the earlier annual period presented in the financial statements and to all new or modified awards thereafter. We plan to adopt the provisions of ASU 2014-12 in the first
quarter of 2016. We do not expect the adoption of this ASU to have a material impact on our results of operations or financial condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I></I>In July
2013, the FASB issued ASU No.&nbsp;2013-11, <I>Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists</I> (&#147;ASU 2013-11&#148;). This update provides explicit
guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This guidance is effective prospectively for fiscal years, and interim
periods within those years, beginning after December&nbsp;15, 2013, with an option for early adoption. We adopted this guidance in 2014 and it did not have a material impact on our financial condition, results of operations or related financial
statement disclosures.<I> </I></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Convertible Notes to Related Parties </B></TD></TR></TABLE>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2011, we entered into a Securities Purchase Agreement for a private placement of up to $4.5&nbsp;million in Senior Secured
Convertible Notes (&#147;Notes&#148;). We received a total of $4.3 million, net of issuance costs, from the issuance of these Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes are
secured by substantially all of our assets, including placing our bank accounts under a control agreement. The Notes bear interest at 6%&nbsp;per annum, payable quarterly in cash or in additional principal amount of Notes, at the election of the
purchasers. The Notes mature on May&nbsp;2, 2021, however, the holders of the Notes may require prepayment of the Notes at any time, at each holder&#146;s option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes are convertible into shares of our common stock at a rate of 1,250 shares for every $1,000 of principal and accrued interest due under the Notes.
There is no right to convert the Notes to the extent that, after giving effect to such conversion, the holder would beneficially own in excess of 9.99% of our outstanding common stock. Each holder of the Notes can increase or decrease this
beneficial ownership conversion limit by written notice to us, which will not be effective until 61 days after delivery of the notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of
September&nbsp;30, 2014, we were in compliance with all covenants under the Notes. Upon the occurrence of an event of default under the Notes, the holders of the Notes have the right to require us to redeem all or a portion of their Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We filed a registration statement with the SEC to register for resale 3.5&nbsp;million shares underlying the Notes. The registration statement was declared
effective on July&nbsp;29,&nbsp;2011. The Note holders have agreed to waive their right to require us to maintain the effectiveness of the registration statement and to register the additional shares underlying the Notes until they provide notice
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes contain an embedded conversion feature that was in-the-money on the issuance dates. Based on an effective fixed conversion rate of
1,250 shares for every $1,000 of principal and accrued interest due under the Notes, the total conversion benefit at issuance exceeded the loan proceeds. Therefore, a debt discount was recorded in an amount equal to the face value of the Notes on
the issuance dates and we began amortizing the resultant debt discount over the respective 10-year term of the Notes. During the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
period ended September&nbsp;30, 2014, accrued interest of approximately $78,000 was paid-in-kind and rolled into the Note principal balance, which resulted in an additional debt discount of
approximately $78,000. For the three months ended September&nbsp;30, 2014 and 2013, interest expense relating to the stated rate was approximately $79,000 and $74,000, respectively, and interest expense relating to the amortization of the debt
discount was approximately $145,000 and $135,000, respectively. For the nine months ended September&nbsp;30, 2014 and 2013, interest expense relating to the stated rate was approximately $233,000 and $218,000, respectively, and interest expense
relating to the amortization of the debt discount was approximately $425,000 and $396,000, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of September&nbsp;30, 2014, the carrying
value of the Notes was approximately $1,450,000, which is comprised of the $5,262,000 principal amount of the Notes outstanding, less debt discount of $3,812,000. If the $5,262,000 principal amount of Notes is converted, we would issue approximately
6,578,000 shares of our common stock. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Stockholders&#146; Equity </B></TD></TR></TABLE>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B><B><I>Amendments to Articles of Incorporation</I></B><B> &#150; </B><B><I>Reverse Stock Split</I></B><B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective January&nbsp;13, 2014, we amended our Certificate of Incorporation to change our name to Heron Therapeutics, Inc. and to effect a 1-for-20 reverse
split of our outstanding common stock. The name change and Reverse Stock Split were approved by our stockholders on September&nbsp;19,&nbsp;2013. As a result of the Reverse Stock Split, the total authorized shares of common stock were reduced from
1,500,000,000 to 75,000,000 shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2011 Private Placement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2011, we sold 8.0&nbsp;million shares of our common stock for net proceeds of $22.8 million (net of approximately $1.2 million in issuance costs). For
each share purchased, the investors received one warrant to purchase 0.5 shares of common stock at an exercise price of $3.60 per share. The warrants were immediately exercisable and expire on July&nbsp;1,&nbsp;2016. The warrants may be exercised
for cash only, or, if a registration statement is not then effective and available for the resale of the shares of common stock issuable upon exercise of the warrants, by surrender of such warrant, or a portion of such warrant, by way of cashless
exercise. There is no right to exercise the warrants to the extent that, after giving effect to such exercise the holder would beneficially own in excess of 9.99% of our outstanding shares of common stock or such other limit as may be designated by
any particular purchaser. Each holder of the warrants can amend or waive the foregoing limitation by written notice to us, with such waiver taking effect only upon the expiration of a 61-day notice period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;29, 2011, we filed a registration statement with the SEC to register for resale the shares and the shares of common stock issuable upon the
exercise of the warrants. The registration statement was declared effective on August&nbsp;4, 2011. We are obligated to maintain the effectiveness of the registration statement until the investors are able to sell shares and the shares of common
stock underlying the warrants without limitation or restriction under Rule 144 of the Securities Act of 1933, as amended (&#147;Rule 144&#148;). There is currently only one investor who is an affiliate of ours and is therefore not able to sell
without limitation under Rule 144, and that investor has agreed to waive its right to require us to maintain the effectiveness of the registration statement until it provides notice otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the nine months ended September&nbsp;30, 2014, warrant holders exercised 460,706 warrants under the cashless exercise provision in the warrant
agreement, which resulted in the net issuance of 303,614&nbsp;shares of common stock and no net cash proceeds to us. During the nine months ended September&nbsp;30, 2013, we received $0.6 million for cash exercises of these warrants. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2012 Private Placement </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2012, we sold
approximately 5.1&nbsp;million shares of our common stock at a purchase price of $10.50 per share, resulting in net proceeds of approximately $50.5 million (net of approximately $3.1 million in issuance costs). On August&nbsp;24, 2012, we filed a
registration statement with the SEC to register these shares for resale. The registration statement was declared effective on September&nbsp;6, 2012. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2013 Common Stock Offering </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2013, we sold approximately 8.6&nbsp;million shares of our common stock at a public offering price of $8.00 per share. We received total net
proceeds of approximately $57.8 million (net of approximately $3.9&nbsp;million in issuance costs). The offering was made pursuant to an effective registration statement, which was previously filed with the SEC and was declared effective. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2014 Common Stock Offering </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2014, we sold
approximately 4.8&nbsp;million shares of our common stock at a public offering price of $11.75 per share. In addition, as a component of the offering, we sold 600,000 pre-funded warrants to purchase shares of our common stock at a public offering
price of $11.74 per share. The pre-funded warrants have an exercise price of $0.01 per share and are exercisable for seven years from the date of issuance. We received total net proceeds of approximately $58.9 million (net of approximately $4.0
million in issuance costs) from the sale of the common stock and the pre-funded warrants. The offering was made pursuant to an effective registration statement, which was previously filed with the SEC and was declared effective. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Option Exercises </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the nine months ended
September&nbsp;30, 2014, approximately 550,000 shares of common stock were issued pursuant to the exercise of stock options, resulting in proceeds to us of approximately $2.8&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock-Based Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes
stock-based compensation expense for the three and nine months ended September&nbsp;30, 2014 and 2013 related to stock options and Employee Stock Purchase Plan (&#147;ESPP&#148;) purchase rights by expense category (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended</B><br><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine&nbsp;Months&nbsp;Ended</B><br><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,423</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,393</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,386</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense included in operating expenses</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,095</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,809</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Impact on basic and diluted net loss per share</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of September&nbsp;30, 2014, there was approximately $26.8 million of total unrecognized compensation cost related to
non-vested, stock-based payment awards granted pursuant to our equity compensation arrangements. Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures. We expect to recognize this compensation cost over a
period of 2.5&nbsp;years, which is the weighted-average vesting period for all stock-based compensation awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We estimated the fair value of each option grant on the grant date using the Black-Scholes option valuation model
with the following weighted-average assumptions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="84%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected life (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We estimated the fair value of each purchase right granted under the ESPP at the beginning of each new offering period using
the Black-Scholes option valuation model. There were no new offering periods for the quarters ended September&nbsp;30, 2014 and 2013. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table
summarizes the stock option activity for the nine months ended September&nbsp;30, 2014: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>Weighted-</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>Average</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>Weighted-</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>Remaining</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>Average</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>Contractual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>Term</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at January&nbsp;1, 2014</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,631</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(719</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expired and forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(812</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at September&nbsp;30, 2014</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,456</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Income Taxes</B> </TD></TR></TABLE>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred income tax assets and liabilities are recognized for temporary differences between financial statements and income tax carrying
values using tax rates in effect for the years such differences are expected to reverse. Due to uncertainties surrounding our ability to generate future taxable income and consequently realize such deferred income tax assets, a full valuation
allowance has been established. We continue to maintain a full valuation allowance against its deferred tax assets as of September&nbsp;30,&nbsp;2014. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more likely than not to be sustained
upon audit by the relevant tax authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. There have been no material changes in our unrecognized tax benefits since
December&nbsp;31,&nbsp;2013 and as such, disclosures included in the Company&#146;s 2013 Annual Report on Form&nbsp;10-K continue to be relevant for the period ended September&nbsp;30, 2014. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx817679_6"></A>ITEM&nbsp;2.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following discussion and analysis of our financial condition and results of operations should be read together with our unaudited
condensed financial statements and related notes included in this quarterly report on Form 10-Q and the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2013 filed with
the Securities and Exchange Commission (the &#147;SEC&#148;), on March&nbsp;7,&nbsp;2014. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This Form 10-Q contains forward-looking
statements within the meaning of the federal securities laws. You can identify forward-looking statements by the use of the words &#147;believe,&#148; &#147;expect,&#148; &#147;anticipate,&#148; &#147;intend,&#148; &#147;estimate,&#148;
&#147;project,&#148; &#147;will,&#148; &#147;should,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;intend,&#148; &#147;assume&#148; and other expressions which predict or indicate future events and trends and which do not relate to historical
matters. You should not rely on forward-looking statements, because they involve known and unknown risks, uncertainties and other factors, some of which are beyond the control of the Company. These risks, uncertainties and other factors may cause
the actual results, performance or achievements of the Company to be materially different from the anticipated future results, performance or achievements expressed or implied by the forward-looking statements. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Factors that might cause these differences include the following: </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>&#149;</I></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><I>estimates of the timing of our resubmission of the New Drug Application (&#147;NDA&#148;) for SUSTOL, and potential regulatory approval for and commercial launch of SUSTOL; </I></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>&#149;</I></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><I>the anticipated progress of our research and development and programs, including the commencement of new clinical trials and preclinical testing; </I></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>&#149;</I></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><I>if approved, the market conditions at commercial launch of SUSTOL or other future product candidates; </I></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>&#149;</I></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><I>our ability to successfully market, commercialize and achieve market acceptance for SUSTOL or other future product candidates, including our positioning relative to competing products; </I></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>&#149;</I></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><I>our ability to successfully develop and achieve regulatory approval for other drug candidates utilizing our proprietary Biochronomer polymer-based drug delivery platform; </I></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>&#149;</I></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><I>our ability to establish key collaborations for our technology, SUSTOL and other future product candidates; </I></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>&#149;</I></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><I>our ability to successfully develop and commercialize any technology that we may in-license or products we may acquire; </I></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>&#149;</I></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><I>unanticipated delays due to manufacturing difficulties, supply constraints, or changes in the regulatory environment; </I></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>&#149;</I></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><I>our ability to successfully establish and maintain key vendor relationships necessary for the manufacture of our products; </I></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>&#149;</I></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><I>uncertainties associated with obtaining and enforcing patents to protect our products, and our ability to successfully defend ourselves against unforeseen third party infringement claims; and
</I></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>our estimates regarding our capital requirements and our needs for, and ability to obtain, additional financing. </I> </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>These forward-looking statements were based on information, plans and estimates at the date of
this Form 10-Q, and we assume no obligation to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes. In addition, please see the &#147;Risk Factors&#148;
section of this Form 10-Q. These risk factors may be updated from time to time by our future filings under the Securities Exchange Act of 1934. You should carefully review all of these factors. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise noted, all historical information in this Item&nbsp;2 regarding share amounts of our common stock, prices per share of our
common stock and loss per share has been adjusted to reflect, on a retroactive basis, the application of the 1-for-20 reverse stock split of our common stock that we effected on January&nbsp;13,&nbsp;2014 (the &#147;Reverse Stock Split&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Overview </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Heron Therapeutics, Inc.
(formerly A.P. Pharma, Inc.) (the &#147;Company,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our&#148;) is a biotechnology company using its proprietary technology and innovative efforts to develop products to address unmet medical needs. Our
proprietary Biochronomer<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> polymer-based drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by extending the duration of action of known active
ingredients. Our product development program also focuses on identifying new delivery methods and formulations utilizing known compounds that may expand or extend the therapeutic effort, or eliminate the drawbacks of current therapies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our lead investigational product candidate, APF530, which we intend to market as
SUSTOL<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (granisetron injection, extended release), subject to regulatory approval, is being developed for the prevention of both acute- and delayed-onset chemotherapy induced nausea and
vomiting (&#147;CINV&#148;). In 2014, we initiated a Phase 3 clinical study with APF530 for the prevention of delayed-onset CINV in patients receiving highly emetogenic chemotherapy (&#147;HEC study&#148;). One of the most debilitating side effects
of cancer chemotherapy, CINV is a leading cause of premature discontinuation of treatment. There is only one injectable 5-HT<SUB STYLE="font-size:85%; vertical-align:bottom">3</SUB> receptor antagonist approved for the prevention of delayed-onset
CINV in patients receiving moderately emetogenic chemotherapy; none are approved for delayed-onset CINV in patients receiving highly emetogenic chemotherapy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SUSTOL contains the 5-HT<SUB STYLE="font-size:85%; vertical-align:bottom">3</SUB> receptor antagonist granisetron formulated in the
Company&#146;s proprietary Biochronomer polymer-based drug delivery platform, which has been shown in clinical studies to maintain therapeutic drug levels of SUSTOL for up to five days with a single subcutaneous injection. Currently available
intravenous and oral formulations of granisetron are approved only for the prevention of acute-onset CINV. Granisetron was selected for SUSTOL because it is widely prescribed by physicians based on a well-established record of safety and efficacy.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In May 2009, we filed the original New Drug Application (&#147;NDA&#148;) with the U.S. Food and Drug Administration (&#147;FDA&#148;),
seeking approval for SUSTOL for the prevention of acute-onset CINV in patients receiving both moderately and highly emetogenic chemotherapy and delayed-onset CINV in patients receiving moderately emetogenic chemotherapy. The FDA issued a Complete
Response Letter (&#147;CRL&#148;) for the SUSTOL NDA in March 2010. In September 2012, we resubmitted our NDA for SUSTOL and, in March 2013, we received a second CRL, which identified several remaining issues that need to be addressed prior to
approval of the SUSTOL NDA. We believe that we have substantially addressed those issues raised in the March 2013 CRL. We are anticipating completing enrollment of our ongoing HEC study in the first quarter of 2015. We intend to include the results
of the study in the resubmission of the SUSTOL NDA, which we anticipate filing shortly thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Biochronomer technology, on which
SUSTOL and certain of our other product candidates are based, consists of bioerodible polymers designed to release drugs over a defined period of time. The results of over 100 <I>in vivo</I> and <I>in vitro</I> studies demonstrate that our
Biochronomer technology is potentially applicable to a range of therapeutic areas, including prevention of CINV, pain management and control of inflammation, among others. We have also completed comprehensive animal and human toxicology studies that
have established that our Biochronomer polymers are well tolerated. Furthermore, our Biochronomer technology can be designed to deliver drugs over periods varying from days to potentially multiple weeks. As part of our product development efforts,
we are researching the potential use of our Biochronomer technology with other drugs for the clinical development of other drug candidates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In November 2013, we initiated a program to expand our pipeline of sustained-release products,
including a new program targeting pain management. Our lead product candidate for this program is HTX-011, a combination of local anesthetic bupivacaine and the anti-inflammatory meloxicam in a formulation utilizing our proprietary Biochronomer
polymer-based drug delivery platform. We are in the process of commencing a Phase 1 study in Europe to examine the product candidate in human candidates. As of 2012, approximately 25 million<SUP STYLE="font-size:85%; vertical-align:top">3</SUP>
procedures associated with post-operative pain were conducted in the U.S. In addition, post-operative pain market sales were approximately $3.1&nbsp;billion<SUP STYLE="font-size:85%; vertical-align:top">4</SUP> in 2012. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In November 2014, we announced our product development program for HTX-019. The investigational product HTX-019 is a proprietary intravenous
formulation of aprepitant, a substance P/neurokinin-1 (NK<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>) receptor antagonist used in combination with a 5-HT<SUB STYLE="font-size:85%; vertical-align:bottom">3</SUB> for the prevention of
CINV. HTX-019 does not contain polysorbate 80. By eliminating the use of surfactant polysorbate 80, HTX-019 may reduce the hypersensitivity reactions observed with fosaprepitant formulations containing this component. At present, there is only one
intravenous NK<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> receptor antagonist approved in the U.S. for the prevention of CINV. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Critical Accounting Policies and Estimates </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been
prepared in accordance with accounting principles generally accepted in the United States (&#147;GAAP&#148;). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets,
liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis, including those related to clinical trial accruals, income taxes and stock-based compensation. We base
our estimates on historical experience and on assumptions that we believe to be reasonable under the circumstances, the results of which form the basis of making judgments about the carrying values of assets and liabilities that are not readily
apparent from other sources. Actual results may differ materially from these estimates under different assumptions or conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There
have been no material changes to the critical accounting policies as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2013 filed with the SEC on March&nbsp;7, 2014. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Recent Accounting Pronouncements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See Note&nbsp;2 to the unaudited condensed financial statements included in Item&nbsp;1 of this Quarterly Report on Form&nbsp;10-Q. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Results of Operations for the Three and Nine Months Ended September&nbsp;30, 2014 and 2013 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>Research and Development Expense </U></I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development expense consisted of the following (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended</B><br><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine Months Ended</B><br><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SUSTOL related costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26,601</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17,061</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New product development related costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Personnel and related costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,165</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,036</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,423</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Facility related costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">449</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total research and development expense</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,216</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40,929</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">3</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Custom Research Project by Design Resources completed in 2013. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">4</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Decision Resources, Acute Pain, December 2012. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the three and nine months ended September&nbsp;30, 2014, research and development expense
increased to $14.7 million and $40.9 million, respectively, from $6.2 million and $24.2 million, respectively, for the same periods in 2013, primarily as a result of an increase in SUSTOL related costs due to the initiation of the Phase 3 HEC study
of APF530 in 2014 and other SUSTOL related activities. In addition, the increase in research and development expense was due to costs associated with new product development, including our new pain management program targeting the relief of
post-surgical pain, which was initiated in November 2013. Finally, the increase in research and development expense was due to an increase in personnel and related costs of approximately $1.0 million and $2.7 million, respectively, mainly due to
additional headcount to support the increased development activities noted above, and an increase for the nine month period due to additional non-cash, stock-based compensation expense of approximately $0.9 million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>General and Administrative Expense </U></I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the three and nine months ended September&nbsp;30, 2014, general and administrative expense decreased to $4.2 million and $14.1 million,
respectively, from $6.4 million and $16.5 million, respectively, for the same periods in 2013, primarily as a result of higher stock-based compensation expense in 2013 resulting from the resignation of our former chief executive officer in August
2013. For the three and nine months ended September&nbsp;30, 2014, general and administrative expenses consist primarily of salaries and related expenses, professional fees, pre-commercialization costs and insurance expense. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>Interest and Other Expense </U></I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest and other expense was $0.2 million and $0.7 million, respectively, for the three and nine months ended September&nbsp;30, 2014, which
was comparable to $0.2 million and $0.6 million for the same periods in 2013. Interest and other expense consists primarily of interest expense and amortization of debt discount related to the Senior Secured Convertible Notes (&#147;Notes&#148;).
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Capital Resources and Liquidity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September&nbsp;30, 2014, we had approximately $86.2 million in cash, compared to $72.3 million as of December&nbsp;31, 2013. The net
increase in cash of approximately $13.9 million was primarily due to the cash proceeds of approximately $58.9 million received from the common stock offering completed in June&nbsp;2014 and $2.8 million from stock option exercises, partially offset
by the use of cash to fund our continued development of SUSTOL, personnel costs and for other general corporate purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Historically,
we have financed our operations, including technology and product research and development, primarily through sales of our common stock and other securities, royalties, revenues from collaboration arrangements, proceeds received from the sale of
discontinued operations and interest earned on short-term investments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In April 2011, we entered into definitive agreements for a
convertible note financing of up to $4.5&nbsp;million. We received a total of approximately $4.3 million, net of issuance costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July
2011, we closed a unit financing where each unit consisted of one share of common stock and a warrant to purchase 0.5 shares of common stock; whereby we received approximately $22.8 million of proceeds, net of issuance costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2012, we closed a private placement of common stock whereby we received approximately $50.5 million of proceeds, net of issuance
costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In November 2013, we closed a public offering of common stock whereby we received approximately $57.8 million of proceeds, net of
issuance costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In June 2014, we closed a public offering of common stock and pre-funded warrants whereby we received approximately $58.9
million of proceeds, net of issuance costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our current working capital is sufficient to fund operations into 2015, including
pursuing regulatory approval to market SUSTOL, and beginning human clinical studies relative to our HTX-011 and HTX-019 development programs. In the event we were to pursue clinical product development in other areas, potentially acquire other
strategic assets, or begin to make significant investments in preparing for commercialization of SUSTOL, we would need to raise additional capital. If we are unable to obtain sufficient financing on acceptable terms or otherwise, we may be required
to reduce or defer our activities. Our capital requirements going forward will depend on numerous factors, including: an approval decision by the FDA with respect to SUSTOL; the timing of and costs associated with the commercial launch of SUSTOL, if
approved; the degree of commercial success of SUSTOL; the number and characteristics of product development programs we pursue and the pace of each program including the timing of clinical trials; the scope, rate of progress, results and costs of
preclinical testing and clinical trials, including our Phase 3 clinical trial of APF530 for the prevention of delayed-onset CINV in patients receiving highly emetogenic chemotherapy; the time, cost and outcome involved in seeking other regulatory
approvals; scientific progress in our research and development programs; the magnitude and scope of our research and development programs; our ability to establish and maintain strategic collaborations or partnerships for research, development,
clinical testing, manufacturing and marketing of our product candidates; the cost and timing of establishing sales, marketing and distribution capabilities if we commercialize products independently; the cost of establishing clinical and commercial
supplies of our product candidates and any products that we may develop; and general market conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may not be able to raise
sufficient additional capital when we need it on favorable terms, or at all. The sale of additional equity in the future may be dilutive to our stockholders. If we are unable to obtain adequate funds on reasonable terms, we may be required to
curtail operations significantly or to obtain funds by entering into financing, supply or collaboration agreements on unattractive terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have no current means of generating material cash flows from operations. There can be no assurance that our product development efforts
related to any of our product candidates will be successfully completed, that required regulatory approvals will be obtained, or that any products, if introduced, will be successfully marketed or achieve commercial acceptance. Until we can generate
significant continuing revenues, we expect to satisfy our future cash needs through public or private equity offerings, debt financings and corporate collaboration and licensing arrangements. We cannot be certain that additional funding will be
available to us on acceptable terms, or at all. Our ability to obtain new financing may be constrained by our failure to achieve significant business objectives, covenants contained in the Notes, and numerous other factors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Contractual Obligations </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Below is
a summary of fixed payments related to certain contractual obligations (in thousands), consisting solely of our operating lease obligations. This table excludes amounts already recorded on our balance sheet as current liabilities as of
September&nbsp;30, 2014. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payment due by period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Less&nbsp;than<BR>1&nbsp;year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">1-3&nbsp;years</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">3-5&nbsp;years</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>More&nbsp;than<BR>5&nbsp;years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">921</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of the Notes may require prepayment of the Notes at any time at each holder&#146;s option. See
Note 4 of Notes to Condensed Financial Statements included in Item&nbsp;1 of this Quarterly Report on Form 10-Q. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also enter into
agreements from time to time with clinical sites and contract research organizations for the conduct of our clinical trials. We make payments to these sites and organizations based in part upon the number of patients enrolled and the length of their
participation in the clinical trials. Under certain of these agreements, we may be subject to penalties in the event that we prematurely terminate these agreements. At this time, due to the variability associated with clinical site and contract
research organization agreements, we are unable to estimate with certainty the future costs we will incur. We intend to use our current financial resources to fund our obligations under these commitments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Off-Balance Sheet Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have no off-balance sheet arrangements that have, or are reasonably likely to have, a current or future effect on our financial condition,
expenses, results of operations, liquidity, capital expenditures or capital resources. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx817679_7"></A>ITEM&nbsp;3.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not hold any
marketable securities at September&nbsp;30, 2014. Our debt obligations of our convertible debt carry a fixed interest rate and, as a result, we are not exposed to interest rate risk on our convertible debt. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx817679_8"></A>ITEM&nbsp;4.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>CONTROLS AND PROCEDURES </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain disclosure controls and procedures that are
designed to ensure that information required to be disclosed in our reports, filed under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported within the time periods specified in the SEC&#146;s rules and forms, and
that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the
disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives. In reaching a
reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. In addition, the design of any system of controls also is based in part upon
certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, a control may become inadequate because of changes
in conditions or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required by the SEC Rule 13a-15(b), we carried out an evaluation under the supervision and with the participation of our management,
including our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our chief
executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected,
or is reasonably likely to materially affect, our internal control over financial reporting. </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>PART&nbsp;II.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>OTHER INFORMATION </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx817679_9"></A>ITEM&nbsp;1.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>LEGAL PROCEEDINGS </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx817679_10"></A>ITEM&nbsp;1A.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>RISK FACTORS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>You should carefully consider the following information about risks and
uncertainties that may affect us or our business, together with the other information appearing elsewhere in this quarterly report on Form 10-Q and in our other filings with the SEC. If any of the following events, described as risks, actually
occur, our business, financial condition, results of operations and future prospects would likely be </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
materially and adversely affected. In these circumstances, the market price of our common stock could decline, and you may lose all or part of your investment in our securities. An investment in
our securities is speculative and involves a high degree of risk. You should not invest in our securities if you cannot bear the economic risk of your investment for an indefinite period of time and cannot afford to lose your entire investment. The
risks described below may include certain additions and revisions to the risks set forth in our annual report on Form 10-K for the fiscal year ended December&nbsp;31, 2013 and our subsequent filings with the SEC. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related To Our Business </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are substantially
dependent upon the approval and success of our investigational product APF530, also referred to as SUSTOL. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have invested a
significant portion of our time and financial resources in the development of our most advanced product candidate, APF530, which we intend to market as SUSTOL subject to regulatory approval, and has been studied in the prevention of acute-onset
chemotherapy-induced nausea and vomiting (&#147;CINV&#148;) in patients undergoing both moderately and highly emetogenic chemotherapy and for the prevention of delayed-onset CINV for patients undergoing moderately emetogenic chemotherapy
(&#147;MEC&#148;). In 2014, we initiated a Phase 3 clinical study with APF530 for the prevention of delayed-onset CINV in patients receiving highly emetogenic chemotherapy (&#147;HEC study&#148;). We are anticipating completing enrollment of the HEC
study in the first quarter of 2015. We intend to include the results of the study in the resubmission of our New Drug Application (&#147;NDA&#148;) for SUSTOL, which we anticipate filing shortly thereafter. There can be no assurance that the HEC
study will conclude on a timely basis, or that the results will be positive for us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to generate revenue in the next one to
two years and our future success, in large part, depends on the approval and successful commercialization of SUSTOL. We will not be able to commercialize SUSTOL until we obtain regulatory approval in the United States or foreign countries. In
September 2012, we resubmitted the NDA seeking approval for APF530 with the U.S. Food and Drug Administration (&#147;FDA&#148;). In March 2013, we received a Complete Response Letter (&#147;CRL&#148;) from the FDA pertaining to our resubmission of
our NDA for APF530. The CRL identified several remaining issues that need to be addressed prior to approval of our NDA for APF530 including issues relating to: manufacturing of SUSTOL, the administration of SUSTOL and our analysis of efficacy data
for SUSTOL under more recent guidelines classifying chemotherapy regimens. We believe we have substantially addressed the issues identified by the FDA in the CRL, although there can be no assurance that the FDA will agree. The FDA&#146;s review of
our resubmission may not produce positive decisions as to whether: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">SUSTOL is safe and effective in its proposed use(s) and whether its benefits outweigh the risks; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the proposed labeling for SUSTOL includes our desired product indications covering acute and delayed-onset CINV, for use in both HEC and MEC regimens; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the methods used in manufacturing SUSTOL and the controls used to maintain its quality are adequate to preserve chain of identity, strength, quality and purity. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delays in obtaining regulatory approval for SUSTOL, or the issuance of another CRL by the FDA, would, among other consequences, delay the
launch of SUSTOL and impact our ability to raise additional capital, which would have a material adverse effect on our business and financial condition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If SUSTOL is approved, but does not attain market acceptance by healthcare professionals and patients, our business and results of operations will
suffer. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if SUSTOL receives regulatory approval for commercial sale, the revenue that we may receive from the sale of SUSTOL
may be less than expected and will depend on many factors that are outside of our control. Factors that may affect revenue from SUSTOL, if approved, include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the scope of our approved product label; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the perception of physicians and other members of the health care community of the safety and efficacy and cost-competitiveness relative to that of competing products; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">acceptance by institutional formulary committees; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">patient and physician satisfaction with the product; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to have SUSTOL manufactured at a commercial production level successfully and on a timely basis; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the cost and availability of raw materials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the size of the potential market for the product; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reimbursement policies of government and third-party payors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">unfavorable publicity concerning the product or similar drugs; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the introduction, availability and acceptance of competing treatments; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">adverse event information relating to the product; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">product liability litigation alleging injuries relating to the product; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">product labeling or product insert language required by the FDA or regulatory authorities in other countries; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">regulatory developments related to the manufacture or continued use of the product; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the extent and effectiveness of sales and marketing and distribution support for the product; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our competitors&#146; decisions as to the timing of competing product launches, pricing and discounting. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our revenue will be adversely affected if, due to these or other factors, our commercialization of SUSTOL does not achieve the acceptance and
demand to sustain product revenue growth. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We rely on third parties to conduct our clinical trials, and their failure to perform their obligations
in a timely and competent manner may delay development and commercialization of our product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have used contract
research organizations to date to oversee our clinical trials for APF530 and we expect to use the same or similar organizations for our future clinical trials and pipeline programs. There can be no assurance that these organizations will perform
their obligations at all times in a competent or timely fashion, and we must rigorously oversee their activities in order to place confidence in their conduction of these trials on our behalf. Different cultural and operational issues in foreign
countries could cause delays or unexpected problems with patient enrollment or with the data obtained from those locations. If we experience significant delays in the progress of our clinical trials or experience doubts with respect to the quality
of data derived from our clinical trials, we could face significant delays in gaining necessary product approvals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have yet to receive regulatory approval for a product utilizing our proprietary drug delivery
technology. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our bioerodible drug delivery technology has not yet been proven through commercial approval, and successful launch,
of a product utilizing this technology. We may not be able to substantiate the commercial viability of our drug delivery technology for a variety of reasons, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the failure to receive regulatory approval of a drug utilizing the technology for delivery; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the inability to show consistent results in the quality or quantity of product manufactured utilizing this delivery technology; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the inability to manufacture drugs using this delivery platform at a cost effective price. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event we
are unable to demonstrate commercial success and viability of products utilizing this delivery technology, our prospects for success and growth would be significantly harmed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If our suppliers and contract manufacturers fail to timely manufacture SUSTOL or fail to comply with stringent regulatory requirements we will face
delays in our ability to obtain regulatory approval for SUSTOL. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not manufacture SUSTOL ourselves and do not currently plan
to develop any capacity to do so. Instead, we have relied on third parties to manufacture and perform important pre-commercialization manufacturing activities for SUSTOL. As part of the process for obtaining regulatory approval, we must demonstrate
that the facilities, equipment and processes used to manufacture SUSTOL are capable of consistently producing a product that meets all applicable quality criteria, and that is comparable to the product that was used in our clinical trials. We must
also provide the FDA with information regarding the validation of the manufacturing facilities, equipment and processes of our third-party suppliers and manufacturers, and data supporting the stability of SUSTOL. If our third-party suppliers and
manufacturers are not in compliance with current Good Manufacturing Practice (&#147;cGMP&#148;) requirements, the approval by regulatory authorities for us to begin marketing a product may be delayed, existing product batches may be compromised, and
we may experience delays in the availability of SUSTOL for commercial distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For example, our most recent CRL from the FDA
regarding our NDA resubmission for SUSTOL stated that the NDA could not be approved due to, among other issues, deficiencies observed during an inspection of the facilities used by our third-party suppliers and manufacturers to produce SUSTOL. If
the FDA is not satisfied with our response and corrective actions taken by these third parties, we may be required to complete additional manufacturing development activities or provide other information to the FDA, which could cause substantial
delays in obtaining regulatory approval for SUSTOL, increase our costs and have a material adverse effect on our business and financial condition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If our suppliers and contract manufacturers are unable to manufacture in commercially viable quantities, we could face delays in our ability to
commercialize SUSTOL, and our costs will increase. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, APF530 has been manufactured primarily in small quantities for
preclinical studies and clinical trials. If in the future APF530 or any of our product candidates are approved for commercial sale, we will need to be able to consistently manufacture our products in larger quantities. The commercial success of our
products will be dependent upon the ability of our contract manufacturers to produce a product in commercial quantities at competitive costs of manufacture. If SUSTOL receives regulatory approval, we plan to scale-up manufacturing for SUSTOL in
order to realize important economies of scale. These scale-up activities would take time to implement, require additional capital investment, process development and validation studies, and regulatory approval. We cannot guarantee that we will be
successful in achieving competitive manufacturing costs through such scale-up activities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We expect to depend on contract manufacturers for manufacturing any future products we develop, and if our
contract manufacturers do not perform as expected, our business could suffer. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not own or operate manufacturing facilities
for the production of clinical or commercial quantities of any product. Our ability to develop and commercialize any products we may develop will depend in part on our ability to manufacture, or arrange for other parties to manufacture, our products
at a competitive cost, in accordance with regulatory requirements, and in sufficient quantities for clinical testing and eventual commercialization. We currently rely on a small number of third-party manufacturers to produce compounds used in our
product development activities and expect to continue to do so to meet the preclinical and clinical requirements of our potential products and for all of our commercial needs. Certain of our contract manufacturers are at present our sole resource to
manufacture certain key components of SUSTOL, and for products in preclinical testing in our research and development program. We may not be able to successfully negotiate long-term agreements with any of these third parties. Further, we may have
difficulties with these relationships, and we may not be able to find replacement contract manufacturers on satisfactory terms or on a timely basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, we, along with our contract manufacturers, are required to comply with FDA requirements related to product testing, quality
assurance, manufacturing and documentation. Our contract manufacturers may not be able to comply with the applicable FDA regulatory requirements. They may be required to pass an FDA preapproval inspection for conformity with cGMPs before we can
obtain approval to manufacture our products and will be subject to ongoing, periodic, unannounced inspection by the FDA and corresponding state agencies to ensure strict compliance with cGMP, and other applicable government regulations and
corresponding foreign standards. If we and our contract manufacturers fail to achieve and maintain high manufacturing standards in compliance with cGMP regulations, we may experience manufacturing errors resulting in defective products that could be
harmful to patients, product recalls or withdrawals, delays or interruptions of production or failures in product testing or delivery, delay or prevention of filing or approval of marketing applications for our products, cost overruns or other
problems that could seriously harm our business. Not complying with FDA requirements could result in an enforcement action such as product recall or prevent commercialization of our product candidates and delay our business development activities.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SUSTOL or any of our product candidates may be in competition with other products for access to the facilities of third parties.
Consequently, SUSTOL or any of our product candidates may be subject to manufacturing delays if our contractors give other companies&#146; products greater priority than our products. For this and other reasons, our third-party contract
manufacturers may not be able to manufacture SUSTOL or any of our other product candidates in a cost-effective or timely manner. If not manufactured in a timely manner, the clinical development of any of our product candidates or their submission
for regulatory approval could be delayed, and our ability to deliver products to market on a timely basis could be impaired. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain of the
components used in the manufacture of SUSTOL and our other product candidates are sourced from a single vendor. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some of the
critical materials and components used in manufacturing SUSTOL and our other product candidates are sourced from single suppliers. An interruption in the supply of a key material could significantly delay our research and development process or
increase our expenses. Specialized materials must often be manufactured for the first time for use in drug delivery technologies, or materials may be used in the technologies in a manner different from their customary commercial uses. The quality of
materials can be critical to the performance of a drug delivery technology, so a reliable source of a consistent supply of materials is important. Materials or components needed for our drug delivery technologies may be difficult to obtain on
commercially reasonable terms, particularly when relatively small quantities are required or if the materials traditionally have not been used in pharmaceutical products. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to establish sales and marketing capabilities or enter into agreements with third parties
to sell and market any products we may develop, we may be unable to generate product revenue. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not currently have an internal
sales organization for the sale, marketing and distribution of SUSTOL, or for any other products we may develop. In order to successfully commercialize SUSTOL or any other product, we must build our sales, marketing, distribution and other
non-technical capabilities or make arrangements with third parties to perform these services. Our Company has no direct experience in developing, training or managing a marketing and sales organization. The establishment and development of a sales
organization to market SUSTOL and our other product candidates will be expensive and time consuming and could delay product launch, and we cannot be certain that we will be able to successfully develop this capacity. If we are unable to establish
adequate sales, marketing and distribution capabilities, whether independently or with third parties, we may not be able to generate product revenue and may not become profitable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to recruit and retain skilled employees, we may not be able to achieve our objectives. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We depend on a small number of key management and technical personnel. Retaining our current employees and recruiting qualified scientific
personnel to perform future research and development and commercialization work will be critical to our success. Competition is always present for highly skilled and experienced personnel, and an inability to recruit or retain sufficient skilled
personnel could result in delays in our business growth and development and adversely impact our research and development or commercial activities. If we lose key members of our senior management team, we may not be able to find suitable
replacements and our business may be harmed as a result. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our business strategy may include acquisitions of other businesses, products or product
licenses. We may not be able to successfully manage such activities. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may engage in strategic transactions that could cause us
to incur contingent liabilities, commitments, or significant expense. In the course of pursuing strategic alternatives, we may evaluate potential acquisitions or investments in strategic technologies, products, or businesses. Future acquisitions or
investments could subject us to a number of risks, including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our inability to appropriately evaluate and take into consideration the potential uncertainties associated with the other party to such a transaction, including but not limited to the prospects of that party and their
existing products or product candidates and regulatory approvals; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">difficulties associated with realizing the perceived potential for commercial success with respect to any acquired technology, product, or business; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to effectively integrate any new technology, product, and/or business including personnel, intellectual property or business relationships; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our inability to generate revenues from acquired technology and/or products sufficient to meet our objectives in undertaking the acquisition or even to offset the associated acquisition and maintenance costs and/or
assumption of liabilities;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the distraction of our management from our existing product programs and initiatives in pursuing an acquisition. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with an acquisition, we must estimate the value of the transaction by making certain assumptions that may prove to be incorrect,
which could cause us to fail to realize the anticipated benefits of a transaction. Any strategic transaction we may pursue may not result in the benefits we initially anticipate, and/or result in costs that end up outweighing the benefits, and may
adversely impact our financial condition and be detrimental to our future business prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our business strategy may include the entry into collaborative agreements. We may not be able to enter into
additional collaborative agreements or may not be able to negotiate commercially acceptable terms for these agreements. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
current business strategy may include the entry into collaborative agreements for the development and commercialization of our products and product candidates. The negotiation and consummation of these types of agreements typically involve
simultaneous discussions with multiple potential collaborators and require significant time and resources from our officers, business development and research and development staff. In addition, in attracting the attention of pharmaceutical and
biotechnology company collaborators, we compete with numerous other third parties with product opportunities as well as the collaborators&#146; own internal product opportunities. We may not be able to consummate collaborative agreements, or we may
not be able to negotiate commercially acceptable terms for these agreements. If we do not consummate collaborative agreements, we may consume money more rapidly on our product development efforts, continue to defer certain development activities or
forego the exploitation of certain geographic territories, any of which could have a material adverse effect on our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may depend on
collaborators as a source of capital and to help us complete the process of developing and testing our products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our strategy for
the development, clinical testing and commercialization of our products and product candidates may require entering into collaborations with corporate partners, licensors, licensees and others. These collaborations may be critical to funding our
operations and our success in bringing our products and product candidates to the market and promoting such marketed products profitably. We could be dependent upon the subsequent success of these other parties in performing their respective
responsibilities and the cooperation of our partners. Our collaborators may not cooperate with us or perform their obligations under our agreements with them. We cannot control the amount and timing of our collaborators&#146; resources that will be
devoted to our research activities related to our collaborative agreements with them. Our collaborators may choose to pursue existing or alternative technologies in preference to those being developed in collaboration with us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under agreements with any collaborators we may work with in the future, we may rely significantly on them, among other activities, to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">fund research and development activities with us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">pay us fees upon the achievement of milestones; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">market for or with us any commercial products that result from our collaborations. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may not
be successful in establishing and overseeing any such collaborative arrangements. If we fail to establish and maintain necessary collaborative relationships our business prospects could suffer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to our Financial Condition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have a
history of losses, we expect to generate losses in the near future, and we may never achieve or maintain profitability. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have
incurred significant operating losses and negative cash flows from operations and had an accumulated deficit of $294.6 million through September&nbsp;30, 2014. Even if SUSTOL is approved, we expect to continue to generate substantial losses over at
least the next several years as we: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">build a sales and marketing organization and commence commercialization of SUSTOL, if approved; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">expand product development activities with respect to our product pipeline; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">conduct preclinical development and clinical trials for our product candidates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">pursue regulatory approvals for any product candidates we may develop in the future; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">engage in commercialization efforts with respect to any future approved product candidates. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To achieve and sustain profitability, we must, alone or with others, successfully develop, obtain regulatory approval for, manufacture, market
and sell our products. If SUSTOL is approved for commercialization, we must successfully launch and commercialize the product. If SUSTOL is not approved, we will likely experience significant delays before we begin to recognize meaningful levels of
revenue, if ever. We will incur substantial expenses in our efforts to develop and commercialize products and we may never generate sufficient revenue to become profitable or to sustain profitability. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Additional capital may be needed to enable us to implement our business plan, and we may be unable to raise capital, which would force us to limit or
cease our operations and related product development programs. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At September&nbsp;30, 2014, the Company had cash and cash
equivalents in the amount of $86.2&nbsp;million. We believe that our current working capital balance is sufficient to fund operations into 2015; including pursuing regulatory approval to market SUSTOL, and beginning human clinical studies relative
to our HTX-011 and HTX-019 development programs. In the event we were to pursue clinical product development in other areas, potentially acquire other strategic assets, or begin to make significant investments in preparing for commercialization of
SUSTOL, we would need to raise additional capital. We are pursuing commercialization of SUSTOL without a partner for the U.S. market, which will likely require us to obtain additional funding and resources to sustain our operations until we can
achieve profitability. The need for and amount of additional funding that we may require depends on various factors, including potential timing of the resubmission of our NDA for SUSTOL and the results of the regulatory review by the FDA, costs
related to manufacturing of SUSTOL, if approved, technological and market developments of drugs that may compete with SUSTOL, the amount of revenues, if any, generated by SUSTOL, and the timing of clinical trials we may conduct in order to
potentially expand our product pipeline. There can be no assurance that SUSTOL will be approved and, if approved, that we will be successful in obtaining the additional necessary financial resources and expertise, with or without a partner, that
will be required to launch SUSTOL. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to raise capital when needed or desired, or we may need to raise capital on unfavorable
terms, which could result in dilution to existing stockholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may not be able to raise sufficient additional capital when we
need it on favorable terms, or at all. If we are unable to obtain adequate funds, we may be required to curtail significantly or cease operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The timing and degree of any future capital requirements will depend on many factors, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the status of regulatory approval of any pending applications with the FDA, as the case may be, and the costs involved with pursuing regulatory approvals; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the number and characteristics of product development programs we pursue and the pace of each program; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the scope, rate of progress, results and costs of preclinical testing and clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to establish and maintain strategic collaborations or partnerships for research, development, clinical testing, manufacturing and marketing of our product candidates; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the cost and timing of establishing sales and marketing capabilities if we commercialize any products independently; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the cost of establishing supply arrangements for clinical and commercial development of our product candidates and any products that we may develop. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we issue additional equity securities or securities convertible into equity securities to raise funds, our stockholders will suffer
dilution of their investment, and such issuance may adversely affect the market price of our common stock. Any debt financing we enter into may involve covenants that restrict our operations. These restrictive covenants may include, among other
things, limitations on borrowing and specific restrictions on the use of our assets, as well as prohibitions on our ability to create liens, pay dividends, redeem capital stock or make investments. Our Senior Secured Convertible Notes
(&#147;Notes&#148;) also include restrictions on our use of cash and financial activities. In the event that additional funds are obtained through arrangements with collaborative partners, these arrangements may require us to relinquish rights to
some of our technologies, product candidates or products on terms that are not favorable to us or require us to enter into a collaboration arrangement that we would otherwise seek to develop and commercialize ourselves. If adequate funds are not
available, we may be required to delay, reduce the scope of, or eliminate one or more of our product development programs and reduce personnel related and other costs, which will have a material adverse effect on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Provisions contained in our Notes limit our ability to incur additional indebtedness. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are secured by substantially all of our assets, including our cash accounts, and the terms of the Notes require us to seek approval
from the holders of the Notes before taking certain actions, including incurring additional indebtedness or modifying the terms of existing indebtedness. The Notes also include events of default which include any default of our financial obligations
under certain material contracts we may enter into. In addition, potential third party lenders may be unwilling to subordinate new debt to the Notes. As a result, we may not be able to raise funds through the issuance of debt in the future, which
could impair our ability to finance our business obligations or pursue business expansion initiatives. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to our Industry </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Clinical trials are expensive and may not result in commercially viable products. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Conducting clinical trials is a lengthy, time-consuming and expensive process. For example, we have incurred significant expenses in developing
APF530 and, even if approved, it may not result in a commercially viable product. Before obtaining regulatory approvals for the commercial sale of any products, we, or our partners, must demonstrate through preclinical testing and clinical trials
that our product candidates are safe and effective for their intended uses in humans. We have incurred and will continue to incur substantial expense and devote a significant amount of time to preclinical testing and clinical trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business, results of operations and financial condition may be materially adversely affected by any delays in, or termination of, our
clinical trials. Factors impacting our ability to generate commercially viable products through the conduct of clinical trials include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">insufficient funds to conduct clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the inability to find partners; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the failure of clinical trials to demonstrate the safety and efficacy of our product candidates to the extent necessary to obtain regulatory approvals; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the failure by us or third-party investigators, contract research organizations, or other third parties involved in the research to adhere to regulatory requirements applicable to the conduct of clinical trials;
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the failure of preclinical testing and early clinical trials to predict results of later clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any delay in completion of clinical trials, resulting in increased costs; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">inability to obtain regulatory approval of our product candidates following completion of clinical trials, or delays in obtaining such approvals. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There can be no assurance that if our clinical trials are successfully initiated and completed we will be able to obtain approval by the FDA
in the United States or similar regulatory authorities elsewhere in the world in a timely manner, if at all. If we fail to successfully develop and commercialize one or more of our product candidates, we may be unable to generate sufficient revenues
to attain profitability and our reputation in the industry and in the investment community would likely be damaged, each of which would cause our stock price to decrease. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Delays in clinical testing could increase our costs and delay our ability to obtain regulatory approval and commercialize our product candidates.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before we can receive regulatory approval for the commercial sale of our potential products, the FDA requires extensive
preclinical safety testing and clinical trials to demonstrate their safety and efficacy. Significant delays in preclinical and clinical testing could materially impact our product development costs and delay regulatory approval of our product
candidates. Completing clinical trials in a timely manner depends on, among other factors: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">obtaining regulatory approval to commence a trial; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">obtaining clinical materials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reaching agreement on acceptable clinical study terms with prospective sites and contract research organizations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">obtaining institutional review board approval to conduct a study at a prospective site; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">recruiting patients to participate in a study. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our failure to successfully establish, recruit
for, and oversee our clinical trials could delay our product development effects and negatively impact our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not obtain regulatory
approval for any of our product candidates. Regulatory approval may also be delayed or revoked or may impose limitations on the indicated uses of a proposed product. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The process for obtaining approval of a new drug is time consuming, subject to unanticipated delays and costs, and requires the commitment of
substantial resources. The regulatory process is uncertain, can take many years and requires the expenditure of substantial resources. Any product that we or our collaborative partners develop must receive all necessary regulatory agency approvals
or clearances before it may be marketed in the United States or other countries. Human pharmaceutical products are subject to rigorous preclinical and clinical testing and other requirements by the FDA in the United States and similar health
authorities in foreign countries. We may not receive necessary regulatory approvals or clearances to market APF530 or any other product candidate, as a result of changes in FDA policies prior to approval or other events. Additionally, data obtained
from preclinical and clinical activities are susceptible to varying interpretations that could delay, limit or prevent regulatory agency approvals or clearances. For example, the FDA may require additional clinical data to support approval, such as
confirmatory studies and other data or studies to address questions or concerns that may arise during the FDA review process. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if granted, regulatory approvals may include significant limitations on the uses for which
products may be marketed. Failure to comply with applicable regulatory requirements can, among other things, result in warning letters, imposition of civil penalties or other monetary payments, delay in approving or refusal to approve a product
candidate, suspension or withdrawal of regulatory approval, product recall or seizure, operating restrictions, interruption of clinical trials or manufacturing, injunctions and criminal prosecution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the marketing and manufacturing of drugs and biological products are subject to continuing FDA review, and later discovery of
previously unknown problems with a product, its manufacture or its marketing may result in the FDA requiring further clinical research or restrictions on the product or the manufacturer, including withdrawal of the product from the market. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to comply with continuing federal, state and foreign regulations, we could lose our approvals to market drugs, and our business would be
seriously harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following initial regulatory approval of any drugs we may develop, including SUSTOL, we will be subject to
continuing regulatory review, including review of adverse drug experiences and clinical results that are reported after our drug products become commercially available. This would include results from any post-marketing tests or continued actions
required as a condition of approval. The manufacturer and manufacturing facilities we use to make any of our drug candidates will be subject to periodic review and inspection by the FDA. If a previously unknown problem or problems with a product or
a manufacturing and laboratory facility used by us is discovered, the FDA or foreign regulatory agency may impose restrictions on that product or on the manufacturing facility, including requiring us to withdraw the product from the market. Any
changes to an approved product, including the way it is manufactured or promoted, often require FDA approval before the product, as modified, can be marketed. We and our contract manufacturers will be subject to ongoing FDA requirements for
submission of safety and other post-market information. If we and our contract manufacturers fail to comply with applicable regulatory requirements, a regulatory agency may: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">issue warning letters; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">impose civil or criminal penalties; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">suspend or withdraw our regulatory approval; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">suspend or terminate any of our ongoing clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">refuse to approve pending applications or supplements to approved applications filed by us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">impose restrictions on our operations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">close the facilities of our contract manufacturers; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">seize or detain products or require a product recall. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, such regulatory review
covers a company&#146;s activities in the promotion of its drugs, with significant potential penalties and restrictions for promotion of drugs for an unapproved use or other inappropriate sales and marketing activities. We are also required to
submit information on our open and completed clinical trials to public registries and databases; failure to comply with these requirements could expose us to negative publicity, fines and penalties that could harm our business. If SUSTOL is
approved, we will also be required to comply with the requirements to submit to governmental authorities information on payments to physicians and certain other third parties; failure to comply with these requirements could expose us to negative
publicity, fines and penalties that could harm our business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We face intense competition from other companies developing products in the CINV indication, including
those with potentially competitive delivery technologies. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SUSTOL, if approved, is expected to face significant competition for the
prevention of CINV.&nbsp;In particular, competition may come from Eisai&#146;s branded drug Aloxi (palonosetron), a&nbsp;5-HT<SUB STYLE="font-size:85%; vertical-align:bottom">3</SUB> antagonist, and also generic versions of the product which may
become available on the market as soon as October 2015 following expiration of the relevant patent. In addition to Aloxi and any future generic versions, SUSTOL will compete with entrenched generic forms of granisetron (formerly marketed by Roche as
Kytril) and ondansetron (formerly marketed by GlaxoSmithKline as Zofran). We are also aware of several companies that have developed, or are developing, both generic and new formulations of granisetron, including those using alternative delivery
methods, such as transdermal formulations such as ProStrakan&#146;s Sancuso (granisetron transdermal patch), which was approved in 2008 and Eisai&#146;s Akynzeo, an oral combination product consisting of netupitant, an NK<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> receptor antagonist, and palonosetron, indicated for the treatment of CINV in both highly emetogenic and moderately emetogenic chemotherapy regimes, which was approved in October 2014.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are several companies that are developing new formulations of existing drugs across various therapeutic areas using novel drug delivery
technologies. Many of these companies have substantially greater financial, research and development, manufacturing, sales and marketing and distribution resources and experience than we do. Companies with focused efforts that may compete with our
product development program relative to a pain management product are Durect Corporation, and Pacira Pharmaceuticals, Inc., each of whom are developing or marketing products that could compete with us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Smaller or early stage companies and research institutions may also prove to be significant competitors, particularly through collaborative
arrangements with large and established pharmaceutical companies. We will also face competition from these parties in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and patient registration
for clinical trials, and acquiring and in-licensing technologies and products complementary to our programs or potentially advantageous to our business. If any of our competitors succeed in obtaining approval from the FDA or other regulatory
authorities for their products sooner than we do or for products that are more effective or less costly than ours, our commercial opportunity could be significantly reduced. Major technological changes can happen quickly in the biotechnology and
pharmaceutical industries, and the development of technologically improved or different products or drug delivery technologies may make our product candidates or platform technologies obsolete or noncompetitive. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we cannot establish pricing of our product candidates acceptable to the United States or foreign governments, insurance companies, managed care
organizations and other payors, or arrange for favorable reimbursement policies, any product sales will be severely hindered. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
continuing efforts of the United States and foreign governments, insurance companies, managed care organizations and other payors of health care costs to contain or reduce costs of health care may adversely affect our ability to generate adequate
revenues and gross margins to make the products we develop commercially viable. Our ability to commercialize any product candidates successfully will depend in part on the extent to which governmental authorities, private health insurers and other
organizations establish appropriate reimbursement levels for the cost of such products and related treatments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In certain foreign
markets, the pricing of prescription pharmaceuticals is subject to government control. In the United States, given recent federal and state government initiatives directed at lowering the total cost of health care, the U.S. Congress and state
legislatures will likely continue to focus on health care reform, reducing the cost of prescription pharmaceuticals and on the reform of the Medicare and Medicaid systems. The trend toward managed health care in the United States, which could
significantly influence the purchase of health care services and products, as well as legislative proposals to reform health care, control pharmaceutical prices or reduce government insurance programs, may result in lower prices for our products, if
approved for marketing. While we cannot predict whether any legislative or regulatory proposals affecting our business will be adopted, the announcement or adoption of these proposals could have a material and adverse effect on our potential
revenues and gross margins. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we cannot arrange for adequate third-party reimbursement for our products, our future revenue will
suffer. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In both domestic and foreign markets, sales of our potential products, including SUSTOL, will depend in substantial part
on the availability of adequate reimbursement from third-party payors such as government health administration authorities, private health insurers and other organizations. Third-party payors often challenge the price and cost-effectiveness of
medical products and services and such pressure may increase in the future. Significant uncertainty exists as to the adequate reimbursement status of newly approved health care products. Any products we are able to successfully develop may not be
reimbursable by third-party payors. In addition, our products may not be considered cost-effective and adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize a profit. Legislation and
regulations affecting the pricing of pharmaceuticals may change before our products are approved for marketing and any such changes could further limit reimbursement. Reimbursement policies utilized by our collaborators or ourselves may be
challenged by regulatory entities, with resultant fines, negative publicity and the need to implement changes that reduce the utilization of our products. If any products we develop do not receive adequate reimbursement, our revenue could be
severely limited. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to adequately protect or enforce our intellectual property rights, we may lose valuable assets or incur costly
litigation to protect our rights. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our success will depend in part on our ability to obtain patents and maintain trade secret
protection, as well as successfully defending these patents against challenges, while operating without infringing the proprietary rights of others. We have filed a number of U.S. patent applications on inventions relating to the composition of a
variety of polymers, specific products, product groups and processing technology. At December&nbsp;31, 2013, we had a total of 15 issued U.S. patents and an additional 38 issued (or registered) foreign patents. The patents on the bioerodible
technologies expire between January 2016 and April 2026. The product SUSTOL is covered by patents in the United States and in foreign countries. Currently, the product SUSTOL is covered by six patents issued in the United States and by seven patents
issued in foreign countries including Brazil, Canada, EU, Japan, and Taiwan. U.S. patents covering SUSTOL have expiration dates ranging from January 2016 to September 2024; foreign patents covering SUSTOL have expiration dates ranging from January
2017 to September 2025. Granted patents include claims covering the product composition, methods of use and methods of preparation. Our existing patents may not cover future products, additional patents may not be issued, and current patents, or
patents issued in the future, may not provide meaningful protection or prove to be of commercial benefit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The patent positions of
pharmaceutical companies, including ours, are uncertain and involve complex legal and factual questions. In addition, the coverage claimed in a patent application can be significantly reduced before the patent is issued. Consequently, our patent
applications may not issue into patents, and any issued patents may not provide sufficient protection for our product candidates or provide sufficient protection to afford us a commercial advantage against competitive technologies or may be held
invalid if challenged or circumvented. Patent applications in the United States are maintained in confidence for at least 18 months after their filing. Consequently, we cannot be certain that the patent applications we are pursuing will lead to the
issuance of any patent or be free from infringement or other claims from other parties. Our competitors may also independently develop products similar to ours or design around or otherwise circumvent patents issued to us or licensed by us. In
addition, the laws of some foreign countries may not protect our proprietary rights to the same extent as U.S. laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may enter into
collaborative agreements which may subject us to obligations that must be fulfilled and require us to manage complex relationships with third parties. In the future, if we are unable to meet our obligations or manage our relationships with our
collaborators under these agreements our revenue may decrease. The loss or diminution of our intellectual property rights could result in a decision by our third-party collaborators to terminate their agreements with us. In addition, these
agreements are generally complex and contain provisions that could give rise to legal disputes, including potential disputes concerning ownership of intellectual property and data under collaborations. Such disputes can lead to lengthy, expensive
litigation or arbitration, requiring us to divert management time and resources to such dispute. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also rely upon trade secrets, technical know-how and continuing technological innovation to
develop and maintain our competitive position. We require our employees, consultants, advisors and collaborators to execute appropriate confidentiality and assignment-of-inventions agreements with us. These agreements typically provide that all
materials and confidential information developed or made known to the individual during the course of the individual&#146;s relationship with us is to be kept confidential and not disclosed to third parties except in specific circumstances, and that
all inventions arising out of the individual&#146;s relationship with us shall be our exclusive property. These agreements may be breached, and in some instances, we may not have an appropriate remedy available for breach of the agreements.
Furthermore, our competitors may independently develop substantially equivalent proprietary information and techniques, reverse engineer our information and techniques, or otherwise gain access to our proprietary technology. We may be unable to
meaningfully protect our rights in trade secrets, technical know-how and other non-patented technology. We may have to resort to litigation to protect our intellectual property rights, or to determine their scope, validity or enforceability. In
addition, interference proceedings declared by the U.S. Patent and Trademark Office may be necessary to determine the priority of inventions with respect to our patent applications. Enforcing or defending our proprietary rights is expensive, could
cause diversion of our resources and may not prove successful. In addition, courts outside the United States may be less willing to protect trade secrets. Costly and time consuming litigation could be necessary to seek to enforce and determine the
scope of our proprietary rights. Any failure to enforce or protect our rights could cause us to lose the ability to exclude others from using our technology to develop or sell competing products. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may infringe on the intellectual property rights of others, and any litigation could force us to stop developing or selling potential products and
could be costly, divert management attention and harm our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We must be able to develop products without infringing the
proprietary rights of other parties. Because the markets in which we operate involve established competitors with significant patent portfolios, including patents relating to the composition of a variety of polymers, specific products, product
groups and processing technology, it could be difficult for us to use our technologies or develop products without infringing the proprietary rights of others. We may not be able to design around the patented technologies or inventions of others and
we may not be able to obtain licenses to use patented technologies on acceptable terms, or at all. If we cannot operate without infringing the proprietary rights of others, we will not be able to develop or commercialize some or all of our product
candidates, and consequently will not be able to earn product revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we are required to defend ourselves in a lawsuit, we could
incur substantial costs and the lawsuit could divert management attention, regardless of the lawsuit&#146;s merit or outcome. These legal actions could seek damages and seek to enjoin testing, manufacturing and marketing of the accused product or
process. In addition to potential liability for significant damages, we could be required to obtain a license to continue to manufacture or market the accused product or process and any license required under any such patent may not be made
available to us on acceptable terms, if at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Periodically, we review publicly available information regarding the development efforts
of others in order to determine whether these efforts may violate our proprietary rights. We may determine that litigation is necessary to enforce our proprietary rights against others. Such litigation could result in substantial expense, regardless
of its outcome, and may not be resolved in our favor. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We could be exposed to significant product liability claims that could be time consuming and
costly to defend, divert management attention and adversely impact our ability to obtain and maintain insurance coverage. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
testing, manufacture, marketing and sale of our products involve an inherent risk that product liability claims will be asserted against us. Although we are insured against such risks up to an annual
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
aggregate limit in connection with clinical trials and commercial sales of our products, our present product liability insurance may be inadequate and may not fully cover the costs of any claim
or any ultimate damages we might be required to pay. Product liability claims or other claims related to our products, regardless of their outcome, could require us to spend significant time and money in litigation or to pay significant damages. Any
successful product liability claim may prevent us from obtaining adequate product liability insurance in the future on commercially desirable or reasonable terms. In addition, product liability coverage may cease to be available in sufficient
amounts or at an acceptable cost. An inability to obtain sufficient insurance coverage at an acceptable cost or otherwise to protect against potential product liability claims could prevent or inhibit the commercialization of our products. A product
liability claim could also significantly harm our reputation and delay market acceptance of our products. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our use of hazardous materials could
subject us to liabilities, fines and sanctions. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our laboratory and clinical testing sometimes involve use of hazardous,
radioactive or otherwise toxic materials. We are subject to federal, state and local laws and regulations governing how we use, manufacture, handle, store and dispose of these materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we believe that our safety procedures for handling and disposing of such materials comply in all material respects with all federal,
state and local regulations and standards, there is always the risk of accidental contamination or injury from these materials. In the event of an accident, we could be held liable for any damages that result and such liability could exceed our
financial resources. If we fail to comply with these regulations and standards or with the conditions attached to our operating licenses, the licenses could be revoked, and we could be subjected to criminal sanctions and substantial financial
liability or be required to suspend or modify our operations. Compliance with environmental and other laws may be expensive and current or future regulations may impair our development or commercialization efforts. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related To Our Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The price of our
common stock has been and may continue to be volatile and our Reverse Stock Split may further increase volatility or cause a decline in value. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The stock markets, in general, and in particular with respect to biotech and life sciences companies, have experienced extreme volatility that
has often been unrelated to the operating performance of particular companies. These broad market fluctuations may adversely affect the trading price of our common stock. In addition, the limited trading volume of our stock may contribute to its
volatility. Our stock price may be particularly volatile given the stage of our business, which is still pre-commercial and subject to more speculation by stock market investors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the past, following periods of volatility in the market price of a particular company&#146;s securities, litigation has often been brought
against that company. If litigation of this type is brought against us, it could be extremely expensive and divert management&#146;s attention and our company&#146;s resources. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our certificate of incorporation, our bylaws and Delaware law contain provisions that could discourage another company from acquiring us and may prevent
attempts by our stockholders to replace or remove our current management. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provisions of Delaware law, our certificate of
incorporation and our bylaws may discourage, delay or prevent a merger or acquisition that stockholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares. In addition, these provisions may
frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace or remove our board of directors. These provisions include authorizing the issuance of
&#147;blank check&#148; preferred stock without any need for action by stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, Section&nbsp;203 of Delaware General
Corporation Law may discourage, delay or prevent a change in control of our company by prohibiting stockholders owning in excess of 15% of our outstanding voting stock from merging or combining with us, unless certain approvals are obtained. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Conversion of our Notes would result in substantial dilution for our existing stockholders. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our outstanding Notes bear interest at a rate of 6%&nbsp;per annum, payable quarterly in cash or in kind, at the election of the holders of the
Notes. The Notes are convertible into shares of our common stock at a rate of 1,250 shares for every $1,000 of principal and accrued interest that is being converted.&nbsp;In the event the holders of the Notes were to opt to convert in full the
outstanding principal and accrued interest due under the Notes as of September&nbsp;30, 2014, we would be required to issue an aggregate of 6.6&nbsp;million shares, representing approximately 23% of our outstanding shares, after giving effect to
such conversion.&nbsp;This would result in substantial dilution of our existing stockholders.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Concentration in stockholder ownership could influence
strategic actions. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our directors, executive officers, principal stockholders and affiliated entities currently beneficially own or
control a significant percentage of our outstanding common stock. In addition, certain of our principal stockholders hold outstanding warrants that are exercisable for additional shares of our common stock. As of September&nbsp;30, 2014, Tang
Capital Partners, LP and its affiliates&#146; (&#147;TCP&#148;) beneficial ownership in our common stock, as determined in accordance with Rule 13d-3 of the Exchange Act, was approximately 17%, excluding the exercise of outstanding warrants. In
addition, TCP has the right to acquire up to an additional 5.3&nbsp;million shares upon conversion of the Notes. Kevin C. Tang, the Managing Director of Tang Capital Management, LLC, the general partner of Tang Capital Partners, LP, is also chairman
of our board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such a substantial concentration of common stock ownership or control could significantly influence corporate
actions on various strategic matters, including, for example, receptivity to collaborations and merger or sale overtures to the extent that stockholder approval is required for such transactions. Further, covenants contained in the Notes would
require approval from the Note holders for any change of control transaction we might consider. Accordingly, we may only be able to pursue transactions that are supported by these large stockholders. In addition, the conversion of the Notes, the
exercise of these warrants, or the sale by our current stockholders of a substantial number of shares, or the expectation that such exercises or sales may occur, could significantly reduce the market price of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Future utilization of net operating loss carry-forwards may be impaired due to recent changes in ownership. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe our net operating losses and tax attributes may be subject to limitation under Section&nbsp;382 of the Internal Revenue Code of
1986. As a result, our deferred tax assets, and related valuation allowance, have been reduced for the estimated impact of the net operating losses and credits that we currently estimate may expire unused. Utilization of our remaining net operating
loss and research and development credit carry-forwards may still be subject to substantial annual limitations due to ownership change limitations provided by the Internal Revenue Code and similar state provisions for ownership changes after
December&nbsp;31, 2013, including those that may come in conjunction with future equity financings or market trades by our stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;2.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="tx817679_11"></A>UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;3.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="tx817679_12"></A>DEFAULTS UPON SENIOR SECURITIES </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;4.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="tx817679_13"></A>MINE SAFETY DISCLOSURES </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;5.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>OT<A NAME="tx817679_14"></A>HER INFORMATION </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;6.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><A NAME="tx817679_15"></A>EXHIBITS </B></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.20pt; font-size:8pt; font-family:Times New Roman">Exhibit<BR>Number</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;31.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;31.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;32.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.INS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Instance Document</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.SCH</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Schema Document</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.CAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Calculation Linkbase Document</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.DEF</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Extension Definition</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.LAB</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Label Linkbase Document</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.PRE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Presentation Linkbase Document</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx817679_16"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Heron Therapeutics, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: November&nbsp;6, 2014</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Barry D. Quart</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Barry D. Quart, Pharm.D.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">(On behalf of the Registrant)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian G. Drazba</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Brian G. Drazba</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Vice President, Finance and Chief Financial Officer</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">(As Principal Financial and Accounting Officer)</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HERON THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEX TO EXHIBITS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:26.20pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit<BR>Number</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;31.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;31.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;32.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.INS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Instance Document</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.SCH</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Schema Document</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.CAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Calculation Linkbase Document</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.DEF</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Extension Definition</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.LAB</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Label Linkbase Document</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.PRE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Presentation Linkbase Document</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>d817679dex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-31.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 31.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION 302 CERTIFICATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, Barry D.
Quart, certify that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">I have reviewed this Quarterly Report on Form 10-Q of Heron Therapeutics, Inc.; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top">The registrant&#146;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control
over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to
us by others within this entity, particularly during the period in which this report is being prepared; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c)</TD>
<TD ALIGN="left" VALIGN="top">Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d)</TD>
<TD ALIGN="left" VALIGN="top">Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the registrant&#146;s most recent fiscal quarter (the registrant&#146;s fourth fiscal quarter
in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over financial reporting; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top">The registrant&#146;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of the
registrant&#146;s board of directors (or persons performing the equivalent functions): </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record,
process, summarize and report financial information; and </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: November&nbsp;6, 2014</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Barry D. Quart</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Barry D. Quart, Pharm.D.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>d817679dex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-31.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 31.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION 302 CERTIFICATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, Brian G.
Drazba, certify that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">I have reviewed this Quarterly Report on Form 10-Q of Heron Therapeutics, Inc.; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top">The registrant&#146;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control
over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to
us by others within this entity, particularly during the period in which this report is being prepared; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c)</TD>
<TD ALIGN="left" VALIGN="top">Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d)</TD>
<TD ALIGN="left" VALIGN="top">Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the registrant&#146;s most recent fiscal quarter (the registrant&#146;s fourth fiscal quarter
in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over financial reporting; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top">The registrant&#146;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of the
registrant&#146;s board of directors (or persons performing the equivalent functions): </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record,
process, summarize and report financial information; and </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: November&nbsp;6, 2014</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian G. Drazba</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Brian G. Drazba</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Finance and</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Financial
Officer (As</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Principal Financial and Accounting Officer)</P></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>d817679dex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-32.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 32.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>18 U.S.C. SECTION 1350, </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AS ADOPTED PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the undersigned, in his capacity as Chief Executive Officer and Chief Financial Officer, respectively, of Heron Therapeutics, Inc. (the
&#147;Registrant&#148;), hereby certifies, for purposes of 18 U.S.C. Section&nbsp;1350, as adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002, to the best of his knowledge that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Quarterly Report of the Registrant on Form 10-Q for the quarter ended September&nbsp;30,&nbsp;2014 (the &#147;Report&#148;), which accompanies this certification, fully complies with the requirements of
Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the information contained in the Report fairly presents, in all material respects, the financial condition of the Registrant at the end of such quarter and the results of operations of the Registrant for such quarter.
</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: November&nbsp;6, 2014 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Barry D. Quart</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barry D. Quart, Pharm.D.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Executive
Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian G. Drazba</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brian G. Drazba</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Vice President, Finance and
Chief Financial Officer (As Principal Financial and Accounting Officer)</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This certification accompanies the Report to which it relates, is not deemed to be filed with the Securities and
Exchange Commission and is not to be incorporated by reference into any filing of Heron Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the
Report), irrespective of any general incorporation language contained in such filing. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Note:</TD>
<TD ALIGN="left" VALIGN="top">A signed original of this written statement required by Section&nbsp;906 has been provided to Heron Therapeutics, Inc. and will be retained by Heron Therapeutics, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request. </TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>5
<FILENAME>hrtx-20140930.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Nov 06 13:31:24 UTC 2014 -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hrtx="http://herontx.com/20140930" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-types="http://fasb.org/us-types/2014-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:compsci="http://compsciresources.com" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="hrtx-20140930.xsd"/>
  <context id="c0_AsOf30Sep2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c1_AsOf31Dec2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="c2_From1Jul2014To30Sep2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c3_From1Jul2013To30Sep2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c4_From1Jan2014To30Sep2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c5_From1Jan2013To30Sep2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c6_AsOf31Dec2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c7_AsOf30Sep2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="c8_AsOf29Oct2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
    </entity>
    <period>
      <instant>2014-10-29</instant>
    </period>
  </context>
  <context id="c9_From13Jan2014To13Jan2014_ReverseStockSplitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">hrtx:ReverseStockSplitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-13</startDate>
      <endDate>2014-01-13</endDate>
    </period>
  </context>
  <context id="c10_From1Jan2011To30Sep2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c11_From1Jan2014To30Sep2014_StockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c12_From1Jan2013To30Sep2013_StockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c13_From1Jan2014To30Sep2014_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c14_From1Jan2013To30Sep2013_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c15_From1Jan2014To30Sep2014_ConvertibleDebtSecuritiesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c16_From1Jan2013To30Sep2013_ConvertibleDebtSecuritiesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c17_AsOf30Apr2011_NotesPayableOtherPayablesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-04-30</instant>
    </period>
  </context>
  <context id="c18_AsOf30Apr2011_InitialClosingAmountMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtSecurityAxis">hrtx:InitialClosingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-04-30</instant>
    </period>
  </context>
  <context id="c19_AsOf30Apr2011_PurchaseOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtSecurityAxis">hrtx:PurchaseOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-04-30</instant>
    </period>
  </context>
  <context id="c20_From1Jun2011To30Jun2011_NotesPayableOtherPayablesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-06-01</startDate>
      <endDate>2011-06-30</endDate>
    </period>
  </context>
  <context id="c21_From1Apr2011To30Apr2011_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-01</startDate>
      <endDate>2011-04-30</endDate>
    </period>
  </context>
  <context id="c22_From1Apr2011To30Apr2011_PrincipalAmountMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hrtx:PrincipalAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-01</startDate>
      <endDate>2011-04-30</endDate>
    </period>
  </context>
  <context id="c23_From28Jul2011To29Jul2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
    </entity>
    <period>
      <startDate>2011-07-28</startDate>
      <endDate>2011-07-29</endDate>
    </period>
  </context>
  <context id="c24_From1Jul2014To30Sep2014_NotesPayableOtherPayablesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c25_AsOf30Sep2014_NotesPayableOtherPayablesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c26_AsOf30Sep2014_InCaseOfDebtConversionMember_NotesPayableOtherPayablesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">hrtx:InCaseOfDebtConversionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c27_From1Jan2014To30Jun2014_InCaseOfDebtConversionMember_NotesPayableOtherPayablesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">hrtx:InCaseOfDebtConversionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-06-30</endDate>
    </period>
  </context>
  <context id="c28_AsOf13Jan2014_ScenarioPreviouslyReportedMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-01-13</instant>
    </period>
  </context>
  <context id="c29_AsOf13Jan2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
    </entity>
    <period>
      <instant>2014-01-13</instant>
    </period>
  </context>
  <context id="c30_From1Jun2011To30Jun2011_PrivatePlacement2011Member_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hrtx:PrivatePlacement2011Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-06-01</startDate>
      <endDate>2011-06-30</endDate>
    </period>
  </context>
  <context id="c31_AsOf30Jun2011_PrivatePlacement2011Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hrtx:PrivatePlacement2011Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-06-30</instant>
    </period>
  </context>
  <context id="c32_From1Jun2011To30Sep2013_PrivatePlacement2011Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hrtx:PrivatePlacement2011Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-06-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c33_From1Jan2014To30Sep2014_PrivatePlacement2011Member_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hrtx:PrivatePlacement2011Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c34_From1Jan2014To30Sep2014_PrivatePlacement2011Member_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hrtx:PrivatePlacement2011Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c35_From1Jan2014To30Sep2014_PrivatePlacement2011Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hrtx:PrivatePlacement2011Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c36_From1Jul2012To31Jul2012_PrivatePlacement2012Member_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hrtx:PrivatePlacement2012Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-07-01</startDate>
      <endDate>2012-07-31</endDate>
    </period>
  </context>
  <context id="c37_AsOf31Jul2012_PrivatePlacement2012Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hrtx:PrivatePlacement2012Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-07-31</instant>
    </period>
  </context>
  <context id="c38_From1Nov2013To30Nov2013_CommonStockMember_JefferiesLLCMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hrtx:JefferiesLLCMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-11-01</startDate>
      <endDate>2013-11-30</endDate>
    </period>
  </context>
  <context id="c39_AsOf30Nov2013_CommonStockMember_JefferiesLLCMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hrtx:JefferiesLLCMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-11-30</instant>
    </period>
  </context>
  <context id="c40_From1Jun2014To30Jun2014_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-06-01</startDate>
      <endDate>2014-06-30</endDate>
    </period>
  </context>
  <context id="c41_AsOf30Jun2014_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-06-30</instant>
    </period>
  </context>
  <context id="c42_AsOf30Jun2014_PreFundedWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hrtx:PreFundedWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-06-30</instant>
    </period>
  </context>
  <context id="c43_From1Jun2014To30Jun2014_PreFundedWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hrtx:PreFundedWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-06-01</startDate>
      <endDate>2014-06-30</endDate>
    </period>
  </context>
  <context id="c44_From1Jun2014To30Jun2014_CommonStockAndPrefundedWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hrtx:CommonStockAndPrefundedWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-06-01</startDate>
      <endDate>2014-06-30</endDate>
    </period>
  </context>
  <context id="c45_From1Jul2014To30Sep2014_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c46_From1Jul2013To30Sep2013_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c47_From1Jan2014To30Sep2014_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c48_From1Jan2013To30Sep2013_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c49_From1Jul2014To30Sep2014_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c50_From1Jul2013To30Sep2013_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c51_From1Jan2014To30Sep2014_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c52_From1Jan2013To30Sep2013_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c53_From1Jan2014To30Sep2014_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c54_From1Jan2013To30Sep2013_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c55_From1Jan2013To31Dec2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <unit id="usd">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="usdPershares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="shares">
    <measure>xbrli:shares</measure>
  </unit>
  <unit id="pure">
    <measure>xbrli:pure</measure>
  </unit>
  <us-gaap:Cash unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">86212000</us-gaap:Cash>
  <us-gaap:Cash unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">72287000</us-gaap:Cash>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">3030000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">638000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">89242000</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">72925000</us-gaap:AssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">2910000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">2882000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:OtherAssetsNoncurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">130000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">130000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:Assets unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">92282000</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">75937000</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">1475000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">1264000</us-gaap:AccountsPayableCurrent>
  <hrtx:AccruedClinicalLiabilities unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">4530000</hrtx:AccruedClinicalLiabilities>
  <hrtx:AccruedClinicalLiabilities unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">1773000</hrtx:AccruedClinicalLiabilities>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">2601000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">2566000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">1218000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">364000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <hrtx:ConvertibleNotesPayableRelatedPartiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">1450000</hrtx:ConvertibleNotesPayableRelatedPartiesCurrent>
  <hrtx:ConvertibleNotesPayableRelatedPartiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">1025000</hrtx:ConvertibleNotesPayableRelatedPartiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">11274000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">6992000</us-gaap:LiabilitiesCurrent>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">292000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">237000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapital unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">375329000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">307578000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">-294613000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">-238870000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">81008000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">68945000</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">92282000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">75937000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="-3">14731000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="-3">6216000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">40929000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">24162000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="-3">4222000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="-3">6448000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">14137000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">16464000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="-3">18953000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="-3">12664000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">55066000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">40626000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="-3">-18953000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="-3">-12664000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">-55066000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">-40626000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OtherNonoperatingExpense unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="-3">241000</us-gaap:OtherNonoperatingExpense>
  <us-gaap:OtherNonoperatingExpense unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="-3">209000</us-gaap:OtherNonoperatingExpense>
  <us-gaap:OtherNonoperatingExpense unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">677000</us-gaap:OtherNonoperatingExpense>
  <us-gaap:OtherNonoperatingExpense unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">614000</us-gaap:OtherNonoperatingExpense>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="-3">-19194000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="-3">-12873000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">-55743000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">-41240000</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c2_From1Jul2014To30Sep2014" decimals="2">-0.66</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c3_From1Jul2013To30Sep2013" decimals="2">-0.84</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c4_From1Jan2014To30Sep2014" decimals="2">-2.17</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c5_From1Jan2013To30Sep2013" decimals="2">-2.69</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c2_From1Jul2014To30Sep2014" decimals="-3">29004000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c3_From1Jul2013To30Sep2013" decimals="-3">15375000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">25679000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">15305000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">389000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">237000</us-gaap:DepreciationAndAmortization>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">5809000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">8333000</us-gaap:ShareBasedCompensation>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">2392000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">202000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">211000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">514000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <hrtx:IncreaseDecreaseInClinicalLiabilities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">2757000</hrtx:IncreaseDecreaseInClinicalLiabilities>
  <hrtx:IncreaseDecreaseInClinicalLiabilities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">302000</hrtx:IncreaseDecreaseInClinicalLiabilities>
  <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">35000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
  <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">454000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">1084000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">70000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">-47425000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">-31136000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">417000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">1518000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">-417000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">-1518000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromWarrantExercises unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">600000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">19000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
  <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">25000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">2832000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">1120000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">58916000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">61767000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">1745000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">13925000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">-30909000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="-3">72287000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c6_AsOf31Dec2012" decimals="-3">53506000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-3">86212000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c7_AsOf30Sep2013" decimals="-3">22597000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <dei:EntityRegistrantName contextRef="c4_From1Jan2014To30Sep2014">HERON THERAPEUTICS, INC. /DE/</dei:EntityRegistrantName>
  <dei:DocumentType contextRef="c4_From1Jan2014To30Sep2014">10-Q</dei:DocumentType>
  <dei:CurrentFiscalYearEndDate contextRef="c4_From1Jan2014To30Sep2014">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityCommonStockSharesOutstanding unitRef="shares" contextRef="c8_AsOf29Oct2014" decimals="INF">29180099</dei:EntityCommonStockSharesOutstanding>
  <dei:AmendmentFlag contextRef="c4_From1Jan2014To30Sep2014">false</dei:AmendmentFlag>
  <dei:EntityCentralIndexKey contextRef="c4_From1Jan2014To30Sep2014">0000818033</dei:EntityCentralIndexKey>
  <dei:EntityCurrentReportingStatus contextRef="c4_From1Jan2014To30Sep2014">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityVoluntaryFilers contextRef="c4_From1Jan2014To30Sep2014">No</dei:EntityVoluntaryFilers>
  <dei:EntityFilerCategory contextRef="c4_From1Jan2014To30Sep2014">Accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityWellKnownSeasonedIssuer contextRef="c4_From1Jan2014To30Sep2014">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:DocumentFiscalYearFocus contextRef="c4_From1Jan2014To30Sep2014">2014</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="c4_From1Jan2014To30Sep2014">Q3</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentPeriodEndDate contextRef="c4_From1Jan2014To30Sep2014">2014-09-30</dei:DocumentPeriodEndDate>
  <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;p id=&quot;PARA337&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;1.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Business&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA1519&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) (the &amp;#8220;Company,&amp;#8221; &amp;#8220;we,&amp;#8221; &amp;#8220;us&amp;#8221; and &amp;#8220;our&amp;#8221;) is a biotechnology company using its proprietary technology and innovative efforts to develop products to address unmet medical needs. Our proprietary Biochronomer&lt;sup style=&quot;vertical-align: baseline; position: relative; bottom:.33em;&quot;&gt;&amp;#174;&lt;/sup&gt; polymer-based drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by extending the duration of action of known active ingredients. Our product development program also focuses on identifying new delivery methods and formulations utilizing known compounds that may expand or extend the therapeutic effort, or eliminate the drawbacks of current therapies.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA1521&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Our lead investigational product candidate, APF530, which we intend to market as SUSTOL&lt;sup style=&quot;vertical-align: baseline; position: relative; bottom:.33em;&quot;&gt;&amp;#174;&lt;/sup&gt; &lt;sup style=&quot;vertical-align: baseline; position: relative; bottom:.33em;&quot;&gt;&lt;/sup&gt;(granisetron injection, extended release), subject to regulatory approval, is being developed for the prevention of both acute- and delayed-onset chemotherapy induced nausea and vomiting (&amp;#8220;CINV&amp;#8221;). In 2014, we initiated a Phase 3 clinical study with APF530 for the prevention of delayed-onset CINV in patients receiving highly emetogenic chemotherapy (&amp;#8220;HEC study&amp;#8221;). One of the most debilitating side effects of cancer chemotherapy, CINV is a leading cause of premature discontinuation of treatment. There is only one injectable 5-HT3 receptor antagonist approved for the prevention of delayed-onset CINV in patients receiving moderately
      emetogenic chemotherapy; none are approved for delayed-onset CINV in patients receiving highly emetogenic chemotherapy.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA1523&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;SUSTOL contains the 5-HT3 receptor antagonist granisetron formulated in the Company&apos;s proprietary Biochronomer polymer-based drug delivery platform, which has been shown in clinical studies to maintain therapeutic drug levels of SUSTOL for up to five days with a single subcutaneous injection. Currently available intravenous and oral formulations of granisetron are approved only for the prevention of acute-onset CINV. Granisetron was selected for SUSTOL because it is widely prescribed by physicians based on a well-established record of safety and efficacy. We own the worldwide rights to SUSTOL.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA1515&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In May 2009, we filed the original New Drug Application (&amp;#8220;NDA&amp;#8221;) with the U.S. Food and Drug Administration (&amp;#8220;FDA&amp;#8221;) seeking approval for SUSTOL for the prevention of acute-onset CINV in patients receiving both moderately and highly emetogenic chemotherapy and delayed-onset CINV in patients receiving moderately emetogenic chemotherapy. The FDA issued a Complete Response Letter (&amp;#8220;CRL&amp;#8221;) for the SUSTOL NDA in March 2010. In September 2012, we resubmitted our NDA for SUSTOL and, in March 2013, we received a second CRL, which identified several remaining issues that need to be addressed prior to approval of the SUSTOL NDA. We believe that we have substantially addressed those issues raised in the March 2013 CRL. We are targeting completing enrollment&amp;#160;of our ongoing HEC study in the first quarter of 2015. We intend to include the results of the study in the resubmission of
      the SUSTOL NDA, which we anticipate filing shortly thereafter.&amp;#160;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA347&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Our core Biochronomer technology, on which SUSTOL and our other product candidates are based, consists of bioerodible polymers designed to release drugs over a defined period of time. The results of over 100 &lt;i&gt;in vivo&lt;/i&gt; and &lt;i&gt;in vitro&lt;/i&gt; studies demonstrate that our Biochronomer technology is potentially applicable to a range of therapeutic areas, including prevention of CINV, pain management and control of inflammation, among others. We have also completed comprehensive animal and human toxicology studies that have established that our Biochronomer polymers are well tolerated. Furthermore, our Biochronomer technology can be designed to deliver drugs over periods varying from days to potentially multiple weeks. We are researching the potential use of our Biochronomer technology with other drugs for the clinical development of other drug candidates.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA349&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In November 2013, we initiated a program to expand our pipeline of sustained-release products, including a new program targeting pain management. We selected HTX-011, a combination of local&amp;#160;anesthetic bupivacaine and the anti-inflammatory meloxicam in a formulation utilizing our proprietary Biochronomer polymer-based drug delivery platform, as the lead product candidate for our&amp;#160;pain management&amp;#160;program. We are in the process of commencing a Phase 1 study in Europe to examine the product candidate in human candidates. As of 2012, approximately 25 million&lt;sup style=&quot;vertical-align: baseline; position: relative; bottom:.33em;&quot;&gt;1&lt;/sup&gt; procedures associated with post-operative pain were conducted in the U.S. In addition, post-operative pain market sales were approximately $3.1&amp;#160;billion&lt;sup style=&quot;vertical-align: baseline; position: relative; bottom:.33em;&quot;&gt;2&lt;/sup&gt; in 2012.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA1512&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In November 2014, we announced the initiation of a product development program for HTX-019. The investigational product HTX-019 is a proprietary intravenous formulation of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist used in combination with a 5-HT3 for the prevention of CINV. HTX-019 does not contain polysorbate 80. By eliminating the use of surfactant polysorbate 80, HTX-019 may reduce the hypersensitivity reactions observed with fosaprepitant formulations containing this component. At present, there is only one intravenous Nk&lt;sub&gt;1&lt;/sub&gt; receptor antagonist approved in the U.S. for the prevention of CINV.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA351&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In January 2014, we changed our name from A.P. Pharma, Inc. to Heron Therapeutics, Inc. Effective January&amp;#160;13,&amp;#160;2014, we effected a 1 - for - 20 reverse split of our outstanding common stock (&amp;#8220;Reverse Stock Split&amp;#8221;) (See Note 5). All historical share and per share amounts have been adjusted to reflect the Reverse Stock Split. All stock options, common stock underlying&amp;#160;convertible notes and warrants outstanding were adjusted to give effect to the Reverse Stock Split.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA353&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Liquidity&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA355&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;We have incurred significant operating losses and negative cash flows from operations and we have an accumulated deficit of $294.6 million as of September 30, 2014. Since 2011, we completed a total of five rounds of equity and/or debt financings, which provided us with cash of approximately $194.3 million, net of issuance costs, to fund operations (see Notes 4 and 5). As of September 30, 2014, we had cash on hand of $86.2 million.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA1516&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;We believe that our current working capital is sufficient to fund operations into 2015, including pursuing regulatory approval to market SUSTOL, and beginning human clinical studies relative to our HTX-011 and HTX-019 development programs. In the event we were to pursue clinical product development in other areas, potentially acquire other strategic assets, or begin to make significant investments in preparing for commercialization of SUSTOL, we would need to raise additional capital. If we are unable to obtain sufficient financing on acceptable terms or otherwise, we may be required to reduce or defer our activities.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
  <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 unitRef="pure" contextRef="c9_From13Jan2014To13Jan2014_ReverseStockSplitMember" decimals="0">20</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet unitRef="usd" contextRef="c10_From1Jan2011To30Sep2014" decimals="-5">194300000</us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet>
  <us-gaap:BasisOfAccounting contextRef="c4_From1Jan2014To30Sep2014">&lt;p id=&quot;PARA359&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2&lt;/b&gt;&lt;b&gt;.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;B&lt;/b&gt;&lt;b&gt;asis of Presentation&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA361&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&amp;#8220;GAAP&amp;#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September&amp;#160;30,&amp;#160;2014 are not necessarily indicative of the results that may be expected for other quarters or the year ending December&amp;#160;31, 2014. The condensed balance sheet at December 31, 2013 has been derived from the audited financial statements as of that date, but does not include
      all of the information and disclosures required by GAAP. The presentation of prior year amounts was reclassified to conform to the current year presentation. For more complete financial information, these unaudited condensed financial statements and the notes thereto should be read in conjunction with the audited financial statements included in the Company&amp;#8217;s Annual Report on Form&lt;/font&gt;&lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&amp;#160;10-K for the fiscal year ended December&amp;#160;31, 2013 filed with the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) on March&amp;#160;7,&amp;#160;2014&lt;/font&gt;&lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:BasisOfAccounting>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;p id=&quot;PARA363&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;3.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Accounting Policies&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA365&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA367&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis, including those related to clinical trial accruals, income taxes and stock-based compensation. We base our estimates on historical experience and on assumptions that we believe to be reasonable under the circumstances, the results of which form the basis of making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates under different assumptions or conditions.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA369&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Cash&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA371&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;We had cash of $86.2 million and $72.3 million at September 30, 2014 and December 31, 2013, respectively. We did not hold any cash equivalents or investment securities as of both dates. Our bank accounts have been placed under a control agreement in accordance with the Senior Secured Convertible Notes (see Note 4).&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA373&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Earnings Per Share&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA375&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Basic earnings per share (&amp;#8220;EPS&amp;#8221;) is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration of common share equivalents. Diluted EPS is computed by dividing the net loss by the weighted-average number of common shares and common share equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, stock options, warrants and common stock underlying convertible notes are considered to be common stock equivalents and are only included in the calculation of diluted EPS when their effect is dilutive.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA377&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Because we have incurred a net loss for all periods presented in the unaudited condensed statements of operations, outstanding stock options, warrants and common stock underlying convertible notes are not included in the computation of net loss per share because their effect would be anti-dilutive.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA379&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;The following table includes the number of outstanding stock options, warrants and common stock underlying convertible notes not included in the computation as of the dates shown below (in thousands):&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;table id=&quot;TBL394&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt;
      &lt;tr id=&quot;TBL394.finRow.1&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.1.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.1.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;6&quot;&gt;
          &lt;p id=&quot;PARA381&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
          &lt;p id=&quot;PARA382&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;As of September 30&lt;/b&gt;&lt;b&gt;,&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.1.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.2&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.lead.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.amt.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA383&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.trail.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA384&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.3&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.lead.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.symb.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.amt.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.trail.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.lead.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.symb.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.amt.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.trail.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.4&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA385&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Stock options outstanding&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,456
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,270
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.5&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &lt;p id=&quot;PARA388&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Warrants outstanding&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          4,108
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          3,969
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.6&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA391&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Common stock underlying convertible notes outstanding&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 37.9pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,578
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 37.9pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,198
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p id=&quot;PARA396&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Comprehensive Income (Loss)&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA398&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Our comprehensive net loss for all periods presented was comprised solely of our net loss and there were no other changes in equity from non-owner sources.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA400&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA402&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In August 2014, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) No. 2014-15, &lt;i&gt;Presentation of Financial Statements &amp;#8211; Going Concern (Subtopic 205-40)&lt;/i&gt; (&amp;#8220;ASU 2014-15&amp;#8221;). ASU 2014-15 requires management to assess an entity&amp;#8217;s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management&amp;#8217;s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management&amp;#8217;s plans, (5) require an express statement and other disclosures when substantial doubt is
      not alleviated, and (6) require an assessment for a period of one year after the date that the financial satements are issued (or available to be issued). The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early adoption is permitted. We plan to adopt the provisions on ASU 2014-15 in 2016. We do not expect the adoption of this ASU to have a material impact on our results of operations or financial condition.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA404&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In June 2014, FASB issued ASU No. 2014-12, &lt;i&gt;Compensation &amp;#8211; Stock Compensation (Topic 718)&lt;/i&gt; (&amp;#8220;ASU 2014-12&amp;#8221;). ASU 2014-12 requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The amendments in ASU 2014-12 may either be applied (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earlier annual period presented in the financial statements and to all new or modified awards thereafter. We plan to adopt the provisions of ASU 2014-12 in the first quarter of 2016. We do not expect the adoption of this
      ASU to have a material impact on our results of operations or financial condition.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA406&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In July 2013, the FASB issued ASU No.&amp;#160;2013-11, &lt;i&gt;Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists&lt;/i&gt; (&amp;#8220;ASU 2013-11&amp;#8221;). This update provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This guidance is effective prospectively for fiscal years, and interim periods within those years, beginning after December&amp;#160;15, 2013, with an option for early adoption. We adopted this guidance in 2014 and it did not have a material impact on our financial condition, results of operations or related financial statement disclosures.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:UseOfEstimates contextRef="c4_From1Jan2014To30Sep2014">&lt;p id=&quot;PARA365&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;&lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA367&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis, including those related to clinical trial accruals, income taxes and stock-based compensation. We base our estimates on historical experience and on assumptions that we believe to be reasonable under the circumstances, the results of which form the basis of making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates under different assumptions or conditions.&lt;/font&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;p id=&quot;PARA369&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;&lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Cash&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA371&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;We had cash of $86.2 million and $72.3 million at September 30, 2014 and December 31, 2013, respectively. We did not hold any cash equivalents or investment securities as of both dates. Our bank accounts have been placed under a control agreement in accordance with the Senior Secured Convertible Notes (see Note 4).&lt;/font&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:LiquidityDisclosureTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;p id=&quot;PARA371&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;&lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;We had cash of $86.2 million and $72.3 million at September 30, 2014 and December 31, 2013, respectively.&lt;/font&gt;&lt;/p&gt;</us-gaap:LiquidityDisclosureTextBlock>
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">0</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">0</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;p id=&quot;PARA373&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;&lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Earnings Per Share&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA375&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Basic earnings per share (&amp;#8220;EPS&amp;#8221;) is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration of common share equivalents. Diluted EPS is computed by dividing the net loss by the weighted-average number of common shares and common share equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, stock options, warrants and common stock underlying convertible notes are considered to be common stock equivalents and are only included in the calculation of diluted EPS when their effect is dilutive.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA377&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Because we have incurred a net loss for all periods presented in the unaudited condensed statements of operations, outstanding stock options, warrants and common stock underlying convertible notes are not included in the computation of net loss per share because their effect would be anti-dilutive.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA379&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;The following table includes the number of outstanding stock options, warrants and common stock underlying convertible notes not included in the computation as of the dates shown below (in thousands):&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;table id=&quot;TBL394&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt;
      &lt;tr id=&quot;TBL394.finRow.1&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.1.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.1.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;6&quot;&gt;
          &lt;p id=&quot;PARA381&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
          &lt;p id=&quot;PARA382&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;As of September 30&lt;/b&gt;&lt;b&gt;,&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.1.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.2&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.lead.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.amt.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA383&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.trail.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA384&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.3&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.lead.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.symb.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.amt.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.trail.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.lead.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.symb.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.amt.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.trail.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.4&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA385&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Stock options outstanding&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,456
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,270
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.5&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &lt;p id=&quot;PARA388&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Warrants outstanding&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          4,108
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          3,969
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.6&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA391&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Common stock underlying convertible notes outstanding&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 37.9pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,578
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 37.9pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,198
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;p id=&quot;PARA396&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;&lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Comprehensive Income (Loss)&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA398&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Our comprehensive net loss for all periods presented was comprised solely of our net loss and there were no other changes in equity from non-owner sources.&lt;/font&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;p id=&quot;PARA400&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;&lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA402&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In August 2014, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) No. 2014-15, &lt;i&gt;Presentation of Financial Statements &amp;#8211; Going Concern (Subtopic 205-40)&lt;/i&gt; (&amp;#8220;ASU 2014-15&amp;#8221;). ASU 2014-15 requires management to assess an entity&amp;#8217;s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management&amp;#8217;s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management&amp;#8217;s plans, (5) require an express statement and other disclosures when substantial doubt is
      not alleviated, and (6) require an assessment for a period of one year after the date that the financial satements are issued (or available to be issued). The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early adoption is permitted. We plan to adopt the provisions on ASU 2014-15 in 2016. We do not expect the adoption of this ASU to have a material impact on our results of operations or financial condition.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA404&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In June 2014, FASB issued ASU No. 2014-12, &lt;i&gt;Compensation &amp;#8211; Stock Compensation (Topic 718)&lt;/i&gt; (&amp;#8220;ASU 2014-12&amp;#8221;). ASU 2014-12 requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The amendments in ASU 2014-12 may either be applied (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earlier annual period presented in the financial statements and to all new or modified awards thereafter. We plan to adopt the provisions of ASU 2014-12 in the first quarter of 2016. We do not expect the adoption of this
      ASU to have a material impact on our results of operations or financial condition.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA406&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In July 2013, the FASB issued ASU No.&amp;#160;2013-11, &lt;i&gt;Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists&lt;/i&gt; (&amp;#8220;ASU 2013-11&amp;#8221;). This update provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This guidance is effective prospectively for fiscal years, and interim periods within those years, beginning after December&amp;#160;15, 2013, with an option for early adoption. We adopted this guidance in 2014 and it did not have a material impact on our financial condition, results of operations or related financial statement disclosures.&lt;/font&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table id=&quot;TBL394&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt;
      &lt;tr id=&quot;TBL394.finRow.1&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.1.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.1.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;6&quot;&gt;
          &lt;p id=&quot;PARA381&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
          &lt;p id=&quot;PARA382&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;As of September 30&lt;/b&gt;&lt;b&gt;,&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.1.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.2&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.lead.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.amt.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA383&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.trail.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA384&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.2.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.3&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.lead.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.symb.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.amt.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.trail.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.lead.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.symb.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.amt.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.3.trail.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.4&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA385&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Stock options outstanding&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,456
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,270
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.4.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.5&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &lt;p id=&quot;PARA388&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Warrants outstanding&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          4,108
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          3,969
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.5.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL394.finRow.6&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA391&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Common stock underlying convertible notes outstanding&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 37.9pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,578
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 37.9pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,198
        &lt;/td&gt;
        &lt;td id=&quot;TBL394.finRow.6.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c11_From1Jan2014To30Sep2014_StockOptionMember" decimals="-3">6456000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c12_From1Jan2013To30Sep2013_StockOptionMember" decimals="-3">6270000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c13_From1Jan2014To30Sep2014_WarrantMember" decimals="-3">4108000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c14_From1Jan2013To30Sep2013_WarrantMember" decimals="-3">3969000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c15_From1Jan2014To30Sep2014_ConvertibleDebtSecuritiesMember" decimals="-3">6578000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c16_From1Jan2013To30Sep2013_ConvertibleDebtSecuritiesMember" decimals="-3">6198000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:DebtDisclosureTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;p id=&quot;PARA408&quot; style=&quot;TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;4. Convertible Notes to Related Parties&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA410&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In April 2011, we entered into a Securities Purchase Agreement for a private placement of up to $4.5&amp;#160;million in Senior Secured Convertible Notes (&amp;#8220;Notes&amp;#8221;). We received a total of $4.3 million, net of issuance costs, from the issuance of these Notes.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA412&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;The Notes are secured by substantially all of our assets, including placing our bank accounts under a control agreement. The Notes bear interest at 6% per annum, payable quarterly in cash or in additional principal amount of Notes, at the election of the purchasers. The Notes mature on May 2, 2021, however, the holders of the Notes may require prepayment of the Notes at any time, at each holder&amp;#8217;s option.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA414&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;The Notes are convertible into shares of our common stock at a rate of 1,250 shares for every $1,000 of principal and accrued interest due under the Notes. There is no right to convert the Notes to the extent that, after giving effect to such conversion, the holder would beneficially own in excess of 9.99% of our outstanding common stock. Each holder of the Notes can increase or decrease this beneficial ownership conversion limit by written notice to us, which will not be effective until 61 days after delivery of the notice.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA416&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;As of September 30, 2014, we were in compliance with all covenants under the Notes. Upon the occurrence of an event of default under the Notes, the holders of the Notes have the right to require us to redeem all or a portion of their Notes.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA418&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;We filed a registration statement with the SEC to register for resale 3.5 million shares underlying the Notes. The registration statement was declared effective on July&amp;#160;29,&amp;#160;2011. The Note holders have agreed to waive their right to require us to maintain the effectiveness of the registration statement and to register the additional shares underlying the Notes until they provide notice otherwise.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA420&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;The Notes contain an embedded conversion feature that was in-the-money on the issuance dates. Based on an effective fixed conversion rate of 1,250 shares for every $1,000 of principal and accrued interest due under the Notes, the total conversion benefit at issuance exceeded the loan proceeds. Therefore, a debt discount was recorded in an amount equal to the face value of the Notes on the issuance dates and we began amortizing the resultant debt discount over the respective 10-year term of the Notes. During the period ended September 30, 2014, accrued interest of approximately $78,000 was paid-in-kind and rolled into the Note principal balance, which resulted in an additional debt discount of approximately $78,000. For the three months ended September 30, 2014 and 2013, interest expense relating to the stated rate was approximately $79,000 and $74,000, respectively, and interest expense relating to the
      amortization of the debt discount was approximately $145,000 and $135,000, respectively. For the nine months ended September 30, 2014 and 2013, interest expense relating to the stated rate was approximately $233,000 and $218,000, respectively, and interest expense relating to the amortization of the debt discount was approximately $425,000 and $396,000, respectively.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA424&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;As of September 30, 2014, the carrying value of the Notes was approximately $1,450,000, which is comprised of the $5,262,000 principal amount of the Notes outstanding, less debt discount of $3,812,000. If the $5,262,000 principal amount of Notes is converted, we would issue approximately 6,578,000 shares of our common stock.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:DebtDisclosureTextBlock>
  <hrtx:ConvertibleDebtIssuableInConnectionWithPrivatePlacement1 unitRef="usd" contextRef="c17_AsOf30Apr2011_NotesPayableOtherPayablesMember" decimals="-5">4500000</hrtx:ConvertibleDebtIssuableInConnectionWithPrivatePlacement1>
  <hrtx:NotesAuthorizedUnderPrivatePlacementInitialClosing unitRef="usd" contextRef="c18_AsOf30Apr2011_InitialClosingAmountMember" decimals="-5">4300000</hrtx:NotesAuthorizedUnderPrivatePlacementInitialClosing>
  <hrtx:PurchaseOptionUnderPrivatePlacement unitRef="usd" contextRef="c19_AsOf30Apr2011_PurchaseOptionMember" decimals="2">0.06</hrtx:PurchaseOptionUnderPrivatePlacement>
  <us-gaap:DebtInstrumentMaturityDate contextRef="c20_From1Jun2011To30Jun2011_NotesPayableOtherPayablesMember">2021-05-02</us-gaap:DebtInstrumentMaturityDate>
  <hrtx:DebtInstrumentConversionRatioShares unitRef="shares" contextRef="c21_From1Apr2011To30Apr2011_CommonStockMember" decimals="INF">1250</hrtx:DebtInstrumentConversionRatioShares>
  <hrtx:DebtInstrumentConversionRatioMultipleOfPrincipal unitRef="usd" contextRef="c22_From1Apr2011To30Apr2011_PrincipalAmountMember" decimals="0">1000</hrtx:DebtInstrumentConversionRatioMultipleOfPrincipal>
  <hrtx:BeneficialOwnershipAfterConversion unitRef="pure" contextRef="c20_From1Jun2011To30Jun2011_NotesPayableOtherPayablesMember" decimals="4">0.0999</hrtx:BeneficialOwnershipAfterConversion>
  <hrtx:NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes contextRef="c20_From1Jun2011To30Jun2011_NotesPayableOtherPayablesMember">P61D</hrtx:NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes>
  <hrtx:CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes unitRef="shares" contextRef="c23_From28Jul2011To29Jul2011" decimals="-5">3500000</hrtx:CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes>
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">78000</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:PaidInKindInterest unitRef="usd" contextRef="c24_From1Jul2014To30Sep2014_NotesPayableOtherPayablesMember" decimals="0">78000</us-gaap:PaidInKindInterest>
  <us-gaap:InterestExpenseDebtExcludingAmortization unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">79000</us-gaap:InterestExpenseDebtExcludingAmortization>
  <us-gaap:InterestExpenseDebtExcludingAmortization unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">74000</us-gaap:InterestExpenseDebtExcludingAmortization>
  <us-gaap:AmortizationOfDebtDiscountPremium unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">145000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfDebtDiscountPremium unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">135000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:InterestExpenseDebtExcludingAmortization unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">233000</us-gaap:InterestExpenseDebtExcludingAmortization>
  <us-gaap:InterestExpenseDebtExcludingAmortization unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">218000</us-gaap:InterestExpenseDebtExcludingAmortization>
  <us-gaap:AmortizationOfDebtDiscountPremium unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">425000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfDebtDiscountPremium unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">396000</us-gaap:AmortizationOfDebtDiscountPremium>
  <hrtx:ConvertibleNotesPayableRelatedPartiesCurrent unitRef="usd" contextRef="c25_AsOf30Sep2014_NotesPayableOtherPayablesMember" decimals="0">1450000</hrtx:ConvertibleNotesPayableRelatedPartiesCurrent>
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c25_AsOf30Sep2014_NotesPayableOtherPayablesMember" decimals="0">5262000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c25_AsOf30Sep2014_NotesPayableOtherPayablesMember" decimals="0">3812000</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c26_AsOf30Sep2014_InCaseOfDebtConversionMember_NotesPayableOtherPayablesMember" decimals="0">5262000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments unitRef="pure" contextRef="c27_From1Jan2014To30Jun2014_InCaseOfDebtConversionMember_NotesPayableOtherPayablesMember" decimals="0">6578000</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTqBhR1cOw37qdfT/PN3Se6viq8MEgNf1gK37o5+ZijZsLc4+wNvBpwat6ujVccMPLaHIcSpbtFx9r9IOsbMrTepi+shSr0uaMJaWQNjypzAebLePqExZr4z4W8JNorPgCB8yim1oO5mMylAQ1EBx/Y2Y5pq3SFd2ZMK+3R/kuRgstR4ZlK8rSrUQ==] CSR-->
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;p id=&quot;PARA426&quot; style=&quot;TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;5. Stockholders&amp;#8217; Equity&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA428&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;i&gt;&lt;b&gt;Amendments to Articles of Incorporation&lt;/b&gt;&lt;/i&gt; &lt;b&gt;&amp;#8211;&lt;/b&gt; &lt;i&gt;&lt;b&gt;Reverse Stock Split&lt;/b&gt;&lt;/i&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA430&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Effective January 13, 2014, we amended our Certificate of Incorporation to change our name to Heron Therapeutics, Inc. and to effect a 1 - for - 20 reverse split of our outstanding common stock. The name change and Reverse Stock Split were approved by our stockholders on September&amp;#160;19,&amp;#160;2013. As a result of the Reverse Stock Split, the total authorized shares of common stock were reduced from 1,500,000,000 to 75,000,000 shares.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA432&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;i&gt;&lt;b&gt;2011 Private Placement&lt;/b&gt;&lt;/i&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA434&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In June 2011, we sold 8.0 million shares of our common stock for net proceeds of $22.8 million (net of approximately $1.2 million in issuance costs). For each share purchased, the investors received one warrant to purchase 0.5 shares of common stock at an exercise price of $3.60 per share. The warrants were immediately exercisable and expire on July&amp;#160;1,&amp;#160;2016. The warrants may be exercised for cash only, or, if a registration statement is not then effective and available for the resale of the shares of common stock issuable upon exercise of the warrants, by surrender of such warrant, or a portion of such warrant, by way of cashless exercise. There is no right to exercise the warrants to the extent that, after giving effect to such exercise the holder would beneficially own in excess of 9.99% of our outstanding shares of common stock or such other limit as may be designated by any particular
      purchaser. Each holder of the warrants can amend or waive the foregoing limitation by written notice to us, with such waiver taking effect only upon the expiration of a 61-day notice period.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA436&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;On July 29, 2011, we filed a registration statement with the SEC to register for resale the shares and the shares of common stock issuable upon the exercise of the warrants. The registration statement was declared effective on August 4, 2011. We are obligated to maintain the effectiveness of the registration statement until the investors are able to sell shares and the shares of common stock underlying the warrants without limitation or restriction under Rule 144 of the Securities Act of 1933, as amended (&amp;#8220;Rule 144&amp;#8221;). There is currently only one investor who is an affiliate of ours and is therefore not able to sell without limitation under Rule 144, and that investor has agreed to waive its right to require us to maintain the effectiveness of the registration statement until it provides notice otherwise.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA438&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;During the nine months ended September 30, 2014, warrant holders exercised 460,706 warrants under the cashless exercise provision in the warrant agreement, which resulted in the net issuance of 303,614&amp;#160;shares of common stock and no net cash proceeds to us. During the nine months ended September 30, 2013, we received $0.6 million for cash exercises of these warrants.&lt;/font&gt; &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA440&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;i&gt;&lt;b&gt;2012 Private Placement&lt;/b&gt;&lt;/i&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA442&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In July 2012, we sold approximately 5.1 million shares of our common stock at a purchase price of $10.50 per share, resulting in net proceeds of approximately $50.5 million (net of approximately $3.1 million in issuance costs). On August 24, 2012, we filed a registration statement with the SEC to register these shares for resale. The registration statement was declared effective on September 6, 2012.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA444&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;i&gt;&lt;b&gt;2013 Common Stock Offering&lt;/b&gt;&lt;/i&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA446&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In November 2013, we sold approximately 8.6 million shares of our common stock at a public offering price of $8.00 per share. We received total net proceeds of approximately $57.8 million (net of approximately $3.9&amp;#160;million in issuance costs). The offering was made pursuant to an effective registration statement, which was previously filed with the SEC and was declared effective.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA448&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;i&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/i&gt;&lt;i&gt;&lt;b&gt;Common Stock Offering&lt;/b&gt;&lt;/i&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA450&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;In June 2014, we sold approximately 4.8 million shares of our common stock at a public offering price of $11.75 per share. In addition, as a component of the offering, we sold 600,000 pre-funded warrants to purchase shares of our common stock at a public offering price of $11.74 per share. The pre-funded warrants have an exercise price of $0.01 per share and are exercisable for seven years from the date of issuance. We received total net proceeds of approximately $58.9 million (net of approximately $4.0 million in issuance costs) from the sale of the common stock and the pre-funded warrants. The offering was made pursuant to an effective registration statement, which was previously filed with the SEC and was declared effective.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA452&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;i&gt;&lt;b&gt;Stock Option Exercises&lt;/b&gt;&lt;/i&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA454&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;For the nine months ended September 30, 2014, approximately 550,000 shares of common stock were issued pursuant to the exercise of stock options, resulting in proceeds to us of approximately $2.8&amp;#160;million.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA456&quot; style=&quot;TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Stock-Based Compensation&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA458&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;The following table summarizes stock-based compensation expense for the three and nine months ended September 30, 2014 and 2013 related to stock options and Employee Stock Purchase Plan (&amp;#8220;ESPP&amp;#8221;) purchase rights by expense category (in thousands):&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;table id=&quot;TBL490&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt;
      &lt;tr id=&quot;TBL490.finRow.1&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.1.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.1.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;6&quot;&gt;
          &lt;p id=&quot;PARA460&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
          &lt;p id=&quot;PARA461&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
          &lt;p id=&quot;PARA462&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;September 30&lt;/b&gt;&lt;b&gt;,&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.1.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.1.lead.D5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.1.amt.D5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;6&quot;&gt;
          &lt;p id=&quot;PARA463&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
          &lt;p id=&quot;PARA464&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Nine&lt;/b&gt; &lt;b&gt;Months Ended&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
          &lt;p id=&quot;PARA465&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;September 30&lt;/b&gt;&lt;b&gt;,&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.1.trail.D5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.2&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.lead.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.amt.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA466&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.trail.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA467&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA468&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.lead.D5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.amt.D5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA469&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.trail.D5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.3&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.lead.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.symb.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.amt.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.trail.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.lead.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.symb.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.amt.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.trail.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.lead.B4&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.symb.B4&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.amt.B4&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.trail.B4&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.lead.B5&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.symb.B5&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.amt.B5&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.trail.B5&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.4&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA470&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Research and development&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          715
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          702
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.lead.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.symb.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.amt.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          2,423
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.trail.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.lead.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.symb.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.amt.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          1,492
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.trail.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.5&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &lt;p id=&quot;PARA475&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;General and administrative&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          1,045
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          3,393
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.lead.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.symb.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.amt.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          3,386
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.trail.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.lead.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.symb.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.amt.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          6,841
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.trail.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.6&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA480&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Stock-based compensation expense included in operating expenses&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          1,760
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          4,095
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.lead.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.symb.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.amt.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          5,809
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.trail.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.lead.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.symb.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.amt.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          8,333
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.trail.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.7&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.lead.B2&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.symb.B2&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.amt.B2&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.trail.B2&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.lead.B3&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.symb.B3&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.amt.B3&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.trail.B3&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.lead.B4&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.symb.B4&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.amt.B4&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.trail.B4&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.lead.B5&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.symb.B5&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.amt.B5&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.trail.B5&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.8&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA485&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Impact on basic and diluted net loss per share&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          0.06
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          0.27
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.lead.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.symb.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.amt.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          0.23
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.trail.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.lead.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.symb.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.amt.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          0.54
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.trail.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p id=&quot;PARA492&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;As of September 30, 2014, there was approximately $26.8 million of total unrecognized compensation cost related to non-vested, stock-based payment awards granted pursuant to our equity compensation arrangements. Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures. We expect to recognize this compensation cost over a period of 2.5&amp;#160;years, which is the weighted-average vesting period for all stock-based compensation awards.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA494&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;We estimated the fair value of each option grant on the grant date using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;table id=&quot;TBL512&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt;
      &lt;tr id=&quot;TBL512.finRow.1&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;em&gt;&lt;/em&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.1.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.1.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;6&quot;&gt;
          &lt;p id=&quot;PARA497&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.1.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL512.finRow.2&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.2.lead.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.2.amt.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA498&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;20&lt;/b&gt;&lt;b&gt;14&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.2.trail.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.2.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.2.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA499&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;20&lt;/b&gt;&lt;b&gt;13&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.2.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL512.finRow.3&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA500&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Risk-free interest rate&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          2.0
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          1.0
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL512.finRow.4&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &lt;p id=&quot;PARA503&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Dividend yield&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 19.55pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          0.0
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 19.55pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          0.0
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL512.finRow.5&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA506&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Volatility&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          102.9
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          104.2
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL512.finRow.6&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &lt;p id=&quot;PARA509&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Expected life (years)&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          6.0
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 54pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          6.0
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p id=&quot;PARA514&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;We estimated the fair value of each purchase right granted under the ESPP at the beginning of each new offering period using the Black-Scholes option valuation model. There were no new offering periods for the quarters ended September 30, 2014 and 2013.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA518&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;The following table summarizes the stock option activity for the nine months ended September 30, 2014:&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;table id=&quot;TBL558&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt;
      &lt;tr id=&quot;TBL558.finRow.1&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.lead.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.symb.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.amt.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.trail.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.lead.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.symb.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.amt.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.trail.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA522&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.2&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.lead.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.symb.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.amt.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.trail.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.lead.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.symb.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.amt.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.trail.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA524&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.3&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.lead.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.symb.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.amt.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.trail.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA526&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA527&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.4&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.lead.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.symb.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.amt.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.trail.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA529&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA530&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.5&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.lead.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.amt.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA532&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.trail.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA533&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA534&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Term&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.6&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.lead.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.amt.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA536&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;(in thousands)&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.trail.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA537&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA538&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;(Years)&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.7&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA539&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Balance at January 1, 2014&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,356
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          8.22
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.lead.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.symb.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.amt.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          8.14
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.trail.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.8&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &lt;p id=&quot;PARA543&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Granted&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          1,631
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          9.95
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.lead.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.symb.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.amt.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.trail.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.9&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA546&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Exercised&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          (719
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &lt;p id=&quot;PARA548&quot; style=&quot;TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;)&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6.29
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.lead.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.symb.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.amt.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.trail.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.10&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &lt;p id=&quot;PARA550&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Expired and forfeited&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          (812
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &lt;p id=&quot;PARA552&quot; style=&quot;TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;)&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          9.82
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.lead.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.symb.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.amt.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.trail.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.11&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA554&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Balance at September 30, 2014&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,456
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          8.67
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.lead.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.symb.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.amt.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          8.18
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.trail.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c28_AsOf13Jan2014_ScenarioPreviouslyReportedMember" decimals="INF">1500000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c29_AsOf13Jan2014" decimals="INF">75000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c30_From1Jun2011To30Jun2011_PrivatePlacement2011Member_CommonStockMember" decimals="-5">8000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c30_From1Jun2011To30Jun2011_PrivatePlacement2011Member_CommonStockMember" decimals="-5">22800000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts unitRef="usd" contextRef="c30_From1Jun2011To30Jun2011_PrivatePlacement2011Member_CommonStockMember" decimals="-5">1200000</us-gaap:PaymentsOfStockIssuanceCosts>
  <hrtx:SharesAvailablePerWarrantExercised unitRef="shares" contextRef="c30_From1Jun2011To30Jun2011_PrivatePlacement2011Member_CommonStockMember" decimals="INF">0.5</hrtx:SharesAvailablePerWarrantExercised>
  <hrtx:ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit unitRef="usdPershares" contextRef="c31_AsOf30Jun2011_PrivatePlacement2011Member" decimals="2">3.60</hrtx:ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit>
  <hrtx:LimitationOnExercisableWarrants unitRef="pure" contextRef="c32_From1Jun2011To30Sep2013_PrivatePlacement2011Member" decimals="4">0.0999</hrtx:LimitationOnExercisableWarrants>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c33_From1Jan2014To30Sep2014_PrivatePlacement2011Member_CommonStockMember" decimals="0">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised unitRef="shares" contextRef="c34_From1Jan2014To30Sep2014_PrivatePlacement2011Member_WarrantMember" decimals="INF">460706</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c33_From1Jan2014To30Sep2014_PrivatePlacement2011Member_CommonStockMember" decimals="INF">303614</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromWarrantExercises unitRef="usd" contextRef="c35_From1Jan2014To30Sep2014_PrivatePlacement2011Member" decimals="-5">600000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c36_From1Jul2012To31Jul2012_PrivatePlacement2012Member_CommonStockMember" decimals="-5">5100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SharesIssuedPricePerShare unitRef="usdPershares" contextRef="c37_AsOf31Jul2012_PrivatePlacement2012Member" decimals="2">10.50</us-gaap:SharesIssuedPricePerShare>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c36_From1Jul2012To31Jul2012_PrivatePlacement2012Member_CommonStockMember" decimals="-5">50500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts unitRef="usd" contextRef="c36_From1Jul2012To31Jul2012_PrivatePlacement2012Member_CommonStockMember" decimals="-5">3100000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c38_From1Nov2013To30Nov2013_CommonStockMember_JefferiesLLCMember" decimals="-5">8600000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockPricePerShare unitRef="usdPershares" contextRef="c39_AsOf30Nov2013_CommonStockMember_JefferiesLLCMember" decimals="2">8.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c38_From1Nov2013To30Nov2013_CommonStockMember_JefferiesLLCMember" decimals="-5">57800000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:PaymentsOfStockIssuanceCosts unitRef="usd" contextRef="c38_From1Nov2013To30Nov2013_CommonStockMember_JefferiesLLCMember" decimals="-5">3900000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c40_From1Jun2014To30Jun2014_CommonStockMember" decimals="-5">4800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockPricePerShare unitRef="usdPershares" contextRef="c41_AsOf30Jun2014_CommonStockMember" decimals="2">11.75</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c42_AsOf30Jun2014_PreFundedWarrantsMember" decimals="INF">600000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:SharePrice unitRef="usdPershares" contextRef="c42_AsOf30Jun2014_PreFundedWarrantsMember" decimals="2">11.74</us-gaap:SharePrice>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c42_AsOf30Jun2014_PreFundedWarrantsMember" decimals="2">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <hrtx:WarrantTerm contextRef="c43_From1Jun2014To30Jun2014_PreFundedWarrantsMember">P7Y</hrtx:WarrantTerm>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity unitRef="usd" contextRef="c44_From1Jun2014To30Jun2014_CommonStockAndPrefundedWarrantsMember" decimals="-5">58900000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:PaymentsOfStockIssuanceCosts unitRef="usd" contextRef="c44_From1Jun2014To30Jun2014_CommonStockAndPrefundedWarrantsMember" decimals="-5">4000000</us-gaap:PaymentsOfStockIssuanceCosts>
  <hrtx:StockIssuedDuringPeriodSharesStockOptionsExercisedNet unitRef="shares" contextRef="c4_From1Jan2014To30Sep2014" decimals="INF">550000</hrtx:StockIssuedDuringPeriodSharesStockOptionsExercisedNet>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-5">26800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c4_From1Jan2014To30Sep2014">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table id=&quot;TBL490&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt;
      &lt;tr id=&quot;TBL490.finRow.1&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.1.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.1.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;6&quot;&gt;
          &lt;p id=&quot;PARA460&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
          &lt;p id=&quot;PARA461&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
          &lt;p id=&quot;PARA462&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;September 30&lt;/b&gt;&lt;b&gt;,&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.1.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.1.lead.D5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.1.amt.D5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;6&quot;&gt;
          &lt;p id=&quot;PARA463&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
          &lt;p id=&quot;PARA464&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Nine&lt;/b&gt; &lt;b&gt;Months Ended&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
          &lt;p id=&quot;PARA465&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;September 30&lt;/b&gt;&lt;b&gt;,&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.1.trail.D5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.2&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.lead.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.amt.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA466&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.trail.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA467&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA468&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.lead.D5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.amt.D5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA469&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.2.trail.D5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.3&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.lead.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.symb.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.amt.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.trail.B2&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.lead.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.symb.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.amt.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.trail.B3&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.lead.B4&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.symb.B4&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.amt.B4&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.trail.B4&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.lead.B5&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.symb.B5&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.amt.B5&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.3.trail.B5&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.4&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA470&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Research and development&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          715
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          702
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.lead.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.symb.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.amt.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          2,423
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.trail.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.lead.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.symb.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.amt.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          1,492
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.4.trail.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.5&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &lt;p id=&quot;PARA475&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;General and administrative&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          1,045
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          3,393
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.lead.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.symb.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.amt.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          3,386
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.trail.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.lead.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.symb.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.amt.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          6,841
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.5.trail.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.6&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA480&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Stock-based compensation expense included in operating expenses&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          1,760
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          4,095
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.lead.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.symb.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.amt.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          5,809
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.trail.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.lead.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.symb.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.amt.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          8,333
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.6.trail.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.7&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.lead.B2&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.symb.B2&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.amt.B2&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.trail.B2&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.lead.B3&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.symb.B3&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.amt.B3&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.trail.B3&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.lead.B4&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.symb.B4&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.amt.B4&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.trail.B4&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.lead.B5&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.symb.B5&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.amt.B5&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.7.trail.B5&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL490.finRow.8&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA485&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Impact on basic and diluted net loss per share&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          0.06
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          0.27
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.lead.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.symb.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.amt.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          0.23
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.trail.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.lead.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.symb.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.amt.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          0.54
        &lt;/td&gt;
        &lt;td id=&quot;TBL490.finRow.8.trail.5&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c45_From1Jul2014To30Sep2014_ResearchAndDevelopmentExpenseMember" decimals="-3">715000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c46_From1Jul2013To30Sep2013_ResearchAndDevelopmentExpenseMember" decimals="-3">702000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c47_From1Jan2014To30Sep2014_ResearchAndDevelopmentExpenseMember" decimals="-3">2423000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c48_From1Jan2013To30Sep2013_ResearchAndDevelopmentExpenseMember" decimals="-3">1492000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c49_From1Jul2014To30Sep2014_GeneralAndAdministrativeExpenseMember" decimals="-3">1045000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c50_From1Jul2013To30Sep2013_GeneralAndAdministrativeExpenseMember" decimals="-3">3393000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c51_From1Jan2014To30Sep2014_GeneralAndAdministrativeExpenseMember" decimals="-3">3386000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c52_From1Jan2013To30Sep2013_GeneralAndAdministrativeExpenseMember" decimals="-3">6841000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="-3">1760000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="-3">4095000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">5809000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="-3">8333000</us-gaap:AllocatedShareBasedCompensationExpense>
  <hrtx:ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare unitRef="usdPershares" contextRef="c2_From1Jul2014To30Sep2014" decimals="2">0.06</hrtx:ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare>
  <hrtx:ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare unitRef="usdPershares" contextRef="c3_From1Jul2013To30Sep2013" decimals="2">0.27</hrtx:ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare>
  <hrtx:ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare unitRef="usdPershares" contextRef="c4_From1Jan2014To30Sep2014" decimals="2">0.23</hrtx:ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare>
  <hrtx:ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare unitRef="usdPershares" contextRef="c5_From1Jan2013To30Sep2013" decimals="2">0.54</hrtx:ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c53_From1Jan2014To30Sep2014_EmployeeStockOptionMember">&lt;table id=&quot;TBL512&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt;
      &lt;tr id=&quot;TBL512.finRow.1&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;em&gt;&lt;/em&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.1.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.1.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;6&quot;&gt;
          &lt;p id=&quot;PARA497&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.1.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL512.finRow.2&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.2.lead.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.2.amt.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA498&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;20&lt;/b&gt;&lt;b&gt;14&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.2.trail.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.2.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.2.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA499&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;20&lt;/b&gt;&lt;b&gt;13&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.2.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL512.finRow.3&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA500&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Risk-free interest rate&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          2.0
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          1.0
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.3.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL512.finRow.4&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &lt;p id=&quot;PARA503&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Dividend yield&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 19.55pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          0.0
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 19.55pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          0.0
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.4.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL512.finRow.5&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA506&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Volatility&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          102.9
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          104.2
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.5.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL512.finRow.6&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &lt;p id=&quot;PARA509&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Expected life (years)&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          6.0
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 54pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          6.0
        &lt;/td&gt;
        &lt;td id=&quot;TBL512.finRow.6.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c53_From1Jan2014To30Sep2014_EmployeeStockOptionMember" decimals="3">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c54_From1Jan2013To30Sep2013_EmployeeStockOptionMember" decimals="3">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c53_From1Jan2014To30Sep2014_EmployeeStockOptionMember" decimals="3">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c54_From1Jan2013To30Sep2013_EmployeeStockOptionMember" decimals="3">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c53_From1Jan2014To30Sep2014_EmployeeStockOptionMember" decimals="3">1.029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c54_From1Jan2013To30Sep2013_EmployeeStockOptionMember" decimals="3">1.042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c53_From1Jan2014To30Sep2014_EmployeeStockOptionMember">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c54_From1Jan2013To30Sep2013_EmployeeStockOptionMember">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table id=&quot;TBL558&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt;
      &lt;tr id=&quot;TBL558.finRow.1&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.lead.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.symb.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.amt.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.trail.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.lead.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.symb.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.amt.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.trail.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA522&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.1.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.2&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.lead.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.symb.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.amt.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.trail.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.lead.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.symb.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.amt.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.trail.B3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA524&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.2.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.3&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.lead.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.symb.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.amt.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.trail.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA526&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA527&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.3.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.4&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.lead.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.symb.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.amt.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.trail.B2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA529&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA530&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.4.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.5&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.lead.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.amt.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA532&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.trail.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA533&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA534&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Term&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.5.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.6&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.lead.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.amt.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA536&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;(in thousands)&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.trail.D2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.lead.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.amt.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA537&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.trail.D3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.lead.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.amt.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt&quot; colspan=&quot;2&quot;&gt;
          &lt;p id=&quot;PARA538&quot; style=&quot;TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;(Years)&lt;/b&gt;&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.6.trail.D4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px&quot;&gt;
          &lt;b&gt;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.7&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA539&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Balance at January 1, 2014&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,356
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          8.22
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.lead.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.symb.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.amt.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          8.14
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.7.trail.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.8&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &lt;p id=&quot;PARA543&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Granted&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          1,631
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          9.95
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.lead.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.symb.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.amt.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.8.trail.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.9&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA546&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Exercised&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          (719
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &lt;p id=&quot;PARA548&quot; style=&quot;TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;)&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6.29
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.lead.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.symb.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.amt.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.9.trail.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.10&quot; style=&quot;BACKGROUND-COLOR: #ffffff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &lt;p id=&quot;PARA550&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Expired and forfeited&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          (812
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &lt;p id=&quot;PARA552&quot; style=&quot;TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;)&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot;&gt;
          9.82
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.lead.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.symb.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.amt.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.10.trail.B4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; BACKGROUND-COLOR: #ffffff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr id=&quot;TBL558.finRow.11&quot; style=&quot;BACKGROUND-COLOR: #cceeff&quot;&gt;
        &lt;td style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &lt;p id=&quot;PARA554&quot; style=&quot;MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
            &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Balance at September 30, 2014&lt;/font&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.lead.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.symb.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.amt.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          6,456
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.trail.2&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.lead.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.symb.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.amt.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          8.67
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.trail.3&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.lead.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.symb.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.amt.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot;&gt;
          8.18
        &lt;/td&gt;
        &lt;td id=&quot;TBL558.finRow.11.trail.4&quot; style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff&quot; nowrap=&quot;nowrap&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c6_AsOf31Dec2012" decimals="-3">6356000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c6_AsOf31Dec2012" decimals="2">8.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c55_From1Jan2013To31Dec2013">P8Y51D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">1631000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c4_From1Jan2014To30Sep2014" decimals="2">9.95</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">719000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c4_From1Jan2014To30Sep2014" decimals="2">6.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod unitRef="shares" contextRef="c4_From1Jan2014To30Sep2014" decimals="-3">812000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c4_From1Jan2014To30Sep2014" decimals="2">9.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c0_AsOf30Sep2014" decimals="-3">6456000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c0_AsOf30Sep2014" decimals="2">8.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c4_From1Jan2014To30Sep2014">P8Y65D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;p id=&quot;PARA560&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;&lt;b&gt;6. Income Taxes&lt;/b&gt;&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA562&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;Deferred income tax assets and liabilities are recognized for temporary differences between financial statements and income tax carrying values using tax rates in effect for the years such differences are expected to reverse. Due to uncertainties surrounding our ability to generate future taxable income and consequently realize such deferred income tax assets, a full valuation allowance has been established. We continue to maintain a full valuation allowance against its deferred tax assets as of September&amp;#160;30,&amp;#160;2014.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p id=&quot;PARA564&quot; style=&quot;TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25&quot;&gt;
      &lt;font style=&quot;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif&quot;&gt;The impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more likely than not to be sustained upon audit by the relevant tax authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. There have been no material changes in our unrecognized tax benefits since December&amp;#160;31,&amp;#160;2013 and as such, disclosures included in the Company&amp;#8217;s 2013 Annual Report on Form&amp;#160;10-K continue to be relevant for the period ended September 30, 2014.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>hrtx-20140930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Nov 06 13:31:24 UTC 2014 -->
<xs:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" targetNamespace="http://herontx.com/20140930" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:hrtx="http://herontx.com/20140930" xmlns:us-types="http://fasb.org/us-types/2014-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" elementFormDefault="qualified" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="hrtx-20140930_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="hrtx-20140930_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="hrtx-20140930_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="hrtx-20140930_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://herontx.com/role/ConsolidatedBalanceSheet" id="hrtx_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Condensed Balance Sheets (Current Period Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/ConsolidatedIncomeStatement" id="hrtx_r_ConsolidatedIncomeStatement">
        <link:definition>002 - Statement - Condensed Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/ConsolidatedCashFlow" id="hrtx_r_ConsolidatedCashFlow">
        <link:definition>003 - Statement - Condensed Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/Note1Business" id="hrtx_r_Note1Business">
        <link:definition>004 - Disclosure - Note 1 - Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/Note2BasisofPresentation" id="hrtx_r_Note2BasisofPresentation">
        <link:definition>005 - Disclosure - Note 2 - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/Note3AccountingPolicies" id="hrtx_r_Note3AccountingPolicies">
        <link:definition>006 - Disclosure - Note 3 - Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/Note4ConvertibleNotestoRelatedParties" id="hrtx_r_Note4ConvertibleNotestoRelatedParties">
        <link:definition>007 - Disclosure - Note 4 - Convertible Notes to Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/Note5StockholdersEquity" id="hrtx_r_Note5StockholdersEquity">
        <link:definition>008 - Disclosure - Note 5 - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/Note6IncomeTaxes" id="hrtx_r_Note6IncomeTaxes">
        <link:definition>009 - Disclosure - Note 6 - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/AccountingPoliciesByPolicy" id="hrtx_r_AccountingPoliciesByPolicy">
        <link:definition>010 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/Note3AccountingPoliciesTables" id="hrtx_r_Note3AccountingPoliciesTables">
        <link:definition>011 - Disclosure - Note 3 - Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/Note5StockholdersEquityTables" id="hrtx_r_Note5StockholdersEquityTables">
        <link:definition>012 - Disclosure - Note 5 - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/Note1BusinessDetails" id="hrtx_r_Note1BusinessDetails">
        <link:definition>013 - Disclosure - Note 1 - Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/Note3AccountingPoliciesDetails" id="hrtx_r_Note3AccountingPoliciesDetails">
        <link:definition>014 - Disclosure - Note 3 - Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTqBhR1cOw37qdfT/PN3Se6viq8MEgNf1gK37o5+ZijZsLc4+wNvBpwat6ujVccMPLaHIcSpbtFx9r9IOsbMrTepi+shSr0uaMJaWQNjypzAebLePqExZr4z4W8JNorPgCB8yim1oO5mMylAQ1EBx/Y2Y5pq3SFd2ZMFTRWL4yqsWDH+3Tj373H5Q==] CSR-->
      <link:roleType roleURI="http://herontx.com/role/EquityExcludedFromCalculationofDilutedEarningsPerShareTable" id="hrtx_r_EquityExcludedFromCalculationofDilutedEarningsPerShareTable">
        <link:definition>015 - Disclosure - Note 3 - Accounting Policies (Details) - Equity Excluded From Calculation of Diluted Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/Note4ConvertibleNotestoRelatedPartiesDetails" id="hrtx_r_Note4ConvertibleNotestoRelatedPartiesDetails">
        <link:definition>016 - Disclosure - Note 4 - Convertible Notes to Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/Note5StockholdersEquityDetails" id="hrtx_r_Note5StockholdersEquityDetails">
        <link:definition>017 - Disclosure - Note 5 - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/StockbasedCompensationExpenseTable" id="hrtx_r_StockbasedCompensationExpenseTable">
        <link:definition>018 - Disclosure - Note 5 - Stockholders' Equity (Details) - Stock-based Compensation Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/OptionValuationAssumptionsTable" id="hrtx_r_OptionValuationAssumptionsTable">
        <link:definition>019 - Disclosure - Note 5 - Stockholders' Equity (Details) - Option Valuation Assumptions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/OptionSummaryTable" id="hrtx_r_OptionSummaryTable">
        <link:definition>020 - Disclosure - Note 5 - Stockholders' Equity (Details) - Option Summary</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://herontx.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Disclosure - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2014-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2014/elts/us-types-2014-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:element name="EquityExcludedFromCalculationOfDilutedEarningsPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_EquityExcludedFromCalculationOfDilutedEarningsPerShareAbstract"/>
  <xs:element name="StockBasedCompensationExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_StockBasedCompensationExpenseAbstract"/>
  <xs:element name="OptionValuationAssumptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_OptionValuationAssumptionsAbstract"/>
  <xs:element name="OptionSummaryAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_OptionSummaryAbstract"/>
  <xs:element name="OperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_OperatingActivitiesAbstract"/>
  <xs:element name="AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract"/>
  <xs:element name="ChangesInOperatingAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract"/>
  <xs:element name="InvestingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_InvestingActivitiesAbstract"/>
  <xs:element name="FinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_FinancingActivitiesAbstract"/>
  <xs:element name="AccruedClinicalLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="hrtx_AccruedClinicalLiabilities"/>
  <xs:element name="ConvertibleNotesPayableRelatedPartiesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent"/>
  <xs:element name="IncreaseDecreaseInClinicalLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="hrtx_IncreaseDecreaseInClinicalLiabilities"/>
  <xs:element name="Note5StockholdersEquityTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="hrtx_Note5StockholdersEquityTablesTable"/>
  <xs:element name="Note5StockholdersEquityTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_Note5StockholdersEquityTablesLineItems"/>
  <xs:element name="ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare"/>
  <xs:element name="Note5StockholdersEquityDetailsOptionValuationAssumptionsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsTable"/>
  <xs:element name="Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems"/>
  <xs:element name="Note1BusinessDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="hrtx_Note1BusinessDetailsTable"/>
  <xs:element name="Note1BusinessDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_Note1BusinessDetailsLineItems"/>
  <xs:element name="Note4ConvertibleNotestoRelatedPartiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable"/>
  <xs:element name="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems"/>
  <xs:element name="ConvertibleDebtIssuableInConnectionWithPrivatePlacement1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1"/>
  <xs:element name="NotesAuthorizedUnderPrivatePlacementInitialClosing" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing"/>
  <xs:element name="PurchaseOptionUnderPrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="hrtx_PurchaseOptionUnderPrivatePlacement"/>
  <xs:element name="DebtInstrumentConversionRatioShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_DebtInstrumentConversionRatioShares"/>
  <xs:element name="DebtInstrumentConversionRatioMultipleOfPrincipal" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal"/>
  <xs:element name="BeneficialOwnershipAfterConversion" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_BeneficialOwnershipAfterConversion"/>
  <xs:element name="NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes"/>
  <xs:element name="CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes"/>
  <xs:element name="Note5StockholdersEquityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="hrtx_Note5StockholdersEquityDetailsTable"/>
  <xs:element name="Note5StockholdersEquityDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_Note5StockholdersEquityDetailsLineItems"/>
  <xs:element name="SharesAvailablePerWarrantExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_SharesAvailablePerWarrantExercised"/>
  <xs:element name="ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit" type="us-types:perUnitItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit"/>
  <xs:element name="LimitationOnExercisableWarrants" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_LimitationOnExercisableWarrants"/>
  <xs:element name="WarrantTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_WarrantTerm"/>
  <xs:element name="StockIssuedDuringPeriodSharesStockOptionsExercisedNet" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet"/>
  <xs:element name="DisclosureAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="hrtx_DisclosureAxis"/>
  <xs:element name="CommonStockAndPrefundedWarrantsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_CommonStockAndPrefundedWarrantsMember"/>
  <xs:element name="EmployeeStockPurchasePlan1997Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_EmployeeStockPurchasePlan1997Member"/>
  <xs:element name="EquityIncentivePlan2007Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_EquityIncentivePlan2007Member"/>
  <xs:element name="InCaseOfDebtConversionMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_InCaseOfDebtConversionMember"/>
  <xs:element name="InitialClosingAmountMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_InitialClosingAmountMember"/>
  <xs:element name="JefferiesLLCMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_JefferiesLLCMember"/>
  <xs:element name="PreFundedWarrantsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_PreFundedWarrantsMember"/>
  <xs:element name="PrincipalAmountMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_PrincipalAmountMember"/>
  <xs:element name="PrivatePlacement2011Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_PrivatePlacement2011Member"/>
  <xs:element name="PrivatePlacement2012Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_PrivatePlacement2012Member"/>
  <xs:element name="PurchaseOptionMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_PurchaseOptionMember"/>
  <xs:element name="ReverseStockSplitMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_ReverseStockSplitMember"/>
  <xs:element name="SubjectToLimitationsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_SubjectToLimitationsMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="hrtx_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>hrtx-20140930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Nov 06 13:31:24 UTC 2014 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_ConsolidatedBalanceSheet" roleURI="http://herontx.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_ConsolidatedIncomeStatement" roleURI="http://herontx.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_ConsolidatedCashFlow" roleURI="http://herontx.com/role/ConsolidatedCashFlow"/>
  <calculationLink xlink:type="extended" xlink:role="http://herontx.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Cash"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_Cash" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="hrtx_AccruedClinicalLiabilities" xlink:href="hrtx-20140930.xsd#hrtx_AccruedClinicalLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="hrtx_AccruedClinicalLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent" xlink:href="hrtx-20140930.xsd#hrtx_ConvertibleNotesPayableRelatedPartiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://herontx.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTqBhR1cOw37qdfT/PN3Se6viq8MEgNf1gK37o5+ZijZsLc4+wNvBpwat6ujVccMPLaHIcSpbtFx9r9IOsbMrTepi+shSr0uaMJaWQNjypzAebLePqExZr4z4W8JNorPgCB8yim1oO5mMylAQ1EBx/Y2Y5pq3SFd2ZM3k8Q4zz7JkaSNAvecSa23Q==] CSR-->
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherNonoperatingExpense" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://herontx.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationAndAmortization" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="hrtx_IncreaseDecreaseInClinicalLiabilities" xlink:href="hrtx-20140930.xsd#hrtx_IncreaseDecreaseInClinicalLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="hrtx_IncreaseDecreaseInClinicalLiabilities" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>hrtx-20140930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Nov 06 13:31:24 UTC 2014 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_ConsolidatedBalanceSheet" roleURI="http://herontx.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_ConsolidatedIncomeStatement" roleURI="http://herontx.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_ConsolidatedCashFlow" roleURI="http://herontx.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note1Business" roleURI="http://herontx.com/role/Note1Business"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note2BasisofPresentation" roleURI="http://herontx.com/role/Note2BasisofPresentation"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note3AccountingPolicies" roleURI="http://herontx.com/role/Note3AccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note4ConvertibleNotestoRelatedParties" roleURI="http://herontx.com/role/Note4ConvertibleNotestoRelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note5StockholdersEquity" roleURI="http://herontx.com/role/Note5StockholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note6IncomeTaxes" roleURI="http://herontx.com/role/Note6IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_AccountingPoliciesByPolicy" roleURI="http://herontx.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note3AccountingPoliciesTables" roleURI="http://herontx.com/role/Note3AccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note5StockholdersEquityTables" roleURI="http://herontx.com/role/Note5StockholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_EquityExcludedFromCalculationofDilutedEarningsPerShareTable" roleURI="http://herontx.com/role/EquityExcludedFromCalculationofDilutedEarningsPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_StockbasedCompensationExpenseTable" roleURI="http://herontx.com/role/StockbasedCompensationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_OptionValuationAssumptionsTable" roleURI="http://herontx.com/role/OptionValuationAssumptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_OptionSummaryTable" roleURI="http://herontx.com/role/OptionSummaryTable"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note1BusinessDetails" roleURI="http://herontx.com/role/Note1BusinessDetails"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note3AccountingPoliciesDetails" roleURI="http://herontx.com/role/Note3AccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note4ConvertibleNotestoRelatedPartiesDetails" roleURI="http://herontx.com/role/Note4ConvertibleNotestoRelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note5StockholdersEquityDetails" roleURI="http://herontx.com/role/Note5StockholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#DocumentAndEntityInformation" roleURI="http://herontx.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Cash" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_AccruedClinicalLiabilities" xlink:href="hrtx-20140930.xsd#hrtx_AccruedClinicalLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="hrtx_AccruedClinicalLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent" xlink:href="hrtx-20140930.xsd#hrtx_ConvertibleNotesPayableRelatedPartiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_OperatingExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_OperatingActivitiesAbstract" xlink:href="hrtx-20140930.xsd#hrtx_OperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="hrtx_OperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:href="hrtx-20140930.xsd#hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:href="hrtx-20140930.xsd#hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:to="hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_IncreaseDecreaseInClinicalLiabilities" xlink:href="hrtx-20140930.xsd#hrtx_IncreaseDecreaseInClinicalLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="hrtx_IncreaseDecreaseInClinicalLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_InvestingActivitiesAbstract" xlink:href="hrtx-20140930.xsd#hrtx_InvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="hrtx_InvestingActivitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_InvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_InvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_FinancingActivitiesAbstract" xlink:href="hrtx-20140930.xsd#hrtx_FinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="hrtx_FinancingActivitiesAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_FinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_FinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_FinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_FinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_FinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/Note1Business">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/Note2BasisofPresentation">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccounting" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_BasisOfAccounting" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/Note3AccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/Note4ConvertibleNotestoRelatedParties">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/Note5StockholdersEquity">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/Note6IncomeTaxes">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiquidityDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiquidityDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LiquidityDisclosureTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/Note3AccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/Note5StockholdersEquityTables">
    <loc xlink:type="locator" xlink:label="hrtx_Note5StockholdersEquityTablesLineItems" xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="hrtx_Note5StockholdersEquityTablesTable" xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="hrtx_Note5StockholdersEquityTablesLineItems" xlink:to="hrtx_Note5StockholdersEquityTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note5StockholdersEquityTablesTable" xlink:to="us-gaap_AwardTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityTablesLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/EquityExcludedFromCalculationofDilutedEarningsPerShareTable">
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_StockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/StockbasedCompensationExpenseTable">
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare" xlink:href="hrtx-20140930.xsd#hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/OptionValuationAssumptionsTable">
    <loc xlink:type="locator" xlink:label="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsTable" xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsTable"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTqBhR1cOw37qdfT/PN3Se6viq8MEgNf1gK37o5+ZijZsLc4+wNvBpwat6ujVccMPLaHIcSpbtFx9r9IOsbMrTepi+shSr0uaMJaWQNjypzAebLePqExZr4z4W8JNorPgCB8yim1oO5mMylAQ1EBx/Y2Y5pq3SFd2ZM4NsbNFUVRly9hSdIf1GcrQ==] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:to="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsTable" xlink:to="us-gaap_AwardTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/OptionSummaryTable">
    <loc xlink:type="locator" xlink:label="hrtx_OptionSummaryAbstract" xlink:href="hrtx-20140930.xsd#hrtx_OptionSummaryAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_OptionSummaryAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_OptionSummaryAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/Note1BusinessDetails">
    <loc xlink:type="locator" xlink:label="hrtx_Note1BusinessDetailsLineItems" xlink:href="hrtx-20140930.xsd#hrtx_Note1BusinessDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="hrtx_Note1BusinessDetailsTable" xlink:href="hrtx-20140930.xsd#hrtx_Note1BusinessDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="hrtx_Note1BusinessDetailsLineItems" xlink:to="hrtx_Note1BusinessDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note1BusinessDetailsTable" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_ReverseStockSplitMember" xlink:href="hrtx-20140930.xsd#hrtx_ReverseStockSplitMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonmonetaryTransactionTypeDomain" xlink:to="hrtx_ReverseStockSplitMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note1BusinessDetailsLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note1BusinessDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note1BusinessDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note1BusinessDetailsLineItems" xlink:to="us-gaap_Cash" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/Note3AccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_Cash" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/Note4ConvertibleNotestoRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:label="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:href="hrtx-20140930.xsd#hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:href="hrtx-20140930.xsd#hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecurityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtSecurityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:to="us-gaap_DebtSecurityAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MajorTypesOfDebtSecuritiesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtSecuritiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtSecurityAxis" xlink:to="us-gaap_MajorTypesOfDebtSecuritiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MajorTypesOfDebtSecuritiesDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtSecuritiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtSecurityAxis" xlink:to="us-gaap_MajorTypesOfDebtSecuritiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_PrincipalAmountMember" xlink:href="hrtx-20140930.xsd#hrtx_PrincipalAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="hrtx_PrincipalAmountMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableOtherPayablesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_NotesPayableOtherPayablesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_InitialClosingAmountMember" xlink:href="hrtx-20140930.xsd#hrtx_InitialClosingAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MajorTypesOfDebtSecuritiesDomain" xlink:to="hrtx_InitialClosingAmountMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_PurchaseOptionMember" xlink:href="hrtx-20140930.xsd#hrtx_PurchaseOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MajorTypesOfDebtSecuritiesDomain" xlink:to="hrtx_PurchaseOptionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_InCaseOfDebtConversionMember" xlink:href="hrtx-20140930.xsd#hrtx_InCaseOfDebtConversionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="hrtx_InCaseOfDebtConversionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1" xlink:href="hrtx-20140930.xsd#hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing" xlink:href="hrtx-20140930.xsd#hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_PurchaseOptionUnderPrivatePlacement" xlink:href="hrtx-20140930.xsd#hrtx_PurchaseOptionUnderPrivatePlacement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="hrtx_PurchaseOptionUnderPrivatePlacement" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_DebtInstrumentConversionRatioShares" xlink:href="hrtx-20140930.xsd#hrtx_DebtInstrumentConversionRatioShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="hrtx_DebtInstrumentConversionRatioShares" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal" xlink:href="hrtx-20140930.xsd#hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_BeneficialOwnershipAfterConversion" xlink:href="hrtx-20140930.xsd#hrtx_BeneficialOwnershipAfterConversion"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="hrtx_BeneficialOwnershipAfterConversion" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes" xlink:href="hrtx-20140930.xsd#hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes" xlink:href="hrtx-20140930.xsd#hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaidInKindInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaidInKindInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_PaidInKindInterest" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent" xlink:href="hrtx-20140930.xsd#hrtx_ConvertibleNotesPayableRelatedPartiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" order="16" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/Note5StockholdersEquityDetails">
    <loc xlink:type="locator" xlink:label="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="hrtx_Note5StockholdersEquityDetailsTable" xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="hrtx_Note5StockholdersEquityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note5StockholdersEquityDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note5StockholdersEquityDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note5StockholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note5StockholdersEquityDetailsTable" xlink:to="us-gaap_StatementScenarioAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note5StockholdersEquityDetailsTable" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hrtx_Note5StockholdersEquityDetailsTable" xlink:to="dei_LegalEntityAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain_0" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_PrivatePlacement2011Member" xlink:href="hrtx-20140930.xsd#hrtx_PrivatePlacement2011Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hrtx_PrivatePlacement2011Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_PrivatePlacement2012Member" xlink:href="hrtx-20140930.xsd#hrtx_PrivatePlacement2012Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hrtx_PrivatePlacement2012Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_CommonStockAndPrefundedWarrantsMember" xlink:href="hrtx-20140930.xsd#hrtx_CommonStockAndPrefundedWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="hrtx_CommonStockAndPrefundedWarrantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_PreFundedWarrantsMember" xlink:href="hrtx-20140930.xsd#hrtx_PreFundedWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="hrtx_PreFundedWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_ReverseStockSplitMember" xlink:href="hrtx-20140930.xsd#hrtx_ReverseStockSplitMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonmonetaryTransactionTypeDomain" xlink:to="hrtx_ReverseStockSplitMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_JefferiesLLCMember" xlink:href="hrtx-20140930.xsd#hrtx_JefferiesLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="hrtx_JefferiesLLCMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioPreviouslyReportedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_SharesAvailablePerWarrantExercised" xlink:href="hrtx-20140930.xsd#hrtx_SharesAvailablePerWarrantExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="hrtx_SharesAvailablePerWarrantExercised" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit" xlink:href="hrtx-20140930.xsd#hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_LimitationOnExercisableWarrants" xlink:href="hrtx-20140930.xsd#hrtx_LimitationOnExercisableWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="hrtx_LimitationOnExercisableWarrants" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_SharePrice" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_WarrantTerm" xlink:href="hrtx-20140930.xsd#hrtx_WarrantTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="hrtx_WarrantTerm" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet" xlink:href="hrtx-20140930.xsd#hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="22" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://herontx.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentDescription" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>hrtx-20140930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no" ?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Nov 06 13:31:24 UTC 2014 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" xlink:type="locator"/>
    <label xlink:label="us-gaap_Cash_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <label xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:type="locator"/>
    <label xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <label xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:type="locator"/>
    <label xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other long-term assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <label xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <label xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_AccruedClinicalLiabilities" xlink:label="hrtx_AccruedClinicalLiabilities" xlink:type="locator"/>
    <label xlink:label="hrtx_AccruedClinicalLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued clinical liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_AccruedClinicalLiabilities" xlink:to="hrtx_AccruedClinicalLiabilities_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator"/>
    <label xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued payroll and employee-related liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator"/>
    <label xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other accrued expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_ConvertibleNotesPayableRelatedPartiesCurrent" xlink:label="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent" xlink:type="locator"/>
    <label xlink:label="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible notes payable to related parties, net of discount</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent" xlink:to="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent_lbl" xlink:type="arc"/>
    <label xlink:label="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent_lbl0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying Value of Notes Outstanding</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent" xlink:to="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:type="locator"/>
    <label xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:type="locator"/>
    <label xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <label xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <label xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:type="locator"/>
    <label xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#x2019; equity</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator"/>
    <label xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#x2019; equity</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator"/>
    <label xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and development</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator"/>
    <label xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" xlink:type="locator"/>
    <label xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:type="locator"/>
    <label xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:type="locator"/>
    <label xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest and other expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <label xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_NetIncomeLoss_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net loss</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator"/>
    <label xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic and diluted net loss per share (in Dollars per share)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator"/>
    <label xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares used in computing basic and diluted net loss per share (in Shares)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" xlink:type="locator"/>
    <label xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="locator"/>
    <label xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of debt discount</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of Debt Discount (Premium)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator"/>
    <label xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator"/>
    <label xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_IncreaseDecreaseInClinicalLiabilities" xlink:label="hrtx_IncreaseDecreaseInClinicalLiabilities" xlink:type="locator"/>
    <label xlink:label="hrtx_IncreaseDecreaseInClinicalLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued clinical liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_IncreaseDecreaseInClinicalLiabilities" xlink:to="hrtx_IncreaseDecreaseInClinicalLiabilities_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="locator"/>
    <label xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued payroll and employee-related liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:type="locator"/>
    <label xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator"/>
    <label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used for operating activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator"/>
    <label xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator"/>
    <label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used for investing activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:type="locator"/>
    <label xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from warrant exercises</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Warrant Exercises</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:type="locator"/>
    <label xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from purchases under the Employee Stock Purchase Plan</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator"/>
    <label xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from stock option exercises</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator"/>
    <label xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net proceeds from sale of common stock and pre-funded warrants</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator"/>
    <label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator"/>
    <label xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in cash</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash at beginning of period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash at end of period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_DisclosureTextBlockAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Text Block [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureTextBlockAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_EquityExcludedFromCalculationOfDilutedEarningsPerShareAbstract" xlink:label="hrtx_EquityExcludedFromCalculationOfDilutedEarningsPerShareAbstract" xlink:type="locator"/>
    <label xlink:label="hrtx_EquityExcludedFromCalculationOfDilutedEarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Excluded From Calculation of Diluted Earnings Per Share [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_EquityExcludedFromCalculationOfDilutedEarningsPerShareAbstract" xlink:to="hrtx_EquityExcludedFromCalculationOfDilutedEarningsPerShareAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator"/>
    <label xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" xlink:type="locator"/>
    <label xlink:label="us-gaap_StockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Option [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator"/>
    <label xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares excluded</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:type="locator"/>
    <label xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="locator"/>
    <label xlink:label="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt Securities [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_StockBasedCompensationExpenseAbstract" xlink:label="hrtx_StockBasedCompensationExpenseAbstract" xlink:type="locator"/>
    <label xlink:label="hrtx_StockBasedCompensationExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock-based Compensation Expense [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_StockBasedCompensationExpenseAbstract" xlink:to="hrtx_StockBasedCompensationExpenseAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <label xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator"/>
    <label xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator"/>
    <label xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <label xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare" xlink:label="hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare" xlink:type="locator"/>
    <label xlink:label="hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact on basic and diluted net loss per share (in Dollars per share)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare" xlink:to="hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <label xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <label xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_OptionValuationAssumptionsAbstract" xlink:label="hrtx_OptionValuationAssumptionsAbstract" xlink:type="locator"/>
    <label xlink:label="hrtx_OptionValuationAssumptionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Option Valuation Assumptions [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_OptionValuationAssumptionsAbstract" xlink:to="hrtx_OptionValuationAssumptionsAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividend yield</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Volatility</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator"/>
    <label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected life (years)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_OptionSummaryAbstract" xlink:label="hrtx_OptionSummaryAbstract" xlink:type="locator"/>
    <label xlink:label="hrtx_OptionSummaryAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Option Summary [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_OptionSummaryAbstract" xlink:to="hrtx_OptionSummaryAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Shares</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Shares</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator"/>
    <label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Remaining Contractual Term</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Remaining Contractual Term</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Granted</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator"/>
    <label xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Exercised</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Expired and forfeited</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expired and forfeited</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#x2019; EQUITY</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders&#x2019; equity:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:type="locator"/>
    <label xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_OperatingActivitiesAbstract" xlink:label="hrtx_OperatingActivitiesAbstract" xlink:type="locator"/>
    <label xlink:label="hrtx_OperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating activities:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_OperatingActivitiesAbstract" xlink:to="hrtx_OperatingActivitiesAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:label="hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:type="locator"/>
    <label xlink:label="hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used for operating activities:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:to="hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:label="hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:type="locator"/>
    <label xlink:label="hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_InvestingActivitiesAbstract" xlink:label="hrtx_InvestingActivitiesAbstract" xlink:type="locator"/>
    <label xlink:label="hrtx_InvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investing activities:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_InvestingActivitiesAbstract" xlink:to="hrtx_InvestingActivitiesAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_FinancingActivitiesAbstract" xlink:label="hrtx_FinancingActivitiesAbstract" xlink:type="locator"/>
    <label xlink:label="hrtx_FinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing activities:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_FinancingActivitiesAbstract" xlink:to="hrtx_FinancingActivitiesAbstract_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BasisOfAccounting" xlink:label="us-gaap_BasisOfAccounting" xlink:type="locator"/>
    <label xlink:label="us-gaap_BasisOfAccounting_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting [Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccounting" xlink:to="us-gaap_BasisOfAccounting_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation, Activity [Table Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="locator"/>
    <label xlink:label="us-gaap_NonmonetaryTransactionTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonmonetary Transaction Type [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_ReverseStockSplitMember" xlink:label="hrtx_ReverseStockSplitMember" xlink:type="locator"/>
    <label xlink:label="hrtx_ReverseStockSplitMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reverse Stock Split [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_ReverseStockSplitMember" xlink:to="hrtx_ReverseStockSplitMember_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term Debt, Type [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="us-gaap_NotesPayableOtherPayablesMember" xlink:type="locator"/>
    <label xlink:label="us-gaap_NotesPayableOtherPayablesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Other Payables [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableOtherPayablesMember" xlink:to="us-gaap_NotesPayableOtherPayablesMember_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtSecurityAxis" xlink:label="us-gaap_DebtSecurityAxis" xlink:type="locator"/>
    <label xlink:label="us-gaap_DebtSecurityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Security [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecurityAxis" xlink:to="us-gaap_DebtSecurityAxis_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_InitialClosingAmountMember" xlink:label="hrtx_InitialClosingAmountMember" xlink:type="locator"/>
    <label xlink:label="hrtx_InitialClosingAmountMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial Closing Amount [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_InitialClosingAmountMember" xlink:to="hrtx_InitialClosingAmountMember_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_PurchaseOptionMember" xlink:label="hrtx_PurchaseOptionMember" xlink:type="locator"/>
    <label xlink:label="hrtx_PurchaseOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase Option [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_PurchaseOptionMember" xlink:to="hrtx_PurchaseOptionMember_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <label xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <label xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <label xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_PrincipalAmountMember" xlink:label="hrtx_PrincipalAmountMember" xlink:type="locator"/>
    <label xlink:label="hrtx_PrincipalAmountMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal Amount [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_PrincipalAmountMember" xlink:to="hrtx_PrincipalAmountMember_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator"/>
    <label xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion Description [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_InCaseOfDebtConversionMember" xlink:label="hrtx_InCaseOfDebtConversionMember" xlink:type="locator"/>
    <label xlink:label="hrtx_InCaseOfDebtConversionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In Case of Debt Conversion [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_InCaseOfDebtConversionMember" xlink:to="hrtx_InCaseOfDebtConversionMember_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <label xlink:label="us-gaap_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioPreviouslyReportedMember" xlink:label="us-gaap_ScenarioPreviouslyReportedMember" xlink:type="locator"/>
    <label xlink:label="us-gaap_ScenarioPreviouslyReportedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Previously Reported [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioPreviouslyReportedMember" xlink:to="us-gaap_ScenarioPreviouslyReportedMember_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <label xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_PrivatePlacement2011Member" xlink:label="hrtx_PrivatePlacement2011Member" xlink:type="locator"/>
    <label xlink:label="hrtx_PrivatePlacement2011Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private Placement 2011 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_PrivatePlacement2011Member" xlink:to="hrtx_PrivatePlacement2011Member_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_PrivatePlacement2012Member" xlink:label="hrtx_PrivatePlacement2012Member" xlink:type="locator"/>
    <label xlink:label="hrtx_PrivatePlacement2012Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private Placement 2012 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_PrivatePlacement2012Member" xlink:to="hrtx_PrivatePlacement2012Member_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <label xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_JefferiesLLCMember" xlink:label="hrtx_JefferiesLLCMember" xlink:type="locator"/>
    <label xlink:label="hrtx_JefferiesLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Jefferies LLC [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_JefferiesLLCMember" xlink:to="hrtx_JefferiesLLCMember_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator"/>
    <label xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc"/>

    <!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTqBhR1cOw37qdfT/PN3Se6viq8MEgNf1gK37o5+ZijZsLc4+wNvBpwat6ujVccMPLaHIcSpbtFx9r9IOsbMrTepi+shSr0uaMJaWQNjypzAebLePqExZr4z4W8JNorPgCB8yim1oO5mMylAQ1EBx/Y2Y5pq3SFd2ZMVy75J1iy7ZDwhrTnu65jTg==] CSR-->
    <loc xlink:href="hrtx-20140930.xsd#hrtx_PreFundedWarrantsMember" xlink:label="hrtx_PreFundedWarrantsMember" xlink:type="locator"/>
    <label xlink:label="hrtx_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre Funded Warrants [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_PreFundedWarrantsMember" xlink:to="hrtx_PreFundedWarrantsMember_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_CommonStockAndPrefundedWarrantsMember" xlink:label="hrtx_CommonStockAndPrefundedWarrantsMember" xlink:type="locator"/>
    <label xlink:label="hrtx_CommonStockAndPrefundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock and Prefunded Warrants [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_CommonStockAndPrefundedWarrantsMember" xlink:to="hrtx_CommonStockAndPrefundedWarrantsMember_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="locator"/>
    <label xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:type="locator"/>
    <label xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-term Debt and Capital Securities, Net</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <label xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1" xlink:label="hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1" xlink:type="locator"/>
    <label xlink:label="hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt Issuable In Connection With Private Placement1</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1" xlink:to="hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing" xlink:label="hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing" xlink:type="locator"/>
    <label xlink:label="hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Authorized Under Private Placement Initial Closing</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing" xlink:to="hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_PurchaseOptionUnderPrivatePlacement" xlink:label="hrtx_PurchaseOptionUnderPrivatePlacement" xlink:type="locator"/>
    <label xlink:label="hrtx_PurchaseOptionUnderPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Option Under Private Placement</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_PurchaseOptionUnderPrivatePlacement" xlink:to="hrtx_PurchaseOptionUnderPrivatePlacement_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" xlink:type="locator"/>
    <label xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Maturity Date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_DebtInstrumentConversionRatioShares" xlink:label="hrtx_DebtInstrumentConversionRatioShares" xlink:type="locator"/>
    <label xlink:label="hrtx_DebtInstrumentConversionRatioShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Ratio, Shares (in Shares)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_DebtInstrumentConversionRatioShares" xlink:to="hrtx_DebtInstrumentConversionRatioShares_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal" xlink:label="hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal" xlink:type="locator"/>
    <label xlink:label="hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Ratio, Multiple of Principal</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal" xlink:to="hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_BeneficialOwnershipAfterConversion" xlink:label="hrtx_BeneficialOwnershipAfterConversion" xlink:type="locator"/>
    <label xlink:label="hrtx_BeneficialOwnershipAfterConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Beneficial Ownership After Conversion</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_BeneficialOwnershipAfterConversion" xlink:to="hrtx_BeneficialOwnershipAfterConversion_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes" xlink:label="hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes" xlink:type="locator"/>
    <label xlink:label="hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notice Period Associated with Beneficial Ownership Percentage Limitation, Convertible Notes</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes" xlink:to="hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes" xlink:label="hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes" xlink:type="locator"/>
    <label xlink:label="hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Shares Registered For Resale In Connection With Convertible Notes (in Shares)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes" xlink:to="hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator"/>
    <label xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest" xlink:type="locator"/>
    <label xlink:label="us-gaap_PaidInKindInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Paid-in-Kind Interest</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaidInKindInterest" xlink:to="us-gaap_PaidInKindInterest_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="locator"/>
    <label xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:type="locator"/>
    <label xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:label="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:type="locator"/>
    <label xlink:label="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Number of Equity Instruments</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:to="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:type="locator"/>
    <label xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized (in Shares)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <label xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues (in Shares)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <label xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator"/>
    <label xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Stock Issuance Costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_SharesAvailablePerWarrantExercised" xlink:label="hrtx_SharesAvailablePerWarrantExercised" xlink:type="locator"/>
    <label xlink:label="hrtx_SharesAvailablePerWarrantExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Available Per Warrant Exercised (in Shares)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_SharesAvailablePerWarrantExercised" xlink:to="hrtx_SharesAvailablePerWarrantExercised_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit" xlink:label="hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit" xlink:type="locator"/>
    <label xlink:label="hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Arrangement, Warrants To Purchase Shares, Purchase Price Per Unit (in Dollars per Share)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit" xlink:to="hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_LimitationOnExercisableWarrants" xlink:label="hrtx_LimitationOnExercisableWarrants" xlink:type="locator"/>
    <label xlink:label="hrtx_LimitationOnExercisableWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Limitation On Exercisable Warrants</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_LimitationOnExercisableWarrants" xlink:to="hrtx_LimitationOnExercisableWarrants_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator"/>
    <label xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised (in Shares)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:type="locator"/>
    <label xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Price Per Share (in Dollars per share)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:type="locator"/>
    <label xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share (in Dollars per share)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator"/>
    <label xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:type="locator"/>
    <label xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Price (in Dollars per share)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator"/>
    <label xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_WarrantTerm" xlink:label="hrtx_WarrantTerm" xlink:type="locator"/>
    <label xlink:label="hrtx_WarrantTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Term</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_WarrantTerm" xlink:to="hrtx_WarrantTerm_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet" xlink:label="hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet" xlink:type="locator"/>
    <label xlink:label="hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Net (in Shares)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet" xlink:to="hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator"/>
    <label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator"/>
    <label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:type="locator"/>
    <label xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiquidityDisclosureTextBlock" xlink:label="us-gaap_LiquidityDisclosureTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_LiquidityDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liquidity Disclosure [Policy Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiquidityDisclosureTextBlock" xlink:to="us-gaap_LiquidityDisclosureTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityTablesTable" xlink:label="hrtx_Note5StockholdersEquityTablesTable" xlink:type="locator"/>
    <label xlink:label="hrtx_Note5StockholdersEquityTablesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 5 - Stockholders' Equity (Tables) [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_Note5StockholdersEquityTablesTable" xlink:to="hrtx_Note5StockholdersEquityTablesTable_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityTablesLineItems" xlink:label="hrtx_Note5StockholdersEquityTablesLineItems" xlink:type="locator"/>
    <label xlink:label="hrtx_Note5StockholdersEquityTablesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 5 - Stockholders' Equity (Tables) [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_Note5StockholdersEquityTablesLineItems" xlink:to="hrtx_Note5StockholdersEquityTablesLineItems_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator"/>
    <label xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator"/>
    <label xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator"/>
    <label xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <label xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator"/>
    <label xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator"/>
    <label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsTable" xlink:label="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsTable" xlink:type="locator"/>
    <label xlink:label="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 5 - Stockholders' Equity (Details) - Option Valuation Assumptions [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsTable" xlink:to="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsTable_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:label="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:type="locator"/>
    <label xlink:label="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 5 - Stockholders' Equity (Details) - Option Valuation Assumptions [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:to="hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="locator"/>
    <label xlink:label="us-gaap_NonmonetaryTransactionTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonmonetary Transaction Type [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonmonetaryTransactionTypeDomain" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_Note1BusinessDetailsTable" xlink:label="hrtx_Note1BusinessDetailsTable" xlink:type="locator"/>
    <label xlink:label="hrtx_Note1BusinessDetailsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 1 - Business (Details) [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_Note1BusinessDetailsTable" xlink:to="hrtx_Note1BusinessDetailsTable_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_Note1BusinessDetailsLineItems" xlink:label="hrtx_Note1BusinessDetailsLineItems" xlink:type="locator"/>
    <label xlink:label="hrtx_Note1BusinessDetailsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 1 - Business (Details) [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_Note1BusinessDetailsLineItems" xlink:to="hrtx_Note1BusinessDetailsLineItems_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain" xlink:type="locator"/>
    <label xlink:label="us-gaap_DebtConversionNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Name [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="us-gaap_DebtConversionNameDomain_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <label xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:type="locator"/>
    <label xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term Debt, Type [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtSecuritiesDomain" xlink:label="us-gaap_MajorTypesOfDebtSecuritiesDomain" xlink:type="locator"/>
    <label xlink:label="us-gaap_MajorTypesOfDebtSecuritiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Types of Debt Securities [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorTypesOfDebtSecuritiesDomain" xlink:to="us-gaap_MajorTypesOfDebtSecuritiesDomain_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <label xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:label="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:type="locator"/>
    <label xlink:label="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 4 - Convertible Notes to Related Parties (Details) [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:to="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:label="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:type="locator"/>
    <label xlink:label="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 4 - Convertible Notes to Related Parties (Details) [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <label xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator"/>
    <label xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <label xlink:label="us-gaap_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Unspecified [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioUnspecifiedDomain_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <label xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityDetailsTable" xlink:label="hrtx_Note5StockholdersEquityDetailsTable" xlink:type="locator"/>
    <label xlink:label="hrtx_Note5StockholdersEquityDetailsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 5 - Stockholders' Equity (Details) [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_Note5StockholdersEquityDetailsTable" xlink:to="hrtx_Note5StockholdersEquityDetailsTable_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityDetailsLineItems" xlink:label="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:type="locator"/>
    <label xlink:label="hrtx_Note5StockholdersEquityDetailsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 5 - Stockholders' Equity (Details) [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_Note5StockholdersEquityDetailsLineItems" xlink:to="hrtx_Note5StockholdersEquityDetailsLineItems_lbl" xlink:type="arc"/>
    <label xlink:label="hrtx_AccruedClinicalLiabilities_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of clinical obligations incurred and payable.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_AccruedClinicalLiabilities" xlink:to="hrtx_AccruedClinicalLiabilities_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_BeneficialOwnershipAfterConversion_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage amount the holder would beneficially own of the company's outstanding common stock.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_BeneficialOwnershipAfterConversion" xlink:to="hrtx_BeneficialOwnershipAfterConversion_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common shares registered for resale in connection with convertible notes.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes" xlink:to="hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible debt issuable in connection with private placement.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1" xlink:to="hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the holder.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent" xlink:to="hrtx_ConvertibleNotesPayableRelatedPartiesCurrent_lbl1" xlink:type="arc"/>
    <label xlink:label="hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The multiple of principal used in calculating the number of shares converted from the notes.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal" xlink:to="hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_DebtInstrumentConversionRatioShares_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of shares per $1,000 of principal of note.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_DebtInstrumentConversionRatioShares" xlink:to="hrtx_DebtInstrumentConversionRatioShares_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase Price Unit (1 Warrant to Purchase 0.5 shares of Common Stock)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit" xlink:to="hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Impact on basic and diluted net loss per common share.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare" xlink:to="hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_IncreaseDecreaseInClinicalLiabilities_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The increase (decrease) during the reporting period in the aggregate amount of obligations related to clinical liabilities.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_IncreaseDecreaseInClinicalLiabilities" xlink:to="hrtx_IncreaseDecreaseInClinicalLiabilities_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_LimitationOnExercisableWarrants_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">There is no right to exercise the Warrants to the extent that the holder would beneficially own in excess of the stated percentage of The Company's outstanding shares of common stock.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_LimitationOnExercisableWarrants" xlink:to="hrtx_LimitationOnExercisableWarrants_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes authorized under private placement initial closing.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing" xlink:to="hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notice period associated with beneficial ownership percentage limitation, convertible notes.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes" xlink:to="hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_PurchaseOptionUnderPrivatePlacement_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase option under private placement.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_PurchaseOptionUnderPrivatePlacement" xlink:to="hrtx_PurchaseOptionUnderPrivatePlacement_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_SharesAvailablePerWarrantExercised_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of shares available to be exercised per warrant.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_SharesAvailablePerWarrantExercised" xlink:to="hrtx_SharesAvailablePerWarrantExercised_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of share options (or share units) exercised during the current period, net of shares retained for cashless exercises.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet" xlink:to="hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_WarrantTerm_lbl0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The exercisable term from the date of issuance.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_WarrantTerm" xlink:to="hrtx_WarrantTerm_lbl0" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_DisclosureAxis" xlink:label="hrtx_DisclosureAxis" xlink:type="locator"/>
    <label xlink:label="hrtx_DisclosureAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_DisclosureAxis" xlink:to="hrtx_DisclosureAxis_lbl" xlink:type="arc"/>
    <label xlink:label="hrtx_CommonStockAndPrefundedWarrantsMember_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock And Prefunded Warrants [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_CommonStockAndPrefundedWarrantsMember" xlink:to="hrtx_CommonStockAndPrefundedWarrantsMember_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_CommonStockAndPrefundedWarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information relating to the proceeds from the issuance of common stock and pre-funded warrants.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_CommonStockAndPrefundedWarrantsMember" xlink:to="hrtx_CommonStockAndPrefundedWarrantsMember_lbl1" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_EmployeeStockPurchasePlan1997Member" xlink:label="hrtx_EmployeeStockPurchasePlan1997Member" xlink:type="locator"/>
    <label xlink:label="hrtx_EmployeeStockPurchasePlan1997Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan 1997 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_EmployeeStockPurchasePlan1997Member" xlink:to="hrtx_EmployeeStockPurchasePlan1997Member_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_EquityIncentivePlan2007Member" xlink:label="hrtx_EquityIncentivePlan2007Member" xlink:type="locator"/>
    <label xlink:label="hrtx_EquityIncentivePlan2007Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Incentive Plan 2007 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_EquityIncentivePlan2007Member" xlink:to="hrtx_EquityIncentivePlan2007Member_lbl" xlink:type="arc"/>
    <label xlink:label="hrtx_InCaseOfDebtConversionMember_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Case Of Debt Conversion [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_InCaseOfDebtConversionMember" xlink:to="hrtx_InCaseOfDebtConversionMember_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_InCaseOfDebtConversionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">When the debt principal is converted into the underlying securities.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_InCaseOfDebtConversionMember" xlink:to="hrtx_InCaseOfDebtConversionMember_lbl1" xlink:type="arc"/>
    <label xlink:label="hrtx_InitialClosingAmountMember_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Initial Closing Amount [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_InitialClosingAmountMember" xlink:to="hrtx_InitialClosingAmountMember_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_JefferiesLLCMember_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Jefferies LLC [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_JefferiesLLCMember" xlink:to="hrtx_JefferiesLLCMember_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_PreFundedWarrantsMember_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre Funded Warrants [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_PreFundedWarrantsMember" xlink:to="hrtx_PreFundedWarrantsMember_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_PreFundedWarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-funded warrants offered as a component of the 2014 Common Stock offering.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_PreFundedWarrantsMember" xlink:to="hrtx_PreFundedWarrantsMember_lbl1" xlink:type="arc"/>
    <label xlink:label="hrtx_PrincipalAmountMember_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Principal Amount [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_PrincipalAmountMember" xlink:to="hrtx_PrincipalAmountMember_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_PrivatePlacement2011Member_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Placement 2011 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_PrivatePlacement2011Member" xlink:to="hrtx_PrivatePlacement2011Member_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_PrivatePlacement2012Member_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Placement 2012 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_PrivatePlacement2012Member" xlink:to="hrtx_PrivatePlacement2012Member_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_PurchaseOptionMember_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Option [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_PurchaseOptionMember" xlink:to="hrtx_PurchaseOptionMember_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_ReverseStockSplitMember_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reverse Stock Split [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_ReverseStockSplitMember" xlink:to="hrtx_ReverseStockSplitMember_lbl0" xlink:type="arc"/>
    <label xlink:label="hrtx_ReverseStockSplitMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The conversion of a reverse stock split where there is a reduction in the shares outstanding.</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_ReverseStockSplitMember" xlink:to="hrtx_ReverseStockSplitMember_lbl1" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_SubjectToLimitationsMember" xlink:label="hrtx_SubjectToLimitationsMember" xlink:type="locator"/>
    <label xlink:label="hrtx_SubjectToLimitationsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subject To Limitations [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_SubjectToLimitationsMember" xlink:to="hrtx_SubjectToLimitationsMember_lbl" xlink:type="arc"/>
    <loc xlink:href="hrtx-20140930.xsd#hrtx_DocumentAndEntityInformationAbstract" xlink:label="hrtx_DocumentAndEntityInformationAbstract" xlink:type="locator"/>
    <label xlink:label="hrtx_DocumentAndEntityInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document and Entity Information [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_DocumentAndEntityInformationAbstract" xlink:to="hrtx_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc"/>
    <label xlink:label="hrtx_IncreaseDecreaseInClinicalLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IncreaseDecreaseInClinicalLiabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hrtx_IncreaseDecreaseInClinicalLiabilities" xlink:to="hrtx_IncreaseDecreaseInClinicalLiabilities_lbl1" xlink:type="arc"/>
    <label xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
    <label xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_AssetsCurrent_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xlink:type="arc"/>
    <label xlink:label="us-gaap_OperatingExpenses_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Accrued Liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <label xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:type="arc"/>
    <label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xlink:type="arc"/>
    <label xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_OtherNonoperatingExpense_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
    <label xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
    <label xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_Assets_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
    <label xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <label xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
    <label xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:type="locator"/>
    <label xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
    <label xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <label xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:type="locator"/>
    <label xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <label xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <label xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" xlink:type="locator"/>
    <label xlink:label="dei_AmendmentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
    <label xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc"/>
    <label xlink:label="us-gaap_StockholdersEquity_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allocated Share-based Compensation Expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl0" xlink:type="arc"/>
    <label xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl0" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <label xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <label xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc"/>
  </labelLink>

</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>hrtx-20140930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Nov 06 13:31:24 UTC 2014 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_ConsolidatedBalanceSheet" roleURI="http://herontx.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_ConsolidatedIncomeStatement" roleURI="http://herontx.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_ConsolidatedCashFlow" roleURI="http://herontx.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note1Business" roleURI="http://herontx.com/role/Note1Business"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note2BasisofPresentation" roleURI="http://herontx.com/role/Note2BasisofPresentation"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note3AccountingPolicies" roleURI="http://herontx.com/role/Note3AccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note4ConvertibleNotestoRelatedParties" roleURI="http://herontx.com/role/Note4ConvertibleNotestoRelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note5StockholdersEquity" roleURI="http://herontx.com/role/Note5StockholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note6IncomeTaxes" roleURI="http://herontx.com/role/Note6IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_AccountingPoliciesByPolicy" roleURI="http://herontx.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note3AccountingPoliciesTables" roleURI="http://herontx.com/role/Note3AccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note5StockholdersEquityTables" roleURI="http://herontx.com/role/Note5StockholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_EquityExcludedFromCalculationofDilutedEarningsPerShareTable" roleURI="http://herontx.com/role/EquityExcludedFromCalculationofDilutedEarningsPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_StockbasedCompensationExpenseTable" roleURI="http://herontx.com/role/StockbasedCompensationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_OptionValuationAssumptionsTable" roleURI="http://herontx.com/role/OptionValuationAssumptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_OptionSummaryTable" roleURI="http://herontx.com/role/OptionSummaryTable"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note1BusinessDetails" roleURI="http://herontx.com/role/Note1BusinessDetails"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note3AccountingPoliciesDetails" roleURI="http://herontx.com/role/Note3AccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note4ConvertibleNotestoRelatedPartiesDetails" roleURI="http://herontx.com/role/Note4ConvertibleNotestoRelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#hrtx_r_Note5StockholdersEquityDetails" roleURI="http://herontx.com/role/Note5StockholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="hrtx-20140930.xsd#DocumentAndEntityInformation" roleURI="http://herontx.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AccruedClinicalLiabilities" xlink:href="hrtx-20140930.xsd#hrtx_AccruedClinicalLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="AccruedClinicalLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesPayableRelatedPartiesCurrent" xlink:href="hrtx-20140930.xsd#hrtx_ConvertibleNotesPayableRelatedPartiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="ConvertibleNotesPayableRelatedPartiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_OperatingExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingExpense" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="OperatingActivitiesAbstract" xlink:href="hrtx-20140930.xsd#hrtx_OperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="OperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:href="hrtx-20140930.xsd#hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:href="hrtx-20140930.xsd#hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:to="ChangesInOperatingAssetsAndLiabilitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInClinicalLiabilities" xlink:href="hrtx-20140930.xsd#hrtx_IncreaseDecreaseInClinicalLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="IncreaseDecreaseInClinicalLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="InvestingActivitiesAbstract" xlink:href="hrtx-20140930.xsd#hrtx_InvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="InvestingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="FinancingActivitiesAbstract" xlink:href="hrtx-20140930.xsd#hrtx_FinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="FinancingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/Note1Business">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/Note2BasisofPresentation">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccounting" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_BasisOfAccounting" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/Note3AccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/Note4ConvertibleNotestoRelatedParties">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/Note5StockholdersEquity">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/Note6IncomeTaxes">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiquidityDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiquidityDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LiquidityDisclosureTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/Note3AccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/Note5StockholdersEquityTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="Note5StockholdersEquityTablesTable" xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityTablesTable"/>
    <loc xlink:type="locator" xlink:label="Note5StockholdersEquityTablesLineItems" xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="Note5StockholdersEquityTablesTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityTablesTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityTablesTable" xlink:to="Note5StockholdersEquityTablesLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityTablesLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/EquityExcludedFromCalculationofDilutedEarningsPerShareTable">
    <loc xlink:type="locator" xlink:label="EquityExcludedFromCalculationOfDilutedEarningsPerShareAbstract" xlink:href="hrtx-20140930.xsd#hrtx_EquityExcludedFromCalculationOfDilutedEarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityExcludedFromCalculationOfDilutedEarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_StockOptionMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_WarrantMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/StockbasedCompensationExpenseTable">
    <loc xlink:type="locator" xlink:label="StockBasedCompensationExpenseAbstract" xlink:href="hrtx-20140930.xsd#hrtx_StockBasedCompensationExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedCompensationExpenseAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare" xlink:href="hrtx-20140930.xsd#hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTqBhR1cOw37qdfT/PN3Se6viq8MEgNf1gK37o5+ZijZsLc4+wNvBpwat6ujVccMPLaHIcSpbtFx9r9IOsbMrTepi+shSr0uaMJaWQNjypzAebLePqExZr4z4W8JNorPgCB8yim1oO5mMylAQ1EBx/Y2Y5pq3SFd2ZMZSwcnb2fD36rdnAilMJu/Q==] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/OptionValuationAssumptionsTable">
    <loc xlink:type="locator" xlink:label="OptionValuationAssumptionsAbstract" xlink:href="hrtx-20140930.xsd#hrtx_OptionValuationAssumptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="Note5StockholdersEquityDetailsOptionValuationAssumptionsTable" xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsTable"/>
    <loc xlink:type="locator" xlink:label="Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionValuationAssumptionsAbstract" xlink:to="Note5StockholdersEquityDetailsOptionValuationAssumptionsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsOptionValuationAssumptionsTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsOptionValuationAssumptionsTable" xlink:to="Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/OptionSummaryTable">
    <loc xlink:type="locator" xlink:label="OptionSummaryAbstract" xlink:href="hrtx-20140930.xsd#hrtx_OptionSummaryAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionSummaryAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionSummaryAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionSummaryAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionSummaryAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/Note1BusinessDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="Note1BusinessDetailsTable" xlink:href="hrtx-20140930.xsd#hrtx_Note1BusinessDetailsTable"/>
    <loc xlink:type="locator" xlink:label="Note1BusinessDetailsLineItems" xlink:href="hrtx-20140930.xsd#hrtx_Note1BusinessDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="Note1BusinessDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note1BusinessDetailsTable" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ReverseStockSplitMember" xlink:href="hrtx-20140930.xsd#hrtx_ReverseStockSplitMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="ReverseStockSplitMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note1BusinessDetailsTable" xlink:to="Note1BusinessDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note1BusinessDetailsLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note1BusinessDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note1BusinessDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note1BusinessDetailsLineItems" xlink:to="us-gaap_Cash" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/Note3AccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/Note4ConvertibleNotestoRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:href="hrtx-20140930.xsd#hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:href="hrtx-20140930.xsd#hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="Note4ConvertibleNotestoRelatedPartiesDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="InCaseOfDebtConversionMember" xlink:href="hrtx-20140930.xsd#hrtx_InCaseOfDebtConversionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="InCaseOfDebtConversionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableOtherPayablesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_NotesPayableOtherPayablesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecurityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtSecurityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:to="us-gaap_DebtSecurityAxis" order="4.0"/>
    <loc xlink:type="locator" xlink:label="InitialClosingAmountMember" xlink:href="hrtx-20140930.xsd#hrtx_InitialClosingAmountMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecurityAxis" xlink:to="InitialClosingAmountMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseOptionMember" xlink:href="hrtx-20140930.xsd#hrtx_PurchaseOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecurityAxis" xlink:to="PurchaseOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MajorTypesOfDebtSecuritiesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtSecuritiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecurityAxis" xlink:to="us-gaap_MajorTypesOfDebtSecuritiesDomain" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="5.0"/>
    <loc xlink:type="locator" xlink:label="PrincipalAmountMember" xlink:href="hrtx-20140930.xsd#hrtx_PrincipalAmountMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="PrincipalAmountMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsTable" xlink:to="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" order="6.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleDebtIssuableInConnectionWithPrivatePlacement1" xlink:href="hrtx-20140930.xsd#hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="ConvertibleDebtIssuableInConnectionWithPrivatePlacement1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NotesAuthorizedUnderPrivatePlacementInitialClosing" xlink:href="hrtx-20140930.xsd#hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="NotesAuthorizedUnderPrivatePlacementInitialClosing" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PurchaseOptionUnderPrivatePlacement" xlink:href="hrtx-20140930.xsd#hrtx_PurchaseOptionUnderPrivatePlacement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="PurchaseOptionUnderPrivatePlacement" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DebtInstrumentConversionRatioShares" xlink:href="hrtx-20140930.xsd#hrtx_DebtInstrumentConversionRatioShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="DebtInstrumentConversionRatioShares" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DebtInstrumentConversionRatioMultipleOfPrincipal" xlink:href="hrtx-20140930.xsd#hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="DebtInstrumentConversionRatioMultipleOfPrincipal" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BeneficialOwnershipAfterConversion" xlink:href="hrtx-20140930.xsd#hrtx_BeneficialOwnershipAfterConversion"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="BeneficialOwnershipAfterConversion" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes" xlink:href="hrtx-20140930.xsd#hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes" xlink:href="hrtx-20140930.xsd#hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaidInKindInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaidInKindInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_PaidInKindInterest" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesPayableRelatedPartiesCurrent" xlink:href="hrtx-20140930.xsd#hrtx_ConvertibleNotesPayableRelatedPartiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="ConvertibleNotesPayableRelatedPartiesCurrent" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4ConvertibleNotestoRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/Note5StockholdersEquityDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="Note5StockholdersEquityDetailsTable" xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="Note5StockholdersEquityDetailsLineItems" xlink:href="hrtx-20140930.xsd#hrtx_Note5StockholdersEquityDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="Note5StockholdersEquityDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacement2011Member" xlink:href="hrtx-20140930.xsd#hrtx_PrivatePlacement2011Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="PrivatePlacement2011Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacement2012Member" xlink:href="hrtx-20140930.xsd#hrtx_PrivatePlacement2012Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="PrivatePlacement2012Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="PreFundedWarrantsMember" xlink:href="hrtx-20140930.xsd#hrtx_PreFundedWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PreFundedWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="CommonStockAndPrefundedWarrantsMember" xlink:href="hrtx-20140930.xsd#hrtx_CommonStockAndPrefundedWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="CommonStockAndPrefundedWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsTable" xlink:to="us-gaap_StatementScenarioAxis" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioPreviouslyReportedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioPreviouslyReportedMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsTable" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis" order="5.0"/>
    <loc xlink:type="locator" xlink:label="ReverseStockSplitMember" xlink:href="hrtx-20140930.xsd#hrtx_ReverseStockSplitMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="ReverseStockSplitMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsTable" xlink:to="dei_LegalEntityAxis" order="6.0"/>
    <loc xlink:type="locator" xlink:label="JefferiesLLCMember" xlink:href="hrtx-20140930.xsd#hrtx_JefferiesLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="JefferiesLLCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsTable" xlink:to="Note5StockholdersEquityDetailsLineItems" order="7.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SharesAvailablePerWarrantExercised" xlink:href="hrtx-20140930.xsd#hrtx_SharesAvailablePerWarrantExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="SharesAvailablePerWarrantExercised" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit" xlink:href="hrtx-20140930.xsd#hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="LimitationOnExercisableWarrants" xlink:href="hrtx-20140930.xsd#hrtx_LimitationOnExercisableWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="LimitationOnExercisableWarrants" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_SharePrice" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="WarrantTerm" xlink:href="hrtx-20140930.xsd#hrtx_WarrantTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="WarrantTerm" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercisedNet" xlink:href="hrtx-20140930.xsd#hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercisedNet" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5StockholdersEquityDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://herontx.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="hrtx-20140930.xsd#hrtx_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityPublicFloat" order="5.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag" order="6.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentDescription" order="7.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey" order="8.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="9.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityVoluntaryFilers" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFilerCategory" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="14.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="15.0"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(0"GC=:&K@$``#P/```3``@"6T-O;G1E;G1?5'EP97-=
M+GAM;""B!`(HH``"````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#,EUU/@S`4AN]-_`^DMP9*
M4><T8[OPXU*7.']`I8=!!FW3=G/[]Q;V$;/@EL4EGAL::,]Y'\[%"^]@M*RK
M8`'&EDJFA$4Q"4!F2I1RFI*/R4O8)X%U7`I>*0DI68$EH^'EQ6"RTF`#7RUM
M2@KG]`.E-BN@YC92&J3?R96IN?.W9DHUSV9\"C2)XQ[-E'0@7>B:'F0X>(*<
MSRL7/"_]XS6)@<J2X'%]L-%*"=>Z*C/N/"E=2+&G$FX4(E_9GK%%J>V5QR"T
M4Z'9^5U@4_?F1V-*`<&8&_?*:X]!EQ7]4F;VJ=0L.MRD@U+E>9F!4-F\]A.(
MK#;`A2T`7%U%[1K5O)1;[@/Z[6%+VX6=&:1YO[;QB1P)$HYK)!PW2#AND7#T
MD'#<(>'H(^&X1\+!8BP@6!R58;%4AL53&19395A<E6&Q58;%5QD68V58G#7!
MXJS)?SFK\]D$:'O].T+;YLC/L76K"NR9/VCKIL>4"VY`O#OC4]S9`7[V/L3A
M,\[8*&U]VC-P^A2V<:ZI#K5O!,:5L`MT7<%HI^B3XNF">\D,FBPJ0'1HTS;[
M#K\!``#__P,`4$L#!!0`!@`(````(0"U53`C]0```$P"```+``@"7W)E;',O
M+G)E;',@H@0"**```@``````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````C)+/3L,P#,;O2+Q#Y/OJ
M;D@(H:6[3$B[(50>P"3N'[6-HR1`]_:$`X)*8]O1]N?//UO>[N9I5!\<8B].
MP[HH0;$S8GO7:GBMGU8/H&(B9VD4QQJ.'&%7W=YL7WBDE)MBU_NHLHN+&KJ4
M_"-B-!U/%`OQ['*ED3!1RF%HT9,9J&7<E.4]AK\>4"T\U<%J"`=[!ZH^^CSY
MLK<T36]X+^9]8I=.C$">$SO+=N5#9@NIS]NHFD++28,5\YS3$<G[(F,#GB;:
M7$_T_[8X<2)+B=!(X/,\WXIS0.OK@2Z?:*GXO<X\XJ>$X4UD^&'!Q0]47P``
M`/__`P!02P,$%``&``@````A`#B30&6&`0``V0T``!H`"`%X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<R"B!`$HH``!````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````+R7RVK#,!!%]X7^@]&^D4=YESC9E$*V;?H!PI[8)K9D)/61
MOZ\PP6D@3#=F-@9)>'0Y=S0:;78_;9-\H?.U-9F`22H2-+DM:E-FXN/P^K02
MB0_:%+JQ!C-Q1B]VV\>'S1LV.L2??%5W/HE1C,]$%4+W+*7/*VRUG]@.35PY
M6M?J$(>NE)W.3[I$J=)T(=W?&&)[$S/9%YEP^R+N?SAW<>?_8]OCL<[QQ>:?
M+9IP9POY;=W)5X@A!M6NQ)")8<K+?F4UB8J%O"\&ILQJ8$K*X88#)!UN."0;
M!<Q6*:"L6C*K65)B0#&K`47*X88#)!UN.#2;!;=5"\HJ%>\'UG*L4DH.]QDG
MCSBW4Z11P(Z&9*-F8^:-K[3#XCVXV*7X&/ARE=],4VDS'U/,T$!<A0Q3EYYB
M3HD!;C5`RE&CWN(^G)O8,5XMZL<D#NX*`W2%63/G"JPI.J,>HR%-K_X,4Y?,
MG5%BN-&09(`;#9!LU*A=1(CO*;RZU`]E_QVJKKQYD&U_`0``__\#`%!+`P04
M``8`"````"$`68[RR[`"``"9!P``#P```'AL+W=O<FMB;V]K+GAM;)25RV[;
M,!!%]P7Z#X+VC5Z.\T#L($\TFS1HTF1)T-+8(D*1*DG5]M]G1,/RR)&+=B61
M%`]G[MRA+BY7E0S^@+%"JTF8',5A`"K7A5"+2?CKY?[;:1A8QU7!I58P"==@
MP\OIUR\72VW>9UJ_!PA0=A*6SM7G463S$BINCW0-"E?FVE3<X=`L(EL;X(4M
M`5PEHS2.QU'%A0HWA'/S+PP]GXL<;G7>5*#<!F)`<H?AVU+4-IQ>S(6$UTU&
M`:_K1UYAW"L9!I);=U<(!\4D/,:A7D)OPC3U=2,DKIYE<19&TR[))Q,4,.>-
M="^8WI:.>J6C-!VW7[92O`I8VMVF=ABLWH0J]++]%*5==Z,,`UCZI3=1N!+7
MXSCNYKZ#6)1N.XGXB/"]@GB.?P;*I[=5A%VI@MTI)]R:/:B-^D)C"5O5'S"S
M)`S,N<`7\U`D;>"4<J-5`<I"P:ZYY"H']MSNL^RF,08()4T))CV,>7;<H5X*
M$7K.?M1@N".8C%"\WL/!]"DWW);LGE!&A#+:C^51.V`)NVZL4&`MV9;2TX\'
M]Z6H@Q4^]B<#%O/P1J,0>K@W`DW!'YZQJSS7#=9$+=B3EB(7V$.[BJ18]:XD
M)X-QC!A6!IO4B9D$UE(M<YK][)5D3#"G@YAC]NQT_EYJ66![L+O?#=J$1G)"
M$&>#B#&Z*M<5L!>^ZF>!]T2711+O;QZ0@,W6&SG6C,9P1CF?''I848QH1C@9
M=MLNGD\6]9Q!/?8YO8;Y9%+/V=F+W8+C0M+R9K15DF%_#EJD99&$$FH3'.RU
M[E^$00XFX7WI;P!JE&38LP<-1T$9;:!DV+G#$O<SRV@/)?]AW58A&E#2\\ZP
M@0\&A&7J)&JOZLX\.!C2^B`(5=F!J'M2[^;(+^+UG7.9XW^E?;1E\:=$V[_J
M]`,``/__`P!02P,$%``&``@````A`&`93K'_!```IQ,``!@```!X;"]W;W)K
M<VAE971S+W-H965T-"YX;6R4F%UOZC@0AN]7VO\0Y1X2.Y\@X*BTZNZ1]DBK
MU7Y<I\%`U"1&25IZ_OV.,R'U."&%&UK@S?CQZ_&,\>K;1Y%;[Z*J,UFN;39W
M;4N4J=QEY6%M__/W\RRVK;I)REV2RU*L[9^BMK]M?OUE=9;5:WT4HK$@0EFO
M[6/3G):.4Z='423U7)Y$"=_L954D#;RM#DY]JD2R:Q\J<H>[;N@425;:&&%9
MW1)#[O=9*IYD^E:(LL$@E<B3!OCK8W:J+]&*])9P15*]OIUFJ2Q.$.(ER[/F
M9QO4MHIT^?U0RBIYR6'>'\Q/TDOL]LT@?)&EE:SEOIE#.`=!AW->.`L'(FU6
MNPQFH&RW*K%?VP]L^<A#V]FL6H/^S<2YUOZWZJ,\_U9ENS^R4H#;L$YJ!5ZD
M?%72[SOU$3SL#)Y^;E?@S\K:B7WREC=_R?/O(CL<&UCN`&:D)K;<_7P2=0J.
M0I@Y#U2D5.8``*]6D:G4`$>2C_;O.=LUQ[7MA?,@<CT&<NM%U,USID+:5OI6
M-[+X#T6L"X5!>!?$`_KN>WYK$`>!VOD])4VR657R;$'2P)#U*5$IR)80^#(Q
MQ.BG>FVF,$45Y$%%6=N1;<$D:EB>]TT8K)QW<#3M)-NAA%'%XT6A%@+H>D28
MMXXX[OF%1(D5B5H#A;;%#R!VC\:-<8>*X!.>D(!!MY,H\=J&X/W`H3'R%B5Q
M:]@L""+?<UW7H",:GW$?))\:@N=3/+66'J3ZM&'J(=#IF"%%V*($7ON9?/K3
MFOPXI2"(D.VW.ZC$AH.1@8:2H'70BQ>Z-4BF"[@7Z0("%MX#IL0&6&R`H03!
M@M@=(=,5L>>1I2=HL*UN]TR)#;2%@8821/-YH%N"GND";Q'J`@*FNIM1.[[.
M-_40S;?H,YUQRZ)D*M^F%`1Q01&GMX(24^\BHT9M48+>S;BW@#YLT#]2B4L4
MA(W!WM3]FX9KU93.-X;>=AK$XXP-X8@B8*J8]-E!X50UUA;W"SBLW7JQ\TWK
M&&HZN`BZGS8V)AZ1>%/6J9JMT=U6ZAA6>D)IEN1.@Y3>R.8@`C^8<%!5;HWQ
M"P>QSA,VKU\:W!<,-<C&W)B,W3FH2Y3#UY975>S;X;"^ZW#1P#C4(-S,CT8K
M"R,BCS'O>G51YZL[$+'0P_3[)A4-_$,-,/0:LY&U@Z[M<0G=('=U##9L&9%O
M+J_>$68^&]L@1,("%E]?X;O:!AOVC<CP9MMI+BL\RJ>WCMDTG]$]OM@>(VW#
M/*:PJ:[0;8\I"5W>NSH'&VD=YE&ETXRG5H>G]PZU,ZYM7VZTCMOJ7_L4;2&1
M>6[I-%V-&3FV$`$]/1`#^5T-I%4;:.:YI=,@&H\]TEG10")A3"FN%$"N>H%6
M`&]T4#U%,>//`5J&;1MY;2-F$"\8*7$=)\89SP5JHRKH]W-B&]`+=FSV8ZZW
MBI!%X4B](1H6^:0?4DZ8B\XYO9VY4AL^F@VETW29"$<M,GCG(\9!S<R#8S;)
M6$IX5S]1O\M-0K.?=!H</>(\'G,0XW39``<*D@T4\*Z.`M<=`T"SHW0:_($9
MA[S=$+3KJ&L3%0<UG`<+,@D$Q'L1O#<H1'40CR+/:RN5;^K.@\.OK_[3_C[F
M@:O?X,;G6[BG:2\UG/X+N"8Y)0?Q(ZD.65E;N=A#2'<>@6\57K3@FT:>VMN*
M%]G`!4G[[Q$NQ`3\QG?G(-Y+V5S>J!N$_HIM\S\```#__P,`4$L#!!0`!@`(
M````(0"Y/[[7\@(``%H(```9````>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM
M;)266V^;,!B&[R?M/UB^+Z>$G!12-53=*FW2-.UP[8`!JX"1[33MO]]G'`@F
M2Y;UH@WX]>OG.^1SU_=O58E>J9",UQ'V'0\C6B<\974>X9\_GNX6&$E%ZI24
MO*81?J<2WV\^?E@?N'B1!:4*@4,M(UPHU:Q<5R8%K8AT>$-K6,FXJ(B"1Y&[
MLA&4I.VFJG0#SYNY%6$U-@XK<8L'SS*6T$>>["M:*V,B:$D4\,N"-;)SJY);
M["HB7O;-7<*K!BQVK&3JO37%J$I6SWG-!=F5$/>;/R5)Y]T^G-E7+!%<\DPY
M8.<:T/.8E^[2!:?-.F40@4X[$C2+\(._BA?8W:S;_/QB]"`'GY$L^.&38.D7
M5E-(-I1)%V#'^8N6/J?Z%6QVSW8_M07X)E!*,[(OU7=^^$Q97BBH=@@!Z;A6
MZ?LCE0DD%&R<(-1."2\!`'ZCBNG.@(20M_;O@:6JB/!DYH1S;^*#'.VH5$],
M6V*4[*7BU6\C\H]6QB0XFDR`_K@>.,$B],/9OUU<0]0&^$@4V:P%/R!H&CA3
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M<(/Q<;V@6CS&7-@';XUFV&P3[U0T\Y6XKC%\9I:;45=1D=.8EJ5$"=_K.1U`
MO_1O^ROD(=!38_1^"U=+.XC=?@%&>T-R^I6(G-42E30#2\^90[,)<SF8!\6;
M=L#NN(*AWGXLX`ZG,)4\!\09YZI[T#.O_Z]@\P<``/__`P!02P,$%``&``@`
M```A`#)9G`&K`P``)PT``!D```!X;"]W;W)K<VAE971S+W-H965T,3DN>&UL
MG%==CZLV$'VOU/^`>+]\DX0HR=7E8]LKM5)5]>.9@)-8"QC9SF;WWW=L)P2;
M%E9]V0W,F9,Y/C,PV7U];QOK#5&&2;>W?<>S+=15I,;=>6__^<?+EXUM,5YV
M==F0#NWM#\3LKX<??]C="'UE%X2X!0P=V]L7SONMZ[+J@MJ2.:1''41.A+8E
MATMZ=EE/45G+I+9Q`\];N6V).ULQ;.EG.,CIA"N4D^K:HHXK$HJ:DD/][()[
M]F!KJ\_0M25]O?9?*M+V0''$#>8?DM2VVFK[_=P16AX;T/WN1V7UX)87$_H6
M5Y0P<N(.T+FJT*GFQ$U<8#KL:@P*Q+%;%)WV]C=_6_B^[1YV\H#^PNC&1I\M
M=B&WGRBN?\$=@M,&GX0#1T)>!?1[+6Y!LCO)?I$._$:M&IW*:\-_)[>?$3Y?
M.-@=@R(A;%M_Y(A5<*)`XP2Q8*I(`P7`7ZO%HC7@1,IW^?^&:W[9V^'*B==>
MZ`/<.B+&7["@M*WJRCAI_U8@J6@@">XDD'$G\0,GV,1^O%IF<55%4F!>\O*P
MH^1F0=?`=[*^%#WH;X'YH4S5,6C]+ZF@49!\$RR2"U0P\.?M$"3ASGV#,ZWN
MF%1AUK8U8.)(AV0/B#A!P9L_;CQS?#VE>""$?2!IT`6G9>H*P?=_=^PA0R3I
M,F)3Q102Z!5E4T0<ZY!\"C%(BBEB1*()#:="5XM"11(TX<B+(#',2!4F&F$,
M&=DB(E]$%',(32<4,C9TWD@!WMMPB$.O!8E1?:HP&]FM_GKEZ1YEXW#DF=GY
M.!QOO$3/+L;A31@^NTC3!`,WUB2&;[E)19*I;:5_?:HPB=3F.9X1SO1PL-:S
M<R/\+%X.9:&'1T.L:5O]'VTBR=1F5)<J#!SPX*WA;+:(R!<1Q1Q"TPD/--/#
MY?D324OSIS!S.A<1^2*BF$-H.L4N,WI1S,^?`)L^&BZE"A/)'EW[1C33HI[Q
M>,Q5-%9OFB@P.W0<]J/DF:TI2G1%GYL^D60JV^CSDRK,G'.+B'P14<PA-)T^
MO`[&U@FARRTJLY9Z]`Z:D[H,R9<AQ2Q$5RLV@D\W*FR-4S^-7DSOH/NKPHN,
M>*;%P]#<?'(COC$>QV)U%44H_M4F>NXX2IG:2]7:UB)Z1AEJ&F95Y"IVS@"F
M8+BK]N'4W\(N!2N1<3\7>[+<=(<`K*E]>4:_EO2,.V8UZ`24GK.&ASQ5BZZZ
MX*27F]&1<%A0Y<<+_"!!L*5Y#H!/A/#'A=C%AI\XAW\```#__P,`4$L#!!0`
M!@`(````(0#_EIJ/6`H``(U,```9````>&PO=V]R:W-H965T<R]S:&5E=#$X
M+GAM;)S<V7+:RA8&X/M3==Z!XCZ`Q$S9WA70/$MUAFN"99O:@%Q`XN3M=[=:
M`GJA]*_8%['=_K0T_312-]'#7S_WN\Z/_'C:%H?'KM8;=#OY85,\;P^OC]W_
M_L?Z,NMV3N?UX7F]*P[Y8_=7?NK^]?3O?SU\%,>_3V]Y?NZP"H?38_?M?'Y?
M]/NGS5N^7Y]ZQ7M^8']Y*8[[]9G]>GSMG]Z/^?JY7&B_Z^N#P:2_7V\/75%A
M<6Q3HWAYV6YRH]A\W^>'LRARS'?K,]O^T]OV_517VV_:E-NOCW]_?_^R*?;O
MK,2W[6Y[_E46[7;VFX7[>BB.ZV\[MM\_M=%Z4]<N?[DKO]]NCL6I>#GW6+F^
MV-#[?9[WYWU6Z>GA><OV@!_VSC%_>>Q^U1:9/NWVGQ[*`_2_;?YQNOFY<WHK
M/NSC]CG8'G)VM-EYXF?@6U'\S:G[S)O8POV[I:WR#"3'SG/^LOZ^.V?%AY-O
M7]_.['2/V1[Q'5L\_S+RTX8=45:FIX]YI4VQ8QO`_NWLMSP:[(BL?Y;?/[;/
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M(%>QZBI70]9CUZ)>CT,;W(;U3,AZO-K45?RZX;IBG6Y<4)MZH5`T2$>.+A35
MIEXHI@T);4A%P_7(977#S<9IP\N1Z[,X7#+!7G52)II[L_K4<\U/?;UQR[KA
M9DV7]92G=74OQF.9&/=$UT:R,85A.W8-W7`J&ZO!R,*&PH'"O1=TA[Q[HM.-
M]1O,1)<W-VAAP@8S)'6B!C,A)R%N,+1.TL*D#8:>S$QMI'RRWES*)^^S>+^N
MSBE?2LHI;5C1!H,VF*)!2MR$="Y6"V.W,$X+X[8P7@OC-YEKYU"^:(,6)FPR
MY%4;-9CA1`YYW,(D#69"7OUIDYG)Z\H:C'9](4C!8Q<$4O#4@>-:"AQM6-$&
M@S:8HD$*'#U85@MC-QB=''2G-G5'[M(&CS;X=<-M#TS*!K6IRX:T(:H;;JI,
M2)6X-G65A#:DM"&[:9#.(KN:D\YBN^Z#+\6ZF=LWFPF]PA&&K??RAG0-DGCG
M@\*`PH3"@L*&PH'"A<*#PH<B@"*$(H(BAB*!(H4B4PDIHNR>X1,1Y4L]=MD;
MZ25^ND9ZQ*4PJHA"84!A0F%!84/A0.%"X4'A0Q%`$4(101%#D4"10I'5HKR%
MN][Q2.ED-RN?2"=?BJ1S>EU!V3TNA5&E$PI#B'%Y$SH=#\HO^2W?A$4L*&PH
M'"A<*#PH?"@"*$(H(BAB*!(H4B'$J=.J4S<@&<E49:28\D%6.K2!;Q/X4C2F
MY!)_*8PJIE`84)A"B*,Q:\JQ=2N&@^&$WE39<"4.%"X4'A2^$&)7QEK#2S*`
M-4(HHMNUS"8-:XEOQ4@<4[EK2.!:4B@RE9`2.O]40OE2-*'D[GXIC"JA4!A0
MF$+,Q'B?WG0\+5C$AL*!PH7"@\(70NS,>"!Z'SD<`2P20A%!$4.10)%"D:F$
M%%*-C:Q(_:CZKK?D-)YD+&%9(54^,3$P,2M2O:6PV3'V)9]4"U>Q,7$P<3'Q
M,/$K(O9HV-B7XBHA)I&\HGG#H8MQE42J,BJ+D!.0XBJ9DLAIY>/<?_ZNK_'%
M:&K)R-6R0LK4BCH*8N`JYH7PJ_!!CPPB6)<_7V_T"+$Q<3!Q,?$P\3$),`DQ
MB3"),4DP23')E$1.+!_YIHD=L:$"T,^*`7/I;G]*8K#4!%+$<86)@8F)B86)
MC8F#B8N)5Y%Y>>4R[)'!1A]7"#`),8DPB3%),$DQR91$3BP?,K]-+$BJ&&&7
MDTH.^9)/T;,.6)E42`Q<Q<3$PL3&Q,'$K<AX5.9PWIN+=UGQ+CD8#,TOY+K>
MPT5]3`),0DPB3&),$DQ23#(ED</+(B:%M]WP/_\PR-T%`AU<K9`RQ**.@ABX
MBHF)=2'E-81\S6M?_OC;*P@'$Q<3#Q,?DP"3$).H(M4HQ+3I=C7&91),4DPR
M)9$#RV<-;GM;'M@)G.[F'UJZ"RR9^UQ62)'&%28&)B8F%B9V1<09'$T&TP%Y
M&W%P$1<3#Q,?DP"3$),(DQB3!),4DTQ)Y-#R>83;T()+!#'M(%\BT-E5_DDZ
M=(D@B`A(TPB@@8N8F%B8V)@X%?G]UKJXB(>)CTF`28A)A$F,28))BDFF)')6
M^8S";59;7A&(B0@ILS,RMK'45+,5XB,!F!B8F)A8F-B8.)BXF'B8^)@$%1&W
M<=K=0$F(2T28Q)@DF*289$HB1Y9/,7PBLF)F0HXLG=SBGP)&W2PD!JYB8F)A
M8F/B8.)BXF'B8Q)@$F(2541,5I"+NKCZ8_6JT'IT5"C!*T@QR91$3BN?:Z!I
M;3'"):8HY+22&^*EIIK'J#I82`Q<Q<3$PL3&Q,'$Q<3#Q,<DP"2LR.\O8B)<
M),8DP23%)%,2*;3ZGTU[E9Q,(,SHM%>%5+=;F!B8F)A8F-B8.)BXF'B8^)@$
MF(05N7:-9(HGPC5B3!),4DPR)9&SVC3IA3M8O6'2:T:.R+)"RLSB22]<Q<3$
MPL3&Q,'$Q<3#Q,<DP"2LB,CLH#<@UVL1+A%CDF"28I(IB1Q9]K8N71.H!PAT
MSFGW2F>[*J2,JJBC(`:N8F)B86)CXF#B8N)AXF,28!(V$'U&ANBB!D1.9(Q)
M@DF*2:8D<E[IG%>[00*]8>YK1J<-*B0NH<:SN<9'KN01^U5EE,&%\V,FKF)A
M8F/B8.)BXF'B8Q)@$F(281)CDE3D<JH;/E63XC*9DLBY98F1^MEVLP<Z7XSV
MM^1&<UFA:F?*3\S1U(HRRM1"8E;K452Q,+$Q<3!Q,?$P\3$),`DQB3"),4DP
M23')E$0.+9WR`A<'#5-=,SI[P!^%P!(MPJK/AORS@#2MMT33RD\+RL2HJBBB
M:&)B86)CXF#B8N)AXF,28!)B$F$28Y)@DF*2*8F<5CK7Q;O8%G=?#7-><Q+)
MI2Y0]1'K2=.<]:HRBDP:F)B86)C8F#B8N)AXF/B8!)B$F$28Q)@DF*289$HB
MQ[9IV@M_KD!OF/::DWO2985N(ZG/R=#MJ@&1&P$#$Q,3"Q,;$P<3%Q,/$Q^3
M`),0DPB3&),$DQ03_I2FW\\ZB=R*IS")I]?L\^-KOLIWNU-G4WSG3UB:LL_0
M75HO3W_Z.N+/)2'M2VW!'C5SWVYI"_8DF/OV4%NP!ZS<MR_UQ;*I_DI?L/_:
M?^\-?<'^AS]K[U\VB#T,ZGW]FH?KX^OV<.KL\A>V*P,V9=/M',7CI,0OY^*]
M?%;/M^+,'@-5_OC&'ON5LV?BL&G/;N>E*,[U+WP%EP>)/?T#``#__P,`4$L#
M!!0`!@`(````(0"Q84$]7@@``.$V```9````>&PO=V]R:W-H965T<R]S:&5E
M=#$W+GAM;)R;6W/B.A:%WZ=J_@/%>P,VF`0JR:D&W^\U=<[,,P$GH1IP"CN=
M[G\_6Y8-2'9K$?*0P,ZG94M:EN1MZ^&O7_M=[V=V++;YX;&O#4;]7G98YYOM
MX?6Q_\_?]K?[?J\H5X?-:I<?LL?^[ZSH__7T[W\]?.;''\5;EI4]4C@4C_VW
MLGR?#X?%^BW;KXI!_IX=Z#\O^7&_*NGK\758O!^SU:8JM-\-]=%H.MROMH<^
M5Y@?K]'(7UZVZ\S,UQ_[[%!RD6.V6Y5T_L7;]KUHU/;K:^3VJ^./C_=OZWS_
M3A+/V]VV_%V)]GO[]=Q[/>3'U?..ZOU+FZS6C7;UI26_WZZ/>9&_E`.2&_(3
M;==Y-IP-2>GI8;.E&K!F[QVSE\?^=VV>ZEI_^/10-=!_M]EG<?&Y5[SEG\YQ
MNPFWAXQ:F_J)]<!SGO]@J+=A(2H\;)6VJQY(C[U-]K+ZV)7_R3_=;/OZ5E)W
M&U0C5K'YYK>9%6MJ49(9Z`936N<[.@'ZW=MOF36H15:_JK^?VTWY]M@?3P?&
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MAFB*.#S`+R>FX3:!LX:NST05KV$:%;^1O2@T'HF%@H9I"H6-RKF07,-(+A/+
M@40.I&U5_>)4AM39IQZGX4+H\>XQJ^E81K..;<Y_T03.YZ^/I?9>=C!BLYAM
MPC!$Q&HCNDC8;4(6<=J(?+(N1Z@!S[8<2T?R.ACQ7/P.8BS5*.AB[D2=L(,1
MB:B#D(\47\$D5S"IFA%L18.M8"LVD(QI'%?;BY42["4'EG+`E`.6'+#E@",'
M7!X0^UP:BKPK&+^+F8K]%70QTI@67L%$5S!Q%R,-PTD7(PUU:0<S.8]L0K_3
M['A#O[-20K_+@:4<,.6`)0=L.>#(`9<'Q'Z7^L*[@O$;IAD5`SD0RH%(#L1R
M()$#Z45`:'):2-S0Y*P479*7X]Q$&K@7G*'CGL9":0Q;0L*$A`4)&Q(.)%Q(
M>)#P(1%`(H1$!(D8$@DD4A4AV(M6@3?8BY5Z[-.$<;*./I&FT05G5/:"A`D)
M"Q(V)!Q(N)#P(.%#(H!$"(F($_?5JGQBC-B/.$7%4".!1*HB!'O13<(-]F*E
M9'M),_:",RI[0<*$A`4)&Q(.)%Q(>)#P(1%`(H1$!(F8$P8WX+C#@`G42%6$
M8"^68I-O:/$ZE)62[24M#!:<4=D+$B8D+$C8D'`@X4+"@X0/B0`2(20B2,20
M2!J"Y25&@Y&T0D^;?Y^GKO.J1_`69;<$;ZGO;1@M>^HL7.4N%IQ1>0H2)B0L
M2-B0<"#A0L*#A`^)@!-3/IA,QIIT>Q-"A0@2,2022*0J0C`5RWH*KKKNSKDJ
M)MM+<O:BAE3^PHB)$0LC-D8<C+@8\3#BUPB?DBA;+BV(`BP18B3"2(R1!".I
M$A'-QA*%7Y\>64Z]-99)J:M%#2G-QG44B(E5+(S8&'$PXF+$PXB/D0`C(48B
MC,0823"2UDA]^5S>3XAF8^G#2[.IYTN-9QO%6TAI>%_4D,)!2XR8&+$P8F/$
MP8B+$0\C/D:"&C$FU=PY&\QFU5*\^36VODGWZR$6C3`28R3!2*I$1-NQ[.6E
M[=B$.J'T![`?3WJ*]I,2HPN-0TK[0<3$*A9&;(PX&'$QXF'$QTC0@;0FWK`#
MDI;,$49BC"08296(Z#CRPRV.8\6D)9PAIV39<VB"^%@[[DK?+&M$84H3(Q9&
M;(PX&'$QXF'$QTB`D1`C$49BC"08296(Z#>6RY5'.)SD8*\BM/PFC?F+&E*8
M:5DCW))W]Y?S?W57:V(-"VG86,/!B(L1#R,^1@*,A#527\GTDDZKX2*L$F,D
MP4BJ1$2OL<3NI=?`+,KSP,(L:LB)6O:B"1E1Z3&(F%C%PHB-$0<C+D8\C/@8
M"3`2UL@?+\\(:\0823"2*A'192R_>^FR*Y,@/"TLNDW.VVJJW'$U8"UKI&XR
MMBX6GY"8(C!I`98`Z&.6Y18E;)'0VL.F4Q.*R\+%B(<1'R,!1D*,1!B),9)@
M)%4BHM-8MO<&I_$DL>@T:6FZT%29Y-II'.%.TZK'<:)/S%JD)JH5GTA8`D$O
M?'9X[?(HX]FT13CX5%V,>!CQ,1)@),1(A)$8(PE&4B4B>HTE@2^]!N9.GC,6
M/=9*Z:H2R[7'.'+I,6DP,C6H8M6(0L7&*HZH,NHPJXM5/(SX&`DP$M:(HM(1
M5HDQDF`D52*"SW3Y$8+:9Q4NWW?*V=P:4DQ&2XR8&+$P8F/$P8B+$:]&^+L2
MACYM+]%]K!)@),0'BK!*C)$$(ZD2$7UVV],#O>/I@2$G=FM(Z3?\]`"K6!BQ
M,>)@Q*T1/I9,:5M&:Q;VL(J/D0`C(48BC,0823#"-N;\^>Z/^XUOO.$;%?;9
M\35;9KM=T5OG'VQ3#3U^>'HXA?F.'T>?T^N>]#ZF%*>=0-^[XDMM3CL)VKRE
MS6F[0#ON:W-ZE[\=C[0YO8W?CB_T^:+SN/J<7FUM\Z8^IS=<VW%+G].+KNVX
MK<_I?5>*#T\5I@U&[ZO7+%H=7[>'HK?+7JBM1@.VR>3(MRCQ+V7^7NW[>,Y+
MVEI4?7RCK609[8,8#0A^R?.R^<(.<-J<]O1_````__\#`%!+`P04``8`"```
M`"$`EL^_!88#``#3#```&0```'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6R4
MEUUOVC`4AN\G[3]$N6\2$Q(^!%2%JMND39JF?5R;Q(#5)(YBM[3_?L<^(21.
M2P,7A=2O7YYSCGUL%K<O>>8\LTIR42Q=X@6NPXI$I+S8+]T_OQ]NIJXC%2U2
MFHF"+=U7)MW;U>=/BZ.H'N6!,>6`0R&7[D&I<N[[,CFPG$I/E*R`D9VH<JK@
ML=K[LJP83<VD//-'01#[.>6%BP[S:HB'V.UXPNY%\I2S0J%)Q3*J@%\>>"E/
M;GDRQ"ZGU>-3>9.(O`2++<^X>C6FKI,G\V_[0E1TFT'<+V1,DY.W>>C9YSRI
MA!0[Y8&=CZ#]F&?^S`>GU2+E$(%.NU.QW=*](_,-B5Q_M3`)^LO94;8^._(@
MCE\JGG[G!8-L0YUT!;9"/&KIMU3_"R;[O=D/I@(_*R=E._J4J5_B^)7Q_4%!
MN2.(2`<V3U_OF4P@HV#CC0Q&(C(`@+].SO72@(S0%_-^Y*DZ+-TP]J))$!*0
M.ULFU0/7EJZ3/$DE\G\H(AJJ,1G5)O!>FY#(&X^BR?0:E[!V@?>32SS8Q<>X
M3)KNJ:*K126.#JP]()<EU2N9S,%9YR>$++^='XA)S[G3D\Q44$LHZO,J#$8+
M_QD*D=2:=5]#NHI-7Q$&8:/Q`;"AA,Q=3ZDG=2FCL[T)9-V76&%L^HKP'$>'
M$;+79KR<02V&3+M.*X/C)G:$0\VXI8FZBLTE18<-3(:S:?'2A<`;-C*QOGF-
MFDMLJ(C,ZHC#*&[0.V"PB8:#:7$7+`QL,-1<`D/%S(!-O1$TY-;K'<RXBSEL
ME^A)-N[9'VN,FC9N&$R:5!G-YBW-M-%TTCGI<EY>@UK<Y2-3:_FO48/)FGFS
M\:S]LG;3!L7M8,[5Z6#JT[75="YC:O%'F*C!Q4;BU@[%#.+P`+#9-6!:;(-9
M*5FC9FP6V\V$S)JR(=AI^+S5WLD8@9X\/&5&_1%:+<+:QM[(9JO'!V2-6(?(
MY7H:M0UG[XM:5"<.SDDK<<WXQYG3'7SP8B/8[SO-;]J#0]%I5]B;9E.;#,F<
M[N##X;#?=^!ZG9F@J&Z\XU;CQ257CP^!`\T5<%K=+6N_.Q,4G9IO;+>Z>GP(
MG'5R#&O)^NK7@^R5MW^&])MR[=0F#0.[*^.U%.];)=VS'[3:\T(Z&=O!V1IX
M$_BF"B^E^*!$:6XL6Z'@,FD^'N#'`X-+5^"!>">$.CWH:V_S<V3U'P``__\#
M`%!+`P04``8`"````"$`^V*E;90&``"G&P``$P```'AL+W1H96UE+W1H96UE
M,2YX;6SL64]OVS84OP_8=R!T;VTGMAL'=8K8L9NM31O$;H<>:9F66%.B0-))
M?1O:XX`!P[IAEP&[[3!L*]`"NW2?)EN'K0/Z%?9(2K(8RTO2!AO6U8=$(G]\
M_]_C(W7UVH.(H4,B).5QVZM=KGJ(Q#X?TSAH>W>&_4L;'I(*QV/,>$S:WIQ(
M[]K6^^]=Q9LJ)!%!L#Z6F[CMA4HEFY6*]&$8R\L\(3',3;B(L()7$53&`A\!
MW8A5UJK59B7"-/90C",@>WLRH3Y!0TW2V\J(]QB\QDKJ`9^)@29-G!4&.Y[6
M-$+.99<)=(A9VP,^8WXT)`^4AQB6"B;:7M7\O,K6U0K>3!<QM6)M85W?_-)U
MZ8+Q=,WP%,$H9UKKUUM7=G+Z!L#4,J[7ZW5[M9R>`6#?!TVM+$6:]?Y&K9/1
M+(#LXS+M;K51K;OX`OWU)9E;G4ZGT4IEL40-R#[6E_`;U69]>\W!&Y#%-Y;P
M]<YVM]MT\`9D\<TE?/]*JUEW\084,AI/E]#:H?U^2CV'3#C;+85O`'RCFL(7
M*(B&/+HTBPF/U:I8B_!]+OH`T$"&%8V1FB=D@GV(XBZ.1H)BS0!O$ER8L4.^
M7!K2O)#T!4U4V_LPP9`1"WJOGG__ZOE3].KYD^.'SXX?_G3\Z-'QPQ\M+6?A
M+HZ#XL*7WW[VY]<?HS^>?O/R\1?E>%G$__K#)[_\_'DY$#)H(=&++Y_\]NS)
MBZ\^_?V[QR7P;8%'1?B01D2B6^0('?`(=#.&<24G(W&^%<,04V<%#H%V">F>
M"AW@K3EF9;@.<8UW5T#Q*`->G]UW9!V$8J9H"><;8>0`]SAG'2Y*#7!#\RI8
M>#B+@W+F8E;$'6!\6,:[BV/'M;U9`E4S"TK']MV0.&+N,QPK')"8**3G^)20
M$NWN4>K8=8_Z@DL^4>@>11U,2TTRI",GD!:+=FD$?IF7Z0RN=FRS=Q=U."O3
M>H<<NDA(",Q*A!\2YICQ.IXI')61'.*(%0U^$ZNP3,C!7/A%7$\J\'1`&$>]
M,9&R;,UM`?H6G'X#0[TJ=?L>FT<N4B@Z+:-Y$W->1.[P:3?$45*&'=`X+&(_
MD%,(48SVN2J#[W$W0_0[^`''*]U]EQ+'W:<7@CLT<$1:!(B>F8D27UXGW(G?
MP9Q-,#%5!DJZ4ZDC&O]=V684ZK;E\*YLM[UMV,3*DF?W1+%>A?L/EN@=/(OW
M"63%\A;UKD*_J]#>6U^A5^7RQ=?E12F&*JT;$MMKF\X[6MEX3RAC`S5GY*8T
MO;>$#6C<AT&]SAPZ27X02T)XU)D,#!Q<(+!9@P17'U$5#D*<0-]>\S210*:D
M`XD2+N&\:(9+:6L\]/[*GC8;^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@SK09HW5-
MX*S,UJ^D1$&WUV%6TT*=F5O-B&:*HL,M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY
M"<=^S1K..YB1L;:[]5'F%N.%BW21#/&8I#[2>B_[J&:<E,7*DB):#QL,^NQX
MBM4*W%J:[!MP.XN3BNSJ*]AEWGL3+V41O/`24#N9CBPN)B>+T5';:S76&A[R
M<=+V)G!4AL<H`:]+W4QB%L!]DZ^$#?M3D]ED^<*;K4PQ-PEJ</MA[;ZDL%,'
M$B'5#I:A#0TSE88`BS4G*_]:`\QZ40J45*.S2;&^`<'PKTD!=G1=2R83XJNB
MLPLCVG;V-2VE?*:(&(3C(S1B,W&`P?TZ5$&?,95PXV$J@GZ!ZSEM;3/E%N<T
MZ8J78@9GQS%+0IR66YVB629;N"E(N0SFK2`>Z%8JNU'N_*J8E+\@58IA_#]3
M1>\G<`6Q/M8>\.%V6&"D,Z7M<:%"#E4H":G?%]`XF-H!T0)7O#`-005WU.:_
M((?ZO\TY2\.D-9PDU0$-D*"P'ZE0$+(/9<E$WRG$:NG>94FRE)")J(*X,K%B
MC\@A84-=`YMZ;_=0"*%NJDE:!@SN9/RY[VD&C0+=Y!3SS:ED^=YK<^"?[GQL
M,H-2;ATV#4UF_US$O#U8[*IVO5F>[;U%1?3$HLVJ9UD!S`I;02M-^]<4X9Q;
MK:U82QJO-3+AP(O+&L-@WA`E<)&$]!_8_ZCPF?W@H3?4(3^`VHK@^X4F!F$#
M47W)-AY(%T@[.(+&R0[:8-*DK&G3UDE;+=NL+[C3S?F>,+:6["S^/J>Q\^;,
M9>?DXD4:.[6P8VL[MM+4X-F3*0I#D^P@8QQCOI05/V;QT7UP]`Y\-I@Q)4TP
MP:<J@:&''I@\@.2W',W2K;\```#__P,`4$L#!!0`!@`(````(0"D2Q5HIPL`
M`"!E```-````>&PO<W1Y;&5S+GAM;,Q=^V_CQA'^O4#_!X+7%@E0GR2*LB3'
M<G#2F<T!5S?(N6B!IB@HB;*9XT,AJ3L[1?_WSBQ?LQ(?2VNE=82<14H[\\UC
MOYU=+JGK[Y]\3_OB1+$;!C-]\+:O:TZP"M=N\##3_WYO74QT+4[L8&U[8>#,
M]&<GUK^_^?WOKN/DV7,^/3I.HH&(()[ICTFRO>KUXM6CX]OQVW#K!/#))HQ\
M.X'#Z*$7;R/'7L?8R/=Z1K]_V?-M-]!3"5?^2D2(;T>?=]N+5>AO[<1=NIZ;
M/#-9NN:OKCX\!&%D+SV`^C0P[54NFQT<B/?=513&X29Y"^)ZX6;CKIQ#E-/>
MM`>2;JZ#G6_Y2:RMPEV0S'2C.*6EGWQ8S_1+74M-7H1K`/&G7W=A\MT?TC]O
M_OSF3?\_WW[WKY^<];]__N;PLY^_U7NY&B(38M`L\VV_42Q\G$KN91;<7&_"
M@!AB@IO06U>?@_!K8.%GD`Q@'G[MYCK^3?MB>W!F@/!6H1=&6@)1!OO8F<#V
MG?0;"]MSEY&+7]O8ONL]IZ<-/,$2(_N>[T*8\&0OU7!>/4M$D]LT01B<34,\
M0VWRP20;3S;;9/]281.G:]2NZQC_<;J8%<UV2=-UF!<'/CQ&5Q$KHB=Z6,YT
MRP(.&?3[Z%8:L!,IFR[ZH.]LRBY'9[-L:`VML53+N%P\C!LJ'%HR7=FBT'HW
M?G\V=\I75F==1L/GZ@'8X>1ZT86NV]"_QQ:^SI$G9Q[03A,Q)I4C?=;U2FZ\
M=WTGUNZ<K]I/H6\'Z%@ZJ+%O<V,REWCRQ4/IF;SSW(<@+13BW19JT57D;A.$
M5B2&?,5<WLD7?V#7\BQ68;1.9AG+BQ@2QO6\H@@>CK!,A#,WUU"/)TX46'"@
M9>_OG[=0)`8P=<!P]M+OM7S[(;*?!P8KE<0:Q*'GKA'%PX*5IEEIL+B\M1:W
M3"]!)HJB1JAE+<8G$'H[GR[D(UU,I[*%&A:\)`M]-\*79*$6_+>0YM-L<#!E
M@2SD:8F+4\G^V_%T.IT,+B>3R=0<#DR3.7F99;0;K)TG!V>7TMQTB&`$"*;#
MR?32`"!]<\)4G17!$`",1Z/):#`U3/B?C4:G1R#;IR-==50)`D51)0@4197-
M9GH2F#_K*;"PH[BO$@2*HDH0*(KJ6#(#CY5'E2!0%%6"0%%4V1J<Q+X*"Z:*
M^RI!H"BJ!(&BJ$HK/C,&GBJ/*D&@**H$P;FCFD^K%K>W%EN1.:S,I-7'F2XL
MXKOK8K-&F*<NPV@-JPGYY9K!$.:(Z;F;:\_9)#`CC=R'1_R;A%OX=QDF"5P'
MNKE>N_9#&-@>O.WE+?*_#2WA2AE<%)OIR:.[^@S*N(68U#>IBE-I*%C/Q-F$
M.3;[8W-D7*83-DFJ?6?M[OQ#ZPK=E7D);D3?MAM.?!@42K)T*!<#>QB%+'R"
M+5BH6:0%&T!.Y"DAV$*&C>7"N*B-I(68C:2!H(VDA:B-T'6J.E?NR76X@XNT
M^P&VK$F_GZY!BNII%DB`5V1,-0C2YM"?K4TJ/-K:IJNMP"\'?6-NX(M5QQ66
MMK0XM+.E0865+2U$;>3S)H\N)[Q8ND!ZKD"RYV_NZR^#`8K2ACF>/1+,^`FO
MC:171X3IKMK<5O$55K>VD63ZGG>[F9Z-IC`XKQS/^X3#Y3\WQ0@-BUXWUT\;
MLO,!MJ/@U@#<6(%O864Y>YN.QND!^+"ND5';2+.W6^_Y;N<OG<AB>U28"G86
M5[#+HSDK(\IC=KG"=]BRG9Z*^3$*$V>5L#TT[%I"'9YA#9Y!)D@$SS'Z8:-'
MI1/!3\+^.$8_+`M5Z@>_*-4/R26L7V8^X&ZA+*DA!#2IF_#(1`"3_QP!!$$%
M`MS=E/D`TE,%`IA4Y0@@04L$`*<A*X[I!P/"9I`#I4K0?RJ5P#&YE9S*$UI9
M1[^@O\%*BZ/?H]Q,^!82O70S'#0`.$IE'<6JHA@2=NAII0O@H,$%%HRZ<H:\
M01WG*W,((5W`4'H$:*#)(_*RDG`NZ"P!-'MD+K$.(4F!5*0:`L!1`H$$8J!H
M_!U0#(I&8)H-BH9@"H$;@\_8)V@DN!%2$0;`HZ17E'7"@!LQSN@&`D$50Y)L
M,%11),6@BB/+4!BJ*))`4,60-!*J*))B4,61)!2J*))``(\H84@:"54423&H
MXL@R%$-5%$D@J&)($HGAB2FR1Y=-TT54LGXZPKVX=4N/$*!\^K\?JZ=-ZT+J
MH&[2!++RYNGL*9TY0BS87(I,I?%^,ANW>N/:J?881NYO,,G$^\I6<,*)=+P/
M,7%7],S7R-[>.T\P%4VO"CUMCC*P!5.I'];7=:V+<NG^.0*+0*1;'-%J.:ZK
MM*[+[R4&O[;=FB"M&-C"@FH0Z.L,@_04D-1%L.>J=A,,DLHQT%#!@-E&AB]F
MLU]V<>)NGCOR!WHH6P4'H%Q5<S2_O@C1\2QR!(4-9`?H&"RR0]/*;#13B?+A
M_N2G*3'21?3C698P/:X&Y#G:@J6:ZRV@(1S)LZ[%%E3S(Z%"@>U3X#N6AO=&
MH-AT%W]3@=`!?S72A@O-G.S]":+*.#5C>?UQ:L;?/4YUQ(++X$UQFF>K[YWR
M];"P[5Y8U@(&)*\1\/'C1B=^K'-/2SB%Z.9%XR9E`@#Q"D9RZ8,I+4QQLQG/
MR,"2O9/2<,ODA:*K&#`JX;WV4:X2-/:T?.Y!AV:.,MMXC:\3A%FNM8_6>;0%
M7/<!21AR2UY(*23P*F(3*9_;VUS%>`A.G;<[)31G10NQ\QZNI7E)\P&^##YT
M<'5]DA*8K,1M=:7L(?(8W\G&0CNUA&K+@*(JG^)(&;Q;>9*2N&SG*%5>%9E.
M@&J'-#D,0/%5E`G%<,">9"5>T'#CVUF0MO;_5^+(]";/QLJPK@.T%3$OHM*<
M+CHE92W"4\[&.B$\8[0/:_^BU]1<KA&J"@]Z3?<RI7;<;^GUG?K2"<H2"J^[
M=^E80M/@'$`[>8XCR;;.S5=T+^KJ%?S^<KP'Z=E4Y`DE(HMT*Z`ZZFG!(X1`
M*A?*`'28_&W^,9!;U%]!P6S.9^7X5@A1-<'51JYJ/&`[`V`O`+FSBK^OJM@Y
MH.'3X.#IM?T_:A?:NQ6&OAB\<*EHN7,]>'H";@G`71TKN)P5^O/T9'8=ODE6
M,0/&@%!9T.F[R@()Z6S:P)T^!!>P6U=9H#Z5-01KB2RXZ:RS+-A]E<G"?5@E
M+A.NM7;%!4TR6;SO1X*^-ZOBR'8LEKC09!%<5%891V1K(@M,[BJKC",$CLH"
MD[O**N,("(DL$Y1TE57&$:)`94&Z=955Q-&$P!%9(T'?7U;&D<]5W%XD@HO*
M*N/(Y^I0,%>IK#*.?*ZBR5UQE7$$J<1?)GS055891YXG3$&>H#:6<>1]/Q+T
M_3ZC\AEO"&9\*J6,';PC/L)E)Q$?I5+*J/%9/A3,\E1*&2\^OTW!_$ZEE)$"
M><0B$SX0MZB(T9#WKBGHW;F]SEF73Q@<9T1@P'/.5SL/GC\?XM/KV?8Y>#@Z
M-0@W2PM)>G16G[4%W`U=".+[`PZC(H)NG[:>'=A)&#UKN&6N$,<'?20H[B]A
M6/B(EV#`H0B@'^!9__`S`AKX)?40G\.X7:J+F*(O\.[!^V>ZB('6*1H^__"J
M71<QT#H5PY,JUD\B8CX$VUT1(9Y+<>@6$?'1#3X[:SYS>`\;`%)$TIVS2R*[
MR#^^2QF"CKG#>^@+&3Q%I(_7S6_XS^K/.[AE/G<B;N4C9(`UM`CPO^T2XD9L
M183@4JZ(D'LW@0>1Y)V8$X&PA$2$L(VU$+''*((R_F%'`?86KNONY6B-1>6F
M8*C^UT_E\Q28WQ/\-0SVI(5B/@".6CL;>^<E]\6',[U\_U?VB!](INQ;/[I?
MPH2)F.GE^X_X["3HQ3`Q`[KY&,/S>."OMHO<F?[?V_EX^O[6,BXF_?GDPAPZ
MHXOI:/[^8F0NYN_?6].^T5_\#UR&/QUR!;\]<<1/<["?$(%MP0/S*O;@!SRB
MS-@,_*?RW$PG!RE\]L`4@`W7K',C>G'QTR8W_P<``/__`P!02P,$%``&``@`
M```A`/HQ"R/],@``2:,``!0```!X;"]S:&%R9613=')I;F=S+GAM;.2=W6Y;
M2;;?[P/D'38,#ZP&)%F?;GO2[0-9LKLUX[9U+'GZ#`:YV"*W)(XIDL--VM9<
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MC_KC3[+OQJ/95<FC_:+?_O:TF&QFNUOKV<[6]E[[R]>]V6:V\V3QEXD,V+&`
MC.Q/!^?E;)KW9O^Y/>R#]@=A$6^*RX%>86FO\NNB_=2#;Y^_>?TJ.^._#DZ>
MOST[/CQ=SXY?'6YF#X^>/VP_G<@[NYETA]K>VOC7]AN'\^E4;'TQ*'OY,/MC
MD4_%L^PHGW4'V-C8WMG8W6Z/$59R.+Z^'H^RT]FX]VX].[W*IT69O9[/3'80
MIO9K!^QGW_;TQ3#O?/O@(A^6'1+B5)`\A=QC=O=C]OOBICWV@RW^Y_'VXZW=
MW?97<8BP\#?%9#R=01Z$Y[-YV7[\P1^+SF=AB#^,A_/1+)_>P+TA^M-Y]=6X
M_5%XTY[/#N'QY7C:)?Z@URL8D*_[/O228;XOAL.-=Z/Q![A>Y"7:V<^.RW)>
M3-LO),$X*::#L41W\1:GY^KR\`+=ZRYND>ZT7P^S+1[@7W?;5!Z.V<]1R2J>
MY<-\U"N0(O"BS-:BF(8!WX[R>7\`>[[(UMZ>'F7WOV@/=3S*SJ[&\Q(]+=>!
ME6%1EMEX=E5,/PS*(BLG16]P,>A"PU'1`QJV3?N[]`69R<L2JG[;GO,P+Z_:
MGYU,BTD^Z&?%1R"Q1"$$'$9'UFN,UG[Q;#Q#P%<_<S(%:*<@H08M_C(?3*1.
MZ]FHF+6'>ZVE9P#XY<:LF%YGOH3V4S[IXN_B%@P'^?E@.)@-BBX'$%Q!=YE-
M\IO\?-A17[Z?SMG>WG`P&@AO:H.U:8G/,M1T/!SZ&J\GP_%-46Q,BZ%IQXKW
M?<5YF#'ROST+(H?IFPT@-AN-9VQ0(#V;C;,XRR3GB0(Y@K'9^"+K`Y9:9WNP
MYIZMH,TP\FH\[(,:_^???_@O_^N'__KOMH&SFZY4.:R6@M7VA`=]M`#S!R<E
M91N#4=;+)P,DI_-D#_LY=Z;UBXM!;["$>IMG,6GM,7VYM67:'OV(`2I]%_86
M$EZ4]")[C53G6A>:_V-5O?C8*R:S#*!P$Y3U\UG^8Q!@]\ZN0P<?`MW8DBAN
MG=U\4Y28V-Z5L:I?O"^&8U/:-F^_*4;PP*4^[U^C+G(29H/W'9WR71`0\'5M
MZO:(+\<@X,5T?)V%9V%O^YGC$>!0X-95*!56TG[R%9HP9,3VY\_R<M#SQ0V&
M<QDPZ8R>S*`P*^459&O(Z1$ZG4]KGW8@/'@0<]D#"?;X>C*W%9[?=0X?H3/P
M,K$3?F<OAN,/=Q*[@_Z?Y^7,9=:PHC<>]?`#J@7SJ1;?T["V"MS5R'PV"B]Q
M\'XQCAX5>,N]@>F`,3._EI/R5_N@S7(#DPV8(F"%2=@9?W')UAW4QC(T*\YG
M2R'M\"H?78**;$`E8FX@C+":]G=D?87M6VQB)%2W<ZN]_F,0O#3!6,'1DSE*
M!XL,7R8+[69[W"XU@P4SM=]Z,1CAN4@15U$S'?>*HA_T\4,^-?^_^%A,>W@G
M':7"SM<>GZ2ES'&7IAF6/7L>#*-[WUE<;7:"&]6FL#F:P35[*[@%MI90(%[`
MM1H598ZH@]5(G+Q^'T:P@>1N7(BR?A86UEE/XBQ#OA_HR?.;[&(!X]JDZ\7!
MJ$<DB0^WUB_\7U\8/"QPODRA\UEV3HPU&FE/(!@8P@-NCQP?)219_M`K'(1L
M.]O(GLW+P0B/LCW*$8X!6#<'X\Z*C[/LV1"CO2(HC.-D1T79FPY\$\1$P:B)
M*CI48A9=H?]4#=J)+[<W/W^*_QN';9(W51S];3%EM\YP!O-)`9SV\&J.1_B\
M:XJEB^GP)CO8/-G,3@#J:^RFOL/)EHS]\+?_08@WR4<WZS_\[7_JSP]%_->\
MU$>BG(_'\RE_L2MXN]GY`*;UKD;CX?CRQO")`8!#[<9`GB*Z.!T4%D;5'M10
M[-GX/2M_7V3%!>3Q-)`:C*9>[,][_EG>[\.G$C__&@FY+OKF7(ZD8IN$H-/&
M+,\&X]X57!BS7.<0G-%_3OA_<@8/AH/+4?8^'WY]KYPC+KXU]QZ27/BK?[R]
MI;]ZK,G4[YJLR+8^F;X@Z^"/G`VN`9M7Q8?LS?@Z'^G;B_QZ`']M8'O\H4TY
M>_KY?W?H^&5F4KKFM^4D[T$P>EH6T_?%O:?99#R\@1G!AO2G\TNX/(3OA+83
M?$:)AG:S7Y1P!G5E&P;74M["T$>Q11`G<?I"5A!-&XS^7/1FB@.RB8E3SR2.
MN%[ZCGZ@;!(#"5=_[AZ?WA-P(J3\RV-;`]*"X2ZG[*R<Q+2IDH`H$99*8/K+
M:4Y\,RS'V84"5T'^*`-E2!I=W&B^$9N2UH?`7(U!8@F<UBD?V3Q/E&,X^*N>
M=RID6G'Z>71V!:9<YUH"V@!>3,-B.LQPL5VW)X8#O#B\7%_N-/]PGO?>F8['
M(,_92*"QF<0AI;1,>27)0[)HL,),WJ61*N??=0'C"4=Q>(OU[.#DQ;Y27!^N
M!GB;'\0^\5M;=YU/WZ$F>9F=OCT]>_TRS?;_M1*L(3=XV<5,`.FBBQRLAZU%
MZ(D&97>^6,_*^;DDVT/$2TD,69PLGT@C\N&Z5.6\D.0$K.)E1,LV'JU[+TET
M^3XG$X"XXR=OF``BE?E-T=_`-6>#E$RU5$$^N8$B9)V!R'P00=C3[\?7N(],
MLR9H/G[U!Z'N)I!M>4VV7IO.$\A#'R0&TK&:NU7P7<[F_9OLPP`:7%J64-FD
M2A,Q+@$G,;$"-CS5`D<6.JX&EU<`'('<;'Q9$.$WER`ROWU^B*_`O$[KZY$A
MA1#@>DS<T2\LM\#0#%>BM$)^6.UZHI30M#'F>N;DR-)(,_1:3QPR(SXE&3V3
M,;:`':Z/YJ8Q^G*&$V'>^Z990U@EG(!ZLFAA^PVY]C>^/=NU-4[89?@^RR_'
MBL;"?B_=VSMS[7J,%\<>+>?<?R(U`54*G5S(PJ1WGF+UQBR`F]E3AP8,-@L>
M$(AKBY;SHJX[$44A$C'1>\%M>-"T]G4[?"<3%,$,.4:_"IS.*Z4^F23EDR1:
M`*BC'(@'Z:(@62>S;4.%W29189%2SOE$+UW(V>CG-Z6K18X,CBZQ7V@\6IJ/
M"E**03I0X<TL),78NOQ]/AB:Q##M-$?)]:B;!Q`Z,L5,"^)79UAC7TT&%Z.%
M`X5C@\1^,_NF!ED?X$H)1/6D[1H@+.Z\<(48X#IK60@-5AWCC\-YSJ.8XLG5
M#5'[(&>;/8P$G7+@@^PRD16+&E"W$0#VQE-SC\O\HHAIQPN227GO9C/['J5C
M.[3A'\;385]395,@`>V%M4Y.D+6J4G,\RK[#E%(0HN0"8LEYP$HQR)AWL9A#
M<Z*.Y)0<3"9#)C/T%)B\.CHP1],@3*^\W3S=S%Z,27"+\?Y.+7G"LO3:B_!:
M613O!!@1N.M<N]L.2/86X*#!>DVM1<QJ%31Z[ZS.M:&78*V!6L9"V7/J`8)_
M*>&PP/]X4Y03"5'VLIB1[G'K\>:E<3(N.\@.#-82O[.,%0G_+;,NE,](UIWS
M*A_MV*XA3O-SK)%D#_<_TXLU&80!6,7:0+OA+5D.HZY$MN#2X9N74<N#QT:.
M'K'&%440A.=8-+;,5A4\,;GY$K!ST-'C`/XFII#%'5>;*\Q'1*J5F<2>X^<R
M.E_ATR%^5VBNM!VQQU[D0VEV&A1/$;:%N:<YSD*"N,2B7:W!AI9:$]9<%F;,
MY#["?A%?C)30EKOZ^1-4B5_DY<?Z*IE'<4OD7@RFF)J_S,E`PV^>AN7[-GSE
MSQ$1#^?HFI[71@S=7.I/-_%AK+!)I0J]9@(;[(A\APE:>F^`8)LZBBZ0=CJ#
M%XR)W;R`%L)-]QNC*LM#71Q?R&T%.8JL@?A5L(=_/`I^:M@=@TVQ1?-UO5MP
ME=$,JM9EH8B5?<GG@S'Q;=^R^2&H:48MP8?+9`>P`(@5FJ%\N*(:SPP89PC>
M7(5J_+2GM[>VLHZ_//CE0D.V[OW@?:@CRC\/<>JO&A]J.W[U1>.'=^;\55<=
M?8D^7OC(LN\!)J2P2T19)G9"PB-AAULLA<#"H@Q[?1D]WN24(,QY*7R4&DO;
ML,ZU($&F?EWUG1&1VRB_M#J)&0PY9T"))'8PNACFU[B[Z/9Z1KJ884Q[B)6_
M#[!F,7'`(<1=_YH65Z2+Y?00^UP#L6:JYLP#O1\'RG"0M8F<,)`TA*R[!?9I
MAR=)_:2J<B48,-2T,='SJ32;1#21:N?5"AD4T`K7ZXD'K*0R$W45=L4MR:Q,
M+<"W*H=Y<3"]OAU$][,!,`Q!Q3OGC,A#R:TH(]X+-=,K2MN+NZM(-.?#@<I1
M)=K0Y)36RCPVF(&:GJWB]:4A__$H>P7P1&OK=K,>U<6$!RN-Z0C$<S*8P"8/
MKDK*%`@/865$OY`N:,A<;FF1-%JR6RVY,VE*;N:W9_^VL;5-M3R7-)TKOQ%L
M"XG/?/CY$QYSR7(Q)]GY?#)XG_=$B4F9&"U#0]$RB*Z"Z&L*8L@=&1S$/:^[
MS5F5D-%V0&G*&S:4\2[)+`CVB,:R*8$=U6Z8Z\(DGS^U5L\'GE]*!AXJ36*4
M&U>'@2?$Z9^2+,68>[NRP\_GJCT(#(J/I`/A17C=,EDI?Z/57YD:IH\0UP.;
MP)TN<UH_HK,S^?,[^QFYQ2',[V`FNO+K9S1#C]`_RF"Q2^1*B/SQ%,IRK$H:
M@&>:.B'-L!%*6<">;?`'G!KY$=J#RJ6S8`+]P_^S(CL8O.#=D$Q3.83H2@,U
M=^;^[N;VYT]D-?YY-F>G(R._JEU%M"7""[(.<B&?PO$ZXNU9I)!3"IB3_?'(
M,.!?@)H\.8AUH`V*:JKL,/7$/;IEN=/PD"RXC9C0I1[/@^TQ0RQ=SS&@:K=0
MTPVY`@\;>D5V\G!4H.A$EX/1QG:V]NKWVU]@9=29T,PA85\LA*BCIXEI'I(M
MT9@P4<LEV,PBQ?TQHC<:DS#T9`UR.KPIQ]-S.?"/B=F>D9,+Z>=HXH)AHU1U
M07J=!;1>6D^C*]%-WIWDHT'5%9V%4TI2)3I!]5K?>;X>;#JW@D)0M(MQ6;&G
M#N1EI--I@=_R1$APC6B\/(`0F6-Q%&1$G?B^EI>K4BNO0C=,#6,Z4'?^BY=N
M_L%`MTBF/)W1PK$5<I30(!4;3`E_EY,MQ2*CJZZ#U,]Q7CV^']&JZLTDG6JA
M;-NWRZJ,SRV;*W\S#/_YT_;N^N=/:1)/]S)+;H56D;T!"4@9FXLS5I(!FD67
M;%PUETJ&JCJTLCQOPAO6'I&=ZCU+<:R=%@4(@VKLDRP_P#&](GPDV:1^M-+Z
M4^0$(^7QKVOO:3/'U_*.N;5^0"1+G187RKF9;BR8TF>H%]GQNAJT4E)2V15E
M^/P)!98,U[K11$HLH^.&IF;:8&IJA%R*J\X^T26W8A$]OMLQ:)\]?4G#]0`#
MU^E"C5$#88D:%<G"4/NC9Q*'A`V`/?AZ^#AJ[9&9A<Y1H8(45%@/QX4UTK0:
MCNPY,@S&2WQ[VO/:;6G:W/L[3_8V'T671LX:'U9II]BZO9F=0ETA$<4'95@!
MB7)<$I^9-5#RGN5TIUZZXT_U27KN\B'"1<%AQA.A9X.]\7H9UL,;$^8A$VQ+
MXNV6<=^&SMU(9^H/5(;(VE=[.`R,R7:H(R)RC6@R6R/Y:%)89GO&%!/&)>NT
MM5U1]W,J<`W%;JBY__C1YDZ<OI-:90<;Z2VYS;'62(;6<I^A75`H6\Z5RE5-
M9Q'!6,&Q&+W?"%3GTW(N*9@6G3*8!@G.D6=U,)%07?5B!/\VMH+&(),@Q:6(
M]T5QB#'LY63QT.W0."?C3S+]&O<8ST%2;X92TF#>&*/0,$,.M"H2\(9YVW5W
M`:?$8[@0C*<04`G`'B*#)?('/!-PJ2XW:P.VZJZMRE?\#I"J:8J[&]XFQB08
M-[I)Q3)!FX!`'3<YE>84.D5N:07C^5!Z%:!&&<?DCH)68?-8^876JU!V/K(:
MA'AW;M6/VJXF,5>^#<W#&_&'B<21O)!N4W^T"9P,_[F"8UM]`#OS`TQO+@!(
M[8]5YW$&4MFZPA9#V1WURRQJ9VDC47J(SE\AKIBTJN-EI][Q<I<)SA1Q,K;U
ML&ATF$7"17`AYU_]V51.'`O@+E%S[$FMH-_WC^?82XTU[9NBN\]6T8WS2`@(
M%I49A5`EKTV.Q')_5X+ZEN(L?YUJ'A`!F_7-P<%)RL,KP3L=7-<H(E+&_W1!
M,<.@TJU&HD`WFQ*\X!%;K>6%&C9TW,.TY@"+TB/IL;TES'CCJBKG^73CW[!/
MM@K8,;PQE^LFZ].WB#?I^2A8AHGD/9^G28#JJM[OI#)PD!,*2EI'%'`#Y-HB
M*K8FC1U/<)0])UUEN(`+)G93Z^JSQBXIU:NM@Z"1>*&B@#!-G[$?TSE)KB^T
MG2H>RVJ-\+K+4HZ,%(Z,0CY0\L!<3.=DM;EAQ7W:2Y)]XTE+J.MML6!V-06Y
MS=PI>L?GT#$C.BNTD[$P\OD3)LJ]&M-*L3,2HA8@BOE6Q\)6!L[&:5)O"9JG
M_LU4S7/P"84`TU91<T/>2I-K^4>L5'DB)L<:RJ/R@*>2[?-PJL).8644/.(K
MZ<0#EB745N$>IAQ]4,>PIHJJLE!!W$(;\=Y^<CZGF!_CDK]3DGP9C3V#:U[A
M,0:0[@0OL-20@3@,`68[W"%`9O626?U3JXCVS]ZK#ZFZX93M!$.C%U$3VIKF
MF9*`PW<&#\F*ID8(4'/^-:4]0A458;L!K'7TB-(_$^-:!LWPY%:N1WE%GFR&
M0X>V'_[VWTO.R>&^#]'V"94;`3[+N\;;WMKXO6F"!K_P0U]1B-CM*!!)AG9Y
M2`791-"IU,W@WI3@^4</"U1>O,;OD1H+R4Z?'QJ0\:>5QCY_^C(H1,=->25?
M?!<K(20*N'\RIM"+2?FJ=:YOP2,KVBM/:W9XX9LK^BEW:]9EP;MMPMXB$0CE
M<]!)*;D.X6>P&W'#]B<[7^GE0I5B3X/LRETU_ANL!IPMZ\4`Y.DZQ_$@V>K3
MV]Z@!O-KZRD-E=+<HB\3%4A!+MC8J#L0'_V96D_W.OI$WF&.X$J,0T=YZ:Z<
M>6H,45D!L0"BA=!R(WU`>[,VIN5."QJE:,:!:;@0%=F("U%!K(92X1LPEXNY
M(,X+L'%>:7?T'F=3G*AD`>P=^CNIOWX,I%L(MJ!+WJA1*;%+22TNU,+I4E6P
M(3Z(S#9S<<"2MVW%:%5U.)JCVH_%>,;WWF!*Q(,-9"B6)BV,T`_O//APO.(;
M6[]XRN9J^7^>]R_=%.;GQ((^(,WC5O000UEKVL<VVWD:Q)>/"!`Q*<U2\DDF
MB*3VR@,UZ"'L94^@3J[!3!@2"91#V!\@0^`D6R>.,T(T$'"PVD=?L#\<)"&)
M(C`KT;><:JQ[5#[C]PH.8Z33BG!L2?>_W*E"+AFQ9'73D5Y[+D)9LFV299W[
M4X@Z]'X5FB6-&SKOQ$OT)^NLAAP9N`G=9F<K#YY&A`K\C-76Z2&+![=>(\GG
M^>B=^85SO5QY%G31*GGI;%&QQ`MW.1VM7LY;X$Y*-D[IHH-?!KJ\?UC+#P@V
M:W%DMO=%!UF?YU-U2Y35::@V;,GG[F4X$?Y<E?00AC\_.34,5X8N'_;4YP@-
MN'=],G_F<HC$$9V*=KZ'+_3WAT(M/U2;Z*284JW,1G.K7ADT>(Y&21;85\MF
M(/+VLK1LW"?\P+.5A,,H<^1JH%D-4=^HS>PHG#>":D6S,N)V_NAGHU>*SZB6
M9;(T44-.EBZ&%`.ZHE(/^V]M[^*2V@_+.5ZIIX:\"]E]$,)5"@VNRC,P*#$?
MVTKOJ<X!AO,:`$C*#=6ILT=,UBRO)"ZVTTKFYB0G&23%$8F+L]?KB]/8`@[+
MP[:=CB@:P8$'58SMVH8/%)>UK7C<(3'%:NP!5+`CK<]"HQI`:HK#1)YX4FDR
MR)CD1&&!RXGZ"<V1A[7!!5KDE541A]`QI*X0+)6>JX3:S\=8X6N'2R:.28S3
M@BJ-.P_+;_#+$P#LC55*E[+N#(FZH*=H_,&LI-F<0('7.2L=_/F7?-MR8VR@
MQDI!EG=M8BO''^PDH#2]1,3*+SHGR`X,9!L`WT:PT[H^U#>T_>#W?LJJ@3OM
M9^3$8MM=%%8J4(V-"P9!+&-?Q3%7:>"(K+TD3[K@)&*]!8,=LT>%IG9Z)C8F
MP4%A1O"TD70I)TXA%4[M-^4J@\U@BNDQ*6-)1IKKD:-EQ=R+:_@@_A+]Q1LT
M;]:-O\P9]-26DH1VN18J`K.7K#>NI.,##T%*QV#I=1'%>@`4R]"-R%7IS[`^
M.VL8%FB^19>V-L??$/GBPM3==)WO4<'0W*7F\ZHR+FY4.QYE!_/+.0UW7H\0
MTU^D?%!M>%(V7(<R[9?9LS'_Y5VE!Z?/@KFTCLN%C[^=2`?L^8/3M_;XJS'7
MC1"L;RBUZI362EJ_8&O9B6-GPJ1JI2PO9KY^^-M_R[ZQUD1\#[KOB>Y.Y^<S
M,C8]J-[?V-L*0EVC^5>M)LM1@961A6(ICFOU0;8D7E)L0L,&T0:B@S)9T.PW
M&^#'6-Z`,(:T,1*=9]Z=B1TU%N!22%<QTZ$((HGV[AOIXWP"AO"@Y5]KF<#D
M@)M=&ZF?$EVV-@-+KNA=108F6=0V_(X*[&O(S!&K%7YC"GX?!>50I(`\`PIS
MJ*5L$ENY'+$@K3Y6DC%LVWJVMJ-"M&7J;.T>ALEV`Q"X(QX7BI*`*6Y&]$',
M1P;;RUB[%0VU90H=HM^F]T2.#JJH.,2?P1.`SBK79\S'1Y9-7MNK*(Q,K"),
MDCQR*FH=NKXR*]L/Z>P/IUVT:<@WJ3MQ))*39'W)U/O5U!*,CQ.&P&!%=8!C
M$4[O1M$(3X#M"U1YU+SVJ#&)RZ%@*B0H`]\%FN07/;^EAEOCHZ&'R9&X6LL;
M)(65GV8=RJ"2G*5T+,%]//\*%3GC_9H\(8AUI=$HOE&JYT7OG"X,Q8.!0F11
M^VG=P"EQE`G%@+-'OEBS%/6WW`*U1,FM@;<59P0MBDO[X4@R'B/S>6NYQ>H2
M$RFH/6%,,3U0Y@G;WEP&JQ(M]E[?L]J*Y$.Y-LUA.L-$X@`CF_>9IQA71QVQ
MIQI;9LRERAR3RI54]:3:#<3-P]O@XX*-J;:^TOK\;LZ6N^UY@3F)&RFZ*C-!
MQ_VO:28.\0'2E0(R!^YQ-3Y>.S.#\.7VXW\J:[#3M@8[[)YA7TR(2;:04>"`
MS(XWZR-2RI.$8V?I:@'S6?B"%*6G;?/>E4X.$!DE[;3!:8RA`LC)V@%#!E7!
M@;?S9GI:R%2?M1*6F@;N",^:"MA0OL5JI*@9D?<L6>OYJNZZ6&$Y5"#-&P`T
M22^:NK<*,2A"DQPJF)_W62UI)88"@G(S$57:Q317=1T"5]PG'8-24@'UX5"+
M)^TK?E8,,-SCH;5S@2=-STM'M$1IG;^^JW'#P;6:ZZ[=,.57[JYV1X#`E:2(
M<Z,.7]V`L]+Z9"9\<P11+%2'C1NK\X6+4>$@A?JS5X/:15,R/-F_Z&3(_TM(
M!\B#=+N>`UV`=E8^V]U09\>O"7<G+:\88_-V1%%I3//+7Y'4L_QC]HR2[@5M
M2-_+%<DYGS:K%0P5Z'&U&UE9@$6;C27,3CG\S74W]K8>L*:!W/X\I$K)6/4W
MLN<?=:*EL^Q_E&.M77`H/5,^:NY!3'`_P:F/.I;'&B[I)#(DQ51*A1;H1E2@
MY(G!WWF=OV3LT47GK[EZGOUI-AR1$FORMPS\U=L*GP-_]2=WA(B_]3>@6/R5
M$\1R$M4-R&5U-8R1'U.KEC&^7,&V&]/`7WEN/%?A2A-W*<6YI[3KV4YYX\'E
MT61"G\H+,@?&8!D)M)Q@1;2?]G9ZJ+G&C+;.L2WU8:J-2=;'LN/QZ%C3L8GU
MENJM!'7,ESH`%C@[LZ>O5-S;H[AW6,M!ZD,`>9R]4:\/2SKQ"]9<X*M:P)&:
MLX[2#"LJ?9TG5U3V*(O_%&*.<2V)<H9"+>\VPV>W%@/$0&=[:I71=/_.04KP
M:U/55TQE`8Y8/<"<?LR/'SV^O[>Y__E3Z.)78'A[[I_0UUCINHD9`:?B@<K4
M_L:XMW>HQ2*.>9RNPA9'4M2Q&3K)VC/4V[=1H8+51=A'`N-:9"8!Q@(JDL%O
M]F)@O9HG)BB"T+?-PHFEWF`7TFD'G%*=Q.,6G_@<'7$5I.ZD0M"CW\BQ0A/(
M=NK`E%U!&,].0@P\]08ZO8:7XSYZ3D#CW3K\RZNA(MGF0,V]RF;GJD.&6\A&
MCIYL'%Z>@4AD!56QN1P,U;RQ;@J$=A`53JDKN'9+%Z[6BVZ'+T7.4XS*)ZH2
M<QT+`6%P30*?62,5*@J\M&=!%FW75PRM.P0M?';PN&6C8&BJ!)C86L.K!S/L
M`JF[*O_)'#JPAK1"Q_;ZSOZ6-\1R:Y4`RM(%][?7N6A5#]1X"#+F:L5!(`PA
MM3U],BF^JV*?K<CV$G8!NZ0`[:"X,"&0:`;$5\Z'>LDNC-%VY.0Q'$SI>:VE
M%'BNG,,4'T$!89WEH9G.;8M:[I"(<'V`[@STPSM/-I\\^8V6(YFL.XIUSLA3
M3KQO;A+-L:PY7%`%E_KABBH'[6INS8SP7`TF-6HS]>C/I$0?Z+#@$*%JDXHB
M6-@<4Q*N<N$HB14MS^LA^IPDUC![M.V7%SAWPDDY2\"*@3Y:1T(.;/L;2?80
M@U*)L0RM%(<HD!J^PB3SL*78/0ZFT3A+H;.SLV\GP048T^"K&X9Y#Z["'>3&
M)9N<5:[T3.O=^I8EY]SEP.)R+23)2M29N5D3##W55,<<`ULZ'"J=I0AEPW36
M#VYZCXLR1GX9L[U6&3E;L2:FJT6;X8\!-5($_$5=A;:[F8Y@136QE7D%3B_[
M[)9X638/X0@2@Z.(ZE3!#ZS\W7QX@T/\Q'MHMBL8#`@0:LV&DW@(8^J"2MPP
M+<M>PBZ=I8\79%2SZ5JS*--+R)3K4^>"%E=#TP`IBU;/9DM,>8%+)[S%.LJX
ME0#4>]K9G[/(.ZF*$2PQHJ;<[\.F2MFS"VYT$?Y:`*]*!(=OF&H#2&.^()"I
M-ULA)>A-!9Q1^%*#IM,)%X./S;%_01QTB7=[75M-=(*!X42S@`HAA_WP9#B&
M9+BHCU@(;.(L@IVH54(8STF^F1JJ8E\<S:J\*M/'?ZQE3H4DK!Z;J0$Y"53H
M=C*@&EW5)ZYW"SG'('2%6=SLP^E^2H&QWO,<F0X*-`FQ(_3A@=")H3952W):
MQKH^+R5]KV_IA9!(*9I]EJGC`X/0MCB"FPGL26<D[W_YV(R5)(-C?[HM=X.V
M&HP5_Z<;&8PY@1=:><VFA<[)B,&^OHJ9E2O16N\2&KS0KW5Y.RD2NJ"+-*W.
M*/1@.1E4Y3%UB8<YY\9WWT1#+=8CNZV5MGGPQ'B@)=__<D__;K;%P$B^NG46
MQ$?[G:(X+:6Y]`5S;^_M5Y-O[]H?S=DKOM"/LJRY]I=@R\[N;D7:SK8)2I.T
M7Y(Q>SLUQNP^>=3=E@XH'BPUVMH*"W8E%`NT>='&K._M;_FD[F/@DLG@3ZV*
M&W3R_OXZ/]%@7.(+=;<W_&5-&^"B:JI8S^S>]:9D,-[]W?7'W!R#]-G9!;U[
MR_`^M-%E'FRA)B$DW+*Q5M1H2?JC]?V@[\M=W`Y73>OWB58MQQU<]0?9<RNW
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M;`&?Q90&G=H6]>]$=U,,N+^SL_DXO;RFK_FTY6]L5^<3Y7DF3]9.1E*&?L'`
MELFPM:6\"N@NH^"MMV.NB4^9+17%R:JK;B3NQ$1,MD7\M83)2F2HFN]W6\NK
M\VB4JQD>;5G*R%YT(0ICTV>`.TWI5Y<)(^PD"\(`UEPG\<(#LU.!,3K;]N",
M&LP9I*=QE-M1J!ZF9YM9LN>AN&Y2B6IR8O"-)2X,/BT]PEI5:Z@"%!%0U?8U
MI/@58E&V07\M88?M@76E*TB/=$61CG23N58R3[$[&29]:[F5\'7(KT^J"+OY
MK7(8K)NWM%)S`N)$(5)IIWWBUT9Y)$([K)7<.?73&,4U^N_+^RSA(?RV!7OC
MFN=M<+;#7O?MGF2DQA!&63N:[,GDT$'-V;.8.ER81DHK5R;)@%?5PQ3-2WCX
MS2"Y=C:I.^#+,T8Z(!AVAGP`0N('"0+D6C^O=2LYDY'GY-'G)),VN$,IQN<>
M@'6PY[5+?_S!+$>6GR&=4I-?,Q-W%6=?2-#TH`>1IZZ82]1,;O'BW$MH"=PS
MBTCJA7R1<MYCKL6DI8D]1DA_<BXE)41J6*?1_6`N"4W=G!6$\!9&M!(N<=6I
ME[XF,(@44,&9&3]M9F]F;^8Z([JW%Y&@5L_@((@^W7Y"F&0=#!@8Y1+4?!=?
MBP5"@TWB!X,.];C5;N]0-X7$^8K[PU4E5YL%MVP'9P*KXZ5SOF,?/9MAJ<X&
M-Y2-(S5;5X#F`CQ4LRQ0-"#T]#"TBC&V7:Y/NG[^Y\Z-^7Z2Q<52Z@8!NYC%
M[(U6M""_99YZ+=%QE\"7T"=8P.BT1-SK9WN/MM:_W'H4GZCG9CM0[$3:F3UL
MLU0GCIL*+HLR'GI0UCX9<T1C=VMW_='VWN=/2P!3LDN67Z^9[4N.!,HS+QNI
MGCMP`"G$+TT^P?VMVF41R;Q&GL1T)LF2J!,!QFI11PH#[&+^E3?['W):_WPZ
M:-_HOZ,/[`<0+8GV]3V.?(RG^C!<\[^XY[AJ;J@YY'AT.W?TZ%`P/6T,,8^N
MZ8#M;VXG%ZW:FHY_9[6>:)EJ'A(WOE+V457-7HY%8MD?)*;M$3:GOK\OGRP6
M-)?XA]R.E1Y9Y!]B7V)+M@.PK_2G6AA$%S$(C)"DN,?T$RU#BA,RVAVU"QWS
MR(>[=C063\OB]NRUSL_!OP7N>?W:*Y?P!1OZN";JMV\H-JH'<ON4M7W%[:]M
MJ]FTI$V>B;YM;[^\W???W7S2*&@GO(C._QE`DHB3`;[.^U9;U?4IYM[+;T_!
MZ6++'1%*[T\XK3K@-`E*X1+2J-P(@Q:;^47[MG?HQ=!;MRU&5<@GH+1@R_9J
MK/KI6[:]O?GE?J6*=GE"K+JX4;:<G=VC%4UX9&Y%V:,06,*I]J_T-,*IOX_.
MO3J=VN5%TWF;;2T"J0*SK<VM[6H(2TG+*0J(;MZ`E%?W0H^L13K\DI(LD[<*
M<B-JN(3GIPCWX\TG"966`-=>+7#N`E<Z%9M9<3`XHHV0.GIS"UCC<!0WSV3V
MGT8S@CKX3Q4]#T%MY[C["W9'FW$'6X[:-.W&ON>B(TK#NP;?/"YG<W'EL%@)
M*C1=-/F2?SS-^D%)3]P$P]7T/O1TDX3[9#82='7`P5BPX85#0")U1[<A78+?
M/I7'B7PN12(E5#J!"TZDLPHO[4C$M:H[73G2K8IDL6\+%ZO!#-.G5;\89G[]
M\],3OXLFN07F*W,]B%(A3J'2@/H%V]O.\9W9I2G?>97KN4*'-J\J4[J[M=[\
MTCSD5]2#_.-%3MO/^G-,M_EI(D`_%?4+)JJ[G&*^FG]XO\DA?JU#PKY*EBC8
MZ(YX*_]6O91A'SOJ>YQ./.@*@IX)C!T^90`Y!FJQK/"Y3<S!JMH4,"X;W-:W
M1S4;*;2TR]L:C:&`0-(T$(&>HII\ZXR@@DN5A4S6`R]B)U6KW;R.&_*%=2B`
M\Y2-*2S"\LNVB4_.[D+0![7FG*L90C\-":^DP1=S:TKH53^D")UV2X=]?T'3
M_!QP,C.E_2#41F'QQKSC&.VWJE=[\59*3R<_8=F.V@=#TVFJX@D^.@?RXYF&
M4%,7D6KGJ?.MR0G")CH,VMM,'J1:B2:RJY52Q=&RNJ&CU=K\8P>&_V%FNCH/
M_XRT];N-TQX!+=`87JL.I^D7+X;>>60SI;/.G<75[N7H'"=^,RC?;5SH_J94
MX%:=O+VPW[0_.-)]!V0\LIM!,>Q`%S\#3M:,ZR4[5R@^M^U$#H:#"PY]VN9T
MS@#?A8U-"$ZG)CSM(88(K&.OXGG])(/M@IU!2$&`GQ7^<:PWCT2JJ^R.Q?&<
M:FB.Z&V!(B9=4@7+6'P#VJVJ9'BBT*@C4V<2H[2Y?CU=S61J]+HIH^N#VSRD
MNM%6WL7AZ,C%]_'*BO;&'Y`SY0J+]L=OXN^0M+\X5+\J--%4T_[JU"Z]:'\:
M':CVYV<<>6M_IE_-K<[*M[^E_M/K$+KV1S6A=T3N6;@'C*@_%?R\WM<>]1L_
MG]/^.)+=T86U+[>?M!_N3(]:4#CQOAOV30C8=0C6:!!HCU2CNRM4[8=?J8/G
M$<5$U2@Y@<_!C>ZU3-5W=^LS7_+\BH(]Y:#JI2X!1P6QN9@Q<"IU8L$[I4U)
M:M<F6=(YF06W+9S2I@2CR^WB53LTLF*!9OR^P6C1\8N07ZWF:G:*D"WT&TJ@
M0LCH9_$M`$\:9BCF187ZI!Z?R7RQ&#-@Z`[=?#1QX<&2Y-/1:77OZ:9(7I_:
MC:SRQV6`:P>O_;Y$]BX83CAB`5]@D,(FNN1*3#9%3@)]CE%Q>R:XH-9?FDJ7
ML),H@Q$Q<Y51P>B-/UA+:[KU#H/&9/9S5V:0F<E/@;."E.-?,5!^R0IQ391:
M3K34][3I&M7N"5P(A?'D*?&)CLD$#M9EA9MBPKEO3^#6Q(AS<G/.ZU_CBL@I
MJ8D.>B\DI1K%3SM3'/5>0$^8DX31'7C#P3O5//G,NI"U@XR1?DK"S[C;J77%
M`QH-;XQ+O92VD0A[Y7O&-4L'MU%N7M.(D])-(JF)DD;7SECYT"CA5O2MWSAM
M@RO]S!=^C__28J(L6BK++IQ+#3!7\;JJ^A43$KN&@RFZ0],E`@HCBW2JV:[#
M\P-III80)7%;KQ]_T:XD%UL,.<1AI?9GS?F6!SSPDX1O[.HU>4,OJBOYZH)F
M?`C,C';MEO['CO34;I^(=^E91=?^(%Z+'W;`N7V1W7H67OE3^.\56'>HV[.D
MH/8/=4VA;&AI^6,&21=2-Q#Y]LGQHWZ=B\/:AN9YO#WKA#2YF?D?LUQ)2?NV
MF!_SOGYAN+[9C8M/?M1`LI=+KF',ULZ$P5U/`H>=YA7JABCB`5!I0:(ZSVO%
M0ZZ(=+VP_A:MEU]2C(WY7>9QYZ_A_0HY,].^K$UO*:UW>RO[TTNUGAYC6LO.
MCVS7EULE4,)9;]OZ$'=JE?'0/+_%BZ$)/UL(G][$T(YS;^Z+'^J:\#NLNS[]
MBMFB3WP[(ZLU6++LM6?U_O2=W2.[<O7UZ4_"<:4#Q8GKL<[A%T^N9W^PBQYU
M#N.@=F7B[;39=M5_;#U;.^)GP@>ZWW?M[>E1=K^#77O[63=S4ATGW%KY+9[P
M9A;[WMHZOJ#1*UO&IE6$KQ2N6A=:[#FU?M+(4OL-`W[QULYP6=7VC?2H2ZO<
M++RPI%MK`$2Z9A^/4X=U.\P["2<)/'5]'++G4NR7W,>Y8>WY1SI6X`"OGST9
MUM1\7<>@VZ08*Y9BRFW;V;4B."Z'.ODKMU%RU0EX[CCA1FB:Y:!UP*87NN:8
MRJ[=<A@.#1W%J^PZ`-]>IS<(<PC<8&V98/QL`+D*H?QN10Z*&.:V"?T^]`TL
M(]%ERW^`PC:[AN/+WC&>W_6([^U*_&BEEFZO_)9C4ERFQ0_)XF^%7V:IU)\Z
MW6;*DK<9<SR2TV)VS-9=4[)5Z^9J33]FNIZ]QN>;QC]!\R4@RAGB1$6'1,P&
M1T$"@BX;H;Z.S@C']H/?P^R0%*VTY,!]^V5CG81FM-M$E^Q"Z/B_9<"?*@RK
M@+$CE`9.ZF#4KHU'W*QN>O>]NMV@U$Y8IS[8#HM$(G?]5+VY;ZW#L?,BHQ-:
M`7*!EVV1:?-NR3#MUTR\CNW"?K7IKG-6F#A-.:RC!;G(UM,=\,<VN,8K.^3_
M["#[[6-\QT%,^UU$T#YM=9OP9W8K@T[.9J_3Z=4#N_RFTI;V2Z_\!&MP=/``
M&C_&MG!(GM5U?KHZ]J4.Q)JO&,V>0Q.C=E,I#\+IUS8)4:F<3V^LRY8T9M]Z
MC]_XZ<T%@E27.IO/BEQW8_$Z=X;D?D2*>72T0^?PVH2=A$-HO]<AM&.[3*#L
M/!0_QU19S6V=H%07N;GE"BJ>SF*UIT!;TW<RY28*D1ZB0'Y1>3"_[DA,T\CJ
M1>?`Z^IH3WNFEI"M9R]TFM#1XM9G:[S&CTCW!0>S6BE+IU`ELK+ED<!M'L;.
MXVR5P]B%!-F5I=!NUB?\]D(G=[EPK)VE8[$S_$JJY<^#S5YN4N@;2B9EM\WK
MWZE_AJO+R^SER\.ETT4=L3!`#A[SZR>+D-Y;IS]%6REICPDVJ_8;3W+P^C++
M<]>=6VT8*G.9@+`&["LPT0JFF0R)%!3\Q58Z2,6!Y-!^\">X;G$YNJX:R7S4
M^D#MW0FADV<%C?G)\;:@L/U\`/N#=*L?-,<=`A*\[YF^W.7DQH>$\U)0G:3P
M*N=Z'*BDVIDEZ^93LKG15?`7-;%^P,;F.J)D0Z'!2L+V?`=1*B3/7H\BI1;G
M1_EJ+W5Y/%(7UO9;-ON"(+R^4&4LZ\^UXM=7U)*#)]\%(`'O';C<)#YZW?'5
M#HPYCX,X2H^T->*P?=%A<2E3UF'QJ:XA`*I-('_J((=#J@\:)=),<?B-+G2O
MXW(M*"!DTKEI.!KW4><5[(W56J,EA(5*6NL2M'AY*RB+?`WC5=2SD@8QM\\2
ME[VH`/?@2^\U:\M<<[.3`C-UW!*7H_9[MKE_GZRZG))?C2RPBDT$,B+R55#0
MI-MQ+`R8QNM4^*J4T:UI+Q3)>S*R@P_J()`/5Z7%^(/:PROR_C>0627%VESZ
MQ2=$53P-IUQ[H$/Q1)N0!SNAU?!1^-6G]@.LY4[.2#A>O&CG@Y.W+,'U,TA,
M=PM66=CZA+WZYA7NC;99\.,:A^X(;/CHE+&I[LDQ.:+G,_[T7^36,A_C&R*6
M*>&*WCOHTX_/K6\ZX41^^K97[[Z7P50L3G.N5=*[*,/:P?"?:=I56_K@T6(4
M^]%3GUHK([6DQ<E83C"L\JT#V^(@?SHXU][T9IVL<VK.",T8"9H<[=L2V'D\
M-6LH=H[=&=E"?'\<%7S?KE%J#_T@?K_OURQ5WS\LR]G3_RL`````__\#`%!+
M`P04``8`"````"$`,6P*X>H#``#P#```&````'AL+W=O<FMS:&5E=',O<VAE
M970S+GAM;)27VXZC.!"&[U?:=T#<![##(41)1@.D=T>:E5:K/5P3<!+4@)'M
M=+K??LMV)V"G)YVYZ0ZIWS_^JLI067UY[5KGA3#>T'[M(B]P'=)7M&[ZP]K]
MY^^GV<)UN"C[NFQI3];N&^'NE\VOOZS.E#WS(R'"`8>>K]VC$,/2]WEU)%W)
M/3J0'B)[RKI2P"4[^'Q@I*S5HJ[U<1#$?E<VO:L=ENP1#[K?-Q4I:'7J2"^T
M"2-M*6#__-@,_.+658_8=25[/@VSBG8#6.R:MA%ORM1UNFKY[=!35NY:X'Y%
M85E=O-7%C7W75(QRNA<>V/EZH[?,J9_ZX+19U0T0R+0[C.S7[E>TW"+D^IN5
M2M"_#3GSR6>''^GY-];4WYN>0+:A3K(".TJ?I?1;+;^"Q?[-ZB=5@3^94Y-]
M>6K%7_3\.VD.1P'ECH!(@BWKMX+P"C(*-AZ.I%-%6]@`_'6Z1K8&9*1\5?_/
M32V.:W<>>U$2S!'(G1WAXJF1EJY3G;B@W7]:I(BN)OC=!%:\FR#LX46$HOAS
M%U_O2`$6I2@W*T;/#G0-W),/I>Q!M`3G"YG>QY7U1ZC`*$V^2A?E!10<ZO.R
MB?#*?X&45N^23$L2UQDEH2G)+Q*90&E;7+X8UR!SR?:BD-4#HBL6),O&FD/9
M/R[8A4(NLBCFYOVR6XG%F=\JHL@T*6XEELGV5C$Q,4#G)NA]0"F&WIO6(#;W
MEFE).)68BOQ31?&I8GM/8>#!1J9UO(\GQ6L7<C>V6&)N/M.2A6I1%"9SJY_R
M:3S&R,I.,0V'08I3TWX[C>,0Q6-=#2HX:(]32;%%M3!OFVE)I*A"C,>[JF.4
M3\-Q&%JKBVD8A6ANY6QKQ.,P'H^M`17_#)046U!6+C,MT5!HD4;64<R-.(XG
MV](/CVD\BH+8JN5V&@^#&(]Q`PN>6(_72HI-K#BP:J4E&FOV$9<I^`#,$'Q$
M9@CNH,GQ9/+LOW^XI-A"LPY/IB6A:L,9M+])GIOAP*IW883CQ.Y",XQ^T(3I
MSR!)L85D'9U,2_3S8H92E([WU6?+%.!%8K5I80BB*`DMP=80A`B'8\<8C8C@
M_34MEWQ5?_Y.4ZLL2&L'V;LFU84+//NHY+9@866A,`780W;U;$$\5M^$E"_T
M24\^"*G'@.F3WWX<9#`?RFKK@X?3(+`8<D.`HGEBO[8-`8[B9&10O2!'T/$6
MX!",#AI2#YAZ_NH(.Y"<M"UW*GJ2PR.&_%^_U8-MAI8P%<%P8WU?R(%7C:S7
M`,R;0WD@?Y3LT/3<:<D>+`,O@:<WTQ.KOA!T4#/.C@J8--7'(_RR(#!O!1Z(
M]Y2*RX6<JJZ_53;_`P``__\#`%!+`P04``8`"````"$`S7^2W)H$``"Z$```
M&````'AL+W=O<FMS:&5E=',O<VAE970R+GAM;)Q878^C-A1]K]3_@'B?@,UW
ME&2U,)IVI5:JJN[VF1`G00,X`F8R\^][[>L!;#+9I"\S27Q\./?#Y\99?7FK
M*^N5M5W)F[5-%JYML:;@N[(YK.WO_SP]Q+;5]7FSRRO>L+7]SCK[R^;77U9G
MWCYW1\9Z"QB:;FT?^_ZT=)RN.+(Z[Q;\Q!I8V?.VSGMXVQZ<[M2R?"<WU95#
M73=TZKQL;&18MK=P\/V^+-@C+UYJUO1(TK(J[T%_=RQ/W0=;7=Q"5^?M\\OI
MH>#U"2BV957V[Y+4MNIB^>W0\#;?5A#W&_'SXH-;OIG1UV71\H[O^P70.2AT
M'G/B)`XP;5:[$B(0:;=:ME_;7\DRH]1V-BN9H!\E.W>3UU9WY.??VG+W1]DP
MR#;4251@R_FS@'[;B8]@LS/;_20K\%=K[=@^?ZGZO_GY=U8>CCV4.X"(1&#+
MW?LCZPK(*-`L:""8"EZ!`/AKU:5H#<A(_B;_G\M=?US;7K@((M<C`+>VK.N?
M2D%I6\5+U_/Z7P01184D5)%XH%ZMTP6-`Q*$/V=Q4)$,\#'O\\VJY6<+N@:>
MV9URT8-D"<PB,@_R<SDR"$GL^2HVR:V`[J`<KQN:K)Q7R&"A("E"(ML:(3HB
MFR,\,D`<D#=HA,COUR@VZ1H]=Z"78:0(B62615S9Y`--`"1F*N!Z<@08DCB)
MW*/&@Q'B3R"!CLBN(31I0'*[-`%>VQ#E4!3/TQ^<(B2618U#2@SIV70]HC2.
MAOV:+&CKJ:S;VDIL,N3Y`SV6#"&!E.>Y9D4S7/;E<NC%PV9-6ZAKNUY-`38T
M&;5*$8*:XH3Z9LJFZQ%-Z+A?DP5G99JRZ[($V)`5#M%BJA""LFA"C.;/M.4X
M'D5KHL0$F]C#=5$";(@:VP-%(00+1&;E^VQ5DY3<(TF`#4EC5Z`DA&">$NCH
M,1-R/9NN1T'BC2%IL@BXYNVIDFC#)686*AC7-IRXX;B.K8/:%,UEB"[/,/KK
ME21HSE.G\(T&2A4&$T?\:*8-.=0Z#<>CK`L3IGMSBQ&T:$W8.#6PH`J##_:#
M69=IZR2*1@O4A0D/G@B[S<,(.K<FT.BH5&%0(`U=(X!,7P_"\63K`H473P3^
MI*3HW)JP,7*5.<1\E(P81R4CN(['U_NTHO_+_,7W*>.H^F/+*'U3^R=^8+1D
MICB4?O<SIR5W30")UCW$-WH]51CU8$(C0WFF`<(D&5M"+^E=0X"@AT/'#0;A
MC[VB4H88*-R`,<1GBN8R1)=WUS@@\WG@C^:IY$TM'V:C/L,R18$-1S^UWKM&
M`IG/!-]H]%1AL)Y>%'CF]]M,1[A1$(T<6L[H77-!HHUF,^>"PJ"X!YKX(3$.
M<F9`O#B.QK.BR[MK+M#Y7#`/8:HP*"\FKCLF1M8\TP!AG$Q.DRY->/W$WVXS
M8+@'FCX2&`:;*@Q^R[TT\S7`I:&/5T6\2=6L/;",555G%?Q%7`,I?`$=/L4K
M:DJ6J;RA&I]GXNHJ+Y_#`MP<3_F!_9FWA[+IK(KM@=)=1&!^+=X]\4W/3_*"
ML^4]W!GERR/\1L#@)N,N`+SGO/]X(VZWPZ\.F_\```#__P,`4$L#!!0`!@`(
M````(0`][#2)QP,``),-```8````>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
ME)==CZ,V%(;O*_4_(.XW8/(Q212RFC":=J56JMK=]MH!)T$#F-K.9.;?[SF8
M`+8G(W*3`'EY_?CX'/MD\_6M++Q7)F3.J]@GD]#W6)7R+*^.L?_C^_.7I>])
M1:N,%KQBL?_.I/]U^^LOFPL7+_+$F/+`H9*Q?U*J7@>!3$^LI'+":U;!+P<N
M2JK@5AP#60M&L^:EL@BB,%P$)<TK7SNLQ1@/?CCD*7OBZ;EDE=(F@A54`;\\
MY;6\NI7I&+N2BI=S_27E90T6^[S(U7MCZGMENOYVK+B@^P+F_49F-+UZ-S>.
M?9FG@DM^4!.P"S2H.^=5L`K`:;O)<I@!AMT3[!#[CV2=D(4?;#=-@/[-V44.
MKCUYXI??1)[]D5<,H@WKI.C^'U:P5+$,5L[W<$7VG+_@J]_@40B#R$:`@\C_
MK\,\1CA*T`TSO+X.^=PLVU_"R]B!G@OU-[_\SO+C2<%(<P@#1F.=O3\QF<(R
MP%B3:(ZN*2_``CZ],L=\@C#2-TV79^H4^]/%9/X03@G(O3V3ZCE'2]]+SU+Q
M\C\M(JV5-HE:$_B^M";A9#F?SQ;+A_$NT]8%OEL7`H:?(P1Z.DVDGJBBVXW@
M%P_R%(!E33'KR1H,/PX'Q`&UCRB._0=8L-B7L":OVW`3O$+4TU:QTPKX[!3$
M5"17!2X<,'0@,(7Q("A&$%PG)-OI!\-Q(VM<5S'M%`8(1&$(@HDRA1S]/#+X
M$N@&\YYU[II0*V8#Q=Q4))\I#$(P&1)^3H;BV(?9=RNR,,?=:<60[,%4)*ZB
M9S?(((G'DZ'8)%N:X^ZT8DBV,A6)J[A!MKB'#,4F&;$374N&:,3.=%=R@PT*
M:ABU<1F'+UF,5LKOM&3(V`,T29EHQ;PIY6A%EF&XZB-LK"P>GJ/W"11;;'VQ
MZ7+0DB$;L2HF<24]OL&VNH<-Q19;;ZO9M,1@LVHF<26]B<%&8.L8'[A&;=%9
MQ;AK-0:>53C)!YI;?+@?CUY8HG?OX6Y"^H31T6LU0[[(JI[D`\TM/MRWQ_/I
M77[(%UEEN</#$C+`X+,J)_E`<XL/=^WQ?'J/-_CLRB#N.>#&S]7<XH-YWL&'
M:C/_(JLL=T1K%LVF,2,KX@1/"^"S.W)NP=UU7F"[9L/UQFWRN0="9-=NZS.&
M[ZY3`WI>A\\I7O=0B)SB=37]-/7FHEM>W<B53!Q9PHI">BD_8PM+8&FZIUU/
MWC;+W0_0W=;TR/ZDXIA7TBO8`5X-)]B("MT?ZQO%ZZ9-W',%?6US>8(_/PS:
MKG`"X@/GZGJ#35WW=VK[$P``__\#`%!+`P04``8`"````"$`8@E="R0#```V
M"@``&0```'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6R45EUOVC`4?9^T_V#Y
MO?F"0$%`5:BZ5=JD:=K'LTD<8C6)(]N4]M_OVH8T#JM+7R".CX_//<?)S>+F
MN:[0$Q62\6:)XR#"B#89SUFS6^+?O^ZOKC&2BC0YJ7A#E_B%2GRS^OQI<>#B
M49:4*@0,C5SB4JEV'H8R*VE-9,!;VL!,P45-%`S%+I2MH"0WB^HJ3*)H$M:$
M-=@RS,4E'+PH6$;O>+:O::,LB:`54:!?EJR5)[8ZNX2N)N)QWUYEO&Z!8LLJ
MIEX,*49U-G_8-5R0;05U/\=CDIVXS>",OF:9X)(7*@"ZT`H]KWD6SD)@6BUR
M!A5HVY&@Q1+?QO--'.-PM3`&_6'T('O72);\\$6P_!MK*+@-.>D$MIP_:NA#
MKF_!XO!L];U)X(=`.2W(OE(_^>$K9;M20=PI5*0+F^<O=U1FX"C0!$FJF3)>
M@0#X13731P,<(<_F_\!R52[Q:!*DTV@4`QQMJ53W3%-BE.VEXO5?"S(5=23)
MD60$ZH_S29!<IW$Z>9\EM(I,@7=$D=5"\`."4P-[RI;H,QC/@?E4F=71U?I6
MJ5"C)KG5+(8+JI"0S],J29)%^`2>9D?,VF*F&'68V$5L3@@=!<CK-$+E0XTC
MR/#_[I\DZ46NI%'D[K<^APPT;\X1:=J1.!K!N[Y&OS8-7F(@[ZQ(DE'':RQ=
M6\RXAWG=V2`V/H2C#4CZVG3&XS=/[\D_O0C.:6__)!D/-%J,3Z,/X6@$/7V-
M?O\T>.C?P)VUQ:3F,$[&Z<25OG&FD^GKT7!433ZB2H.'J@;;KBW&YY@/X6B#
M)ZGOV&6IZD7OI6HQ/HT^A*-1-\#>V\6?J@8/_1NF:C$VU7$<70]2[4^/9I-9
M-^VHFGU$E08/54T[7ONL6HS/,1_"T1;#BZUOV66QFE7OY7H$^61Z(:[.0>/P
M1PO-^=S%8;9'T/&13:?#<-WY>/8Z;Y79]FV[6TW%CFYH54F4\;UNS3&\";J[
M]K-AK3\;3./O)J!KMV1'OQ.Q8XU$%2U@:11,X74A;-^W`\5;TURV7$&_-I<E
M?)]1:(91`.""<W4:Z';6??&M_@$``/__`P!02P,$%``&``@````A`*H+Y5E$
M`P``V@D``!D```!X;"]W;W)K<VAE971S+W-H965T,30N>&ULG%9=;YLP%'V?
MM/^`_%X^0R`HI&J"NE7:I&G:Q[,#)E@%C&RG:?_]KNU``XG:="\0;LX]/N=>
M?,WR]KFIK2?"!65MBCS;119I<U;0=I>BW[_N;V)D"8G;`M>L)2EZ(0+=KCY_
M6AX8?Q05(=("AE:DJ)*R2QQ'Y!5IL+!91UKXIV2\P1(>^<X1'2>XT$E-[?BN
M.W<:3%MD&!)^#0<K2YJ3C.7[AK32D'!28PGZ144[T;,U^35T#>:/^^XF9TT'
M%%M:4_FB29'5Y,G#KF4<;VOP_>S-<-YSZX<S^H;FG`E62AOH'"/TW//"63C`
MM%H6%!RHLEN<E"FZ\Y(L1LYJJ>OSAY*#./EMB8H=OG!:?*,M@6)#FU0#MHP]
M*NA#H4*0[)QEW^L&_.!604J\K^5/=OA*Z*Z2T.T0#"E?2?&2$9%#08'&]D/%
ME+,:!,#5:JAZ,Z`@^%G?#[2058J"N1U&;N`!W-H2(>^IHD16OA>2-7\-R#M2
M&1+_2`+W(XDWMV=^&,4?80F.+'#O60([\MQ%$%TO978D@?N1Q(_L.`QG\_A]
M%L<41]<ZPQ*OEIP=+'A_P;[HL-H-7@+,EXL+5578.P5.480LJ)N`%^)IY7O>
MTGF"+N9'S-I@X'J"\<>838]135/$61\X30J&)`>T#H*A$]<+5F`EN%]HW0=.
M%AJ6T5(VYXA@8C$SD+'%V4`S4@L=OUZM`H_43@.;:2`S@;&4\+(4Z.[U4A08
M-LRHB_.!5U=J;3!P'3K]NK*IY;N(["W$J)"P3T[5JV$0P$AY^WU522F"=@T*
M?2^:N#"8MUR\B\AZA-X1[K#`R,#\?PRHI*F!>.`W;3"86&_'&W\QFWN!Z[Z*
M,)T8@X(XC@`S`64&=+D4(R\P`3[>#)4T];*8>#&84'OQ%C-E9*IR8S"756JS
MV5N(D0_UI7#U\%/@L?[@=4295AB(:44\]SWX8)C4>',*B7Q?]V%<!#A3U4*7
M#1KYYLPT<[PA?$<VI*Z%E;.].@\#*-\0'8[JNT!-P4E\[2?K2_&-G\"L`;PS
M),#1VN$=^8[YCK;"JDD)2[FV.GJX.9S-@V2=/E6V3,*AJG]6\`U%8,R[-H!+
MQF3_H!88OLI6_P```/__`P!02P,$%``&``@````A`">$XN/-`P``6@X``!@`
M``!X;"]W;W)K<VAE971S+W-H965T-2YX;6R45]MNXC`0?5]I_R'R>PD.%`@B
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M%!*`7R\3V!I0$?8:D0"`16)V$9G,1M?S\82"N_?$M7D0&))X\5X;F?US3M0F
MY6+9U.Z98>N5D@</]AN\=<&P>^@2`O?G`DF@[RTZ1V1./(#14,"7]>)ZY;\`
MY[ATN7,N\%NYT,K#!\P*&,"&`Z,S`F-1,),[9ZC#!/TPDTM@T!FJ6DM^,:O"
M.F#G,JVY'"O0X`<NP_FA,^P`L*K*MIBWD)W/`&1HAN'(Z&R1J]*6%FCO8RZ+
M*I<&Q]DE2.C<1'*6J>W/>FM`@]4)X#D)@O$($ONX/7%=$Z&TU/MD$?9S094=
M?!#0N8GD+%TN83.LY3*GY[G@NB9"::ES"<?]7"ALWG`RUKN)59JZ="C`UR-;
M#0NA;S_>&;NL!8&1P-3@<T(K\&#44<^`E>(0'.7"!HA(#Y^6/MC]">&0G8%P
M,@!AJV-#2U.#SPE1HGB6!S>;]6X5[UT,`+YQ(O$^J4>V?&:+\_UF%[9`2B5H
M,)J<Z+B+I(!VM:`T]>Q0KQI,!C#JR@'MT8-P>H+118)`NXI0FGH8]6G">(:7
M_KFVZZH"[9.%$U=2<)$L6.]F1Y2F+J4`#W.MH:TL3,'X\3&RRUH0&`E,C:8[
M7L*-9@\ND@7KW0)S2M'#IR4+9VATU2`H3?5;-#S>Z$T:%ZE!X(Y^77I*4P^-
M'C6@`[:E//@U=</>[&S+B:D@N$@+K'=K6TX-!C"==]OL_.UCE[4@^I2@/1FX
M2=Z-RQE76_Z%IZGV8KG'*3V``;BR5E\0M[9H;?MT>0M)H%A7;V"R+]B6_V!J
M*W+MI7P#,<>C.11:N6\#]V!D`:G#?"\-S/3V[PZ^X3A,P78DVDAIWA\0H/HJ
M7/\'``#__P,`4$L#!!0`!@`(````(0#E>[!^D`(``(@&```8````>&PO=V]R
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M^\T+>BF85D:5-@(ZXAU]&?.*K`@P;=:%@`A<VI'F98ZW27:WP&2S[O/S4_"3
M&;PC4ZO31RV*SZ+ED&PHDRO`7JE'!WTHG`D.DQ>G=WT!OFI4\)(>&OM-G3YQ
M4=46JCV#@%Q<67&YYX9!0H$F2F>.B:D&'(`52>$Z`Q)"S_WS)`I;YSA=1=-T
MME@F@$=[;NQ..$Z,V,%8)7]Y5'+E\BSIE06>5Y;)/)HMXLD($N(]Z@.\IY9N
MUEJ=$#0-2)J.NA9,,B!^/2((Q6&W#ISC!4;@JX$J'#=)'*_)$5+'KI@[CX'U
M#R8@"(@&95`;K^S`3MGEUKERYPU#F?1UF<E;9!PXQ[`&YY?S0.N%/60Z@,P"
MXEE\`!D?GP-#"2"JH)S$22#VTAXT0AIZ:KRT`_?2(;=7"UR3@3/_2._\+5(.
M_%S*6Z;][1LV!_38,`)WX:;Q*@+X_SO4G7NN<+4,.R6))R&SOF3^YON+(;FN
M^`?>-`8Q=7"W.H56#]8P<+:I\_IO^S3;]EU*P@<8!!VM^!>J*]$:U/`2*.-H
M`5G6?I3XC54=>`[30%F8`/UK#1.?0[?'$8!+I>S3!H1)^(=L?@,``/__`P!0
M2P,$%``&``@````A`/&!,;*A"0``=C$``!@```!X;"]W;W)K<VAE971S+W-H
M965T-RYX;6RLFUMOX[P1AN\+]#\8OO]B2[*=`Y)\B"U2I-`"1='#M==1$F-M
M*["=/?S[#D52XO!5DVBQ-YODX7#D.9!Z16MO__RQWXV^5<?3MC[<C9.+Z7A4
M'3;UX_;P?#?^][_D'U?CT>F\/CRN=_6ANAO_K$[C/^__^I?;[_7QZ^FEJLXC
M\G`XW8U?SN?7F\GDM'FI]NO31?U:'6CDJ3[NUV?Z\_@\.;T>J_5C,VF_FZ33
MZ6*R7V\/8^OAYO@9'_73TW93Y?7F;5\=SM;)L=JMS_3Y3R_;UY/WMM]\QMU^
M??SZ]OK'IMZ_DHLOV]WV_+-Q.A[M-S?Z^5`?UU]V%/>/9+;>>-_-'^!^O]T<
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M&0"6"%I2OR,1Q@TM:=8D<Q[YTMJDH5%DLFI-VNP`$4`DD`*(`J*!E"%A2:+]
MYG<DR;BAQ4BE");2(LJ2-7HW2ZU)FR4@`H@$4@!10#20,B0L2[2[LBSUWQK\
MMF*LFV3X():6I.0_2,\E3\^J-?+3<B`"B`12`%%`-)`R)"QVND\,B-U8\]@M
MH:K[L%9`<B`"B`12`%%`-)`R)"Q0N@\,"-18\T`MB8I\%16Y-?+9R($((!)(
M`40!T4#*D+#8C98-;ZCO-[BQYK%;$A892`Y$`)%`"B`*B`92AH0%2JJ%!6J4
MPYQNI0.5@W'#,V")46O!$K^.JM\:M=4'(H!((`40!40#*4/"DF(D%,O*^^5O
MS'GT#H4-@"A')!!)1`4BA4@C*AGB,1O]]/F63ZS<HCN<+]W2(;;@LRRJ>&?D
MY^6(!"*)J$"D$&E$)4,\"T8\#<B"U5HL"Q:QR@/*C3*@!1-8"40248%((=*(
M2H9XS$8,A3&;/2"=7]#2';@+)%96T:5\<9<.\7T@F<9=X?28?9RT#PV`1.?+
MNY>("D0*D494,L0S9(10F*$/]@.KFU@:0BG5/!6M$D`Y(H%((BH0*40:4<D0
MC]D(H`$Q6[W$8K:([0=)DL2E;ZU\47-SV&`6QZQM(X%((BH0*40:4<D03X.1
M1P/28-442T,HL%SI`>4)((%((BH0*40:4<D0C]G(HC!FLR%D5^:T9_".8!46
MRX<37>2L4P9)_.R<M%9=6P`2:"41%8@4(HVH9(BGR`BJ,$4?[`A6?[$TA)+,
MM06@/`$D$$E$!2*%2",J&>(Q&[T4QOSK]PFKO%@Z6C$6=@6HA]:JZPI`(@$D
M$16(%"*-J&2(92@=IAL;<ZX;'0ITP0I1CD@@DH@*1`J11E0RQ&,>IAM3U(T.
M11(A.G=<=59MZ1$)1!)1@4@ATHA*AG@:C*`+%\?[&T)J]5^X`AQBI0>5F*.5
M0"01%8@4(HVH9(C'W"<<D_G%I=G:7[:;K\N:=G@J>$\N,CI>;G:]!PHX?G;T
M*#@C090[9&H2W$BB<T;16?F^D8@*1`J11E0Z1-J1W//LQ*+1;)?#LX-:T@@J
M\[`=9@=0[JRH>N8</YTFT8(2G4&7&'!3X,54-]%YCG9IW1EXSR5SP]-DQ-Z`
MA6/,HSW3H4XNKLQ>8JPZE",2B"2B`I%"I!&5#/&8C=@;$+/5AFRS<(CB#'H_
M.F!>I:V5+T2.2'BT:#IE,9M';J0WZ+[\*#SJ'M@4(NV1\YQ>1L]]I3=H//,4
M&;$W($56&[(4.40**DA1?,B<ME9=B@`);W7=I&B63*-C3.D,Z#;IW11^SE6+
M%"+MD?6<72^B([*2>>8I,MHP3%&CQQ:-3._9<:D=VRW7JDJ6+8=X0T5AKM+6
MRH>9(Q(>N;+/+R,WTAN$#06>E;?J>DQ[Y#PGUY'GTAOT-)01A6&V/DB1U9`L
M14Y6AOLNH#P%)!!)1`4BA4@C*AEB'9(-TZ.-.=];'3+;=["(HAY==59M6R`2
MB"2B`I%"I!&5#/$T#).H&4I4A^AF[P-<(<H1"40248%((=*(2H9XS+$>_>6'
MM0REJD/F!M=U11IM[JO.RB<M1R00240%(H5((RH9XAF*U>O[&T*&,M4AUA76
M*D`Y6@E$$E&!2"'2B$J&>,Q&X'U^$\R<'@S.<QWB&T(:'^IU5EWIK2^:Z)%`
M*XFH0*00:40E0SP-1AX.2(,QC_9%BX(ZKS)`.2*!2"(J$"E$&E')$(\YUIQF
M0[BD%[,&G^EE*$<=BC:$^$ROL_(MD",2B"2B`I%"I!&5#/$,&=TWH"N<3`P7
MAT6L*P#E&2"!2"(J$"E$&E')$(_9R*XP9M,5BZQYA!_XY4_F%%R8#XNBMH@>
M%U=N(EEU;=%.]$B@E414(%*(-**2(9XB(^C"%'UPG[#Z+Q2.&4C"%:(<D4`D
M$16(%"*-J&2(Q4ROE_*835O\PFL!C1^^<SH4]41T.+'JK'P#Y(@$(HFH0*00
M:43F)5NS[]O&M/FQ+\W:=R_WU?&Y6E6[W6FTJ=_,"[&4T/O;%MNW=9?9XL9L
M.A0'C%S22/.D`B-7--(\.,+(-8U<]WF;3?UKP3"'1D@=]WT">I68-&3?2$HC
MS5(&;QF--$(81F8TTMS?861.(\WZCD<2BI2^<NCY!`E%2D?M/2,IQ6.?M&-O
M*<5#YX%]<R@>.@OK&Z'KT"-4STA"<^PZCJ^34`[L^1N,4`[LL1.,4`[H>\:^
MZU"'T+=Q?2/4(?0E5,\(3>F=01-Z[2G-O5FFX/MCIQS3RR(]5TXHQ_0"!8[0
M@>R-.2+M&YG=F/-&'*'#1)K3-T)ON3_TULM<OL?3TA2XCYMV[>$/LYL'6N#X
MD994P;X/M*3Z->6;M)6EM]Y?U\_5W]?'Y^WA--I53[0)3)N;Y]&^-V__.->O
MM`G2N^_UF=YW;WY]H?_?4-'+T5,CP)[J^NS_H`\T:?_'Q/W_````__\#`%!+
M`P04``8`"````"$`\QPHZ%4"``"6!0``&0```'AL+W=O<FMS:&5E=',O<VAE
M970Q-2YX;6R,5-ENVS`0?"_0?R#X'E&'KQB2@\2&VP`-4!0]GFF*D@B+HD#2
M1_Z^2]%6?2'UBRU*LZ.9V5VE3WM9HRW71J@FPU$08L0;IG+1E!G^]7/Y,,'(
M6-KDM%8-S_`[-_AI]OE3NE-Z;2K.+0*&QF2XLK:=$F)8Q24U@6IY`T\*I26U
M<-0E,:WF-.^*9$WB,!P1246#/<-4W\.ABD(POE!L(WEC/8GF-;6@WU2B-4<V
MR>ZADU2O-^T#4[(%BI6HA7WO2#&2;/I:-DK350V^]]&`LB-W=[BBEX)I951A
M`Z`C7NBUYT?R2(!IEN8"'+C8D>9%AI^CZ7R`R2SM\ODM^,Z<7"-3J=T7+?)O
MHN$0-K3)-6"EU-I!7W-W"XK)5?6R:\!WC7)>T$UM?ZC=5R[*RD*WAV#(^9KF
M[PMN&`0*-$$\=$Q,U2``?I$4;C(@$+KO_G<BMU6&DU$P'(=)!'"TXL8NA:/$
MB&V,5?*/!T4'*D\2'T@24']X'@?Q9!@-1_]G(5Y19W!!+9VE6NT0#`V\T[34
MC6`T!6;G+(%\;CL#2Z[FV15UI8`VT(WM+([#E&PA0G;`O-S`G"/FUX@DZB$$
M]/4BP?JIR(_%.3"8P*@7%X7#GK<S\.(Q@Q/,!6+^$>),&[SH?FT.G&'@[K4E
MR84T#YETJ4Y&<02;?A'M_!0RCN/)^!1R)@X<WB_.@<_%Q?&_AOC@/,:KNY1U
M^YG7XU?+3UY+2_Y&=2D:@VI>0!1A,(8]T'ZQ_,&JMINPE;*P$-UE!=\_#N,7
M!@`NE++'@UO=_HLZ^PL``/__`P!02P,$%``&``@````A`#,4S+91`P``3@L`
M`!@```!X;"]W;W)K<VAE971S+W-H965T."YX;6R45MMNVS`,?1^P?Q#TWMAR
MTMP0ITA7=!NP`<.PR[-BR[%0VS(DI6G_?I04N[YE=5Z"F*;.X2$IFIN[ESQ#
MSTPJ+HH0DXF/$2LB$?/B$.+?OQYOEA@I38N89J)@(7YE"M]M/W[8G(1\4BEC
M&@%"H4*<:EVN/4]%*<NIFHB2%?`F$3*G&A[EP5.E9#2VA_+,"WQ_[N64%]@A
MK.48#)$D/&(/(CKFK-`.1+*,:HA?I;Q4%5H>C8'+J7PZEC>1R$N`V/.,ZU<+
MBE$>K;\>"B'I/@/=+V1&HPK;/O3@<QY)H42B)P#GN4#[FE?>R@.D[2;FH,"D
M'4F6A'A'UO=DA;WMQB;H#V<GU?B/5"I.GR6/O_&"0;:A3J8">R&>C.O7V)C@
ML-<[_6@K\$.BF"7TF.F?XO2%\4.JH=RWH,@(6\>O#TQ%D%&`F02W!BD2&00`
MORCGIC4@(_0EQ`$0\UBG(9[.)[<+?TK`'>V9TH_<0&(4'946^5_G1&Q0#LN&
M]D`UW6ZD."&H-WBKDIKN(6L`KF)R"'64EX*$Z`S(SJ"$>($1\"O([/,68MIX
MSY"-Z.QS[WS@]\VG]O`@FCHD"*,9TG!Z*F;C;)A-NDPH]\[0I`F&::;7T!AG
MR'<S^&!>XSIFYS-K^+REH"407,8+-,Y0')#UEK=@T:%V3B.HH5'&4QMG2UTG
MUUF">2N891U,2R4XC:<RSFTJ9YG9YFUV!S19$]8T[&)A+LR%>U0UBCG79CA;
MFJU"@M6P&#.#&]?D_SUIG-M4SM(7LVK#VML7+$>H,0?;%&=+2\W4'U9#8':-
MEV.]VV1G4U\0`?XFLE4TAS'U7GGLP0Z)P0)36Q*Y(.FJJ6&N4R=_9].`I,Z@
M&-UQQ`T$`*[O3V5J2[HPH,A5<\)Z=Q)8C07@;UU-\]7I56E4W]F3'18W%#IE
MFEXHTU53@?3'PMDT4*:!P3!=3D?<)=(?#96I7:?9!4U7#0?2GPYGTX"FH?G@
M!Y/%^]>I/R!@M1FX3MU/E-M>W(J0,WE@GUB6*12)H]E,`OBVU]9Z:]K9#N_:
M9^N=VZ:\^@UL,R4]L.]4'GBA4,82P/2M'.GV(?>@10D]!CN-T+#'V+\I[*T,
MON^^&26)$+IZ,+U=;\+;?P```/__`P!02P,$%``&``@````A`,_A89&R`@``
M5@<``!D```!X;"]W;W)K<VAE971S+W-H965T,3`N>&ULE%7;;IPP$'VOU'^P
M_!X,["V@9:--H[216JFJ>GGV&@-6,$:V-YO\?<=XET`V;<@+E^'XG#DS]K"^
M>I0U>N#:"-5D.`I"C'C#5"Z:,L._?MY>7&)D+&UR6JN&9_B)&WRU^?AA?5#Z
MWE2<6P0,C<EP96V;$F)8Q24U@6IY`U\*I26U\*I+8EK-:=XMDC6)PW!))!4-
M]@RIGL*ABD(P?J/87O+&>A+-:VHA?U.)UIS8))M")ZF^W[<73,D6*':B%O:I
M(\5(LO2N;)2FNQI\/T9SRD[<W<L9O11,*Z,*&P`=\8F>>TY(0H!IL\X%.'!E
M1YH7&=Y&Z76"R6;=U>>WX`<S>$:F4H?/6N1?1<.AV-`FUX"=4O<.>I>[$"PF
M9ZMONP9\URCG!=W7]H<Z?.&BK"QT>P&&G*\T?[KAAD%!@2:(%XZ)J1H2@"N2
MPNT,*`A][.X'D=LJP[,XB.;A$M!HQXV]%8X1([8W5LD_'A,=F3Q'?.2`^XEC
M&2Q6X2QZFX3X?#I[-]32S5JK`X(M`Y*FI6X#1BD0O^X'C#CLUH$SO,((<C70
M@X=-=)FLR0,4CATQUQX#UV=,CR`@VBN#VG1E!W;*KK(NE6L?&,K$K\O,WB/C
MP-":8?))V/-Z98^9#S"+'C$R")#I!AT8>@"VGNN61#VQE_:@"=*PJ:9+.W`G
MW1?W&(%3,DCF'_5=OD?*@<=2/C+O#M]P=\`F&SKPYVT6K""U_^]1MW`L<8P,
M]TJ4S/K2CGKFQO7DX^#`8RD?.7>3C&D[-ZO$C8HWW+B%8XEC9.QF_L*-GV/^
MH$NN2_Z)U[5!3.W=C(KAZ/;1?GQN8]>$E_%YNNW&*ND_P%AK:<F_45V*QJ":
M%T`9=IW1?C#Z%ZM:R!RFF[(PT;K'"OY?'$YO&(#Q0BE[>@%ATO\1-W\!``#_
M_P,`4$L#!!0`!@`(````(0`O*F(R6@T``+\_```9````>&PO=V]R:W-H965T
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M=QK7'S]4`?KO=O/]X/Q^=7C:?4_WVX=R^[JA:%.>5`8^[79?E&G^H!`5OH;2
M296!^?[J8?.X^OI\7.Z^9YOMYZ<CI;M+;Z1>;/#P5[0YK"FB)-,,NTIIO7NF
M"M#_5R];U30H(JL_[QHA.=X^')_N&NU>LWO3:@=D?O5I<S@F6R79N%I_/1QW
M+__31H&1TB(=(T(_C4C0['>[G5[_YOTB9%G5A'ZR2-`,^]V@V[N@*CVC0C^-
M2GCQZU#?J&I"/[DFE[_.K1&AGRP2-H-.ZY*7":@Y5#51O_SRZP246ZUBD_P+
M^0G:+$._\"O]0H8"3I'ZA74NCV]PP]6A7UCF_=6YUOV@ZE;1ZKCZ^&&_^WY%
M8Q6U],/;2HU\P2"@%L`=2C?_NHO]J(=1UU(J]TKFKD%5H\YSH&'AV\>PU?UP
M_8VZ\MK8#-$F\"U&;*'ZK9*-)(@E2"1()<@DR"4H)!A+4$HPD6`JP4R"N00+
M"98.N*;TU#FB=OQ/Y$C)J!QQ=(<,G*2)A+`%%XDDB"5()$@ER"3()2@D&$M0
M2C"18"K!3(*Y!`L)E@[P$D(C`B2D36/6Z5F(^X@J1?.-UT=Z?L"'VB9TC40W
M&M4F=5*`Q$`2("F0#$@.I``R!E("F0"9`ID!F0-9`%FZQ,L13<Z0([52N'!@
M4S(T-E)+<$:V&Y$U;70V:[5)G34@,9`$2`HD`Y(#*8",@91`)D"F0&9`YD`6
M0)8N\;)&"?*R=KY'*>LJ.1S4H29MO?134\@(2&0(3<=U2FG1Y:<TKHU8.@&2
M`LF`Y$`*0VP5QT#*NI1;Q;Y?Q4EMQ%6<`ID!F0-9`%D:4E712P_%S$N/7BTT
MU;+W^+1=?QGN].+Y1-K:M"K0:P4EXF=-$S=K0")-0IHCG:R)CAC71AR2!$@*
M)`.2`RDT<:HX!E+6I<Y4<5(;<16G0&9`YD`60)::Z"IZ6:-EV=_/FA+QLV9(
MNUY0C(!$FH2A61(&';\-Q_5SCD8"&BF0K"ZE%YI!VU?-Z^>L6H#&&$A9ES*J
MHJZ3^CFK3D%C!F1>ESI=UT7]G%67KH:71W6(X:[53_0RVCIR-U/6?L(,J;;G
M55<<`8F`Q$`2("F0#$@.I``R!E("F0"9`ID!F0-9`%FZQ`L\;6HO"+RR]@-O
MB!HE>7O4%4/7J+;A=A#5Q)8*NK=^4X^U47A3=;";0"P6$Z-A%_UIK<I^LIJ<
M\9/[?EJA7XT"_(QK5?93UN2,GXGQT]<#1B<477L*CF:U+#N:U^2,HX7G*.C<
MBC=:NHZ\QJ`.)[S6\$N38*7BMQ)&U`QM,Q&3_L@:\>M&!H6W]4`<&T1[$C7J
M!*V.;!=<ICIMJ\:"%)4SMK+*N:_<;M^*!!5<QBJ/4;ED*ZL\D<I]L22;<AFK
M/$/E.5M9Y86OW.MWQ+G#DLOHLT=WZQVH/;D[YJID4V^[8+E328A,ZYV^VH[4
MF0YZ+;]/C;B@72E&!K7]59`<$]A*S[K!C51.6-D9%AA99QG+G'66LY5VUFG=
MBJ96L+)U-F9DG94L<];9A*VTLVZ_)5Y]RLK6V8R1=39GF;/.%FREG?7;;='4
MEZQ<.?/'"'5R()M-T+4+Y3]V;]0D?G9BH+:=8BIAU*\[^PA1A"A&E"!*$66(
M<D0%HC&B$M$$T131#-$<T0+1TD-^CM31@<Q1V%/W!I?T;GT`06YX/!ZJDV/*
M6IM^.+U;C#DC8T5C`!>,N.#99AFS5:<:VUO-EA@G$U:V?2!E9)UE+'/66<Y6
M["P4RY:"E:VS,2/KK&29L\XF;%4[$QUNRLK6V8R1=39GF;/.%FS%SKIBN;]D
MY1.]6QU?R);S"[U;GX*H%EJWD[`E)OQA4)^56"LQQ(ZLC6U+=3%&,5HEB%)$
M&:(<48%HC*A$-$$T131#-$>T0+3TD#\"4$_W\GA^0Z6F:SD::]1V1V-`D2GH
M6,6,["HE862U4D09HIR1U2H86:TQHM*@KM=1;L1`-;%6W)*FGI8?4G4(X7:-
MGX14GUEXHZ<YQK!5'ZF;,S6@6A0ABAG9,"2,;,$4488H9V2U"D96:XRH-$B$
M5.PM)M;*AM1]1S^DZCS@@I":XP-W0M+(B=](72?*D`**V<J&(6%DPY`BR@P2
M81`M*[=6'(8"M<:(2EO0CHG!C9@M)M:*Y:>>EA]EM?F_(,KFK,"-LD9>E`%%
MZH[5#WS,R(TR6*5L90.?&22B+!I;;JTX#`5JC1&5MJ`;93%-3JP5RT\]+3_*
M:E=]093-)MR-LD9>E`%%@48B,F+:C*T55STQR)%/$66VH!L9L0[+K17+%Z@U
M1E3:@JZ\6'E-K!7+3STM+_#A/W)H4:GX6UF#G("-$$4&=;PE\8U8ZL36BM\H
M0:T4468+N@$3>\/<6K%\@5IC1*4MZ,CWQ79]8JU8?NII^?F@.?>"CJ"N/<32
M@Q$M-^K58]`70^S(6G&E(D2Q0:$^=>NUY6U8PF7LPCME9!?>F45.E>2)9<[.
M])%EOQG21^B<?Z(7%2QJ78\96=<EHHGT(^\>IEP&%_AT7W%1=G";7BG<-3I^
M=L30/#)6-%[:[!@MBV+6ZNG#O%Y;)#DQ!M3:6"9%Y<RBL]G1_CM!Y>RV>=NY
M=?^).;9`UV/KAVM3(IH81'[8:NI9^;U%[:C?/VVHBWC96S3JT!K'Z2WB;49<
MT#:L"%%L4'4*R,?Y05_,BXFQZM!,[G@44U"*\IE%3D'L1?J%S,$_G5J(T:Y@
M&;??F+C8URO9RJ*)0:1L,^,6]#/SLZWPNVZ$PWHGS"Z'!HD.)`:'$1>TO25"
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M$-G8M`&*K1);)8A21!FB'%&!:(RH1#1!-$4T0S1'M$"T])"?-K7]EFE3AUX7
M?GB0%M1FF+0I"@.Q<1@:J_.)U$I>(@'%5LDF$JQ2M,H0Y8@*1&-$):()HBFB
M&:(YH@6BI8?\1*IS`$RDO8=[W_)$GR:XIY1TV5[U4#LGC!C9E4%DD+_ME9_\
MB*V5S9J6IX*,4K3*$.6("H/T#MV+CAJ(_GYT*A7_4,`@]U``46101]_`A"VY
M08NM`4<A09D4468+GO[056X-6+GP9/PP7;975Y?S8FW$R%L;]<2.862MN%(1
MHM@@&KRJ=_,_,Y!P`1KDZTDAZ(G9/&4KNWS)$.6^)['I++C`CSSY(52[2K<?
MGK\6H(4?A-`@&LZ<%Y/[`2[H]$%$L4$=_>D8,1PGYJDZNW$\00CK^G"R,O24
MG_54_,R3'T*U!ZM#2)7[20C-ELTY.E47TJIA^JU0K'9'UHI?+$(4&V1:8=`*
MFV+_F7"A'[4/_:$CMG);8EU-KD`NO76:<O/$.C_RYH=2[8XN"*793+FAK/=7
M;AL1R_L1?1&R"KC;&@'%QLIL#$6+3LQ39U>8HFR&*&=9LX?RQXG"D]7!T=^Y
MU%\.>]GL/V]&F^?GP]5Z]U5]G[+J+#767_:DN^F!NEZE/,DG86^@EL6GGMS0
MDVK:%&7NP_[@GNIUJDR?RE11%&5HAAVH.0_+T.PR4!,(/J'98:`F`'Q"7UZ]
MKY(LO`SI2ZW5.97D(57KA,ZP35^"/<'O.X-[^E0!.AY2'$^]^#T%^)XVB5B"
M;C@&ZOX"G]#EQ$!=/>`3NE<8J%L#?$+G\P-U^HY/Z&B=`GSJ"9V*#]29-Y:A
M>V7R<ZK6=#U*3TXU"[HQI%J?:A9TV4=E3CVA^R\J<ZI9T-45E3GYI#M8G*Q9
M;[`X5:]E=[`\Q:.;`7UV'=\]H]<XQ4MZB5-\?C-8G.+#[F!XRN^H.QB=XE%W
M0%\UP?I$O0%]F0%YT1W05QJ0C[L#^F(#\>NZK=/7I]]6GS>3U?[S]O5P];QY
MI.&@52VA]_H+V/J/H_E(VZ?=D;XX77VZ[8F^*+^A+^&TFC3G/.YV1_Y#.:B_
M>O_Q_P```/__`P!02P,$%``&``@````A`.H$DIQ-!```40\``!D```!X;"]W
M;W)K<VAE971S+W-H965T,3(N>&ULK)==CZ)(%(;O-]G_0+@?^5"Q)>I$!02R
MFVPV,[O7-)9*&BA#87_\^SE%4315QYE,)WVC\G!XY;QUJNK4ZNMK51K/I&$%
MK=>F,[%-@]0Y/1;U>6U^_Q9]>3`-UF;U,2MI3=;F&V'FU\V??ZQ>://$+H2T
M!BC4;&U>VO;J6Q;++Z3*V(1>20UW3K2ILA8NF[/%K@W)CMU#56FYMNU955;4
MIE#PF]_1H*=3D9.`YK>*U*T0:4B9M?#^[%)<F52K\M^1J[+FZ7;]DM/J"A*/
M15FT;YVH:52YGYQKVF2/)>3]ZLRR7&IW%TB^*O*&,GIJ)R!GB1?%.2^MI05*
MF]6Q@`RX[49#3FMSZ_BI8YO69M49]%]!7MCHM\$N].70%,>_BIJ`VS!.?`0>
M*7WBH<F1(WC80D]'W0C\TQA'<LIN9?LO?8E)<;ZT,-QSR(@GYA_?`L)R<!1D
M)NZ<*^6TA!>`3Z,J>&F`(]GKVG3ACXMC>UF;4V\R7]A3!\*-1\+:J."2II'?
M6$NK_T60TTL)$8CL1."[%W&<B?LP=^;>!U26O0I\?US%$GEU-@59FVU6#7TQ
MH/;@S=DUXY7L^#`0AC1(I#-8]C/'P"JNLN4R:W-A&F`&@V%^WKCV=&4]P]#D
M?<P.QSAJQ%Y&\''@LH$.0AU$.CCH(-9!HH-T!"RP9?`&!OTSO.$RW!N9U4Z"
MD5F:$3)"/A+H(-1!I(.##F(=)#I(1T`Q8OHY1G`9F$"C(G'LN9KY3L2XXR`M
M9#^$#.X@$B(2(7)`)$8D020=$\6DV>>8Q&5@,L)0C*;23'-)!/W2I2%D<`F1
M$)$(D0,B,2()(NF8*"[!&GAG3DT6P-M+D3_MJ%A.[RS04UA7Q&K#13J/9&Z[
MGDR'2;9')!#$A=D^..LX6G&%0Y"4CA`Y(!(CDB"2"N)TKZA8XGV&)5Q$M:0G
M(TL0"01QW7[%=K0Z"X?[@QM(XX!(/#PE]@%'VPB2X;Y43<<:BC>PHRCE<J<L
M8`N5=<&C51-Z,GNO"T0"1$)$(D0.B,2()(BD8Z(DRAO.\3[\ZT1YM)IH3Z#(
M1L7MJ<O&?@B2Q@>(A#WQNI+P9G--(^KOOV]G!Z01(Y*HJN["5M\L':LJOD"W
M\P%?>+3J2T]`?^3+0OWW_1`T^()(V)-EY\O,L1]4C4C<=[MVM%NE#D@C1B11
M5*=+;ZFJIF-5Q1?>JRG&\,;-]7@7^Y/F5DZ2[DG5)(G4ZM$RW+]'#39A%$K4
M%]!\H<E$,F!401*)#IQW?C%&B42]LK/4E/E!HAO^3EFX)0X&HN.M2',F>U*6
MS,CIC3?]?#`'*@XDP=R'M1L2U+GGPVJ(>>SYL)YA#@>;K7N'[_B!YQYW?6B_
ML,YNZD/+@?EVYF\A7WQC-_-A]P5N#1G`@>::G<G?67,N:F:4Y`2YV]V>VX@C
MD;AHZ17J`HXUM(6C3/?S`D=7`N-A3Z`V3I2V\H+_P7`8WOP```#__P,`4$L#
M!!0`!@`(````(0!:_O@D_A4``$2%```8````>&PO=V]R:W-H965T<R]S:&5E
M=#DN>&ULK-U;<]LXEL#Q]ZW:[^#R^]C6U;8JR50LWN]DS>X^NQTE<75LI6QW
MI_O;[X$("`3^C&RE>A[&Z1]QH7`(D@?4Y=V__WKX=O+GYNGY?OOX_G1R=G%Z
MLGF\VWZZ?_SR_O1__A/]Z^KTY/GE]O'3[;?MX^;]Z=^;Y]-_?_CO_WKW8_OT
M^_/7S>;E1%IX?'Y_^O7EY?OJ_/SY[NOFX?;Y;/M]\RA;/F^?'FY?Y#^?OIP_
M?W_:W'[:57KX=CZ]N%B>/]S>/Y[V+:R>WM+&]O/G^[M-L+W[XV'S^-(W\K3Y
M=OLB^__\]?[[LVGMX>XMS3W</OW^Q_=_W6T?ODL3O]U_NW_Y>]?HZ<G#W2K]
M\KA]NOWMF[SNOR;SVSO3]NX_T/S#_=W3]GG[^>5,FCOO=Y2O^?K\^EQ:^O#N
MT[V\`C7L)T^;S^]//TY6W>7B]/S#N]T`_>_]YL?SX-\GSU^W/^*G^T_%_>-&
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MF9N1,FZ)M2FA3@.JV<"'T(?(A]B'Q(?4A\R'W(?"A]*'RH?:A\:'UH=N`.<2
MGGV,9![\$S%2S:@8F=&],6"#-O4"8DJ8*H$/H0^1#[$/B0^I#YD/N0^%#Z4/
ME0^U#XT/K0_=`)R`R.GEGPB(:D8NC<ZDN70C<-.7F0X++=PBZWV1?90@(22"
MQ)`$DD(R2`XI("6D@M20!M)"NJ$X09,S_#\1--6,G"SET!B<ZJ[<D-STA0Y&
M;5]D'S5("(D@,22!I)`,DD,*2`FI(#6D@;20;BA.U.1R[$1M_!;47(94Z5UP
MS*#>]+)PPW7MAFN]+V2J!9`0$D%B2`))(1DDAQ20$E)!:D@#:2'=4)Q8R`W.
M$;%0I=U8]"*SP@SS&A)`0D@$B2$))(5DD!Q20$I(!:DA#:2%=$-Q!E[NJXX8
M>%7:'?A>%G)JM.>L^84W"?:%3'0"2`B)(#$D@:20#))#"D@)J2`UI(&TD&XH
M3BSD'OF(6*C2;BQZ&4X"2``)(1$DAB20%))!<D@!*2$5I(8TD!;2#<49>,E:
MG8%7F<IT<29GJR-S%=60&Y->U+K"8'Y,O/FQ+[2?'Y`0$D%B2`))(1DDAQ20
M$E)!:D@#:2'=4)PPJ:4")TZ'K]B[XFXT-`VG""D@A:2(%),24DK*2#FI()6D
MBE23&E)+ZAQR8Z$RRF%V_THL^@14[FW-(7ZC5F]DLGB7#C]-M*5,Q8`4DB)2
M3$I(*2DCY:2"5)(J4DUJ2"VI<\@-C\HOCPA/GXXZX>G)F2J@0"4K$L1!J9`4
MD6)20DI)&2DG%:225)%J4D-J29U#;BQ4WCB,A;J\S*[4^O:QUQ>U^NA=8#1Y
M5YB9=X6QI>PTTNELO\JNUL1"EHI(,2DAI:2,E),*4DFJ2#6I(;6DSB$W="IY
M'(;NE;-<GVO*H6!&^4:M_KH39$T*2"$I(L6DA)22,E).*D@EJ2+5I(;4DCJ'
MW%BHY'$8BU^^2U,+\?XLZLF;17-_%NU+F?@&NBVI:"@D1:28E)!24D;*206I
M)%6DFM206E+GD!LYE7T.(_?*+.J356<6#?/7W?K]6CT3<2=60`I)$2DF):24
ME)%R4D$J216I)C6DEM0YY,9"99]'Q*)/5IU8].1-%7_E6#UX4N&Q\R(@A:2(
M%),24DK*2#FI()6DBE23&E)+ZAQRPZ-RU"/"TZ>T3GB&6:Z>*J!`/8]S9T](
MBD@Q*2&EI(R4DPI22:I(-:DAM:3.(3<6*A$](A9]WNK$HB<OQ?$>7JXG^U+F
M$A*00E)$BDD)*25EI)Q4D$I21:I)#:DE=0XYX9D>MQJP*^ZN!F@:)"]K4D`*
M21$I)B6DE)21<E)!*DD5J28UI);4.>3&XKC5@"E7`S1Y5Q7OD>7:EMI/%5)(
MBD@Q*2&EI(R4DPI22:I(-:DAM:3.(3<\*DM_^YELVB?UPS.9)F>J(/4/6"HD
M1:28E)!24D;*206I)%6DFM206E+GD!L+?S7@\,VPC+B?JVCRKBK><^*U+66G
M2M^65#04LE1$BDD)*25EI)Q4D$I21:I)#:DE=0ZYX3DNXY\RX]<D79A17I,"
M4DB*2#$I(:6DC)23"E))JD@UJ2&UI,XA-Q9^QO_*5&%:KRXG?18R?/SB/Z.W
MI4S$`E)(BD@Q*2&EI(R4DPI22:I(-:DAM:3.(3<\QZ7U4Z;UFIRIPK2>I4)2
M1(I)"2DE9:2<5)!*4D6J20VI)74.N;$X+JV?,JW7Y%Y5%OZ3?%O*3I6^+>>J
M`HI8,28EI)24D7)202I)%:DF-:26U#GDAD>EVT?<@/79N7,#AH1]/04%I)`4
MD6)20DI)&2DG%:225)%J4D-J29U#;BS\M/Z7UY&GS/@UJ9.F?=Z_\)_WVU)V
M%O5M245#(4M%I)B4D%)21LI)!:DD5:2:U)!:4N>0$[G9<1G_KKB;\6L:7G!(
M`2DD1:28E)!24D;*206I)%6DFM206E+GD!N+XS)^]6D0N1$;GM$T>1<<__F_
M+67F14`*21$I)B6DE)21<E)!*DD5J28UI);4.>2&Y[B,?\:,7Y,S59CQLU1(
MBD@Q*2&EI(R4DPI22:I(-:DAM:3.(3<6QV7\,V;\FKRKBO^,WY:R4Z5O:WA5
M8:F(%),24DK*2#FI()6DBE23&E)+ZAQRPW-<QC]CQJ_)F2I]J0$%+!62(E),
M2D@I*2/EI()4DBI236I(+:ESR(W%<1G_C!F_)O==^0O_0;XM9:=*WY94-!2R
M5$2*20DI)66DG%202E)%JDD-J25U#KGA.2[CGS'CUS28%VM20`I)$2DF):24
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M*2G3--C5G%38B@=VM;2ES*Y6I)K4D%I2IZG?53>0_C+!KP62JP=S38.G;*1`
MDSR-5=\;,+V8>#>"H2U@!B9B,S$IL15URUXVEMH"IN6,S>2DPE8<W^?2%C`M
M5VRF)C6VXO@^M[:`:;ESFG%#>]P2PYQ+#(;F]JQ*"D@A*2+%I(24DC)23BI(
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MVU)F]`--:JUZ?XB,G"'Z'F45=1?]2[_ER+1L9U)LR,ZDY$V=I:94W]G\XMH[
MU#+3LNTL-V0[*TPS!U]9:4KUG2VN+KR38V5:MIW5AFQGC6GF8&>M*=5W=C6;
M>8=Z9UH>.4?XBSO^.>(_V^\_N^>6-83]33<7?>::KO93<DT*2"$I(L6DA)22
M,E).*D@EJ2+5I(;4DCJ'W/.XO^BSF]K+W4<)CYC=7`N:]Z16R>TD77KGG+4N
M)><`.[MUQ8.'96B:G^]F]\79A7>>C$S+=@[$AFQGB6GF8&>I*64ZFWJW,9EI
MV7:6&[*=%::9@YV5IM2^,V_"5:9EVUEMR';6F&8.=M::4J8S?UV[,RV/S&Y_
M/>H79S?7J>98E%J3`E)(BD@Q*2&EI(R4DPI22:I(-:DAM:3.(7=V^^M4N]G]
M*]]#,><2EB9WM7?IW4*N;2D[P_NVAL\062HBQ:2$E)(R4DXJ2"6I(M6DAM22
M.H><R"W\]:K#*XR[XN["E*;A:B\I((6DB!23$E)*RD@YJ2"5I(I4DQI22^H<
M<F,AYU#G]O>56*CB7BQZ\J:*=V)?+_:E]E.%%)(B4DQ*2"DI(^6D@E22*E)-
M:D@MJ7/(#<]QRT;J0:X?GIZ<J0(*=,5!J9`4D6)20DI)&2DG%:225)%J4D-J
M29U#;BS\92/_IN!-R^SJ'5Q^B'J2QV-F;JQU*7E*8RC0I)8M[$VGO^@4VE*F
M8D2*20DI)66:^OUR1T>M-_AY]-$/(19ZA<2^K^!&TV`HUJ1`D^3Y>K767[NV
M!>S`])T-6H[9<F(KZI:]4UMJ"YB6,Z<9=YC\Y897SK=<6EAHDC_V.%AZ+W=M
M2YF="DBA)KW2Z-W>1*:")"V#GKSL/S:E[/UY0DK=GKQ4*3,5?M:3.X1^ZOW*
M$#+%7NQ3[.$+\[*LM2UEAW!?T5"H2\E#'75X>"L\D=ZJ/@MZ:`C1;,+.TX,]
M9:_UY`ZARD.'D_65(>S3UN$"UT*3>Q1ZN>/:EC+C%9!"3?HHG%Q,S[Q%G\A4
M^MGQT:]OFE+#(W&_FV8'4K^W^9EWW&>FG9_UY@ZEGRJ^,I1,"1>:Y,_@&/&7
MA6TI\TH"4JA)GD.IH]$[HB.]58Y&TT;,-A)2:IKM%\J\9C.G67=P_!SME<%A
M(K;0^=3@R24I((6DB!23$E)*RD@YJ2"5I(I4DQI22^H<<F*Q/"[KVA5W[_0U
M>7?ZWEQ=VU+F(`M((2DBQ:2$E)(R4DXJ2"6I(M6DAM22.H?<\!R7B"V9B&D:
MW,.O20$I)$6DF)204E)&RDD%J215I)K4D%I2YY`;B^.RKB6S+DWN5+GT[@[6
MMI2=*CHWL]>PD*4B4DQ*2"DI(^6D@E22*E)-:D@MJ7/(#8^?B!V^JBR9<6ER
MIDI?:D`!2X6DB!23$E)*RD@YJ2"5I(I4DQI22^H<<F/AIWVOQ(+YW1)9V)H4
MD$)#]CEP9,BFS3$I(:6&;%N9(=M63BHTJ14<>_-VZ>4WI2UE)GKEM.4.J4KP
MWGYSOM3YX"!EUC1(;->D@!0:LL,0&;+#$),24FK(MI49LFWEI$*3-Z3>37II
M2]DA[4=B9'%BJ1*L(X94YV/#(>W)&5)0L.M'?5WI_@8[-&2'(3)D2\6D1),W
M#-Z1E=I29A@RMI63"EMQ>.!Z:QNE+66:KYRVW`-7)5M'C++.S8:CW--@_-9+
M4$`*#0U'&15C4\H.?*+)&V7O8$MM*3,,&=O*286M.!QE;[&FM*5,\Y73ECO*
MQR6<2R:<FIQ1[DL-*-"EO)'Q5G]"6\KL>L3F8U)B*PY'QDLM4UO*-)^QK9Q4
MV(K#YKWUB=*6,LU73EONP/O)["^M_RZ9XVH:#/Z:%&ARUW\OO66"T)8RKRAB
M6S$IL16'`^8E=ZDM99K/V%9.*FS%0?-7W@UQ:4N9YBNG+2<>E\<EM+OB;D)K
MR%G$NO).L6M;RNQ40`HUR3<I[%9>9@OO4(Y,';O*'QNR-_N)I<$X^>\034UG
M_3M$Y<NQY7<Y!__SNLY,H[;KW)#MNB"5?C_^.\(K4X=OH;@\+I_=%?>BTZ>X
MZCU8]M;JRCLUKTU%>TX/2*$F>:^0BLYD.?."'.D"PZ4Q-I-8&NP2HZ-WO%^$
MNSZ[GE\/_^==8S-VG=M^S"%7D$I-LMAG2E5.*7>V')?37C*GU:3>-3.(A_=J
MUJ:B/;`"4JA)?0?,H"WONAB9'IV5T2OO$A2S^<32H'G&2>?:_2R2]X5Y9[O,
M-#.<-WI<[,LK3"E+I29Y>38RPXIN9/QT]I>N*Y?,<C5Y$\@[.:Q-Q>$$TFU9
M"DU;<O4:!,R[GD:ZE'J[P:`4`H;F$[L3@XH,6%]1KVY?G_DG@TPW,YC%N6W9
MA*(@E9J<J33<2S=@?L[[:P%C*GRIR3WC>9?XM2UE7E%`"C7IMP@OY[P>Z<[L
M,1JSF<32P<#T;>DG.%=G2^_`R$PSMK/<D)TV!:G4M&]YXHU&9>KL6G;#I-+!
M83KBA^EM;]%5GZ+S'MAK&JP5K4D!*21%I)B4D%)21LI)!:DD5:2:U)!:DOJ)
M;#6$_7CU,>I_\KK_!=R'S=.7S7KS[=OSR=WV#_5SUI?7<IW><_];VS?+V4HM
M1,E![V^Y7)B?X?:WS*]6ZBV$(W7FU[)EER[Z=187*_6&J9$Z"_FY;\F'QK9,
M9<LND45KTH\\E!FI,Y/7(V\A'MLRERV[SWGYK<WDE?8?',26I6Q9CK9V*5MV
MTP-U9'3ZK,/?,I4Z_=4+6Z2.W.2.[/547FG_01*_SDQ&5#ZI,E)G)B,JGW48
MVR(C*B>OD2U3J2,?-AW;(G7DTXMC6V2L^\//W[>IC+5\J>98'1GK_GV<J"-C
M+=\N.%)G(G7Z-WS[=2921WYH8*R.C+5\Q_W8%AEK^<;UL2TRUO)EWR-;IC+6
M_?7/WP.I,EIC(C7DIZM&VIK(2,NO)HUMD9'NWP[@]S*1D9:?B!FK(R,M/UC"
M+1\GJX^C45/=CY2_46$><S6A1OSC?/513D'L^$;V:&R';B2*H^4EAJ,AE`B.
M!E#B-Q8^675:J34E[I$L&*W4<A"WR'K,2JVV<(LLI4AK8UMD%41:&]LBJPG2
MVMCA(`L!TMK8%LGAI;6Q+?+>M)5ZMQCW3=Z7M0KEW5#<(N^KDCIC6V1-7?H9
MW[*0+6.1D=52V>NQV,A"I]09VW*SE`-?'LARWVZ6<N3)X\&Q+7+LR9,I;I$O
M"5BIC^V/;)E?K-3GP+E%/M,O!^#8%ODL]DI]W)IUY+/4*_5Q:6Z1ST*OU,>=
MN44^RRQ[,+;E1O;@9G0/Y"L;5NO1+?+-#2OU70KL1[X*0/9M[/7(%RVLU&?T
M64>^;V&E/JHO6\[WYY+G#^^^WW[9E+=/7^X?GT^^;3[+3<'%[@L-GNZ_J/NX
M_C]>](>L?MN^O&P?9/G@].3KYO;31GZ>ZT+](.7G[?;%_(?JX,?VZ??GKYO-
MRX?_%P```/__`P!02P,$%``&``@````A`!E%^<(&"@``)S,``!D```!X;"]W
M;W)K<VAE971S+W-H965T,3$N>&ULK)M=;^(\%L?O5]KO@+A_"DF`%M3V$21V
M[&A76JWVY9JA:8L&2`7,V[??XSA.?/S/MI/1W,R4GX]/XK^/CT],N/_S^_$P
M^EJ>+_OJ]#".;J;C47G:54_[T\O#^-__DG_<C4>7Z_;TM#U4I_)A_*.\C/]\
M_.M?[K]5Y\^7U[*\CLC#Z?(P?KU>WU:3R67W6AZWEYOJK3Q1RW-U/FZO]/'\
M,KF\G<OM4]WI>)C$T^EB<MSN3V/K877^&1_5\_-^5V;5[LNQ/%VMDW-YV%[I
M_B^O^[>+\W;<_8R[X_;\^<O;'[OJ^$8N/NT/^^N/VNEX=-RM],NI.F\_'6C<
MWZ/9=N=\UQ_`_7&_.U>7ZOEZ0^XF]D9QS,O)<D*>'N^?]C0"(_OH7#X_C-?1
MJIA-QY/'^UJ@_^S+;Q?O[]'EM?J6G_=/?]N?2E*;YLG,P*>J^FQ,]9-!U'D"
MO64]`_\XCY[*Y^V7P_6?U3=5[E]>KS3=<QJ1&=CJZ4=67G:D*+FYB>?&TZXZ
MT`W0OZ/CWH0&*;+]_C".Z<+[I^OKPSA9W,QOITE$YJ-/Y>4J]\;E>+3[<KE6
MQ_]:HZAQ99TDC9-9ZR2ZO8EFTX7Q\4X_:JTO3O\W%X^CF_AN'LT_ZKEH>E(8
M-SU_[HK+IA_]/_"*$4U-?;/FCY^YYL0J74]<MKUN'^_/U;<1K0;2\O*V-6LK
M6AEG;LJL4.TD_K\YI,DS7M;&S</X=CRBZ;E0X'U]C);S^\E7"I9=8[/IL>$6
MJ;,PD6'<9B$0(9`AR$.@0J!#4'A@0K*TVE`8_@YMC!NCC1O5QH%.K#@0PEFX
M+ED(1`AD"/(0J!#H$!0>8$+0DOH=0A@WM*3]()F&06)M8M\H,$E;DU8=(`*(
M!)(#44`TD,(G3"3*-[]#)..&%B--A;>4%CP^-M;H795:DU8E(`*(!)(#44`T
MD,(G3"7*KDRE_JW!I15C78OA!K&Q)";_G3S3.RY/VAJY;AD0`40"R8$H(!I(
MX1,V=MHG!HS=6/.Q6T*S[H:5`LF`""`22`Y$`=%`"I^P@=(^P`9J-I4Y9=F!
MFXIQPQ6PQ&SDWNPO@]EOC9Q,&1`!1`+)@2@@&DCA$R:**7)_PTYKW$!^N.42
M;*S1N_FA-6E5`B*`2"`Y$`5$`RE\PE2B6HBI]'Y^,-8\0BQA^2%)N#II:],.
M'8@`(H'D0!00#:3P"1NZ*;\&C+TVYX-OD)\A$&6(!"*)*$>D$&E$!4-\S*;V
M"E=%/+^A%3XP642VBJ.-T\WJID$\7433(!HZ*]<Q0R00240Y(H5((RH8X@J9
MHBQ4R#Q4#=7'%G=!81'LG!O33"OJW<S1V72"M=T<$F@E$>6(%"*-J&"("V8J
M-%^P]U-(9`LZ\N=N?=,@'C?+<)OIK%S'#)%`)!'EB!0BC:A@B,M@2C!?AE]]
MLK.EG-&[W7/I6(4OHDW4%GR=55BW=S:=8&TWAP1:240Y(H5((RH8XH*9NLT7
M[(.X,>9!^K6(;3Y1%'&I4K-VS1*;M0&7(1*()*(<D4*D$14,<1E,53=`!EL$
MLN7CUX7U<WP:`<H0"40248Y((=*("H;XF$W1YH_9K)7DSAQ2#4ZSMOYC>K0E
M8;<VHBA\Y(]:*[<4,D0"D424(U*(-**"(2Z1J=A\B3Y8';;`8S+X-5\3%H"R
M")!`)!'EB!0BC:A@B(_9E&K^F$U8_%IQ8HL^)D=3!U*(M7DUBL)2-6JMNJ@`
M)-!*(LH1*40:4<$04R@>5K+6YCQG-L@O61%EB`0BB2A'I!!I1`5#?,QAR?K^
M2HBQ+FT0KR^B6;!/=%;MU",2B"2B')%"I!$5#'$93,GG+XX/9+`5HK\"8B@:
M4T09(H%((LH1*40:4<$0'W-86MJ:ZN;6+.+7_>[SIJ*U3!/>HT5"I^+VK-P4
MUT'EX)!WM(,H:Y"9$R]E!&66Z*Q<W$A$.2*%2",J&D2%)[GGZO17G$/5:>M-
M=_L;4U`9P7QU`&6-%<V>^?HAGH8+2G0&SK-$SSDBU75L/`=96G<&SG/!W'"9
M3/TW8.$8\R!G-JBK(%.32XQ5AS)$`I%$E"-2B#2B@B$^YF%%98Q%I4,T3B_V
M@W/QM+-R$Y$A$@XMZDA9S.:!&^D,NN]L<H?LUY;FRRF%2#O4>(YO@^>DPAG4
MGKE$80W:DT-(X#:)8)T9-X@J*$^BX&@P[:PZB=J.#@EGM:PEFD7A$;ML#&B;
M='URU^>N10J1=LAZ3I:+X+FZ8)ZY1*8V]%=.78\MZC+]`[5L5<EVGP;Q@`K.
M0]*XM7+#S!`)AYIIG]\&;J0S\`,*/"MGU<68=JCQ'"T#SX4SZ`DH4R>&:IGG
MOH$'1[&M-TF[+JPHN_)J9=-8F=VA#;Y@9TH[FT[,IICM4KM`*XDH1Z00:40%
M0RR\DF'%;&W.$W.#3.YO18BB(,#3SJJ5`9%`)!'EB!0BC:A@B,LPK+Y-L+YM
M$,6"&V"**$,D$$E$.2*%2",J&.)C#HO97W[22[#.;9#9';NHB(.=(>VLG&@9
M(H%((LH1*40:4<$05ZB_]!V<39*V^.W$B*?!8<BFL7HWFW0VG6#6N1=X`JTD
MHAR10J01%0QQP4R%ZJ??]W>HI"EHO6/H!O%L$@>)-^VL.AFL+^KHD$`KB2A'
MI!!I1`5#7`:*^B$R&/,@J5KD36J:`,H0"40248Y((=*("H;XF,-JUV236WJ3
M;?AJP4(XL2C()L$"2CLK%P(9(H%((LH1*40:4<$05VA8L9M@L=L@%A76RD,9
M6@E$$E&.2"'2B`J&^)A-P><G!!,5BZ1^/!Y8DB5-[>@G"XN"L`@>5-.F(UEU
M8=%V=$B@E424(U*(-**"(2Y16+)^D#/;RM3=^B:!>C)%E"$2B"2B')%"I!$5
M#+$QT_NX&!:_\+),[8=GS@8%,1&>,W963L4,D4`D$>6(%"*-R+R5;/*^#4RK
MCWW+V+ZL>BS/+V5:'@Z7T:[Z8MX@GLWHR;3%S>O-2;):DR<:1]!"!<7*[-5]
M+3-JJ7=*Z#.GEGJE0,N"6A:]WFZII7X6@SYWU%(_&D/+DEJ6?=YF4_>^=M@G
MIA;[[`TM](XWG1#VC#2.J:5.&4&?=;Q<K:GTZ^M#]T9/3#TM"=T!/43TM=`=
M4*G=UT)WT'N==12OUO9\+[@W>B-A9;[L[_$6T9SV]EE'L]6:'HS[^M!LVT,R
MN`[--CT=]_6AV:;O#OM::+;I*[.^%IIM^F*IKX44I2]4>EKH,KU7H8OT76-]
M1Y+URDS7[KTT7;GWPA%-);VBTW-+$4UE[S7H+'IE3H>Q#YW#KLQ1*[;0.2KU
MZ6NAWR6L^Z>8+M_C:6,BN8^;5=[#UQ0/?1)N*!KZ[F=#L5"'PJ2-$OJ9PMOV
MI?S[]ORR/UU&A_*9DM"TWKS/]H<.]L.U>J,D3#]6J*[T`X7ZSU?Z04I)!X93
M4P`^5]75?2"))NU/7![_!P``__\#`%!+`P04``8`"````"$`X@7W\C(!``!`
M`@``$0`(`61O8U!R;W!S+V-O<F4N>&UL(*($`2B@``$`````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````G)%!3\,@&(;O)OZ'AGM+Z>:BI&6)FIU<8N+,
MC#>$;RNQ4`)HMW\OZ[HZHR>/Y'UY>+Z/<K[33?()SJO65(AD.4K`B%8JLZW0
M\VJ17J/$!VXD;UH#%=J#1W-V>5$*2T7KX-&U%EQ0X)-(,IX*6Z$Z!$LQ]J(&
MS7T6&R:&F]9I'N+1;;'EXIUO`1=Y/L,:`I<\<'P`IG8DH@$IQ8BT'Z[I`5)@
M:$"#"1Z3C.#O;@"G_9\7^N2LJ578VSC3H'O.EN(8CNV=5V.QZ[JLF_0:T9_@
ME^7#4S]JJLQA5P(0.^RGX3XLXRHW"N3MGNW>7)-X7Y?X=U9*T=M1X8`'D$E\
MCQ[M3LEZ<G>_6B!6Y&2:$I+FLU5!*)G2JYO7$I]:PWTV`O4@\&_B"<!Z[Y]_
MSKX```#__P,`4$L#!!0`!@`(````(0#:G#TT;@(``.X&```0``@!9&]C4')O
M<',O87!P+GAM;""B!`$HH``!````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````)R57V_:,!#`WR?M.T1Y;P.TJR9D4K6T52=M*QJT>[2,<R%6@YWY#@3]
M]+LD`\*6(*UOCN_?[^Y\%W&]6>;!&CP:9T=A_[P7!F"U2XQ=C,+GV</9YS!`
M4C91N;,P"K>`X77\\8.8>%>`)P,8L`N+HS`C*H91A#J#I<)S%EN6I,XO%?&G
M7T0N38V&.Z=72[`4#7J]JP@V!#:!Y*S8.PQKC\,UO==IXG3)AR^S;<'`L;@I
MBMQH19QE_,UH[]"E%-QO-.0B:@H%TTU!K[RA;=P34?-33+7*8<R.XU3E""(Z
M7(A'4&71)LIXC,6:AFO0Y'R`YHW+-@B#N4(H<4;A6GFC+#%6J59_5.>\0/+Q
M3^=?,0,@%!$KU)?5L:G;/)O+>-"O-/ATK%EZJ$E8<,PX,Y0#/J43Y:D-N=]D
MKBAJXAIHUT5Y8Q-Y;XGK);_8NMO&-<GW.8P=-]HB)/)6Y<IJD-,J33E>><_5
MW"N6=:FC'$RFI`C*9X/2I?*)WYZB_S(9*\SD0ZO)=T<@^_)VA<8"'I5]3U+I
M#)@<344P\8!,4SVI;J<7\D9KM^+RV(6<.'Z#/##=ZI>2$^9I)#//098A49*3
M/]J+4R%]DE-R^C5S><)3+.]_K;@3W1&NN$G:+4'.U*:#I(58SK<U_59VNV[-
ME>/,NTU:X4^;'-HD[X"4R4^4LYV(S;J).DWJ^?HSC,>OHK-K)VS:,S^)UFGR
MGC"#[A)TQKEHVAPMEK]6R5=C7_&YF+D[GMG=KCR^%--,>4AXB^SDAPOQR&O2
MYZ63<:;L`I*=SK^"<K._U+^ON']YWKOH\=)NW(GH\*.*?P,``/__`P!02P$"
M+0`4``8`"````"$`IXW6AJX!```\#P``$P``````````````````````6T-O
M;G1E;G1?5'EP97-=+GAM;%!+`0(M`!0`!@`(````(0"U53`C]0```$P"```+
M`````````````````.<#``!?<F5L<R\N<F5L<U!+`0(M`!0`!@`(````(0`X
MDT!EA@$``-D-```:``````````````````T'``!X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+`0(M`!0`!@`(````(0!9CO++L`(``)D'```/````````
M`````````-,)``!X;"]W;W)K8F]O:RYX;6Q02P$"+0`4``8`"````"$`8!E.
ML?\$``"G$P``&`````````````````"P#```>&PO=V]R:W-H965T<R]S:&5E
M=#0N>&UL4$L!`BT`%``&``@````A`+D_OM?R`@``6@@``!D`````````````
M````Y1$``'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"+0`4``8`"```
M`"$`,EF<`:L#```G#0``&0`````````````````.%0``>&PO=V]R:W-H965T
M<R]S:&5E=#$Y+GAM;%!+`0(M`!0`!@`(````(0#_EIJ/6`H``(U,```9````
M`````````````/`8``!X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L!`BT`
M%``&``@````A`+%A03U>"```X38``!D`````````````````?R,``'AL+W=O
M<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"+0`4``8`"````"$`EL^_!88#``#3
M#```&0`````````````````4+```>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM
M;%!+`0(M`!0`!@`(````(0#[8J5ME`8``*<;```3`````````````````-$O
M``!X;"]T:&5M92]T:&5M93$N>&UL4$L!`BT`%``&``@````A`*1+%6BG"P``
M(&4```T`````````````````EC8``'AL+W-T>6QE<RYX;6Q02P$"+0`4``8`
M"````"$`^C$+(_TR``!)HP``%`````````````````!H0@``>&PO<VAA<F5D
M4W1R:6YG<RYX;6Q02P$"+0`4``8`"````"$`,6P*X>H#``#P#```&```````
M``````````"7=0``>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!`BT`%``&
M``@````A`,U_DMR:!```NA```!@`````````````````MWD``'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;%!+`0(M`!0`!@`(````(0`][#2)QP,``),-```8
M`````````````````(=^``!X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"
M+0`4``8`"````"$`8@E="R0#```V"@``&0````````````````"$@@``>&PO
M=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+`0(M`!0`!@`(````(0"J"^591`,`
M`-H)```9`````````````````-^%``!X;"]W;W)K<VAE971S+W-H965T,30N
M>&UL4$L!`BT`%``&``@````A`">$XN/-`P``6@X``!@`````````````````
M6HD``'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+`0(M`!0`!@`(````(0#E
M>[!^D`(``(@&```8`````````````````%V-``!X;"]W;W)K<VAE971S+W-H
M965T-BYX;6Q02P$"+0`4``8`"````"$`\8$QLJ$)``!V,0``&```````````
M```````CD```>&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!`BT`%``&``@`
M```A`/,<*.A5`@``E@4``!D`````````````````^ID``'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"+0`4``8`"````"$`,Q3,ME$#``!."P``&```
M``````````````"&G```>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L!`BT`
M%``&``@````A`,_A89&R`@``5@<``!D`````````````````#:```'AL+W=O
M<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"+0`4``8`"````"$`+RIB,EH-``"_
M/P``&0````````````````#VH@``>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM
M;%!+`0(M`!0`!@`(````(0#J!)*<300``%$/```9`````````````````(>P
M``!X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L!`BT`%``&``@````A`%K^
M^"3^%0``1(4``!@`````````````````"[4``'AL+W=O<FMS:&5E=',O<VAE
M970Y+GAM;%!+`0(M`!0`!@`(````(0`91?G"!@H``"<S```9````````````
M`````#_+``!X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L!`BT`%``&``@`
M```A`.(%]_(R`0``0`(``!$`````````````````?-4``&1O8U!R;W!S+V-O
M<F4N>&UL4$L!`BT`%``&``@````A`-J</31N`@``[@8``!``````````````
M````Y=<``&1O8U!R;W!S+V%P<"YX;6Q02P4&`````!X`'@`$"```B=L`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 5 - Stockholders' Equity<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
        <td class="text"><p id="PARA426" style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>5. Stockholders&#8217; Equity</b></font>
    </p><br/><p id="PARA428" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><i><b>Amendments to Articles of Incorporation</b></i> <b>&#8211;</b> <i><b>Reverse Stock Split</b></i></font>
    </p><br/><p id="PARA430" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Effective January 13, 2014, we amended our Certificate of Incorporation to change our name to Heron Therapeutics, Inc. and to effect a 1 - for - 20 reverse split of our outstanding common stock. The name change and Reverse Stock Split were approved by our stockholders on September&#160;19,&#160;2013. As a result of the Reverse Stock Split, the total authorized shares of common stock were reduced from 1,500,000,000 to 75,000,000 shares.</font>
    </p><br/><p id="PARA432" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><i><b>2011 Private Placement</b></i></font>
    </p><br/><p id="PARA434" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In June 2011, we sold 8.0 million shares of our common stock for net proceeds of $22.8 million (net of approximately $1.2 million in issuance costs). For each share purchased, the investors received one warrant to purchase 0.5 shares of common stock at an exercise price of $3.60 per share. The warrants were immediately exercisable and expire on July&#160;1,&#160;2016. The warrants may be exercised for cash only, or, if a registration statement is not then effective and available for the resale of the shares of common stock issuable upon exercise of the warrants, by surrender of such warrant, or a portion of such warrant, by way of cashless exercise. There is no right to exercise the warrants to the extent that, after giving effect to such exercise the holder would beneficially own in excess of 9.99% of our outstanding shares of common stock or such other limit as may be designated by any particular
      purchaser. Each holder of the warrants can amend or waive the foregoing limitation by written notice to us, with such waiver taking effect only upon the expiration of a 61-day notice period.</font>
    </p><br/><p id="PARA436" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On July 29, 2011, we filed a registration statement with the SEC to register for resale the shares and the shares of common stock issuable upon the exercise of the warrants. The registration statement was declared effective on August 4, 2011. We are obligated to maintain the effectiveness of the registration statement until the investors are able to sell shares and the shares of common stock underlying the warrants without limitation or restriction under Rule 144 of the Securities Act of 1933, as amended (&#8220;Rule 144&#8221;). There is currently only one investor who is an affiliate of ours and is therefore not able to sell without limitation under Rule 144, and that investor has agreed to waive its right to require us to maintain the effectiveness of the registration statement until it provides notice otherwise.</font>
    </p><br/><p id="PARA438" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the nine months ended September 30, 2014, warrant holders exercised 460,706 warrants under the cashless exercise provision in the warrant agreement, which resulted in the net issuance of 303,614&#160;shares of common stock and no net cash proceeds to us. During the nine months ended September 30, 2013, we received $0.6 million for cash exercises of these warrants.</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></font>
    </p><br/><p id="PARA440" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><i><b>2012 Private Placement</b></i></font>
    </p><br/><p id="PARA442" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In July 2012, we sold approximately 5.1 million shares of our common stock at a purchase price of $10.50 per share, resulting in net proceeds of approximately $50.5 million (net of approximately $3.1 million in issuance costs). On August 24, 2012, we filed a registration statement with the SEC to register these shares for resale. The registration statement was declared effective on September 6, 2012.</font>
    </p><br/><p id="PARA444" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><i><b>2013 Common Stock Offering</b></i></font>
    </p><br/><p id="PARA446" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In November 2013, we sold approximately 8.6 million shares of our common stock at a public offering price of $8.00 per share. We received total net proceeds of approximately $57.8 million (net of approximately $3.9&#160;million in issuance costs). The offering was made pursuant to an effective registration statement, which was previously filed with the SEC and was declared effective.</font>
    </p><br/><p id="PARA448" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><i><b>2014</b></i><i><b>Common Stock Offering</b></i></font>
    </p><br/><p id="PARA450" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In June 2014, we sold approximately 4.8 million shares of our common stock at a public offering price of $11.75 per share. In addition, as a component of the offering, we sold 600,000 pre-funded warrants to purchase shares of our common stock at a public offering price of $11.74 per share. The pre-funded warrants have an exercise price of $0.01 per share and are exercisable for seven years from the date of issuance. We received total net proceeds of approximately $58.9 million (net of approximately $4.0 million in issuance costs) from the sale of the common stock and the pre-funded warrants. The offering was made pursuant to an effective registration statement, which was previously filed with the SEC and was declared effective.</font>
    </p><br/><p id="PARA452" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><i><b>Stock Option Exercises</b></i></font>
    </p><br/><p id="PARA454" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For the nine months ended September 30, 2014, approximately 550,000 shares of common stock were issued pursuant to the exercise of stock options, resulting in proceeds to us of approximately $2.8&#160;million.</font>
    </p><br/><p id="PARA456" style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Stock-Based Compensation</b></font>
    </p><br/><p id="PARA458" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table summarizes stock-based compensation expense for the three and nine months ended September 30, 2014 and 2013 related to stock options and Employee Stock Purchase Plan (&#8220;ESPP&#8221;) purchase rights by expense category (in thousands):</font>
    </p><br/><table id="TBL490" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellspacing="0" cellpadding="0" border="0">
      <tr id="TBL490.finRow.1">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.1.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.1.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6">
          <p id="PARA460" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b></b></font>
          </p>
          <p id="PARA461" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Three Months Ended</b></font>
          </p>
          <p id="PARA462" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>September 30</b><b>,</b></font>
          </p>
        </td>
        <td id="TBL490.finRow.1.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.1.lead.D5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.1.amt.D5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6">
          <p id="PARA463" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b></b></font>
          </p>
          <p id="PARA464" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Nine</b> <b>Months Ended</b></font>
          </p>
          <p id="PARA465" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>September 30</b><b>,</b></font>
          </p>
        </td>
        <td id="TBL490.finRow.1.trail.D5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL490.finRow.2">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.lead.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.amt.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA466" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2014</b></font>
          </p>
        </td>
        <td id="TBL490.finRow.2.trail.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA467" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2013</b></font>
          </p>
        </td>
        <td id="TBL490.finRow.2.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA468" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2014</b></font>
          </p>
        </td>
        <td id="TBL490.finRow.2.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.lead.D5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.amt.D5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA469" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2013</b></font>
          </p>
        </td>
        <td id="TBL490.finRow.2.trail.D5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL490.finRow.3">
        <td>
          &#160;
        </td>
        <td id="TBL490.finRow.3.lead.B2">
          &#160;
        </td>
        <td id="TBL490.finRow.3.symb.B2">
          &#160;
        </td>
        <td id="TBL490.finRow.3.amt.B2">
          &#160;
        </td>
        <td id="TBL490.finRow.3.trail.B2">
          &#160;
        </td>
        <td id="TBL490.finRow.3.lead.B3">
          &#160;
        </td>
        <td id="TBL490.finRow.3.symb.B3">
          &#160;
        </td>
        <td id="TBL490.finRow.3.amt.B3">
          &#160;
        </td>
        <td id="TBL490.finRow.3.trail.B3">
          &#160;
        </td>
        <td id="TBL490.finRow.3.lead.B4">
          &#160;
        </td>
        <td id="TBL490.finRow.3.symb.B4">
          &#160;
        </td>
        <td id="TBL490.finRow.3.amt.B4">
          &#160;
        </td>
        <td id="TBL490.finRow.3.trail.B4">
          &#160;
        </td>
        <td id="TBL490.finRow.3.lead.B5">
          &#160;
        </td>
        <td id="TBL490.finRow.3.symb.B5">
          &#160;
        </td>
        <td id="TBL490.finRow.3.amt.B5">
          &#160;
        </td>
        <td id="TBL490.finRow.3.trail.B5">
          &#160;
        </td>
      </tr>
      <tr id="TBL490.finRow.4" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA470" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Research and development</font>
          </p>
        </td>
        <td id="TBL490.finRow.4.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.4.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.4.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          715
        </td>
        <td id="TBL490.finRow.4.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.4.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.4.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.4.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          702
        </td>
        <td id="TBL490.finRow.4.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.4.lead.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.4.symb.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.4.amt.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          2,423
        </td>
        <td id="TBL490.finRow.4.trail.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.4.lead.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.4.symb.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.4.amt.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          1,492
        </td>
        <td id="TBL490.finRow.4.trail.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL490.finRow.5" style="BACKGROUND-COLOR: #ffffff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          <p id="PARA475" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">General and administrative</font>
          </p>
        </td>
        <td id="TBL490.finRow.5.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          1,045
        </td>
        <td id="TBL490.finRow.5.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.5.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          3,393
        </td>
        <td id="TBL490.finRow.5.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.5.lead.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.symb.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.amt.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          3,386
        </td>
        <td id="TBL490.finRow.5.trail.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.5.lead.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.symb.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.amt.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          6,841
        </td>
        <td id="TBL490.finRow.5.trail.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL490.finRow.6" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA480" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stock-based compensation expense included in operating expenses</font>
          </p>
        </td>
        <td id="TBL490.finRow.6.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.6.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.6.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          1,760
        </td>
        <td id="TBL490.finRow.6.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.6.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.6.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.6.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          4,095
        </td>
        <td id="TBL490.finRow.6.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.6.lead.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.6.symb.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.6.amt.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          5,809
        </td>
        <td id="TBL490.finRow.6.trail.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.6.lead.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.6.symb.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.6.amt.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          8,333
        </td>
        <td id="TBL490.finRow.6.trail.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL490.finRow.7" style="BACKGROUND-COLOR: #ffffff">
        <td style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.lead.B2" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.symb.B2" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.amt.B2" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.trail.B2" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.lead.B3" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.symb.B3" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.amt.B3" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.trail.B3" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.lead.B4" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.symb.B4" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.amt.B4" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.trail.B4" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.lead.B5" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.symb.B5" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.amt.B5" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.trail.B5" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
      </tr>
      <tr id="TBL490.finRow.8" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
          <p id="PARA485" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Impact on basic and diluted net loss per share</font>
          </p>
        </td>
        <td id="TBL490.finRow.8.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.8.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.8.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          0.06
        </td>
        <td id="TBL490.finRow.8.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.8.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.8.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.8.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          0.27
        </td>
        <td id="TBL490.finRow.8.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.8.lead.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.8.symb.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.8.amt.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          0.23
        </td>
        <td id="TBL490.finRow.8.trail.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.8.lead.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.8.symb.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.8.amt.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          0.54
        </td>
        <td id="TBL490.finRow.8.trail.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
    </table><br/><p id="PARA492" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of September 30, 2014, there was approximately $26.8 million of total unrecognized compensation cost related to non-vested, stock-based payment awards granted pursuant to our equity compensation arrangements. Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures. We expect to recognize this compensation cost over a period of 2.5&#160;years, which is the weighted-average vesting period for all stock-based compensation awards.</font>
    </p><br/><p id="PARA494" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We estimated the fair value of each option grant on the grant date using the Black-Scholes option valuation model with the following weighted-average assumptions:</font>
    </p><br/><table id="TBL512" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellspacing="0" cellpadding="0" border="0">
      <tr id="TBL512.finRow.1">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom">
          <em></em>
        </td>
        <td id="TBL512.finRow.1.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL512.finRow.1.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6">
          <p id="PARA497" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>September 30,</b></font>
          </p>
        </td>
        <td id="TBL512.finRow.1.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL512.finRow.2">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL512.finRow.2.lead.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL512.finRow.2.amt.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA498" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>20</b><b>14</b></font>
          </p>
        </td>
        <td id="TBL512.finRow.2.trail.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL512.finRow.2.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL512.finRow.2.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA499" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>20</b><b>13</b></font>
          </p>
        </td>
        <td id="TBL512.finRow.2.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL512.finRow.3" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA500" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</font>
          </p>
        </td>
        <td id="TBL512.finRow.3.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.3.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.3.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          2.0
        </td>
        <td id="TBL512.finRow.3.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          %
        </td>
        <td id="TBL512.finRow.3.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.3.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.3.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          1.0
        </td>
        <td id="TBL512.finRow.3.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          %
        </td>
      </tr>
      <tr id="TBL512.finRow.4" style="BACKGROUND-COLOR: #ffffff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          <p id="PARA503" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dividend yield</font>
          </p>
        </td>
        <td id="TBL512.finRow.4.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.4.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.4.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 19.55pt; BACKGROUND-COLOR: #ffffff">
          0.0
        </td>
        <td id="TBL512.finRow.4.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          %
        </td>
        <td id="TBL512.finRow.4.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.4.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.4.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 19.55pt; BACKGROUND-COLOR: #ffffff">
          0.0
        </td>
        <td id="TBL512.finRow.4.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          %
        </td>
      </tr>
      <tr id="TBL512.finRow.5" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA506" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Volatility</font>
          </p>
        </td>
        <td id="TBL512.finRow.5.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.5.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.5.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          102.9
        </td>
        <td id="TBL512.finRow.5.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          %
        </td>
        <td id="TBL512.finRow.5.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.5.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.5.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          104.2
        </td>
        <td id="TBL512.finRow.5.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          %
        </td>
      </tr>
      <tr id="TBL512.finRow.6" style="BACKGROUND-COLOR: #ffffff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          <p id="PARA509" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected life (years)</font>
          </p>
        </td>
        <td id="TBL512.finRow.6.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.6.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.6.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          6.0
        </td>
        <td id="TBL512.finRow.6.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL512.finRow.6.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.6.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.6.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 54pt; BACKGROUND-COLOR: #ffffff">
          6.0
        </td>
        <td id="TBL512.finRow.6.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
    </table><br/><p id="PARA514" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We estimated the fair value of each purchase right granted under the ESPP at the beginning of each new offering period using the Black-Scholes option valuation model. There were no new offering periods for the quarters ended September 30, 2014 and 2013.</font>
    </p><br/><p id="PARA518" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table summarizes the stock option activity for the nine months ended September 30, 2014:</font>
    </p><br/><table id="TBL558" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellspacing="0" cellpadding="0" border="0">
      <tr id="TBL558.finRow.1">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.lead.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.symb.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.amt.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.trail.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.lead.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.symb.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.amt.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.trail.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA522" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Weighted-</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.1.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL558.finRow.2">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.lead.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.symb.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.amt.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.trail.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.lead.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.symb.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.amt.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.trail.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA524" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Average</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.2.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL558.finRow.3">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.lead.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.symb.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.amt.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.trail.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA526" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Weighted-</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.3.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA527" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Remaining</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.3.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL558.finRow.4">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.lead.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.symb.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.amt.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.trail.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA529" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Average</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.4.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA530" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Contractual</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.4.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL558.finRow.5">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.5.lead.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.5.amt.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA532" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Shares</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.5.trail.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.5.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.5.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA533" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Exercise</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.5.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.5.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.5.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA534" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Term</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.5.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL558.finRow.6">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.6.lead.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.6.amt.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA536" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>(in thousands)</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.6.trail.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.6.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.6.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA537" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Price</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.6.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.6.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.6.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA538" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>(Years)</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.6.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL558.finRow.7" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA539" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance at January 1, 2014</font>
          </p>
        </td>
        <td id="TBL558.finRow.7.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.7.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.7.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          6,356
        </td>
        <td id="TBL558.finRow.7.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.7.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.7.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL558.finRow.7.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          8.22
        </td>
        <td id="TBL558.finRow.7.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.7.lead.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.7.symb.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.7.amt.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          8.14
        </td>
        <td id="TBL558.finRow.7.trail.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL558.finRow.8" style="BACKGROUND-COLOR: #ffffff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff">
          <p id="PARA543" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</font>
          </p>
        </td>
        <td id="TBL558.finRow.8.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.8.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.8.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          1,631
        </td>
        <td id="TBL558.finRow.8.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.8.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.8.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          $
        </td>
        <td id="TBL558.finRow.8.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          9.95
        </td>
        <td id="TBL558.finRow.8.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.8.lead.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.8.symb.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.8.amt.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.8.trail.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
      </tr>
      <tr id="TBL558.finRow.9" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff">
          <p id="PARA546" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</font>
          </p>
        </td>
        <td id="TBL558.finRow.9.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.9.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.9.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          (719
        </td>
        <td id="TBL558.finRow.9.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          <p id="PARA548" style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</font>
          </p>
        </td>
        <td id="TBL558.finRow.9.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.9.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL558.finRow.9.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          6.29
        </td>
        <td id="TBL558.finRow.9.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.9.lead.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.9.symb.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.9.amt.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.9.trail.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
      </tr>
      <tr id="TBL558.finRow.10" style="BACKGROUND-COLOR: #ffffff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff">
          <p id="PARA550" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expired and forfeited</font>
          </p>
        </td>
        <td id="TBL558.finRow.10.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.10.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.10.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          (812
        </td>
        <td id="TBL558.finRow.10.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          <p id="PARA552" style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</font>
          </p>
        </td>
        <td id="TBL558.finRow.10.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.10.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          $
        </td>
        <td id="TBL558.finRow.10.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          9.82
        </td>
        <td id="TBL558.finRow.10.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.10.lead.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.10.symb.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.10.amt.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.10.trail.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
      </tr>
      <tr id="TBL558.finRow.11" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA554" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance at September 30, 2014</font>
          </p>
        </td>
        <td id="TBL558.finRow.11.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.11.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.11.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          6,456
        </td>
        <td id="TBL558.finRow.11.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.11.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.11.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL558.finRow.11.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          8.67
        </td>
        <td id="TBL558.finRow.11.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.11.lead.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.11.symb.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.11.amt.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          8.18
        </td>
        <td id="TBL558.finRow.11.trail.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
    </table><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph d<br><br> -Article 4<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%\Q93<S-#`V95\S93<R7S1E-&5?.&4V-5\X9&,V
M9&%A93DW-V8B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7
M96(@4&%G92P@86QS;R!K;F]W;B!A<R!A(%=E8B!!<F-H:79E(&9I;&4N("!)
M9B!Y;W4@87)E('-E96EN9R!T:&ES(&UE<W-A9V4L('EO=7(@8G)O=W-E<B!O
M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
M4&QE87-E(&1O=VYL;V%D(&$@8G)O=W-E<B!T:&%T('-U<'!O<G1S(%=E8B!!
M<F-H:79E+"!S=6-H(&%S($UI8W)O<V]F="!);G1E<FYE="!%>'!L;W)E<BX-
M"@T*+2TM+2TM/5].97AT4&%R=%\Q93<S-#`V95\S93<R7S1E-&5?.&4V-5\X
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?06YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N9&5N<V5D7T)A
M;&%N8V5?4VAE971S7T-U<G)E/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0V]N9&5N<V5D7U-T871E;65N='-?;V9?3W!E<F%T/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N9&5N<V5D
M7U-T871E;65N='-?;V9?0V%S:%]&/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`T+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^3F]T95\Q7T)U<VEN97-S/"]X.DYA;64^#0H@("`@
M/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`U
M+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L
M5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\R7T)A<VES7V]F7U!R97-E
M;G1A=&EO;CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970P-BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/DYO=&5?,U]!8V-O=6YT:6YG7U!O;&EC:65S/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`W+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\T7T-O;G9E<G1I8FQE7TYO=&5S
M7W1O7U)E/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#`X+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M3F]T95\U7U-T;V-K:&]L9&5R<U]%<75I='D\+W@Z3F%M93X-"B`@("`\>#I7
M;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,#DN:'1M
M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K
M<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S9?26YC;VUE7U1A>&5S/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#$P+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^06-C;W5N=&EN9U]0
M;VQI8VEE<U]B>5]0;VQI8WE?/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$Q+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^3F]T95\S7T%C8V]U;G1I;F=?4&]L:6-I97-?5&%B/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#$R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\U7U-T
M;V-K:&]L9&5R<U]%<75I='E?5&%B/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$S+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^3F]T95\Q7T)U<VEN97-S7T1E=&%I;',\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T,30N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S-?06-C;W5N
M=&EN9U]0;VQI8VEE<U]$970\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713
M;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,34N:'1M;"(O/@T*("`@
M/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@
M("`@/'@Z3F%M93Y.;W1E7S-?06-C;W5N=&EN9U]0;VQI8VEE<U]$970Q/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#$V+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\T7T-O
M;G9E<G1I8FQE7TYO=&5S7W1O7U)E,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q-RYH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/DYO=&5?-5]3=&]C:VAO;&1E<G-?17%U:71Y7T1E
M=#PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970Q."YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?
M-5]3=&]C:VAO;&1E<G-?17%U:71Y7T1E=#$\+W@Z3F%M93X-"B`@("`\>#I7
M;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3DN:'1M
M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K
M<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S5?4W1O8VMH;VQD97)S7T5Q=6ET
M>5]$970R/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#(P+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M3F]T95\U7U-T;V-K:&]L9&5R<U]%<75I='E?1&5T,SPO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R
M,2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@(#PO>#I%>&-E
M;%=O<FMS:&5E=',^#0H@(#QX.E-T>6QE<VAE970@2%)E9CTS1")7;W)K<VAE
M971S+W)E<&]R="YC<W,B+SX-"B`@/'@Z06-T:79E4VAE970^,#PO>#I!8W1I
M=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T<G5C='5R93Y&86QS93PO>#I0<F]T
M96-T4W1R=6-T=7)E/@T*("`\>#I0<F]T96-T5VEN9&]W<SY&86QS93PO>#I0
M<F]T96-T5VEN9&]W<SX-"B`\+W@Z17AC96Q7;W)K8F]O:SX-"CPO>&UL/CPA
M6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G
M92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC<F]S;V9T($5X8V5L(%A0(&]R
M(&YE=V5R+CPO<#X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7S%E-S,T,#9E7S-E-S)?-&4T95\X938U7SAD8S9D86%E.3<W9@T*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Q93<S-#`V95\S93<R7S1E
M-&5?.&4V-5\X9&,V9&%A93DW-V8O5V]R:W-H965T<R]3:&5E=#`Q+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%3D=!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY$;V-U;65N
M="!!;F0@16YT:71Y($EN9F]R;6%T:6]N/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^3V-T+B`R.2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$;V-U;65N="!A;F0@16YT:71Y
M($EN9F]R;6%T:6]N(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@4F5G:7-T<F%N="!.86UE
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG2$523TX@5$A%4D%0
M155424-3+"!)3D,N("]$12\\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N="!4>7!E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG,3`M43QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-U<G)E;G0@1FES8V%L(%EE
M87(@16YD($1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<M
M+3$R+3,Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^16YT:71Y($-O;6UO;B!3=&]C:RP@4VAA<F5S($]U='-T86YD
M:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,CDL,3@P+#`Y
M.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^06UE;F1M96YT($9L86<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B=F86QS93QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D5N=&ET>2!#96YT<F%L($EN9&5X($ME>3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S`P,#`X,3@P,S,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@
M0W5R<F5N="!297!O<G1I;F<@4W1A='5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG665S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^16YT:71Y(%9O;'5N=&%R>2!&:6QE<G,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B=.;SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!&:6QE
M<B!#871E9V]R>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)T%C
M8V5L97)A=&5D($9I;&5R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^16YT:71Y(%=E;&PM:VYO=VX@4V5A<V]N960@
M27-S=65R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG3F\\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$
M;V-U;65N="!097)I;V0@16YD($1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/E-E<"`S,"P-"@D),C`Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O8W5M96YT($9I<V-A;"!9
M96%R($9O8W5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,C`Q
M-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D1O8W5M96YT($9I<V-A;"!097)I;V0@1F]C=7,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B=1,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
M#0HM+2TM+2T]7TYE>'1087)T7S%E-S,T,#9E7S-E-S)?-&4T95\X938U7SAD
M8S9D86%E.3<W9@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Q93<S
M-#`V95\S93<R7S1E-&5?.&4V-5\X9&,V9&%A93DW-V8O5V]R:W-H965T<R]3
M:&5E=#`R+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E
M9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T
M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%-%-!13X-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T
M<F]N9SY#;VYD96YS960@0F%L86YC92!3:&5E=',@*$-U<G)E;G0@4&5R:6]D
M(%5N875D:71E9"D@*%531"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O
M=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-U<G)E;G0@87-S971S.CPO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A
M<V@\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@.#8L,C$R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`W
M,BPR.#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E!R97!A:60@97AP96YS97,@86YD(&]T:&5R(&-U<G)E;G0@87-S
M971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#`S,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8S.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E1O=&%L(&-U<G)E;G0@87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XX.2PR-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XW,BPY,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E<G1Y(&%N9"!E<75I<&UE;G0L
M(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPY,3`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#@X
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3W1H97(@;&]N9RUT97)M(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3,P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3,P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@87-S971S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XY,BPR.#(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-2PY,S<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0W5R
M<F5N="!L:6%B:6QI=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y!8V-O=6YT<R!P87EA8FQE/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0W-3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,C8T/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-R=65D(&-L:6YI
M8V%L(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT+#4S,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L-S<S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!8V-R=65D('!A>7)O;&P@86YD(&5M<&QO>65E+7)E
M;&%T960@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(L-C`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,BPU-C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D]T:&5R(&%C8W)U960@97AP96YS97,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,C$X/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S8T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)T:6)L
M92!N;W1E<R!P87EA8FQE('1O(')E;&%T960@<&%R=&EE<RP@;F5T(&]F(&1I
M<V-O=6YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0U,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M,#(U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5&]T86P@8W5R<F5N="!L:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3$L,C<T/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPY.3(\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W1O8VMH
M;VQD97)SXH"9(&5Q=6ET>3H\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(Y,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(S-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^061D:71I;VYA;"!P86ED+6EN(&-A
M<&ET86P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,W-2PS,CD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M,#<L-3<X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y!8V-U;75L871E9"!D969I8VET/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@R.30L-C$S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#(S."PX-S`I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@<W1O8VMH
M;VQD97)SXH"9(&5Q=6ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^.#$L,#`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-C@L.30U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^5&]T86P@;&EA8FEL:71I97,@86YD('-T;V-K
M:&]L9&5R<^*`F2!E<75I='D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@.3(L,C@R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`W-2PY,S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7S%E-S,T,#9E7S-E-S)?-&4T95\X938U7SAD8S9D
M86%E.3<W9@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Q93<S-#`V
M95\S93<R7S1E-&5?.&4V-5\X9&,V9&%A93DW-V8O5V]R:W-H965T<R]3:&5E
M=#`S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%-DU!13X-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SY#;VYD96YS960@4W1A=&5M96YT<R!O9B!/<&5R871I;VYS("A5;F%U9&ET
M960I("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!E>&-E<'0@4&5R(%-H87)E
M(&1A=&$L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,CXY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3,\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q
M-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R
M,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/D]P97)A=&EN9R!E>'!E;G-E<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<V5A<F-H(&%N9"!D979E;&]P
M;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q-"PW,S$\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#8L,C$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`T,"PY,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#(T+#$V,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V5N97)A;"!A;F0@861M:6YI<W1R
M871I=F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L,C(R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPT
M-#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ-"PQ,S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ-BPT-C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!O<&5R871I;F<@97AP96YS97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$X+#DU,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#8V-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4U+#`V
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C0P+#8R-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3&]S<R!F<F]M(&]P97)A=&EO;G,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#$X+#DU,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,BPV-C0I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-34L,#8V*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0P+#8R-BD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DEN=&5R97-T(&%N9"!O=&AE<B!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@R-#$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,C`Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#8W-RD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V,30I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,3DL,3DT*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,3(L.#<S
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M)"`H-34L-S0S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^)"`H-#$L,C0P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0F%S:6,@86YD(&1I;'5T960@;F5T(&QO
M<W,@<&5R('-H87)E("AI;B!$;VQL87)S('!E<B!S:&%R92D\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,"XV-BD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N.#0I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@R+C$W*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M,BXV.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E-H87)E<R!U<V5D(&EN(&-O;7!U=&EN9R!B87-I8R!A;F0@9&EL
M=71E9"!N970@;&]S<R!P97(@<VAA<F4@*&EN(%-H87)E<RD\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(Y+#`P-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#,W-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(U+#8W.3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#,P
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE
M/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,64W
M,S0P-F5?,V4W,E\T931E7SAE-C5?.&1C-F1A864Y-S=F#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T,Z+S%E-S,T,#9E7S-E-S)?-&4T95\X938U7SAD
M8S9D86%E.3<W9B]7;W)K<VAE971S+U-H965T,#0N:'1M;`T*0V]N=&5N="U4
M<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4
M>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-
M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP
M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP
M="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@
M3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@
M(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5$
M,D%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-O;F1E;G-E9"!3=&%T96UE
M;G1S(&]F($-A<V@@1FQO=W,@*%5N875D:71E9"D@*%531"`D*3QB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,CXY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3,\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#4U+#<T,RPP,#`I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@T
M,2PR-#`L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY!9&IU<W1M96YT<R!T;R!R96-O;F-I;&4@
M;F5T(&QO<W,@=&\@;F5T(&-A<V@@=7-E9"!F;W(@;W!E<F%T:6YG(&%C=&EV
M:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I;VX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C,X.2PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,S<L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:RUB
M87-E9"!C;VUP96YS871I;VX@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-2PX,#DL,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^."PS,S,L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]R=&EZ871I;VX@
M;V8@9&5B="!D:7-C;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#(U+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C,Y-BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0VAA;F=E<R!I;B!O<&5R871I
M;F<@87-S971S(&%N9"!L:6%B:6QI=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5P86ED(&5X<&5N<V5S(&%N
M9"!O=&AE<B!A<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#(L,SDR+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@R,#(L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^06-C;W5N=',@<&%Y86)L93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$Q+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4Q-"PP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)U
M960@8VQI;FEC86P@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(L-S4W+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,P,BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)U960@<&%Y<F]L;"!A
M;F0@96UP;&]Y964M<F5L871E9"!L:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,S4L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#4T+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W1H97(@86-C<G5E
M9"!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PP
M.#0L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-S`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^3F5T(&-A<V@@=7-E9"!F;W(@;W!E<F%T:6YG(&%C
M=&EV:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0W+#0R
M-2PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,S$L,3,V+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^26YV97-T:6YG(&%C=&EV:71I
M97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4'5R8VAA<V5S(&]F('!R;W!E<G1Y(&%N9"!E<75I<&UE;G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0Q-RPP,#`I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PU,3@L,#`P*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DYE="!C87-H('5S960@9F]R(&EN=F5S=&EN9R!A8W1I=FET:65S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T,3<L,#`P*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L-3$X+#`P,"D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^1FEN86YC:6YG(&%C=&EV:71I97,Z/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!W
M87)R86YT(&5X97)C:7-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C8P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@<'5R8VAA<V5S('5N9&5R('1H
M92!%;7!L;WEE92!3=&]C:R!0=7)C:&%S92!0;&%N/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ.2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-2PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@
M<W1O8VL@;W!T:6]N(&5X97)C:7-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,BPX,S(L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PQ,C`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@<')O8V5E9',@9G)O
M;2!S86QE(&]F(&-O;6UO;B!S=&]C:R!A;F0@<')E+69U;F1E9"!W87)R86YT
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3@L.3$V+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y.970@8V%S:"!P<F]V:61E9"!B>2!F:6YA;F-I;F<@86-T:79I=&EE<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C$L-S8W+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-S0U
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DYE="!I;F-R96%S92`H9&5C<F5A<V4I(&EN(&-A<V@\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S+#DR-2PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S,"PY,#DL,#`P
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V%S:"!A="!B96=I;FYI;F<@;V8@<&5R:6]D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XW,BPR.#<L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3,L-3`V+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A
M="!E;F0@;V8@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#@V+#(Q,BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#(R+#4Y-RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7S%E-S,T,#9E7S-E-S)?-&4T95\X938U
M7SAD8S9D86%E.3<W9@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Q
M93<S-#`V95\S93<R7S1E-&5?.&4V-5\X9&,V9&%A93DW-V8O5V]R:W-H965T
M<R]3:&5E=#`U+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^3F]T92`Q("T@0G5S:6YE<W,\8G(^/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$:7-C;&]S=7)E(%1E>'0@0FQO
M8VL@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0G5S:6YE<W,@1&5S8W)I<'1I;VX@86YD($)A<VES(&]F
M(%!R97-E;G1A=&EO;B!;5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<"!I9#TS1%!!4D$S,S<@<W1Y;&4],T0G5$585"U!
M3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U
M)SX@("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G
M/CQB/C$N)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[0G5S:6YE<W,\
M+V(^/"]F;VYT/B`@("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$Q-3$Y
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,
M24Y%+4A%24=(5#H@,2XR-2<^("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68G/DAE<F]N(%1H97)A<&5U=&EC<RP@26YC+B`H9F]R
M;65R;'D@02Y0+B!0:&%R;6$L($EN8RXI("AT:&4@)B,X,C(P.T-O;7!A;GDL
M)B,X,C(Q.R`F(S@R,C`[=V4L)B,X,C(Q.R`F(S@R,C`[=7,F(S@R,C$[(&%N
M9"`F(S@R,C`[;W5R)B,X,C(Q.RD@:7,@82!B:6]T96-H;F]L;V=Y(&-O;7!A
M;GD@=7-I;F<@:71S('!R;W!R:65T87)Y('1E8VAN;VQO9WD@86YD(&EN;F]V
M871I=F4@969F;W)T<R!T;R!D979E;&]P('!R;V1U8W1S('1O(&%D9')E<W,@
M=6YM970@;65D:6-A;"!N965D<RX@3W5R('!R;W!R:65T87)Y($)I;V-H<F]N
M;VUE<CQS=7`@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)A<V5L:6YE.R!P
M;W-I=&EO;CH@<F5L871I=F4[(&)O='1O;3HN,S-E;3LG/B8C,3<T.SPO<W5P
M/B!P;VQY;65R+6)A<V5D(&1R=6<@9&5L:79E<GD@<&QA=&9O<FT@:7,@9&5S
M:6=N960@=&\@:6UP<F]V92!T:&4@=&AE<F%P975T:6,@<')O9FEL92!O9B!I
M;FIE8W1A8FQE('!H87)M86-E=71I8V%L<R!B>2!E>'1E;F1I;F<@=&AE(&1U
M<F%T:6]N(&]F(&%C=&EO;B!O9B!K;F]W;B!A8W1I=F4@:6YG<F5D:65N=',N
M($]U<B!P<F]D=6-T(&1E=F5L;W!M96YT('!R;V=R86T@86QS;R!F;V-U<V5S
M(&]N(&ED96YT:69Y:6YG(&YE=R!D96QI=F5R>2!M971H;V1S(&%N9"!F;W)M
M=6QA=&EO;G,@=71I;&EZ:6YG(&MN;W=N(&-O;7!O=6YD<R!T:&%T(&UA>2!E
M>'!A;F0@;W(@97AT96YD('1H92!T:&5R87!E=71I8R!E9F9O<G0L(&]R(&5L
M:6UI;F%T92!T:&4@9')A=V)A8VMS(&]F(&-U<G)E;G0@=&AE<F%P:65S+CPO
M9F]N=#X@("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$Q-3(Q('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%
M24=(5#H@,2XR-2<^("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68G/D]U<B!L96%D(&EN=F5S=&EG871I;VYA;"!P<F]D=6-T(&-A
M;F1I9&%T92P@05!&-3,P+"!W:&EC:"!W92!I;G1E;F0@=&\@;6%R:V5T(&%S
M(%-54U1/3#QS=7`@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)A<V5L:6YE
M.R!P;W-I=&EO;CH@<F5L871I=F4[(&)O='1O;3HN,S-E;3LG/B8C,3<T.SPO
M<W5P/B`\<W5P('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B87-E;&EN93L@
M<&]S:71I;VXZ(')E;&%T:79E.R!B;W1T;VTZ+C,S96T[)SX\+W-U<#XH9W)A
M;FES971R;VX@:6YJ96-T:6]N+"!E>'1E;F1E9"!R96QE87-E*2P@<W5B:F5C
M="!T;R!R96=U;&%T;W)Y(&%P<')O=F%L+"!I<R!B96EN9R!D979E;&]P960@
M9F]R('1H92!P<F5V96YT:6]N(&]F(&)O=&@@86-U=&4M(&%N9"!D96QA>65D
M+6]N<V5T(&-H96UO=&AE<F%P>2!I;F1U8V5D(&YA=7-E82!A;F0@=F]M:71I
M;F<@*"8C.#(R,#M#24Y6)B,X,C(Q.RDN($EN(#(P,30L('=E(&EN:71I871E
M9"!A(%!H87-E(#,@8VQI;FEC86P@<W1U9'D@=VET:"!!4$8U,S`@9F]R('1H
M92!P<F5V96YT:6]N(&]F(&1E;&%Y960M;VYS970@0TE.5B!I;B!P871I96YT
M<R!R96-E:79I;F<@:&EG:&QY(&5M971O9V5N:6,@8VAE;6]T:&5R87!Y("@F
M(S@R,C`[2$5#('-T=61Y)B,X,C(Q.RDN($]N92!O9B!T:&4@;6]S="!D96)I
M;&ET871I;F<@<VED92!E9F9E8W1S(&]F(&-A;F-E<B!C:&5M;W1H97)A<'DL
M($-)3E8@:7,@82!L96%D:6YG(&-A=7-E(&]F('!R96UA='5R92!D:7-C;VYT
M:6YU871I;VX@;V8@=')E871M96YT+B!4:&5R92!I<R!O;FQY(&]N92!I;FIE
M8W1A8FQE(#4M2%0S(')E8V5P=&]R(&%N=&%G;VYI<W0@87!P<F]V960@9F]R
M('1H92!P<F5V96YT:6]N(&]F(&1E;&%Y960M;VYS970@0TE.5B!I;B!P871I
M96YT<R!R96-E:79I;F<@;6]D97)A=&5L>2`@#0H@("`@("!E;65T;V=E;FEC
M(&-H96UO=&AE<F%P>3L@;F]N92!A<F4@87!P<F]V960@9F]R(&1E;&%Y960M
M;VYS970@0TE.5B!I;B!P871I96YT<R!R96-E:79I;F<@:&EG:&QY(&5M971O
M9V5N:6,@8VAE;6]T:&5R87!Y+CPO9F]N=#X@("`@#0H@("`@/"]P/CQB<B\^
M/'`@:60],T1005)!,34R,R!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y
M.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@("`-"B`@("`@
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M3"X\+V9O;G0^("`@("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$Q-3$U
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,
M24Y%+4A%24=(5#H@,2XR-2<^("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68G/DEN($UA>2`R,#`Y+"!W92!F:6QE9"!T:&4@;W)I
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M<&]N<V4@3&5T=&5R("@F(S@R,C`[0U),)B,X,C(Q.RD@9F]R('1H92!355-4
M3TP@3D1!(&EN($UA<F-H(#(P,3`N($EN(%-E<'1E;6)E<B`R,#$R+"!W92!R
M97-U8FUI='1E9"!O=7(@3D1!(&9O<B!355-43TP@86YD+"!I;B!-87)C:"`R
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M<B!O9B`R,#$U+B!792!I;G1E;F0@=&\@:6YC;'5D92!T:&4@<F5S=6QT<R!O
M9B!T:&4@<W1U9'D@:6X@=&AE(')E<W5B;6ES<VEO;B!O9B`@(`T*("`@("`@
M=&AE(%-54U1/3"!.1$$L('=H:6-H('=E(&%N=&EC:7!A=&4@9FEL:6YG('-H
M;W)T;'D@=&AE<F5A9G1E<BXF(S$V,#L\+V9O;G0^("`-"B`@("`\+W`^/&)R
M+SX\<"!I9#TS1%!!4D$S-#<@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF
M>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@
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M=',@;V8@;W9E<B`Q,#`@/&D^:6X@=FEV;SPO:3X@86YD(#QI/FEN('9I=')O
M/"]I/B!S='5D:65S(&1E;6]N<W1R871E('1H870@;W5R($)I;V-H<F]N;VUE
M<B!T96-H;F]L;V=Y(&ES('!O=&5N=&EA;&QY(&%P<&QI8V%B;&4@=&\@82!R
M86YG92!O9B!T:&5R87!E=71I8R!A<F5A<RP@:6YC;'5D:6YG('!R979E;G1I
M;VX@;V8@0TE.5BP@<&%I;B!M86YA9V5M96YT(&%N9"!C;VYT<F]L(&]F(&EN
M9FQA;6UA=&EO;BP@86UO;F<@;W1H97)S+B!792!H879E(&%L<V\@8V]M<&QE
M=&5D(&-O;7!R96AE;G-I=F4@86YI;6%L(&%N9"!H=6UA;B!T;WAI8V]L;V=Y
M('-T=61I97,@=&AA="!H879E(&5S=&%B;&ES:&5D('1H870@;W5R($)I;V-H
M<F]N;VUE<B!P;VQY;65R<R!A<F4@=V5L;"!T;VQE<F%T960N($9U<G1H97)M
M;W)E+"!O=7(@0FEO8VAR;VYO;65R('1E8VAN;VQO9WD@8V%N(&)E(&1E<VEG
M;F5D('1O(&1E;&EV97(@9')U9W,@;W9E<B!P97)I;V1S('9A<GEI;F<@9G)O
M;2!D87ES('1O('!O=&5N=&EA;&QY(&UU;'1I<&QE('=E96MS+B!792!A<F4@
M<F5S96%R8VAI;F<@=&AE('!O=&5N=&EA;"!U<V4@;V8@;W5R($)I;V-H<F]N
M;VUE<B!T96-H;F]L;V=Y('=I=&@@;W1H97(@9')U9W,@9F]R('1H92!C;&EN
M:6-A;"!D979E;&]P;65N="!O9B!O=&AE<B!D<G5G(&-A;F1I9&%T97,N/"]F
M;VYT/B`@("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$S-#D@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)
M1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF)SY);B!.;W9E;6)E<B`R,#$S+"!W92!I;FET:6%T960@82!P<F]G
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M:&4@;&5A9"!P<F]D=6-T(&-A;F1I9&%T92!F;W(@;W5R)B,Q-C`[<&%I;B!M
M86YA9V5M96YT)B,Q-C`[<')O9W)A;2X@5V4@87)E(&EN('1H92!P<F]C97-S
M(&]F(&-O;6UE;F-I;F<@82!0:&%S92`Q('-T=61Y(&EN($5U<F]P92!T;R!E
M>&%M:6YE('1H92!P<F]D=6-T(&-A;F1I9&%T92!I;B!H=6UA;B!C86YD:61A
M=&5S+B!!<R!O9B`R,#$R+"!A<'!R;WAI;6%T96QY(#(U(&UI;&QI;VX\<W5P
M('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B87-E;&EN93L@<&]S:71I;VXZ
M(')E;&%T:79E.R!B;W1T;VTZ+C,S96T[)SXQ/"]S=7`^('!R;V-E9'5R97,@
M87-S;V-I871E9"!W:71H('!O<W0M;W!E<F%T:79E('!A:6X@=V5R92!C;VYD
M=6-T960@:6X@=&AE(%4N4RX@26X@861D:71I;VXL('!O<W0M;W!E<F%T:79E
M('!A:6X@;6%R:V5T('-A;&5S('=E<F4@87!P<F]X:6UA=&5L>2`D,RXQ)B,Q
M-C`[8FEL;&EO;CQS=7`@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)A<V5L
M:6YE.R!P;W-I=&EO;CH@<F5L871I=F4[(&)O='1O;3HN,S-E;3LG/C(\+W-U
M<#X@:6X@,C`Q,BX\+V9O;G0^("`@(`T*("`@(#PO<#X\8G(O/CQP(&ED/3-$
M4$%203$U,3(@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE.
M.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`@#0H@("`@("`\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9B<^26X@3F]V96UB97(@,C`Q-"P@=V4@
M86YN;W5N8V5D('1H92!I;FET:6%T:6]N(&]F(&$@<')O9'5C="!D979E;&]P
M;65N="!P<F]G<F%M(&9O<B!(5%@M,#$Y+B!4:&4@:6YV97-T:6=A=&EO;F%L
M('!R;V1U8W0@2%18+3`Q.2!I<R!A('!R;W!R:65T87)Y(&EN=')A=F5N;W5S
M(&9O<FUU;&%T:6]N(&]F(&%P<F5P:71A;G0L(&$@<W5B<W1A;F-E(%`O;F5U
M<F]K:6YI;BTQ("A.2S$I(')E8V5P=&]R(&%N=&%G;VYI<W0@=7-E9"!I;B!C
M;VUB:6YA=&EO;B!W:71H(&$@-2U(5#,@9F]R('1H92!P<F5V96YT:6]N(&]F
M($-)3E8N($A46"TP,3D@9&]E<R!N;W0@8V]N=&%I;B!P;VQY<V]R8F%T92`X
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M+B!F;W(@=&AE('!R979E;G1I;VX@;V8@0TE.5BX\+V9O;G0^("`-"B`@("`\
M+W`^/&)R+SX\<"!I9#TS1%!!4D$S-3$@<W1Y;&4],T0G5$585"U!3$E'3CH@
M:G5S=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-
M"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SY);B!*86YU
M87)Y(#(P,30L('=E(&-H86YG960@;W5R(&YA;64@9G)O;2!!+E`N(%!H87)M
M82P@26YC+B!T;R!(97)O;B!4:&5R87!E=71I8W,L($EN8RX@169F96-T:79E
M($IA;G5A<GDF(S$V,#LQ,RPF(S$V,#LR,#$T+"!W92!E9F9E8W1E9"!A(#$@
M+2!F;W(@+2`R,"!R979E<G-E('-P;&ET(&]F(&]U<B!O=71S=&%N9&EN9R!C
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M("`@#0H@("`@/"]P/CQB<B\^/'`@:60],T1005)!,S4S('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@
M,2XR-2<^("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9B<^/&(^3&EQ=6ED:71Y/"]B/CPO9F]N=#X@("`-"B`@("`\+W`^/&)R+SX\
M<"!I9#TS1%!!4D$S-34@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@
M34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF
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M8F5R(#,P+"`R,#$T+B!3:6YC92`R,#$Q+"!W92!C;VUP;&5T960@82!T;W1A
M;"!O9B!F:79E(')O=6YD<R!O9B!E<75I='D@86YD+V]R(&1E8G0@9FEN86YC
M:6YG<RP@=VAI8V@@<')O=FED960@=7,@=VET:"!C87-H(&]F(&%P<')O>&EM
M871E;'D@)#$Y-"XS(&UI;&QI;VXL(&YE="!O9B!I<W-U86YC92!C;W-T<RP@
M=&\@9G5N9"!O<&5R871I;VYS("AS964@3F]T97,@-"!A;F0@-2DN($%S(&]F
M(%-E<'1E;6)E<B`S,"P@,C`Q-"P@=V4@:&%D(&-A<V@@;VX@:&%N9"!O9B`D
M.#8N,B!M:6QL:6]N+CPO9F]N=#X@("`@#0H@("`@/"]P/CQB<B\^/'`@:60]
M,T1005)!,34Q-B!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'
M24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@("`-"B`@("`@(#QF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SY792!B96QI979E('1H870@;W5R
M(&-U<G)E;G0@=V]R:VEN9R!C87!I=&%L(&ES('-U9F9I8VEE;G0@=&\@9G5N
M9"!O<&5R871I;VYS(&EN=&\@,C`Q-2P@:6YC;'5D:6YG('!U<G-U:6YG(')E
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M9&5F97(@;W5R(&%C=&EV:71I97,N/"]F;VYT/B`@("`@#0H@("`@/"]P/CQB
M<B\^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q
M93<S-#`V95\S93<R7S1E-&5?.&4V-5\X9&,V9&%A93DW-V8-"D-O;G1E;G0M
M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,64W,S0P-F5?,V4W,E\T931E7SAE-C5?
M.&1C-F1A864Y-S=F+U=O<FMS:&5E=',O4VAE970P-BYH=&UL#0I#;VYT96YT
M+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT
M+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL
M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@,B`M($)A<VES(&]F
M(%!R97-E;G1A=&EO;CQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D1I<V-L;W-U<F4@5&5X="!";&]C:R!;06)S=')A
M8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y"87-I<R!O9B!!8V-O=6YT:6YG(%M497AT($)L;V-K73PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQP(&ED/3-$4$%203,U.2!S='EL93TS
M1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'24XZ(#!P=#L@3$E.12U(14E'
M2%0Z(#$N,C4G/B`@#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9B<^/&(^,CPO8CX\8CXN)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[0CPO8CX\8CYA<VES(&]F(%!R97-E;G1A=&EO;CPO8CX\+V9O;G0^("`@
M("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$S-C$@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q
M+C(U)SX@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M)SY4:&4@86-C;VUP86YY:6YG('5N875D:71E9"!C;VYD96YS960@9FEN86YC
M:6%L('-T871E;65N=',@:&%V92!B965N('!R97!A<F5D(&EN(&%C8V]R9&%N
M8V4@=VET:"!A8V-O=6YT:6YG('!R:6YC:7!L97,@9V5N97)A;&QY(&%C8V5P
M=&5D(&EN('1H92!5;FET960@4W1A=&5S("@F(S@R,C`[1T%!4"8C.#(R,3LI
M(&9O<B!I;G1E<FEM(&9I;F%N8VEA;"!I;F9O<FUA=&EO;B!A;F0@=VET:"!T
M:&4@:6YS=')U8W1I;VYS('1O($9O<FT@,3`M42!A;F0@07)T:6-L92`Q,"!O
M9B!296=U;&%T:6]N(%,M6"X@06-C;W)D:6YG;'DL('1H97D@9&\@;F]T(&EN
M8VQU9&4@86QL(&]F('1H92!I;F9O<FUA=&EO;B!A;F0@9&ES8VQO<W5R97,@
M<F5Q=6ER960@8GD@1T%!4"!F;W(@8V]M<&QE=&4@9FEN86YC:6%L('-T871E
M;65N=',N($EN('1H92!O<&EN:6]N(&]F(&UA;F%G96UE;G0L(&%L;"!A9&IU
M<W1M96YT<R`H8V]N<VES=&EN9R!O9B!N;W)M86P@<F5C=7)R:6YG(&%C8W)U
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M,#LS,2P@,C`Q-"X@5&AE(&-O;F1E;G-E9"!B86QA;F-E('-H965T(&%T($1E
M8V5M8F5R(#,Q+"`R,#$S(&AA<R!B965N(&1E<FEV960@9G)O;2!T:&4@875D
M:71E9"!F:6YA;F-I86P@<W1A=&5M96YT<R!A<R!O9B!T:&%T(&1A=&4L(&)U
M="!D;V5S(&YO="!I;F-L=61E("`@#0H@("`@("!A;&P@;V8@=&AE(&EN9F]R
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M97)I9B<^)B,Q-C`[,3`M2R!F;W(@=&AE(&9I<V-A;"!Y96%R(&5N9&5D($1E
M8V5M8F5R)B,Q-C`[,S$L(#(P,3,@9FEL960@=VET:"!T:&4@4V5C=7)I=&EE
M<R!A;F0@17AC:&%N9V4@0V]M;6ES<VEO;B`H)B,X,C(P.U-%0R8C.#(R,3LI
M(&]N($UA<F-H)B,Q-C`[-RPF(S$V,#LR,#$T/"]F;VYT/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF)SXN/"]F;VYT/B`@("`@#0H@("`@/"]P/CQB
M<B\^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q
M93<S-#`V95\S93<R7S1E-&5?.&4V-5\X9&,V9&%A93DW-V8-"D-O;G1E;G0M
M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,64W,S0P-F5?,V4W,E\T931E7SAE-C5?
M.&1C-F1A864Y-S=F+U=O<FMS:&5E=',O4VAE970P-RYH=&UL#0I#;VYT96YT
M+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT
M+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL
M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@,R`M($%C8V]U;G1I
M;F<@4&]L:6-I97,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY!8V-O=6YT:6YG(%!O;&EC:65S(%M!8G-T<F%C=%T\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-I
M9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I97,@6U1E>'0@0FQO8VM=/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@:60],T1005)!,S8S
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,
M24Y%+4A%24=(5#H@,2XR-2<^("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9B<^/&(^,RXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#M!8V-O=6YT:6YG(%!O;&EC:65S/"]B/CPO9F]N=#X@("`@(`T*("`@
M(#PO<#X\8G(O/CQP(&ED/3-$4$%203,V-2!S='EL93TS1"=415A4+4%,24=.
M.B!J=7-T:69Y.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@
M(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/E5S
M92!O9B!%<W1I;6%T97,\+V(^/"]F;VYT/B`@("`@#0H@("`@/"]P/CQB<B\^
M/'`@:60],T1005)!,S8W('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[
M($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`@#0H@("`@("`\
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M<B!C;VYD:71I;VYS+CPO9F]N=#X@("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS
M1%!!4D$S-CD@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE.
M.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF)SX\8CY#87-H/"]B/CPO9F]N=#X@("`-
M"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$S-S$@<W1Y;&4],T0G5$585"U!
M3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U
M)SX@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SY7
M92!H860@8V%S:"!O9B`D.#8N,B!M:6QL:6]N(&%N9"`D-S(N,R!M:6QL:6]N
M(&%T(%-E<'1E;6)E<B`S,"P@,C`Q-"!A;F0@1&5C96UB97(@,S$L(#(P,3,L
M(')E<W!E8W1I=F5L>2X@5V4@9&ED(&YO="!H;VQD(&%N>2!C87-H(&5Q=6EV
M86QE;G1S(&]R(&EN=F5S=&UE;G0@<V5C=7)I=&EE<R!A<R!O9B!B;W1H(&1A
M=&5S+B!/=7(@8F%N:R!A8V-O=6YT<R!H879E(&)E96X@<&QA8V5D('5N9&5R
M(&$@8V]N=')O;"!A9W)E96UE;G0@:6X@86-C;W)D86YC92!W:71H('1H92!3
M96YI;W(@4V5C=7)E9"!#;VYV97)T:6)L92!.;W1E<R`H<V5E($YO=&4@-"DN
M/"]F;VYT/B`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$S-S,@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)
M1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF)SX\8CY%87)N:6YG<R!097(@4VAA<F4\+V(^/"]F;VYT/B`@#0H@
M("`@/"]P/CQB<B\^/'`@:60],T1005)!,S<U('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^
M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^0F%S
M:6,@96%R;FEN9W,@<&5R('-H87)E("@F(S@R,C`[15!3)B,X,C(Q.RD@:7,@
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M<R!D:6QU=&EV92X\+V9O;G0^("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!
M4D$S-S<@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P
M<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT('-T>6QE
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M:79E+CPO9F]N=#X@("`@#0H@("`@/"]P/CQB<B\^/'`@:60],T1005)!,S<Y
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,
M24Y%+4A%24=(5#H@,2XR-2<^("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&
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M92!D871E<R!S:&]W;B!B96QO=R`H:6X@=&AO=7-A;F1S*3H\+V9O;G0^("`@
M("`-"B`@("`\+W`^/&)R+SX\=&%B;&4@:60],T140DPS.30@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q,#`E.R!415A4+4E.1$5.5#H@,'!X
M)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P(&)O<F1E<CTS1#`^
M("`@#0H@("`@("`\='(@:60],T140DPS.30N9FEN4F]W+C$^("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)
M1TXZ('1O<"<^("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I
M;E)O=RXQ+FQE860N1#,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)
M0T%,+4%,24=..B!T;W`G/B`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M,SDT+F9I;E)O=RXQ+F%M="Y$,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5D525$E#04PM04Q)1TXZ('1O<#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P
M="<@8V]L<W!A;CTS1#8^("`@("`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$S
M.#$@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P=#L@
M3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9B<^/&(^/"]B/CPO9F]N=#X@("`@(`T*("`@
M("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@:60],T1005)!,S@R('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0[($Q)3D4M2$5)
M1TA4.B`Q+C(U)SX@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68G/CQB/D%S(&]F(%-E<'1E;6)E<B`S,#PO8CX\8CXL/"]B
M/CPO9F]N=#X@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N,2YT<F%I;"Y$
M,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O
M<#L@0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[(%!!1$1)3D<M0D]45$]-
M.B`Q<'@G/B`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@:60]
M,T140DPS.30N9FEN4F]W+C(^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O<"<^("`@#0H@("`@
M("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXR+FQE860N1#(@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`G/B`@
M#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXR+F%M="Y$
M,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O
M<#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P="<@8V]L<W!A;CTS1#(^("`@
M("`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$S.#,@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G
M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9B<^/&(^,C`Q-#PO8CX\+V9O;G0^("`@(`T*("`@("`@("`@(#PO<#X@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I
M;E)O=RXR+G1R86EL+D0R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)4
M24-!3"U!3$E'3CH@=&]P.R!0041$24Y'+4)/5%1/33H@,7!X)SX@("`@#0H@
M("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXR+FQE860N1#,@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`G
M/B`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXR+F%M
M="Y$,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ
M('1O<#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@<V]L:60[(%1%6%0M
M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P="<@8V]L<W!A;CTS1#(^
M("`@("`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$S.#0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N
M,C4G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9B<^/&(^,C`Q,SPO8CX\+V9O;G0^("`@(`T*("`@("`@("`@(#PO<#X@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT
M+F9I;E)O=RXR+G1R86EL+D0S('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!6
M15)424-!3"U!3$E'3CH@=&]P.R!0041$24Y'+4)/5%1/33H@,7!X)SX@("`@
M#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@:60],T140DPS.30N
M9FEN4F]W+C,^("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#,Y-"YF:6Y2;W<N,RYL96%D+D(R/B`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N
M9FEN4F]W+C,N<WEM8BY",CX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O
M=RXS+F%M="Y",CX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C,N=')A
M:6PN0C(^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C,N;&5A9"Y"
M,SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXS+G-Y;6(N0C,^("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N,RYA;70N0C,^("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),,SDT+F9I;E)O=RXS+G1R86EL+D(S/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@
M#0H@("`@("`\='(@:60],T140DPS.30N9FEN4F]W+C0@<W1Y;&4],T0G0D%#
M2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@-S`E.R!615)424-!3"U!3$E'
M3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`@(`T*
M("`@("`@("`@(#QP(&ED/3-$4$%203,X-2!S='EL93TS1"=-05)'24XM0D]4
M5$]-.B`P<'0[($U!4D=)3BU43U`Z(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G
M/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M)SY3=&]C:R!O<'1I;VYS(&]U='-T86YD:6YG/"]F;VYT/B`-"B`@("`@("`@
M("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#,Y-"YF:6Y2;W<N-"YL96%D+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2
M3U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I
M;E)O=RXT+G-Y;6(N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z
M(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2
M.B`C8V-E969F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C0N86UT
M+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q,B4[(%9%4E1)
M0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM
M3$5&5#H@,S@N-W!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*
M("`@("`@("`@(#8L-#4V(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N-"YT<F%I;"XR('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E
M9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN
M4F]W+C0N;&5A9"XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@
M,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z
M("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N-"YS>6UB
M+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXT+F%M="XS('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!724142#H@,3(E.R!615)424-!3"U!3$E'3CH@
M8F]T=&]M.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.+4Q%1E0Z(#,X+C=P
M=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`V
M+#(W,"`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T14
M0DPS.30N9FEN4F]W+C0N=')A:6PN,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM
M3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N;W=R87`]
M,T1N;W=R87`^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@:60],T140DPS.30N
M9FEN4F]W+C4@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F
M)SX@("`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$S.#@@<W1Y;&4],T0G34%2
M1TE.+4)/5%1/33H@,'!T.R!-05)'24XM5$]0.B`P<'0[($Q)3D4M2$5)1TA4
M.B`Q+C(U)SX@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9B<^5V%R<F%N=',@;W5T<W1A;F1I;F<\+V9O;G0^(`T*("`@("`@
M("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),,SDT+F9I;E)O=RXU+FQE860N,B!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+
M1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N
M9FEN4F]W+C4N<WEM8BXR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!72414
M2#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],
M3U(Z("-F9F9F9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N-2YA
M;70N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$R)3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@<FEG:'0[($U!4D=)
M3BU,1494.B`S."XW<'0[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@
M#0H@("`@("`@("`@-"PQ,#@@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXU+G1R86EL+C(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F
M9F9F9B<@;F]W<F%P/3-$;F]W<F%P/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF
M:6Y2;W<N-2YL96%D+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(
M.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/
M4CH@(V9F9F9F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXU+G-Y
M;6(N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F
M)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C4N86UT+C,@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q,B4[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,S@N
M-W!T.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`@
M(#,L.38Y(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#,Y-"YF:6Y2;W<N-2YT<F%I;"XS('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($U!4D=)
M3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G(&YO=W)A
M<#TS1&YO=W)A<#X@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!I9#TS1%1"3#,Y
M-"YF:6Y2;W<N-B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C8V-E969F
M)SX@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E
M9F8G/B`@(`T*("`@("`@("`@(#QP(&ED/3-$4$%203,Y,2!S='EL93TS1"=-
M05)'24XM0D]45$]-.B`P<'0[($U!4D=)3BU43U`Z(#!P=#L@3$E.12U(14E'
M2%0Z(#$N,C4G/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF)SY#;VUM;VX@<W1O8VL@=6YD97)L>6EN9R!C;VYV97)T:6)L
M92!N;W1E<R!O=71S=&%N9&EN9SPO9F]N=#X@("`@#0H@("`@("`@("`@/"]P
M/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS
M.30N9FEN4F]W+C8N;&5A9"XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!7
M24142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M
M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N
M-BYS>6UB+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C
M965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXV+F%M="XR('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,3(E.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.+4Q%1E0Z
M(#,W+CEP=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@
M("`@("`V+#4W."`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPS.30N9FEN4F]W+C8N=')A:6PN,B!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-
M05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N
M;W=R87`],T1N;W=R87`^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXV
M+FQE860N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E
M969F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C8N<WEM8BXS('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,
M24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N-BYA;70N,R!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!S97)I9CL@5TE$5$@Z(#$R)3L@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@5$585"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`S-RXY<'0[($)!
M0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@-BPQ.3@@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT
M+F9I;E)O=RXV+G1R86EL+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)
M1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%1E0Z
M(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<@;F]W<F%P/3-$;F]W
M<F%P/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`\+W1R/B`@(`T*("`@(#PO=&%B;&4^/&)R+SX\<"!I9#TS1%!!
M4D$S.38@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P
M<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68G/CQB/D-O;7!R96AE;G-I=F4@26YC;VUE("A,
M;W-S*3PO8CX\+V9O;G0^(`T*("`@(#PO<#X\8G(O/CQP(&ED/3-$4$%203,Y
M."!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'24XZ(#!P=#L@
M3$E.12U(14E'2%0Z(#$N,C4G/B`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68G/D-O;7!R96AE;G-I=F4@:6YC;VUE("AL;W-S*2!I
M<R!D969I;F5D(&%S('1H92!C:&%N9V4@:6X@97%U:71Y(&1U<FEN9R!A('!E
M<FEO9"!F<F]M('1R86YS86-T:6]N<R!A;F0@;W1H97(@979E;G1S(&%N9"!C
M:7)C=6US=&%N8V5S(&9R;VT@;F]N+6]W;F5R('-O=7)C97,N($]U<B!C;VUP
M<F5H96YS:79E(&YE="!L;W-S(&9O<B!A;&P@<&5R:6]D<R!P<F5S96YT960@
M=V%S(&-O;7!R:7-E9"!S;VQE;'D@;V8@;W5R(&YE="!L;W-S(&%N9"!T:&5R
M92!W97)E(&YO(&]T:&5R(&-H86YG97,@:6X@97%U:71Y(&9R;VT@;F]N+6]W
M;F5R('-O=7)C97,N/"]F;VYT/B`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!
M4D$T,#`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P
M<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF)SX\8CY296-E;G0@06-C;W5N=&EN9R!0<F]N
M;W5N8V5M96YT<SPO8CX\+V9O;G0^(`T*("`@(#PO<#X\8G(O/CQP(&ED/3-$
M4$%2030P,B!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'24XZ
M(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@(`T*("`@("`@/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68G/DEN($%U9W5S="`R,#$T+"!T:&4@1FEN
M86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A<F1S($)O87)D("@F(S@R,C`[1D%3
M0B8C.#(R,3LI(&ES<W5E9"!!8V-O=6YT:6YG(%-T86YD87)D<R!5<&1A=&4@
M*"8C.#(R,#M!4U4F(S@R,C$[*2!.;RX@,C`Q-"TQ-2P@/&D^4')E<V5N=&%T
M:6]N(&]F($9I;F%N8VEA;"!3=&%T96UE;G1S("8C.#(Q,3L@1V]I;F<@0V]N
M8V5R;B`H4W5B=&]P:6,@,C`U+30P*3PO:3X@*"8C.#(R,#M!4U4@,C`Q-"TQ
M-28C.#(R,3LI+B!!4U4@,C`Q-"TQ-2!R97%U:7)E<R!M86YA9V5M96YT('1O
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M86YS+"`H-2D@<F5Q=6ER92!A;B!E>'!R97-S('-T871E;65N="!A;F0@;W1H
M97(@9&ES8VQO<W5R97,@=VAE;B!S=6)S=&%N=&EA;"!D;W5B="!I<R`@#0H@
M("`@("!N;W0@86QL979I871E9"P@86YD("@V*2!R97%U:7)E(&%N(&%S<V5S
M<VUE;G0@9F]R(&$@<&5R:6]D(&]F(&]N92!Y96%R(&%F=&5R('1H92!D871E
M('1H870@=&AE(&9I;F%N8VEA;"!S871E;65N=',@87)E(&ES<W5E9"`H;W(@
M879A:6QA8FQE('1O(&)E(&ES<W5E9"DN(%1H92!A;65N9&UE;G1S(&EN($%3
M52`R,#$T+3$U(&%R92!E9F9E8W1I=F4@9F]R('1H92!A;FYU86P@<&5R:6]D
M(&5N9&EN9R!A9G1E<B!$96-E;6)E<B`Q-2P@,C`Q-BP@86YD(&9O<B!A;FYU
M86P@<&5R:6]D<R!A;F0@:6YT97)I;2!P97)I;V1S('1H97)E869T97(N($5A
M<FQY(&%D;W!T:6]N(&ES('!E<FUI='1E9"X@5V4@<&QA;B!T;R!A9&]P="!T
M:&4@<')O=FES:6]N<R!O;B!!4U4@,C`Q-"TQ-2!I;B`R,#$V+B!792!D;R!N
M;W0@97AP96-T('1H92!A9&]P=&EO;B!O9B!T:&ES($%352!T;R!H879E(&$@
M;6%T97)I86P@:6UP86-T(&]N(&]U<B!R97-U;'1S(&]F(&]P97)A=&EO;G,@
M;W(@9FEN86YC:6%L(&-O;F1I=&EO;BX\+V9O;G0^("`@#0H@("`@/"]P/CQB
M<B\^/'`@:60],T1005)!-#`T('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I
M9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`@#0H@("`@
M("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^26X@2G5N92`R,#$T
M+"!&05-"(&ES<W5E9"!!4U4@3F\N(#(P,30M,3(L(#QI/D-O;7!E;G-A=&EO
M;B`F(S@R,3$[(%-T;V-K($-O;7!E;G-A=&EO;B`H5&]P:6,@-S$X*3PO:3X@
M*"8C.#(R,#M!4U4@,C`Q-"TQ,B8C.#(R,3LI+B!!4U4@,C`Q-"TQ,B!R97%U
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M86UE;F1M96YT<R!I;B!!4U4@,C`Q-"TQ,B!M87D@96ET:&5R(&)E(&%P<&QI
M960@*&$I('!R;W-P96-T:79E;'D@=&\@86QL(&%W87)D<R!G<F%N=&5D(&]R
M(&UO9&EF:65D(&%F=&5R('1H92!E9F9E8W1I=F4@9&%T92!O<B`H8BD@<F5T
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M92!P<F]V:7-I;VYS(&]F($%352`R,#$T+3$R(&EN('1H92!F:7)S="!Q=6%R
M=&5R(&]F(#(P,38N(%=E(&1O(&YO="!E>'!E8W0@=&AE(&%D;W!T:6]N(&]F
M('1H:7,@("`-"B`@("`@($%352!T;R!H879E(&$@;6%T97)I86P@:6UP86-T
M(&]N(&]U<B!R97-U;'1S(&]F(&]P97)A=&EO;G,@;W(@9FEN86YC:6%L(&-O
M;F1I=&EO;BX\+V9O;G0^("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$T
M,#8@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[
M($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF)SY);B!*=6QY(#(P,3,L('1H92!&05-"(&ES<W5E
M9"!!4U4@3F\N)B,Q-C`[,C`Q,RTQ,2P@/&D^4')E<V5N=&%T:6]N(&]F(&%N
M(%5N<F5C;V=N:7IE9"!487@@0F5N969I="!7:&5N(&$@3F5T($]P97)A=&EN
M9R!,;W-S($-A<G)Y9F]R=V%R9"P@82!3:6UI;&%R(%1A>"!,;W-S+"!O<B!A
M(%1A>"!#<F5D:70@0V%R<GEF;W)W87)D($5X:7-T<SPO:3X@*"8C.#(R,#M!
M4U4@,C`Q,RTQ,28C.#(R,3LI+B!4:&ES('5P9&%T92!P<F]V:61E<R!E>'!L
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M,C`Q,RP@=VET:"!A;B!O<'1I;VX@9F]R(&5A<FQY(&%D;W!T:6]N+B!792!A
M9&]P=&5D('1H:7,@9W5I9&%N8V4@:6X@,C`Q-"!A;F0@:70@9&ED(&YO="!H
M879E(&$@;6%T97)I86P@:6UP86-T(&]N(&]U<B!F:6YA;F-I86P@8V]N9&ET
M:6]N+"!R97-U;'1S(&]F(&]P97)A=&EO;G,@;W(@<F5L871E9"!F:6YA;F-I
M86P@<W1A=&5M96YT(&1I<V-L;W-U<F5S+CPO9F]N=#X@#0H@("`@/"]P/CQB
M<B\^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q
M93<S-#`V95\S93<R7S1E-&5?.&4V-5\X9&,V9&%A93DW-V8-"D-O;G1E;G0M
M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,64W,S0P-F5?,V4W,E\T931E7SAE-C5?
M.&1C-F1A864Y-S=F+U=O<FMS:&5E=',O4VAE970P."YH=&UL#0I#;VYT96YT
M+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT
M+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL
M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@-"`M($-O;G9E<G1I
M8FQE($YO=&5S('1O(%)E;&%T960@4&%R=&EE<SQB<CX\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D1E8G0@1&ES8VQO<W5R
M92!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y$96)T($1I<V-L;W-U<F4@6U1E>'0@0FQO8VM=/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@:60],T1005)!-#`X('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3CH@,'!T.R!,24Y%+4A%
M24=(5#H@,2XR-2<^("`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF)SX\8CXT+B!#;VYV97)T:6)L92!.;W1E<R!T;R!296QA=&5D
M(%!A<G1I97,\+V(^/"]F;VYT/B`@(`T*("`@(#PO<#X\8G(O/CQP(&ED/3-$
M4$%2030Q,"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'24XZ
M(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@(`T*("`@("`@/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68G/DEN($%P<FEL(#(P,3$L('=E(&5N=&5R
M960@:6YT;R!A(%-E8W5R:71I97,@4'5R8VAA<V4@06=R965M96YT(&9O<B!A
M('!R:79A=&4@<&QA8V5M96YT(&]F('5P('1O("0T+C4F(S$V,#MM:6QL:6]N
M(&EN(%-E;FEO<B!396-U<F5D($-O;G9E<G1I8FQE($YO=&5S("@F(S@R,C`[
M3F]T97,F(S@R,C$[*2X@5V4@<F5C96EV960@82!T;W1A;"!O9B`D-"XS(&UI
M;&QI;VXL(&YE="!O9B!I<W-U86YC92!C;W-T<RP@9G)O;2!T:&4@:7-S=6%N
M8V4@;V8@=&AE<V4@3F]T97,N/"]F;VYT/B`@(`T*("`@(#PO<#X\8G(O/CQP
M(&ED/3-$4$%2030Q,B!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-
M05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@(`T*("`@("`@/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/E1H92!.;W1E<R!A<F4@<V5C
M=7)E9"!B>2!S=6)S=&%N=&EA;&QY(&%L;"!O9B!O=7(@87-S971S+"!I;F-L
M=61I;F<@<&QA8VEN9R!O=7(@8F%N:R!A8V-O=6YT<R!U;F1E<B!A(&-O;G1R
M;VP@86=R965M96YT+B!4:&4@3F]T97,@8F5A<B!I;G1E<F5S="!A="`V)2!P
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M=&EM92P@870@96%C:"!H;VQD97(F(S@R,3<[<R!O<'1I;VXN/"]F;VYT/B`@
M#0H@("`@/"]P/CQB<B\^/'`@:60],T1005)!-#$T('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR
M-2<^("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^
M5&AE($YO=&5S(&%R92!C;VYV97)T:6)L92!I;G1O('-H87)E<R!O9B!O=7(@
M8V]M;6]N('-T;V-K(&%T(&$@<F%T92!O9B`Q+#(U,"!S:&%R97,@9F]R(&5V
M97)Y("0Q+#`P,"!O9B!P<FEN8VEP86P@86YD(&%C8W)U960@:6YT97)E<W0@
M9'5E('5N9&5R('1H92!.;W1E<RX@5&AE<F4@:7,@;F\@<FEG:'0@=&\@8V]N
M=F5R="!T:&4@3F]T97,@=&\@=&AE(&5X=&5N="!T:&%T+"!A9G1E<B!G:79I
M;F<@969F96-T('1O('-U8V@@8V]N=F5R<VEO;BP@=&AE(&AO;&1E<B!W;W5L
M9"!B96YE9FEC:6%L;'D@;W=N(&EN(&5X8V5S<R!O9B`Y+CDY)2!O9B!O=7(@
M;W5T<W1A;F1I;F<@8V]M;6]N('-T;V-K+B!%86-H(&AO;&1E<B!O9B!T:&4@
M3F]T97,@8V%N(&EN8W)E87-E(&]R(&1E8W)E87-E('1H:7,@8F5N969I8VEA
M;"!O=VYE<G-H:7`@8V]N=F5R<VEO;B!L:6UI="!B>2!W<FET=&5N(&YO=&EC
M92!T;R!U<RP@=VAI8V@@=VEL;"!N;W0@8F4@969F96-T:79E('5N=&EL(#8Q
M(&1A>7,@869T97(@9&5L:79E<GD@;V8@=&AE(&YO=&EC92X\+V9O;G0^("`@
M("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$T,38@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q
M+C(U)SX@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M)SY!<R!O9B!397!T96UB97(@,S`L(#(P,30L('=E('=E<F4@:6X@8V]M<&QI
M86YC92!W:71H(&%L;"!C;W9E;F%N=',@=6YD97(@=&AE($YO=&5S+B!5<&]N
M('1H92!O8V-U<G)E;F-E(&]F(&%N(&5V96YT(&]F(&1E9F%U;'0@=6YD97(@
M=&AE($YO=&5S+"!T:&4@:&]L9&5R<R!O9B!T:&4@3F]T97,@:&%V92!T:&4@
M<FEG:'0@=&\@<F5Q=6ER92!U<R!T;R!R961E96T@86QL(&]R(&$@<&]R=&EO
M;B!O9B!T:&5I<B!.;W1E<RX\+V9O;G0^("`@("`-"B`@("`\+W`^/&)R+SX\
M<"!I9#TS1%!!4D$T,3@@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@
M34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF
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M;"!T:&5Y('!R;W9I9&4@;F]T:6-E(&]T:&5R=VES92X\+V9O;G0^(`T*("`@
M(#PO<#X\8G(O/CQP(&ED/3-$4$%2030R,"!S='EL93TS1"=415A4+4%,24=.
M.B!J=7-T:69Y.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@
M(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/E1H92!.
M;W1E<R!C;VYT86EN(&%N(&5M8F5D9&5D(&-O;G9E<G-I;VX@9F5A='5R92!T
M:&%T('=A<R!I;BUT:&4M;6]N97D@;VX@=&AE(&ES<W5A;F-E(&1A=&5S+B!"
M87-E9"!O;B!A;B!E9F9E8W1I=F4@9FEX960@8V]N=F5R<VEO;B!R871E(&]F
M(#$L,C4P('-H87)E<R!F;W(@979E<GD@)#$L,#`P(&]F('!R:6YC:7!A;"!A
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M=6YT(&]V97(@=&AE(')E<W!E8W1I=F4@,3`M>65A<B!T97)M(&]F('1H92!.
M;W1E<RX@1'5R:6YG('1H92!P97)I;V0@96YD960@4V5P=&5M8F5R(#,P+"`R
M,#$T+"!A8V-R=65D(&EN=&5R97-T(&]F(&%P<')O>&EM871E;'D@)#<X+#`P
M,"!W87,@<&%I9"UI;BUK:6YD(&%N9"!R;VQL960@:6YT;R!T:&4@3F]T92!P
M<FEN8VEP86P@8F%L86YC92P@=VAI8V@@<F5S=6QT960@:6X@86X@861D:71I
M;VYA;"!D96)T(&1I<V-O=6YT(&]F(&%P<')O>&EM871E;'D@)#<X+#`P,"X@
M1F]R('1H92!T:')E92!M;VYT:',@96YD960@4V5P=&5M8F5R(#,P+"`R,#$T
M(&%N9"`R,#$S+"!I;G1E<F5S="!E>'!E;G-E(')E;&%T:6YG('1O('1H92!S
M=&%T960@<F%T92!W87,@87!P<F]X:6UA=&5L>2`D-SDL,#`P(&%N9"`D-S0L
M,#`P+"!R97-P96-T:79E;'DL(&%N9"!I;G1E<F5S="!E>'!E;G-E(')E;&%T
M:6YG('1O('1H92`@#0H@("`@("!A;6]R=&EZ871I;VX@;V8@=&AE(&1E8G0@
M9&ES8V]U;G0@=V%S(&%P<')O>&EM871E;'D@)#$T-2PP,#`@86YD("0Q,S4L
M,#`P+"!R97-P96-T:79E;'DN($9O<B!T:&4@;FEN92!M;VYT:',@96YD960@
M4V5P=&5M8F5R(#,P+"`R,#$T(&%N9"`R,#$S+"!I;G1E<F5S="!E>'!E;G-E
M(')E;&%T:6YG('1O('1H92!S=&%T960@<F%T92!W87,@87!P<F]X:6UA=&5L
M>2`D,C,S+#`P,"!A;F0@)#(Q."PP,#`L(')E<W!E8W1I=F5L>2P@86YD(&EN
M=&5R97-T(&5X<&5N<V4@<F5L871I;F<@=&\@=&AE(&%M;W)T:7IA=&EO;B!O
M9B!T:&4@9&5B="!D:7-C;W5N="!W87,@87!P<F]X:6UA=&5L>2`D-#(U+#`P
M,"!A;F0@)#,Y-BPP,#`L(')E<W!E8W1I=F5L>2X\+V9O;G0^("`@(`T*("`@
M(#PO<#X\8G(O/CQP(&ED/3-$4$%2030R-"!S='EL93TS1"=415A4+4%,24=.
M.B!J=7-T:69Y.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@
M(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/D%S(&]F
M(%-E<'1E;6)E<B`S,"P@,C`Q-"P@=&AE(&-A<G)Y:6YG('9A;'5E(&]F('1H
M92!.;W1E<R!W87,@87!P<F]X:6UA=&5L>2`D,2PT-3`L,#`P+"!W:&EC:"!I
M<R!C;VUP<FES960@;V8@=&AE("0U+#(V,BPP,#`@<')I;F-I<&%L(&%M;W5N
M="!O9B!T:&4@3F]T97,@;W5T<W1A;F1I;F<L(&QE<W,@9&5B="!D:7-C;W5N
M="!O9B`D,RPX,3(L,#`P+B!)9B!T:&4@)#4L,C8R+#`P,"!P<FEN8VEP86P@
M86UO=6YT(&]F($YO=&5S(&ES(&-O;G9E<G1E9"P@=V4@=V]U;&0@:7-S=64@
M87!P<F]X:6UA=&5L>2`V+#4W."PP,#`@<VAA<F5S(&]F(&]U<B!C;VUM;VX@
M<W1O8VLN/"]F;VYT/B`-"B`@("`\+W`^/&)R+SX\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H
M=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S%E-S,T,#9E7S-E-S)?-&4T95\X
M938U7SAD8S9D86%E.3<W9@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#
M.B\Q93<S-#`V95\S93<R7S1E-&5?.&4V-5\X9&,V9&%A93DW-V8O5V]R:W-H
M965T<R]3:&5E=#`Y+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z
M('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C
M:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-
M151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT
M+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V
M87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#
M;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B
M;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R
M/CQS=')O;F<^3F]T92`U("T@4W1O8VMH;VQD97)S)R!%<75I='D\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q-#QB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C
M:VAO;&1E<G,G($5Q=6ET>2!.;W1E(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K:&]L9&5R<R<@
M17%U:71Y($YO=&4@1&ES8VQO<W5R92!;5&5X="!";&]C:UT\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!I9#TS1%!!4D$T,C8@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4
M.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF)SX\8CXU+B!3=&]C:VAO;&1E<G,F(S@R,3<[($5Q=6ET>3PO8CX\+V9O
M;G0^("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$T,C@@<W1Y;&4],T0G
M5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4
M.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF)SX\:3X\8CY!;65N9&UE;G1S('1O($%R=&EC;&5S(&]F($EN8V]R<&]R
M871I;VX\+V(^/"]I/B`\8CXF(S@R,3$[/"]B/B`\:3X\8CY2979E<G-E(%-T
M;V-K(%-P;&ET/"]B/CPO:3X\+V9O;G0^(`T*("`@(#PO<#X\8G(O/CQP(&ED
M/3-$4$%2030S,"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'
M24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@(`T*("`@("`@/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/D5F9F5C=&EV92!*86YU87)Y(#$S
M+"`R,#$T+"!W92!A;65N9&5D(&]U<B!#97)T:69I8V%T92!O9B!);F-O<G!O
M<F%T:6]N('1O(&-H86YG92!O=7(@;F%M92!T;R!(97)O;B!4:&5R87!E=71I
M8W,L($EN8RX@86YD('1O(&5F9F5C="!A(#$@+2!F;W(@+2`R,"!R979E<G-E
M('-P;&ET(&]F(&]U<B!O=71S=&%N9&EN9R!C;VUM;VX@<W1O8VLN(%1H92!N
M86UE(&-H86YG92!A;F0@4F5V97)S92!3=&]C:R!3<&QI="!W97)E(&%P<')O
M=F5D(&)Y(&]U<B!S=&]C:VAO;&1E<G,@;VX@4V5P=&5M8F5R)B,Q-C`[,3DL
M)B,Q-C`[,C`Q,RX@07,@82!R97-U;'0@;V8@=&AE(%)E=F5R<V4@4W1O8VL@
M4W!L:70L('1H92!T;W1A;"!A=71H;W)I>F5D('-H87)E<R!O9B!C;VUM;VX@
M<W1O8VL@=V5R92!R961U8V5D(&9R;VT@,2PU,#`L,#`P+#`P,"!T;R`W-2PP
M,#`L,#`P('-H87)E<RX\+V9O;G0^("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS
M1%!!4D$T,S(@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE.
M.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF)SX\:3X\8CXR,#$Q(%!R:79A=&4@4&QA
M8V5M96YT/"]B/CPO:3X\+V9O;G0^("`@("`-"B`@("`\+W`^/&)R+SX\<"!I
M9#TS1%!!4D$T,S0@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%2
M1TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SY);B!*=6YE(#(P,3$L('=E('-O
M;&0@."XP(&UI;&QI;VX@<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VL@9F]R
M(&YE="!P<F]C965D<R!O9B`D,C(N."!M:6QL:6]N("AN970@;V8@87!P<F]X
M:6UA=&5L>2`D,2XR(&UI;&QI;VX@:6X@:7-S=6%N8V4@8V]S=',I+B!&;W(@
M96%C:"!S:&%R92!P=7)C:&%S960L('1H92!I;G9E<W1O<G,@<F5C96EV960@
M;VYE('=A<G)A;G0@=&\@<'5R8VAA<V4@,"XU('-H87)E<R!O9B!C;VUM;VX@
M<W1O8VL@870@86X@97AE<F-I<V4@<')I8V4@;V8@)#,N-C`@<&5R('-H87)E
M+B!4:&4@=V%R<F%N=',@=V5R92!I;6UE9&EA=&5L>2!E>&5R8VES86)L92!A
M;F0@97AP:7)E(&]N($IU;'DF(S$V,#LQ+"8C,38P.S(P,38N(%1H92!W87)R
M86YT<R!M87D@8F4@97AE<F-I<V5D(&9O<B!C87-H(&]N;'DL(&]R+"!I9B!A
M(')E9VES=')A=&EO;B!S=&%T96UE;G0@:7,@;F]T('1H96X@969F96-T:79E
M(&%N9"!A=F%I;&%B;&4@9F]R('1H92!R97-A;&4@;V8@=&AE('-H87)E<R!O
M9B!C;VUM;VX@<W1O8VL@:7-S=6%B;&4@=7!O;B!E>&5R8VES92!O9B!T:&4@
M=V%R<F%N=',L(&)Y('-U<G)E;F1E<B!O9B!S=6-H('=A<G)A;G0L(&]R(&$@
M<&]R=&EO;B!O9B!S=6-H('=A<G)A;G0L(&)Y('=A>2!O9B!C87-H;&5S<R!E
M>&5R8VES92X@5&AE<F4@:7,@;F\@<FEG:'0@=&\@97AE<F-I<V4@=&AE('=A
M<G)A;G1S('1O('1H92!E>'1E;G0@=&AA="P@869T97(@9VEV:6YG(&5F9F5C
M="!T;R!S=6-H(&5X97)C:7-E('1H92!H;VQD97(@=V]U;&0@8F5N969I8VEA
M;&QY(&]W;B!I;B!E>&-E<W,@;V8@.2XY.24@;V8@;W5R(&]U='-T86YD:6YG
M('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@;W(@<W5C:"!O=&AE<B!L:6UI="!A
M<R!M87D@8F4@9&5S:6=N871E9"!B>2!A;GD@<&%R=&EC=6QA<B`-"B`@("`@
M('!U<F-H87-E<BX@16%C:"!H;VQD97(@;V8@=&AE('=A<G)A;G1S(&-A;B!A
M;65N9"!O<B!W86EV92!T:&4@9F]R96=O:6YG(&QI;6ET871I;VX@8GD@=W)I
M='1E;B!N;W1I8V4@=&\@=7,L('=I=&@@<W5C:"!W86EV97(@=&%K:6YG(&5F
M9F5C="!O;FQY('5P;VX@=&AE(&5X<&ER871I;VX@;V8@82`V,2UD87D@;F]T
M:6-E('!E<FEO9"X\+V9O;G0^("`@("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS
M1%!!4D$T,S8@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE.
M.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF)SY/;B!*=6QY(#(Y+"`R,#$Q+"!W92!F
M:6QE9"!A(')E9VES=')A=&EO;B!S=&%T96UE;G0@=VET:"!T:&4@4T5#('1O
M(')E9VES=&5R(&9O<B!R97-A;&4@=&AE('-H87)E<R!A;F0@=&AE('-H87)E
M<R!O9B!C;VUM;VX@<W1O8VL@:7-S=6%B;&4@=7!O;B!T:&4@97AE<F-I<V4@
M;V8@=&AE('=A<G)A;G1S+B!4:&4@<F5G:7-T<F%T:6]N('-T871E;65N="!W
M87,@9&5C;&%R960@969F96-T:79E(&]N($%U9W5S="`T+"`R,#$Q+B!792!A
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M:&4@4V5C=7)I=&EE<R!!8W0@;V8@,3DS,RP@87,@86UE;F1E9"`H)B,X,C(P
M.U)U;&4@,30T)B,X,C(Q.RDN(%1H97)E(&ES(&-U<G)E;G1L>2!O;FQY(&]N
M92!I;G9E<W1O<B!W:&\@:7,@86X@869F:6QI871E(&]F(&]U<G,@86YD(&ES
M('1H97)E9F]R92!N;W0@86)L92!T;R!S96QL('=I=&AO=70@;&EM:71A=&EO
M;B!U;F1E<B!2=6QE(#$T-"P@86YD('1H870@:6YV97-T;W(@:&%S(&%G<F5E
M9"!T;R!W86EV92!I=',@<FEG:'0@=&\@<F5Q=6ER92!U<R!T;R!M86EN=&%I
M;B!T:&4@969F96-T:79E;F5S<R!O9B!T:&4@<F5G:7-T<F%T:6]N('-T871E
M;65N="!U;G1I;"!I="!P<F]V:61E<R!N;W1I8V4@;W1H97)W:7-E+CPO9F]N
M=#X@("`@(`T*("`@(#PO<#X\8G(O/CQP(&ED/3-$4$%2030S."!S='EL93TS
M1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'24XZ(#!P=#L@3$E.12U(14E'
M2%0Z(#$N,C4G/B`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68G/D1U<FEN9R!T:&4@;FEN92!M;VYT:',@96YD960@4V5P=&5M8F5R
M(#,P+"`R,#$T+"!W87)R86YT(&AO;&1E<G,@97AE<F-I<V5D(#0V,"PW,#8@
M=V%R<F%N=',@=6YD97(@=&AE(&-A<VAL97-S(&5X97)C:7-E('!R;W9I<VEO
M;B!I;B!T:&4@=V%R<F%N="!A9W)E96UE;G0L('=H:6-H(')E<W5L=&5D(&EN
M('1H92!N970@:7-S=6%N8V4@;V8@,S`S+#8Q-"8C,38P.W-H87)E<R!O9B!C
M;VUM;VX@<W1O8VL@86YD(&YO(&YE="!C87-H('!R;V-E961S('1O('5S+B!$
M=7)I;F<@=&AE(&YI;F4@;6]N=&AS(&5N9&5D(%-E<'1E;6)E<B`S,"P@,C`Q
M,RP@=V4@<F5C96EV960@)#`N-B!M:6QL:6]N(&9O<B!C87-H(&5X97)C:7-E
M<R!O9B!T:&5S92!W87)R86YT<RX\+V9O;G0^(#QF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF)SX\+V9O;G0^(`T*("`@(#PO<#X\8G(O/CQP(&ED/3-$
M4$%2030T,"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'24XZ
M(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@(`T*("`@("`@/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQI/CQB/C(P,3(@4')I=F%T92!0;&%C
M96UE;G0\+V(^/"]I/CPO9F]N=#X@("`@(`T*("`@(#PO<#X\8G(O/CQP(&ED
M/3-$4$%2030T,B!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'
M24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@(`T*("`@("`@/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/DEN($IU;'D@,C`Q,BP@=V4@<V]L
M9"!A<'!R;WAI;6%T96QY(#4N,2!M:6QL:6]N('-H87)E<R!O9B!O=7(@8V]M
M;6]N('-T;V-K(&%T(&$@<'5R8VAA<V4@<')I8V4@;V8@)#$P+C4P('!E<B!S
M:&%R92P@<F5S=6QT:6YG(&EN(&YE="!P<F]C965D<R!O9B!A<'!R;WAI;6%T
M96QY("0U,"XU(&UI;&QI;VX@*&YE="!O9B!A<'!R;WAI;6%T96QY("0S+C$@
M;6EL;&EO;B!I;B!I<W-U86YC92!C;W-T<RDN($]N($%U9W5S="`R-"P@,C`Q
M,BP@=V4@9FEL960@82!R96=I<W1R871I;VX@<W1A=&5M96YT('=I=&@@=&AE
M(%-%0R!T;R!R96=I<W1E<B!T:&5S92!S:&%R97,@9F]R(')E<V%L92X@5&AE
M(')E9VES=')A=&EO;B!S=&%T96UE;G0@=V%S(&1E8VQA<F5D(&5F9F5C=&EV
M92!O;B!397!T96UB97(@-BP@,C`Q,BX\+V9O;G0^("`@#0H@("`@/"]P/CQB
M<B\^/'`@:60],T1005)!-#0T('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I
M9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`@#0H@("`@
M("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^/&D^/&(^,C`Q,R!#
M;VUM;VX@4W1O8VL@3V9F97)I;F<\+V(^/"]I/CPO9F]N=#X@("`@#0H@("`@
M/"]P/CQB<B\^/'`@:60],T1005)!-#0V('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`@
M#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^26X@3F]V
M96UB97(@,C`Q,RP@=V4@<V]L9"!A<'!R;WAI;6%T96QY(#@N-B!M:6QL:6]N
M('-H87)E<R!O9B!O=7(@8V]M;6]N('-T;V-K(&%T(&$@<'5B;&EC(&]F9F5R
M:6YG('!R:6-E(&]F("0X+C`P('!E<B!S:&%R92X@5V4@<F5C96EV960@=&]T
M86P@;F5T('!R;V-E961S(&]F(&%P<')O>&EM871E;'D@)#4W+C@@;6EL;&EO
M;B`H;F5T(&]F(&%P<')O>&EM871E;'D@)#,N.28C,38P.VUI;&QI;VX@:6X@
M:7-S=6%N8V4@8V]S=',I+B!4:&4@;V9F97)I;F<@=V%S(&UA9&4@<'5R<W5A
M;G0@=&\@86X@969F96-T:79E(')E9VES=')A=&EO;B!S=&%T96UE;G0L('=H
M:6-H('=A<R!P<F5V:6]U<VQY(&9I;&5D('=I=&@@=&AE(%-%0R!A;F0@=V%S
M(&1E8VQA<F5D(&5F9F5C=&EV92X\+V9O;G0^("`@("`-"B`@("`\+W`^/&)R
M+SX\<"!I9#TS1%!!4D$T-#@@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF
M>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@
M(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SX\:3X\8CXR,#$T/"]B
M/CPO:3X\:3X\8CY#;VUM;VX@4W1O8VL@3V9F97)I;F<\+V(^/"]I/CPO9F]N
M=#X@#0H@("`@/"]P/CQB<B\^/'`@:60],T1005)!-#4P('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@
M,2XR-2<^("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9B<^26X@2G5N92`R,#$T+"!W92!S;VQD(&%P<')O>&EM871E;'D@-"XX(&UI
M;&QI;VX@<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VL@870@82!P=6)L:6,@
M;V9F97)I;F<@<')I8V4@;V8@)#$Q+C<U('!E<B!S:&%R92X@26X@861D:71I
M;VXL(&%S(&$@8V]M<&]N96YT(&]F('1H92!O9F9E<FEN9RP@=V4@<V]L9"`V
M,#`L,#`P('!R92UF=6YD960@=V%R<F%N=',@=&\@<'5R8VAA<V4@<VAA<F5S
M(&]F(&]U<B!C;VUM;VX@<W1O8VL@870@82!P=6)L:6,@;V9F97)I;F<@<')I
M8V4@;V8@)#$Q+C<T('!E<B!S:&%R92X@5&AE('!R92UF=6YD960@=V%R<F%N
M=',@:&%V92!A;B!E>&5R8VES92!P<FEC92!O9B`D,"XP,2!P97(@<VAA<F4@
M86YD(&%R92!E>&5R8VES86)L92!F;W(@<V5V96X@>65A<G,@9G)O;2!T:&4@
M9&%T92!O9B!I<W-U86YC92X@5V4@<F5C96EV960@=&]T86P@;F5T('!R;V-E
M961S(&]F(&%P<')O>&EM871E;'D@)#4X+CD@;6EL;&EO;B`H;F5T(&]F(&%P
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M(&1E8VQA<F5D(&5F9F5C=&EV92X\+V9O;G0^("`-"B`@("`\+W`^/&)R+SX\
M<"!I9#TS1%!!4D$T-3(@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@
M34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SX\:3X\8CY3=&]C:R!/<'1I
M;VX@17AE<F-I<V5S/"]B/CPO:3X\+V9O;G0^("`@("`-"B`@("`\+W`^/&)R
M+SX\<"!I9#TS1%!!4D$T-30@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF
M>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@
M(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SY&;W(@=&AE(&YI;F4@
M;6]N=&AS(&5N9&5D(%-E<'1E;6)E<B`S,"P@,C`Q-"P@87!P<F]X:6UA=&5L
M>2`U-3`L,#`P('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@=V5R92!I<W-U960@
M<'5R<W5A;G0@=&\@=&AE(&5X97)C:7-E(&]F('-T;V-K(&]P=&EO;G,L(')E
M<W5L=&EN9R!I;B!P<F]C965D<R!T;R!U<R!O9B!A<'!R;WAI;6%T96QY("0R
M+C@F(S$V,#MM:6QL:6]N+CPO9F]N=#X@("`-"B`@("`\+W`^/&)R+SX\<"!I
M9#TS1%!!4D$T-38@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE.
M.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`@(`T*("`@("`@/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/E-T;V-K+4)A<V5D($-O;7!E
M;G-A=&EO;CPO8CX\+V9O;G0^("`@#0H@("`@/"]P/CQB<B\^/'`@:60],T10
M05)!-#4X('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@
M,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`@#0H@("`@("`\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9B<^5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM
M87)I>F5S('-T;V-K+6)A<V5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E(&9O<B!T
M:&4@=&AR964@86YD(&YI;F4@;6]N=&AS(&5N9&5D(%-E<'1E;6)E<B`S,"P@
M,C`Q-"!A;F0@,C`Q,R!R96QA=&5D('1O('-T;V-K(&]P=&EO;G,@86YD($5M
M<&QO>65E(%-T;V-K(%!U<F-H87-E(%!L86X@*"8C.#(R,#M%4U!0)B,X,C(Q
M.RD@<'5R8VAA<V4@<FEG:'1S(&)Y(&5X<&5N<V4@8V%T96=O<GD@*&EN('1H
M;W5S86YD<RDZ/"]F;VYT/B`-"B`@("`\+W`^/&)R+SX\=&%B;&4@:60],T14
M0DPT.3`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q,#`E.R!4
M15A4+4E.1$5.5#H@,'!X)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P(&)O<F1E<CTS1#`^("`@#0H@("`@("`\='(@:60],T140DPT.3`N9FEN
M4F]W+C$^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9CL@5D525$E#04PM04Q)1TXZ('1O<"<^("`@#0H@("`@("`@("`@/&(^)B,Q
M-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),-#DP+F9I;E)O=RXQ+FQE860N1#,@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`G/B`@#0H@("`@("`@("`@
M/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXQ+F%M="Y$,R!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O<#L@0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@
M34%21TE.+4Q%1E0Z(#!P="<@8V]L<W!A;CTS1#8^("`@("`-"B`@("`@("`@
M("`\<"!I9#TS1%!!4D$T-C`@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R
M.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^/&(^/"]B/CPO
M9F]N=#X@("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@:60]
M,T1005)!-#8Q('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.
M.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/E1H<F5E($UO;G1H<R!%
M;F1E9#PO8CX\+V9O;G0^("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@
M("`\<"!I9#TS1%!!4D$T-C(@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R
M.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^/&(^4V5P=&5M
M8F5R(#,P/"]B/CQB/BP\+V(^/"]F;VYT/B`@#0H@("`@("`@("`@/"]P/B`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N
M9FEN4F]W+C$N=')A:6PN1#,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%
M4E1)0T%,+4%,24=..B!T;W`[($)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE
M.R!0041$24Y'+4)/5%1/33H@,7!X)SX@(`T*("`@("`@("`@(#QB/B8C,38P
M.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#0Y,"YF:6Y2;W<N,2YL96%D+D0U('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!615)424-!3"U!3$E'3CH@=&]P)SX@(`T*("`@("`@("`@(#QB
M/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,2YA;70N1#4@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`[($)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($U!
M4D=)3BU,1494.B`P<'0G(&-O;'-P86X],T0V/B`@("`@#0H@("`@("`@("`@
M/'`@:60],T1005)!-#8S('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@
M34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/CPO8CX\+V9O
M;G0^("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP(&ED/3-$
M4$%2030V-"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@
M,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SX\8CY.:6YE/"]B/B`\8CY-;VYT
M:',@16YD960\+V(^/"]F;VYT/B`-"B`@("`@("`@("`\+W`^(`T*("`@("`@
M("`@(#QP(&ED/3-$4$%2030V-2!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97([($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SX\8CY397!T
M96UB97(@,S`\+V(^/&(^+#PO8CX\+V9O;G0^("`-"B`@("`@("`@("`\+W`^
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y
M,"YF:6Y2;W<N,2YT<F%I;"Y$-2!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5D525$E#04PM04Q)1TXZ('1O<#L@0D]21$52+4)/5%1/33H@;65D:75M(&YO
M;F4[(%!!1$1)3D<M0D]45$]-.B`Q<'@G/B`@#0H@("`@("`@("`@/&(^)B,Q
M-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(@:60],T140DPT.3`N9FEN4F]W+C(^("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)
M1TXZ('1O<"<^("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I
M;E)O=RXR+FQE860N1#(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)
M0T%,+4%,24=..B!T;W`G/B`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M-#DP+F9I;E)O=RXR+F%M="Y$,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5D525$E#04PM04Q)1TXZ('1O<#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P
M="<@8V]L<W!A;CTS1#(^("`@("`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$T
M-C8@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P=#L@
M3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9B<^/&(^,C`Q-#PO8CX\+V9O;G0^("`@(`T*
M("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXR+G1R86EL+D0R('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@=&]P.R!0041$24Y'+4)/
M5%1/33H@,7!X)SX@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP
M+F9I;E)O=RXR+FQE860N1#,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%
M4E1)0T%,+4%,24=..B!T;W`G/B`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B
M/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$
M5$),-#DP+F9I;E)O=RXR+F%M="Y$,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9CL@5D525$E#04PM04Q)1TXZ('1O<#L@0D]21$52+4)/5%1/33H@(S`P,#`P
M,"`Q<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z
M(#!P="<@8V]L<W!A;CTS1#(^("`@("`-"B`@("`@("`@("`\<"!I9#TS1%!!
M4D$T-C<@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P
M=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9B<^/&(^,C`Q,SPO8CX\+V9O;G0^("`@
M(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXR+G1R86EL+D0S('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@=&]P.R!0041$24Y'
M+4)/5%1/33H@,7!X)SX@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M-#DP+F9I;E)O=RXR+FQE860N1#0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%9%4E1)0T%,+4%,24=..B!T;W`G/B`@#0H@("`@("`@("`@/&(^)B,Q-C`[
M/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-#DP+F9I;E)O=RXR+F%M="Y$-"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5D525$E#04PM04Q)1TXZ('1O<#L@0D]21$52+4)/5%1/33H@(S`P
M,#`P,"`Q<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%
M1E0Z(#!P="<@8V]L<W!A;CTS1#(^("`@("`-"B`@("`@("`@("`\<"!I9#TS
M1%!!4D$T-C@@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ
M(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^/&(^,C`Q-#PO8CX\+V9O;G0^
M("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXR+G1R86EL+D0T('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@=&]P.R!0041$
M24Y'+4)/5%1/33H@,7!X)SX@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B
M/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$
M5$),-#DP+F9I;E)O=RXR+FQE860N1#4@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%9%4E1)0T%,+4%,24=..B!T;W`G/B`@#0H@("`@("`@("`@/&(^)B,Q
M-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),-#DP+F9I;E)O=RXR+F%M="Y$-2!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O<#L@0D]21$52+4)/5%1/33H@
M(S`P,#`P,"`Q<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.
M+4Q%1E0Z(#!P="<@8V]L<W!A;CTS1#(^("`@("`-"B`@("`@("`@("`\<"!I
M9#TS1%!!4D$T-CD@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'
M24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^/&(^,C`Q,SPO8CX\+V9O
M;G0^("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXR+G1R86EL+D0U('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@=&]P.R!0
M041$24Y'+4)/5%1/33H@,7!X)SX@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[
M/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@
M#0H@("`@("`\='(@:60],T140DPT.3`N9FEN4F]W+C,^("`@#0H@("`@("`@
M(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,RYL96%D+D(R
M/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C,N<WEM8BY",CX@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXS+F%M="Y",CX@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPT.3`N9FEN4F]W+C,N=')A:6PN0C(^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60]
M,T140DPT.3`N9FEN4F]W+C,N;&5A9"Y",SX@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M-#DP+F9I;E)O=RXS+G-Y;6(N0C,^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF
M:6Y2;W<N,RYA;70N0C,^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXS
M+G1R86EL+D(S/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXS+FQE
M860N0C0^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,RYS>6UB+D(T
M/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C,N86UT+D(T/B`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,RYT<F%I;"Y"-#X@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,RYL96%D+D(U/B`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60]
M,T140DPT.3`N9FEN4F]W+C,N<WEM8BY"-3X@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M-#DP+F9I;E)O=RXS+F%M="Y"-3X@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN
M4F]W+C,N=')A:6PN0C4^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!I9#TS
M1%1"3#0Y,"YF:6Y2;W<N-"!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C
M8V-E969F)SX@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%=)1%1(.B`U,B4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'
M4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@("`@#0H@("`@("`@("`@/'`@:60]
M,T1005)!-#<P('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@34%21TE.
M+51/4#H@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/E)E<V5A<F-H(&%N9"!D
M979E;&]P;65N=#PO9F]N=#X@("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O
M=RXT+FQE860N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C
M8V-E969F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C0N<WEM8BXR
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M
M0T],3U(Z("-C8V5E9F8G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXT
M+F%M="XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@.24[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'
M24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`-
M"B`@("`@("`@("`W,34@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXT+G1R86EL+C(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C
M965F9B<@;F]W<F%P/3-$;F]W<F%P/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF
M:6Y2;W<N-"YL96%D+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(
M.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/
M4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXT+G-Y
M;6(N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/
M54Y$+4-/3$]2.B`C8V-E969F)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2
M;W<N-"YA;70N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#DE
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4+4%,24=..B!R:6=H=#L@
M34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^
M("`@#0H@("`@("`@("`@-S`R("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-"YT<F%I;"XS('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z
M("-C8V5E9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT
M.3`N9FEN4F]W+C0N;&5A9"XT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!7
M24142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M
M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N
M-"YS>6UB+C0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#
M2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@("`-"B`@("`@("`@("`D("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N
M9FEN4F]W+C0N86UT+C0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(
M.B`Y)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@<FEG
M:'0[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E
M9F8G/B`@(`T*("`@("`@("`@(#(L-#(S(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-"YT<F%I;"XT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,
M24=..B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],
M3U(Z("-C8V5E9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T14
M0DPT.3`N9FEN4F]W+C0N;&5A9"XU('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]5
M3D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2
M;W<N-"YS>6UB+C4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q
M)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@
M0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@("`-"B`@("`@("`@("`D
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT
M.3`N9FEN4F]W+C0N86UT+C4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)
M1%1(.B`Y)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@
M<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C
M8V5E9F8G/B`@(`T*("`@("`@("`@(#$L-#DR(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-"YT<F%I;"XU
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M
M0T],3U(Z("-C8V5E9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-
M"B`@("`@(#QT<B!I9#TS1%1"3#0Y,"YF:6Y2;W<N-2!S='EL93TS1"="04-+
M1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!
M0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@(`T*("`@("`@("`@(#QP(&ED
M/3-$4$%2030W-2!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($U!4D=)
M3BU43U`Z(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SY'96YE<F%L(&%N9"!A
M9&UI;FES=')A=&EV93PO9F]N=#X@(`T*("`@("`@("`@(#PO<#X@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O
M=RXU+FQE860N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C
M9F9F9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C4N<WEM8BXR
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O
M;&ED.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#0Y,"YF:6Y2;W<N-2YA;70N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9CL@5TE$5$@Z(#DE.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0[
M($U!4D=)3BU,1494.B`S."XW<'0[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F
M9F8G/B`@("`@#0H@("`@("`@("`@,2PP-#4@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXU+G1R86EL+C(@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@4$%$1$E.1RU"3U143TTZ(#%P>#L@34%21TE.+4Q%
M1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<@;F]W<F%P/3-$
M;F]W<F%P/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C4N;&5A9"XS
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-2YS>6UB+C,@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@<V]L:60[($)!0TM'
M4D]53D0M0T],3U(Z("-F9F9F9F8G/B`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I
M;E)O=RXU+F%M="XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@
M.24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.+4Q%
M1E0Z(#,X+C=P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@("`-
M"B`@("`@("`@("`S+#,Y,R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@:60],T140DPT.3`N9FEN4F]W+C4N=')A:6PN,R!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M.R!0041$24Y'+4)/5%1/33H@,7!X.R!-05)'24XM3$5&5#H@,'!T.R!"
M04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)R!N;W=R87`],T1N;W=R87`^("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-2YL96%D+C0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-#DP+F9I;E)O=RXU+G-Y;6(N-"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@0D%#2T=23U5.1"U#3TQ/
M4CH@(V9F9F9F9B<^(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C4N86UT
M+C0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Y)3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,S@N-W!T
M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@("`@(`T*("`@("`@("`@
M(#,L,S@V(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#0Y,"YF:6Y2;W<N-2YT<F%I;"XT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%!!1$1)
M3D<M0D]45$]-.B`Q<'@[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M
M0T],3U(Z("-F9F9F9F8G(&YO=W)A<#TS1&YO=W)A<#X@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-#DP+F9I;E)O=RXU+FQE860N-2!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+
M1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N
M9FEN4F]W+C4N<WEM8BXU('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!72414
M2#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!X('-O;&ED.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F
M)SX@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-2YA;70N-2!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#DE.R!615)424-!3"U!3$E'3CH@
M8F]T=&]M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`S."XW<'0[($)!0TM'4D]5
M3D0M0T],3U(Z("-F9F9F9F8G/B`@("`@#0H@("`@("`@("`@-BPX-#$@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I
M;E)O=RXU+G1R86EL+C4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(
M.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@4$%$1$E.1RU"3U143TTZ
M(#%P>#L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F
M9F9F9B<@;F]W<F%P/3-$;F]W<F%P/B`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT
M<B!I9#TS1%1"3#0Y,"YF:6Y2;W<N-B!S='EL93TS1"="04-+1U)/54Y$+4-/
M3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M
M0T],3U(Z("-C8V5E9F8G/B`@(`T*("`@("`@("`@(#QP(&ED/3-$4$%2030X
M,"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($U!4D=)3BU43U`Z(#!P
M=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF)SY3=&]C:RUB87-E9"!C;VUP96YS871I
M;VX@97AP96YS92!I;F-L=61E9"!I;B!O<&5R871I;F<@97AP96YS97,\+V9O
M;G0^("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXV+FQE860N,B!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'
M3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@:60],T140DPT.3`N9FEN4F]W+C8N<WEM8BXR('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[
M($)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@34%21TE.+4Q%
M1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@("`-"B`@
M("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPT.3`N9FEN4F]W+C8N86UT+C(@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68[(%=)1%1(.B`Y)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]2
M1$52+4)/5%1/33H@(S`P,#`P,"`S<'@@9&]U8FQE.R!415A4+4%,24=..B!R
M:6=H=#L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C
M965F9B<^("`@#0H@("`@("`@("`@,2PW-C`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXV+G1R86EL+C(@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@4$%$1$E.1RU"3U143TTZ(#-P>#L@34%21TE.+4Q%
M1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<@;F]W<F%P/3-$
M;F]W<F%P/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C8N;&5A9"XS
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-BYS>6UB+C,@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`S<'@@9&]U8FQE.R!-05)'
M24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`@
M(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-BYA;70N,R!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!S97)I9CL@5TE$5$@Z(#DE.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[(%1%6%0M04Q)
M1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2
M.B`C8V-E969F)SX@("`-"B`@("`@("`@("`T+#`Y-2`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C8N=')A
M:6PN,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!0041$24Y'+4)/5%1/33H@,W!X.R!-05)'
M24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N;W=R
M87`],T1N;W=R87`^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-BYL
M96%D+C0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F
M9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXV+G-Y;6(N-"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'
M3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[
M($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G
M/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXV+F%M="XT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!724142#H@.24[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VT[($)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$58
M5"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M
M0T],3U(Z("-C8V5E9F8G/B`@(`T*("`@("`@("`@(#4L.#`Y(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N
M-BYT<F%I;"XT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%!!1$1)3D<M0D]45$]-.B`S<'@[
M($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G
M(&YO=W)A<#TS1&YO=W)A<#X@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O
M=RXV+FQE860N-2!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C
M8V-E969F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C8N<WEM8BXU
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O
M=6)L93L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C
M965F9B<^("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C8N86UT+C4@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Y)3L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`S<'@@9&]U8FQE
M.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=2
M3U5.1"U#3TQ/4CH@(V-C965F9B<^("`@#0H@("`@("`@("`@."PS,S,@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I
M;E)O=RXV+G1R86EL+C4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(
M.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@4$%$1$E.1RU"3U143TTZ
M(#-P>#L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C
M965F9B<@;F]W<F%P/3-$;F]W<F%P/B`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT
M<B!I9#TS1%1"3#0Y,"YF:6Y2;W<N-R!S='EL93TS1"="04-+1U)/54Y$+4-/
M3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G0D%#2T=2
M3U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF
M:6Y2;W<N-RYL96%D+D(R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F
M9F9F9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-RYS>6UB+D(R
M('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-RYA;70N0C(@<W1Y;&4],T0G0D%#2T=2
M3U5.1"U#3TQ/4CH@(V9F9F9F9B<^(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN
M4F]W+C<N=')A:6PN0C(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@(V9F
M9F9F9B<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-RYL96%D+D(S
M('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-RYS>6UB+D(S('-T>6QE/3-$)T)!0TM'
M4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF
M:6Y2;W<N-RYA;70N0C,@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@(V9F
M9F9F9B<^(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C<N=')A:6PN0C,@
M<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-RYL96%D+D(T('-T>6QE/3-$)T)!0TM'
M4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF
M:6Y2;W<N-RYS>6UB+D(T('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F
M9F9F9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-RYA;70N0C0@
M<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPT.3`N9FEN4F]W+C<N=')A:6PN0C0@<W1Y;&4],T0G0D%#2T=2
M3U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF
M:6Y2;W<N-RYL96%D+D(U('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F
M9F9F9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-RYS>6UB+D(U
M('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-RYA;70N0C4@<W1Y;&4],T0G0D%#2T=2
M3U5.1"U#3TQ/4CH@(V9F9F9F9B<^(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN
M4F]W+C<N=')A:6PN0C4@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@(V9F
M9F9F9B<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R(&ED/3-$5$),-#DP+F9I
M;E)O=RXX('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#
M04PM04Q)1TXZ('1O<#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@
M("`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$T.#4@<W1Y;&4],T0G34%21TE.
M+4)/5%1/33H@,'!T.R!-05)'24XM5$]0.B`P<'0[($Q)3D4M2$5)1TA4.B`Q
M+C(U)SX@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9B<^26UP86-T(&]N(&)A<VEC(&%N9"!D:6QU=&5D(&YE="!L;W-S('!E
M<B!S:&%R93PO9F]N=#X@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXX+FQE
M860N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F
M)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C@N<WEM8BXR('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@
M34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^
M("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C@N86UT+C(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Y)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`S<'@@9&]U8FQE.R!415A4
M+4%,24=..B!R:6=H=#L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#
M3TQ/4CH@(V-C965F9B<^("`@#0H@("`@("`@("`@,"XP-B`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O
M=RXX+G1R86EL+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q
M)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@4$%$1$E.1RU"3U143TTZ(#-P
M>#L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F
M9B<@;F]W<F%P/3-$;F]W<F%P/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN
M4F]W+C@N;&5A9"XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@
M,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z
M("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N."YS>6UB
M+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`S<'@@
M9&]U8FQE.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C
M8V-E969F)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N."YA;70N,R!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#DE.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B
M;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,'!T.R!"04-+
M1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`-"B`@("`@("`@("`P+C(W("`@
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT
M.3`N9FEN4F]W+C@N=')A:6PN,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!0041$24Y'+4)/
M5%1/33H@,W!X.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2
M.B`C8V-E969F)R!N;W=R87`],T1N;W=R87`^("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#0Y,"YF:6Y2;W<N."YL96%D+C0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.
M1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O
M=RXX+G-Y;6(N-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#-P>"!D;W5B;&4[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M
M0T],3U(Z("-C8V5E9F8G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXX
M+F%M="XT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@.24[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(",P,#`P,#`@
M,W!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`P
M<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@(`T*("`@("`@("`@
M(#`N,C,@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#0Y,"YF:6Y2;W<N."YT<F%I;"XT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%!!
M1$1)3D<M0D]45$]-.B`S<'@[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]5
M3D0M0T],3U(Z("-C8V5E9F8G(&YO=W)A<#TS1&YO=W)A<#X@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),-#DP+F9I;E)O=RXX+FQE860N-2!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"
M04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT
M.3`N9FEN4F]W+C@N<WEM8BXU('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!7
M24142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#
M2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@("`-"B`@("`@("`@("`D("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N
M9FEN4F]W+C@N86UT+C4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(
M.B`Y)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@
M(S`P,#`P,"`S<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.
M+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@#0H@
M("`@("`@("`@,"XU-"`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXX+G1R86EL+C4@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@4$%$1$E.1RU"3U143TTZ(#-P>#L@34%21TE.+4Q%1E0Z(#!P=#L@
M0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<@;F]W<F%P/3-$;F]W<F%P/B`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@/"]T<CX@("`-"B`@("`\+W1A8FQE/CQB<B\^/'`@:60],T1005)!-#DR
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,
M24Y%+4A%24=(5#H@,2XR-2<^("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF)SY!<R!O9B!397!T96UB97(@,S`L(#(P,30L('1H97)E
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M/B`@("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$T.30@<W1Y;&4],T0G
M5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4
M.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF)SY792!E<W1I;6%T960@=&AE(&9A:7(@=F%L=64@;V8@96%C:"!O<'1I
M;VX@9W)A;G0@;VX@=&AE(&=R86YT(&1A=&4@=7-I;F<@=&AE($)L86-K+5-C
M:&]L97,@;W!T:6]N('9A;'5A=&EO;B!M;V1E;"!W:71H('1H92!F;VQL;W=I
M;F<@=V5I9VAT960M879E<F%G92!A<W-U;7!T:6]N<SH\+V9O;G0^("`-"B`@
M("`\+W`^/&)R+SX\=&%B;&4@:60],T140DPU,3(@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68[(%=)1%1(.B`Q,#`E.R!415A4+4E.1$5.5#H@,'!X)R!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P(&)O<F1E<CTS1#`^("`@#0H@
M("`@("`\='(@:60],T140DPU,3(N9FEN4F]W+C$^("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#<P)3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;2<^("`@#0H@("`@("`@("`@/&5M/CPO96T^("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU,3(N
M9FEN4F]W+C$N;&5A9"Y$,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;2<^("`@("`-"B`@("`@("`@("`\8CXF(S$V
M,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPU,3(N9FEN4F]W+C$N86UT+D0S('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-
M.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!-05)'
M24XM3$5&5#H@,'!T)R!C;VQS<&%N/3-$-CX@("`-"B`@("`@("`@("`\<"!I
M9#TS1%!!4D$T.3<@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'
M24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^/&(^4V5P=&5M8F5R(#,P
M+#PO8CX\+V9O;G0^("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU,3(N9FEN4F]W+C$N=')A
M:6PN1#,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!0041$24Y'
M+4)/5%1/33H@,7!X)SX@("`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@
M("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@
M("`@/'1R(&ED/3-$5$),-3$R+F9I;E)O=RXR/B`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VTG/B`-"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU,3(N9FEN4F]W+C(N
M;&5A9"Y$,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)
M1TXZ(&)O='1O;2<^("`@("`-"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU
M,3(N9FEN4F]W+C(N86UT+D0R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XM3$5&5#H@
M,'!T)R!C;VQS<&%N/3-$,CX@("`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$T
M.3@@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P=#L@
M3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9B<^/&(^,C`\+V(^/&(^,30\+V(^/"]F;VYT
M/B`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXR+G1R86EL+D0R('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!0
M041$24Y'+4)/5%1/33H@,7!X)SX@(`T*("`@("`@("`@(#QB/B8C,38P.SPO
M8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#4Q,BYF:6Y2;W<N,BYL96%D+D0S('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@(`T*("`@("`@("`@
M(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N,BYA;70N1#,@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT
M97([($U!4D=)3BU,1494.B`P<'0G(&-O;'-P86X],T0R/B`@(`T*("`@("`@
M("`@(#QP(&ED/3-$4$%2030Y.2!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97([($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SX\8CXR,#PO
M8CX\8CXQ,SPO8CX\+V9O;G0^("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU,3(N9FEN4F]W
M+C(N=')A:6PN1#,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[(%!!1$1)3D<M0D]45$]-.B`Q<'@G/B`@#0H@("`@
M("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@:60],T140DPU,3(N9FEN4F]W
M+C,@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`-
M"B`@("`@("`@("`\<"!I9#TS1%!!4D$U,#`@<W1Y;&4],T0G34%21TE.+4)/
M5%1/33H@,'!T.R!-05)'24XM5$]0.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U
M)SX@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9B<^4FES:RUF<F5E(&EN=&5R97-T(')A=&4\+V9O;G0^("`@(`T*("`@("`@
M("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-3$R+F9I;E)O=RXS+FQE860N,B!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+
M1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU,3(N
M9FEN4F]W+C,N<WEM8BXR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!72414
M2#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],
M3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N,RYA
M;70N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$R)3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@<FEG:'0[($U!4D=)
M3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@("`-
M"B`@("`@("`@("`R+C`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXS+G1R86EL+C(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C
M965F9B<@;F]W<F%P/3-$;F]W<F%P/B`@#0H@("`@("`@("`@)2`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O
M=RXS+FQE860N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C
M8V-E969F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPU,3(N9FEN4F]W+C,N<WEM8BXS
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N,RYA;70N,R!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$R)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@5$585"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!
M0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@("`-"B`@("`@("`@("`Q+C`@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M-3$R+F9I;E)O=RXS+G1R86EL+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%
M1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<@;F]W<F%P/3-$
M;F]W<F%P/B`@#0H@("`@("`@("`@)2`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@:60],T140DPU,3(N9FEN4F]W
M+C0@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@("`-
M"B`@("`@("`@("`\<"!I9#TS1%!!4D$U,#,@<W1Y;&4],T0G34%21TE.+4)/
M5%1/33H@,'!T.R!-05)'24XM5$]0.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U
M)SX@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9B<^1&EV:61E;F0@>6EE;&0\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W`^
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4Q
M,BYF:6Y2;W<N-"YL96%D+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)
M1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#
M3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXT
M+G-Y;6(N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F
M9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPU,3(N9FEN4F]W+C0N86UT+C(@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q,B4[(%9%4E1)0T%,+4%,
M24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@
M,3DN-35P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@#0H@("`@
M("`@("`@,"XP("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N-"YT<F%I;"XR('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[
M($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G
M(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@("4@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N-"YL
M96%D+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F
M9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXT+G-Y;6(N,R!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'
M3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@:60],T140DPU,3(N9FEN4F]W+C0N86UT+C,@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68[(%=)1%1(.B`Q,B4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[
M(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,3DN-35P=#L@0D%#
M2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@#0H@("`@("`@("`@,"XP("`@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4Q
M,BYF:6Y2;W<N-"YT<F%I;"XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!7
M24142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($U!4D=)3BU,1494
M.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G(&YO=W)A<#TS1&YO
M=W)A<#X@(`T*("`@("`@("`@("4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`\+W1R/B`@(`T*("`@("`@/'1R(&ED/3-$5$),-3$R+F9I;E)O=RXU
M('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@#0H@
M("`@("`@("`@/'`@:60],T1005)!-3`V('-T>6QE/3-$)TU!4D=)3BU"3U14
M3TTZ(#!P=#L@34%21TE.+51/4#H@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G
M/E9O;&%T:6QI='D\+V9O;G0^(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXU
M+FQE860N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E
M969F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPU,3(N9FEN4F]W+C4N<WEM8BXR('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,
M24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N-2YA;70N,B!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!S97)I9CL@5TE$5$@Z(#$R)3L@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@5$585"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!0TM'
M4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@("`-"B`@("`@("`@("`Q,#(N.2`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU,3(N
M9FEN4F]W+C4N=')A:6PN,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$
M5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@
M,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N;W=R87`],T1N;W=R
M87`^("`-"B`@("`@("`@("`E("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@:60],T140DPU,3(N9FEN4F]W+C4N;&5A9"XS('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#4Q,BYF:6Y2;W<N-2YS>6UB+C,@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#
M2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R
M+F9I;E)O=RXU+F%M="XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!72414
M2#H@,3(E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4+4%,24=..B!R
M:6=H=#L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C
M965F9B<^("`@(`T*("`@("`@("`@(#$P-"XR(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N-2YT<F%I;"XS
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M
M0T],3U(Z("-C8V5E9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@
M("4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@
M("`@/'1R(&ED/3-$5$),-3$R+F9I;E)O=RXV('-T>6QE/3-$)T)!0TM'4D]5
M3D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@("`@(#QT9"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2
M3U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@#0H@("`@("`@("`@/'`@:60],T10
M05)!-3`Y('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@34%21TE.+51/
M4#H@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/D5X<&5C=&5D(&QI9F4@*'EE
M87)S*3PO9F]N=#X@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXV+FQE860N
M,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!
M3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@:60],T140DPU,3(N9FEN4F]W+C8N<WEM8BXR('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#4Q,BYF:6Y2;W<N-BYA;70N,B!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5TE$5$@Z(#$R)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$58
M5"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M
M0T],3U(Z("-F9F9F9F8G/B`@("`-"B`@("`@("`@("`V+C`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O
M=RXV+G1R86EL+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q
M)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@
M0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<@;F]W<F%P/3-$;F]W<F%P/B`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N-BYL96%D+C,@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-3$R+F9I;E)O=RXV+G-Y;6(N,R!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+
M1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU,3(N
M9FEN4F]W+C8N86UT+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(
M.B`Q,B4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I
M9VAT.R!-05)'24XM3$5&5#H@-31P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F
M9F9F9B<^("`@("`-"B`@("`@("`@("`V+C`@("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXV+G1R86EL
M+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.
M1"U#3TQ/4CH@(V9F9F9F9B<@;F]W<F%P/3-$;F]W<F%P/B`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@
M(`T*("`@(#PO=&%B;&4^/&)R+SX\<"!I9#TS1%!!4D$U,30@<W1Y;&4],T0G
M5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4
M.B`Q+C(U)SX@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68G/E=E(&5S=&EM871E9"!T:&4@9F%I<B!V86QU92!O9B!E86-H('!U<F-H
M87-E(')I9VAT(&=R86YT960@=6YD97(@=&AE($534%`@870@=&AE(&)E9VEN
M;FEN9R!O9B!E86-H(&YE=R!O9F9E<FEN9R!P97)I;V0@=7-I;F<@=&AE($)L
M86-K+5-C:&]L97,@;W!T:6]N('9A;'5A=&EO;B!M;V1E;"X@5&AE<F4@=V5R
M92!N;R!N97<@;V9F97)I;F<@<&5R:6]D<R!F;W(@=&AE('%U87)T97)S(&5N
M9&5D(%-E<'1E;6)E<B`S,"P@,C`Q-"!A;F0@,C`Q,RX\+V9O;G0^("`@#0H@
M("`@/"]P/CQB<B\^/'`@:60],T1005)!-3$X('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^
M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^5&AE
M(&9O;&QO=VEN9R!T86)L92!S=6UM87)I>F5S('1H92!S=&]C:R!O<'1I;VX@
M86-T:79I='D@9F]R('1H92!N:6YE(&UO;G1H<R!E;F1E9"!397!T96UB97(@
M,S`L(#(P,30Z/"]F;VYT/B`@#0H@("`@/"]P/CQB<B\^/'1A8FQE(&ED/3-$
M5$),-34X('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,3`P)3L@
M5$585"U)3D1%3E0Z(#!P>"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG
M/3-$,"!B;W)D97(],T0P/B`@(`T*("`@("`@/'1R(&ED/3-$5$),-34X+F9I
M;E)O=RXQ/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`-"B`@("`@("`@("`\8CXF
M(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@:60],T140DPU-3@N9FEN4F]W+C$N;&5A9"Y",B!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^("`@("`-"B`@
M("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C$N<WEM8BY",B!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O
M;2<^("`@("`-"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W
M+C$N86UT+D(R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M.R!415A4+4%,24=..B!C96YT97(G/B`@("`-"B`@("`@
M("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C$N=')A:6PN0C(@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG
M/B`-"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C$N;&5A
M9"Y",R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ
M(&)O='1O;2<^("`@("`-"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N
M9FEN4F]W+C$N<WEM8BY",R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;2<^("`@("`-"B`@("`@("`@("`\8CXF(S$V
M,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPU-3@N9FEN4F]W+C$N86UT+D(S('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4+4%,24=..B!C
M96YT97(G/B`@("`-"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN
M4F]W+C$N=')A:6PN0C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)
M0T%,+4%,24=..B!B;W1T;VTG/B`-"B`@("`@("`@("`\8CXF(S$V,#L\+V(^
M("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T14
M0DPU-3@N9FEN4F]W+C$N;&5A9"Y$-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^("`@("`-"B`@("`@("`@("`\
M8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@:60],T140DPU-3@N9FEN4F]W+C$N86UT+D0T('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4+4%,
M24=..B!C96YT97([($U!4D=)3BU,1494.B`P<'0G(&-O;'-P86X],T0R/B`@
M("`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$U,C(@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G
M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9B<^/&(^5V5I9VAT960M/"]B/CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]P
M/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU
M-3@N9FEN4F]W+C$N=')A:6PN1#0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`-"B`@("`@("`@("`\8CXF(S$V
M,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@
M("`-"B`@("`@(#QT<B!I9#TS1%1"3#4U."YF:6Y2;W<N,CX@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'
M3CH@8F]T=&]M)SX@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I
M;E)O=RXR+FQE860N0C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)
M0T%,+4%,24=..B!B;W1T;VTG/B`@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[
M/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-34X+F9I;E)O=RXR+G-Y;6(N0C(@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`@("`@#0H@("`@("`@
M("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXR+F%M="Y",B!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$58
M5"U!3$E'3CH@8V5N=&5R)SX@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B
M/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$
M5$),-34X+F9I;E)O=RXR+G1R86EL+D(R('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@#0H@("`@("`@("`@/&(^
M)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-34X+F9I;E)O=RXR+FQE860N0C,@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`@("`@#0H@
M("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXR+G-Y;6(N0C,@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VTG/B`@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O
M=RXR+F%M="Y",R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@8V5N=&5R)SX@("`@#0H@("`@
M("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXR+G1R86EL+D(S('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M)SX@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXR+FQE
M860N1#0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VTG/B`@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X
M+F9I;E)O=RXR+F%M="Y$-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@8V5N=&5R.R!-05)'
M24XM3$5&5#H@,'!T)R!C;VQS<&%N/3-$,CX@("`@#0H@("`@("`@("`@/'`@
M:60],T1005)!-3(T('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%2
M1TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/D%V97)A9V4\+V(^
M/"]F;VYT/B`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C(N=')A:6PN1#0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VTG/B`-"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!I9#TS1%1"
M3#4U."YF:6Y2;W<N,SX@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@#0H@("`@("`@
M("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXS+FQE860N0C(@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`@
M("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXS+G-Y
M;6(N0C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VTG/B`@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X
M+F9I;E)O=RXS+F%M="Y",B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@8V5N=&5R)SX@("`@
M#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXS+G1R86EL
M+D(R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@
M8F]T=&]M)SX@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O
M=RXS+FQE860N1#,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VTG/B`@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B
M/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$
M5$),-34X+F9I;E)O=RXS+F%M="Y$,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@8V5N=&5R
M.R!-05)'24XM3$5&5#H@,'!T)R!C;VQS<&%N/3-$,CX@("`@#0H@("`@("`@
M("`@/'`@:60],T1005)!-3(V('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E
M<CL@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/E=E:6=H
M=&5D+3PO8CX\+V9O;G0^("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXS
M+G1R86EL+D0S('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M)SX@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X
M+F9I;E)O=RXS+FQE860N1#0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VTG/B`@("`@#0H@("`@("`@("`@/&(^)B,Q
M-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),-34X+F9I;E)O=RXS+F%M="Y$-"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@
M8V5N=&5R.R!-05)'24XM3$5&5#H@,'!T)R!C;VQS<&%N/3-$,CX@("`@#0H@
M("`@("`@("`@/'`@:60],T1005)!-3(W('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&-E;G1E<CL@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB
M/E)E;6%I;FEN9SPO8CX\+V9O;G0^("`@(`T*("`@("`@("`@(#PO<#X@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I
M;E)O=RXS+G1R86EL+D0T('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M)SX@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B
M/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@
M("`@("`\='(@:60],T140DPU-3@N9FEN4F]W+C0^("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O
M='1O;2<^(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N
M-"YL96%D+D(R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M)SX@("`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@
M("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#4U."YF:6Y2;W<N-"YS>6UB+D(R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@(`T*("`@("`@("`@(#QB
M/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-"YA;70N0C(@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)
M1TXZ(&-E;G1E<B<^("`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U
M."YF:6Y2;W<N-"YT<F%I;"Y",B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(`T*("`@("`@("`@(#QB/B8C,38P
M.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#4U."YF:6Y2;W<N-"YL96%D+D0S('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@(`T*("`@("`@
M("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-"YA;70N1#,@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%
M6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P="<@8V]L<W!A;CTS
M1#(^("`@(`T*("`@("`@("`@(#QP(&ED/3-$4$%2034R.2!S='EL93TS1"=4
M15A4+4%,24=..B!C96YT97([($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@
M,2XR-2<^("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF)SX\8CY!=F5R86=E/"]B/CPO9F]N=#X@(`T*("`@("`@("`@(#PO
M<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M-34X+F9I;E)O=RXT+G1R86EL+D0S('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@#0H@("`@("`@("`@/&(^)B,Q
M-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),-34X+F9I;E)O=RXT+FQE860N1#0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`@("`@#0H@("`@
M("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXT+F%M="Y$-"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@
M5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XM3$5&5#H@,'!T)R!C;VQS<&%N
M/3-$,CX@("`@#0H@("`@("`@("`@/'`@:60],T1005)!-3,P('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4
M.B`Q+C(U)SX@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68G/CQB/D-O;G1R86-T=6%L/"]B/CPO9F]N=#X@#0H@("`@("`@
M("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60]
M,T140DPU-3@N9FEN4F]W+C0N=')A:6PN1#0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`-"B`@("`@("`@("`\
M8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M/"]T<CX@("`-"B`@("`@(#QT<B!I9#TS1%1"3#4U."YF:6Y2;W<N-3X@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!
M3"U!3$E'3CH@8F]T=&]M)SX@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M-34X+F9I;E)O=RXU+FQE860N1#(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`@("`@#0H@("`@("`@("`@/&(^
M)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-34X+F9I;E)O=RXU+F%M="Y$,B!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'
M3CH@8V5N=&5R.R!-05)'24XM3$5&5#H@,'!T)R!C;VQS<&%N/3-$,CX@("`@
M#0H@("`@("`@("`@/'`@:60],T1005)!-3,R('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&-E;G1E<CL@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G
M/CQB/E-H87)E<SPO8CX\+V9O;G0^(`T*("`@("`@("`@(#PO<#X@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O
M=RXU+G1R86EL+D0R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!
M3"U!3$E'3CH@8F]T=&]M)SX@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M-34X+F9I;E)O=RXU+FQE860N1#,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`@("`@#0H@("`@("`@("`@/&(^
M)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-34X+F9I;E)O=RXU+F%M="Y$,R!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'
M3CH@8V5N=&5R.R!-05)'24XM3$5&5#H@,'!T)R!C;VQS<&%N/3-$,CX@("`@
M#0H@("`@("`@("`@/'`@:60],T1005)!-3,S('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&-E;G1E<CL@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G
M/CQB/D5X97)C:7-E/"]B/CPO9F]N=#X@("`-"B`@("`@("`@("`\+W`^(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF
M:6Y2;W<N-2YT<F%I;"Y$,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;2<^(`T*("`@("`@("`@(#QB/B8C,38P.SPO
M8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#4U."YF:6Y2;W<N-2YL96%D+D0T('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@(`T*("`@("`@("`@
M(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-2YA;70N1#0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M
M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P="<@8V]L<W!A;CTS1#(^
M("`@(`T*("`@("`@("`@(#QP(&ED/3-$4$%2034S-"!S='EL93TS1"=415A4
M+4%,24=..B!C96YT97([($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR
M-2<^("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF)SX\8CY497)M/"]B/CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]P/B`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N
M9FEN4F]W+C4N=')A:6PN1#0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VTG/B`-"B`@("`@("`@("`\8CXF(S$V,#L\
M+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-
M"B`@("`@(#QT<B!I9#TS1%1"3#4U."YF:6Y2;W<N-CX@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@
M8F]T=&]M)SX@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O
M=RXV+FQE860N1#(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VTG/B`@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B
M/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$
M5$),-34X+F9I;E)O=RXV+F%M="Y$,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P
M,#`P,"`Q<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%
M1E0Z(#!P="<@8V]L<W!A;CTS1#(^("`@#0H@("`@("`@("`@/'`@:60],T10
M05)!-3,V('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P
M<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/BAI;B!T:&]U<V%N9',I/"]B
M/CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C8N=')A:6PN
M1#(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VT[($)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/
M5%1/33H@,7!X)SX@("`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U
M."YF:6Y2;W<N-BYL96%D+D0S('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@(`T*("`@("`@("`@(#QB/B8C
M,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!I9#TS1%1"3#4U."YF:6Y2;W<N-BYA;70N1#,@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($U!
M4D=)3BU,1494.B`P<'0G(&-O;'-P86X],T0R/B`@(`T*("`@("`@("`@(#QP
M(&ED/3-$4$%2034S-R!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!
M4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SX\8CY0<FEC93PO8CX\
M+V9O;G0^("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-BYT<F%I;"Y$
M,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[(%!!1$1)3D<M0D]4
M5$]-.B`Q<'@G/B`@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X
M+F9I;E)O=RXV+FQE860N1#0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VTG/B`@("`@#0H@("`@("`@("`@/&(^)B,Q
M-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),-34X+F9I;E)O=RXV+F%M="Y$-"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/
M33H@(S`P,#`P,"`Q<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%2
M1TE.+4Q%1E0Z(#!P="<@8V]L<W!A;CTS1#(^("`@#0H@("`@("`@("`@/'`@
M:60],T1005)!-3,X('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%2
M1TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/BA996%R<RD\+V(^
M/"]F;VYT/B`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C8N=')A:6PN1#0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VT[($)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/
M33H@,7!X)SX@("`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R
M(&ED/3-$5$),-34X+F9I;E)O=RXW('-T>6QE/3-$)T)!0TM'4D]53D0M0T],
M3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@(#QT9"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5TE$5$@Z(#4U)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@
M0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@("`-"B`@("`@("`@("`\
M<"!I9#TS1%!!4D$U,SD@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!-
M05)'24XM5$]0.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^0F%L86YC92!A
M="!*86YU87)Y(#$L(#(P,30\+V9O;G0^("`-"B`@("`@("`@("`\+W`^(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF
M:6Y2;W<N-RYL96%D+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(
M.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/
M4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXW+G-Y
M;6(N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F
M)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C<N86UT+C(@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q,B4[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,'!T
M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`@#0H@("`@("`@("`@
M-BPS-38@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$
M5$),-34X+F9I;E)O=RXW+G1R86EL+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@34%21TE.
M+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<@;F]W<F%P
M/3-$;F]W<F%P/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-RYL96%D
M+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXW+G-Y;6(N,R!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@
M8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C
M8V-E969F)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-RYA;70N,R!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$R)3L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494
M.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@("`-"B`@("`@
M("`@("`X+C(R("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@:60],T140DPU-3@N9FEN4F]W+C<N=')A:6PN,R!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F
M)R!N;W=R87`],T1N;W=R87`^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O
M=RXW+FQE860N-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C
M8V-E969F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C<N<WEM8BXT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-RYA;70N-"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$R)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@5$585"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!
M0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@("`-"B`@("`@("`@("`X+C$T
M("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T14
M0DPU-3@N9FEN4F]W+C<N=')A:6PN-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM
M3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N;W=R87`]
M,T1N;W=R87`^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@:60],T140DPU-3@N
M9FEN4F]W+C@@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!0041$24Y'+4Q%1E0Z(#EP=#L@0D%#2T=2
M3U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@("`@("`\<"!I9#TS1%!!
M4D$U-#,@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!-05)'24XM5$]0
M.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^1W)A;G1E9#PO9F]N=#X@("`-
M"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N."YL96%D+C(@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$
M5$),-34X+F9I;E)O=RXX+G-Y;6(N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/
M54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN
M4F]W+C@N86UT+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q
M,B4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I9VAT
M.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F
M)SX@("`@#0H@("`@("`@("`@,2PV,S$@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXX+G1R86EL+C(@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/
M4CH@(V9F9F9F9B<@;F]W<F%P/3-$;F]W<F%P/B`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#4U."YF:6Y2;W<N."YL96%D+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.
M1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O
M=RXX+G-Y;6(N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T.R!"
M04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@("`@(`T*("`@("`@("`@("0@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U
M."YF:6Y2;W<N."YA;70N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$
M5$@Z(#$R)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@
M<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-F
M9F9F9F8G/B`@("`-"B`@("`@("`@("`Y+CDU("`@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C@N=')A
M:6PN,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/
M54Y$+4-/3$]2.B`C9F9F9F9F)R!N;W=R87`],T1N;W=R87`^("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),-34X+F9I;E)O=RXX+FQE860N0C0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M
M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N
M."YS>6UB+D(T('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@:60],T140DPU-3@N9FEN4F]W+C@N86UT+D(T('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4+4%,
M24=..B!R:6=H=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXX+G1R86EL+D(T('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+
M1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\
M='(@:60],T140DPU-3@N9FEN4F]W+CD@<W1Y;&4],T0G0D%#2T=23U5.1"U#
M3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!0041$24Y'+4Q%
M1E0Z(#EP=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@
M("`@("`\<"!I9#TS1%!!4D$U-#8@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@
M,'!T.R!-05)'24XM5$]0.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^17AE
M<F-I<V5D/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+CDN
M;&5A9"XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E
M9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N.2YS>6UB+C(@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-34X+F9I;E)O=RXY+F%M="XR('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!724142#H@,3(E.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=2
M3U5.1"U#3TQ/4CH@(V-C965F9B<^("`@(`T*("`@("`@("`@("@W,3D@("`@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U
M."YF:6Y2;W<N.2YT<F%I;"XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!7
M24142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($U!4D=)3BU,1494
M.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G(&YO=W)A<#TS1&YO
M=W)A<#X@(`T*("`@("`@("`@(#QP(&ED/3-$4$%2034T."!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N
M,C4G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9B<^*3PO9F]N=#X@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXY
M+FQE860N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E
M969F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+CDN<WEM8BXS('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,
M24=..B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],
M3U(Z("-C8V5E9F8G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXY+F%M
M="XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,3(E.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.
M+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@(`T*
M("`@("`@("`@(#8N,CD@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N.2YT<F%I;"XS('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C
M8V5E9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N
M9FEN4F]W+CDN;&5A9"Y"-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F
M9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXY+G-Y;6(N0C0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[
M($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#4U."YF:6Y2;W<N.2YA;70N0C0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!"
M04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T14
M0DPU-3@N9FEN4F]W+CDN=')A:6PN0C0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z
M("-C8V5E9F8G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!I9#TS1%1"3#4U
M."YF:6Y2;W<N,3`@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F
M9B<^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@4$%$1$E.1RU,1494.B`Y<'0[($)!
M0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@("`@("`@/'`@:60]
M,T1005)!-34P('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@34%21TE.
M+51/4#H@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/D5X<&ER960@86YD(&9O
M<F9E:71E9#PO9F]N=#X@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ,"YL
M96%D+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F
M9B<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,3`N<WEM8BXR('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,
M24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@:60],T140DPU-3@N9FEN4F]W+C$P+F%M="XR('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF.R!724142#H@,3(E.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!
M3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],
M3U(Z("-F9F9F9F8G/B`@("`-"B`@("`@("`@("`H.#$R("`@("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W
M+C$P+G1R86EL+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q
M)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@;65D
M:75M(&YO;F4[(%!!1$1)3D<M0D]45$]-.B`P<'@[($U!4D=)3BU,1494.B`P
M<'0[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G(&YO=W)A<#TS1&YO=W)A
M<#X@(`T*("`@("`@("`@(#QP(&ED/3-$4$%2034U,B!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G
M/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9B<^*3PO9F]N=#X@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ,"YL
M96%D+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F
M9B<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,3`N<WEM8BXS('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,
M24=..B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],
M3U(Z("-F9F9F9F8G/B`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C$P+F%M="XS
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,3(E.R!615)424-!
M3"U!3$E'3CH@8F]T=&]M.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.+4Q%
M1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@("`-"B`@
M("`@("`@("`Y+C@R("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@:60],T140DPU-3@N9FEN4F]W+C$P+G1R86EL+C,@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[(%!!1$1)3D<M0D]4
M5$]-.B`P<'@[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z
M("-F9F9F9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU
M-3@N9FEN4F]W+C$P+FQE860N0C0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-F
M9F9F9F8G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C$P+G-Y;6(N
M0C0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPU-3@N9FEN4F]W+C$P+F%M="Y"-"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@
M<FEG:'0[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-34X+F9I;E)O=RXQ,"YT<F%I;"Y"-"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/
M33H@;65D:75M(&YO;F4[(%!!1$1)3D<M0D]45$]-.B`P<'@[($)!0TM'4D]5
M3D0M0T],3U(Z("-F9F9F9F8G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!I
M9#TS1%1"3#4U."YF:6Y2;W<N,3$@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/
M4CH@(V-C965F9B<^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#
M3TQ/4CH@(V-C965F9B<^("`@#0H@("`@("`@("`@/'`@:60],T1005)!-34T
M('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@34%21TE.+51/4#H@,'!T
M.R!,24Y%+4A%24=(5#H@,2XR-2<^(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68G/D)A;&%N8V4@870@4V5P=&5M8F5R(#,P
M+"`R,#$T/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C$Q
M+FQE860N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E
M969F)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ,2YS>6UB+C(@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,3$N86UT+C(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q,B4[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VT[($)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$58
M5"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M
M0T],3U(Z("-C8V5E9F8G/B`@("`@#0H@("`@("`@("`@-BPT-38@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O
M=RXQ,2YT<F%I;"XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@
M,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(&UE
M9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,'!X.R!-05)'24XM3$5&5#H@
M,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N;W=R87`],T1N;W=R
M87`^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ,2YL96%D+C,@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,3$N<WEM8BXS('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E
M9F8G/B`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C$Q+F%M="XS('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!724142#H@,3(E.R!615)424-!3"U!3$E'3CH@
M8F]T=&]M.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.+4Q%1E0Z(#!P=#L@
M0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@("`-"B`@("`@("`@("`X
M+C8W("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60]
M,T140DPU-3@N9FEN4F]W+C$Q+G1R86EL+C,@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]2
M1$52+4)/5%1/33H@;65D:75M(&YO;F4[(%!!1$1)3D<M0D]45$]-.B`P<'@[
M($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G
M(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W
M+C$Q+FQE860N-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C
M8V-E969F)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ,2YS>6UB
M+C0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,3$N86UT+C0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q,B4[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,'!T
M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`@(`T*("`@("`@("`@
M(#@N,3@@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
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M9B<@;F]W<F%P/3-$;F]W<F%P/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@(#PO=&%B;&4^
M/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7S%E-S,T,#9E7S-E-S)?-&4T95\X938U7SAD8S9D86%E.3<W9@T*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Q93<S-#`V95\S93<R7S1E-&5?.&4V
M-5\X9&,V9&%A93DW-V8O5V]R:W-H965T<R]3:&5E=#$P+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3F]T92`V("T@26YC;VUE
M(%1A>&5S/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@
M,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^26YC;VUE(%1A>"!$:7-C;&]S=7)E(%M!8G-T<F%C=%T\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN8V]M
M92!487@@1&ES8VQO<W5R92!;5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<"!I9#TS1%!!4D$U-C`@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q
M+C(U)SX@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M)SX\8CXV+B!);F-O;64@5&%X97,\+V(^/"]F;VYT/B`@("`-"B`@("`\+W`^
M/&)R+SX\<"!I9#TS1%!!4D$U-C(@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S
M=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@
M("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
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M96UB97(F(S$V,#LS,"PF(S$V,#LR,#$T+CPO9F]N=#X@("`-"B`@("`\+W`^
M/&)R+SX\<"!I9#TS1%!!4D$U-C0@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S
M=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@
M("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SY4:&4@:6UP86-T
M(&]F(&%N('5N8V5R=&%I;B!I;F-O;64@=&%X('!O<VET:6]N(&]N('1H92!I
M;F-O;64@=&%X(')E='5R;B!M=7-T(&)E(')E8V]G;FEZ960@870@=&AE(&QA
M<F=E<W0@86UO=6YT('1H870@:7,@;6]R92!L:6ME;'D@=&AA;B!N;W0@=&\@
M8F4@<W5S=&%I;F5D('5P;VX@875D:70@8GD@=&AE(')E;&5V86YT('1A>"!A
M=71H;W)I='DN($%N('5N8V5R=&%I;B!I;F-O;64@=&%X('!O<VET:6]N('=I
M;&P@;F]T(&)E(')E8V]G;FEZ960@:68@:70@:&%S(&QE<W,@=&AA;B!A(#4P
M)2!L:6ME;&EH;V]D(&]F(&)E:6YG('-U<W1A:6YE9"X@5&AE<F4@:&%V92!B
M965N(&YO(&UA=&5R:6%L(&-H86YG97,@:6X@;W5R('5N<F5C;V=N:7IE9"!T
M87@@8F5N969I=',@<VEN8V4@1&5C96UB97(F(S$V,#LS,2PF(S$V,#LR,#$S
M(&%N9"!A<R!S=6-H+"!D:7-C;&]S=7)E<R!I;F-L=61E9"!I;B!T:&4@0V]M
M<&%N>28C.#(Q-SMS(#(P,3,@06YN=6%L(%)E<&]R="!O;B!&;W)M)B,Q-C`[
M,3`M2R!C;VYT:6YU92!T;R!B92!R96QE=F%N="!F;W(@=&AE('!E<FEO9"!E
M;F1E9"!397!T96UB97(@,S`L(#(P,30N/"]F;VYT/B`@("`@#0H@("`@/"]P
M/CQB<B\^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO
M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R
M=%\Q93<S-#`V95\S93<R7S1E-&5?.&4V-5\X9&,V9&%A93DW-V8-"D-O;G1E
M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,64W,S0P-F5?,V4W,E\T931E7SAE
M-C5?.&1C-F1A864Y-S=F+U=O<FMS:&5E=',O4VAE970Q,2YH=&UL#0I#;VYT
M96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT
M96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH
M=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N
M="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\
M<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO
M*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A
M9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$
M240P15E$04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L
M(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^06-C;W5N=&EN9R!0
M;VQI8VEE<RP@8GD@4&]L:6-Y("A0;VQI8VEE<RD\8G(^/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY!8V-O=6YT:6YG(%!O
M;&EC:65S(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E5S92!O9B!%<W1I;6%T97,L(%!O;&EC>2!;4&]L
M:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'`@:60],T1005)!,S8U('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I
M9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/E5S92!O9B!%<W1I;6%T97,\+V(^
M/"]F;VYT/B`@#0H@("`@/"]P/CQB<B\^/'`@:60],T1005)!,S8W('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%
M24=(5#H@,2XR-2<^("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)
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M+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#87-H(&%N9"!#87-H($5Q=6EV86QE;G1S+"!0;VQI8WD@6U!O;&EC
M>2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQP(&ED/3-$4$%203,V.2!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y
M.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF)SX\8CY#87-H/"]B/CPO9F]N=#X@("`-"B`@
M("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$S-S$@<W1Y;&4],T0G5$585"U!3$E'
M3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@
M("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SY792!H
M860@8V%S:"!O9B`D.#8N,B!M:6QL:6]N(&%N9"`D-S(N,R!M:6QL:6]N(&%T
M(%-E<'1E;6)E<B`S,"P@,C`Q-"!A;F0@1&5C96UB97(@,S$L(#(P,3,L(')E
M<W!E8W1I=F5L>2X@5V4@9&ED(&YO="!H;VQD(&%N>2!C87-H(&5Q=6EV86QE
M;G1S(&]R(&EN=F5S=&UE;G0@<V5C=7)I=&EE<R!A<R!O9B!B;W1H(&1A=&5S
M+B!/=7(@8F%N:R!A8V-O=6YT<R!H879E(&)E96X@<&QA8V5D('5N9&5R(&$@
M8V]N=')O;"!A9W)E96UE;G0@:6X@86-C;W)D86YC92!W:71H('1H92!396YI
M;W(@4V5C=7)E9"!#;VYV97)T:6)L92!.;W1E<R`H<V5E($YO=&4@-"DN/"]F
M;VYT/CPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DQI<75I9&ET>2!$:7-C;&]S=7)E(%M0;VQI8WD@5&5X="!"
M;&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!I9#TS
M1%!!4D$S-S$@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE.
M.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!S97)I9B<^5V4@:&%D(&-A<V@@;V8@)#@V+C(@;6EL;&EO;B!A;F0@
M)#<R+C,@;6EL;&EO;B!A="!397!T96UB97(@,S`L(#(P,30@86YD($1E8V5M
M8F5R(#,Q+"`R,#$S+"!R97-P96-T:79E;'DN/"]F;VYT/CPO<#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5A<FYI
M;F=S(%!E<B!3:&%R92P@4&]L:6-Y(%M0;VQI8WD@5&5X="!";&]C:UT\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!I9#TS1%!!4D$S-S,@
M<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)
M3D4M2$5)1TA4.B`Q+C(U)SX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9B<^/&(^16%R;FEN9W,@4&5R(%-H87)E/"]B/CPO9F]N=#X@#0H@("`@/"]P
M/CQB<B\^/'`@:60],T1005)!,S<U('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU
M<W1I9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`@#0H@
M("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^0F%S:6,@96%R
M;FEN9W,@<&5R('-H87)E("@F(S@R,C`[15!3)B,X,C(Q.RD@:7,@8V%L8W5L
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M=&EV92X\+V9O;G0^("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$S-S<@
M<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)
M3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/
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M9F]N=#X@("`@#0H@("`@/"]P/CQB<B\^/'`@:60],T1005)!,S<Y('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%
M24=(5#H@,2XR-2<^("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)
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M<R!S:&]W;B!B96QO=R`H:6X@=&AO=7-A;F1S*3H\+V9O;G0^("`@("`-"B`@
M("`\+W`^/&)R+SX\=&%B;&4@:60],T140DPS.30@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68[(%=)1%1(.B`Q,#`E.R!415A4+4E.1$5.5#H@,'!X)R!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P(&)O<F1E<CTS1#`^("`@#0H@
M("`@("`\='(@:60],T140DPS.30N9FEN4F]W+C$^("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O
M<"<^("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXQ
M+FQE860N1#,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,
M24=..B!T;W`G/B`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I
M;E)O=RXQ+F%M="Y$,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#
M04PM04Q)1TXZ('1O<#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P="<@8V]L
M<W!A;CTS1#8^("`@("`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$S.#$@<W1Y
M;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P=#L@3$E.12U(
M14E'2%0Z(#$N,C4G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9B<^/&(^/"]B/CPO9F]N=#X@("`@(`T*("`@("`@("`@
M(#PO<#X@#0H@("`@("`@("`@/'`@:60],T1005)!,S@R('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q
M+C(U)SX@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68G/CQB/D%S(&]F(%-E<'1E;6)E<B`S,#PO8CX\8CXL/"]B/CPO9F]N
M=#X@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N,2YT<F%I;"Y$,R!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O<#L@0D]2
M1$52+4)/5%1/33H@;65D:75M(&YO;F4[(%!!1$1)3D<M0D]45$]-.B`Q<'@G
M/B`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@:60],T140DPS
M.30N9FEN4F]W+C(^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O<"<^("`@#0H@("`@("`@("`@
M/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXR+FQE860N1#(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`G/B`@#0H@("`@
M("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXR+F%M="Y$,B!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O<#L@0D]2
M1$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E
M;G1E<CL@34%21TE.+4Q%1E0Z(#!P="<@8V]L<W!A;CTS1#(^("`@("`-"B`@
M("`@("`@("`\<"!I9#TS1%!!4D$S.#,@<W1Y;&4],T0G5$585"U!3$E'3CH@
M8V5N=&5R.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^/&(^
M,C`Q-#PO8CX\+V9O;G0^("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXR
M+G1R86EL+D0R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!
M3$E'3CH@=&]P.R!0041$24Y'+4)/5%1/33H@,7!X)SX@("`@#0H@("`@("`@
M("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXR+FQE860N1#,@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`G/B`@#0H@
M("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXR+F%M="Y$,R!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O<#L@
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@<V]L:60[(%1%6%0M04Q)1TXZ
M(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P="<@8V]L<W!A;CTS1#(^("`@("`-
M"B`@("`@("`@("`\<"!I9#TS1%!!4D$S.#0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@8V5N=&5R.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^
M/&(^,C`Q,SPO8CX\+V9O;G0^("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O
M=RXR+G1R86EL+D0S('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!
M3"U!3$E'3CH@=&]P.R!0041$24Y'+4)/5%1/33H@,7!X)SX@("`@#0H@("`@
M("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@:60],T140DPS.30N9FEN4F]W
M+C,^("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF
M:6Y2;W<N,RYL96%D+D(R/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W
M+C,N<WEM8BY",CX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXS+F%M
M="Y",CX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C,N=')A:6PN0C(^
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C,N;&5A9"Y",SX@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXS+G-Y;6(N0C,^("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N,RYA;70N0C,^("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$
M5$),,SDT+F9I;E)O=RXS+G1R86EL+D(S/B`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@
M("`\='(@:60],T140DPS.30N9FEN4F]W+C0@<W1Y;&4],T0G0D%#2T=23U5.
M1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@/'1D('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF.R!724142#H@-S`E.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`@(`T*("`@("`@
M("`@(#QP(&ED/3-$4$%203,X-2!S='EL93TS1"=-05)'24XM0D]45$]-.B`P
M<'0[($U!4D=)3BU43U`Z(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SY3=&]C
M:R!O<'1I;VYS(&]U='-T86YD:6YG/"]F;VYT/B`-"B`@("`@("`@("`\+W`^
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y
M-"YF:6Y2;W<N-"YL96%D+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)
M1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#
M3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXT
M+G-Y;6(N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E
M969F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C0N86UT+C(@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q,B4[(%9%4E1)0T%,+4%,
M24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@
M,S@N-W!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@
M("`@(#8L-#4V(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#,Y-"YF:6Y2;W<N-"YT<F%I;"XR('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($U!
M4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G(&YO
M=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C0N
M;&5A9"XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E
M9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N-"YS>6UB+C,@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXT+F%M="XS('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!724142#H@,3(E.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.+4Q%1E0Z(#,X+C=P=#L@0D%#
M2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`V+#(W,"`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N
M9FEN4F]W+C0N=')A:6PN,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$
M5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@
M,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N;W=R87`],T1N;W=R
M87`^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@:60],T140DPS.30N9FEN4F]W
M+C4@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@("`-
M"B`@("`@("`@("`\<"!I9#TS1%!!4D$S.#@@<W1Y;&4],T0G34%21TE.+4)/
M5%1/33H@,'!T.R!-05)'24XM5$]0.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U
M)SX@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9B<^5V%R<F%N=',@;W5T<W1A;F1I;F<\+V9O;G0^(`T*("`@("`@("`@(#PO
M<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M,SDT+F9I;E)O=RXU+FQE860N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$
M+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W
M+C4N<WEM8BXR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-F
M9F9F9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N-2YA;70N,B!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$R)3L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494
M.B`S."XW<'0[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@
M("`@("`@-"PQ,#@@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),,SDT+F9I;E)O=RXU+G1R86EL+C(@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@
M34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<@
M;F]W<F%P/3-$;F]W<F%P/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N
M-2YL96%D+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F
M9F9F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXU+G-Y;6(N,R!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@:60],T140DPS.30N9FEN4F]W+C4N86UT+C,@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%=)1%1(.B`Q,B4[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,S@N-W!T.R!"
M04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`@(#,L.38Y
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y
M-"YF:6Y2;W<N-2YT<F%I;"XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!7
M24142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($U!4D=)3BU,1494
M.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G(&YO=W)A<#TS1&YO
M=W)A<#X@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!I9#TS1%1"3#,Y-"YF:6Y2
M;W<N-B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@
M(`T*("`@("`@("`@(#QP(&ED/3-$4$%203,Y,2!S='EL93TS1"=-05)'24XM
M0D]45$]-.B`P<'0[($U!4D=)3BU43U`Z(#!P=#L@3$E.12U(14E'2%0Z(#$N
M,C4G/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF)SY#;VUM;VX@<W1O8VL@=6YD97)L>6EN9R!C;VYV97)T:6)L92!N;W1E
M<R!O=71S=&%N9&EN9SPO9F]N=#X@("`@#0H@("`@("`@("`@/"]P/B`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN
M4F]W+C8N;&5A9"XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@
M,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z
M("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N-BYS>6UB
M+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXV+F%M="XR('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!724142#H@,3(E.R!615)424-!3"U!3$E'3CH@
M8F]T=&]M.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.+4Q%1E0Z(#,W+CEP
M=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`V
M+#4W."`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T14
M0DPS.30N9FEN4F]W+C8N=')A:6PN,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM
M3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N;W=R87`]
M,T1N;W=R87`^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXV+FQE860N
M,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!
M3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C8N<WEM8BXS('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#,Y-"YF:6Y2;W<N-BYA;70N,R!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5TE$5$@Z(#$R)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$58
M5"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`S-RXY<'0[($)!0TM'4D]5
M3D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@-BPQ.3@@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O
M=RXV+G1R86EL+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q
M)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@
M0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<@;F]W<F%P/3-$;F]W<F%P/B`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`\+W1R/B`@(`T*("`@(#PO=&%B;&4^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUP<F5H96YS:79E($EN8V]M
M92P@4&]L:6-Y(%M0;VQI8WD@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<"!I9#TS1%!!4D$S.38@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q
M+C(U)SX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^/&(^0V]M<')E
M:&5N<VEV92!);F-O;64@*$QO<W,I/"]B/CPO9F]N=#X@("`@#0H@("`@/"]P
M/CQB<B\^/'`@:60],T1005)!,SDX('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU
M<W1I9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`@#0H@
M("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
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M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3F5W($%C8V]U;G1I;F<@4')O;F]U;F-E;65N=',L(%!O;&EC>2!;4&]L:6-Y
M(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'`@:60],T1005)!-#`P('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[
M($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68G/CQB/E)E8V5N="!!8V-O=6YT:6YG(%!R;VYO
M=6YC96UE;G1S/"]B/CPO9F]N=#X@(`T*("`@(#PO<#X\8G(O/CQP(&ED/3-$
M4$%2030P,B!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'24XZ
M(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@(`T*("`@("`@/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68G/DEN($%U9W5S="`R,#$T+"!T:&4@1FEN
M86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A<F1S($)O87)D("@F(S@R,C`[1D%3
M0B8C.#(R,3LI(&ES<W5E9"!!8V-O=6YT:6YG(%-T86YD87)D<R!5<&1A=&4@
M*"8C.#(R,#M!4U4F(S@R,C$[*2!.;RX@,C`Q-"TQ-2P@/&D^4')E<V5N=&%T
M:6]N(&]F($9I;F%N8VEA;"!3=&%T96UE;G1S("8C.#(Q,3L@1V]I;F<@0V]N
M8V5R;B`H4W5B=&]P:6,@,C`U+30P*3PO:3X@*"8C.#(R,#M!4U4@,C`Q-"TQ
M-28C.#(R,3LI+B!!4U4@,C`Q-"TQ-2!R97%U:7)E<R!M86YA9V5M96YT('1O
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M86YS+"`H-2D@<F5Q=6ER92!A;B!E>'!R97-S('-T871E;65N="!A;F0@;W1H
M97(@9&ES8VQO<W5R97,@=VAE;B!S=6)S=&%N=&EA;"!D;W5B="!I<R`@#0H@
M("`@("!N;W0@86QL979I871E9"P@86YD("@V*2!R97%U:7)E(&%N(&%S<V5S
M<VUE;G0@9F]R(&$@<&5R:6]D(&]F(&]N92!Y96%R(&%F=&5R('1H92!D871E
M('1H870@=&AE(&9I;F%N8VEA;"!S871E;65N=',@87)E(&ES<W5E9"`H;W(@
M879A:6QA8FQE('1O(&)E(&ES<W5E9"DN(%1H92!A;65N9&UE;G1S(&EN($%3
M52`R,#$T+3$U(&%R92!E9F9E8W1I=F4@9F]R('1H92!A;FYU86P@<&5R:6]D
M(&5N9&EN9R!A9G1E<B!$96-E;6)E<B`Q-2P@,C`Q-BP@86YD(&9O<B!A;FYU
M86P@<&5R:6]D<R!A;F0@:6YT97)I;2!P97)I;V1S('1H97)E869T97(N($5A
M<FQY(&%D;W!T:6]N(&ES('!E<FUI='1E9"X@5V4@<&QA;B!T;R!A9&]P="!T
M:&4@<')O=FES:6]N<R!O;B!!4U4@,C`Q-"TQ-2!I;B`R,#$V+B!792!D;R!N
M;W0@97AP96-T('1H92!A9&]P=&EO;B!O9B!T:&ES($%352!T;R!H879E(&$@
M;6%T97)I86P@:6UP86-T(&]N(&]U<B!R97-U;'1S(&]F(&]P97)A=&EO;G,@
M;W(@9FEN86YC:6%L(&-O;F1I=&EO;BX\+V9O;G0^("`@#0H@("`@/"]P/CQB
M<B\^/'`@:60],T1005)!-#`T('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I
M9GD[($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`@#0H@("`@
M("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^26X@2G5N92`R,#$T
M+"!&05-"(&ES<W5E9"!!4U4@3F\N(#(P,30M,3(L(#QI/D-O;7!E;G-A=&EO
M;B`F(S@R,3$[(%-T;V-K($-O;7!E;G-A=&EO;B`H5&]P:6,@-S$X*3PO:3X@
M*"8C.#(R,#M!4U4@,C`Q-"TQ,B8C.#(R,3LI+B!!4U4@,C`Q-"TQ,B!R97%U
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M86UE;F1M96YT<R!I;B!!4U4@,C`Q-"TQ,B!M87D@96ET:&5R(&)E(&%P<&QI
M960@*&$I('!R;W-P96-T:79E;'D@=&\@86QL(&%W87)D<R!G<F%N=&5D(&]R
M(&UO9&EF:65D(&%F=&5R('1H92!E9F9E8W1I=F4@9&%T92!O<B`H8BD@<F5T
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M92!P<F]V:7-I;VYS(&]F($%352`R,#$T+3$R(&EN('1H92!F:7)S="!Q=6%R
M=&5R(&]F(#(P,38N(%=E(&1O(&YO="!E>'!E8W0@=&AE(&%D;W!T:6]N(&]F
M('1H:7,@("`-"B`@("`@($%352!T;R!H879E(&$@;6%T97)I86P@:6UP86-T
M(&]N(&]U<B!R97-U;'1S(&]F(&]P97)A=&EO;G,@;W(@9FEN86YC:6%L(&-O
M;F1I=&EO;BX\+V9O;G0^("`-"B`@("`\+W`^/&)R+SX\<"!I9#TS1%!!4D$T
M,#8@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0[
M($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF)SY);B!*=6QY(#(P,3,L('1H92!&05-"(&ES<W5E
M9"!!4U4@3F\N)B,Q-C`[,C`Q,RTQ,2P@/&D^4')E<V5N=&%T:6]N(&]F(&%N
M(%5N<F5C;V=N:7IE9"!487@@0F5N969I="!7:&5N(&$@3F5T($]P97)A=&EN
M9R!,;W-S($-A<G)Y9F]R=V%R9"P@82!3:6UI;&%R(%1A>"!,;W-S+"!O<B!A
M(%1A>"!#<F5D:70@0V%R<GEF;W)W87)D($5X:7-T<SPO:3X@*"8C.#(R,#M!
M4U4@,C`Q,RTQ,28C.#(R,3LI+B!4:&ES('5P9&%T92!P<F]V:61E<R!E>'!L
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M,C`Q,RP@=VET:"!A;B!O<'1I;VX@9F]R(&5A<FQY(&%D;W!T:6]N+B!792!A
M9&]P=&5D('1H:7,@9W5I9&%N8V4@:6X@,C`Q-"!A;F0@:70@9&ED(&YO="!H
M879E(&$@;6%T97)I86P@:6UP86-T(&]N(&]U<B!F:6YA;F-I86P@8V]N9&ET
M:6]N+"!R97-U;'1S(&]F(&]P97)A=&EO;G,@;W(@<F5L871E9"!F:6YA;F-I
M86P@<W1A=&5M96YT(&1I<V-L;W-U<F5S+CPO9F]N=#X\+W`^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q93<S-#`V95\S93<R
M7S1E-&5?.&4V-5\X9&,V9&%A93DW-V8-"D-O;G1E;G0M3&]C871I;VXZ(&9I
M;&4Z+R\O0SHO,64W,S0P-F5?,V4W,E\T931E7SAE-C5?.&1C-F1A864Y-S=F
M+U=O<FMS:&5E=',O4VAE970Q,BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N
M8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O
M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/DYO=&4@,R`M($%C8V]U;G1I;F<@4&]L:6-I97,@
M*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P
M+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY!8V-O=6YT:6YG(%!O;&EC:65S(%M!8G-T<F%C=%T\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D
M=6QE(&]F($%N=&ED:6QU=&EV92!396-U<FET:65S($5X8VQU9&5D(&9R;VT@
M0V]M<'5T871I;VX@;V8@16%R;FEN9W,@4&5R(%-H87)E(%M486)L92!497AT
M($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQT86)L
M92!I9#TS1%1"3#,Y-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z
M(#$P,"4[(%1%6%0M24Y$14Y4.B`P<'@G(&-E;&QS<&%C:6YG/3-$,"!C96QL
M<&%D9&EN9STS1#`@8F]R9&5R/3-$,#X@(`T*("`@("`@/'1R(&ED/3-$5$),
M,SDT+F9I;E)O=RXQ/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`G/B`@(`T*("`@("`@("`@
M(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N,2YL96%D+D0S('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@=&]P)SX@(`T*("`@
M("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N,2YA;70N1#,@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`[($)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C
M96YT97([($U!4D=)3BU,1494.B`P<'0G(&-O;'-P86X],T0V/B`@("`@#0H@
M("`@("`@("`@/'`@:60],T1005)!,S@Q('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&-E;G1E<CL@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB
M/CPO8CX\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@
M(#QP(&ED/3-$4$%203,X,B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([
M($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SX\8CY!<R!O9B!3
M97!T96UB97(@,S`\+V(^/&(^+#PO8CX\+V9O;G0^("`@#0H@("`@("`@("`@
M/"]P/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T14
M0DPS.30N9FEN4F]W+C$N=')A:6PN1#,@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%9%4E1)0T%,+4%,24=..B!T;W`[($)/4D1%4BU"3U143TTZ(&UE9&EU
M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,7!X)SX@(`T*("`@("`@("`@(#QB
M/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\
M+W1R/B`@(`T*("`@("`@/'1R(&ED/3-$5$),,SDT+F9I;E)O=RXR/B`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,
M+4%,24=..B!T;W`G/B`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y
M-"YF:6Y2;W<N,BYL96%D+D0R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!6
M15)424-!3"U!3$E'3CH@=&]P)SX@(`T*("`@("`@("`@(#QB/B8C,38P.SPO
M8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#,Y-"YF:6Y2;W<N,BYA;70N1#(@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%9%4E1)0T%,+4%,24=..B!T;W`[($)/4D1%4BU"3U143TTZ(",P,#`P
M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($U!4D=)3BU,1494
M.B`P<'0G(&-O;'-P86X],T0R/B`@("`@#0H@("`@("`@("`@/'`@:60],T10
M05)!,S@S('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P
M<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/C(P,30\+V(^/"]F;VYT/B`@
M("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N,BYT<F%I;"Y$,B!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O<#L@4$%$1$E.
M1RU"3U143TTZ(#%P>"<^("`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@
M("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#,Y-"YF:6Y2;W<N,BYL96%D+D0S('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M.R!615)424-!3"U!3$E'3CH@=&]P)SX@(`T*("`@("`@("`@(#QB/B8C,38P
M.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#,Y-"YF:6Y2;W<N,BYA;70N1#,@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`[($)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($U!4D=)3BU,
M1494.B`P<'0G(&-O;'-P86X],T0R/B`@("`@#0H@("`@("`@("`@/'`@:60]
M,T1005)!,S@T('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.
M.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/C(P,3,\+V(^/"]F;VYT
M/B`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N,BYT<F%I;"Y$,R!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O<#L@4$%$
M1$E.1RU"3U143TTZ(#%P>"<^("`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO
M8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*
M("`@("`@/'1R(&ED/3-$5$),,SDT+F9I;E)O=RXS/B`@(`T*("`@("`@("`\
M=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C,N;&5A9"Y",CX@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXS+G-Y;6(N0C(^("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N,RYA;70N0C(^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),,SDT+F9I;E)O=RXS+G1R86EL+D(R/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$
M5$),,SDT+F9I;E)O=RXS+FQE860N0C,^("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y
M-"YF:6Y2;W<N,RYS>6UB+D(S/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN
M4F]W+C,N86UT+D(S/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N,RYT
M<F%I;"Y",SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R(&ED/3-$5$),,SDT
M+F9I;E)O=RXT('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G
M/B`@#0H@("`@("`@(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$
M5$@Z(#<P)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#
M3TQ/4CH@(V-C965F9B<^("`@("`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$S
M.#4@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!-05)'24XM5$]0.B`P
M<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9B<^4W1O8VL@;W!T:6]N<R!O=71S=&%N
M9&EN9SPO9F]N=#X@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C0N;&5A9"XR
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N-"YS>6UB+C(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),,SDT+F9I;E)O=RXT+F%M="XR('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF.R!724142#H@,3(E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4
M+4%,24=..B!R:6=H=#L@34%21TE.+4Q%1E0Z(#,X+C=P=#L@0D%#2T=23U5.
M1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`V+#0U-B`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W
M+C0N=')A:6PN,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T.R!"
M04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N;W=R87`],T1N;W=R87`^("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXT+FQE860N,R!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60]
M,T140DPS.30N9FEN4F]W+C0N<WEM8BXS('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'
M4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF
M:6Y2;W<N-"YA;70N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z
M(#$R)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@<FEG
M:'0[($U!4D=)3BU,1494.B`S."XW<'0[($)!0TM'4D]53D0M0T],3U(Z("-C
M8V5E9F8G/B`@#0H@("`@("`@("`@-BPR-S`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXT+G1R86EL+C,@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#
M3TQ/4CH@(V-C965F9B<@;F]W<F%P/3-$;F]W<F%P/B`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*
M("`@("`@/'1R(&ED/3-$5$),,SDT+F9I;E)O=RXU('-T>6QE/3-$)T)!0TM'
M4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#
M2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@#0H@("`@("`@("`@/'`@:60]
M,T1005)!,S@X('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@34%21TE.
M+51/4#H@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/E=A<G)A;G1S(&]U='-T
M86YD:6YG/"]F;VYT/B`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N-2YL96%D
M+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXU+G-Y;6(N,B!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@
M8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPS.30N9FEN4F]W+C4N86UT+C(@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68[(%=)1%1(.B`Q,B4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%
M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,S@N-W!T.R!"04-+1U)/
M54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`@(#0L,3`X(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2
M;W<N-2YT<F%I;"XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@
M,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[
M($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G(&YO=W)A<#TS1&YO=W)A<#X@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C4N;&5A9"XS('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#,Y-"YF:6Y2;W<N-2YS>6UB+C,@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#
M2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT
M+F9I;E)O=RXU+F%M="XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!72414
M2#H@,3(E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4+4%,24=..B!R
M:6=H=#L@34%21TE.+4Q%1E0Z(#,X+C=P=#L@0D%#2T=23U5.1"U#3TQ/4CH@
M(V9F9F9F9B<^("`-"B`@("`@("`@("`S+#DV.2`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W+C4N=')A:6PN
M,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!
M3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$
M+4-/3$]2.B`C9F9F9F9F)R!N;W=R87`],T1N;W=R87`^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@
M#0H@("`@("`\='(@:60],T140DPS.30N9FEN4F]W+C8@<W1Y;&4],T0G0D%#
M2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"
M04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`-"B`@("`@("`@("`\<"!I
M9#TS1%!!4D$S.3$@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!-05)'
M24XM5$]0.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^0V]M;6]N('-T;V-K
M('5N9&5R;'EI;F<@8V]N=F5R=&EB;&4@;F]T97,@;W5T<W1A;F1I;F<\+V9O
M;G0^("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXV+FQE860N,B!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'
M3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@:60],T140DPS.30N9FEN4F]W+C8N<WEM8BXR('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[
M($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#,Y-"YF:6Y2;W<N-BYA;70N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5TE$5$@Z(#$R)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'
M3CH@<FEG:'0[($U!4D=)3BU,1494.B`S-RXY<'0[($)!0TM'4D]53D0M0T],
M3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@-BPU-S@@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),,SDT+F9I;E)O=RXV+G1R
M86EL+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=2
M3U5.1"U#3TQ/4CH@(V-C965F9B<@;F]W<F%P/3-$;F]W<F%P/B`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N-BYL96%D+C,@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@
M0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M,SDT+F9I;E)O=RXV+G-Y;6(N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$
M+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPS.30N9FEN4F]W
M+C8N86UT+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q,B4[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!-
M05)'24XM3$5&5#H@,S<N.7!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F
M)SX@(`T*("`@("`@("`@(#8L,3DX(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#,Y-"YF:6Y2;W<N-BYT<F%I;"XS('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z
M("-C8V5E9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`\
M+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?,64W,S0P-F5?,V4W,E\T931E7SAE-C5?.&1C-F1A864Y-S=F#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S%E-S,T,#9E7S-E-S)?-&4T95\X
M938U7SAD8S9D86%E.3<W9B]7;W)K<VAE971S+U-H965T,3,N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$561$%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@-2`M(%-T
M;V-K:&]L9&5R<R<@17%U:71Y("A486)L97,I/&)R/CPO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]T92`U("T@4W1O8VMH
M;VQD97)S)R!%<75I='D@*%1A8FQE<RD@6TQI;F4@271E;7-=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE9'5L92!O
M9B!%;7!L;WEE92!397)V:6-E(%-H87)E+6)A<V5D($-O;7!E;G-A=&EO;BP@
M06QL;V-A=&EO;B!O9B!296-O9VYI>F5D(%!E<FEO9"!#;W-T<R!;5&%B;&4@
M5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M=&%B;&4@:60],T140DPT.3`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)
M1%1(.B`Q,#`E.R!415A4+4E.1$5.5#H@,'!X)R!C96QL<W!A8VEN9STS1#`@
M8V5L;'!A9&1I;F<],T0P(&)O<F1E<CTS1#`^("`@(`T*("`@("`@/'1R(&ED
M/3-$5$),-#DP+F9I;E)O=RXQ/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`G/B`@(`T*("`@
M("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,2YL96%D+D0S('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@=&]P)SX@
M(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,2YA;70N
M1#,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T
M;W`[($)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,
M24=..B!C96YT97([($U!4D=)3BU,1494.B`P<'0G(&-O;'-P86X],T0V/B`@
M("`@#0H@("`@("`@("`@/'`@:60],T1005)!-#8P('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U
M)SX@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68G/CQB/CPO8CX\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@
M("`@("`@(#QP(&ED/3-$4$%2030V,2!S='EL93TS1"=415A4+4%,24=..B!C
M96YT97([($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SX\8CY4
M:')E92!-;VYT:',@16YD960\+V(^/"]F;VYT/B`@(`T*("`@("`@("`@(#PO
M<#X@#0H@("`@("`@("`@/'`@:60],T1005)!-#8R('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U
M)SX@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68G/CQB/E-E<'1E;6)E<B`S,#PO8CX\8CXL/"]B/CPO9F]N=#X@(`T*("`@
M("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),-#DP+F9I;E)O=RXQ+G1R86EL+D0S('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@=&]P.R!"3U)$15(M0D]45$]-
M.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#%P>"<^("`-"B`@("`@
M("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C$N;&5A9"Y$-2!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O<"<^("`-
M"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C$N86UT+D0U
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@=&]P
M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'
M3CH@8V5N=&5R.R!-05)'24XM3$5&5#H@,'!T)R!C;VQS<&%N/3-$-CX@("`@
M(`T*("`@("`@("`@(#QP(&ED/3-$4$%2030V,R!S='EL93TS1"=415A4+4%,
M24=..B!C96YT97([($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M)SX\8CX\+V(^/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@
M("`@("`\<"!I9#TS1%!!4D$T-C0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N
M=&5R.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^/&(^3FEN
M93PO8CX@/&(^36]N=&AS($5N9&5D/"]B/CPO9F]N=#X@#0H@("`@("`@("`@
M/"]P/B`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$T-C4@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N
M,C4G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9B<^/&(^4V5P=&5M8F5R(#,P/"]B/CQB/BP\+V(^/"]F;VYT/B`@#0H@
M("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@:60],T140DPT.3`N9FEN4F]W+C$N=')A:6PN1#4@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`[($)/4D1%4BU"3U14
M3TTZ(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,7!X)SX@(`T*("`@
M("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R(&ED/3-$5$),-#DP+F9I;E)O
M=RXR/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%9%4E1)0T%,+4%,24=..B!T;W`G/B`@(`T*("`@("`@("`@(#QB/B8C,38P
M.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#0Y,"YF:6Y2;W<N,BYL96%D+D0R('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!615)424-!3"U!3$E'3CH@=&]P)SX@(`T*("`@("`@("`@(#QB
M/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,BYA;70N1#(@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`[($)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($U!
M4D=)3BU,1494.B`P<'0G(&-O;'-P86X],T0R/B`@("`@#0H@("`@("`@("`@
M/'`@:60],T1005)!-#8V('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@
M34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/C(P,30\+V(^
M/"]F;VYT/B`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,BYT<F%I;"Y$
M,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ('1O
M<#L@4$%$1$E.1RU"3U143TTZ(#%P>"<^("`@(`T*("`@("`@("`@(#QB/B8C
M,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,BYL96%D+D0S('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@=&]P)SX@(`T*("`@("`@("`@
M(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,BYA;70N1#,@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`[($)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([
M($U!4D=)3BU,1494.B`P<'0G(&-O;'-P86X],T0R/B`@("`@#0H@("`@("`@
M("`@/'`@:60],T1005)!-#8W('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E
M<CL@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/C(P,3,\
M+V(^/"]F;VYT/B`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,BYT<F%I
M;"Y$,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ
M('1O<#L@4$%$1$E.1RU"3U143TTZ(#%P>"<^("`@(`T*("`@("`@("`@(#QB
M/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,BYL96%D+D0T('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@=&]P)SX@(`T*("`@("`@
M("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,BYA;70N1#0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`[($)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT
M97([($U!4D=)3BU,1494.B`P<'0G(&-O;'-P86X],T0R/B`@("`@#0H@("`@
M("`@("`@/'`@:60],T1005)!-#8X('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E
M;G1E<CL@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB/C(P
M,30\+V(^/"]F;VYT/B`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,BYT
M<F%I;"Y$-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)
M1TXZ('1O<#L@4$%$1$E.1RU"3U143TTZ(#%P>"<^("`@(`T*("`@("`@("`@
M(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,BYL96%D+D0U('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@=&]P)SX@(`T*("`@
M("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,BYA;70N1#4@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`[($)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C
M96YT97([($U!4D=)3BU,1494.B`P<'0G(&-O;'-P86X],T0R/B`@("`@#0H@
M("`@("`@("`@/'`@:60],T1005)!-#8Y('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&-E;G1E<CL@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/CQB
M/C(P,3,\+V(^/"]F;VYT/B`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N
M,BYT<F%I;"Y$-2!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM
M04Q)1TXZ('1O<#L@4$%$1$E.1RU"3U143TTZ(#%P>"<^("`@(`T*("`@("`@
M("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`\+W1R/B`@(`T*("`@("`@/'1R(&ED/3-$5$),-#DP+F9I;E)O=RXS
M/B`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN
M4F]W+C,N;&5A9"Y",CX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXS
M+G-Y;6(N0C(^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,RYA;70N
M0C(^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXS+G1R86EL+D(R/B`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXS+FQE860N0C,^("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,RYS>6UB+D(S/B`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPT.3`N9FEN4F]W+C,N86UT+D(S/B`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#0Y,"YF:6Y2;W<N,RYT<F%I;"Y",SX@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y
M,"YF:6Y2;W<N,RYL96%D+D(T/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN
M4F]W+C,N<WEM8BY"-#X@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXS
M+F%M="Y"-#X@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C,N=')A:6PN
M0C0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C,N;&5A9"Y"-3X@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXS+G-Y;6(N0C4^("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N,RYA;70N0C4^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-#DP+F9I;E)O=RXS+G1R86EL+D(U/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@
M("`@("`\='(@:60],T140DPT.3`N9FEN4F]W+C0@<W1Y;&4],T0G0D%#2T=2
M3U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!724142#H@-3(E.R!615)424-!3"U!3$E'3CH@
M8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`@(`T*("`@
M("`@("`@(#QP(&ED/3-$4$%2030W,"!S='EL93TS1"=-05)'24XM0D]45$]-
M.B`P<'0[($U!4D=)3BU43U`Z(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SY2
M97-E87)C:"!A;F0@9&5V96QO<&UE;G0\+V9O;G0^("`@("`-"B`@("`@("`@
M("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#0Y,"YF:6Y2;W<N-"YL96%D+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2
M3U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I
M;E)O=RXT+G-Y;6(N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z
M(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T
M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`@(`T*("`@("`@("`@
M("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#0Y,"YF:6Y2;W<N-"YA;70N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5TE$5$@Z(#DE.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4+4%,24=.
M.B!R:6=H=#L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@
M(V-C965F9B<^("`@#0H@("`@("`@("`@-S$U("`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-"YT<F%I
M;"XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)
M0T%,+4%,24=..B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]5
M3D0M0T],3U(Z("-C8V5E9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPT.3`N9FEN4F]W+C0N;&5A9"XS('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!
M0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y
M,"YF:6Y2;W<N-"YS>6UB+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)
M1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%1E0Z
M(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@("`-"B`@("`@
M("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60]
M,T140DPT.3`N9FEN4F]W+C0N86UT+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%=)1%1(.B`Y)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!
M3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],
M3U(Z("-C8V5E9F8G/B`@(`T*("`@("`@("`@(#<P,B`@("`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C0N
M=')A:6PN,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T.R!"04-+
M1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N;W=R87`],T1N;W=R87`^("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXT+FQE860N-"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T14
M0DPT.3`N9FEN4F]W+C0N<WEM8BXT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($U!4D=)3BU,
M1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@("`@#0H@
M("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),-#DP+F9I;E)O=RXT+F%M="XT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!724142#H@.24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%
M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$
M+4-/3$]2.B`C8V-E969F)SX@("`-"B`@("`@("`@("`R+#0R,R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W
M+C0N=')A:6PN-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T.R!"
M04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N;W=R87`],T1N;W=R87`^("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXT+FQE860N-2!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60]
M,T140DPT.3`N9FEN4F]W+C0N<WEM8BXU('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($U!4D=)
M3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@("`@
M#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXT+F%M="XU('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!724142#H@.24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[
M(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/
M54Y$+4-/3$]2.B`C8V-E969F)SX@("`-"B`@("`@("`@("`Q+#0Y,B`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN
M4F]W+C0N=')A:6PN-2!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z
M(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T
M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N;W=R87`],T1N;W=R87`^
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@(#PO='(^("`@#0H@("`@("`\='(@:60],T140DPT.3`N9FEN4F]W+C4@
M<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'
M3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@("`-"B`@
M("`@("`@("`\<"!I9#TS1%!!4D$T-S4@<W1Y;&4],T0G34%21TE.+4)/5%1/
M33H@,'!T.R!-05)'24XM5$]0.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^
M1V5N97)A;"!A;F0@861M:6YI<W1R871I=F4\+V9O;G0^("`-"B`@("`@("`@
M("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#0Y,"YF:6Y2;W<N-2YL96%D+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2
M3U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I
M;E)O=RXU+G-Y;6(N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z
M(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B`C
M,#`P,#`P(#%P>"!S;VQI9#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C4N86UT+C(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Y)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@<V]L:60[(%1%6%0M
M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,S@N-W!T.R!"04-+1U)/54Y$
M+4-/3$]2.B`C9F9F9F9F)SX@("`@(`T*("`@("`@("`@(#$L,#0U(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2
M;W<N-2YT<F%I;"XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@
M,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%!!1$1)3D<M0D]45$]-.B`Q
M<'@[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F
M9F8G(&YO=W)A<#TS1&YO=W)A<#X@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I
M;E)O=RXU+FQE860N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z
M(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2
M.B`C9F9F9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C4N<WEM
M8BXS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)
M0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X
M('-O;&ED.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#0Y,"YF:6Y2;W<N-2YA;70N,R!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5TE$5$@Z(#DE.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG
M:'0[($U!4D=)3BU,1494.B`S."XW<'0[($)!0TM'4D]53D0M0T],3U(Z("-F
M9F9F9F8G/B`@("`@#0H@("`@("`@("`@,RPS.3,@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXU+G1R86EL
M+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@4$%$1$E.1RU"3U143TTZ(#%P>#L@34%21TE.
M+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<@;F]W<F%P
M/3-$;F]W<F%P/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C4N;&5A
M9"XT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)
M0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G
M/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-2YS>6UB+C0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@<V]L:60[($)!
M0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP
M+F9I;E)O=RXU+F%M="XT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!72414
M2#H@.24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.
M+4Q%1E0Z(#,X+C=P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@
M("`-"B`@("`@("`@("`S+#,X-B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C4N=')A:6PN-"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@
M8F]T=&]M.R!0041$24Y'+4)/5%1/33H@,7!X.R!-05)'24XM3$5&5#H@,'!T
M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)R!N;W=R87`],T1N;W=R87`^
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-2YL96%D+C4@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),-#DP+F9I;E)O=RXU+G-Y;6(N-2!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@0D%#2T=23U5.1"U#
M3TQ/4CH@(V9F9F9F9B<^(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C4N
M86UT+C4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Y)3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,S@N
M-W!T.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@("`@(`T*("`@("`@
M("`@(#8L.#0Q(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#0Y,"YF:6Y2;W<N-2YT<F%I;"XU('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%!!
M1$1)3D<M0D]45$]-.B`Q<'@[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]5
M3D0M0T],3U(Z("-F9F9F9F8G(&YO=W)A<#TS1&YO=W)A<#X@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(@:60],T140DPT.3`N9FEN4F]W+C8@<W1Y;&4],T0G
M0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`-"B`@("`@("`@("`\
M<"!I9#TS1%!!4D$T.#`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!-
M05)'24XM5$]0.B`P<'0[($Q)3D4M2$5)1TA4.B`Q+C(U)SX@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^4W1O8VLM8F%S
M960@8V]M<&5N<V%T:6]N(&5X<&5N<V4@:6YC;'5D960@:6X@;W!E<F%T:6YG
M(&5X<&5N<V5S/"]F;VYT/B`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N
M-BYL96%D+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C
M965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXV+G-Y;6(N,B!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B
M;&4[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E
M9F8G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXV+F%M="XR('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@.24[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@
M5$585"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]5
M3D0M0T],3U(Z("-C8V5E9F8G/B`@(`T*("`@("`@("`@(#$L-S8P(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2
M;W<N-BYT<F%I;"XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@
M,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%!!1$1)3D<M0D]45$]-.B`S
M<'@[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E
M9F8G(&YO=W)A<#TS1&YO=W)A<#X@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I
M;E)O=RXV+FQE860N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z
M(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2
M.B`C8V-E969F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C8N<WEM
M8BXS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)
M0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X
M(&1O=6)L93L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@
M(V-C965F9B<^("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C8N86UT+C,@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Y)3L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`S<'@@9&]U
M8FQE.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#
M2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@#0H@("`@("`@("`@-"PP.34@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP
M+F9I;E)O=RXV+G1R86EL+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)
M1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@4$%$1$E.1RU"3U14
M3TTZ(#-P>#L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@
M(V-C965F9B<@;F]W<F%P/3-$;F]W<F%P/B`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT
M.3`N9FEN4F]W+C8N;&5A9"XT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!7
M24142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M
M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N
M-BYS>6UB+C0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P
M,"`S<'@@9&]U8FQE.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/
M3$]2.B`C8V-E969F)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N-BYA
M;70N-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#DE.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P
M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,'!T
M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`-"B`@("`@("`@("`U
M+#@P.2`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T14
M0DPT.3`N9FEN4F]W+C8N=')A:6PN-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!0041$24Y'
M+4)/5%1/33H@,W!X.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/
M3$]2.B`C8V-E969F)R!N;W=R87`],T1N;W=R87`^("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#0Y,"YF:6Y2;W<N-BYL96%D+C4@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2
M3U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I
M;E)O=RXV+G-Y;6(N-2!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z
M(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B`C
M,#`P,#`P(#-P>"!D;W5B;&4[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]5
M3D0M0T],3U(Z("-C8V5E9F8G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O
M=RXV+F%M="XU('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@.24[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(",P,#`P
M,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494
M.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@(`T*("`@("`@
M("`@(#@L,S,S(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#0Y,"YF:6Y2;W<N-BYT<F%I;"XU('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%!!
M1$1)3D<M0D]45$]-.B`S<'@[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]5
M3D0M0T],3U(Z("-C8V5E9F8G(&YO=W)A<#TS1&YO=W)A<#X@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(@:60],T140DPT.3`N9FEN4F]W+C<@<W1Y;&4],T0G
M0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPT.3`N9FEN4F]W+C<N;&5A9"Y",B!S='EL93TS1"="04-+1U)/
M54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN
M4F]W+C<N<WEM8BY",B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C9F9F
M9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C<N86UT+D(R('-T
M>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-#DP+F9I;E)O=RXW+G1R86EL+D(R('-T>6QE/3-$)T)!0TM'4D]5
M3D0M0T],3U(Z("-F9F9F9F8G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN
M4F]W+C<N;&5A9"Y",R!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C9F9F
M9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C<N<WEM8BY",R!S
M='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPT.3`N9FEN4F]W+C<N86UT+D(S('-T>6QE/3-$)T)!0TM'4D]5
M3D0M0T],3U(Z("-F9F9F9F8G/B`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O
M=RXW+G1R86EL+D(S('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F
M9F8G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C<N;&5A9"Y"-"!S
M='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPT.3`N9FEN4F]W+C<N<WEM8BY"-"!S='EL93TS1"="04-+1U)/
M54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN
M4F]W+C<N86UT+D(T('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F
M9F8G/B`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXW+G1R86EL+D(T('-T
M>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M:60],T140DPT.3`N9FEN4F]W+C<N;&5A9"Y"-2!S='EL93TS1"="04-+1U)/
M54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN
M4F]W+C<N<WEM8BY"-2!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C9F9F
M9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C<N86UT+D(U('-T
M>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-#DP+F9I;E)O=RXW+G1R86EL+D(U('-T>6QE/3-$)T)!0TM'4D]5
M3D0M0T],3U(Z("-F9F9F9F8G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!I
M9#TS1%1"3#0Y,"YF:6Y2;W<N."!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2
M.B`C8V-E969F)SX@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68[(%9%4E1)0T%,+4%,24=..B!T;W`[($)!0TM'4D]53D0M0T],3U(Z
M("-C8V5E9F8G/B`@("`@#0H@("`@("`@("`@/'`@:60],T1005)!-#@U('-T
M>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@34%21TE.+51/4#H@,'!T.R!,
M24Y%+4A%24=(5#H@,2XR-2<^(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68G/DEM<&%C="!O;B!B87-I8R!A;F0@9&EL=71E
M9"!N970@;&]S<R!P97(@<VAA<F4\+V9O;G0^("`-"B`@("`@("`@("`\+W`^
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y
M,"YF:6Y2;W<N."YL96%D+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)
M1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#
M3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXX
M+G-Y;6(N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#-P>"!D;W5B;&4[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],
M3U(Z("-C8V5E9F8G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXX+F%M
M="XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@.24[(%9%4E1)
M0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X
M(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,1494.B`P<'0[
M($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@(`T*("`@("`@("`@(#`N
M,#8@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#0Y,"YF:6Y2;W<N."YT<F%I;"XR('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%!!1$1)
M3D<M0D]45$]-.B`S<'@[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M
M0T],3U(Z("-C8V5E9F8G(&YO=W)A<#TS1&YO=W)A<#X@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-#DP+F9I;E)O=RXX+FQE860N,R!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+
M1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N
M9FEN4F]W+C@N<WEM8BXS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!72414
M2#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,W!X(&1O=6)L93L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=2
M3U5.1"U#3TQ/4CH@(V-C965F9B<^("`@("`-"B`@("`@("`@("`D("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPT.3`N9FEN
M4F]W+C@N86UT+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Y
M)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P
M,#`P,"`S<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.+4Q%
M1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@#0H@("`@
M("`@("`@,"XR-R`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXX+G1R86EL+C,@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@4$%$1$E.1RU"3U143TTZ(#-P>#L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#
M2T=23U5.1"U#3TQ/4CH@(V-C965F9B<@;F]W<F%P/3-$;F]W<F%P/B`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@:60],T140DPT.3`N9FEN4F]W+C@N;&5A9"XT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#0Y,"YF:6Y2;W<N."YS>6UB+C0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52
M+4)/5%1/33H@(S`P,#`P,"`S<'@@9&]U8FQE.R!-05)'24XM3$5&5#H@,'!T
M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`@(`T*("`@("`@("`@
M("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#0Y,"YF:6Y2;W<N."YA;70N-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5TE$5$@Z(#DE.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]4
M5$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!-
M05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@
M("`-"B`@("`@("`@("`P+C(S("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@:60],T140DPT.3`N9FEN4F]W+C@N=')A:6PN-"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'
M3CH@8F]T=&]M.R!0041$24Y'+4)/5%1/33H@,W!X.R!-05)'24XM3$5&5#H@
M,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N;W=R87`],T1N;W=R
M87`^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N."YL96%D+C4@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-#DP+F9I;E)O=RXX+G-Y;6(N-2!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[($U!4D=)3BU,
M1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@("`@#0H@
M("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),-#DP+F9I;E)O=RXX+F%M="XU('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!724142#H@.24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@
M<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C
M8V5E9F8G/B`@(`T*("`@("`@("`@(#`N-30@("`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#0Y,"YF:6Y2;W<N."YT<F%I
M;"XU('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)
M0T%,+4%,24=..B!B;W1T;VT[(%!!1$1)3D<M0D]45$]-.B`S<'@[($U!4D=)
M3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G(&YO=W)A
M<#TS1&YO=W)A<#X@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@/"]T86)L93X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D
M=6QE(&]F(%-H87)E+6)A<V5D($-O;7!E;G-A=&EO;BP@06-T:79I='D@6U1A
M8FQE(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'1A8FQE(&ED/3-$5$),-34X('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M.R!724142#H@,3`P)3L@5$585"U)3D1%3E0Z(#!P>"<@8V5L;'-P86-I;F<]
M,T0P(&-E;&QP861D:6YG/3-$,"!B;W)D97(],T0P/B`@("`-"B`@("`@(#QT
M<B!I9#TS1%1"3#4U."YF:6Y2;W<N,3X@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@
M#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ+FQE860N
M0C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VTG/B`@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I
M;E)O=RXQ+G-Y;6(N0C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)
M0T%,+4%,24=..B!B;W1T;VTG/B`@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[
M/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-34X+F9I;E)O=RXQ+F%M="Y",B!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@8V5N
M=&5R)SX@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O
M=RXQ+G1R86EL+D(R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!
M3"U!3$E'3CH@8F]T=&]M)SX@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M-34X+F9I;E)O=RXQ+FQE860N0C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`@("`@#0H@("`@("`@("`@/&(^
M)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ+G-Y;6(N0C,@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`@("`@#0H@
M("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ+F%M="Y",R!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@5$585"U!3$E'3CH@8V5N=&5R)SX@("`@#0H@("`@("`@("`@/&(^)B,Q
M-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),-34X+F9I;E)O=RXQ+G1R86EL+D(S('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@#0H@("`@("`@
M("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ+FQE860N1#0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`@
M("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ+F%M
M="Y$-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XM3$5&5#H@,'!T
M)R!C;VQS<&%N/3-$,CX@("`@#0H@("`@("`@("`@/'`@:60],T1005)!-3(R
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0[($Q)
M3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68G/CQB/E=E:6=H=&5D+3PO8CX\+V9O;G0^("`@
M(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ+G1R86EL+D0T('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@#0H@
M("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@:60],T140DPU-3@N9FEN
M4F]W+C(^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(`T*("`@("`@("`@(#QB/B8C
M,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!I9#TS1%1"3#4U."YF:6Y2;W<N,BYL96%D+D(R('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@(`T*("`@
M("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,BYS>6UB+D(R('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M)SX@("`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N
M,BYA;70N0C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,
M24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^("`@(`T*("`@("`@
M("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,BYT<F%I;"Y",B!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^
M(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,BYL96%D
M+D(S('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@
M8F]T=&]M)SX@("`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF
M:6Y2;W<N,BYS>6UB+D(S('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M)SX@("`@(`T*("`@("`@("`@(#QB/B8C,38P
M.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#4U."YF:6Y2;W<N,BYA;70N0C,@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(&-E
M;G1E<B<^("`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2
M;W<N,BYT<F%I;"Y",R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#
M04PM04Q)1TXZ(&)O='1O;2<^(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@
M("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#4U."YF:6Y2;W<N,BYL96%D+D0T('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@(`T*("`@("`@("`@(#QB
M/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,BYA;70N1#0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)
M1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P="<@8V]L<W!A;CTS1#(^("`@
M(`T*("`@("`@("`@(#QP(&ED/3-$4$%2034R-"!S='EL93TS1"=415A4+4%,
M24=..B!C96YT97([($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M)SX\8CY!=F5R86=E/"]B/CPO9F]N=#X@(`T*("`@("`@("`@(#PO<#X@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I
M;E)O=RXR+G1R86EL+D0T('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M)SX@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B
M/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@
M("`@("`\='(@:60],T140DPU-3@N9FEN4F]W+C,^("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O
M='1O;2<^(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N
M,RYL96%D+D(R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M)SX@("`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@
M("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#4U."YF:6Y2;W<N,RYS>6UB+D(R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@(`T*("`@("`@("`@(#QB
M/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,RYA;70N0C(@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)
M1TXZ(&-E;G1E<B<^("`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U
M."YF:6Y2;W<N,RYT<F%I;"Y",B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(`T*("`@("`@("`@(#QB/B8C,38P
M.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#4U."YF:6Y2;W<N,RYL96%D+D0S('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@(`T*("`@("`@
M("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,RYA;70N1#,@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%
M6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P="<@8V]L<W!A;CTS
M1#(^("`@(`T*("`@("`@("`@(#QP(&ED/3-$4$%2034R-B!S='EL93TS1"=4
M15A4+4%,24=..B!C96YT97([($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@
M,2XR-2<^("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF)SX\8CY796EG:'1E9"T\+V(^/"]F;VYT/B`@("`-"B`@("`@("`@
M("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#4U."YF:6Y2;W<N,RYT<F%I;"Y$,R!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(`T*("`@("`@("`@(#QB
M/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,RYL96%D+D0T('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@(`T*
M("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,RYA;70N1#0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VT[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P="<@8V]L
M<W!A;CTS1#(^("`@(`T*("`@("`@("`@(#QP(&ED/3-$4$%2034R-R!S='EL
M93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@,'!T.R!,24Y%+4A%
M24=(5#H@,2XR-2<^("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF)SX\8CY296UA:6YI;F<\+V(^/"]F;VYT/B`@("`-"B`@
M("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!I9#TS1%1"3#4U."YF:6Y2;W<N,RYT<F%I;"Y$-"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(`T*("`@("`@
M("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`\+W1R/B`@(`T*("`@("`@/'1R(&ED/3-$5$),-34X+F9I;E)O=RXT
M/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VTG/B`-"B`@("`@("`@("`\8CXF(S$V,#L\
M+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60]
M,T140DPU-3@N9FEN4F]W+C0N;&5A9"Y",B!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^("`@("`-"B`@("`@("`@
M("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C0N<WEM8BY",B!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^("`@
M("`-"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C0N86UT
M+D(R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@
M8F]T=&]M.R!415A4+4%,24=..B!C96YT97(G/B`@("`-"B`@("`@("`@("`\
M8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@:60],T140DPU-3@N9FEN4F]W+C0N=')A:6PN0C(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`-"B`@
M("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C0N;&5A9"Y$,R!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O
M;2<^("`@("`-"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W
M+C0N86UT+D0S('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M.R!415A4+4%,24=..B!C96YT97([($U!4D=)3BU,1494
M.B`P<'0G(&-O;'-P86X],T0R/B`@("`-"B`@("`@("`@("`\<"!I9#TS1%!!
M4D$U,CD@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P
M=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9B<^/&(^079E<F%G93PO8CX\+V9O;G0^
M("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-"YT<F%I;"Y$,R!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(`T*
M("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-"YL96%D+D0T
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M)SX@("`@(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2
M;W<N-"YA;70N1#0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%
M1E0Z(#!P="<@8V]L<W!A;CTS1#(^("`@(`T*("`@("`@("`@(#QP(&ED/3-$
M4$%2034S,"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@
M,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SX\8CY#;VYT<F%C='5A;#PO8CX\
M+V9O;G0^(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXT+G1R86EL+D0T('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M)SX@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@:60],T140DPU
M-3@N9FEN4F]W+C4^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(`T*("`@("`@("`@
M(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-2YL96%D+D0R('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@
M(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-2YA;70N
M1#(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VT[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P="<@
M8V]L<W!A;CTS1#(^("`@(`T*("`@("`@("`@(#QP(&ED/3-$4$%2034S,B!S
M='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@,'!T.R!,24Y%
M+4A%24=(5#H@,2XR-2<^("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF)SX\8CY3:&%R97,\+V(^/"]F;VYT/B`-"B`@("`@
M("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#4U."YF:6Y2;W<N-2YT<F%I;"Y$,B!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(`T*("`@("`@("`@
M(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-2YL96%D+D0S('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@
M(`T*("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-2YA;70N
M1#,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VT[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P="<@
M8V]L<W!A;CTS1#(^("`@(`T*("`@("`@("`@(#QP(&ED/3-$4$%2034S,R!S
M='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@,'!T.R!,24Y%
M+4A%24=(5#H@,2XR-2<^("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF)SX\8CY%>&5R8VES93PO8CX\+V9O;G0^("`@#0H@
M("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@:60],T140DPU-3@N9FEN4F]W+C4N=')A:6PN1#,@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`-"B`@("`@
M("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C4N;&5A9"Y$-"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^
M("`@("`-"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C4N
M86UT+D0T('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'
M3CH@8F]T=&]M.R!415A4+4%,24=..B!C96YT97([($U!4D=)3BU,1494.B`P
M<'0G(&-O;'-P86X],T0R/B`@("`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$U
M,S0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P=#L@
M3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!S97)I9B<^/&(^5&5R;3PO8CX\+V9O;G0^("`@(`T*
M("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-34X+F9I;E)O=RXU+G1R86EL+D0T('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@#0H@("`@
M("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@:60],T140DPU-3@N9FEN4F]W
M+C8^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(`T*("`@("`@("`@(#QB/B8C,38P
M.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#4U."YF:6Y2;W<N-BYL96%D+D0R('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@(`T*("`@("`@
M("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-BYA;70N1#(@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C
M96YT97([($U!4D=)3BU,1494.B`P<'0G(&-O;'-P86X],T0R/B`@(`T*("`@
M("`@("`@(#QP(&ED/3-$4$%2034S-B!S='EL93TS1"=415A4+4%,24=..B!C
M96YT97([($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^("`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SX\8CXH
M:6X@=&AO=7-A;F1S*3PO8CX\+V9O;G0^("`@(`T*("`@("`@("`@(#PO<#X@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X
M+F9I;E)O=RXV+G1R86EL+D0R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B!M961I=6T@
M;F]N93L@4$%$1$E.1RU"3U143TTZ(#%P>"<^("`@("`-"B`@("`@("`@("`\
M8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@:60],T140DPU-3@N9FEN4F]W+C8N;&5A9"Y$,R!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^("`@("`-
M"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C8N86UT+D0S
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!
M3$E'3CH@8V5N=&5R.R!-05)'24XM3$5&5#H@,'!T)R!C;VQS<&%N/3-$,CX@
M("`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$U,S<@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G
M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9B<^/&(^4')I8V4\+V(^/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]P/B`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N
M9FEN4F]W+C8N=')A:6PN1#,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(&UE9&EU;2!N
M;VYE.R!0041$24Y'+4)/5%1/33H@,7!X)SX@("`@(`T*("`@("`@("`@(#QB
M/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-BYL96%D+D0T('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@("`@(`T*
M("`@("`@("`@(#QB/B8C,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-BYA;70N1#0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VT[($)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,
M24=..B!C96YT97([($U!4D=)3BU,1494.B`P<'0G(&-O;'-P86X],T0R/B`@
M(`T*("`@("`@("`@(#QP(&ED/3-$4$%2034S."!S='EL93TS1"=415A4+4%,
M24=..B!C96YT97([($U!4D=)3CH@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M)SX\8CXH665A<G,I/"]B/CPO9F]N=#X@(`T*("`@("`@("`@(#PO<#X@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I
M;E)O=RXV+G1R86EL+D0T('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B!M961I=6T@;F]N
M93L@4$%$1$E.1RU"3U143TTZ(#%P>"<^("`@("`-"B`@("`@("`@("`\8CXF
M(S$V,#L\+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T
M<CX@("`-"B`@("`@(#QT<B!I9#TS1%1"3#4U."YF:6Y2;W<N-R!S='EL93TS
M1"="04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`U-24[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@
M("`@#0H@("`@("`@("`@/'`@:60],T1005)!-3,Y('-T>6QE/3-$)TU!4D=)
M3BU"3U143TTZ(#!P=#L@34%21TE.+51/4#H@,'!T.R!,24Y%+4A%24=(5#H@
M,2XR-2<^(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68G/D)A;&%N8V4@870@2F%N=6%R>2`Q+"`R,#$T/"]F;VYT/B`@#0H@
M("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@:60],T140DPU-3@N9FEN4F]W+C<N;&5A9"XR('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[
M($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#4U."YF:6Y2;W<N-RYS>6UB+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.
M1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O
M=RXW+F%M="XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,3(E
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4+4%,24=..B!R:6=H=#L@
M34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^
M("`@(`T*("`@("`@("`@(#8L,S4V(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N-RYT<F%I;"XR('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z
M("-C8V5E9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU
M-3@N9FEN4F]W+C<N;&5A9"XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!7
M24142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M
M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N
M-RYS>6UB+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#
M2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@("`-"B`@("`@("`@("`D("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N
M9FEN4F]W+C<N86UT+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(
M.B`Q,B4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I
M9VAT.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E
M969F)SX@("`@#0H@("`@("`@("`@."XR,B`@("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXW+G1R86EL
M+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.
M1"U#3TQ/4CH@(V-C965F9B<@;F]W<F%P/3-$;F]W<F%P/B`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#4U."YF:6Y2;W<N-RYL96%D+C0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#
M2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X
M+F9I;E)O=RXW+G-Y;6(N-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$
M5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/
M3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C<N
M86UT+C0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q,B4[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'
M24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`@
M#0H@("`@("`@("`@."XQ-"`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXW+G1R86EL+C0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@
M(V-C965F9B<@;F]W<F%P/3-$;F]W<F%P/B`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@
M/'1R(&ED/3-$5$),-34X+F9I;E)O=RXX('-T>6QE/3-$)T)!0TM'4D]53D0M
M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@("`@(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@4$%$1$E.1RU,
M1494.B`Y<'0[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@
M("`@("`@/'`@:60],T1005)!-30S('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ
M(#!P=#L@34%21TE.+51/4#H@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/D=R
M86YT960\+V9O;G0^("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C@N;&5A
M9"XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)
M0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G
M/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N."YS>6UB+C(@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&ED/3-$5$),-34X+F9I;E)O=RXX+F%M="XR('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!724142#H@,3(E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!4
M15A4+4%,24=..B!R:6=H=#L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.
M1"U#3TQ/4CH@(V9F9F9F9B<^("`@(`T*("`@("`@("`@(#$L-C,Q(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2
M;W<N."YT<F%I;"XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@
M,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[
M($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G(&YO=W)A<#TS1&YO=W)A<#X@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C@N;&5A9"XS('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#4U."YF:6Y2;W<N."YS>6UB+C,@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@34%2
M1TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@
M("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@:60],T140DPU-3@N9FEN4F]W+C@N86UT+C,@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%=)1%1(.B`Q,B4[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,'!T.R!"04-+
M1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@("`@#0H@("`@("`@("`@.2XY-2`@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M-34X+F9I;E)O=RXX+G1R86EL+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%
M1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<@;F]W<F%P/3-$
M;F]W<F%P/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N."YL96%D+D(T
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60]
M,T140DPU-3@N9FEN4F]W+C@N<WEM8BY"-"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/
M4CH@(V9F9F9F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXX+F%M
M="Y"-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ
M(&)O='1O;3L@5$585"U!3$E'3CH@<FEG:'0[($)!0TM'4D]53D0M0T],3U(Z
M("-F9F9F9F8G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N."YT
M<F%I;"Y"-"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\
M+W1R/B`@(`T*("`@("`@/'1R(&ED/3-$5$),-34X+F9I;E)O=RXY('-T>6QE
M/3-$)T)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@4$%$1$E.1RU,1494.B`Y<'0[($)!0TM'4D]53D0M0T],3U(Z("-C
M8V5E9F8G/B`@#0H@("`@("`@("`@/'`@:60],T1005)!-30V('-T>6QE/3-$
M)TU!4D=)3BU"3U143TTZ(#!P=#L@34%21TE.+51/4#H@,'!T.R!,24Y%+4A%
M24=(5#H@,2XR-2<^(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68G/D5X97)C:7-E9#PO9F]N=#X@("`@(`T*("`@("`@("`@
M(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$
M5$),-34X+F9I;E)O=RXY+FQE860N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I
M9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/
M54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN
M4F]W+CDN<WEM8BXR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@
M,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z
M("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N.2YA;70N
M,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$R)3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@<FEG:'0[($U!4D=)3BU,
M1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@("`-"B`@
M("`@("`@("`H-S$Y("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@:60],T140DPU-3@N9FEN4F]W+CDN=')A:6PN,B!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E
M969F)R!N;W=R87`],T1N;W=R87`^("`-"B`@("`@("`@("`\<"!I9#TS1%!!
M4D$U-#@@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE..B`P<'0[
M($Q)3D4M2$5)1TA4.B`Q+C(U)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/BD\+V9O;G0^("`-"B`@("`@("`@
M("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#4U."YF:6Y2;W<N.2YL96%D+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2
M3U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I
M;E)O=RXY+G-Y;6(N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z
M(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T
M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`@(`T*("`@("`@("`@
M("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#4U."YF:6Y2;W<N.2YA;70N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5TE$5$@Z(#$R)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'
M3CH@<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z
M("-C8V5E9F8G/B`@("`-"B`@("`@("`@("`V+C(Y("`@("`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+CDN
M=')A:6PN,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T.R!"04-+
M1U)/54Y$+4-/3$]2.B`C8V-E969F)R!N;W=R87`],T1N;W=R87`^("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-34X+F9I;E)O=RXY+FQE860N0C0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]5
M3D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2
M;W<N.2YS>6UB+D(T('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!
M3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+CDN86UT+D(T('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4
M+4%,24=..B!R:6=H=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXY+G1R86EL+D(T('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"
M04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@
M("`\='(@:60],T140DPU-3@N9FEN4F]W+C$P('-T>6QE/3-$)T)!0TM'4D]5
M3D0M0T],3U(Z("-F9F9F9F8G/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%!!1$1)
M3D<M3$5&5#H@.7!T.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*
M("`@("`@("`@(#QP(&ED/3-$4$%2034U,"!S='EL93TS1"=-05)'24XM0D]4
M5$]-.B`P<'0[($U!4D=)3BU43U`Z(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G
M/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M)SY%>'!I<F5D(&%N9"!F;W)F96ET960\+V9O;G0^("`-"B`@("`@("`@("`\
M+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#4U."YF:6Y2;W<N,3`N;&5A9"XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]5
M3D0M0T],3U(Z("-F9F9F9F8G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN
M4F]W+C$P+G-Y;6(N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z
M(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2
M.B`C9F9F9F9F)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ,"YA
M;70N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$R)3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,'!T
M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@("`@#0H@("`@("`@("`@
M*#@Q,B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-34X+F9I;E)O=RXQ,"YT<F%I;"XR('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/
M4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,'!X
M.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F
M)R!N;W=R87`],T1N;W=R87`^("`-"B`@("`@("`@("`\<"!I9#TS1%!!4D$U
M-3(@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE..B`P<'0[($Q)
M3D4M2$5)1TA4.B`Q+C(U)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68G/BD\+V9O;G0^("`-"B`@("`@("`@("`\
M+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"
M3#4U."YF:6Y2;W<N,3`N;&5A9"XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF
M.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]5
M3D0M0T],3U(Z("-F9F9F9F8G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN
M4F]W+C$P+G-Y;6(N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z
M(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T
M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@#0H@("`@("`@("`@)"`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X
M+F9I;E)O=RXQ,"YA;70N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$
M5$@Z(#$R)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@
M<FEG:'0[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-F
M9F9F9F8G/B`@("`@#0H@("`@("`@("`@.2XX,B`@("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ,"YT
M<F%I;"XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(&UE9&EU;2!N
M;VYE.R!0041$24Y'+4)/5%1/33H@,'!X.R!-05)'24XM3$5&5#H@,'!T.R!"
M04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)R!N;W=R87`],T1N;W=R87`^("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ,"YL96%D+D(T('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+
M1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X
M+F9I;E)O=RXQ,"YS>6UB+D(T('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F
M9F9F)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ,"YA;70N0C0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F
M9F9F)SX@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2;W<N,3`N=')A:6PN0C0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VT[($)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/
M33H@,'!X.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(@:60],T140DPU-3@N9FEN4F]W+C$Q('-T>6QE/3-$
M)T)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VT[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@(`T*("`@("`@("`@
M(#QP(&ED/3-$4$%2034U-"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[
M($U!4D=)3BU43U`Z(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SY"86QA;F-E
M(&%T(%-E<'1E;6)E<B`S,"P@,C`Q-#PO9F]N=#X@("`@(`T*("`@("`@("`@
M(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$
M5$),-34X+F9I;E)O=RXQ,2YL96%D+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2
M3U5.1"U#3TQ/4CH@(V-C965F9B<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF
M:6Y2;W<N,3$N<WEM8BXR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!72414
M2#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],
M3U(Z("-C8V5E9F8G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C$Q
M+F%M="XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,3(E.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#-P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@
M,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`@(`T*("`@("`@
M("`@(#8L-#4V(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
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M9B<@;F]W<F%P/3-$;F]W<F%P/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U."YF:6Y2
M;W<N,3$N;&5A9"XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@
M,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z
M("-C8V5E9F8G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C$Q+G-Y
M;6(N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/
M54Y$+4-/3$]2.B`C8V-E969F)SX@#0H@("`@("`@("`@)"`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ
M,2YA;70N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$R)3L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@<FEG:'0[($U!
M4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@
M("`@#0H@("`@("`@("`@."XV-R`@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-34X+F9I;E)O=RXQ,2YT<F%I;"XS('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,
M24=..B!B;W1T;VT[($)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!0041$
M24Y'+4)/5%1/33H@,'!X.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$
M+4-/3$]2.B`C8V-E969F)R!N;W=R87`],T1N;W=R87`^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-34X+F9I;E)O=RXQ,2YL96%D+C0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#
M2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4U
M."YF:6Y2;W<N,3$N<WEM8BXT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!7
M24142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M
M0T],3U(Z("-C8V5E9F8G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W
M+C$Q+F%M="XT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,3(E
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4+4%,24=..B!R:6=H=#L@
M34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^
M("`@("`-"B`@("`@("`@("`X+C$X("`@("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@:60],T140DPU-3@N9FEN4F]W+C$Q+G1R86EL+C0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@;65D:75M(&YO;F4[(%!!
M1$1)3D<M0D]45$]-.B`P<'@[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]5
M3D0M0T],3U(Z("-C8V5E9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@
M("`-"B`@("`\+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^16UP;&]Y964@4W1O8VL@3W!T:6]N(%M-96UB
M97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/DYO=&4@-2`M(%-T;V-K:&]L9&5R<R<@17%U:71Y("A486)L97,I(%M,:6YE
M($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4V-H961U;&4@;V8@4VAA<F4M8F%S960@4&%Y;65N="!!=V%R9"P@
M4W1O8VL@3W!T:6]N<RP@5F%L=6%T:6]N($%S<W5M<'1I;VYS(%M486)L92!4
M97AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQT
M86)L92!I9#TS1%1"3#4Q,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$
M5$@Z(#$P,"4[(%1%6%0M24Y$14Y4.B`P<'@G(&-E;&QS<&%C:6YG/3-$,"!C
M96QL<&%D9&EN9STS1#`@8F]R9&5R/3-$,#X@("`@(`T*("`@("`@/'1R(&ED
M/3-$5$),-3$R+F9I;E)O=RXQ/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`W,"4[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VTG/B`@(`T*("`@("`@("`@(#QE;3X\+V5M/B`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXQ+FQE
M860N1#,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VTG/B`@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R
M+F9I;E)O=RXQ+F%M="Y$,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P
M="<@8V]L<W!A;CTS1#8^("`@#0H@("`@("`@("`@/'`@:60],T1005)!-#DW
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0[($Q)
M3D4M2$5)1TA4.B`Q+C(U)SX@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68G/CQB/E-E<'1E;6)E<B`S,"P\+V(^/"]F;VYT
M/B`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXQ+G1R86EL+D0S('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"
M3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#%P
M>"<^("`@("`-"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!I9#TS
M1%1"3#4Q,BYF:6Y2;W<N,CX@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@#0H@("`@
M("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXR+FQE860N1#(@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG
M/B`@("`@#0H@("`@("`@("`@/&(^)B,Q-C`[/"]B/B`@("`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXR
M+F%M="Y$,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@<V]L:60[
M(%1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+4Q%1E0Z(#!P="<@8V]L<W!A
M;CTS1#(^("`@#0H@("`@("`@("`@/'`@:60],T1005)!-#DX('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0[($Q)3D4M2$5)1TA4
M.B`Q+C(U)SX@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68G/CQB/C(P/"]B/CQB/C$T/"]B/CPO9F]N=#X@("`-"B`@("`@
M("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I
M9#TS1%1"3#4Q,BYF:6Y2;W<N,BYT<F%I;"Y$,B!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@4$%$1$E.1RU"3U14
M3TTZ(#%P>"<^("`-"B`@("`@("`@("`\8CXF(S$V,#L\+V(^("`@("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU,3(N9FEN
M4F]W+C(N;&5A9"Y$,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#
M04PM04Q)1TXZ(&)O='1O;2<^("`@("`-"B`@("`@("`@("`\8CXF(S$V,#L\
M+V(^("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60]
M,T140DPU,3(N9FEN4F]W+C(N86UT+D0S('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B`C
M,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XM
M3$5&5#H@,'!T)R!C;VQS<&%N/3-$,CX@("`-"B`@("`@("`@("`\<"!I9#TS
M1%!!4D$T.3D@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ
M(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!S97)I9B<^/&(^,C`\+V(^/&(^,3,\+V(^
M/"]F;VYT/B`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXR+G1R86EL+D0S
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M.R!0041$24Y'+4)/5%1/33H@,7!X)SX@(`T*("`@("`@("`@(#QB/B8C
M,38P.SPO8CX@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R
M/B`@(`T*("`@("`@/'1R(&ED/3-$5$),-3$R+F9I;E)O=RXS('-T>6QE/3-$
M)T)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`@#0H@("`@("`@("`@
M/'`@:60],T1005)!-3`P('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@
M34%21TE.+51/4#H@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/E)I<VLM9G)E
M92!I;G1E<F5S="!R871E/"]F;VYT/B`@("`-"B`@("`@("`@("`\+W`^(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4Q,BYF
M:6Y2;W<N,RYL96%D+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(
M.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/
M4CH@(V-C965F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXS+G-Y
M;6(N,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F
M)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@:60],T140DPU,3(N9FEN4F]W+C,N86UT+C(@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q,B4[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,'!T
M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@("`@#0H@("`@("`@("`@
M,BXP("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS
M1%1"3#4Q,BYF:6Y2;W<N,RYT<F%I;"XR('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($U!4D=)
M3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G(&YO=W)A
M<#TS1&YO=W)A<#X@(`T*("`@("`@("`@("4@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N,RYL96%D+C,@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXS+G-Y;6(N,R!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60]
M,T140DPU,3(N9FEN4F]W+C,N86UT+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%=)1%1(.B`Q,B4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M
M04Q)1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/
M3$]2.B`C8V-E969F)SX@("`@#0H@("`@("`@("`@,2XP("`@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N
M,RYT<F%I;"XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!
M0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*
M("`@("`@("`@("4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R
M/B`@(`T*("`@("`@/'1R(&ED/3-$5$),-3$R+F9I;E)O=RXT('-T>6QE/3-$
M)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!S97)I9CL@5D525$E#04PM04Q)1TXZ(&)O='1O
M;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`@#0H@("`@("`@("`@
M/'`@:60],T1005)!-3`S('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@
M34%21TE.+51/4#H@,'!T.R!,24Y%+4A%24=(5#H@,2XR-2<^(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68G/D1I=FED96YD
M('EI96QD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU,3(N9FEN4F]W+C0N
M;&5A9"XR('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F
M9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N-"YS>6UB+C(@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXT+F%M="XR('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L('-E<FEF.R!724142#H@,3(E.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.+4Q%1E0Z(#$Y+C4U<'0[($)!
M0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@(`T*("`@("`@("`@(#`N,"`@
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU
M,3(N9FEN4F]W+C0N=')A:6PN,B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@
M5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&
M5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F)R!N;W=R87`],T1N
M;W=R87`^("`-"B`@("`@("`@("`E("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@:60],T140DPU,3(N9FEN4F]W+C0N;&5A9"XS('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N-"YS>6UB+C,@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@
M0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),
M-3$R+F9I;E)O=RXT+F%M="XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!7
M24142#H@,3(E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4+4%,24=.
M.B!R:6=H=#L@34%21TE.+4Q%1E0Z(#$Y+C4U<'0[($)!0TM'4D]53D0M0T],
M3U(Z("-F9F9F9F8G/B`@(`T*("`@("`@("`@(#`N,"`@("`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU,3(N9FEN4F]W+C0N
M=')A:6PN,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!-05)'24XM3$5&5#H@,'!T.R!"04-+
M1U)/54Y$+4-/3$]2.B`C9F9F9F9F)R!N;W=R87`],T1N;W=R87`^("`-"B`@
M("`@("`@("`E("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@
M("`-"B`@("`@(#QT<B!I9#TS1%1"3#4Q,BYF:6Y2;W<N-2!S='EL93TS1"="
M04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[
M($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@(`T*("`@("`@("`@(#QP
M(&ED/3-$4$%2034P-B!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($U!
M4D=)3BU43U`Z(#!P=#L@3$E.12U(14E'2%0Z(#$N,C4G/B`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF)SY6;VQA=&EL:71Y
M/"]F;VYT/B`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N-2YL96%D+C(@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V-C965F9B<^("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXU+G-Y;6(N,B!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T14
M0DPU,3(N9FEN4F]W+C4N86UT+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[
M(%=)1%1(.B`Q,B4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)
M1TXZ(')I9VAT.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2
M.B`C8V-E969F)SX@("`@#0H@("`@("`@("`@,3`R+CD@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXU+G1R
M86EL+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@34%21TE.+4Q%1E0Z(#!P=#L@0D%#2T=2
M3U5.1"U#3TQ/4CH@(V-C965F9B<@;F]W<F%P/3-$;F]W<F%P/B`@#0H@("`@
M("`@("`@)2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-3$R+F9I;E)O=RXU+FQE860N,R!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+
M1U)/54Y$+4-/3$]2.B`C8V-E969F)SX@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU,3(N
M9FEN4F]W+C4N<WEM8BXS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!72414
M2#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],
M3U(Z("-C8V5E9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N-2YA
M;70N,R!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$R)3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U!3$E'3CH@<FEG:'0[($U!4D=)
M3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-C8V5E9F8G/B`@("`-
M"B`@("`@("`@("`Q,#0N,B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@:60],T140DPU,3(N9FEN4F]W+C4N=')A:6PN,R!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!S97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C8V-E
M969F)R!N;W=R87`],T1N;W=R87`^("`-"B`@("`@("`@("`E("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!I9#TS
M1%1"3#4Q,BYF:6Y2;W<N-B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C
M9F9F9F9F)SX@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R
M:68[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z
M("-F9F9F9F8G/B`@(`T*("`@("`@("`@(#QP(&ED/3-$4$%2034P.2!S='EL
M93TS1"=-05)'24XM0D]45$]-.B`P<'0[($U!4D=)3BU43U`Z(#!P=#L@3$E.
M12U(14E'2%0Z(#$N,C4G/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF)SY%>'!E8W1E9"!L:69E("AY96%R<RD\+V9O;G0^
M("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N-BYL96%D+C(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@<V5R:68[(%=)1%1(.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;3L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&ED
M/3-$5$),-3$R+F9I;E)O=RXV+G-Y;6(N,B!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!S
M97)I9CL@5TE$5$@Z(#$E.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"04-+
M1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60],T140DPU,3(N
M9FEN4F]W+C8N86UT+C(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(
M.B`Q,B4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[(%1%6%0M04Q)1TXZ(')I
M9VAT.R!-05)'24XM3$5&5#H@,'!T.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F
M9F9F)SX@("`@#0H@("`@("`@("`@-BXP("`@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N-BYT<F%I;"XR
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M
M0T],3U(Z("-F9F9F9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@:60]
M,T140DPU,3(N9FEN4F]W+C8N;&5A9"XS('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L('-E
M<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'
M4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!I9#TS1%1"3#4Q,BYF
M:6Y2;W<N-BYS>6UB+C,@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@<V5R:68[(%=)1%1(
M.B`Q)3L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1"U#3TQ/
M4CH@(V9F9F9F9B<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&ED/3-$5$),-3$R+F9I;E)O=RXV+F%M
M="XS('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L('-E<FEF.R!724142#H@,3(E.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M.R!415A4+4%,24=..B!R:6=H=#L@34%21TE.
M+4Q%1E0Z(#4T<'0[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8G/B`@("`@
M#0H@("`@("`@("`@-BXP("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!I9#TS1%1"3#4Q,BYF:6Y2;W<N-BYT<F%I;"XS('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L('-E<FEF.R!724142#H@,24[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VT[($U!4D=)3BU,1494.B`P<'0[($)!0TM'4D]53D0M0T],3U(Z("-F
M9F9F9F8G(&YO=W)A<#TS1&YO=W)A<#X@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`\+W1A
M8FQE/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M,64W,S0P-F5?,V4W,E\T931E7SAE-C5?.&1C-F1A864Y-S=F#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S%E-S,T,#9E7S-E-S)?-&4T95\X938U
M7SAD8S9D86%E.3<W9B]7;W)K<VAE971S+U-H965T,30N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$582D%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@,2`M($)U<VEN
M97-S("A$971A:6QS*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C0U($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C`@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*86XN(#$S+"`R,#$T/&)R/E)E=F5R
M<V4@4W1O8VL@4W!L:70@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]T92`Q("T@0G5S:6YE<W,@*$1E
M=&%I;',I(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:VAO;&1E<G,G($5Q=6ET>2!.;W1E
M+"!3=&]C:R!3<&QI="P@0V]N=F5R<VEO;B!2871I;SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5T86EN960@16%R;FEN9W,@*$%C
M8W5M=6QA=&5D($1E9FEC:70I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B0@*#(Y-"PV,3,L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^)"`H,C,X+#@W,"PP,#`I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@
M9G)O;2!)<W-U86YC92!O9B!,;VYG+71E<FT@1&5B="!A;F0@0V%P:71A;"!3
M96-U<FET:65S+"!.970\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$Y-"PS,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D-A<V@\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@.#8L,C$R+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@-S(L,C@W+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*
M/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S%E-S,T,#9E7S-E-S)?-&4T
M95\X938U7SAD8S9D86%E.3<W9@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO
M+R]#.B\Q93<S-#`V95\S93<R7S1E-&5?.&4V-5\X9&,V9&%A93DW-V8O5V]R
M:W-H965T<R]3:&5E=#$U+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I
M;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL
M.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@
M(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T
M97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O
M:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI
M<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\
M=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-D%!0SX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A
M;CTS1#$^/'-T<F]N9SY.;W1E(#,@+2!!8V-O=6YT:6YG(%!O;&EC:65S("A$
M971A:6QS*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY!8V-O=6YT:6YG(%!O;&EC
M:65S(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#87-H/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#@V+#(Q,BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#<R+#(X-RPP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@17%U:79A;&5N
M=',L(&%T($-A<G)Y:6YG(%9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
M7TYE>'1087)T7S%E-S,T,#9E7S-E-S)?-&4T95\X938U7SAD8S9D86%E.3<W
M9@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Q93<S-#`V95\S93<R
M7S1E-&5?.&4V-5\X9&,V9&%A93DW-V8O5V]R:W-H965T<R]3:&5E=#$V+FAT
M;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B
M;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I
M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%2T=!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.;W1E
M(#,@+2!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A:6QS*2`M($5Q=6ET>2!%
M>&-L=61E9"!&<F]M($-A;&-U;&%T:6]N(&]F($1I;'5T960@16%R;FEN9W,@
M4&5R(%-H87)E/&)R/DEN(%1H;W5S86YD<RP@=6YL97-S(&]T:&5R=VES92!S
M<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,CXY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P
M+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@
M,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D5Q=6ET>2!/<'1I;VX@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/D%N=&ED:6QU=&EV92!396-U<FET:65S
M($5X8VQU9&5D(&9R;VT@0V]M<'5T871I;VX@;V8@16%R;FEN9W,@4&5R(%-H
M87)E(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E-H87)E<R!E>&-L=61E9#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-BPT-38\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#(W,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N="!;365M8F5R
M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M06YT:61I;'5T:79E(%-E8W5R:71I97,@17AC;'5D960@9G)O;2!#;VUP=71A
M=&EO;B!O9B!%87)N:6YG<R!097(@4VAA<F4@6TQI;F4@271E;7-=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F5S
M(&5X8VQU9&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#$P
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,L.38Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#;VYV97)T:6)L92!$96)T(%-E8W5R:71I97,@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D%N
M=&ED:6QU=&EV92!396-U<FET:65S($5X8VQU9&5D(&9R;VT@0V]M<'5T871I
M;VX@;V8@16%R;FEN9W,@4&5R(%-H87)E(%M,:6YE($ET96US73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E<R!E
M>&-L=61E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPU-S@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV
M+#$Y.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M,64W,S0P-F5?,V4W,E\T931E7SAE-C5?.&1C-F1A864Y-S=F#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S%E-S,T,#9E7S-E-S)?-&4T95\X938U
M7SAD8S9D86%E.3<W9B]7;W)K<VAE971S+U-H965T,3<N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$55,4))/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@-"`M($-O;G9E
M<G1I8FQE($YO=&5S('1O(%)E;&%T960@4&%R=&EE<R`H1&5T86EL<RD@*%53
M1"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,3XP($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^.2!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3X\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0R/C$@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y*=6PN(#(Y+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^4V5P+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T/&)R/DEN($-A<V4@;V8@
M1&5B="!#;VYV97)S:6]N(%M-96UB97)=/&)R/DYO=&5S(%!A>6%B;&4L($]T
M:&5R(%!A>6%B;&5S(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^26X@0V%S92!O9B!$96)T($-O
M;G9E<G-I;VX@6TUE;6)E<ET\8G(^3F]T97,@4&%Y86)L92P@3W1H97(@4&%Y
M86)L97,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^07!R+B`S,"P@,C`Q,3QB<CY#;VUM;VX@4W1O8VL@6TUE;6)E<ET\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,3QB
M<CY.;W1E<R!087EA8FQE+"!/=&AE<B!087EA8FQE<R!;365M8F5R73QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R
M/DYO=&5S(%!A>6%B;&4L($]T:&5R(%!A>6%B;&5S(%M-96UB97)=/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D%P<BX@,S`L(#(P,3$\8G(^
M3F]T97,@4&%Y86)L92P@3W1H97(@4&%Y86)L97,@6TUE;6)E<ET\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^07!R+B`S,"P@,C`Q,3QB<CY)
M;FET:6%L($-L;W-I;F<@06UO=6YT(%M-96UB97)=/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D%P<BX@,S`L(#(P,3$\8G(^4'5R8VAA<V4@
M3W!T:6]N(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D%P<BX@,S`L(#(P,3$\8G(^4')I;F-I<&%L($%M;W5N="!;365M8F5R
M73QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY.;W1E(#0@+2!#;VYV97)T:6)L92!.;W1E<R!T;R!296QA=&5D(%!A<G1I
M97,@*$1E=&%I;',I(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)T
M:6)L92!$96)T($ES<W5A8FQE($EN($-O;FYE8W1I;VX@5VET:"!0<FEV871E
M(%!L86-E;65N=#$\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`T+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYO=&5S($%U=&AO<FEZ960@56YD
M97(@4')I=F%T92!0;&%C96UE;G0@26YI=&EA;"!#;&]S:6YG/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#,P,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4'5R8VAA<V4@3W!T:6]N(%5N9&5R(%!R:79A=&4@4&QA8V5M96YT/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XP
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D1E8G0@26YS=')U;65N="P@36%T=7)I='D@1&%T93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^36%Y(#(L#0H)"3(P,C$\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1&5B="!);G-T<G5M96YT($-O;G9E<G-I;VX@4F%T:6\L(%-H87)E
M<R`H:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ+#(U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1&5B="!);G-T<G5M96YT($-O;G9E<G-I
M;VX@4F%T:6\L($UU;'1I<&QE(&]F(%!R:6YC:7!A;#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F5N969I
M8VEA;"!/=VYE<G-H:7`@069T97(@0V]N=F5R<VEO;CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.2XY.24\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F]T:6-E
M(%!E<FEO9"!!<W-O8VEA=&5D('=I=&@@0F5N969I8VEA;"!/=VYE<G-H:7`@
M4&5R8V5N=&%G92!,:6UI=&%T:6]N+"!#;VYV97)T:6)L92!.;W1E<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S8Q(&1A>7,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V]M;6]N(%-H87)E<R!296=I<W1E<F5D($9O<B!297-A;&4@26X@
M0V]N;F5C=&EO;B!7:71H($-O;G9E<G1I8FQE($YO=&5S("AI;B!3:&%R97,I
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#4P,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1&5B="!);G-T<G5M96YT+"!5;F%M;W)T:7IE9"!$:7-C
M;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<X+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW
M."PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS+#@Q,BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y086ED+6EN+4MI;F0@26YT97)E
M<W0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW
M."PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y);G1E<F5S="!%>'!E;G-E+"!$96)T+"!%>&-L=61I;F<@
M06UO<G1I>F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-SDL,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-S0L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,C,S+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(Q."PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]R=&EZ
M871I;VX@;V8@1&5B="!$:7-C;W5N="`H4')E;6EU;2D\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ-#4L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,U+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0R-2PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.38L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0V%R<GEI;F<@5F%L=64@;V8@3F]T97,@3W5T<W1A
M;F1I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0U,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PT-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$L,#(U+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0U,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$96)T
M($EN<W1R=6UE;G0L($9A8V4@06UO=6YT/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`U+#(V,BPP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-2PR-C(L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1&5B="!);G-T<G5M96YT+"!#;VYV97)T:6)L92P@3G5M8F5R(&]F($5Q
M=6ET>2!);G-T<G5M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-BPU-S@L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7S%E-S,T,#9E7S-E-S)?-&4T95\X938U
M7SAD8S9D86%E.3<W9@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Q
M93<S-#`V95\S93<R7S1E-&5?.&4V-5\X9&,V9&%A93DW-V8O5V]R:W-H965T
M<R]3:&5E=#$X+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%2%1!2SX-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY.;W1E(#4@+2!3=&]C:VAO;&1E<G,G($5Q=6ET>2`H1&5T86EL
M<RD@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,CXY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#,^.2!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XR."!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,3XQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0T/C$@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,"!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y397`N(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DIA;BX@,3,L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,3QB<CY0<FEV871E(%!L86-E
M;65N="`R,#$Q(%M-96UB97)=/&)R/D-O;6UO;B!3=&]C:R!;365M8F5R73QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T
M/&)R/E!R:79A=&4@4&QA8V5M96YT(#(P,3$@6TUE;6)E<ET\8G(^0V]M;6]N
M(%-T;V-K(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/E-E<"X@,S`L(#(P,30\8G(^4')I=F%T92!0;&%C96UE;G0@,C`Q,2!;
M365M8F5R73QB<CY787)R86YT(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^4')I=F%T92!0;&%C
M96UE;G0@,C`Q,2!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y397`N(#,P+"`R,#$S/&)R/E!R:79A=&4@4&QA8V5M96YT(#(P
M,3$@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M2G5N+B`S,"P@,C`Q,3QB<CY0<FEV871E(%!L86-E;65N="`R,#$Q(%M-96UB
M97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,S$L
M(#(P,3(\8G(^4')I=F%T92!0;&%C96UE;G0@,C`Q,B!;365M8F5R73QB<CY#
M;VUM;VX@4W1O8VL@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^2G5L+B`S,2P@,C`Q,CQB<CY0<FEV871E(%!L86-E;65N="`R
M,#$R(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DIU;BX@,S`L(#(P,30\8G(^4')E($9U;F1E9"!787)R86YT<R!;365M8F5R
M73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y.;W8N(#,P+"`R
M,#$S/&)R/D-O;6UO;B!3=&]C:R!;365M8F5R73QB<CY*969F97)I97,@3$Q#
M(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU
M;BX@,S`L(#(P,30\8G(^0V]M;6]N(%-T;V-K(%M-96UB97)=/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,30\8G(^0V]M
M;6]N(%-T;V-K(&%N9"!0<F5F=6YD960@5V%R<F%N=',@6TUE;6)E<ET\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2F%N+B`Q,RP@,C`Q-#QB
M<CY38V5N87)I;RP@4')E=FEO=7-L>2!297!O<G1E9"!;365M8F5R73QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*86XN(#$S+"`R,#$T/&)R
M/E)E=F5R<V4@4W1O8VL@4W!L:70@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]T92`U("T@4W1O8VMH
M;VQD97)S)R!%<75I='D@*$1E=&%I;',I(%M,:6YE($ET96US73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E-T;V-K:&]L9&5R<R<@17%U:71Y($YO=&4L(%-T;V-K(%-P;&ET
M+"!#;VYV97)S:6]N(%)A=&EO/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!3=&]C:RP@4VAA<F5S
M($%U=&AO<FEZ960@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-S4L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-3`P+#`P,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y3=&]C:R!)<W-U960@1'5R:6YG(%!E<FEO9"P@4VAA<F5S+"!.97<@
M27-S=65S("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XX+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS,#,L-C$T/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L,3`P+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^."PV,#`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-"PX,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y3=&]C:R!)<W-U960@1'5R:6YG(%!E<FEO9"P@
M5F%L=64L($YE=R!)<W-U97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,C(L.#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U,"PU,#`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4&%Y;65N=',@;V8@4W1O8VL@27-S=6%N8V4@0V]S=',\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,C`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPQ,#`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS+#DP,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E<R!!=F%I;&%B;&4@4&5R
M(%=A<G)A;G0@17AE<F-I<V5D("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XP+C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES
M92!0<FEC92!!<G)A;F=E;65N="P@5V%R<F%N=',@5&\@4'5R8VAA<V4@4VAA
M<F5S+"!0=7)C:&%S92!0<FEC92!097(@56YI="`H:6X@1&]L;&%R<R!P97(@
M4VAA<F4I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,RXV/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DQI;6ET871I;VX@3VX@17AE<F-I<V%B;&4@5V%R
M<F%N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY
M+CDY)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!)<W-U86YC92!O9B!#;VUM
M;VX@4W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C4W+#@P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R92UB87-E9"!#;VUP96YS871I
M;VX@07)R86YG96UE;G0@8GD@4VAA<F4M8F%S960@4&%Y;65N="!!=V%R9"P@
M3F]N+4]P=&EO;B!%<75I='D@26YS=')U;65N=',L($5X97)C:7-E9"`H:6X@
M4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT
M-C`L-S`V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@5V%R<F%N="!%>&5R
M8VES97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV,#`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C8P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@27-S=65D+"!0<FEC92!0
M97(@4VAA<F4@*&EN($1O;&QA<G,@<&5R('-H87)E*3PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3`N-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V%L
M92!O9B!3=&]C:RP@4')I8V4@4&5R(%-H87)E("AI;B!$;VQL87)S('!E<B!S
M:&%R92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,3$N-S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D-L87-S(&]F(%=A<G)A;G0@;W(@4FEG:'0L
M($YU;6)E<B!O9B!396-U<FET:65S($-A;&QE9"!B>2!787)R86YT<R!O<B!2
M:6=H=',@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-C`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R92!0<FEC92`H:6X@
M1&]L;&%R<R!P97(@<VAA<F4I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,3$N-S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VQA<W,@;V8@5V%R<F%N
M="!O<B!2:6=H="P@17AE<F-I<V4@4')I8V4@;V8@5V%R<F%N=',@;W(@4FEG
M:'1S("AI;B!$;VQL87)S('!E<B!S:&%R92D\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C`Q/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G0@
M5&5R;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG-R!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M($ES<W5A;F-E(&]R(%-A
M;&4@;V8@17%U:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU
M."PY,38L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4X+#DP,"PP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F4M8F%S
M960@0V]M<&5N<V%T:6]N($%R<F%N9V5M96YT(&)Y(%-H87)E+6)A<V5D(%!A
M>6UE;G0@07=A<F0L($]P=&EO;G,L($5X97)C:7-E<R!I;B!097)I;V0L($YE
M="`H:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-34P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@4W1O8VL@
M3W!T:6]N<R!%>&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(L.#,R+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$L,3(P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16UP;&]Y
M964@4V5R=FEC92!3:&%R92UB87-E9"!#;VUP96YS871I;VXL($YO;G9E<W1E
M9"!!=V%R9',L($-O;7!E;G-A=&EO;B!#;W-T($YO="!Y970@4F5C;V=N:7IE
M9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R-BPX,#`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^16UP;&]Y964@4V5R=FEC92!3:&%R92UB87-E
M9"!#;VUP96YS871I;VXL($YO;G9E<W1E9"!!=V%R9',L($-O;7!E;G-A=&EO
M;B!#;W-T($YO="!Y970@4F5C;V=N:7IE9"P@4&5R:6]D(&9O<B!296-O9VYI
M=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S(@>65A<G,@
M-B!M;VYT:',\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
M"@T*+2TM+2TM/5].97AT4&%R=%\Q93<S-#`V95\S93<R7S1E-&5?.&4V-5\X
M9&,V9&%A93DW-V8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,64W
M,S0P-F5?,V4W,E\T931E7SAE-C5?.&1C-F1A864Y-S=F+U=O<FMS:&5E=',O
M4VAE970Q.2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T
M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E
M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P1457044^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^3F]T92`U("T@4W1O8VMH;VQD97)S)R!%<75I='D@*$1E=&%I;',I
M("T@4W1O8VLM8F%S960@0V]M<&5N<V%T:6]N($5X<&5N<V4@*%531"`D*3QB
M<CY);B!4:&]U<V%N9',L(&5X8V5P="!097(@4VAA<F4@9&%T82P@=6YL97-S
M(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/CD@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3,\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4VAA<F4M8F%S
M960@0V]M<&5N<V%T:6]N($%R<F%N9V5M96YT(&)Y(%-H87)E+6)A<V5D(%!A
M>6UE;G0@07=A<F0L($-O;7!E;G-A=&EO;B!#;W-T(%M,:6YE($ET96US73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4VAA<F4M8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N<V4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,2PW-C`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0L,#DU/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U+#@P.3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@."PS
M,S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DEM<&%C="!O;B!B87-I8R!A;F0@9&EL=71E9"!N970@;&]S<R!P97(@
M<VAA<F4@*&EN($1O;&QA<G,@<&5R('-H87)E*3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`P+C`V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C(W/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C(S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C4T/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-E
M87)C:"!A;F0@1&5V96QO<&UE;G0@17AP96YS92!;365M8F5R73PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R92UB
M87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@8GD@4VAA<F4M8F%S960@
M4&%Y;65N="!!=V%R9"P@0V]M<&5N<V%T:6]N($-O<W0@6TQI;F4@271E;7-=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y3:&%R92UB87-E9"!C;VUP96YS871I;VX@97AP96YS93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-S$U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S`R/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPT,C,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0Y,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V5N97)A
M;"!A;F0@061M:6YI<W1R871I=F4@17AP96YS92!;365M8F5R73PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R92UB
M87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@8GD@4VAA<F4M8F%S960@
M4&%Y;65N="!!=V%R9"P@0V]M<&5N<V%T:6]N($-O<W0@6TQI;F4@271E;7-=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y3:&%R92UB87-E9"!C;VUP96YS871I;VX@97AP96YS93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#`T-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,RPS.3,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,L,S@V/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`V
M+#@T,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M,64W,S0P-F5?,V4W,E\T931E7SAE-C5?.&1C-F1A864Y-S=F#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S%E-S,T,#9E7S-E-S)?-&4T95\X938U
M7SAD8S9D86%E.3<W9B]7;W)K<VAE971S+U-H965T,C`N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$5(3$%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@-2`M(%-T;V-K
M:&]L9&5R<R<@17%U:71Y("A$971A:6QS*2`M($]P=&EO;B!686QU871I;VX@
M07-S=6UP=&EO;G,@*$5M<&QO>65E(%-T;V-K($]P=&EO;B!;365M8F5R72D\
M8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#(^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q
M-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R
M,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;7!L
M;WEE92!3=&]C:R!/<'1I;VX@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&4@-2`M(%-T;V-K:&]L9&5R
M<R<@17%U:71Y("A$971A:6QS*2`M($]P=&EO;B!686QU871I;VX@07-S=6UP
M=&EO;G,@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4FES:RUF<F5E(&EN=&5R97-T(')A=&4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(N,#`E/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2XP,"4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1I=FED
M96YD('EI96QD/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C`P
M)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y6;VQA=&EL:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,#(N.3`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3`T+C(P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^17AP96-T960@;&EF92`H>65A<G,I/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG-B!Y96%R<SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<V('EE87)S
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^
M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q93<S
M-#`V95\S93<R7S1E-&5?.&4V-5\X9&,V9&%A93DW-V8-"D-O;G1E;G0M3&]C
M871I;VXZ(&9I;&4Z+R\O0SHO,64W,S0P-F5?,V4W,E\T931E7SAE-C5?.&1C
M-F1A864Y-S=F+U=O<FMS:&5E=',O4VAE970R,2YH=&UL#0I#;VYT96YT+51R
M86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y
M<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*
M("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E
M(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T
M('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.
M;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@
M/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14E'
M044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P
M86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3F]T92`U("T@4W1O8VMH;VQD
M97)S)R!%<75I='D@*$1E=&%I;',I("T@3W!T:6]N(%-U;6UA<GD@*%531"`D
M*3QB<CY);B!4:&]U<V%N9',L(&5X8V5P="!097(@4VAA<F4@9&%T82P@=6YL
M97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3W!T:6]N(%-U
M;6UA<GD@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C8L,S4V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"U!=F5R86=E($5X97)C:7-E(%!R
M:6-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`X+C(R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y7
M96EG:'1E9"U!=F5R86=E(%)E;6%I;FEN9R!#;VYT<F%C='5A;"!497)M/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG."!Y96%R<R`V-2!D87ES
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)S@@>65A<G,@-3$@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^1W)A;G1E9#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`Y+CDU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1W)A;G1E9#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PV,S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES960\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#<Q.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES960\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-BXR.3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&ER960@86YD(&9O
M<F9E:71E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.#$R*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D5X<&ER960@86YD(&9O<F9E:71E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`Y+C@R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XV+#0U-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E=E:6=H=&5D+4%V97)A9V4@17AE<F-I<V4@
M4')I8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@."XV-SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E=E:6=H=&5D+4%V97)A9V4@4F5M86EN:6YG($-O;G1R86-T=6%L(%1E<FT\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<X('EE87)S(#8U(&1A
M>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG."!Y96%R<R`U,2!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
M+2TM/5].97AT4&%R=%\Q93<S-#`V95\S93<R7S1E-&5?.&4V-5\X9&,V9&%A
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M+BXO5V]R:V)O;VLN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`Q
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P,BYH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,#,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#`T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P
M-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#8N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`W+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970P."YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,#DN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$P+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970Q,2YH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,3(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#$S+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q-"YH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,34N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#$V+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970Q-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3@N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$Y+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970R,"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,C$N:'1M;"(O/@T*/"]X;6P^#0HM+2TM+2T]7TYE>'1087)T7S%E-S,T
C,#9E7S-E-S)?-&4T95\X938U7SAD8S9D86%E.3<W9BTM#0H`
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 4 - Convertible Notes to Related Parties<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt Disclosure [Text Block]</a></td>
        <td class="text"><p id="PARA408" style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>4. Convertible Notes to Related Parties</b></font>
    </p><br/><p id="PARA410" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In April 2011, we entered into a Securities Purchase Agreement for a private placement of up to $4.5&#160;million in Senior Secured Convertible Notes (&#8220;Notes&#8221;). We received a total of $4.3 million, net of issuance costs, from the issuance of these Notes.</font>
    </p><br/><p id="PARA412" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Notes are secured by substantially all of our assets, including placing our bank accounts under a control agreement. The Notes bear interest at 6% per annum, payable quarterly in cash or in additional principal amount of Notes, at the election of the purchasers. The Notes mature on May 2, 2021, however, the holders of the Notes may require prepayment of the Notes at any time, at each holder&#8217;s option.</font>
    </p><br/><p id="PARA414" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Notes are convertible into shares of our common stock at a rate of 1,250 shares for every $1,000 of principal and accrued interest due under the Notes. There is no right to convert the Notes to the extent that, after giving effect to such conversion, the holder would beneficially own in excess of 9.99% of our outstanding common stock. Each holder of the Notes can increase or decrease this beneficial ownership conversion limit by written notice to us, which will not be effective until 61 days after delivery of the notice.</font>
    </p><br/><p id="PARA416" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of September 30, 2014, we were in compliance with all covenants under the Notes. Upon the occurrence of an event of default under the Notes, the holders of the Notes have the right to require us to redeem all or a portion of their Notes.</font>
    </p><br/><p id="PARA418" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We filed a registration statement with the SEC to register for resale 3.5 million shares underlying the Notes. The registration statement was declared effective on July&#160;29,&#160;2011. The Note holders have agreed to waive their right to require us to maintain the effectiveness of the registration statement and to register the additional shares underlying the Notes until they provide notice otherwise.</font>
    </p><br/><p id="PARA420" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Notes contain an embedded conversion feature that was in-the-money on the issuance dates. Based on an effective fixed conversion rate of 1,250 shares for every $1,000 of principal and accrued interest due under the Notes, the total conversion benefit at issuance exceeded the loan proceeds. Therefore, a debt discount was recorded in an amount equal to the face value of the Notes on the issuance dates and we began amortizing the resultant debt discount over the respective 10-year term of the Notes. During the period ended September 30, 2014, accrued interest of approximately $78,000 was paid-in-kind and rolled into the Note principal balance, which resulted in an additional debt discount of approximately $78,000. For the three months ended September 30, 2014 and 2013, interest expense relating to the stated rate was approximately $79,000 and $74,000, respectively, and interest expense relating to the
      amortization of the debt discount was approximately $145,000 and $135,000, respectively. For the nine months ended September 30, 2014 and 2013, interest expense relating to the stated rate was approximately $233,000 and $218,000, respectively, and interest expense relating to the amortization of the debt discount was approximately $425,000 and $396,000, respectively.</font>
    </p><br/><p id="PARA424" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of September 30, 2014, the carrying value of the Notes was approximately $1,450,000, which is comprised of the $5,262,000 principal amount of the Notes outstanding, less debt discount of $3,812,000. If the $5,262,000 principal amount of Notes is converted, we would issue approximately 6,578,000 shares of our common stock.</font>
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 20, 22<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19,20,22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E4SAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Condensed Balance Sheets (Current Period Unaudited) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
        <td class="nump">$ 86,212<span></span></td>
        <td class="nump">$ 72,287<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
        <td class="nump">3,030<span></span></td>
        <td class="nump">638<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">89,242<span></span></td>
        <td class="nump">72,925<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
        <td class="nump">2,910<span></span></td>
        <td class="nump">2,882<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
        <td class="nump">130<span></span></td>
        <td class="nump">130<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump">92,282<span></span></td>
        <td class="nump">75,937<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
        <td class="nump">1,475<span></span></td>
        <td class="nump">1,264<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_AccruedClinicalLiabilities', window );">Accrued clinical liabilities</a></td>
        <td class="nump">4,530<span></span></td>
        <td class="nump">1,773<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and employee-related liabilities</a></td>
        <td class="nump">2,601<span></span></td>
        <td class="nump">2,566<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
        <td class="nump">1,218<span></span></td>
        <td class="nump">364<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_ConvertibleNotesPayableRelatedPartiesCurrent', window );">Convertible notes payable to related parties, net of discount</a></td>
        <td class="nump">1,450<span></span></td>
        <td class="nump">1,025<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">11,274<span></span></td>
        <td class="nump">6,992<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#x2019; equity:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
        <td class="nump">292<span></span></td>
        <td class="nump">237<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
        <td class="nump">375,329<span></span></td>
        <td class="nump">307,578<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
        <td class="num">(294,613)<span></span></td>
        <td class="num">(238,870)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#x2019; equity</a></td>
        <td class="nump">81,008<span></span></td>
        <td class="nump">68,945<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#x2019; equity</a></td>
        <td class="nump">$ 92,282<span></span></td>
        <td class="nump">$ 75,937<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_AccruedClinicalLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of clinical obligations incurred and payable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_AccruedClinicalLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_ConvertibleNotesPayableRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the holder.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_ConvertibleNotesPayableRelatedPartiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapital</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 12<br><br> -Article 7<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 18<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.9)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 9<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Cash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeRelatedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.32)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 25<br><br> -Article 7<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 32<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.21)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 21<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.17)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 17<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseAndOtherAssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 7<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 2 - Basis of Presentation<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Accounting [Text Block]</a></td>
        <td class="text"><p id="PARA359" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2</b><b>.&#160;&#160;&#160;&#160;&#160;B</b><b>asis of Presentation</b></font>
    </p><br/><p id="PARA361" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September&#160;30,&#160;2014 are not necessarily indicative of the results that may be expected for other quarters or the year ending December&#160;31, 2014. The condensed balance sheet at December 31, 2013 has been derived from the audited financial statements as of that date, but does not include
      all of the information and disclosures required by GAAP. The presentation of prior year amounts was reclassified to conform to the current year presentation. For more complete financial information, these unaudited condensed financial statements and the notes thereto should be read in conjunction with the audited financial statements included in the Company&#8217;s Annual Report on Form</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#160;10-K for the fiscal year ended December&#160;31, 2013 filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on March&#160;7,&#160;2014</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">.</font>
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BasisOfAccounting</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureTextBlockAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-14-400994-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-14-400994-xbrl.zip
M4$L#!!0````(`.V`9D6P$T@ZA60``+<P!0`1`!P`:')T>"TR,#$T,#DS,"YX
M;6Q55`D``PWC6U0-XUM4=7@+``$$)0X```0Y`0``[%WK<Z.XLO]^J^[_P)U;
MM;5;%<<&_$QF4^7)8R=GLTY.DMG'_3*%0;9U!@,K01*?O_YV2V#S,`;'V(GG
M>#[L.B#4KU^WNB4A/OY/K:;\0AS"#)]8RG"FT/,?_>E/2DTY=Z?>@TF5:\>'
MNZ9/GPA<<YX(@[_A_L3WO9-Z_?GY^=B$IMRDC'`W8";A>$&IU<X4_/??__41
MB9PS@B1.E,=)H`S<)Z715E3]1%=/M*;RY?%<T1IJ4SX$3[P,F:V\3&V'__PA
M1@@O'[ML7-<:#;U.'>X;CDD^R)8G>)>NV=Y:/!!OW*[+FU'3@-?&AN'-VXX,
M/A1MPQMUY+[64&NZ&CUBD537G)C'8_>I#C>6-+>I\VT%[WA[:/`Y[Q/FO\R;
M3PAS'?\%U2YZ;O3TQEQ(>T6O?]Y`MS$9_9E'^%(AQ9TE;%/N-C6ULTKKLD7T
M0(B5^0/+L+/@/:V49UUTK/9ZO;JX.V_*E[4#!M3ZG[_=/)@3,C5J<P!$R%24
MC]C)"1?W[\E($9V>H+0_?^!TZMFH<7%MPL@(:(#>:Y&.CU^X]:%^)CLRP03D
MQ5>H]?,'L_&USV]'>N.!>-A8$L1FT)`X/O5G9_,+<(E:>'%$P;$$*R0A3`2<
M\^M?/YPUX%]7[39T_6-]\5B\__J"0'3)(XRZ5I*DT(5_)DW:J^F-C_7HVKRG
MQ7-2QGHH9-134FA5"JU>$!-ZU=^WT'I-U0#'&PNM?;UB[E3]1V"C)A_=]VQS
M$)3Y%Q"&0ZMWP)<_UA=7%27>FCA6K*U$2'3ME<K2X\K2%\IZCUA)*$M?0UEZ
M1<IJALHRG/U#EKIK9+7BRMHS9)565E7(:B<"M?8.510+U%I%@;J3&)+?(RX2
MHU,U0W)7"*WU;DW_G4:.1!ZB-FI:;V.A>S(6Z//(.?_Y]9Y`_<+)@^^:WQX\
MF_J_D>F0L%WJ!0,`&4_)0CYQ3=8;)^0%N#(COA2+0D-.7>?G#V&E<3)PG:GK
M$(@6LT=F.!Q+,]=YA(RU_T+YAS/,4$]RY/Q87THF%7'J<_XV'014O>P@(-MN
M&-?41GP44#-#YOM"?D)=ZAN,F:J:EV%\%<"Y]1!9,0_9#P?I0Y<6M0.<L7@@
M9L"H3PF_?#'MP"(62HQ3&X%OH'2WHTN#.=09\SO"'B8&(Y]FRSN0WA41R2AH
MA6MMP;%VC10M+[TZ(.7](N4M4DM5SXTI?Q@,QJL]''%W`I.$=E:-T]]!-&GF
M1I,#1MXA1MXDCK1RXTBX"$&'-KD@0W^AK`5J#IB98Z9`6_DH^@[B3#LWSAPP
MM(<8>I,X%$T;]3V&9=K7@>L3?F?,#%#&K3\A+/R]=\AYF+C,?R1LBB9=3!\L
MIAE6RKE%F\=FA,#<S4I6IKHI*UX[@%_#/K==#N[0G[I!/.G8#P/&7'$6F_K)
M%VVK&<,VK-9+6>TN8.;$X"15;NZUN9;)M,T*<0MVTJ)IMV`^[1;^/$3+W8Z0
M8-%VV1%2M*U@A-3"6<302='ZD;]"ZC%U'3$!LG=S0P^0,A%\_/+O`/C$+,IU
MX,],:I02,=?4E5NZN8:EFY586LNU]!VCCDD]P][?H?0:@B`+L(]X=%XFU_=L
M8CE]IW7E%@VPL=8+?^YLH'VEKCHUK5M65QVQS+BIKIIY6W\.P][.)Q=VOI5)
M:R6W^!ULOLO"L*HMBUH[9<5KYQR3\1'*+J<]^#PM+V'B_;!P4KA/LR\._3L@
M%X2;C(HR)%%.YBNDV-8'W.7@KI.9WI8ETP&!!P16.Y5>39$G)]`6&ZD>3.(8
MT,,=(T_4#;@]NR<>:(]8^UOI13*EUN\+)-W19,U\C]2FD:>7M.1[W!FU!;'U
M_#DJJ/&>``%WMF$*&.#%,-PNG\#8.V"?VP8'FPLYDL5MCN`E,/U]S:7L?-9,
M#U^6*8'"/:H<M@FXBF:\VU6D;[J6B2;1RO+!CCO9V[:.SU:U%JSG[VT[C"'_
MX6/(6^QOT7/?$%N%Q_06NP,.MX'#DEOUO@,0YF_4.PR%W^T+`7H[OO:A@=6C
MG\NLKOVG#H7:?^)0J*VQ&B/:XLN=F^(QW*97`H7?=>PI#[@JRJFY]38MI[HR
MF@S<IVBC;O@S&S*^_H.,1M`[X3<WYWMKT:H]MPP3%J$G-V1LV)="23$@956Z
MHU"AU]0U=O1"VRJ&KFA7X0%BWRG$DJ>\J%5,^#03T\>)];K#)K=M%M6E)WFJ
M6NEJ)B=F#_;=FF\V*YJ,;6HIB]TQ<A4X%K'"(CRV`V=?#!=F?*$`M^R>CB?)
M?8E+1=SN^0[;L)V>&U</5MS-*1V[C[#-,F-IW[%`/:,\!.P'``KBKP!!*9EW
M.9FT>T"T<C?2WA-.#&9.0#,7Y(G8KB>T^>*!ILF>36%?.Z8[)7-(W+BFL=CI
M%#4J(?#WO*NVV<X[(?``A3>$PIL<?YC=(GF("F\/A;=8;6AV<U_D/T#A3:/"
MSM_';_9R<P5YC+D-BNE;4^I0[C,#3S5(@V%?DL=2<"@E]$Z/$]IYSM!JY.8,
M!TB\/23>(G=HY9]L>(#$VT/B30Z(SC_"\`")MX?$6^02K?S]G)=3SW9GA"P[
MW7(_0-!_-IB5?8<I5[#O>KM2*__$P8.EOZOS1UN9#P$D/T>R(YMN7UWAH?CK
MJRMPJ-15P*WXH#8E!@\8.0N_UW/RY>'B8SVZJ"SZP^=C?\>[NR.,XZER/+9=
MPJ)/H*&$U/C(()CB-Z?<U*N:A4PL$)KN)=G_!7%<&-:B>\MHB,]%G4B&ETBZ
MH)+N:Z[KA6P%NIEK):7K'!96=^9!F\0J6+(WO)W56;:[:(W*X!,%[]WCYXT0
M$TJ(&'$A\R4CQ2(FG1HV__E##7RJV]94#;SA8SW>X=FZ5-*?#DI1Z6A:MU-,
MY8X1SZ!6F,)`:B/>TNUS3GQ^'C`&/KF!J'I#;R1X*$'N+*/O#7DL4%1;[[Z&
MQ02'5>FKV].:26BDZ+Z.:B%4>EJK--4[YD+`]&=WMN'XH!Y<IQ,3:@.RB>A:
M3TU#)9_.$J=\+5L%NM&Z76T3MF+@&;B.N3%"U)1#+>V_"CX*]/):/F23#130
M@[BVS$7.UB94Y!6MGMXI0\@T\9RKZ)2#S8.`VNRDO'$IA6P06IN1(AMK[>8Z
MC(BU>6C#`F*=VU`@FX9]0XTAM<7)MQNHI-D*X59`(@:X#9@I4DNGHZ_)3+K`
MN"<V9*!6K/'FL-':#35AK4)B53-8%$I;[?;&#,HX(W5>J?I43>TNB6AYE+)9
MRNLY*]";GO+"8L86#A`[ACI^%$NH\3LHFJI17K,5\\]UB)YM@=DB_VV$V<YK
MF8T,42W^5*V3M/,RVVY`OR@-[O6T0O+94FBQ$^MWPP[(1@E@JBA*=;TA]:+@
ME!KK2U#O6Q;%*2+#OH-Z`8]<\JAOV)N42YV6KO620^YR(IDD9'U>BJ).H]/J
M=%_#RSWQ#>H0*SHX'T)5,`V$.UV0$<Z>;:"BFM9KME4]P5<QP276VXS+`N75
M-+TKJN]-N10`G+BV11B7&R(WJ2XA/TA:--O]V2;TBT),M]=LK4<_%H2@UJI4
M&]E"HHA8=LS?A+VURX_UV5NY\645;_E?:,[6*KJ:@OD*FIF:Y=4<YG\6.0TZ
M36VOQ6`U_.5_B3A=VC1ZJ9"_(PWF?_XW/30VU;:V`8<%RZ:5X+"I:4D6"XB>
M5<9B>2`VF]VW8;$T%M6FFHHYA3Q6QF1I.*KM9JH@6I/)6P\70&`(#N^OG`LH
M'PF[O58R+<G065(SKL-*::2I6CM=,E;,2FE$M5J-5-%?-2NE<=-LM+77LR(W
MB-RXO!JTU%;`94%J8WY*0Z:V`C,5\E,:-[45P*F0G]+@J:U`STI^<*YFX#IN
M"FJ5@`@&YNS$T!)B9YOS5!I(6J.W*YY*@ZG=Z>R*I]*`:JM+)O6*>1H0O_)(
MU%-[25X21-*C9VD.UHD]W8Z^!0[6B3:=YC8X6".^J%JS49Z#S$<)#4Y-3,?Q
MLX3$2O"TV&+R"HAHP%OCN-V.S=JO)KT-3DM!27+:;;XIIZ4@AYQJQVKG33DM
M!4W):;OW:D[_(/C^-K'Z3Q#6QF00X+:YVY%X]#;P\45X"[K+%>#UP)53RHU&
M,K2]CI^S'0A5/KMOZ:GUX?<K5.D(K+7:G=Z>"%6^4H4,?PN6NB`>`SIR@SK4
MO%.7^?3?XL]*1D.]F[3$"GII=W\E:^6GHE+3$VNP%D4K8N&1`I!:5:>P5C>5
M]"ZGE9D86Y^ETHKJZKK^&I8@XV`$6ET0^?]K)]P.=T%&A#&R?%M<)5K4]-0"
MX.MX2=N]>HG*H[51C4`%\J1VY51C#%4M8#U%-5OZ;L1H:1VW4G74&HR&7\I)
MMU]SLU!YE79:G<6V@U)TSRKEM+1.]1"WZS!:8/K\K3[5#%FM`A#DTU^RZ%H5
M^^6G)EM%(%[%?P'O.=N%JEDP:'2+.,\AOPVV2^L[M3*_!M-IJ$"1CMOJ[YB+
MKS58GV9?8(2%YZ-9G+[ITZ?J]%UK=IJIK=KE.5B"]&K8+S_+H:NJWJZ.?0CI
MN/#(']V^^7=`&<G=G%W-4JV:S#[+DT\G)=4POD8ADMK;N!;GI2!S[3P1OA7$
MIY1>GOZ66"^/]HS:U^,]\WZ#28C%D7AXT-GE"V$FK6I]#/TR]:)#+L'5[%US
M'AB.2<+"EG]Q+,(@R.+[?4^8W2XO1A![%0U+O5Q)-N$M^R+,UD4N7VNT=BUR
M["59'@'#JB93[NJ9=VY6DUW^/M#K62T?6<6;?!6R.C<6>S!L,%GQ/K(UIBEZ
MJ:U0Q83+QM`KZL##U8?_MMIIEXK_2Q@HG:VMR7QY<'2:I7*U'-XS;X."J^+_
MT#)/8".L:<6;R^G\M9H8JJ=?"ER'A:WQOT:NV>BEIN76%:",!'VP*&,S,-ZF
M.]"7O[!;2'$+C+83C&J9.`+5=OM=,/JJ%ZW?@M%.@M'LX*VU>AN9'C\B<"E.
M3[@G8['_S?$'QI24]?VSSY?WMP/E$?[7O[O\\GA]_G"D7`_.CY7ZQ67]8SVO
M_]A@ADTN7#/`H@%/UBA-6FW4_BDIQ!]/RA:^@')%N6G8?Q&#7<HS'$H3J46'
M/ZSJ[2RMS-A+(#)UBJW1%"P2R8\_:[U;TT]#\WIP)5YWAMJ@UXOK=A6YI#[Z
MH"8+575E&^/22A@!>2())CHXRZ#H'.XPP[Z&3/'E5S(K32%^R$=N;V=9U(86
MD5^)!FGQ(*:`ER;[%QX%4=1;"JNRZ>^N'3B^P697U":L/,6!&R>8ZF4I)7'K
M'%`V=EEYA?9-D]@X%0+YJN@A3C;190:\?Q#;_M5QGYT'&,]<!Q(-R/`(>Z6(
M.;V=99U_X597<*6\2O&_R3B0ZBF7EAS!UZ/V3WT9K5A/9\L"F[R_;O#18J<R
MY?:6R9@^!9PZA/,+PDU&O7")$Y>&(;#<072`'D2A]@@\?+(A:)1FZ`?;/_7P
M8)0?_@Y<__2N?]_7]8[\0^'^S";AG<?+/Q]K_9OK7P8GRK\"[M/1[%3YK7__
MRS5<:'C0^N9Z<%G[?'G]R^?'$T4]UEKRP1_&<"_R`OR')$?`7J+[J]O!8^WA
M^O\NX5'1F[APU?_M^N:O$^613B$1'Y!GY=Z=&LZ1O'"D<%#;:$$&>Q[B#_7X
M!V/JG?XO%#FG97]%2L9.ZL.HNSIR&HD@)1"7O3D]5H]^IO2HMM3>-A2Y?3U^
M)LQUE,<)1!N/!#XUH0EDQ<?*CR.730FS9TK_^.Y8N8.A:6K(>S\I/_H3HDA]
M=C6M<8HS"(8S.YI?4D_CMY])WIV`QV_`H!>_Z08L=O<GA7+%4(;4]8DY<5S;
M'6-$%805-.A8H3Y7/.9ZC!*,RTJL(79-'<=]$N\(*&0$XD%KWX4A6KS+@@]:
M@2FO&98%KH;UX)3XRI18N/*E.%@U'RNW`4M0^41=<P):=$%=:"@>>`D[B1>-
MX?F:8=.Q<Z(,H="P`7^GBN=R\6KEB<)PA0<8.U6&KN^[TY-C72?3TQC>)7@[
M30E5H"$PXKGV#,C6L$]+L5@P!GELZ`CX\J!+-"+JS2(<:$,3$(Y.@7O0`=K0
M7Q@>91K!V**X(]#4OXCIB^5:3QC>%$T@DU"&,P6"#9'9$'9A!4SN8(#G##/Z
M]0U'#?$W4(*F#'2(R>Q<?:CK2/=BRANNC9DQ58"(JXPP&`-^H;/PV##,?\$"
MSPOYP#03U^+"M"@GOE6)DRX*L&K3?V-[R06"Q`T<:.I/##"G@2)X^)C+0F$R
MRI``.1(M;"H.M9(:LYCQ/#3,;QREC$Y4D4]"!7^<#B3KQA%-W<\X@E:UB8%.
M)J:UQX9\9WAN:A,S6@NT>*3T[ZY:>N-(>9Y0<Z(\(SZD#5RP#?L&'F=PY>'+
MP^/MS:[]:7OT8E1^!)P[E!,?0Z]T->CD*(0B."GTAK,1/X&6@R'>1M4P,D:$
M8QYI>.C!AGV$KCTDB/30DXAP!0%4C\$E)_)'8&L"[ACXI"8<!KS(F!&K!OX"
M^L93_%P)XAEP!`:#CAP#7-`0K9_<*<6<6ODQ'O2O![_'X_,Q#`X*IAI'TJ;P
MA,A@#1P\.%%TQ0SW$(!Z`VNF/%/@28(AA^LDET@0^E4\4#7&$E")2>@3\C6A
MXPD,501B@CLF0"0I4ISMSY?GDGZ2]UM'1#[D8>IR#$UB_5<L1RH<@A"&!(+C
M`_H]SIFR!(VCD#T<H]`1\#$3-8CM0:HI5",,P@=DG."`U`GF0=-GQ/`Q!!Z+
M<9A@'ZX#TD#"'8_$K=KG1UW([`$*P"Z^,7;QO;<0#[FV+ZW%J6N)J@-HST-&
MCDI/%0?9@WHU2;TBBV7BZ/J!5-_/0"KCGDCJ#>IP8<Y\R\<C230&$@S"XKDP
M+?O!@$!URG.3EE)91!2NP94AY!!'X1,<6X%2PJMQ%EW$<2KX3XRIHF,;`Y5P
MHE!21`U$7'AHA+F"9<RXC`R&@DD=`!^"(`0NPR$NE'KS>'FLA!4_H,AX,J@M
MG(3BI`-@'YO*$1X82V0'0#FNM02"A=LM=R(9.Q>P/E9^B?7R#%J!40$X"_T@
M%&Y(9`S`$RE1+`M]"SK&XFX(32&;\B8S3DV*2X)2_\@41%#;KL%`"D)1/A%C
M@NDR"SGAQHCX,J.%D`2:-V?'RA\09YZEU9]=9EM(2F&X[UC80[*3]:KUZYS6
M?KH5#$V_0=ZG-1H],3QAIBNS/A>T1#%3P3XN$*)]#X_[E?$Y/G(,+OJ)>D2@
M%+OX<OQPK%RYKB6,(ON(O9.<ZN8JU0TGY!M&Q&A4C^.G'!9S0JP8\V,Q'9DK
M&"BSJ4&YX2(OC..(IH#`@'X>B%P`8Y)-()F^)]Q#$LH-\7T(0HG4XOXFH:)(
M#:%6!M@A&I1!0(*,HR%2CP>(CO+L9UR_$%8&1PN&D+J@5T(U*1Z,:1>D/4IT
MI(=/H82"6PY>!RH!?J+X-S_%V(*;N*'?5G!PIXXH0%'*L,S`:A%=;TBB<A+^
MAOB+HK@+8X<YQT(RX<M#"+]$U&C0$[`T@9B&<5!\0Y(:-EISWBF401AB)&UF
MB&7N<`182(8RB*XQX,$0,"8BLS&E.?`G<9AKVYB(+&9*@#O4F^N,76PRSYVB
M_D>4P2CT=V`P-"&T!E(M06:1TU/'M`-+5D]H$%OF4/AGHJ_06)R'*%^$A:2"
M8H4#*L.D'M9FX-`B4YM`V0;:00`28P1<Q>>'DN%OO=BG-[<Q5[:;R@R&#I(<
M\A=3(T<XX$B-+MQ"6AV5F"W@N("0&*N.,$_A$.:$18?4)="8BFD#F5(D9Q["
MND8D`O`$>`^XF$5&>$"2(L_C%L@`.63DB,%%M%8;#:$IBH(!;)[HDROL)R[(
M^:/$;1B<8_>C!,6"".6(V!QZ&$J;HQX<MSW7)W.WDX,#RHAN#/[FC*/*89[I
M&+B:?!0B'V&9C-\84X\@H@*+8#AC++X^(;C'M`^\4,[!C&QC.C5D;6@`QV-I
M$2[\2T0$,5<2NC"QQ"]&)GCN/=YT<.E)1OT`Z`"_+]240LU3-91>=!7/-9;K
M9&Y2-#_F)]!AN$H!HU_`D+<I`.UHI3H!1A@2X[`(<\TX+"08N/)DB(5/9<3<
MJ4P-H7W<')#7^13$!X;(-SX/<"P\JR::I)H_HH05V2H6Q;@NP2]9BH:?>:8;
MG[?"SN9M8UZR:0FC-[<QI;R33&L`-HP&8CTS&Q!-]($EHVDXG!*DGIA5$1DN
M""9.3:M%$2.:G(W[E"&F`^>]S8>TE%\)3,QS\\^/?]8:J@H.A=XRQ'F]T"EM
M%RR[&"N@W.!@5O3F8>#1)\-$CH0W(11PY*G-7=05TY$V^A>P0C&!C]4<L0E)
M=\7<<<DRS)`UH9ALR\1F`=7YO#G*D=)&[(94W-QEPE'8P]UA_]_>ES`W;C-I
M_Q5^LTG5I%Y9$2]9RN$J>^S)ZV3&]MI.9O-N;:4H$K*94*3"PT=^_8<&P%.D
M#IH'*"I5^ZY'$@ET`WC0W6@\[=$HA[/`C^A4US2&(\9;]D4`V<-T%+4%Z(8]
MGND1_BF%G\32$$X]9BQ@.XV80B\8JX@E*:G"PK0LK+;:8G%B.H0.`AN!"_N:
MYSDZG:8$`_`[_2/&S8`ADJCR&2(T8!0&>L+3)AX`GOD:(TL<Y#[+HIN>9N'&
MR(O2LG\E#\5X@&8UJT%*J<$DL3OI[8$74>JLAYC$+1K%U&S;"6R=N8H,Q4(O
M;.TQ!BQ$"C93:LL4!<;9CVCD,(D-R5!&$DV@:;S-`PNG[0.0,;]`1\+-MS;"
MR_(O\$:.1.']U2_B-[EQHX#Y"$D,9$$7&FS*=SQIX"/LL>%@O=J.'P:K"(!Y
MCCN#93_!3MG9:W1X$F[$;/OU`G>NZ2!`YJ%!]'8XIG$1A*+)@X^O>"UY8-J0
M;$GXCIXV8229X:%\"A?MW/%B]:1#/ZR?M"^F1P^&;+)'G/HD+(-`HWY.%#8>
MBJN_Z(J<):&$_&-];#:)%&NT^S8?1:WC^*B1M?>S9@<PZZ.EIS^"94V-`QNR
MVH@-N'(8#1M0X2'V!0G9`_ZRU\?HB@V3^!]1HS3&3\P443@BXW2$NR3`..'9
M)WC8^/=#^]%)Y(7I)(L+:P8R,I*AC%OV)$GP$N[@^51HX_T=0@)P4`OJ-W@:
M8JL:STP\AVA$]9&$)VWB'87_6I"+K=1J)Y%8S8!1#5VLN44.C!XAPK+2-&V!
M]M*A.>J#=-\#N"=@@=$=JT>/V;)AO2,:6GVFUT.\E![HKI;HT`,[;F>G6$7]
M>JNQK-81[F\PC>63^7=@8MOAM3@G95>-U!&IK5\CH6MKTG(BA@!^H@EA;O"U
MP@N"V%KW/#8/;?1`;2P=:B?-+>?9HUC!?@W(3^9KZ#1#7D+$PDSB#SI=U%])
M4V4X#NU/L+3AF"(**\*9-2#%4+@S8;>5B",!4!5YX!J>XSZ-ZI'3#)?F'>!_
M(GJE`W?D6W),-L-[4W@#P`M#6DMV1P!ODW0S(R*1#3]E)XJXGW+8SP'6`.F^
MR2YSX/YXX"K!D4H`[E6LA_<>0QM/4(A2".@4R#F@*C-8+[`=3YPUK*?)>"B%
MS5=@,8Z[:3%FX[2P)X09(<^.^Q<]`J:4[-B:\`(XK3%)OLCJR&`3PR'1TU38
M*'"]`/[(.?Q/I$O0N-V`#.@,/9@V,7&8UY4]G0O]`G@>>LP\8O)P9-FM&K0>
M\6\`OHG)`E.#8#W$8Z"7B>A(GEF,K1\:)6&AL51(C=Y&93^@<;D'B*(1)@R2
M@T.DHA+_A5*00,UJ<J^5'%,`MX9+0D:.2SU8%[MT5LA'$YT[DLG][`26$47J
M2>@\<N&P(&SPL.1SX@RXD.X?AOZ<&;%Y$Z,:K6=RA*>#+4A_C-R%!U(0`9]Q
M(Z1Q,'!G$*HBTK/=F]B[!"#FB'CR-(>*7`_:[?@NOE:P>T[I"HW."NTX8`C-
M68?MFY;3@,#]+;Q(C-/D20V^=(HJ*TPO1SFJT9]_,,L@?C&K,)K(HQ]!9NTZ
M+OGU/=OV(M[\DV,_W..!.\=(3>YDD*EPA_`")X.QJ<#8*)F(*Q9=N5+AVBHA
M(=Q\CW.+'F4N;K(A9EPHU$PMGRNLUA"/;-#"DM*6%?FC3.YPSFM`S8`LR;6T
M)K=X5TMNW$VG#H(>&`5I#@J].Z/A+8@>5&`OPX88!,-,LC^Q,MQ)UX;".?6>
MX5VN00P<&JJ(I_42([X.QP">\$!IP<FV`@B<\+QMTC8I]^VE?+2?3D]O5LZ;
MX0#3-1>)'IHV1!/H/D(,RO#\WX3#I(!%(S",?X2L6[CA1'YV"K$ZO`V((Y@C
MMW0GAW?<'?T/-KZ(5)#H\DHB#Z^"X9"@2GALBF4)CTNS'8!D,FP(D]AEM(W,
M7@60)]S_Z&%[GIJC#=U9XHV;[HUQH'A`&J:>'!V5]^RLCVQP<]Q'=T$.O\'D
M(3%B8$[!L/8-/13$B`Q)A`BBR>#80W\T8:Z9;AAIH8+$@\TD-H9"1`02G0"&
M$1/_T474([8AY(S]5O_1$VC:9&3!QJL5F[)I+Y]LXJ#>L&.F13(>2;['4Y0"
M&#8;)0SCC1J]+./\'FJKL(-OLKG#8Z](<P66&WV.&\AT1@S]!U@:\1J8:1:9
MU=XC@MQ7/WI48$_(<=85UBI)32`.#CF(8$LJ=R%I[*0=OY.FWLX"/P[;A3,L
M!H.2<XT*E!I5DO0(N0Y$)6',`M*D\(2QL&5'4RA\.+XD+87!@="`)L\E7PD9
M-JX`!XQYTSK17;*,R'WB+>$F/-.AH0T2_<.=\1Z)<4@L-(T%2^T_`UN/@Z4;
M]1_.Z)6$/(HUXO'WGG!JVWC5"/3>&EB.@!ZI/:/&S3$.AXV.?HD6V9Q<BXIF
M,^Y_X6266295I(_8'B%ZO7BA<3P0/<SM2$+OW<6'%/(Z+!LG;N@XLX(;4DUI
M8SMK<ZU>++Z+W9?X9S<.E)A'7C7WNL8=#X?))2RSA)D;*K-*(ZR;X;1(H[_2
M@Y<+W$F((E6JFFXF1K$]"]N7T9:U8:.@>P!L-!#*(Y!'3"VV'WK);)XP5H%"
MA1,XQ!M?L%@R0Q&V98U%QHG-`3L`!!'9;@EQ/Q8"L6(ZN@$YC+`#]D;$JIC0
MZ(^+6%`SVJV96+`L2)(1)3J%WR;>29(`T)-F!7`*!U&'N-MD_X\R`&<`;\D0
M%4T^#-N%_3P,`_DNJ"^T"LDSS@)R#U]8U\F!`\MVT!,<1#0#$M(-5GJ2.!L!
MP5T3@>%$PI+VJG*?$P$ZA^WDGF,S&E(#L:P>T]6#!3U!]0;9-$4:F*46RB.B
M\E-+F<3W_@R,!V9%S)R`#J3.Z!H$4"A*C&-6[6P*,(L4S`R39IAIQ`2B06P:
M%,.:T$GBA.X'Q.JF'033U##G$"L"';DTH!8:AUYR^E&!Z8_93(BT15P%F\:]
MWGJ'31YW,V\I0DJ@WZCL%.:XF[[[EV3@/Q/P)[/XJV,I/H$`GV7U^(`FPV==
M&8`O;TE/92UZ<<$P#;(`((PGP&U>TBR*&5`$XHZ'<5Y(RHY,3"^ZW,8RBR#=
M=:;9?X7A@50TP=)T0@%FD,S3,-E2>\`^91BESD89J$UK@RM#3%O\?*)X,#M+
MB8Y5!.6;S/+9=;YTW'`+*T4(-UC%A,^D<"GMJIEN&F"$U5]`H5KB<_RD%W1Q
M<Y>]Z8ZW.)V=4,X`XY_,Z,8U'/?!^2=\02[\L/H"1QHM,"#8I,)`F,('1_N$
M6"9U4!^EH)!,VP&9[+"!A;&;A$T4OR*Y*(="6#@!]UY@V31!I?VE&='YS:\1
M1C`0'+F0K')*#$`B1[#Y!^XKRW.@M\=I4&$9N$O'0RQ8DE`^B29DLB6BM(=D
M[S*I$T).Q@1-&PSC8M0>23V>%([8BF"\V20\E8XB)'I'KG<FAN'Y$9'?F&Z8
M<P&7_^$'&&[?F%MTW$TS_XQ=P7O.)A9H\<0DL4G+BM+.6=PI5GE>+"GA&$!"
M4'24.TA-S>IF3R)D%T\%LN:BJ1`)%,-,>`,Q-2F>P]`626,NFA^[SY!N6G[@
M",X=RW*>"5:P>Z1$T337.L:GZD=VTZAJT64I>O>&7KO%;HWS++PGOW<"#S?I
M??/=SHX\$S4<P_NS3_)4R1G"-VCY>^'+Y?G]O^'!T=??"V0R7%Z=7US=P^"_
ML,9T9%G>4H.S<];D*/'-$H[D5[Z983,-N>D/<Z:,[V8%'&+?_M9Y'HJYS["G
MC.H4\-O%[?WEA]-/X2+PG65!R[3M63HR&]M/B2&-AM4W"K[!$A3)/82[`\/S
M/$NS3D&;EU-;^,V(^;UP=GU[?G%[='9]?W_]^3OAO\B)_D@0ER_8=[=,@TU]
M]@BP,",WA,&C3Q<?R7+PPTGOP&JP66?'Z;RF%3UF47BRR>5,M[[+,7UC;L3F
MZ&1B;BP3CM8:M6RZE]`!M:QFZN5D(PPV!2_6J*[\6O-=S;1:6FU`T!4L""/)
M]\+-Z?GYY=5/T9=BN,O4@T+T<W>GG4?JZ<XCL9TG;R7NT\XCT9VG"3%KW7FD
M77>>3<&K#D!L=,2\CA<R,3VJ0E`I1-!F9LT&E&P/&_;=*I7VQ"K=&1OR',ON
M88/<*C8T,VL:QX8R-I2\UH;*[6G4P0J&1*9P=59DRE7>G/>ZF#78'(!4NK4:
M&Z.S.R-<_6-7-(5J&KO&FB-C)S<[=G)%8U<&"O)VEK/3#[_\='O]Z]7YT8?K
M3]>W>//3=83F\WRU5.UYL:#G,<0\LQA+Z1CPYKQ-%[.ZS-M9\PY&V1X>0C@1
M@'UV?WVSQ>[:U.9ZEXRB)^/K><?HB3E2U=ZJ4#"HW.H.P]YOG0"U+5V%PE(?
M!0>`K$UN:8W@27N7D'-FC&UY,CR&=G=6T'B@J.-*=$/QO(U9D74[-JI!L)UG
M5UNR[M%_-#2#"&94;HUW8.D0S.BCX(`9M<G=$F9(QZ,*,:.-6<$/9I0Q7/,,
MMYS^S\E_S1BN.RR_U6YM-E4G7395O^00WC1DI:I<6:GK)F3%P*MR9:4V*G@7
MK=3U"E(&XFA2B6XXMU*3:FC-2E6YLE*;QXP^"MY%*W6]@N3!=#RM$#.XM5(;
MP8PR5FH>.U?+X=6WA50W6:G3O`2ZSEBI'[9./2XT8W-T5)DE.^;*DFTPA##F
MRI)M5'!^+=GCX;1D[$0]KL*2'?-NR7(1;QUS9<DVCQE]%)Q?2[8\9HC3*C&#
M6TNVM7@K_0PN-45I6\67U:8UL,XF.U<W2T&JUL\EY=9X_\GQO&^*4M022MKF
M-M\T+UC+_VV^M&(8Z<A[N!7Y#:V$3<M-L3(JC)W*M$."9B.@9';A76+*I>%J
MMA>6&R!L(X25@S#AL@M_21(1^I#MV$?.LYUD[Z"UN)+]V^(**I"FD8=(83?/
ML8`"FE'01X\S#C.7L?+:#NLBE<]+"%C0M[=,%64TZN14B1;3+8+L4R')(`5%
M>:#R![G@6\V*4D9UE$:I7TV7MG`:/."N,59P6#<?(WZDA-+NP)O47#Q[SQS\
M_])5+T_OSC(<!Z0B9.[CORY)Z:#D\Z=WOZ8>OW*&I#M'P)@-LI,2;S<9#L*X
MFW?Q;>V(?D_\7OB)L!I]<*">LRV\OPMFOK,T=?QJ]4@942BEQ>,RG0D;3U>1
M3GQ1Q`H%5$!DP0I`@.VGR0`I-=`KXT6$,M$(D$H3*/N2SOHY(Z0`CKMT&$TF
M8X)B-Y.#)98>_Y`698FY42.Z(3VJG(M_0"J2D.OM]%8S&X2A<+=$.N&ILQ@W
MJ:!A(0S&!BI^$]+5AT7\S*BB]2,EO4Y6K!0,!^MV(+R7O@DU0W1`2:?@040*
M75$6+$+J2@$XIIH*&5D91.)WR7$?$F)2YE-*M1"R/T#]\@>J*W8'/L5VFAJ$
MI:7!A>[W2MS34)E)%DS"M;`B(:GC8UGHB94[@\&C;$V,B2O-KK&A"VI:62^P
M*W@Q\T!B+]JN9Q%:P+7SN)N4/.S].-4:G:BD&<K=&E=HA)HXE-@3*FQ&M]/I
M!*,,DA%]6DRSZ:)PT;^']T4UFRD7!OWJ&\HEFIAH6.O)545H0**R+B'QAT9)
M-%D/&0,K[5S$0`1`@=\RIL(2D9)/T3TT,\>2=42%"\TE=5=ILB(I#`DT(SXI
M@/@%D4$C*QQ^$59#>S(]FMF8%H.6VQI3_B-*^$OY9:DX81LA(0D\BM],ZU=$
M5%^"N5AJ.B$-!6,@62TS+BR`Y8Q'(V+Y>B/)ES+:=)V#VZWLY\!&;".#/2G:
MA["&XSU%2NPI'Q+4=*F]@Z:NIKY^?T]VCV-QLGGKD(JV#BG>.BABPSPC]+;`
M2D4+'2;9`SV!5!9CVP#Y0H\(/O1'X+\S$BN5O-PS?:B*Z#Z9>D2;,Z,D.1%L
M)5N-)TZJHWAJIA?C%DL*F(8H<86'LK^/JU?D+UZ5KD(3^+ORU^$Z])`(7QXR
M"6#.$*WE"G"DD7TDIB4CJQCHKY^).0+UXDD):>`?-BAS<:S/6`$$`_&/WL\`
M2/TU;Z3E!5=&-;%%)YE&8@Z06#_L`Q1J(P6`*_PUQ;S'M%M023,E'>UF$OTV
M`MP\/3.*"T1OC7HQ(M2.?[O"7QTE:QJ"/^N5$?$1.WX5`E-TR_(1U#@JM*_Q
M?/C5=I'N/-CF/_@5]]J+<(9L;`WZPA>P0C0!"F7$?.X0H!`^`$$FGOHPR:"`
MX9VYP*:`2YZ&'Y"2+QKYYP<7X0%+/2%<O$#%Z?7X"OU.X^L]S*B`.A;,:/1@
M]EFD^M-#8%+2/Z=PP:P0G&/A@Z3P/N[OC`G_3(4GE9E21:LH.VA">(\)#T];
ML?#P3YT*GWP"]QB$9^)$O4[A<!K*YF0!1(3>C"AV+2BSWQ6!<8(U7`U)'6E%
M!IM=Y""-HI2Y1.O,PC](,<U4Y^V8+Q*+&]%!KEWL.6MZ4(P`(3]MWK`F+.?M
MHR")"C1;L7GGU)WYU4/7\XB/^6UTWY5S(S80=-F:D7K'N.6!COI`1WV@H]Y3
M.NH8!6($3@/I219G@<^9U,OR'B]BBDV"T*\555NHG/>PB0.D`\WU@>:Z*IKK
MO&6YU;I;K8X25<(]CS:-:E9I]7-T#R;FQE%<-QPY1FUFM$_]#VSW^0TVGW45
M$T=_G'K7\]PRB:-W)Z/TO"IN(ENZLGR'1-HA$:L0%%=5AT*&]!OD$G[T*C>B
MZMGC&]B(MJ>,WW53.C#&'QCC#XSQ!\;X`V/\@3'^P!A_8(P_,,8?&.,/C/$'
MQO@#8_R!,?[`&-^%G>?`&-^MG>?`&%_@$26FQX$QOEILV'>K],`8WVEL.##&
MUX`-96RH`V-\K<T=&.,/C/&[C-V!,?[`&']@C.\2*<>!,;X>N0^,\9UG(]D2
M,_I'Y'-@C-\KS#@PQA\8X\MS<1X8XP^,\;4#[X$QOE,[SH$Q_L`8S\'2X<E*
M/3#&'QCCN<&,,E;J@3&^4U;J@3&>SQ#"@3&>PUWIP!C/0^QD2\S@Q*`[,,8W
MA1E\6K('QG@>,"//DJ6?A8SQ\97N#9>T3\CC\1WS)*4WI6*G#U1YM[MZOOH&
M\M]*L-2GQ^9`5'\@JE]#5!_/D00=PY:K,4O,@`<L0>"6XG^O?#77P)C?P&HN
M2Y._XX(^\.0?>/(///D'GOP#3_Z!)__`DW_@R3_PY!]X\@\\^0>>_`-/_H$G
M_\"3SQ]/?EX09M=@2@Z5Z)W^B(S`0M?S4_R6D'+L+F+%O7BA'%@0=_D0\U]=
MS[/!VW(1FSVENMHN@^/`=%7Q0'/&*7!@NNHNI\":@Y/-23@%:CDP7=67OW1@
MNMHE=_#`=+7?.\^!Z:J[$'M@NLH7],!T52DV=-XJ/3!=M8`-!Z:K`]-5,\T=
MF*X.3%>[C-V!Z>K`='5@NNK298(#TU4]<A^8KCI_BV)+S.C?!:0#T]5>8<:!
MZ>K`='5@NCHP77%-WL*3E7I@NCHP77'#6K,E9G!BK!V8KIK"C*Y9J0>FJP/3
M57U6ZH'IZL!TQ44(X<!TQ>&N=&"ZXB%VLB5F<&+0'9BNFL(,/BW9`],5#YB1
M9\G2SU:9KJJ_997EU7GC>T\7<(L,6VLFO;?EP8?>N_1=+E$LNLSU!SE$OR9G
MZ)_)S8!W@H%T<Z%9WH_OCN1W)V-%'8]&HU@EE73X)!R09O4@)?4@QWJ0M]"#
M=#S:&SW(A?.!1:KS=:"(HTE-.FA!"4KA9%BK!'DZGNZ/$M3"F?`A]OK.T<R/
M>U"P/K!96X]:FE?*N'!F[*H4O&\WH!3HRGET_[@B"K9-M($6FOL[$1.D=^":
M$ZZ5H9`8*^&*A"U\1[AE5[AO-!<T7YR3G;`+MJ%R$"MGK&M$7T#*MG1-"Z[.
MBP/A&0DDEYY0?@!%AQ!/4N$F</5'S4/"Z8.+4)+1R36?"!^"I=%+['#5,%B"
MNK]2AFILG"U,RR)<*S9^KVWBA\GK<6NK8Y5D8R"?I'D8O@`#C8Y,0DJ#6_(U
M"UK%[<D":V9`>1/FA)B"T<]X/M8!Y8)\1/$7E`;%8VV_E=5(["9!'W#>4-T#
M<XS'1F;VFN0``RH&RPII*X';"Q0:DZO!%""\,OC;F6;_)6B4YL"C\40\5(!)
MKF,)6CB)*-D.;7@&;&"$5`)YOJ#YPOAKX)8@O#2+@;#47@GM`"."H<1SNN8]
M`CD#_A,N^P-P`H4-)7+#?VD4\G&721L#@9&+(0OI2:JY)9O>KI?LT4+S`Y?P
M>7S67@4)B"HDO%`>G6<@FJ/L)X^.A66+V'7"!U\C&K2EBW#7PY41_P9(>NQ7
MP<?#0;J%-/V1O2W%X\:X+S+3<M=9V4VNK?2L3(:B"4+1#3R<D'HR@DTXKUQ"
MIC07Q(&DCL)?$UX1PA/XE3B`:TWX!XD)8QLP;=T`&?%<-`+$IG`T?&2:$#8Z
MX&DE#C]C7(0N)H89?T@FW(M/R!L?-7_`N%`>S*<$ER"($^`90-_@$0B+YY?P
MS-BX@!I&IVO1>29@BEYT(/3#4DR'T^G7H3:2Y$])S0#[5331TC-2U^"%NHL`
MY[&6L#E#_R9<*W';`F&=]1[-9:*W@F4N3!\0X]D%'BT;3@N`&0P+%N"1?7XT
M<;//)C!%.3Y09\5L,T"%8@EC43"T5X]IQT"624:)=9&^;06==U\)W:1=6KW"
M/V`,=,^,+AC0$)N/EDDV-4JF8P&US1.RM1B$$S/XUR5C*G)TRN9)-T-"J<G@
MRD!S#7@G,\^N@3Y"N4,XXL(U$0)AX-%_&1CZZ49"[`>@ZHR`V'0+=N'=Q[F;
MS-=?@#?*(G:-BQY,SV<\GS'7$!E94/#=Q0>J4/@9'ITY(2GR-(R.\E`-#:$0
M]A)'>FD0*VQ'`Z)MW=+`$(C7JD/YOQ(,7]-!BNY+C'?0:(90'B;8]`E=W+-F
MTDF"A[M@FBPTC+X:8X"+6K<9TOG%W6:,=)%6*"M<9!JLT0:#(?SOUX@2EF$8
MX4=]-KTL_NPX)Z5N^@GQ+@SV&PP*0`2&(0.[K<DM8(ZHP408"&'^F/81UMP1
MWGRP3AG81'8WT*CA*7BF`26Z0U\:$T&:+^EWU[B74S2C;D2BQ9"'3?/C/L-F
MBPQ"/X8$R]&`&]F!CT*#`/<(S#F\<F:4%HS8GZ`+8'ES#<JG"-2XU#+%DQZW
MRHR$.7:A!&`S1FE,S=4<$>^9\#G2UV$<_2><T)3%3`-JLE1'\&80,GB&_&YX
M8AP1(EY"MYQL=RB<!Q'[<<R+BT7(VX=6-`U;R1*KY\4$_C5LL'QU/"&#!-I8
M:J9QA*?'7R8,$OX_[!98H><9]B`QEC/-`M%#.X+*%RLS7N`9>0OZ,!0^,MI?
M_Q&CDH!GJ/_H%4I'>DA9ZB+Q@'72]A#EA2-:HATG4&30^0J29MN?$AW`"[\Z
M5N#O06(P@"4[XM9;UTJT[-G`:TEO9G7R93HA*FK<"U%65[L1*\@V[2;U(\ER
MW#5)G)364"G%*%)",?)TG*.8@IR7[3>!;KIBQ08H*<$!_)*@_!STRIM_`T4=
M4=W2]6PFRV.PI[]2!])8(L.1Y]`GX#%V=0:"!2;""@A\)0\FHD17_N56KZ>O
M)OTB+ATPG(.I3?PPPG::$8KD=I#7%;NEVYL/<=2X(+Z;.#-X=/V7[S+!Z4O8
M*_#?ES;^PJ;!CB_8<KRAX;J;,%HGQN'PP#.RL?#C/TZ]Z[D\.EVZ8-G]091R
M0P,QUV`3L;_S(N#JNQ,\R/38[$T]/$G)2;IP&OB/C@N,J;_"5IY]Y!+J"&C6
M!ZPR4LM@C823C(3I1VG(O4`X.2G<[MTZ20@51E?I&63NPVNEF&:D2+]OM?_2
MNY/1<#1F?=^B]9/5,X=+&UO?`7SY&:P^TW\]!TA/=4P:L7.'`,X=1#AW8']N
MG$HG$&L[&JE'(RF]%O+;/4FOAO0//T1&W2UL!W>A#[#N'$ABQ^9,I=#U4+LT
M59(<&J^J]O+JX[L3$=NH3+E;].1D^ZY_QE8/5*BXGM]$F+5F8DA2H1#1\T5S
M?(3%B.?WKKU*RW06Q8ZNP]#1*41YXO?$4BPQRF7%*#^-$@(I9-)/IU,FTN9.
MK2`/]@5OB!U\ZGF.3NI>`&3EO`G_#)B)M`?T">)BQ`I)`&#L3E6R5F[&XGD,
M1-7V\B2]RY"I3Z;M+7.QD8%-Q5L2>,AB^8K$&]8<34V0)C\'%M6!-&5_9M%7
MSFPM;^K6:B)&>KK_:C-C$AGGH5&Q9M6-&!J'1ZSI194Y*=_84C9GZ`9[3I?V
M+]AON@Q-X'4($)[\$C6FSOAW6#JKW5[M14X20_C5!371051ZVDVWUM@\7R=`
M4?^S_4OG96S;]$GU/9:3/4XF$&1[K%31X^17U_/06(2)<^.B!?";5J!<D5AR
MB4R&38VNIFZ\I9O;:E24W]K-*L:_.-<BW5OLZ9:<`-7W62U*>LGV69Q4TN<W
M38=M%8R=^39G[;8ZE:?CDMW,NE5)1&>Y+BS5Y0.MUK86"]3TMK7C_D`A(L?7
MV]BIW(RF>$O\B%V0;.96Y;U7I;&T9EN.^U"QJ?#&;LL3<5VWM[`F2NEZG.DT
MMJ_`?21S-;:>:8_K'(@UDB0G8`#M7,\O2.W4^"?>>I_C>`5EJ#E>J;@KB9.[
M2P'VP`__[^A(^-\OGW]3_N]__T=?!B^_V^K4^.?XZ>'W5_O7\^#YIV-W>OR+
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MFRF-G<;UX7Q'.,5K5+=HS/<RKJKJV!F]T5I3T4L2E0#C'PJKC=W"&:>'6+7`
MNZ5E^GDO?M/9M-S-L^F+Z,08+]1`<U\%.(2*,F-(&3\X4@A<X0,@*=2BI0?)
MJ7$BN5NTC#@IR8V?@X_^C5S\'1SL:DL4X#'&'<#/#<,L`Y:[I0FB<$0.HX]P
MTX++ALN#@=J<CP7'ZZ1!U@%X=\Z(TRP?<N;P1%,SX;5>8MG".7%T0).HL)5)
MT)"'PFFZI"P<A^2TF#P7UZ+0=N)X(Y5Q1[KG(B/0$:NX+@ZP24A.>>!4!*OK
M6(W^15_RQJQ&N9NYMJL+'")<`HNY"U'0??,:+W'\*'?S^#%1=96FJGMXS@N3
MX2B;YY27#`HK$]+!PUP-<B(H2<-)]/![EBV>/:<<2D(B;SV=2_X-/2,G>;ND
M\2B+V*`KQ[2AJ*KC>G&V.E0]?J87C&!!A`\(HZ%:M*Y(GK"`7I"KFQY)B:!I
M>E_)P_&()$B3!RF./(=<8S0E<`$E;J@L[`4DA9J5^C;=G'0N,0T6X\Q[(;,9
M<C=9=V@19)J%;</1O.,.!'->G+U&\F5)?FPRVX=DZD3%G,.*S"R9C0%4@7I,
M=HQ(*Y9':F(/A?T>T%1V\#=9VBM)MF5?#U92$=/?0E*K1C)105)RPAPV5)`'
M'/4CV8F=<X%3;ZDB$;A`AUAZTAXM`TX3>;5HK`WDF0\V2=K`BH"<]27X[WH`
M)2?#E1\ET.?F%T<:T$FJ$K))(=PH#1!&'-'R]%9T#K$FE1@R(-D(F22A2?LK
M694=3T0Z&ZBR\3R/DD`T82P>&5@N]D::U?3V;%.YFUG%UV$QU^D@1M8*\D\3
MZY76D]YR^=(!RU_")9-53X,'K'I!H0+2$J*`>S/+?"!S^BW)IE'&:`+KX>UA
M37H/6=:6BLADI,9`CM6-EW!R85`]^W@C8&%=6&FW`6Y25)2PQXF[6Z<ZV=O$
MJ8Q-8TC&849Q\I95^'BVX"W#-IH?[@/8V.1_8HF%YT<'?@(K>X[GCLGL:XP]
MK'@W*P(-BYR`?TH[.?*E!1K$)<FC)A]!BDPZL8F5574R,1U?TX^K_6Y(""X#
M'=UTB1.IH=MD"`XBLR=T5F(30AF/!L>C<3SGX_S<E?TV+A<>E@</WQO=*<O+
M$27=1'[JTI\\D@=C48G-G2(#S(9BPN1Q8NA$5B39CE))LEMH0B88&QF$7XV&
MX\C$C&RI4-IP?GH)&$Q/N'J]E-+1!*6;T81<STQJR#-3NNG-)@K"2[%GEG:D
MU*&XC9]&+NU%/E'LZ8C8/4JX.F&1;EAU>&UG/;N,#Z>.$I=A"OP\.=&_/#_O
M.K(C)&I(2&^RE.B*3MQAH&9320LGAI@Q[=M;KS`KW0P1Y"Y>66#$AC2N=8T5
MYX;$A9L6\*YJZZ8/@-?OE?-$)U"T/^6LX4EBH]J\AK%YK>/OJ;832WDR'*6"
M%LFK_#32N&DY'V\.V\C#:2[OP,JZAO46=?*9N+P&">/`[X@AF;J4E+\TH[NM
M<*W%14^F$WBX%Q0<4AA`;NSDKN.WFY%*-\W(W$6;K:1JYO^RY,K>4;%J-TV9
M1,!4*5K22F(IE5_2V*L^5I-K^C*^D$7]37*W`_N,\<6-\#5QS\;L8`"OH*-Y
M0&SG9-PLL@K>UD\E&S#-:X[>5LV-N8Z&(S%^!8U;NB@57(7]W(,+U`+<JO-B
MPA&#.<8A"I4!O\EPN@G\E$1,?!7SXNXD8ZLK_HZ?KQJ.$7/75=U-8WL5!!GZ
MD:L;PD7H-];BH*C=M`MWN<@XR#HNZBASI6OUS)-<!C-2:R`;Q_22U0HS[DLZ
MG)"SH*7A9,6:>:N)KU:>K=)HO@J9]$?TYCAPIB';RTNW>(-^NFE-W9.S%,MR
MGDE$BNQ'7K!8:'!R[]%I>#0C:M,3:HONT,Y3EZ))X&N7V[_T#BX-RJ:F//G%
MQ6)I.:\H3#&(&,5N++QE)&/1%W<W-\DX=+SYD_BN!R=#88\AF^/!<5^%]R3*
MAS<2W)3WS7<[F7Q444G>7&6:9_550I,[@N*N9"I=7IU?7!%"7%8H6]"1!<72
M@46+-3E*?+,$JVKEFQFP"KCI#W,F7*90`Q8P)`86<Y^IO_J"[RP+6A:R*5*E
MRH/G$B(GY:;TX(U41T\*VKR<0(K=4!'XL^O;\XO;J-[%?Y%;6B.H!0]FOFFD
MB;)U0CBXR@\=3GH'5H/-.CLNV&]"#60Q?+S)<4NWO@V$-U6,(YX6A1O:%K4V
M"M225Z:D8VJY)_O39[HM7<"VM&GGWUU-FQR$#J@IN56G%43^&!0JK=HR+BDL
MHB3T[:`19$,%"\%V;/2]<'-Z?GYY]5/TI1CNPFVA--V-\HI[[N%NU(28?.U&
M>3.^8WA2QVZT*:;0`;5<81\IL4ZBS[?9G\JJ+6_]=$QM'.].K:!3F[L3_7R+
M`G\);4D]]1LEME-77GR+LYU:HCMU$V+6NE.GY^D6._6FV&@'L#7G$+6^,HVI
M.<,0M)E9LP$EV\.&?8\I27L24]H9&X[W`AOD5K&AF5G#+3;D>3Q[B`U-B,D7
M-FPZ,^P&-K1K-S0S:[C%AGV/_DE[$OW;&1NF>X$-[=H-S<R:QK&A3.Q%7AM[
MR>WIF^LL)YNG<'56%`*JO#E2S[JYY@"DTJW5V!B=W1GAZA^[HBE4T]@UUAP9
M.[G9L9,;'CNEV;%KK#DR=DJS8Z<T/';Y.8&UC5UCS9&Q*[10ZAD[M:*Q*[,%
MYWDJ&ZK:9]52]4D)2S%4I:]7;9N9X_O.`AO%VW0QJ\L<B_8X+[N*V<ZAZ40$
M8)_=7]]L8=4V9=3>(@]IKOY($E,-](0L9QE=[-WM7+OL)%8H'E0>*`_S3-\Z
M!VI;O0I%IC8$S_IVY9;#5U5XP@H!S+J4,%VCA*3;21*JR^LEJ95C45V5OYQF
M*+IW8H((MO/L:DO6/?J/AE81@8_*8^E=@8\V!.<./NI20AOP,9*JA8].3)"V
MX:/R<'M7X*,-P;F#C[J4T`)\2`-%DBM$CT[,C[;1H_*`?%?0HPW!N4./NI30
M`GJ(`V4J58@>G9@?M:%'F6A:GL9R^C\G_S433=L!@5:[M3E^EB=Q9^)G/R$;
MN6&)=6-AVHSEXPEE(FBUA<]4KL)GZ^9EQ5N0VE[X;'-"Q3:JJ5$S;874=LLT
MR=NXY,GPN`"S<\`ENWN-%+42_;47>,O)NMAR2TNJ9].65N?<XRD<USP<M2)X
M%^"HC1!=NW`D#^1I%:ZXVF(@;T_@B)/P7O-PU(K@78"C-D)^K</19%PA'+4Q
MM?8$CCB)%S8/1ZT(W@4X:B.&V"X<C0<31:P0CMJ86KS#49D`9-ZE[Y;3^=Z6
MPK<I`#GI=`+?W28J2].&,O2T^HNS1!"<A!)A]%MO)<^OMCCEF*LX98-'96/N
MXI0R1GC#"686XNHT;<Q;V#*II]H.W(['HTITQT_(4MYZ%]SE%*[.!<I3R+)Y
M9.(H9,DU,G$4P6P`F93!:%K%8<J8H^AE1Y&)D^AE\\C$4?22:V3B*)C9`#*I
M@\EH6B$R\1#(["@R<1+(;!Z9.`ID<HU,',4U&T"FR4"6JSCQ'7,4T^0-F<K$
M-//(ZMZ>5%DB_[%*)#I.<X^\1;C*>Y:B*>&J9TE&DYT[5F._TN0G/,ZS/`>N
M[=%,4:IPU;,D^PJ'\ZRTRNJ?9UOR2;0PSWCL69(IAL-Y5EIE]<^S"FY:U#3/
M>.Q9DM6&PWE66F7-&J)YS*B<':Y3QLB*R'$FG;[<<[E8:KHO.+8PTSQ3IQPY
MIA5`94>H.6PYGA<706[JPL^DKP?ID\-!^K:*ZM]!^F@X&N<HJ9SZ#F?I;P2G
M_IVE3PYGZ;N`4[_.TD=#Z;AB<#H<IY<&I_X=IT\.Q^F[@%._CM,Q.,D5@]/A
M1+TT./7O1'UR.%'?!9SZ=:(^&JI*Q>!T.%3?+I9)/]/PZ,+'\*^9^VWX9S;0
M-]U4)?[/P//-^6N9PB[U!?A./<&9"\GZNP,!*C\-!/\1N4AXUCQ!6RY=Y\5<
M:#ZR7H6OI/%P(BQ,RX([-OAAW_$U2PAL%^G.@VW^D[V&HSN>+[C(TB!HZ#M0
MU?;H"7GX7[@WB;L[2^T5>+<%[5ES#4]X<#4;GE@&KA?@/^%1)W`%]'=@^J_I
M)C07__@!P>/>4+C?ID//6`!AA@3-@''!/YD[KC`/_``+K3_"VSRX+X3[200G
MW\^1"=_C)KX@<G]()[V*VL$Z,[V<MIPGK%D-XJ2F8X#*)+P$H\GYBC07#\SS
MHZD_"OAYK'CA&0&`(.-(PX]J#T@`A<&M)?8.Z*R&!?"*[CY1)0X++C?%T=A-
MDWI33>X2D[J!60W#$PT<Z'.NF:[PI%D!`O4C#6O:61)%D6D&`6[X&?V'@1\3
M`@_4#1^>61K6\9W^Z%BX;?88O(MJ>N$8R,+3R7^D+3F6Y3S#LRMCJ'E>L""/
M>]_EALH+AX5@4`K55;&VV-QH]#7;S"ZOSB^N"#*SND>"CBRH?:5C^5B3H\0W
M2\TP5K^9.:Z!W/2'FX^,L(!1+>X"A*_Z'(@IX'A4N(T5;S6X*V@1#M>W],_2
M6W92]J:JR.8(N"IB+37A4M(V4TNVW/WOG<K"C=?.E16<W8-BLBDC(IX:V2VH
MVE/!U.1IJJALP?19(,,,%F#?H"UJQU6^N+8^C4_HK*B,6MU'["MHTS32A%4V
M:R].S@6NLEJ;#0G;8+G-C;BZ%X5XTV!*_EA7F[<VA(W*;S8VD3:@:%NHT0]K
M3-H?:VQ'U-B+$KUYJ+&F:F_]J-'81&H8-<H87EMFG^\-QY`ZZC3'T*WI_74T
M=Q&0">&5CR"BJ?G9A,<:%Y'<JY3'E.#MI3RV+'B=*8SBNL*@%9YDI?0C#4?;
M(>IFW>QI7<"OJ]%.GS(05[&BCX+7F5'8"E:(56/%WA4!W`HKRMBF%5SR:]$V
MW73!*<\VS9L;G;%-S\TGTT"V(;R:R#)63-+Z;%*^RE;7?1<P)3A/-FFC@G-K
MDXK3H:INS\2<SK"J:*OAOESU+IS+E9NE?)6I;AXN^B@XMV8I3W#!K65:*UR4
ML4RWO..^1U'3/"[ZSEBFOSF6YIN6Z;^FK=+:+%*^*D$V&`!HLQ)DRX)S:Y&6
MCGR,I&%I<L^4:CBW1EL-DO)5I;%YJ.BCX-Q:H^6A0AF6+E:>`Q7<6J+<Q4BW
MK!&T1S'2O)R8SEBB%^2R#C($RYPCX3VY<O--)E1:FU7*5]V?!OW_-NO^M"QX
MYZS2'$A(Z6=<5=2CS3H]M48]*IY!/)FGS6-&'P7GUCQ5E1U`HU[4X-9";00U
M\BQ5^MEVE]15L8;[O,G.M7>==QFX^J/F(3J!H]OC@6T@ESQS<7=S(V@^^7N&
M'DS;ADNZX>,V[H,SG^-VXTO6NUT!'@KW],8\_(_MY+W1(_>VX85_!YKK(]<3
MD`V%*5?OWQ.F3?R'O'*%.S'J6]S@5L5--V#XO,%]G[I*3>\_>\%BH;GF/XC>
MD2=WW\/!T'3??`)>@%##>'01'AC;?RQ6\MMO8:MYVMVG6]CJI.E;V)Q<%4P(
MOJ;*Q+Y<^DE*6URY8A^E+:R&44LL9O424;''U8S\:ZIN[.<RWN>[>ZO+N"_2
M%A8;Z=<R;GZX6UK&YY43+'(\L9L2MK(+MAM/$Z1-9&D=N&'[)>1WBD=])?FZ
MXC.%U17?PCJH>@UL?_P6B]\SWI*$X+UR1J1>.2-2SYT1J3_.B-0K9T3JE3,B
M]=P9D?KCC$B]<D:D?75&-AV*=<`9.:4<LX6N2&V.B-1O1T3NJR,B]\H1D7OE
MB,@]=T3D_C@B<@\8#;,3NSDBNL8LF+QT](Y9,*V&4^6&.0HY6/']\%GD??59
M]H`P_A8M-!.R\%I=\?WT6Y2^^BU*K_P6I5=^B])SOT7IC]^B],IO4?;5;]D#
MHO76(J]*?WP6I5<^B[*G/HN<1P'?L=7^`;_>U70_T*RB%5__@N^GRY)_!:D'
M+HO:@UI526F;K575&/KM0<KKW:/F(J]QX%,;KCO%P5KOAU^C[JE?(^=)U+&U
M?O&"7-WTBAV;!M;[_GLV:J\\&W5?/9L]R""[1^ZBC8,8M=]>35&=Z+WW:L:]
M\FK&/:W`J\I[D)KRWK0%_]$)/,TV&&U@PR`Y;KSR+E^US;<%DWZX3>.>%N95
MY3W(>KEQ37V-4]4$B+0U<3H"(OWPQ<8-^V+\@,@F1K0.@,C[WV,&XT8/G<<-
M>VN\84@9%R]OTVJY:@UCF5/5M[+U;[/>.LT<?J99FJTC8([\6;,#S7T51,H>
MV-22.^:*/KSV@@U)P7FB#V]4\,[1AV^J5#$>R.JX$M5PSAY>ME)%Q1.()_;P
MYB&#6Y;HC1OH5U68]L?\4HF7Q8_)4))R=/`6".G$)&D;0BHW\[L"(7T4'%"C
M-KG;00U1J1@UVI@7_*!&&?<W+]S"::FL,)Y`-3W=NNK%)A=8R=MK.N,"_T1K
M*326_C/ARN&MO01,4G">'-Y&!>^<P[NI7I8X&,MB):KAW.%ML5S6"F1PXO`V
M#QG<^C(;*T15XO!.NN?P;L*/Z7"JYNC@+1#2B4G2-H2<-7>PQ0-P]$=<0@W0
M2N8Q@X4RZ%BQ#A@]`%]CWJPWFG<8V?)A[-N\T0T1HCQO-"\ELS/>:'@O9<4?
MK=$CG7+ED388$YQRY9$V*GCG/-)-P=#WQ^(T1P?EM,.Y4UHZ&)H'EYORQ2PT
M]W?)%LN,2YU@67.-^Q6$Y,0!;QXAN?6MFCEQGG;/`=^8L3*4JH;+3DR2UASP
M*0<.>//`T1]Q>73`-R>T5JL##ASP')$;=<#%/!:H70,%?+G@NQ\(JWE*Z)`+
MOC1=9)`:]7/'G2-S]7BX-DM3'''EC%<9S]I"=)[<\89%;\TAW^WF4I6'0.\G
M8E59CUB![?GLN]SA&2U?ZCXVR@/D3>Q<!R<_AEY.O/PVH)=;%VY%&97[^`R"
M.^7D;SQ@FPXGE2-L*\N#+X2M>.FU'QAH`VOZ)#"/P8&UD%JU`AJ/#.P*&!R>
MY8OB=J&$M2&/ID())4(Q>79JW@3I3.`@<9GZ#BU]M)@A5Y!'N?>I<Y11G2$K
M<A5#J#(DMX7H/,40&A:=MQB"O'P1#">86:C:@ZST2=9`J>3N-=;?OH40N#CX
M"M&($[>Z#33BUJU>44;U;K78/;=Z(^1,AN/C'"V\"77VQZWF"G6XO>A</^KT
M4_2]N.6=01MQ4C7:M#(WNHLV>>X[_4S#QBU\#/^:N=_"GS]\&WA'#YJV_.[.
M=_2_'AW+0*YW\7=@^J]7CH_.34^W'"]PT3UZ\<\L_)L3^M(?P@<_.(N%8Y/'
M:5&2T\!_=%SS'V0(@6WZMVC^XSN/?/-.T+%3B5]$/M.ER1^GWO5<E'_6;'`[
M_[C3D:VYIG/CHB?3"3SK]18M'=='QF?BH+X3#*2;"\WR?GQW>?7QW8FHCMA_
ML2!K^G,2ZJF*SD_3G5_IV['ZIIZ1GUUZ7H",\\`U[8<;/'D=@SZ(IS;YRMO0
M27GTQT?768@_!]!'\=Z11^S//VY<\TGST8VEZ6B!;!\^I%K^(]'/5;T?J>].
M)EG)MNOLUD+^IED!RI$Q\(QF!)2DR782IGMZ(JQ(>*.]0N-XID1O@+C+!\?S
MVQ!,E#)RK>O?"17ET?5?OF,3]@D#,L`(EOZ+Y@(;070)I/FI2);9:*C^\.V6
M70RAB_P\_)2P`)_"#Q](Z^PA[]ZY"5S]4?,0?7'X+_)[_/)?L;BI$<2?Y4LN
M$J381MZD=-*[$WDX'C'AJNAM2OQ/YL+T-=]T[&N;O1RT%KXOEFR)P3\KD;0R
MEG=HB?^4MY1-@7$;3:=3)MV&SF2WG!O7P3NIX4$GPAE[/4_,E;4K2V:=I[@=
M=UXI/1%'6)S$DMK4NQP<A#$[P\-EX)\MD>T1722&^>PU_@E;LJ?/FFM<88TM
MX;=TR[ZT/=\-R(+>>ETJ9=3!1J9@32KCT?%HG`#/&L4[J6?CK'Z2$,W((WDL
M*F_?.)-S+(-RZ[<5M81<V4UDG-U#UG0FNW2K&9UQB#\6[J6$I0C_S)-"VG9S
M5,6JS!KR`_I@",#DL^WVBV.Z7VPA4V:_$/%F.,HLN[QN;+MF=K##:AJ1D=JV
M'5:/8')VJFUAAU6[A"94KBOG"?9M``+VYVKG__@9>ZVX#>1]^O2AP"/(8L*V
M2R<MF68AIH`2RV;*S*RR<N`%-!FF9"CH3M[T>I-%4NU8J,=9YZ6$15)ZO50K
MBSS=:9W4L=DH*<=%B1T79?,R5[9T(U=WE.K6A9)V/S;T&G81<7BL;K4*TJ$4
M2_-P.\P`N'9O(:YX%4`#^'&D8W%]/-0?-,M"QMEK:-NS'VX<!2DCQ8V+/@:V
M@8SP10465Q:8WMC-U3D&O26*V6XT2LC!QD3)[.RDT1PLRI4PY3]&7T9BB75V
M'KMZXH8!V-2]A)C$860_@$J)F2[*A:NUJ+,G-\>_,S\T\=J5@<X%49>N#NJ>
MK,-%1=D&14YM;*BA^0:5$I"?K"#CQOZMN-$E,;YJ691L.'$3R"?C4NL`E7Q)
M'<C88;Q"_B:L*?*15L!%56G'RW<E.R87BZ7EO")TA]PGO!3R/6?L%C\AST<&
M<9*]>\?7K.3WH*@KQ_\=88%TY\%.A[-7!W3$EG6.F"0:.LYN8[7U<F75U=82
M'9R/CLL^@M^)V\Z#DQOI]_'G!O21V\L<AU-_1$9`5OHV/3FU+$>GX;9YMBVR
MR*+#GJT50L[R(&:7.LY3IGFW*RLYO!N-OF;GF)=7YQ=7Y-2-E1P2=&1!42H=
MKT'6Y"CQS5(SC-5O9HYK(#?]8?8B6$X.+)8P.K!L*:W5=Y;%)]963>7+DG(W
M5?$Q(VCS<C93ZQ&+66N-MO&:\_N<1&=EG+>&.U:E+9X,)7*;"]22E_+>,;7<
M/[H("9]Q(X^><`&66K&BRJIITW7.#J@IF2&?5A#Y8U"HM&K3YE-8U%0!T3PT
MVJ7R7UN[D=J/W:@),?G:C?)F?,?PI([=*"]+KF-JN3+M1#GF>!5MLS^555O>
M^NF8VCC>G5I!IS9WIZWO3B:T550S>=_]1HGMU)7?8>)LIY;H3MV$F`W6]MYB
MI\XCM^X8MD:W8?-WZ]H05`H1M)E9L[%Z=UO8L.\Q)6E/8DH[8T->)?;N88/<
M*C8T,VNXQ8;:"3KXP(8FQ.0+&S:QO'<#&]JU&YJ9-=QBP[Y'_Z0]B?[MC`UY
M18.ZAPWMV@W-S)K&L:%,[$5>&WO)[>F;[X`GFV=\>D4AH,J;HVQVC35'N.2D
M0J"LMC'&VR:MF65UC%W1%*II[!IKCHR=W.S8R0V/G=+LV#767)+#L:FQ4QH>
M.[79L6NL.3)VA19*/6.G5C1V9;;@/$^EY3*0+,=074LC5Z:$28Y%>]SI^A.W
MR$.:JS^2`A0&>D*6LX34[16KMCZS5N&<0+*VU:NT1Q_9=KVSE!;J9)*<-D.B
ME-3*L:BNRE].,_M:&K+:5<0WXV/=\-$=OL<:X:,N);0!'R.I6OCHQ`1I&SZX
MY2^L&S[:$)P[^*A+"2W`AS10)+E"].C$_&@;/2H/R'<%/=H0G#OTJ$L)+:"'
M.%"F4H7HT8GYT2B3ZZ9H6I[&=JR36G4TK<)21WGQLSR).Q,_^PG9R-4L$C[3
MC(5IFQZ>^;[YA#(1M-K"9RI7X;,-]7NKW(+4%JNO;$RH:+X&5DHS;874WE[?
M59X,C\M6(!0'(T6M1'_M!=YRLBYJJ#!8Y]SC*1S7/!QQ4%J#3SAJ(T37+AS)
M`WE:A2NNMAC(VQ,XXB2\USP<<5![@T\X:B/DUSH<34K7KLN!HS:FUI[`$2?Q
MPN;AJ!7!NP!';<00VX6C\6"BB!7"41M3BW<X*A.`S+OTW7(Z7ZUUH)5)IQ/X
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M@8\,P4:^8#F>)RR1*Y`JI$U=^)GT]2!]<CA(WU91_3M('PU'XQPEE5/?X2S]
MC>#4O[/TR>$L?1=PZM=9^F@H'5<,3H?C]-+@U+_C],GA.'T7<.K7<3H&)[EB
M<#J<J)<&I_Z=J$\.)^J[@%._3M1'0U6I&)P.A^K;Q3+I9QH>7?CXAV\#[^A!
MTY;?W>F/R`@L=#V_6"PMYQ6A.^0^F3JZ@RC8&=Q$^9"XB')J68Y._KJ>WR+=
M>;#-?Y!Q@U7GX-]YOG>/7OPS_)N_3L(>_1`VQ9Y%1OZK+]@5E\`V_5LT__%=
MX!GO!-VQ??Q*\H&NJ']\=)V%^'-@04FG>T<>W:$E_/E'2'U]:AOG,?$U>^=G
M4I#WG6`@W5QHEO?CNR/YW<FQJ.)Y'ZMBN_Z=5"[4."F4'`LEEQ)J)'$AU#$3
M2K,K&"E)D>124E4NUB0IUEO'2E2FY0:K<K&FA>N*46)AJ4Y3A%CK!1LIY996
M]9"AC@I75RG19'E:<BI6+YI8N,9*BC89\R*:5+C.2HDVGB@B)Z))14MM91$=
MPVB4ZW/5G9:+%E&VT\IH6GKE5XYJ1<LCVVEU,IKRTFFU:.)G.SV1Y=)`1#O]
MZ/HOW]%3T6O[#,Y$8>^B)Z)7R/_D>!XV[/`[%HY-WFG:YXYE:2Y\3#Y("8(_
M)">G7ID)+[T[@3.?'[Y]>Z>:EW"KU4$DE(Z[*>%62XE**'=3PJW6'9%052J6
M<-45BU?PC?8*9N3IL^8:A!S@>@F+V?M-LP+JD'E>L*"?W8-W%_E?&?'D0ELA
M\OOBU[--](2XX/#6E!>NBK6=I8Y&7[/@P^75^<45\:19G4I!1Q;4*M5-^X$U
M.4I\L]0,8_6;F>,:R$U_F.LN9Y)\L(AAH$$L\,FKSMQA*C@>%08>BH,#N"MH
M`5\0+Y_^63K(DI2=U>^MO;1YCH"K(M92Q3<E+:GBVY"PM1;R':^=*]F\KFG>
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M;%*%*YNT;O:&E.`\V:2-"LZM32I.AZJZ?>V,=$Y\15N-PKM9NDN5C,K-4H4K
ML[1YN.BCX-R:I3S!!;>6::UP4<8RW9*5:(^BIGG5@SICF?[F6)IO6J;_FK9*
M:[-(^:K=W6``H,W:W2T+SJU%6CKR,9*&I>G84ZKAW!IM-4C*5UWMYJ&BCX)S
M:XV6APIE*%4(%=Q:HMS%2+>LZKA',=*\G)C.6*)P]4H'FDG+G"/A_2O27.^;
M3*BT-JN4KTJ-#?K_;59J;%GPSEFE.9"0TL^XJJA'FY45:XUZ5#R#>#)/F\>,
M/@K.K7FJ*CN`1KVHP:V%V@AJY%FJ]+-UM$)5W&4]8>W%5V7SR8E<5[,?$#1R
M]IK?[D?-=*$]E&@+TBL_N@A=LN3*6\U/W!E>!B[*WA4N<YDV<8U8)I?=I<3=
M_=KEX4V#2B&_QPX:%/='@Z&+$*93-#0'1W5I,$\>WC18R1S<0PW&!R=-S$(1
M(^&T9AVF)<KR9[6NQ+=/1*Q$16I?B;/-3<YV:?(>N0NQ"B*+F_'O&>W4TM55
MOJC&U%)F#K6HEASS,-6J[F/8\U_749H4<](4\9:H>?=Q.\=;LBY$K$Z:IBWA
MY&Y]0O`UA33WY99L4MKBXIS[*&UAP<]:#B]6;]T6ARB;D7]-8=']7,;[?-E]
M=1GW1=K">JK]6L;-#W=+R_B\\AH2'$_LIH2MC)%BX_&[E+??=(R2X@N"LP5D
M',6COG);J>)#^-45W\(ZJ'H-;)^O$HO?,Z*OA."]<D:D7CDC4L^=$:D_SHC4
M*V=$ZI4S(O7<&9'ZXXQ(O7)&I'UU1O(DZI@S<OJ$7.T!%;HBM3DB4K\=$;FO
MCHC<*T=$[I4C(O?<$9'[XXC(/:``SD[LYIA;&[-@\NYO=<R":36<*C=,ZLO!
MBN^'SR+OJ\^R!Q56;M%",VW3?FAUQ??3;U'ZZK<HO?);E%[Y+4K/_1:E/WZ+
MTBN_1=E7OV4/*I.T%GE5^N.S*+WR690]]5GDO)HI'5OM'_#K74WW`\TJ6O'U
M+_A^NBRI@>^3RZ+VH+AC4MIFBSLVAGY[D/)*[M9YC0.?VG"A1@[6>C_\&G5/
M_1HY3Z*.K?6+%^3JIE?LV#2PWO??LU%[Y=FH^^K9[$$&&5RL;^,@1NVW5S/N
MJU<S[I57,^YIR7I5WH/4E/>F+?B/3N!IML%X=AL&R7'CI>HS$VB!##-8"+9C
MHXT%J5M97GURF\8]K62ORGN0]7+CFOH:IZH)$&EKXG0$1/KABXT;]L7X`9$\
MTJZ.@<C[WV/*_T8/G<<->VN\84@9%R]OTVJYS!NCF5/5MY:WV6:]=;K4QIEF
M:;:.!,T7?M;L0'-?!7$@`"M@4TONF*MZ&[57.$H*SE.]C48%[UR]C4VEG<8#
M61U7HAK.RVV4+>U4\03BJ=Q&\Y#!;5F%C1OH5U68]L?\UMXHBQ^3H23EZ.`M
M$-*)2=(VA%1NYG<%0OHH.*!&;7*W@QJB4C%JM#$O^$&-,NYO7KB%T]J283R!
M:GJZ=9FH32ZPDK?7=,8%_LG5;!\9C:7_3+AR>&NOF984G">'MU'!.^?P;BHP
M*0[&LEB):CAW>%NL+[D"&9PXO,U#!K>^S,:2BI4XO)/N.;R;\&,ZG*HY.G@+
MA'1BDK0-(6?-'6SQ`!S]$9=0`[22><Q@H0PZ5JP#1@_`UY@WZXWF'4:V?!C[
M-F]T0X0HSQO-2\GLC#<:WDM9\4=K]$BG7'FD#<8$IUQYI(T*WCF/=%,P]/VQ
M.,W103GM<.Z4E@Z&YL'EIGPQ"\W]7;+%,N-2)UA^TU22RI0K![QYA.36MVKF
MQ'G:/0=\8\;*4*H:+CLQ25ISP*<<..#-`T=_Q.71`=^<T%JM#CAPP'-$;M0!
M%_-8H'8-%/#E@N]^(*SF*:%#+OC2=)$A:+8AS!UWCLS5X^':+$UQQ)4S7F4\
M:PO1>7+'&Q:]-8=\MYM+51X"O9^(564]8@6VY[/O<H=GM'RI^]@H#Y`WL7,=
MG/P8>CGQ\MN`7FY=N!5E5.[C,PCNE)._\8!M.IQ4CK"M+`^^$+;BI==^8*`-
MK.F3P#P&!]9":M4*:#PRL"M@<'B6+XK;A1+6ACR:"B64",7DV:EY$Z0S@8/$
M9>H[M/318H9<01[EWJ?.449UAJS(50RARI#<%J+S%$-H6'3>8@CR\D4PG&!F
MH6H/LM(G60.EDKO76'_[%D+@XN`K1"-.W.HVT(A;MWI%&=6[U6+WW.J-D#,9
MCH]SM/`FU-D?MYHKU.'VHG/]J--/T??BEG<&;<1)U6C3RMSH+MKDN>_T,PT;
MM_#Q#]\&WM&#IBV_N],?D1%8Z'I.ZHF<:1XR/CB+);(]S3<=^U3WS2?3?[V'
M1^_1BW]F.?I?)V%S/T3OR7_:=37[`2V0[9^]QC^YT5[AH]-GS36NE_!#[SKP
M/5^S#=-^N`J(*QK8IG^+YC^^\TBADW>"CMU1W`'RF3[^X]2[GLOB.=*QORJ]
M$PRDFPO-\GY\=R2_.QG+ZAC;]`DYJ^Y?K2H(ZV^S>G9AFCVA*XT5$WC&#7)W
M58_T[@0(7&I1S;I^GPCY&IMM;GFV<\M1.>-$C3`@U9?2:E+5/SZZSD+\6;.Q
MFN1[)]08GD(WD]]5\3RCIF8[>U+M!"/<`=ZEC2>-Z1@_N8[G;5AE2E(]"E;/
MZ`XMX<_L>A/'LECI>LOIZ\G."\[;J9$W+[JMM(67'UPGW4%3U4FQJD$?@_FE
MYP7(.`]</`/I.VAI*?(E:R.ZZ%/5A#D6I^GYLG-/=ET<F]08OKCY^0#9S17.
MAYT$J7X;^TB3T`*LCU/;(.EIY`U1=ZJ:0A-1JA1R-G:\:`>KL\T&06E2H4WP
M)KG:MRY'U'PJFGECI=_6Y1KU$.MR?'RP+M<N/3`NQVK;QN6*QBYMW5F@>^WE
MW/1TR_'P\HU<OJU%RSLI'6^J-OQGX/GF_'6GI+ZDNULSQ?MX*%#="%@YQ44W
MT][V,GJ%^VWXYXIB-J4Z\JF8<S1'+F2=FU0KOO8B:)Z'?(_DH5NF-C,MTS?Q
MN_"D%5RD.P^V^0\B*>J"CQ9+QP7V;L.<XQ<A6\<_G"'_&2%;F)NV9NNF9N%N
M:SZU>,A;$VWIFNN^XCDM/&E6@)\-//@'?(.W&?QOTQ80?K/NT_8>D?`*'/V"
M%^B/J4:A=^AEB7^)^^8[N*=XU7AH*)P'"/X=X%^Y/EY`1!:\(%PG(*M,<`)7
MH%*^P@\?D(V@;6$>P*X'?8&(2=AIZ#]>0![Z.\#R6*^X(<W""F$]*E3G0-#P
M&RV+"$HP0=`LRWDF)_>/&F@-JPQY$-DQO4=D#(4OB"Q5TZ82P.H'`=:]2'O`
M/_!\P<2:COJ2'%-/<.9QED`<C))'@_@?L/R'V06QZWK85+R/S_5PCV>8N5AB
M=`5%:78\;Y)#NG0\DVC>L<F<3'SE(CQK;&&!I<-#FEPPFD]^:VGN`QYF05O@
M"0@?X<]-3U@X>*Y9YE\(3RG\F2W8C@^C/H.9Y4$'P&5;PF@'AHG?_4K>YB(+
M/6GP'ACDP']T7#R/A\+IIIX_FW@*01OI3IIS/'?(?+20Y]&>:((Z^IKVS7QT
ML-F/-3-#L'2BG@T%K#@7)O(3HC/9A@GK8^7BY:\_PN9'%C,LML!.-`B=FN$E
M-X<IBQ<_GL3G2,_.3C$].V6R##4*`P.,`^$F!VWH5F"0%4@4!+NP9K_2QR>2
M>/R])Y`WG-HVWD"%6X01S(>!Q);N(FY%'!W]DEI^LX2R0RQ:4C<(V=#@:N[-
MRAI:NXIB&V+=[AUN]C]\^S)S+1H'^/]02P,$%`````@`[8!F13T&GHN-!P``
M,T8``!4`'`!H<G1X+3(P,30P.3,P7V-A;"YX;6Q55`D``PWC6U0-XUM4=7@+
M``$$)0X```0Y`0``W5QM4^(Z%/Y^9^Y_Z/5^N7=VV/*B(HXZ@Z![<1%0=%W=
MV=D)[4&B;5.3E!=__4U*<7AI2X'6XNX7H:1Y3I_GG)/D)-VCOS(9Y0M80!$'
M7>F,%%SYAYO_*AFE0DR[K6&E9G'QJ\9Q'\0UJP]4?!>_]SBW#U5U,!A\UD13
MIF$*C#A4`R8O*)G,B2+__?G'D02I4)`0A\I-SU$:I*]D]Y5<X;"0.\SO*K<W
M%26?S>V.;Q)W&-AZ[B`&RM`T+':\,P4V[%#C,Z&/:CZ;+:B3ACOCEH=#>6&F
M_:#@MLZ52B75_?6M*<-^#46W.?7[9;VM]<!$&6PQCBQ-`C!\R-R+=:(ACHD5
MP2XEL(7\EIDTR\A+F5P^4\A]'C)]YV3,G*(<46+`-705U_1#/K+A>(=ATS:D
M1>ZU'H6NL(3R849RF"T5LK*/O^657_27T(P1`^N2_5-DR&=I]P#XCB*[OKVN
MO3U%#RBQ^%"JI\K?U,!;U8FT<1M8LP0XM+GX;(*UJHWS=PLSXS>Q@ECOW""#
M%6U[NTT]\8C3D*$YANM(=6'#C'4PY&#IH$_LD]VMH=.;&PDX@V@S$(9T8D(G
M"`;J@'&\X[#,(T+VKS)CP%G%H=2588:EL16N-W<1Z[@N[=VG2O94,#B;7''Y
MS&1SGF?_[0\PY5`KFRJ93<)"M]^)6K-ZE>FL@8AJ$PO$QQFQ%@/?:Z$RQS3=
MWC)8^.OD_BXEYA(9.)E_>$)UH,<[N1UE`/BQQ^5'E]*U"&U1L!'6SX8V6`S*
MEM[DPN42]X@HL.JT1V^E()'(\_3*+^BU2;`F%Z631)HJYWYD^].Z&`9K!P*Q
MQ71GU!(IE0LISUX<;,N1I0$)14`(WNR#;)<.X40%>_MZLDQ%5(-86G(9R1]H
M6X,A@!:/_4(\8T,=HPXV,,>0Y%#@@[*)PY0UC3@69RTT0AT#DIS5^"--\YV&
MTP2K-I--`V@*2*LK2>%.I`4`=<146/R`!0U35D6:AX?<GFY,AM.[]-&#\N-:
MOGXFEC5D!&*]8\CEP/O$ZW+0]$>O:#$0@;Z@A+K!6#9VCO?1:@EBZC/L:#HM
MX\T3:7?#&;8;NU[5"XN<V"`<)OG1<Y$6HL&*^2>RE3I,>04:(;>MQH^GS%Y<
ML\$V)]ISCQBB5R;GG7R41-3XH&Q4LR"F22RWTV_(<.;K4/'4+^8QTATD@W6:
MJ6<L$!/WHJZLZUB:BHR66*?7K`JR,4=&(K/!`*CT!\-H8@12%>N,Y1HXPA;H
M9XA:V'ID(JL[IN/FCBITL883&08CH*:<>:-I%(6]Q):`8JG_/NEW*>86K;!"
M29F6+F3>$K#6^BA/YM<J(&>X6R'JW%[(29([)/.[1&M/W6VY:RIBSJOU)E*`
M7019/W"O@8%0OB=DK$(?#.*6Z+R.D\FQ88`II]=`^6:S:RAE07.3M>09;\,;
M`JJLF]C"C$O[^I"@0,L@W?ATM^]_W%U^V_WYX[MF.\-[:Z^DOQ;[C_<CZ[;J
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M`V<!-MHYF/"7K,%^,"EG.U^19@HJ?M3$NZ_LUFP:Q")S7IQ8E<L/:^MU""1I
M,6PSTW'[OI.HM^,L&T2CX$)VTZ*DCX41IZ-;)F=G;YY8EH?._+8'XLHJ4='7
M=_E4<V-*_KVBIM/./T=7'!M/DZZK8%/0\)@-,32:A'+\ZGY-0I<PN+37JIMI
M%$IDW%O][1ZB<(J$??(XJLB#B0D6@/2QM0JB+[`@M&Y-=<H)FMTJ='@5,W<S
MN47!Q(Z9A&++03]Z.HQ`:\`^UUHJBM1+03A+%<9_:];<B8`D5%P.^M%5C$!K
MP)[8ZEN5BUCK'K:(UM/'3(^K4.5)LQ]+B6<1,_B\P?L$6PA^^BNE6(,NC&E/
MY&)"(@<<5G@?A8/`T]U5B%O=0(H]:0]B*G8M(GL'OJO0!4K!_^#W^R@=R9+?
M+*JCL>\Y06FQ=!)GX:)F]8&E5KCP0]_@'1`TDCL=[(:4M1<'4P@\XIW$(ZZ`
MOJ4SD!!?F#DXOP+-B]60S/IS_0"SS[&%+"TM%_9#W^0U)J(!Z.Q<Z'6'*$5R
MXPZHAA/:J@W%V]I%3(CB<V]XA)`99Z%N&JG&F"/?9FQVW4H&N[4$CA@$1#S@
MOLSR_@4.&3R)2[R1;5N:M=9PALTDBKM>.&V9>PBE:4LT-O%5/6FO\`?]G:(_
M@-:`DF)\*8"VD2&\++DS9A%0MW/RO$G4SK$:=&Q^[1>S10*0?V3_?8$DBUY`
M,='G9_*)'(!>!3]E:=?A:F[G+/*Z:LFII=_H\7UGX4L.+_]&C^^;&,)>7_(]
M0W#T]I^9N*W^!U!+`P04````"`#M@&9%.X^D,V8>``!ZT0$`%0`<`&AR='@M
M,C`Q-#`Y,S!?9&5F+GAM;%54"0`##>-;5`WC6U1U>`L``00E#@``!#D!``#M
M75MSV[B2?M^J_0\^.2^[->5Q;.<R24VV2KYE/>/8.KY,3N;4J2F:A&3,4*0"
MD+:57[\`2$HDQ0L`H@DQJWD91Q+1S:\;C4:CN_'SWW9W=SZB`!$G0M[._6('
M'_]7-/OOG=V=XW`VOW'QSGD0L6_="#\B]EGPB`C[-_O^(8KF[_?VGIZ>?G39
M3ZF+":)A3%Q$^0<[N[O_L\/_^\__^)D3.2:(DWB_<_L0[UR&CSLOW^SL'[X_
MW']_\&KG[O9XY^#E_JOD(?:$CX._[AV*=IYG?D`_O,@1>[XG_H\AF>X=O'QY
MN)?]\$7RR_?/_(/"[Y\.Q:_WW[U[MR>^7?Z4XJH?LF'W]_[YZ>+&?4`S9Q<'
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M=V-?6+EP<H+]F,W.4X<$##,Z1N3FP2%(<"+Q(EU&-_J:`DSN\GC<P40!%1R<
M/O,_I=]&8A"C3%_-^?B_.7XL"(THC6?B(RK+<=L()N=G0NLFGLT<LE!CL/"0
M83.[]"A.4.1@7]D1R1XSZQ=5&"(U_AH&,,MIZY*MQK?T<'T89#76&P8P`/E)
MZ,9\5S`*O%,FUFAQ'DQ",I-U5!L?SYPJA[C2#%9O(+/]']\YOA9\>YB1I8S*
MKH<F3NRS35%*)L_O<@P<1'OLD;WT-WOKC_?$;#AS<*#-:_)TSGQ"</O`AB!N
M?(]VEY35&*X:(#^O0"`6T.S.T.P>$45\"X^NU@$(-AW?5V../[!BB2DK#C"?
M7!>,>($M]!RA@'D[&6/\:8T81D:*$?-#MT#!YX&@D&0$?.<>^1]>Q'1WZCCS
M/Y;Q!<89.F=_TDJ(Q(M.''HOWC9]>(^;I#WD1S3[1!BIW9?[:8CH[PU4<IJE
MSW3J.``RO/(R4DY7LAR1(L],]ADKJ1K(Z4GZS(3YNS)RB<)Z($+"5IL/+UZR
MWPH-?N\R_6$J=NJ+7[%9@*9)*"K[W@^9@_KA143BPEMJRN/&18%#<#AZQK!Z
M5""4K@'&A5-I41N%5=#'2D$5$5J75UD>NA))R=P%=(Y</,'(.TG7,`"IU!(K
MO(%9X:POSHV2J=+,@H#J`6L7DED1_?&R=R%!2RCS]6!$Q`%+A;3?-)/TY,2V
MP2BBHWL:\1,F"-&4*(`M-B5G2W_9*4,"#?YQ3`C?K8#+H$P(;&JT2Z):[=:E
ML(:-Q)JB)0I^Y@.!O!C7ILXWZE@>\`0!*'S'!,T=[*4!0K8SOXJ8_U]@#@)^
M&;*0R[A!^4@A*&.KNILJ<!-5LJJ;*Y1J^`\,.U-C$C)?/5J,V9Y81+6^QGC.
MU[%+!#1K&NAMA&B:)TH36G"K>6X^7H:!"S=5J@EM]&I>@TW[?.EBK>#,U&:#
MG;U]BNZA:70OL'./?<Q/*-CT6C\)@/1DI6G;7=7E=AKR0+9.E*Z"[&$3TD#-
MXG125>8:^>EL5#1M6W+82<?.@L?C(%VR:DIYPV%37#+N60U6K<)1DHPX6&6D
MV+/>,?L"NXZ?XU/J7+;A\<V8'`UHM[Y_N\^E-1-.9W,_7""4'IJO,PLQ*=J)
M6G:0U6:(!(9`FYK$)4RTIA_1M5"TZS&HB:T-/`G73\/&E?-54K-:3%JI%F"U
MU5,:T&843<$0JH&4"NJ5^>UH/W-JZ/:O8?*\-GZ.W.=&J7EKM`'"4?:V)?9'
MYN.>Q^%L%@:"-$\=!4G'6*-A44!J(EE'1V;;H[GO\3P!A../'>R=!\?.'$>.
M#R&0.E*6+9N:;&KQ`O+&KWG^9[#*8&?>23R+Q:)WPI!R,8B9DZ!J]\19160R
M$$*%3*O*@_I8E88UJ:I0:O>U0:*L-J*K&Q/[Z1*JJT%38F*E":][Q8S7W#<@
MJ;#E4EG-8.\V%W:;"[O-A=WFPFYS8;>YL-M<V,J(])PW86&.=YIC!9H66T]L
M""?7#5"URD=S=TD1>XL'YKR=H$?DAR*C)Z4.L[%L(FAS3]FJIL4M92-N0!8O
MZ6?D,Z(C;\;0X?SQ]D6`\FHC:3&FIB2P5NC`0IUK;/9B]NQN*245M='TF4XG
M6".4;``O0@HKD1R9S2_2J`1'>@NO=UA]&09A2?A@Q]15M`8@E5J89`ZD]41S
MB2+8"5(D8#U<*2.'$B8RA\QZ&3BE;C6\.YC+78VDF0V$--I(6CT[DY%-*V9`
MQ\^?$9X^,`*C1S8WI^@RYB]R-1$\7,41[['H,;YZ$*$F)YMO_G0A3B7^9N-"
MS\M.B!WB4]NP\S;LO`T[;\/.V[#S-NR\#3OGY"2R19?[V!'O[YV<3U='G:LS
M:)N>MQI9:5Y?VM\=+LR_W3#*;A@;`RD:)3+>GS&-."_T-KQ&S'5PL8\8:4[T
M-F1_<'_SCA$Z"TG7B6&,V*;/(G.HPL5H3M"<,(N:-%X-O-$L)!'^EO9S-#\!
MF\A9$2>(^N?G;R/`<$Y@&K\H-@$&<2ZJ*7V?PJR#%:ZY1TY=KB8GZ#XZP514
M3HX)FN%X!B'2=J*65DYP^4K`;?XD(ZE->G""*:+GP8KCI)M`D*\B4UIG%8>T
M$)X%DZ<6I'"++'/@"&)6XP0E_S\/TI9!)VB""$'5K8,@IK8F)S8"O!VF17Y*
MZV(/5RZSSE&I&+X?P9>)VK3I$&)>`]7X(BU87R>LVVA`;B1[CI6^D%2`@LL4
M6&>@OL2^GRG80/^[LKA-./>YZM;4YO<C[#KBMOPN"$'7`MR>YZ`;,.3.X9B$
MC]A#WM&"NXGY-UIZB4#11%GJW^=V6`5^XYDNZ:+RB&B'6&33\YL>7FQ\=[CN
M%<R?2K5IY'Z-,4&U71TAYIP"=7MS3D(K"VTQ%1`%BQC6S.6*5^G1E%91'XQ8
M51"%V9N<X<!AYE[;.C8]O^G6L?'=VQ/YM*TC"5V$/,IO$?SL$.+PD@Y$7`R4
MM=](S^:67D+W2JV!&W"#"\;DZ9Y3&O.KC=*\0'H7,*K,R65ZAA]Y@*@Z_,^M
M-+AL._%FSV1VT()NT@`[D<FS*)H5))=#TDQ;0?)RVXD.=*K7(`@7!*K4,'+C
M^$S/X+IW2%"U%O`Q,45+`+;&=$QZJ!7\]^BA5E$?C+E5012L4H5SP*PY_Q_7
MGT>F23QJCP@.O7*$"4*P2O0WO])!#4[I^@9#8ATQA2-DP70+KF>?%.$-WKXH
M(IB*\&V#"/LJ4"E<2?U"-ZC+4R[8*\0$W3+R1^S'?T&V>V@BI]^T[6AY,3=U
M"9ZGV5^\OHA>3<;,G66R%/[JDBC$NVEP8;?'A83L\U-$!V7IO61?,^9`\!L6
M^-6_6/?[F#V)!%>WQX-,CC4B5A<%5=5?ATBN6J4OM3Y<L38.?>QR+U)W25@?
M"O1.QGIJNGN7&SP-\`2[/)Z_-CKH$B!)V?;=8:T"+J3A2J*Y61/B5;G_?!06
M6\_K]H_,\E03ZP%J[:LIZ1OZXH"@$Z&.E&7-;Q9>L9*@!BO)FT'[TO/7%3U<
MS77FYQ3Z[<Y?H-BE)J-RY)ZT7Y[X1K6XKY)V<]?G6DQE3\[[FB9ODK*^6^<Y
M<8QTU6HY3#]+0!,Y_76@8E30Z=!(S_**("'04A9>`W0;M#:LNVI'"_'7HHOZ
M#WYK<$?YR0F-\(RY@B!'%R4*-F/8:GY^&1K(*^8K8N9"-T'-D!QAJV$)-8E)
M(@G3B?8",Y(>\P%Z6D0:Z0UJ0]V,'-`U@^5V:SW,MS:2%GU?-8&U8@=75L&3
M;0AZX/U='E'B?"34^["7LK3MGF(HVDQI0,'.X"_14XYGYK>Q/UUQ0DE[DZTR
M#X.RL.H(RS6;M!C-%QW/J/Y)U>`]]QOW`7DQ3WP:L8$]WC.2S>`;Y,9$),V<
M/KM^S%#FJ5)\DL=1VEB@;+UA(S_FN1R00PHA(ZFFXA:CK;H34Z20-8YY4=,I
MM+I\0'(H[9X9C>-7]0?58+/O)J`:,EB6/,C@T;E-J)ZI?W*(=\M^"-4=M$@`
MTC-H[0RJJ)J%]C-%F*#"'=6)\R->=#%-7)*CQ>HW:76:X&W%8.#Q1/M+9X8`
MFXM"\`D7_9+J2EHY$]I;3'45SI!4":@)*I0RP:M34PM5*_HDU755+R:4=HK(
MU85\*OB"1J-!M<0L7_0%:)\+0:1ZL,$:'V?>^)(V(H_8136O[(OAA#_.6Q=,
M`_R-O;#(93\.:02<.07&K+5:'W7'L@?)`=UZON*X>J[D2\]X*GW"-Z7Q+/E,
M@-*3@AGAT&8)H`G%,B.FUL,*8\I4T/>D4FIA1VDD.!FTR5'#7.[6]S[B,\FK
M%D),CN_&OF`_G*2WS*Q%FL3V4#^LVBW.51?B,;---\5;AQV+L8`@V`4T9CF$
M7!9J[[`QK80P(5U3-^=8FJI'B^H!P()L@.S:O\@'Q"X4HGN0TH8*\%33A(W[
MM=($/'^2"^+!S]MVQ5$,[\&('R96)Z<`E@-OFZ4#<A<AZ=<M0,?B:F)PU@Z9
M)<W>6BU"+V&TM$$6G#2*!&PGVFC(HH201#<HS5RX944?K\Y:<0<GFC:2-E,8
M-035BB!,/*>C]1[->`K*!OK8*6-64_P!MWZ&Q";;'*Z/&)%8->[+L:WT4HJ.
MH2`SH7K0B)!I%C?G:`H^/&224<`3S]H@$9!Z@AY;F0L9=:B37/6/2KF%BO@T
MD8/SSS5B-@!S=KW&L@9VJ7104Y*&B[HT$[2<-B6A]Q+R`K[6N9$J3*2D76AV
MHR0FY09SUW-&^AI1Q%Z.5R^>H$?DAZ+A?NJ'P6WG9,C:S4:2,D1Y(4HA"30%
M/Z(`$<?G%ZUZ,X83+PS@FP5P.<H1MAK34A:D))APEY\FZS6JZ?2=L@&R"Y>C
M;#DPUH/_+"L"\W8YN7%C-G?<Z"K@S>Y<;D^2C(GT]B+V$HR961@(YC#39-]W
MR'*W7U*,F@N`.E&P&&P#%+X)Z*4[N/<18TF"\K798SKM1YIRFTY0Y&"?UE.M
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M]C^ZY!\?/OQ[Y_CF>G>WQQB.6?UO*V&3U3B+J3S;"C<-V]"M^&V#:I9``KW;
M\K=M^=O&*].V_&U;_K8M?S-D+NI>[,S!1%SWD5M(KS']ZXP@=,X\'()H=,VV
MZ58L1V>F[=V79-2![5'*4)E^)CGGL2$W0MX)YI=+!=X@]+.2Z:U^JDH9J&,@
M".>_A;P>RV>P#DI#2VQO6GW?!JIH6=`R+1+UU70MI6N=^WL5[F\1F>V#:2<,
MMW;\2&"U!!*L3&_'G@/F-_%LYI#%,D:N'D`NC*-T]7CUD]KEV[KV)"T\OXHC
M&CF!AX/I90Q6`F&<20O'4^UB-V+GZ^6R:5NW=4X_(SQ]8!-_](B(,T79M<=C
M@MW-<C\46;?9?\*&QC7+$2PK0GL1:GV#:\1!9I\?L]6``Q@[/E^=#C;*[>CP
M&A;]$34%[5N\0$U3M`-YZ;M\Y#5<]#Q($A8VSFX:9-]>B,&<Y30I38F]F95E
MO/@.'TE(00Y[(=C\?[$\5\H'K&V^V%^>LRT=\DYBPCM2"[*"0YIO7)5IMP>B
M+.I<#&(AU`"WM6>^G74LXW"X2YG:&PQ"O7H6:JJ:;WI6S9:7.`O)!.$H9E-J
M%'BGSW-,Q`C+E]K$U:V=Z>_!G>HNN53EWFZ:$]7*^L:91]`7^BZL):S(4TW^
MJ=%X]G7CQOY13'&`*$T/$UYTR*XNC[5V_-":/5T_@G*LLW9,M7SNZJ?[+#"7
MA[>0>%SSV@:2BO4NY0J#61@P5LCBELTSRJ8F`PPRQ[B%(J`(Y7..&W6S<.-6
M"WPP9=OU5.$2A5MIVNZ7)Z?)<L*#3NEMHPR3GBLG0KNYMN:E:#Z15IB):\2<
M")KD==[,?5S=**UZ`:M[UG*IIZQ96:YGM1@`UE6L95MP>[WB(&GUQ?7LFOM^
M,,DLJCS8;IHOY:'H(PR4*'K-F0U6K<M'KAO/>%]SY)TP"%T,TAM-@JK5-#@E
M6<I`*%%$JR6^,0E=A#S*&Z;Q"*L3N.AJ<A$&4WX>R/OPB3N\YSAR_%PC/P0B
M57UF[.;E*DF[`^*M1V%ZG2L=^@`A33'N<&9A`H/$`9'ENW;U0PW+2JFAW[;[
MW6FLO&1J-=;X[H>/SCV+1\?G1R"CZ-@A9,%8$]FK4/`W4!S41>XMX&U2VU%N
M9U[EFN_R?],HO$;"`QD[)"I9';U(HBP)];BG^LB=[AF6):<6*E4;U<(MQ-KR
M*P16%<&S<T<Q=\)6&ZBCQ5V`O\;H!%&78'&(`15UE2-LL=UFMTF0MY"2&`/E
M<!>IPS9OJ*5EN0&#DI;7BTZMN8)1:<$$8!OE93?N:EQDL(TTEPT&DP@5/R\.
M`^$/`=G/9H)@\ZU'L]D"*5BI08D<G+6L)@16OB1E*:7TN-!/HAHMF'/&2F(P
MIK%6.';-HAGYR-I"S42ID$19@`_RX+Z:D+4[]0Q:OFH$H>I52L0@>WM5D^KI
MF+?)[#7I;*-H5"ZC,RH@J(Y9]2*R:O<Z"DC2XFG[[.GQQ0)RNUR@\1V8N77<
M8$Y]/CE_AH2K`KV:%*_;@C-UK31M9R?5*6U>0.W`@5W!V48:QOK)2<W^QKBK
MX`#OS>3DS@/*!A'9T(#FL$1E,YK#&C&*9?PD3VH[R@H^-%A):P-"@]7Z6B^5
M/IJLUE&$"P362L>^O=,7$%"RY9C@P,5SQT\N5U1(M:Q^TN*5"FU&8'FF5?/.
M<!N?]*X%GN@'>;-LF8C5ZVH:@X_%*V37P('*[6>KV-A9\`7K*GI`)/T;\+;?
M-I(69TM+M*28!]X"G.$CI.0"$XZ&XQ^SD7`P5;9.#8];!%UV`[>ZQJ4!!=,+
M=F(;8^(^.!0U=*^N60ZJ'K2;_J.,=O7+&]Y?I'(]YG0FQ3,^)?UN&,!RM4/;
M07U.NYM0@+`JI?O*12XO^YLQ$@8!$E49GW'TP#R$1[;5&?N.*\XHRL4.U3+1
M'MQ6HS\S*4+ZF`+XL^(51G'$5C=^5]9=P"B4*1>-JI1H-8:UW#W53.J7*I32
M]X9U694J.=%8I*K'&;S<I,"2Z9YL8K__R8E$@.\$J#EW`[7!6E49)(TWQ1*L
M%RF6ZM&2UDU2\TQFG,'/,RFP6EM:`0CJ4^Q'>,[O55]&.KI+K6I0V]67P#*L
MQ+&U$92..(]0((H&'?_J*6`</.#Y:!+Q2SHSAJ0$*#&,U=JN[O*2`4JB;Y*>
M8XE=E'2[&5$:,AX8W]RQK>")_<QE^N1,T06>X4CTRBF_NZS?:9CJ8%=%*"E(
M-2=2W64N[]:EUVB**;_\QSL+R36BSOK.2$LSNM(8ONWNC'(J^7>P)UYW@3,+
M&=UO_)8=*@K2X!WA*J*#EK@"MEE4P71%P]C!WGGP*PZ\[#8O"#E64/DN!%>%
M7B8ITZD;&87T?GNN,Z?/KA][20R=*XQ8#"#D)TU[R/L?=:`S43=&AO0JXW-T
MDE!R9@K&!,UP/(.0<CO1[V+22F";";8ADM0I3)\_?"R^P'%,B&S@3VG`@>^1
MU,#+Y-=^<U5'/^C,<5%R@`GO_N1H#5>8[3!FLFN*+AF07/XEQ#5-5Y,DNV/U
MDQYR(Z6X^!X651WP,TUH"DOUVIRB_O*^+OUVZT==0[3U.$]F+/T>O/6CJ[68
M:!O'2E]>!3$43A-;0;'5JW=9C'CL.Y1>302?X`7/:\0VHD.OI.96%CBOPP>3
MRI>G`Y?I74%E`PK\VE2UD%M9@1-8I<LZ,9@4[QJQ;$0QLYY0`*M84F*?'=[K
M/[HBU[Q//Y1EJR<V5,O6`)_9Y*5&@N`FKI*<[<*^5M5M%11T:4L#45#35R\N
MNV;0E,3,U[JL&>IM=QL#[EYC/QN#.8!2-27;AC8E,6T;VFP;VM18OQL7!0[!
M(;C5*Q"RW^FAB[$K8M:>/ZLGH93(74#GR,43C#S`+C:UQ/HIEI4Q=E6:6A!/
M/6!`C0UK*0+UL6D2TD;8.VT1P38RW-Z_9<@"2M[$57^`:%A\VYNXMC=Q;6_B
M6L/2[(;90_B/"S1U_-,@:NT&1I'[XS1\W&,/)9)B?Y0%5#7@L+:_E9"TUW<H
MPYX,WV;E9#$OC&9G!]N@2QFNQ7<VWXFC3*/)^.@B:\>H*((+T3XP:ZI2*#%D
M@.VK=9.I>]QBOX;Z<\9\,YG:]S9^U%9'\:`;T@=#1?I`OD?#MG7/@%OWI(<$
M<!(H$K#</T,:_Q(L$(U*<B(>!=Z801[S1+"4<G7KI,:"I9:1-EOQ52`Q??MC
M:@/1F:X`ZIZUK.T2)]ZY):#F]<U[C-NKB-LP`,+\%S29(((1O;@X5H"[XC%+
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M3&FN:B1T$?+H&7N%S!Q?37)N,,C2UDIT8%-.`<WVGE%Z[B:?Q4=L`GL\^HP"
MZB1P+2?^T6+UDW09'CTYQ+MD&B?ZO*X5A=>MD(9NUP/D=YC.+:@$P7I:Y32^
MY#[`>,5-]+X#J[&.H42/JPXF@R;;J6S9%Y^!S?=*8I8[;G29K=7@276JTA29
MPYO)"H[A)59':T@;G7;@)-I/F2SNS%JPK*X2.79\'WE'B\S52W_87WVU`DL#
M-;"=)2'3XTK?!@N-!#.ZR>@#MK(I/#*]JDS.U,(.>OGE4BE`SLOT&/F>9F4[
MZC*=JM1C$BDA?I^95/PA__NAQ1H*[YK!V13C,1=9(,E"G##:6VBA2'6(_HL,
MF)DD&T)$6A'TIG,T\66R^USM-B^17'!6;^2!6;LN&&82;6HP;F!V5C(`/3FK
MB0Y,N`IH9LD#QLOD3F=S/UP@=(/((ULSJ\-(ESP!A4;($Q$C>AM&CI__GI_`
ML??_@J)KY(;3`"IA!([9(5IU0-%EZF:^H`&,Z<0FBNL7Q$?\=R!>=L]O,,RM
M5]]BSA2V/6K61P?:D]!-+ED/O"03]SR8A&26]*+7J<G,!LR-LP:_?B5AX^CJ
M2\LJ`3FY%H7O%O@MK-T9K1S5ANF6E4FQ!+(,A^G2]SQ7/*/>G&:(T2QL5%5Q
M+KZ]^>8>G$;:NOX,4]?QOR"'G`9>\_62LFC7CFRQDD`%_7IDVHN1-"W,6L;M
M51S1R`F\]9MUM>U-(XV!B$8&+<.IK"NRX_C>Q^Z9'SH-=R^HR20_Y`#L4@4.
M,C>HJ@,^8AQYXIX&WS$P`8K#64F,4(6ZA$!K5J@^Q">(N@3/FV]R4D8Z/^H0
M7)MJ.$Q?4YJS88P4<?QSYHT__XH:HL"*1KXTK)UMEZ99+T-B//$R1RM9XY-"
M-+9L\#9LL8$]2./H@S`\S?B8O>9S1>^WT(\#7DU[AGVV0S<EB/*P0YH.:Y!(
M7+2I"[\@<<Q\W&E(C-FBXJ"#\C!+>$CD#>HB_QGY_J]!^!3<((>&`?+$`4E#
M2;&:#.J&'Y0T:C$RGA68YR\)T1G;%5</.PR#5`,)0(Y?GMIJ`W[&/C$8("P/
M/(AUN185TU='KA/+@M4`0L@//81M0@,P4E=`-H7N?][CI.X=B@00_P=02P,$
M%`````@`[8!F18'A#OYZ-0``SI\"`!4`'`!H<G1X+3(P,30P.3,P7VQA8BYX
M;6Q55`D``PWC6U0-XUM4=7@+``$$)0X```0Y`0``[7UK<]S&L?;W5.4_S%'>
M.I$JI"1*=ASIQ#FUO/G0IDB&I*S8KE0*Q,Z2L+&8-8`EN?[U[]QPV=T9S`68
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M/GKOW;MWK_A?ZZ%%HAI(I]U[]8\/IU?Q'9Y'NTG&`(L9@2)Y7_!?GI(X*CG*
M1KZ0=@3[:;<:MLM^M;OW9O?MWLO'8OKL;XC^[_>_0^BO.4GQ)9XA]M^/ER=:
MDN]>L1&O,GS+0+ZF:H!/HQN<4KX9D?=W.9ZI'T[S?.U9QLL[QLO>GQDO?]!.
M6:X65(>*9+Y(\;-7?5D>EELK1E,VZ)2.D./8O!TRY62E!K7FQ8\ESJ:X)30V
M-8E5K\(GG$7%#9]U6>S>1M'B%5/\5S@MB^HWN^PWNZ_WI#K\0?[Z7U<E?;<Y
MSLKSV7&24;5,HO2"%`E3QLE-4;(/M&*.O]S7SWP>%>^5,BTG.0.L>BDVI?_T
M_TIO:I%80;TMP\JV\&^8\L!,&\YV/UX]^UO-`2(S5/.`*B;03Q4;__RKF/EO
M+6FQGR=Y);(HCPW\R1&O8D)-PZ+<76-UEI.Y)_#$'U$!$&6LI>'!%/$@*NXT
MBM;^TY8B66@2>SZLIC`*L#JPA@G1O^NF#,,*\2+'BRB9'CTN<%;@238]+^]P
M/BD*7!8'RSRGNJ>1L<.3VRI@HP06!,+JB&0`8<%!@:C3A`AC`L6"/HHX-[4B
M`:B1"^S$&\QU)0RJ@3:Z9JU5%FK52X%*4D:IPJ_HT*)K]HA.84`LCU$Y+-4@
MM"4B"QI0K"XH>B55T*-?E\F"K7UG6&^"S(]X:DG7U*&MCJ#,K0VNR.Z@#)<M
MM0%1'"M\B3MHD&K5LG-G](T[S4SG6`^'6#E?6.WA)!&-[&]W:6P^'\7>=,-(
M'/`!]6<%(YTK4`]=$!.`K3?CK3/Z!68\R<8Q669E<1&MHIL4&WR-SL&*Y<1"
M]LHIPQJ"BB9:"*+`JM`-(G'!9DU5='J2EX]<^J_?O7W-9<]^PR;/EWAZ0$<F
M,?V0DN@F26GTC#<_<\O1#M^]8<;@PF=T42P)H[2A#!&LV,))G'""=!N.YHN4
MK#"^Q"E/)38<=5L/Z^<\_5+C_#"*18T*?3H5/JID:3<7/$$KFSOTQ!-/>+]5
MP&VM?78/^:5CNN>&\&HCJ7Q5/J99TL"<6B.T6]ZM#6!VV1;U$B?WX1*Z=IZ1
M$E?KJ-3GBRC7:XWW\RXI76<B@?.^#2<H8ZQ4_A$J":H,V$(PQ&-NMI,P30KN
MI(`HG+]42$^T=3[Y0$)][13X:'8:.U/Z>;Y*LEOT?90N,9,;9PN=+TN^WTW_
M]&\JP-<Z"89=HJR7I<&]H/[K3^]$KLK)`5F([!:?I^/(')#YG&17)8E_X1^F
M;LM0,\PCU;(Y5>@5A5%#!2,'O*.H@XS880&;@YE.^;9UE%Y$R?0D.X@6"?V>
M=$F8[M&^6S_J60.'3#51Q';@=I,,Q8)N.YT/D9,Q8$J<@((T(9>XC)(,3X^B
M/*.K>$&=ZN5\R1?#0SQ+XD2W\-@_Z%.E8)X]>#!>T4-301#6`#G`2WQAT[HT
M?>42VAVMN$`5&^AY6V"2DQ?`1B"DR-1N:.!B.+JPW9%T2N7#=AO+E<82Z`=Z
MKB7;$X*YH$6+]'__X9%"\^Y_^$YQN8+>(>Z`E=AB!;F2M-SB23:UUA[;Q[QV
MATR3@^E5*Z3AB=TGI&?6`E"'0$9<X2S621:3.:X+.PT5NX;1GK9+,VM8;T40
M14V)KK(8%T2;3*@2)ZA@/>$"4TIW5*$/\3U."2^OD55]6B?8XAD__[=CXK#*
M5)'F=FK:$(?V?VV0)1Z(P2;RQ*F?E'(UF<Z3+&$ZS@[Y=.N5Y5,>"1S#S&%5
M2Q+GFA6MD0?=;[)%EWC!!IKZ.5^P,V4T;I",Z&JLM..\W*JMV<#\*%)1WMZI
MA-BHU*)(+,&!<X9J-L0R>TH*HVYLC_19NA33A;4JC`)B@JJT@V0%<.C?!:%*
M-=30P*Y,?`_]C&1D0U^[ZA\ZAGNIBF9.:WWI..)HX327F/ZY;!T]D38%OOBA
M"]?-L@<#7K!*=(9+HWU1CO$,K];F`EAU*#V44E*0JXP:+V(!@B9<<H#3*7/K
M9J:WH'R:6&HW_,/61,KL[P7.K^ZB'.]'11*S4"9)E]2R:;XLRZ<\P@3#S&$7
M=$Y,A)^"'"\68KJ#J.%#!6,(/4\R=$C2-,I;OWT!G>ZPE0#Q@A94!3_AY/:.
M,C"YIXO++3Y;SF]P?C[C/+;J?.PTL]]D/KZ$'\7`9^89\0(M"ZK";&^:S!=+
M'KS<V&JXF.$%J,WL*3LRI$Q@O9E63P!V=/PX)0^%?=\'[2/>VV#ZJ0%[/3#:
MB!-7II5A6SSH,5:W=N@$#C*[?(@7.8X3'IVR+-*<Y&7R&_]1HUD63W@E;SKF
M#:M5;<(B!=@B#>E@VR!+G`$#W)F7;@.>LNY1-`#L4J/NP5X:I)XRM$DB\2^[
MK)?3E*^C%=7MF!W&)'6C2ES`@E.<MNJ>SP[Q37DHR^\O<CQ/EG.-#ED_YUL\
M:)H_<+%7BSP_DT`9@#V8X`XT\43/.45@-7OH@J]-"3$V4,4'>BXY>0%\$#>8
ML,;)09QD<8ZIH3K$XK\GF>QL<XAG.,^QNL.-OKJBQV0^`:`?1<]4LZY;GU_+
MHZV.`D"5&GTD1(9$'C;,V^9WXZ2\M4YKGO.O'>J>WSGA[6%I];T-QE%*'<2=
M^M>!FV70ISX1NDW)LO^!TX-.3KG]]##:8VZ.$/R`H!O8Q!?#L8V6_GR]M?TR
M3S',2JRG`ZB4SHT5QC%X%C+IM'UV6(^MO)H3_-:::WC>8\O+F@:`RIJ:,HRC
MF2;,.]72`DS0:.<,ERPY?)&3^V2*I_NKCP6>4C:KTHH)Z\7>I9/N$W@EV^S)
M`)5#Q&P_@&]IS4C>*LB+:D:@-V$])$'Z`@R7M*,^+-O+**[))/YUF>18VPI2
MHZCN$W@IJCT9D/*N"_K[NXC%V62&%LK&G\"QC8<<2%]XX=14\QF=9/>XZ&-/
M.R88TIXJR(QB3Y.*CZ=G3[LD8;:G!H`![6E.8HRGQ3%]YT]1GD?LE`C.XT1?
M/6_SB'\S9.W4P9LA<\JB=/I!T*:^IB0.;1QM(";NN#GO=Y@F#KW5L2X6R0$Z
M4HGE<Y3+.%L;;:Y.BF+);AR2=4C%QVR*<QJOT)4SN6<Y:O6.+5MF;>S#$-/[
M^5\#,0%I=1:UD[9D'"(:(Z(J?X'XEC^J_#C$F!O1*`TB5\V',I2XQEE$N9S.
M%_S<3?6MZ^I"K9\;8#E5S@^IW?R0/XV099W*^`MK-^(:Y33"V&N)U<X.N\X*
M6R/YJ%?;*>SM,Z$$]836W/PJ2JF9Z^P(8O^@S^:$>?:P)H*%?(MU,T%ILR1%
MW.IVQQ,5BQSOSMC".*W<<^#KD*SE8%K7M/AZM*"R(P!K/BH^$(W@KZ0XCT;I
MYA)2:",TH=(D$^2-??Y9I8X)ALPJ*<A`9I46DAUVX^RL8D6=6!HOK=0E"G-:
MR8`PG*8RYJBGSO[#OIA[^NVP`A2<)V2ZN1NFT56?*7R60!<Z0.J:2++H^502
M?L%/3*U?)0EVF:2S%$A_=&%WY-5<3LJJTW=G/V&79[W,J14%5]5<<!%<E5%>
MNBDH/P$5E>@&WR89.[O)MY3X;$]#.770&[6R`U&EY1Q`8DZ.F0#Y*'/<^ZL$
MAEF%K4)4_Q:"TD1U84^Q)46<DF*9XVO\6.Y3(K\8SD=:/.%WBDT_;^!3;#5A
MQ"@C3EK3<`_B+)L%OL09-L`C2:)2ERKV!4F3F#64[%8H\P,>M5_Z24%NDF-+
M2D58I4H0AUG,L&[?+&?`RS;=I*ZU%G'GT6.<+JF_SR+3@RB-66=D<71&'!;?
M[*:@T9X!9W2OSNY'-ZP&"MY0Q1QBW*$6>_RTE>Q14'?;IBR*S@30)\*'%",9
M7#JP'OR$?G^\>T1RCZ]PO,QY\+OV'KS?A'R/K;8C*_4$D\=$>U%K>(H^MCL<
M5X&-?XLN:@C3;XJ2AC7^`((EX!(#W>UH;;Y\P*S-B>8;TH[S.XF_.1O(8B$(
MHI\$26B/5X_@9EM\'3"`WFT_39_,F9<5QAJOS^V31AR$`9`&3%CR!'TKT*`2
M&LZ`;B,/Z[G(NK!..ZD<XUD4LC976(6KZO5&LHUJU(@%%)"]D%IW,+(&"(T&
M=VJ$Y5,>'J1A9KA;4WE;B[8GN*5%$)E+2YR)%X"@3EG57D-DO$R9RL[!GJVV
M5%.&[K(E6Z/()*4R,PG29*L33N*"$F!KK:VK;-@ML<8>@#8/J18O2P]?.S=`
MSRU)^X^RGH5?_#M2CM(2Y\[;L73HV6VBJ#.5G,I6=6[5]*0C(>GTH'O>T6IZ
MN+9M;2:0Y&*4!*(;[,073?`C]NW;E$Z9GK"&A?ITGL437JM>Q[S`UV!5I#=3
M:C`KH`V^^NNP=+#!K86=-RIUNNH.3_JMBA8$`"_):K'0V+5-UQU`X5Q@M[TY
MR^3!ATV?I5PQL.;\2_>%)6X/^W:NM"("T#&$T[?LCPJ2^W)#G_2!%#)W8;@(
MK-,L.CWKM?1:48"[XVV=";UM!-))-_SM;W_SW&'0M)B;+Z@?>9YM-,4_PR6[
MH>0"YP?\F`C_.)),WH!197950<8@$SIDU?H3#>PE<M80-8W6MS!TW3,2O)G=
M(.(C0\L%TN9.'J)\>DT)=M4FJ,;X+NKMN0+7`#!2B-%2Q"@@Z[02-V(!!J0&
M5&?";7?9C>/]P@[MM(&WW==/Q'=LOX-<>63$EC@BUB?W)N9D1=$B6BZ*Y5P<
M@>U*O-D_Y;(Q;CEU6&61VE$S@%H<C'`ON"O<Q`M&V%(?95PR81NKMSQUL[]J
MALBV7=R*'D=)SLOW6V]SF12_'.<85[=17M+(1[?-`$5WP$M!!N0N<$*'4MR=
M49(HJ>X%I3X^>-@,)V/C%26!1#?V-3F>K\5"O9AZRH<).WZ:3:&^TRZZXW^G
M*NY"'[\1E-`JP2EH?PXXL8;Z-$W2^LP_S>\)J]E/DW(%_7&J*?O45`*P%_;[
M;&@]B1NYP@@V]`>J%QCLGC+G_,;\<C<N+W>-\_E>U]<9E*!G%4XPO@)G#B0I
ME"8SC)ZO<)2W+I.%^BK#"G3S8PPNIO[IBJOE?![E*W.&0C/0-1NOG`PD#2%I
M@E<A6F!(;,&!3'1Z+R>R[UOK5F5QV_+0;I")CD?Y]>"\@#4&$<=+8.MJPTEN
M"*_&1B2Z9!VPAD`T(ME4D/_HAXU`1G!RAWF7C?ONJR:<%WD2#QZ/^E'WW!$%
MXA+,<%=,[$HNZHZOB//QV61]/94@S)=L*UGG?L&`/$(L"@[*]Q_=&UJN\#N%
M/O&H\04O\3Q*V*'>`Y+Q@&49I2Q0?3-T8J4_)\`9%W^&QUM]:I90BR?$F!K#
M&(RD)D/D<881OCK!\^1T=92URDI5_Z.I4*)_4KFIPK!>?\-;V)]DHA=NB&!I
M>`["[+$/QR?`T1+.#'CSE#%D[>*;AA'A9[`%KWR_;W)2Z$JS`U(:*9VAX"CP
MH9KM3_!)?(,])#=@'&@0!^@:R>J<V0T:>'JXS%E_5!$D\#RPRT59_A/UZ#/A
M1`_D%M]1;F+J@?UF[PEO1`%/V?9>ZNH+'L=T[;R8Z)&;`.,5P,/;_LJ>R/H2
M1NA#NGG>HGQ*'[CA'8])/L-)N:0:Q.X9?UPD.9^A?N=`CI\U7=A":%ON@!9(
M2A=/^2G6F>#H\_,3[04]H-?H)+_/)RXSOM8(F]2#\!1HK0[).LC2W?7]_SM\
M^]"[BH-)''"%%[VCKJ-'ZVZ7%D_T:/ZEG!>D^1>E;.Q^"=?\JQO?K>9?1M@`
M.Y<7!2Z-=_$H!WGU$E^;*7#/A:NKH^LK\$8+:JR(#0;`%XMP/@Z6><XLHXT&
M:,;Z7.:AFB]P`V9!#$6<]'O0>S<ZT=M2C0Y80,M:3I/HAIU.2O@*N=UCU:`S
MKH_[.7ZV5,(JU^G)9/_D].3ZY.@*3<X.T=7U^<%W_W=^>GAT>?7??WBD`+_[
M'W3T]X\GUS^`5@D[RX#T0Q;0%VJQ9V?#S`]X&#+]I##6+&WH@YHT"S#5JO14
MC)NS.?,P8#YMO^%;?M?V"7,&W@,7^#C9)!\K%%B1SA>8!8[9K>P2:'*FC>/]
MUD'MM*'/_TFR50/2XCUP!&;&DSBBU._@IR30W%/???S3.-R]'WS'I%#*$-64
MWP-WH#+C2=Q@L@[*U`HQF?Z\+$J^Q71-+C%[@23%LA'C-:'_8%=`?RSP])CD
MCMHS]-SNJC84!X$S`0V7J"0HK_AL^H#2W[)_Q^Q"\27EEN58$1E=G0<7,`DH
MMYX?RL$=2]P6)UE#3B1*LFD[$NGX'/QF<#UD[T8E<!0@>$%)UE96S@[?*5!&
M!\&UUE,.I#?`EA5@FH;,V3TN[&VOQ7!W<]HQ:>BLNB0\FJFSP9.XP=33(!TG
M643-HJU"6`QW5XB.2<,J1$UX-(6PP9.XP02;7]]?%DF&B^(0%W&>\$U':L+V
MHR(ISF<7%'NZ^O(=QVO\6.Y3'G[11(S^$_F%DN[TPNIBQ0]J,<27-\X2N[F^
MS13ZB;&%.%_0NX$])$6&PA\P!2M9FL0QNVB6?GXZ!=:-\]IZWIHML/952M80
M'%7%M%@22X@`:YR2VRR9)7&4E0TK%R1-8FJ@35;/[6'?$R)61`+G8AL>VCI6
M<:%1-HC4K)L$2!]800]OQ'=XNDPQ_4#Z7;!M5.%@A/PJ80=G)_"'(?GEQK?%
M,6I=G5SQC)CJHA;7[*&*;T091YQS^C%%[`;F\>QW0)T@4**&6T'6[PPV?6^&
MT9YKA&96X.N=51H+H*XF2+7W.X]OY95W`MLKD_/S@VS_:FB,=0&T20.AC*:S
M+(R70[MI*I1#4M^C@_/[),::&F=Q<R*WURQW3WVMW_!4%"T?D*(TN]:AZ7FU
M1`_%%)R3TES@)#@7/H?B6NP=U+#/'FQ>`(DW0/P5#-X*K+L22E647DM`%0#N
M.EF_DOHP0ON`L.H6)*X`]M_SD$1\0^I!F8'[>-O?JN07<89WUNYC*W9T=VYU
M?*N@'^J@.J#\.H<6[#C!O\:HB!V$E?>'9S]9OU72A>(X7]'&BB<Y>THAN)?4
M#)^$FS1@5R/%\2.3BML\XKE2=$T]RB&RL6RW%<;=I\A&MZMG))N3#)=1OKK.
M(ZK_,=^A6G7>YFOWD-\N9O?<8?6K11NUB(]Y`;`EU,0'P#X%LY?XGIV&YL[#
MU2)-2N6%OS9#':U0UY0`![HE9>E;<MJJJWY#5UF8,"7V0(%V.B%YR;IDLIRC
MP<9TCO6ZQD0Q7V`'BY'<I4HV1XSHCLZ.@+0!Z$*3.,`$FF%C&;^"!BO,#SLO
M[W`N_UUT7B]N^92'$AEF#KTZ4>)(4MQ!G'[U8Z&\;QQD?;+#FGB!"*IL3./E
M5MNJPS#IAGFHT^94`'M3%;E-,P2T)Z4$CM@A8JL,NCKAI$RB](#ZW:S@<,ZJ
M&_0^BWFT:_VY?D8`KT421Y(Z$N2A;88MLL0)LE[5XQ<4L#L:_HO\EUX?NL:Y
MQ3G:Z0#4H"(K<Z+;\@\M_$X8B24X@(5P953RGD1B_Y&EB&ADE95%E]]J\XQ7
M"K%KXL#WE(JMY8;DMA,+LIML@RSQ0`PVFT?YH`$Z#\DZW5CM.*\JLJW9`A]Q
MXN1DF`P;()OQ(Y:PP!9,G61%F2_YODRW]ZD>V*-,:GU"`"^T(3A26JT#1F*+
M33_'(T^R.%E$J<D3[1SHZH0J)X-P/"JZ'9YG<-^C$TABBQ!D<I[IWP')6`J/
M>D+[JX]9\NL2M\^7=!L*ZV>]5A0K"@#&I.%A[:31.`&N/>2D!Y)6"Y,N#CY@
MOO5LG697)&P>[Y/"[YH7)")&C#[;^]Y4(E54#!`66\!,'+&#3.U7OO95C+,H
M3XA-B*0:ZU6.JY@O=.V$H#2"E>E&3Q7^Z&`!+I853%SD^#XARR)=7>(%R4L\
M[0R";!_S/%G3/3F,#NV@ACZJ&`"W0LZ`$S\<1\C>'*1149S/>)!G8Y9TXSU;
MG.NF#1R`,VJ\M$N$X./9*2V<*EO5!5*?>@7JU]]3$A=I%',Z=,1>9]!E&.T1
M>6EFA`F_&'%44T>,_"CI?PMDB1-D?:/P31)OG+3BS>!:\69<K7CS5+1B$]D.
MK5!`YAZE%SA^>4ON7TUQ(I88^H_-E87^ZE^G^#9*C[)2O4G<,<(EYZ^8)G`C
M9$8,"6K`*;DNR(@1BGZ;PM_BV0SG"2Y.3P_TW[U^E$_@NST;P+=>$T64JN(3
M#_V!=T!(K'`!#&6E"_(I8G>2E.?Y);M/I,-O-([W\QNUTP+YC9(P(CGBI+?,
M`L06CA%:X@C8IA[)E_BOW5WTTZ</WW_QSY_^$2^6CS]D7[Z;_O;5_>T/J^SC
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M7V?+/W_Y\_7MUU__$QU<7>[N>EA1&O8=+[,IGDKHU=5Y-D-][*EF2A`'"B-!
MNOI8E&5XX9VG;DR)/5!](JS63NHDFU)B,TN=<'K0O1>?U?0`VK*V(\[:H-6L
MC*H];N@37U"!C^\J>P<T5?!-TOR2'?C:TV:$_*;Q/8+K2&ZD[A([[<,/.^V=
M$\X6=&6[KXR,K2;L@(?<#[[(28SQM&#M?]C5U1%%YWQV2K+;JF*??HP'T2(I
MH[1I&G2&=7<:])[/*^ON336LOE=LB994%6/,$V:L-<<XN.V6[+5:6NT@RB%T
MLKZ_`,G`<H%+[[-.Y^QCO8]27M-7'M#%9Y5DM^P0N^ZJ5+N'/`.VSKD#1VVL
M`WZ+^`Z*2E31YYT/,+1N6D)-?`#LYZ<R8UXF-RGF]5U,T^F_3S+ZAPSSPY*?
MDO)N,\^XZ2,,,I=KOMB77NA:SYHK82$KOA"KLJ@Y0XPUM)5UW@.K/N\M+3*@
M&'KM6_`C5)-E>4=RUCOG(_6]\TUJZZ<G5-KK/XO'D0=W8A"GZ1J&$.=H6SW1
MQMD9P-"LAWS((*CW*#-;/\2AI*O,#]D_UOO8C7+VP#[FQ@$<C<Z-=!ZG&V[U
M\1PCB&/5T'^(2GZ*\)`RIG$&S0]XGNE43PI:5[^#*M*(T88N@S7`JJVQU^'5
M;YMOG<9&-,];`&WN[;@^YF&,+&:'/8FQF<C9$5VA"O0\R>0_7T`6!;C`3_Q`
M[;'`=5+ZL$S+9,$:3-7G"9P5K&,.GVT25UICZU[%DK@G1#(%6I+M+1TK931`
MWB?"W<<9GB4Q]>G.'S)*\BY93&8ESAL.5,IH_Y1+)8OEU('O`JGIHYH!Q#EH
M*1Z@8^\`-?&"L-]R28.&),:B(>ND*`BE6N(IBV@57-!A,;O8YA:?)O-$]*-O
MQ<<\`-$$GV&(N.94!F<D>-S*6A3+?L,-P^B!95>4FMXPC1JNJXT;D;;AC$,N
M[N'$3R#DVBM[(S=/N3=RB6^3@G['_,;.2UQ$VVDDFZ]IH"E]'(N>I&&.H0M'
MMF$/';.R)LZ@*DFY]6F,Y0,/)5<RO+``*_+6':F/630GE*G?\)0UTF3'=*T"
M_([G!CD[KY@?..1O<8`J%L8]6=^%N38)8``2=,<]2J8GV7=)1O^??2J%=BM=
M.]!3M[8G#)R:I/1VDVR744052>!:C@X0B2TRD-I1T3]Z9*VC^5Z0N*%)M*MB
M*LP]"8W.N#[NMRUM2R5TZV;!!9)L[,B6F#4KJ,T+9+K260JD'[:CK9O'48Q%
M5PNKY7)[N$_7*MV<P"LC(RQ[CX`6L!LAU2Z":JA@RRA5"2SA#"Y9?>?Y3!3+
M-4/LNA:Y3.1G\]SI`>MCBZ4=))CB-Q&)*LL67[`MLWK(2:O(KNA#GO1IJIA%
M2-3LE.OJQ\Q/].W.MCDO7)^V>L.G516AB7N!^[=IL59W<NN"$++_`&6%U0;1
M,&:9LYMT>2Y*,'>&'_B?],T(7![N4W!N)`)09HX$$TAP(9.;E3JRRMH',4*=
MAX&J,K<7QV9MN1/&D!&,ACM><.FIHNIG_?JSV%`83STY'VWMA+TYS`E^LT;J
M484SF?)>LJH!2%6%SF\%U"9>S(]XIV#T4X=.Q@C*3?^6^CP"IPY^SL`&9.*.
M7*]M%+G*WT=)RJIOJ1;+XV='CSB/DV++B7-\RGF;VSQUZ/M&A/=6,<#O3Z^.
M<=<\0"^AKJ@3+S3[[7A74U[D"8VZ&95;7LA8G6>\)E75H^"J^HF/IYQ]S!)E
M.>N0\_KLS0U!/W!K<<DAXB11B\>=YECL-4%UY6SE$]:_$`\R56?<<NT^)&D:
MY05:T%_R\2\`BSL&E3D)),@^Y47-#OEY)OEB'VC%BNH[L'S$M73#,&W@ECDU
M<72>H1;Y6F_AVJO8XDO<@1O_?&LKL-?Y@+;/^3J"IOG'.IG:SMY`AL/V@!O/
MEVI0!`V"U9?`-E9V?Z6^.OF,?C_\%,160E/G@D*2]`NY`S(&X/TJKC!N^Q3H
M9M5U83A]AUUY,F<[$[\SG@L-JC4$7AD`<[)<:"+Y4?E&_'==WVG7>,^>L+II
M00)$07>GY3GS/VRYS@6@ZVP/^*9^FF"$;((>\3O%V5IFI5R&X3[[[;HY`RM6
M)*^1%]M(KHH%H5<FK(D;AK`;\<K6=M5N:M.+XR!*4SS=7U5^O!SHU+C0?59/
MI[HG]9&Z(+9WZQLFD>"2N1=UTJ)Z8K0]JZ'$:VJQZ"<S<`>??\I=R_S:@![K
M.I\'8"&79M:X:H,MV^L`;J[36[",W=)U+:=6_[%65EU3N%YS#6DK331'LY`;
M.=UFS*91'%UM^\G29!A=!-1K)TS.S-ITJ;*OBC^[9EI;4X15JTJ;&"70T[XJ
MD$CWV_?;O>RJ"^%_%!%T$S%O]_'K/Y'/II(7P2>?^Y$\-]:K0-1"5:4>]`W4
MI7#!-TY[29<,)3+`M?IHODC)"N,KG-]3NZG.09VQHM*BQ%,NO>*:E%':_CNK
M-#@CY0^XO,0QN<TZ2CJ#T_,)XX,Q%7@W5[*-)-](]V'R7*M@7GR`Q<[ZA\MX
M9T<OT8I^>0W[D/%3>,4@P`*'35H$>R5AO/BA5?XK-D[GK8_#A%_T",OK9VX)
M=JH6"#-^DKM^KW\+"]&M7!!FPZ@R@![!1W;7Z5%1)O-HN_U!]R"?M7=]IK"?
MR4=Q!6U-C6HU29-XA7Z2_[W&CR7:IR_P"]"E``8\B0U.P,GQJ+CCG:G7N@<+
M_!A\'#U=,L?E6;^3/384`)I#BZ[EFUVBK;0-K%VTO21(#X#A=IM/$\K0E+4S
M3(HX)<4RQR:%M'G$,XG8-77H4CE)&36DQ[=P5E`3=_P@=S:.HCRCX7Q1;5':
M63W+ISRZGQIF#NQS2N+-SK.=@8/P%"T1)UY0VA:_#W5H=I'C.^H\)O?X)(O)
M7+)FN>(Z/NYY%X,EE>"':QLND&#CZ7AXSI(@_?`%C!C.\,,DYHV#6*XS)QG]
MIVA-7;CHJN\TG@NT*[G`C0;Q`VK80>O\/"7/T5M*9!CHGU2I<J$KR>3_=TU9
M9?>U44&?17-\2.91HNM.%)*45V5;`'X"^R.BAIB31S\)BN!?1U`QNM0*]Q2/
M=4Y!?V/*E]OWO%VS8R\%_W_5WJK]4\Z'1<U3A[__!'V)=I'RGK_G@H\7Z"?^
M#\";HAT@)UY0]NZ-K*=UFF3XI,1S7<-CAR=]-N;M*#P-M6+L(,[//\$.(3M*
MP$J]E+`">KH3ZK%,DW194C^\=2F?:7&W?<PKY6F:/*P&MJFOW\](&1AM&;8&
MG/CA"'B$)K[#TR6KD%?S)QH@XBD[YL=<@:4\:#K;3&BH5MVP1'S;)`W*3.!*
M*,DKVU72?`FHXE><)VUQS+>BMI)HVSX`C.,:1@4(A%PA0\*>O.M\EE#3#[BB
MN#,QRLKC_KT!.T?!1&U<R_I)$&[-$QG.*\H=#V5/F?92/CM=+*MG?!(AG1.'
M[N+,2*.:-JJ(J_PJD-[--A@3#^Q@2QB:E<BJH&>2II+Q\]EFR0[OL67G6@6@
MY7EL*@1+<'Z60ZU;PSI[L&&^*F;C[*L<+EB/*X1F*!VO0/)^:N7JQC<P>6&!
MJ`0K3;=GY<D?#-DN1AW+/PNE!*[UI'["#9/`/\1EE*2%.+["6I@*#HMB.1<G
M6EQS^VX3>EPVYT]TU,RM9/$%'2!;Y-1\HA:C6VO72$E=1S$:<KWN\NEU-M"7
M"Y_]!_=)W7R\86A_'JJO6A<"^VX#B[;O=S!RG'Y&LCG)*)/YZIJN[T7$;[)C
M>\N=H;KM8UZY*]/DH56[IHY:Y!&CK]P,@2C8L86;^*%HI6]ZR[NWORRH&A>%
MU/9.#Z)SL*>E5,X)8`'WJ(&K2+>LWB@E`-VX$A>T!E8'XR)K?,"K5D0[ZXB*
M`1P'.2#<I2!6T4GP>[6:B[N-F_6FX3Y1O&Y.@'NP&K(=>_)`EUUUPDK<X`(^
M7<T=,A:6TV4Q*SL5J'.LSRD/U7P@M90US6VE@4C`=.)('``"-3=7=R3GS6N8
M%AN=8<-HWQH*]:RALW^4Z&Y)J<K;1G5>+T@=;C>LQ`DKR`*##]'/)&=L%.<S
MQE&S?=NI1[:/>055ILG#ZA6GSI6)=T#CJUIKOW\,TV2--O$#$2Z&7[\]TLHY
MZAKNZQRIY@2^)'1LYZ@35NU]G\'*][]HWR1*?RY*<HG3J&2G"7*NM1;QNM<D
M7@&;$R6`(.X+&L2U6$*<)U02)+E"DJVNR!\F]O>3$1D"^_Z'`VQ)&],(WA/Y
M'AUP)OA$E5:=A7]*BMN=K^@E!_BFNGR7H'.)U@_LUPZW-2%0KUMQ%^,8_ET'
MAMMM:#7`0`8-RH:X-EK2]81?`Q[]O"-U2!Y3@3KA-34T'O?8"<ZB/"$?LV*!
MXV26X&EW&L,TWK=443-MZ')#078'M0B/=Z;8B"UQ1,QYV2IP_/*6W+^:XD3H
M$/W'INK07_WK*"O9OK5*4W1_=DB(;DX1.`?**0'GK[0HD>[7#U@`XUG2-<36
MK&'VIU&F,E+89HN\78W)T-NX>DK&2,SAT:':`(P0:MDHUGBAE8L,[!3,(GPR
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MI1$+P21:5%R^!*U']H52H0T#R,1Q/=A4J0NQ(JZG8`_8BIGQ*U+VPLO^)&/'
MI)E)Y\9>T.;+=4:RZL<%R?EZOH-B-Z<@0@]Y4I8XHVI#YNS>KI(P/X#^@5F3
M':I@=)'E2\Z43<?,,B+4$5SA*&=)K1N\(I071H$L<![Q?H'Q*F:Z.4,IR6YQ
MOH,>[I*8VJHHH^,1?HSOV/DK8=HBU.0TY-)'^6(DZ!_G)*<<-[OKSRE<;/FG
M[+07N!<[*"HE#]7YRF;]?`GHKKHH4)?&NVF?ZXJXOFG;++.73#4_+-,R6;`#
MFO33RN)D$:5`9NZ:BFPNJ3,1+BKZ:,G.YC%;%Z7Q,A5*Q@2<U?=QRG53+H=5
MOP4^9GU5#*T!KMAN:4$OX;@M>YVDQ#H,)/JS34&R:P'_W][.Z]>OUS6!_L`$
M"KNF6>#D)D8%MNHLJ$9P:[<+MHZS5M<,7I,+"O1=5(A3G$7U4W6E\4=JU:$B
M&TE:7@C)**/G>_6^"%UNZA&O7WY9B9^*63K$/(:'NAMR,'"WU&%PB;E]Z2<T
M1HS+\VP_*I)XDDT/63L6?M/;*2E8IY66[YUD\F[.]MW7`)HB>*1+/_55*)?<
MQYD*/E%&?9:4<LKM0MP*E>`,>R\(M_1A.($XNKC4G\PQ5:Q#+/Y+_>G1,EAL
MP4\D/^CY5'+T@KJ:>;7"YYC[MO2GA>B20;T`]OOH]I;&R,R+;3F-K<16+FM$
MJ'VI$U]I\X*`:F.#][9Z.$M)F2+7Z,!I,D]DMZ5,&B;F:%:V"$[ZU+M/"KJ@
MHYSOC5-AX>K^8";D^NI@^@?V,WXL,4^-13;Y,:HI--3`11T"%257B463:Z-_
M8#IXH$RA-4N1-ID67'L,DMK2&Q?).AH.'I),EN4=R5G+AX\9A7XS^#X1T>(!
M-=4402C?D=>%135G:,E8V\Z#5+$LB@5[D'&A.WC*'8T>^#OYEY26<#NHQ9T4
M!:%?%?UR6+I%D:MM<M>-]HV41!5\5TM%5',N,F.-A6#V03#?M@9IS?Y.9UX5
M1%V&Q5^E30$E[&A:*F=7]!90:C9TM"(321I3`N<^6$"S)5M7.)U,@PA/)O=1
MDK*5A:J&7%SJZZ,!G<?&]Y.+=53QQ5P&GFN43/'`X4%P"OHIF_':DI\CQ*[9
M/^\+P>'S0/(S+-!SDLO?+.D25[QH";85+-3I<'ES.XL:&]W(V=Y_)M/.<53<
MI<PWK"8J(-V!D6]V]TPB2"UDIQ,!OW'<N+&('^>L,[O5)@;?#:.`@W[7+3"V
M!*,#JM\)D^;JP<ECHBQ84H]PKDM:GR;PP;?6I9",&F1MD08N8H3!>5>1IW+8
M!\FNN:$R9F[%M`K*/F!F\YR_*#><V]E41+E`-1M-E/V3X`2T>-`*&UVE@`.B
M+ND1Z]E!MG_I:C47_<9X3HNO=2(=LLA)C/&T:"QB90DWDQ:BO"O'NU+DTA$"
M7?,"2UJ]&>IF8>L.F(Q<G8&G\MA[]^ZK=0;7=F/L'_,H/;:8/7#I>=WBF*M2
MLZ%#1R'&Q"B&PP5TX@=E'TWBU:8G&0N;DWM.@[Y=EP[9/."\DG?."M*TI:8M
MU(51WU:7X+IB!2YQ!<UYY^6`!>6S]7Y"(*O_2<;N?\?H7#:L:,C#"Z,+!L4^
MB"5FCMNAAFD!%O9/=UCL9/&"OJ;`(6D7L2297.IY'BKEA5U-.11@J>>@0M/5
M+1F%UDYN3WCJ!^CK$?L&DC(2I)6K'H`@="`HQ&"%EZ,5^Q;/9CBGVG=Z>@""
M?DT048HJT$-#OOW&6U`;0''3<^KD'L,'B)0J.GX"`:'F[;>3W!8H#88[P'IP
ML1V=T2ANQH\`1`6*^#D/T?Y.;F<SKW.M2DJ,7]O9_`RDY;D:U/6/@`M!3;-K
M"0@/N>+%%8";X''=H]O80:+:MP<%.M]\JRDSQ=\;9_75@Z`2@`U>_:7P9CPI
MO'DR4GAC+P457KWVJV'PK[(N\A:";>!A=Z)U>)N0<=IKOL0L=A#IFJM%FL!8
M>4E5KJF<[BB&7O/V6YC;H.2VMG;,".`)7?-#K76"@I]2RJ5,1#:[X#)YX/6#
M955%R`9-E^(@G"P2K2KXFJ(^P)!Y`/&97".[7.35\N9G')?7I"G>V7#3UJH#
MC*,=>J089@S<-T?01=<$M2B/\BE;@$J<T.JE$(?RLYQD4]'!I;7)-+DIRCR*
M2Y5JN#SGJB0V<P?>B98<\+TRV6ZGO?OV4\4&K+/C!#KQ1-,U$6=9G.ZT6+CF
MY"QX@,R/!JWR[][<W!93W<DM*NZH#K#_L%V-^RBE2E&(,J%-XJ$+$"@/_-/B
M_VAQLU/=?WI2GP2I6'H!D^7S0:LMR]YHNW;2LVV`-J$V8,KLP'$:W6Y8=.W?
MG1HM;LT2^);UBA1BM.":H*F!(H;W=RC,K*]*+PI<ML]X!_PB!:T=)*D!-QE?
M>U/5UZ2'PCY:K^:2U[H6UV02TR\SQQ<YZU90KMCF+E\EZ6\77G7FCF&\9(25
M\$A64,7+#M\B+W>$`U(Q!&L"[8%2B<P39MN<0'-'AO)FVN90[?ZJ&2)YXA?Z
MRG+8\R8>_(39P3,\G=`8++K%:Z=T`WLP`UQ/+-^'_J-YHQU4O1.2+X6JMQ)'
ML(&_<R!AJ=1Q##UQMTWG5=N4HT?&H\=9*3>]J^FABB!D*^*MMU4)KAL25W/1
M\J5A%M86P;%6U^UW5N%L0,9=E[<#FG.6GY/-^_H<,/>+#ENA!,L)<F:0Y`8I
M`T48\5CCI)*:'\C6E[!XQ!E5ND&$.D?9]#`J-YOT&L>YE<9JIP-*$LF8E1)%
MC"J$"34C2"QQ<<PB#+B.BO-=GZMG);@'R2H%PSZPHZ00L$<8K,ZD3,JJY2V[
M?CRT?]Z1L(I*5#??Y:R`JH05./;YJ2Y4G2,SYQ.)@1V!(4U!Q3/KFBSM/Z3G
M[(ZM\E/O)R'KC0)KTU(8;,LWO%SL)!-\FN*PD56IL-4E\5:-(GUV4?MP8O-:
MD`)IC:N].\,ELZ87.;E/IGBZO_I(V:'^>!6_3N(RN8<(>"@C8IVJ6&&*^/RC
M:)OY`C4Q?\,1L$;90Z52"$^@!Y+G27:/BZ<DSYJA)R=/!50.\C0![2K/[5"9
M1LFL'K;JK3M.'J)B`DDN8'/\1E#LD@Y=2'ID05D*XXQD9"/U%SH9RC-";;I5
M5A0T*:IY>65NU`8HX`#_F.0SG)1+UK4FFU*&DEP4+E4+\!-PS6P]L]:[B(VX
MYFU&\OM#"R=$1L!-(_J;]8L<+Z)D>HAGF%UG([\)2EJD1OE6\CBV7G)6F16N
M4S(/S;D:/_5L@YW=DN`LA5"%+Z+HK=4[0L2WK3R5(CMM_Y`J56UU4V#7Y"#W
M![:/B^T(>UBT<YQ`3J0CW,0'0[51&4ZYJ,7+H_0DF^+'[_!*KT_J<>Z['<KI
M8)1&T$2<**)4H78[NA$DEK@X.D.:T.0XR:(L?D(Q8,W0DXL!%5`YQ(`FH%V=
M!9#%?VLM!ZN@TY?.@6W_BB_P$T[3[S+RD%U19X!D5)0LR[QYQL1ZO/<:JYD7
MQ%(RVKN_,.*HHHX$>>@+>TWH$D?(0J^FHOSDLNKV?U5&Y7*SQZ'M<.<*YJY)
M8598V;BTIHT$<:C@P!I9X@98>*LC[@EDV?ZS:*ZJ.>D:YM)/2S<7B'XT)!&C
M"6U,-.@1.U3<DX&]MW_JK=I_MWU#Q1ZTT];ADTA8#2J](-N'_OIC>3#3V]Y]
M3])E5D;YZCA)<:Y?(37C?,/.C>E`C%Y-$PFB\(NA#D1B"8U/&O[&G'2]<:Y7
MO\3S*,GH[P](Q@]_+J.4=:=^\[E6XFV9O/H-4>L5$7M'V*!L!!EJ+>"(JA3:
M#/)O[2`J\2W)];DWY2COP')M-A`+R"FBBB1LUDV-';$")%BP6%4V'R=%'*4_
MX"@_IK]1K8*&D<XAHF8^H&IS014QLHC3A5P+35`2:X3"AX,7RYLTB8]3$FUV
ML.@<X]"M0CD/B#40]!`G"%)PW`T9L<#"N5RT=7IEDDWY)H^XY*\079GA3F[5
MIW#+%70`90)!M>`[`0=DGT7H9&>A%6-=LS/:"6&-M#P9M&6F0:VT"DZEG=;`
M9'M3C8>.R*QALTSHSXN9AGJX<KHIP^I(E=]MK^-;1\>"JX@13F*/43`34G?3
M.,1%G">+=NNXEAR[AKD:#M5<4'U,6B3!UO1.[#:;FF@P"6@@*@-U34ETK!OM
M/SOZ;^TI@!8'1@KZD.@:0J3[U=T/]D#[9FV"?Y2>&9J499[<+,OJRL>+:/VP
M/=2Y+*-_YN21694UI%S=\52=[(8IGZZ90-I,WPCEU';0*`LGW$$-L+O5M[;V
MB6]V#5J)[;#[]12VOD**UFLG#$S7G!>8[?+BZOJN2W8/WA-H)U)?C"894G84
M&:6D6X^42DF\D78MWYY%Q0U_0TE9N($X+8OJ-YO^8+-\4CZXW](^H+3EDJ@&
MN40#ZID"MRFN:*&?.#60F[@,D!$;*'RRN0-HP&F2X1/ZS\V<DGF@8[I`/R&8
M0C"*B),$:SIL`:-*.Y38*&R^?`TZ_)?J57[_._I+^C/S!O[V^]_]?U!+`P04
M````"`#M@&9%:D"V"6,>``"2T@$`%0`<`&AR='@M,C`Q-#`Y,S!?<')E+GAM
M;%54"0`##>-;5`WC6U1U>`L``00E#@``!#D!``#M75ESX[:R?K]5]S_XS'FY
MMU*.MUDR4YE3)<MVKA(OBI=,9DZ=2M$D)".A0`U!VM;\^@MPL4@*)+$2I..\
MQ&-+Z,;7"QJ-1N/'?VQO;_T$$`B="'A;MZLM./Z?:/&_6]M;XV"QO'+AU@1%
MY*]N!.\!^1VZ!R'Y-_G[710M/^SL/#P\?.^2CV(7A@`'<>@"3'^QM;W]KRWZ
MWW__UX^4R#@$E,2'K>N[>.L\N-_:?;NU=_#A8._#_NNMF^OQUO[NWNOT2^0;
M/D1_W3H8;#TN?(0_OBH0>[P-_>^#<+ZSO[M[L)-_\%7ZR0^/]!>ESS\<))_>
M>__^_4[RUZ>/8LCZ(!EV;^?WL],K]PXLG&V(<.0@EQ+`\`-.?GD:N$X$`\3!
MUU;M)^B_MO./;=-?;>_M;Q_L??^(O5?_2I';VOHQ#'QP"69;">L?HM42?'R%
MX6+I4XZ2W]V%8$8X":/';8KA[ON#73K&/^EO_@C_(#+#@0\]BOZAX].Y7-T!
M$+W:HD/?7$Z>9G$'P@!%CU1Z._1O.[5?W<E%JYO!"2+$P55$?EX`),IC]=N$
M3?TLCAU\=^('#X*\/7UMYU^Z@#L/(K!W&&.(`,8<[)0_G\A0'R/[APZ&.)A-
MB1<@V"?VP<D3\ZM:58Q2.1BY;A"C"*+YE`C%A8`7,]8W-:/W.O.L\-8']-\X
M"BZ!3_5FZI#?<K/:/HXVFZ##O[F*`O>ON\#W0(B/O\8P6G$RROJF9DS?IN[@
MVGGDAJ_TE1V-3GA3@PY7R4\\>#5\62>/-:I^[1!=4C"5[/O:[9FA04*LUG]?
M*ZOIR,>/KA][P#L)@\78\=W83[Q<,#N"?DRL\]@)$<$,3T%X=>>$(.&$8R(J
MHVN=9@(FC60\&C<"A!,.CA_IC]RSX1A$*],72SK^;XX?)X1&&,>+Y%>8E^.V
M$73:9TKK*EXLG'`EQF#I2YK=[%-$<00B!_K"@4C^-;UQ$<,1B?'7,(!>3EN7
M;#&^N8?KPB&+L=XP@`;(CP(WIKN"$?*.B5BCU03-@G#!&Z@V?CT/JI:%"/:4
M,%-B$SQ&`!$OG3-*AY78>ZW%1@CZ@5NBX=.=:1#F)'SG%O@?7\5X>^XXRS^>
M=D87LQ.(R)#0\:<!AHGKNL41W>978$RY2W:N,P??)MO7;+@="N\.\".<_R8!
M?'MW+]O%_E.(;H:A_*0REVB0_;7_5..4J`:8D!^Q46[75'9*.E-4TE%8GH`3
MNCE/Y,>2AFYF,+)/["Q)2(&B;?<.^D_*/2.AB)SB14&];(.0N(:/K_:^WU57
MERL7(">$P>@1FI5#B=":;9MB*)D*$_`R.CIPSP:\07@)7#B#P#L*%@Y$1K"O
M);8.R"R+@*5^)4G4XY5)8S>51A\FTZY/!9>7L;^?L2^G3B32!A$VN6A5*/0$
MZ8VEHXAV%92"HFP1IF<@#(%WF@)9RU3"48*VM*VG?(SCD$[+O(RJA*SZ6+9B
M;DII`QT-PI(U)IJ;-B&>9%R[AM.HBD6II!A8%,(T!$L'>EFV@VPS+B*R*2CQ
M;T)&/&1M+YK<0N3"L!#,*,A8@V<T[A'M!_[<DF/+:%]<1E$0.?[I6E"2MA@L
M01BMIF3?G>SXO\9P29??<V#("!OH]42(S7;7A)<&@Y.28L'XSP/DFC,Z-J&>
MAR$UZ,A;GO(*F#)CSBOV72+Y_#,1'*@[/SDYG$+G%OJ0)HN)+6\F94U&]-RT
M;<<D?#LR?BAU1"6JTNY@Q]9`S:IUBNI\C9`-[>HD_6EZ@H6GSHKF9TQ&G6Q*
MQ0#,KDQY(M`:M'1(4$A\A)$P!MZ8_`ZZQ)VO9\%U&-?P];Y86(,TFB:O9>,F
M94G'BZ4?K`#(3E(WIV+"J-J)6M\9B%D8!XI:HD^%S4*J?=W(MX6B[0!'3+9M
M\,G'M/+K8+42(O/LY7((MH#9KE5H0+MY3S[IB2&4R?!UU_OX;LQQ^/ZUP>[>
M6$JD=;MY;-XN]D*,PIL+TWM&Z3.C8+$(4,(=+7\T4GBS0<-R]82(W#;QL78:
MZWE)H8WC3QWH3=#864)BVD;V@36DK#M2,=G5(F9O!W))"R'1NI2;A%KQ(DZ6
MZ2,P@RXTXE`YJ-JNBQ"1*P^(%O/?K,LT72R20S-/%D[Z<N9&4N8V4N4]2K^I
MI%1K\-1U0IS4;>]4"[?S<G-#!=W5BZK2>E<9R&1P74=*)8A\J=WN?^UVBXKQ
MEVNK(O]2L-T$^4O!]DO!=I\+MB^6M,<(B;JSXCRCM=OUQ'JC3AOK2"F;7@]6
MY\>1Z\T3!F2>=R0>.P+WP`^2`J^,03.;SR:"=@VI59O+V\Y&Y+24"$B)-&W\
MXQ.^1MX"(DBG0/O\&!1J&TFKRZV05%O!LYF=W9A))U[6]HZ34Y\;/:V*/592
M"6J22^/NTP";E5V!3$]B$[Z5L0B/U0+C\P`%%24R5BW`HC4(J=4")9'&>9^*
M#H%Y4D6BN`:>@\BLI94)6-_.\PFL@HK&BF3)`JQ*!QO:,<RE\53:X,9(^54+
MR7XD!AJEV(J:AHH.28%^`G!^1W@8W1./,`?G\>(6A!>SA,V+.*(]%SW">@=R
MEN1D"&Y7%F3YHA'?:EK]J<>B:F^(BUD^E-$T12.]E[SZ\\ZK\RC;2W*]'\G0
ME^3Z2W*]C\GUI]WPB/;G3H_+V>L5NZ"YZ?N6<SG-$4[CQ&T5VKUL)?FWDIUF
M14?>GS&.**?X.K@$;H!<Z`/"&&7I.B`_T!7X!@/O)`A5;4H;L5X;H#Y(-13<
M25GK$2#47)A"BKS1(@@C^"UK!ZG?=IO(69*T;K,H6GTCNC8OQ>:)D'*/82-A
M%YO2,Q1V':96.^T4-.YB=@1NHR.(DQN^TQ`L8+PP(?)VHM86;9/RY\"Z:R\_
MOG/0'.`)6D\E[;^!BM<3A19VP2&M[&U-2%D42@U7/65K84-`G-`12/\_05D[
ML*.,!V9;,$.ELC*<V-F^REE*T?QE@9<(`\IG?]<@Q$#U`'"3^THGB&XTI$K4
MVD)A0A\V$)6/#***S`6EOLF;;)\-OI$L17OR0N0$2.'Z14F`FDRVOK5$-];;
M0/_Y>/4FD!4J!$SH0TT[BFZ4H8ZXE8C0A"+4HBM?3U!UZ[()6!K>3L/@'GK`
M.US10+<X\Z<XUU!VEI?Z,\P!B&"OH"9JY403=`^P0FZWZ?N]3M<V3MS6AHU$
M@YDNCMRO,0Q!;1M9$^8J0-V2:#FTM=2$5P!.Y:V78I5SC;=@S+A#3\VB/@S1
MB\"IL/52<[[9RS_2SK?I^[UVOHT3M]54B^B*"X"'Z9N1GYPP=.B-)!"ZT-!E
MD49ZUI(='#I9Z7/>`)JMNH,B5Q.,8_I67%;EB6\0X8E$\&3^\)YFX-AG-72)
M,"YV)=XL6;B"@JB)PN;967$62>^-]!51G.NZD3KL=J)#]!(U\-DJ>F#J9WCE
M^$1+S76JX:!J)TNFP[HKZ.EH=*HSI&9,L<.0FD5]&)Y<!$YK^8R<6<HI65#H
M_Z@>WA.-I*<M((2!5TW?F9"^$/V>5.DR0W4Y0'4U6=4H^Q'1WC!<$44UUYV3
MBW"O=V:"&&9R?BLNYV6B.829,#)E[15N_]BU+/-G(G6*8R;W=[)R/T;>AM0[
MN1Q'FWKO'<:8H(#Q*_G.E+2<RP]P'()KPL`A^?!?)N_%-9&3/QW*<3@"V`WA
M,JM,I9<?\<5L6@#]B:B)N4EP8?N6#H?TBV8E@[.FU$EG1K6?3"<H3>>5@DM_
M'@:6BC@K]B$.U(C];!"Q'&&(6L<F2-H:0'6F_@=K]J>!#UVZ"U)X]V]C,*-O
M1M=3D[[-"><(SJ!+C]DV1C>ZFG!2MAZ0M8NX=)^`$\_A&<[KZHLK45!^;$6^
M%7!>=I_Z(J.K!YN2_,)1'M"HP=21LFXAS>(K7ZVJ04O?X^6=V<,;1FMOG0WT
M*8UN7YPI4=3Z&``=N2,KX2?>LQ=96/)N?CJ@%E6-EQ0[,Z>WZ4WK:^<Q74D4
M>LJ3,;I939K(*=WJJ(YJU&(:Z5E?7#A$6JGX;0!O8,O,9@1YN$I^6DE;R.`W
M+#>8GECB""Y(Z&GD/+!"P>Z9C]CNHPJ./GW7=:Z7:*]1=\9'V'+F14RLG%A:
M?(>=<.61B*2C%:N1GO452TRVS=C9>U2XVH"S`\MM(VDU8!>3:BMZMBXNT'*]
M$-P!A.$]2(.EE+<N/#,O;=NG1H+>F1M2+3UKI6NL'@K3(H$F^=%-#IIQ9PH@
MS,/`?+DXQAK:U=H_/TF:!F*5,\3![TJNW#O@Q;28<D0&]F@W8N(,KH`;ATFA
MW?&CZ\<$9UI^2?U%'&4=9ZH+A=G<F'XN!Q5'FY"2KD>-;.:MU0WX.:2O&\%A
M=:-FW_7B&$9XH]4XYFE-^VD)]D[[U&.:-T'.([=*QVFY1>K!";UK\D%3C:;+
M!*Q)@-\.2HW4RNA46WS+[D*SOAV%NRAG@#X%8&3_64O,^H:$I7JE_68]3I4F
MTUI[3X[H/<)Y&N$>KM:?R>YS)VRO>4<>O2!V[BR`P8;A)OBTG`)N$[X9V=0T
MZ>^M(^)=(RM=RQ7#_2?#`^$]=$&-*/QDN"24I+U+Y@A^(X)("JS'`8X,%UH9
M8]:.78@%0^SX7[O8[+V$N9X4V\:+USCIM8!T:AC'B_1W"6X=*:`6#OL9&'$J
MGAX963OI84VD9#+IU<*5':7BX&2X+DL,<&T'1YWD)5(X2ND7QW=C/QD[F&6O
M>VUD89(00&)WT4CNHHZ<4,<711(ZE@/5')>Q][?T<JC4:5V-@;K,BYYL@"[>
M+$7O>HS,3/I6XS-DBJP<KM@#&,LQ&637;D&M$;]7RG"9E+2F?%DG>;*:_)C%
M#(EY&]RHQ#:19,OZ<IF37)F`]1Q_QW*KP*O)Y`K7HNCUEC4;YL381M)NH52W
M0FV%7^F5PN9)F4UEM]+\>WG==A$4:NIL']CT/AJI38C;"()'"UK$T<-P-V/,
M\OF/YDVJ1BW*!3>T"V=)!'=;S:5E;_U(IY6243<R=/D+0B+9([Z1="2)-!V$
MF,\5Z614(437PX;1Q)%N%NUX/R%C,GK(QTX6*5WN7#?YRFB;2O<TD;/=WLZD
M#]J\$EH#N98<X"4!CTR<WM$Z`O?`#Y*G"C)=-;<-Y"%K.Q#FT/>BK+B0K"9;
MI&3V$T`@='SZP*^W@`A2AT*C(.-2XR-LV3@%Q<8)IED?:FXGWDS0[NY`4%(M
MV+&+HY[SZJ`]H*OFFV0S3BE)4--J/[,L(WMF/LK6L\>&0O'2]IA3"/+[7X4G
M!">+)0F!+Q!MR^?2!3,]4<W>1"-3)*PN`I2P#HF%^[X3/NW<N;:A:A22^?SX
MC^WMK7]_.OOM]7_^_;N[C!\_HS?OO6_O[N>?5^CF*'[XZ5WX_MTO^W_>7*^P
M_^[>_;;K_QS]<#,^G7J?O_@';]#OMQ?CH\GJI^NOAW>7>^[%P\&[K][L>F=Z
M?G`%WM[#KS^<'<_/9WOS7P[>!6^^^P+__()/W=??/9S?'RX?G.AM_.=OKGLV
M/77^;^)>+6^CD\?WX?O)!;X]"Z_!$GZ'[Z["W=@Y^]GY].OYGZOEMQ&X/073
MK\>/7\+7WUY_^N'G\R"<SL>'/ZS@8B^X>+,X6_FC7_>.#Q]W/N]_?K/\>G!U
MXNU_.?MR]>"BV_W9T<';T$,CZ)_]'._\^O'C?[;&5Y?;VY8C,8/FHJB)&JK9
M.LL<I<=^M35ZPGU9ZL<32AAQ#*/KTM$1B!SHXS8@>+A6HR#J+V6IU25K],[I
MM'+UJGM'P:^*#>7VO-JA:2OP-[^3)6:+_->U7NYJO=S5>KFK]7)7RX*#TK!*
M:SC0;A53G91.'!@FCV\46+N$^*^3$(`)(KL]@*-+LJ.T8D_*3`],N1KW]AV(
MV.*E,)V3HVD.E^SGCB!]3PQY@]!?)M,O^BLD8BT/>?9'?W\+Z.4#GR`_*`VN
ML-VK&VP]5.&JE+7<A%-1XXTZH\T)WHI,\!J$BSUCVFN&6UN;,G-J:TBJFOI"
M=I@+O8H7"R=<%:KF)!*@V2`2.<_J-SN/^+-KVQ=QA",'>1#-SV-C-V^T,VGE
MJD"CS+4L$/5"D8_):Q["M*UMGP"<WQ$',KH'H3,'^4O=TQ"Z_8IQ!%FWEFNU
MH9W-0I2/PUDZVVTDTSK72T!S6.3W8[*Z4*ACQZ>+X7ZO0AR%:=@]S^'5XZYE
M*Q^6L_UPQYGR;.H_T0N%>(+2$_+>N6*-[%M*G>ASQCI%*1^EE^M];(4/Y;G^
M%`;8R.&I"3:??UC`%([-UO')_GE"MJS`.XI#VFLY]<!T$KC8NBJW$L^(,HES
MT?^55P)9B9;Q[U--0&!.:QG->Y\V5YO/9K@+I]@,^J^''4LTT^&WRNNGE=7S
M)`AG`$8Q$>0(><>/2Q@F(SQ-OH]K:3O3@X_PU,66Z>4[==_:3\7LG9\U.J'A
MNUVS\LZT_8=A>N&-W.X?NWU486;*_5EK)5,PF:Z]ETWW'*,.XE8]^=K>ZV&K
MT_Q[*&>;#/.LN_1144EGAY)U-ZB]W>?=^Z[(W8LV5VKILR2&(^[LZ:J]PQA#
M!##.ZC=>2<;9C*=633Y5U41._.R"!838E2OVMR5?S*H.ME$Y(\S.J>7.,P):
MDA>LU\A#TR6G\P`M`D1&#E?7Q#U@P@!!P>2MIQ:*-JNY&E6_]!AG"VI*G5\N
MP3W=`B4IVJNE#]D]6]DZ7_==ZQ?J^?2,8EP[?5T7X?6;BKEK3*TT+?=RX1<K
M/XK]N'#4Z@M:%JB-5AT:W[Y<VT;:H1832"XI,&9*=T5YL'J3M35FV#@C$X+7
MWK6;2SH?M'[58.2Z\8(^>0"\(S"#+C027W)0M7=I0$C6//C)%\/I66*F8>`"
MX&':')4>W3K(!1>STP#-Z2:+]J`>(6_L+&'D^(4^Q<"(Z.69Z9';;E0)!;AU
MW/R0:PGOX#L3TD[&'8@IIQAHN,[0=9*!\<"]8KIA\*_;/T-]YI=-K5(K=KN6
ME@0-@NX=GU9EC**Q$X8KPGURK<B4C!HH6N^V(2R_)OBT7'CMV%^]+KR`0?^-
MH^`2)"'3U`FCDO>25CNZS*[3849SI6Q*<FE27FC$TJ=BHTJUW>(E(9YL%1_9
M>EJJ6?GR;;Z@K#=2L])VL=Y_'JYN$/P:@R.`W1`FQS2F$K1\A"W&^%*F5W35
MG-"JR7&"R(I`MA-E8@*YW,8!>F$YW.J9-')LQ,-*EU/V7,PVIJJE9?E`2E2<
M[=CIZ/OVU$PZS<[1X^P`)>&5(>?73-#>_EC9Y[4@J:&O5=:(E29/33Y/5R5B
M^ZD)'@TM/RJW`5.E-9]<A\0R>7,.C$W([ONLHC*H`:OLL22KJH(PRK.')H_1
MV82LB$&/?V(#5WUW3_+DEC`T=5:4]D5$=KK9SP:?T6PC:==>FI2T?%C;`IR6
MYU(VV#'9%I1-RGHXS2V26K`T%005'CI=F=QAEF@,UVUMPE6X32MN$A,$(^CX
M8S_`$,W3)Q"%MHRU7[?J<.J4*MT7UD]97\F/D!2F<>C>T<UJ?:-I-O[,+]I.
M8S>!SYZIMF-P*0]TYOP9A-2SX319L#YY-;<NM-*TO,MHDB$_;GIJDNC8$X2C
M,$[JQ@VN$14J5NN*M*P45=@*]^UEUNQI")$+EXXOO%"POVE]C6"K5>*HV%/5
M6!.JPQC,IPZ9M.RG#NL%UPY4/^H]I>U;\DRMT*9`>*4L4$M@I:5+Y.<)(G]`
M("FH_02C.V(S]X2'J>^X27:D6AW*=@W2@_<^B#]EU13)8ZFC5$/X]!:/XHCL
M`.G+63>(T*_R58ZFN8]N!8>U>4E#2=HR$&IZ0DQR]\%D46(SPAYGL(+D`DE#
MD::&H.#,B9*X_<A08_@&:L-TR3PPZBG^%!-OF9_*W8"TKQ:78?*,,UC#Y`))
M0\<Y?9([B_T(+NESP$^;#'4QL@8=Q/Y57*A,_"0ZR:G6L1X"E-SC</R+!T3X
MNX/+T2RB#X3F['*)E6.8_I<!,*7(`Y!\]S1YOTHF`EV0=A4:81P0#LF$:-3-
MX)A\S*6`S\$I7,`4^"HHO&&O9JK#7&T-H"_1ZDQM9U1X`QA?@CG$]*4L[R0(
M+P%V-C=S4OJB2F.XWE\97?EF8,J7&LHKUPUR%@%A[1M]C0HGU?WF(W(6T>$J
M@P"P\GVY%._(31WH3=`O$'GYFWDFI,R@,GRQLJ!3:%:E>NDY9X*^9(1PDJ$[
M?G3]V$N/BJG&)?":D"\W[<'NU<115FCQI-XKO,A*>L29^YII"!8P7IC0@G:B
MPS=Z#F!SP4ODTI1*,:K3RPK0RG,<QV'(FQ45&G"@&STQT'+1*K\XH2%`.W%<
MD)[PFH_+"K0&*N=V#'/9*K[MH$&RQ7DFG5LO9FD5]OHC'=21<'$Q^/5<!OE<
M4Q0S=MW>3ZY_?E.VGP*[(Y#)6\DM%"5;)]8C(W8AN6T<[>QM*+8"BZ>P']T>
M^90J/Y]N%9U2=\&-.S-CW\'X8I80-7ZK;H-8/Q_O;;]%MXF:DE2J9]<$QSVQ
M<KZZK_?C8E:=DF6E?;5SUU;?IRJ-?35I[`]9&OO]J`LO<FVNR))!Q?[E(![!
M-<&DI_`[&_F30QN)1Q?A)6T-;FK)J"<VL"6C`;6J6`2=%#B):;B<C<R^S%CG
MH=C?M:[IK2J6NJB:F=ON$,SDWKBK8I*S?%^%2XY<L.D-=O_N;2140M[&QA$'
M,G7L+YTC^M`Y(K,[<\B7"5A?8X1QKP"DY)$*,APACZQD,]DUG&^DH>@X)R[R
M%=TZ=B`O/58$K*:YQ\J!2H^5G)4K%R`GA('Q5;Q$R%J9G\KB78:JVJ-`4@[9
MF,1:[V$08W]U"99!&`'/W%K22K,O#H^EFR7)M()7[:VB)J0;A)?`A3,(/(/M
M56J)V6Z"("P7!EXZ&MJ]O+>DYM`X7UYZ(Q6<O;R\]/+R$C?-O\_+2WS"\@#\
MXQ3,'?\81:V]HS!POY\']SOD2ZE(R`]52;`&'$3FA(E$Y;Z_(+@_@QFQ.@CP
MZ>E8P"DQOF;-'S7H!P6--4-KW3THKRF;;0Z&5Y%+HUG90;3@OSGEVH9R_;4\
M[M*2P@TEE=CZY74V;;(\?2[OM!4R6>F5J76["<-I[0UR%MOI2`JZ$3P=+ZC(
MVSGM#$/V@G%(WX-);DNF')Z#A^1/AC)07)0':],<H.IX:4VKV)/W?&Q(O4)X
M>-;-":B.WAZ2]P97235T5CV3/PDX#K"9VO1&>D.TZ68`-73]$!1LMH;<$\9I
MJ$C4+3M0.GX$H0OQQI+,WD9Q#-/'C2E35#R0:&C>(22FG/0TA"X846[F2:XV
M/_V[#O)V3RGW^;^2SY,9W*"-QV_9@M1":$B&J0=9&TU!UOTE+E`V"ZJO.>-<
MXFX;HX<G>4PIMF*AH^&&Y)+)?$*W$,8;63=;B0[)1@6@U-)(0_*-!C+E0^(9
M/'JB#Q#.P'SR*(>K]4>R,&#TX(3>.5':I$??QIVSNC58TT,/!OD=8.1M5'SV
M&GT43*82QI@)V)OH#=WG;`*HT/A#S\%?&I2D.\8\)$E^9\QE,(GU\XR\W>#9
MR.GHX2$G38<V"4SF8UZ8=;0&LU%K1TVA)X=Z,Q9FT7Y^OWS]],38\7W@':[R
M6#7[8'=7A@18&J(#5Q:#0O</Y0X1B1XG2FW,GZ>C#]6!9]CHZ.*AS\A+.86G
M/SZIE)%33CE&GHU!MT.NJ7V'D)9D;-#'Z+C2,<7/#R7U4IIC#K)B(DQ?HB5,
M@X-T&IUE6LI4!Q=0\2"92UHBHZ98>M1X+)K\,=V/K_??YX`O^2TW\I!\J"1V
MN;!5TFK*-LUDS[1)LXD.2>0"4.9BEDA3Z<EF'"^6?K`"X`J$]V0=9^?DSFDI
M$XZ`EZ3?\'40.7[Q[_0LE>#T&427P`WFR%1=D3EF![=@&)1;7MRB5J?6-WU,
MW6[2(#SY%?V<D6U!QS,8X#:R:QGG"JV:7.RDA>!1X*9O%B(O+7V>H%D0+M)>
MQ^)^OFFXF@Z"-2_+\`PD&G2L"[S3'OYT6T.?8=15VUX9U8Z7%Q%!N>J]"HKB
M<^ITX)P9>L5&'>72:%:VSS+@EC&H-#P21C3K67P"L>OXGX$3'B.O^5DU7G1K
M1[86#,N@78]/I4V+]'V8C0+MBSC"D8.\S=<FI3U)(XU!R8,',[6[^&LJT_C6
MA^Z)'S@-;6K%!%$<<C`>AX%&Y5*P,,`CPH.7M-;V'0U:7A[.4C&)#+05'*I7
M&N5Q/0+8#>&R^24/87B+HPXG'&&#LG%A3=J!DY%#QY^0*/GQ%]"0-!;TV95A
M;6V5%+QT%9A"L9U\K)VMR&EO#^+O:1^*6,/%Z,;1!^12FE$J%);)>9AT^-\"
M/T;TWOL)],GN61?ZU6&'I_,;P!0KOJ26RG3<9+@Q"3SG0:C-Q90''6`<6$&E
M6(>EYM,_`=__!04/Z`HX.$#`2\Y`&OHOB0%?-_P`15"+5+&62G6_GZ;&M&U-
MV<,.R=G4`%,L/9)R-OFXZ_WN"?F-!O]>-_"`%M9:;(K%1)(;SO+8>2;8`/+%
MH8<3P3?`4RS3:<YT_[A#Q[QU,$C^^?]02P,$%`````@`[8!F1=).RM='"P``
MT%X``!$`'`!H<G1X+3(P,30P.3,P+GAS9%54"0`##>-;5`WC6U1U>`L``00E
M#@``!#D!``#M7.%SVC@6_WXS]S_H^'+=Z5$P)$W)-)DAD+1T2:"!-&UW=G:,
M+4!96W(D.8'^]2?)-F"P94.RJ>^6?BG(3T^_I]_3>T^RR/M_E<O@`\20FAS:
M8#0'J/6*N[^`,F@1UQM8"'0P%T\MCAZ@:,,/D(KOXOF4<^^X4GE\?'QC"5%F
M(0H9\:D%F6P`Y?(ID/_^^8_W<I`6A7*(8S"<^N"*/(#J6V#4C^O&<>T`W`Q;
MH%8U#H).HL>,'3-K"ET3S%P'L^/9B#KHI+0RIFQY0^BD4JM6ZQ6$&3>Q!4NA
M//;=9&F;TPJ?>[`B)"!%5@EPDTX@OS)=R#S3@HMN4T@)YC-I2T5BJS;JU4C]
MC,6T/]8C)$;EZV5WH)`OH!"<`PW!Y06BH-^4\EDN,#XK2QU+2&.3C93ZZ(GJ
M4JX:Y;JQL,!!^,\D(XQ&HU%13R/1#<GXU,O'(Y.)J8<.="'F%X2Z;3@V?8>?
ME.Y]TT%C!.W2"I,V7^A;U758"1Z63I7;`"#=P,28<),C@J/6L-WS$!Z3TZA-
MM$HDQQ&<:S@&RHQC.04G)89<SY'^H=JF%(X%!C'%Y6@Z_W#,T1N!,1(QJ46)
M`_5S5/$H\<2*0&*2EQ,1*-CH'9\W^;@BQH1.=PFY5#E]-GL\"E_<'C$F$RZ@
M^%HSZ_F(LN'XQ0T38R*,$LQZ+J,LTWEQH\28EN\DDA4W2TH/A2%`?KBY[B3&
M):529`A&'&3+6']F.C(F#Z80\A)`=F#R'_2/5*%5+XG&7L[\J8BO(O$,A'NI
M0*.2%+8A9B)UA7J`4L3`JY9/J93IBYA*;'"#3=]&8KQ?WE?6U28,Z@N5/7RJ
M/J_[=*@@%-'WC;O->L^,@=?H6>N]8*@2HVASH>U&7@>+9KB8ZU3^UN5.DZR*
M<5A+Y7#1R@`9@YXGJQ+11["YIV]+^EHFFUXXY#&5MX5`LB$QQNHY&9,Z@52Z
M9RP?8U>$0^/,9PA#QF)4Q9^<ZOD1=3-H(V8YA/D4BB^R-Y"Q,M*0R,&>A24+
MM3.3(4;&_16K-PA)%,K,68>)[,@HJ-3)A;.J<+]<M$35FY9%?,P1GO1%++-$
M[;/!4Y),QA)ZFTB2#'Q+72!2ED#1GJ"(H(/PD`"-'"B_,TZNH2-33M]4I>H&
M7=D]LHN*HT3^#H)D%2E7C0QP`D+](!Q@O^:TE!X..+'^G!+'AI2=W_N(SS=(
M3)+)6'/O$CD[5,7&4M>_0:`MB:,]11%%;X,Z?&C.$A98[&&"Z3%6&HFLR/@8
M:`%*37)!L>=#\K&9?<[FZE-\U6C$,C@RJNL<)22I_\C3W$`?>!4U)A?C>]YT
MY<70%*DC5Y$12F95A(:Q3;$!7@5J4ZC;<Z=+4RG<I4MF<E?;*FGIR-L3M[$%
M;D-N(D>S$XX$L@\MC'KFIAB\"M7ME]8.83&-*XUH#M:2CS)20Z.&P/\W\M1;
MU-]N+[\<_/[;5\OS9]_P8</^<?0P^3;'-VW_\<,1;1S]6KN[&<Z9<_1@_:@Z
MG_B[FU:W;W_[[M0/\==1K]7NS#\,[\^FUX;5>ZP?W=OC8:5_51_`MP_H_MWE
M^>1J;$Q^K1^1P]??T=UWUK4.7C]>/9QYCR9_Z]]]L:S+?M?\V+$&WHA?S!JT
MT>FQT24=0@^]9M,!K?KFY2?S]O/5W=S[T82C+NS?G\^^TX,?![?O/ET1VI^T
MSM[-D6N0WJ%[.7>:GXWSLUGE6^W;H7=?'US8M>^7%\/KV^[!_)[=MC^^K@_O
MZD?UCX>?3TY^!ZW!=?AB>5=W#@+S^<QR?!O:%Y2XK24I9-Q&CB]VAN<FQ<+5
M6!_2P=2D4(7QF*\_14]FEDD^,\I<!N)YF'<B7$`"`RO(Y'%3B`U$X.1+$J#@
M_0W6T>Y!,/.<(BTDYNZ8Z1?)QU1YCSDR$MZ>:4TEF<:M1C1'NDL^MDJO)G7\
M[>F3]*EYDV^R;7F!"6*FQCZ?R8\)43R'>.:BW.X<*Q:ME4!9C0]6`8`0P9[G
M-)Y[GASKB^GX:M`F8[ZKFM@FR5FR6<<MR4=BN0@.A@:+L<'*X/L@G,'NP'==
MD\[3"(T]UI\UUS9.S+:F,!QM?X"6SEJ;6+Z\#-#$]KDH4?F\@\>$NBLO4[42
MV6]Y-EB,]`&A$`0:P8K*OP]9[RNQ.Y&J-6B+W9\,VD4S<CU".<`;UUYU=VN#
M*[E=8BE]FB[R6SGJ5Y9-9:-6KAMO9LQ>7"_;$H8T/+C@MAV,J-].,/17:5.`
M*!"K/2>FZ:F.%>APMM!57NI:(-IR9C:O,^>9G/5><FH:<FJ,MT\'LGJ3>3LP
M!%]I\.1`E'B9.*^[1!WDX(>;TQ!>;E:CGI2TF_]>VN:_.6)<7J4O@>!6J+K5
M?BS:A%"'0U<NZ1(P0ZF3$J>^O,^II#QUCW&H^MD^#6,J1HXCTU\DRWS1&7%?
M/OU`B>]%@R"A?B6%/A&_9F94.CU+*:B+,P'Y8&KL3*\IBV-D#HRK43#)P+#J
M*9I-Z[#"B]A)5JA+I'C2E+]@0?(4I$BVI(/3N%[3OO,95[<NA^0:6@1;R(%7
MD'<)$RWB@[R(>2-\^X+00D_`LUFBF:W6U,03R#IXV9\QR)FH&+O('"&G8'.R
M)=Y4S^_@!\B*2KP.G(;+"X1%15E0FW3@=*O9LL0P=DO4J4AL`E8XCIOD$BSV
MI'2>9-38=%BB54$-SJ-'H^!'$B<EBT(;\2<LW'30J0ZY?@C>-^=RZ/A)>/BS
MC0*;OI49Z>FU@P4047^T8?!_!_\U'K#TZ[5YL.'H*=.0#[_&[[7W,,(CGQ=>
MTC8_GHJ>U/)'L!,W-P?:=*ZUG<5N7PW&?GX$RXES;3NVYM>NV)+Q'I9WVRV1
ML\*M1)C3Q4Y"U-O"D=5^`N$V$4CI8H,138'80$K35-N.WKZS7S\)_]8^$)XS
M9IYF%WXEY#0D-3OLJK;XRV<+$RJGZ0LKZ1Y4(9TC&>2VIA6,UW1X^B6?]]5_
M(9G<#OSS3$3!>-\>MC8[KFAKPQ'OB"`@D8GBB6`,+8GH%O%IGZ(',4;?,2W5
MV_C?J(>W,TF;"EC3YU-"T0]HWV`12]>[=^2+%M-I.40LRTF!IV<'8W2ALN]3
M:RK*[2";)&HK\&3D0:^S7CF8P$;52[_`\YC0="U7NJK`UL.&:GOA$C(/2FV4
MT"JX]!V./`?VQF+JL(4\T_DKMXE/I7QK6U+#PAG$<(PLL5!ZCU@HF2*O.>:R
M((]TKFT?++FT7I;Z'!BU:1)9,/B#%:(\)$*-R#,R>":H[0?VF1/812X*WO"N
MYZJX7T36O?"4/+]5N@BQLCMCUW""F)A\=7I\#9FYF97T,_93HL=3+=AQAU7(
M`C0+;M:F(KU_P<K,/$#3`T?@+,T'(2\!B$5T:U(J$OCY3$PM8O*O;_UTO\X!
M4O?"/102><*"3=EOHAZ'.MB01+5%,$[T3<F+L6XP6A1&T?T+::!LWZTTVOG5
M^W-8HG/\9>3LX7`PB3/2__.39!;`U`@62@PA=0N1VE;QZ!A1BUMNC*#=]F6`
M";)AP*]Z&!3$;+$4KN#Z"ZV?LF1WPIU*W_+F7G.&7C[PBEQC(P&'A8ZR6J3&
MD:5'VC`Y2].;V.Y3./;%)L:.7/<2NB-(%RM,_>7'8YNX)GIIU\P'5+L+.7<]
MA\PA5$H644AL"XQ&XZ@XEN:!F>J20:KM8!D%T8/J5JM6BV2=%J`NZ(A"4>ZT
MQW(#MMQ^%,<R+3[=>]/5LY*F*W\,5R2C4M%IBIM/<#P6,"#K=EO%L24!53HM
M(L)<%#04ID'3&1,>1A3-O9*!:3QK_72M5C6,0IF3AFX[FVJ%MJF6PZ;8P6B!
MK$G"E9I-KZ&,XD$F'G@.*M#*28.FV53[HSMH\2%9;E<*%-0TZ#1NIOOY37$N
MTN5"J9Q0_<(EN-\?&/U?4$L!`AX#%`````@`[8!F1;`32#J%9```MS`%`!$`
M&````````0```*2!`````&AR='@M,C`Q-#`Y,S`N>&UL550%``,-XUM4=7@+
M``$$)0X```0Y`0``4$L!`AX#%`````@`[8!F13T&GHN-!P``,T8``!4`&```
M`````0```*2!T&0``&AR='@M,C`Q-#`Y,S!?8V%L+GAM;%54!0`##>-;5'5X
M"P`!!"4.```$.0$``%!+`0(>`Q0````(`.V`9D4[CZ0S9AX``'K1`0`5`!@`
M``````$```"D@:QL``!H<G1X+3(P,30P.3,P7V1E9BYX;6Q55`4``PWC6U1U
M>`L``00E#@``!#D!``!02P$"'@,4````"`#M@&9%@>$._GHU``#.GP(`%0`8
M```````!````I(%ABP``:')T>"TR,#$T,#DS,%]L86(N>&UL550%``,-XUM4
M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`[8!F16I`M@EC'@``DM(!`!4`
M&````````0```*2!*L$``&AR='@M,C`Q-#`Y,S!?<')E+GAM;%54!0`##>-;
M5'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`.V`9D723LK71PL``-!>```1
M`!@```````$```"D@=S?``!H<G1X+3(P,30P.3,P+GAS9%54!0`##>-;5'5X
C"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``!NZP``````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 3 - Accounting Policies<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
        <td class="text"><p id="PARA363" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>3.&#160;&#160;&#160;&#160;&#160;Accounting Policies</b></font>
    </p><br/><p id="PARA365" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Use of Estimates</b></font>
    </p><br/><p id="PARA367" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis, including those related to clinical trial accruals, income taxes and stock-based compensation. We base our estimates on historical experience and on assumptions that we believe to be reasonable under the circumstances, the results of which form the basis of making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates under different assumptions or conditions.</font>
    </p><br/><p id="PARA369" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Cash</b></font>
    </p><br/><p id="PARA371" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We had cash of $86.2 million and $72.3 million at September 30, 2014 and December 31, 2013, respectively. We did not hold any cash equivalents or investment securities as of both dates. Our bank accounts have been placed under a control agreement in accordance with the Senior Secured Convertible Notes (see Note 4).</font>
    </p><br/><p id="PARA373" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Earnings Per Share</b></font>
    </p><br/><p id="PARA375" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic earnings per share (&#8220;EPS&#8221;) is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration of common share equivalents. Diluted EPS is computed by dividing the net loss by the weighted-average number of common shares and common share equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, stock options, warrants and common stock underlying convertible notes are considered to be common stock equivalents and are only included in the calculation of diluted EPS when their effect is dilutive.</font>
    </p><br/><p id="PARA377" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Because we have incurred a net loss for all periods presented in the unaudited condensed statements of operations, outstanding stock options, warrants and common stock underlying convertible notes are not included in the computation of net loss per share because their effect would be anti-dilutive.</font>
    </p><br/><p id="PARA379" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table includes the number of outstanding stock options, warrants and common stock underlying convertible notes not included in the computation as of the dates shown below (in thousands):</font>
    </p><br/><table id="TBL394" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellspacing="0" cellpadding="0" border="0">
      <tr id="TBL394.finRow.1">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.1.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.1.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6">
          <p id="PARA381" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b></b></font>
          </p>
          <p id="PARA382" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>As of September 30</b><b>,</b></font>
          </p>
        </td>
        <td id="TBL394.finRow.1.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL394.finRow.2">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.2.lead.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.2.amt.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA383" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2014</b></font>
          </p>
        </td>
        <td id="TBL394.finRow.2.trail.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.2.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.2.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA384" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2013</b></font>
          </p>
        </td>
        <td id="TBL394.finRow.2.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL394.finRow.3">
        <td>
          &#160;
        </td>
        <td id="TBL394.finRow.3.lead.B2">
          &#160;
        </td>
        <td id="TBL394.finRow.3.symb.B2">
          &#160;
        </td>
        <td id="TBL394.finRow.3.amt.B2">
          &#160;
        </td>
        <td id="TBL394.finRow.3.trail.B2">
          &#160;
        </td>
        <td id="TBL394.finRow.3.lead.B3">
          &#160;
        </td>
        <td id="TBL394.finRow.3.symb.B3">
          &#160;
        </td>
        <td id="TBL394.finRow.3.amt.B3">
          &#160;
        </td>
        <td id="TBL394.finRow.3.trail.B3">
          &#160;
        </td>
      </tr>
      <tr id="TBL394.finRow.4" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA385" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stock options outstanding</font>
          </p>
        </td>
        <td id="TBL394.finRow.4.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.4.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.4.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #cceeff">
          6,456
        </td>
        <td id="TBL394.finRow.4.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL394.finRow.4.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.4.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.4.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #cceeff">
          6,270
        </td>
        <td id="TBL394.finRow.4.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL394.finRow.5" style="BACKGROUND-COLOR: #ffffff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          <p id="PARA388" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrants outstanding</font>
          </p>
        </td>
        <td id="TBL394.finRow.5.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL394.finRow.5.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL394.finRow.5.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          4,108
        </td>
        <td id="TBL394.finRow.5.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL394.finRow.5.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL394.finRow.5.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL394.finRow.5.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          3,969
        </td>
        <td id="TBL394.finRow.5.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL394.finRow.6" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA391" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Common stock underlying convertible notes outstanding</font>
          </p>
        </td>
        <td id="TBL394.finRow.6.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.6.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.6.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 37.9pt; BACKGROUND-COLOR: #cceeff">
          6,578
        </td>
        <td id="TBL394.finRow.6.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL394.finRow.6.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.6.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.6.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 37.9pt; BACKGROUND-COLOR: #cceeff">
          6,198
        </td>
        <td id="TBL394.finRow.6.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
    </table><br/><p id="PARA396" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Comprehensive Income (Loss)</b></font>
    </p><br/><p id="PARA398" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Our comprehensive net loss for all periods presented was comprised solely of our net loss and there were no other changes in equity from non-owner sources.</font>
    </p><br/><p id="PARA400" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Recent Accounting Pronouncements</b></font>
    </p><br/><p id="PARA402" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In August 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-15, <i>Presentation of Financial Statements &#8211; Going Concern (Subtopic 205-40)</i> (&#8220;ASU 2014-15&#8221;). ASU 2014-15 requires management to assess an entity&#8217;s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management&#8217;s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management&#8217;s plans, (5) require an express statement and other disclosures when substantial doubt is
      not alleviated, and (6) require an assessment for a period of one year after the date that the financial satements are issued (or available to be issued). The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early adoption is permitted. We plan to adopt the provisions on ASU 2014-15 in 2016. We do not expect the adoption of this ASU to have a material impact on our results of operations or financial condition.</font>
    </p><br/><p id="PARA404" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In June 2014, FASB issued ASU No. 2014-12, <i>Compensation &#8211; Stock Compensation (Topic 718)</i> (&#8220;ASU 2014-12&#8221;). ASU 2014-12 requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The amendments in ASU 2014-12 may either be applied (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earlier annual period presented in the financial statements and to all new or modified awards thereafter. We plan to adopt the provisions of ASU 2014-12 in the first quarter of 2016. We do not expect the adoption of this
      ASU to have a material impact on our results of operations or financial condition.</font>
    </p><br/><p id="PARA406" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In July 2013, the FASB issued ASU No.&#160;2013-11, <i>Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists</i> (&#8220;ASU 2013-11&#8221;). This update provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This guidance is effective prospectively for fiscal years, and interim periods within those years, beginning after December&#160;15, 2013, with an option for early adoption. We adopted this guidance in 2014 and it did not have a material impact on our financial condition, results of operations or related financial statement disclosures.</font>
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6MAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed Statements of Operations (Unaudited) (USD $)<br>In Thousands, except Per Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
        <td class="nump">$ 14,731<span></span></td>
        <td class="nump">$ 6,216<span></span></td>
        <td class="nump">$ 40,929<span></span></td>
        <td class="nump">$ 24,162<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
        <td class="nump">4,222<span></span></td>
        <td class="nump">6,448<span></span></td>
        <td class="nump">14,137<span></span></td>
        <td class="nump">16,464<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
        <td class="nump">18,953<span></span></td>
        <td class="nump">12,664<span></span></td>
        <td class="nump">55,066<span></span></td>
        <td class="nump">40,626<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
        <td class="num">(18,953)<span></span></td>
        <td class="num">(12,664)<span></span></td>
        <td class="num">(55,066)<span></span></td>
        <td class="num">(40,626)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Interest and other expense</a></td>
        <td class="num">(241)<span></span></td>
        <td class="num">(209)<span></span></td>
        <td class="num">(677)<span></span></td>
        <td class="num">(614)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (19,194)<span></span></td>
        <td class="num">$ (12,873)<span></span></td>
        <td class="num">$ (55,743)<span></span></td>
        <td class="num">$ (41,240)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per share (in Dollars per share)</a></td>
        <td class="num">$ (0.66)<span></span></td>
        <td class="num">$ (0.84)<span></span></td>
        <td class="num">$ (2.17)<span></span></td>
        <td class="num">$ (2.69)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares used in computing basic and diluted net loss per share (in Shares)</a></td>
        <td class="nump">29,004<span></span></td>
        <td class="nump">15,375<span></span></td>
        <td class="nump">25,679<span></span></td>
        <td class="nump">15,305<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of other expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating expense recognized during the period. Such amounts may include: (a) unusual costs, (b) loss on foreign exchange transactions, (c) losses on securities (net of profits), and (d) miscellaneous other expense items.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 9<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.9)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherNonoperatingExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 985<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EU1BI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 4 - Convertible Notes to Related Parties (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">0 Months Ended</th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="2">1 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="3"></th>
        <th class="th" colspan="1">1 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 29, 2011</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014

</div>
          <div>In Case of Debt Conversion [Member]

</div>
          <div>Notes Payable, Other Payables [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014

</div>
          <div>In Case of Debt Conversion [Member]

</div>
          <div>Notes Payable, Other Payables [Member]</div>
        </th>
        <th class="th">
          <div>Apr. 30, 2011

</div>
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2011

</div>
          <div>Notes Payable, Other Payables [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014

</div>
          <div>Notes Payable, Other Payables [Member]</div>
        </th>
        <th class="th">
          <div>Apr. 30, 2011

</div>
          <div>Notes Payable, Other Payables [Member]</div>
        </th>
        <th class="th">
          <div>Apr. 30, 2011

</div>
          <div>Initial Closing Amount [Member]</div>
        </th>
        <th class="th">
          <div>Apr. 30, 2011

</div>
          <div>Purchase Option [Member]</div>
        </th>
        <th class="th">
          <div>Apr. 30, 2011

</div>
          <div>Principal Amount [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems', window );"><strong>Note 4 - Convertible Notes to Related Parties (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1', window );">Convertible Debt Issuable In Connection With Private Placement1</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 4,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing', window );">Notes Authorized Under Private Placement Initial Closing</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_PurchaseOptionUnderPrivatePlacement', window );">Purchase Option Under Private Placement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.06<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">May
				02,
				 2021<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_DebtInstrumentConversionRatioShares', window );">Debt Instrument Conversion Ratio, Shares (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,250<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal', window );">Debt Instrument Conversion Ratio, Multiple of Principal</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_BeneficialOwnershipAfterConversion', window );">Beneficial Ownership After Conversion</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">9.99%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes', window );">Notice Period Associated with Beneficial Ownership Percentage Limitation, Convertible Notes</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">61 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes', window );">Common Shares Registered For Resale In Connection With Convertible Notes (in Shares)</a></td>
        <td class="nump">3,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">78,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">78,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,812,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Paid-in-Kind Interest</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">78,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Interest Expense, Debt, Excluding Amortization</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">79,000<span></span></td>
        <td class="nump">74,000<span></span></td>
        <td class="nump">233,000<span></span></td>
        <td class="nump">218,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount (Premium)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">145,000<span></span></td>
        <td class="nump">135,000<span></span></td>
        <td class="nump">425,000<span></span></td>
        <td class="nump">396,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_ConvertibleNotesPayableRelatedPartiesCurrent', window );">Carrying Value of Notes Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,450,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,450,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,025,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,450,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 5,262,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 5,262,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Debt Instrument, Convertible, Number of Equity Instruments</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,578,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_BeneficialOwnershipAfterConversion">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage amount the holder would beneficially own of the company's outstanding common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_BeneficialOwnershipAfterConversion</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common shares registered for resale in connection with convertible notes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_CommonSharesRegisteredForResaleInConnectionWithConvertibleNotes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Convertible debt issuable in connection with private placement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_ConvertibleDebtIssuableInConnectionWithPrivatePlacement1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_ConvertibleNotesPayableRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the holder.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_ConvertibleNotesPayableRelatedPartiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The multiple of principal used in calculating the number of shares converted from the notes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_DebtInstrumentConversionRatioMultipleOfPrincipal</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_DebtInstrumentConversionRatioShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares per $1,000 of principal of note.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_DebtInstrumentConversionRatioShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_Note4ConvertibleNotestoRelatedPartiesDetailsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Notes authorized under private placement initial closing.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_NotesAuthorizedUnderPrivatePlacementInitialClosing</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Notice period associated with beneficial ownership percentage limitation, convertible notes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_NoticePeriodAssociatedWithBeneficialOwnershipPercentageLimitationConvertibleNotes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_PurchaseOptionUnderPrivatePlacement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Purchase option under private placement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_PurchaseOptionUnderPrivatePlacement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfDebtDiscountPremium</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21521-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22(a)(5))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face (par) amount of debt instrument at time of issuance.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 55<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentFaceAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22(a)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentMaturityDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 55<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentUnamortizedDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpenseDebtExcludingAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaidInKindInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ENGAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document And Entity Information<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Oct. 29, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">HERON THERAPEUTICS, INC. /DE/<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-Q<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--12-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">29,180,099<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0000818033<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Accelerated Filer<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Sep. 30,
				 2014<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2014<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">Q3<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCurrentReportingStatus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityVoluntaryFilers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityWellKnownSeasonedIssuer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EHTAK">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 5 - Stockholders' Equity (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">9 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="3">9 Months Ended</th>
        <th class="th" colspan="1">28 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="4">1 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">0 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jan. 13, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2011

</div>
          <div>Private Placement 2011 [Member]

</div>
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014

</div>
          <div>Private Placement 2011 [Member]

</div>
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014

</div>
          <div>Private Placement 2011 [Member]

</div>
          <div>Warrant [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014

</div>
          <div>Private Placement 2011 [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013

</div>
          <div>Private Placement 2011 [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2011

</div>
          <div>Private Placement 2011 [Member]</div>
        </th>
        <th class="th">
          <div>Jul. 31, 2012

</div>
          <div>Private Placement 2012 [Member]

</div>
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Jul. 31, 2012

</div>
          <div>Private Placement 2012 [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014

</div>
          <div>Pre Funded Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Nov. 30, 2013

</div>
          <div>Common Stock [Member]

</div>
          <div>Jefferies LLC [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014

</div>
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014

</div>
          <div>Common Stock and Prefunded Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Jan. 13, 2014

</div>
          <div>Scenario, Previously Reported [Member]</div>
        </th>
        <th class="th">
          <div>Jan. 13, 2014

</div>
          <div>Reverse Stock Split [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_Note5StockholdersEquityDetailsLineItems', window );"><strong>Note 5 - Stockholders' Equity (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stockholders' Equity Note, Stock Split, Conversion Ratio</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">75,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,500,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8,000,000<span></span></td>
        <td class="nump">303,614<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8,600,000<span></span></td>
        <td class="nump">4,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 22,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 50,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,900,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_SharesAvailablePerWarrantExercised', window );">Shares Available Per Warrant Exercised (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.5<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit', window );">Exercise Price Arrangement, Warrants To Purchase Shares, Purchase Price Per Unit (in Dollars per Share)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 3.60<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_LimitationOnExercisableWarrants', window );">Limitation On Exercisable Warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">9.99%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">57,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">460,706<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from Warrant Exercises</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">600,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">600,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share (in Dollars per share)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 10.50<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of Stock, Price Per Share (in Dollars per share)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 8.00<span></span></td>
        <td class="nump">$ 11.75<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">600,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price (in Dollars per share)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 11.74<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_WarrantTerm', window );">Warrant Term</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from Issuance or Sale of Equity</a></td>
        <td class="nump">58,916,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">58,900,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Net (in Shares)</a></td>
        <td class="nump">550,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from Stock Options Exercised</a></td>
        <td class="nump">2,832,000<span></span></td>
        <td class="nump">1,120,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</a></td>
        <td class="nump">$ 26,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
        <td class="text">2 years 6 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Purchase Price Unit (1 Warrant to Purchase 0.5 shares of Common Stock)</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_ExercisePriceArrangementWarrantsToPurchaseSharesPurchasePricePerUnit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_LimitationOnExercisableWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>There is no right to exercise the Warrants to the extent that the holder would beneficially own in excess of the stated percentage of The Company's outstanding shares of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_LimitationOnExercisableWarrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_Note5StockholdersEquityDetailsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_Note5StockholdersEquityDetailsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_SharesAvailablePerWarrantExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of shares available to be exercised per warrant.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_SharesAvailablePerWarrantExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period, net of shares retained for cashless exercises.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_StockIssuedDuringPeriodSharesStockOptionsExercisedNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_WarrantTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exercisable term from the date of issuance.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_WarrantTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Exercise price per share or per unit of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrecognized cost of unvested share-based compensation awards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for cost incurred directly with the issuance of an equity security.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsOfStockIssuanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOrSaleOfEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (j)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromWarrantExercises</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SaleOfStockPricePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of non-option equity instruments exercised by participants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Price of a single share of a number of saleable stocks of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount per share or per unit of equity securities issued by non-development stage entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharesIssuedPricePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Stock Split<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6525746<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ED2AE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed Statements of Cash Flows (Unaudited) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (55,743,000)<span></span></td>
        <td class="num">$ (41,240,000)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used for operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">389,000<span></span></td>
        <td class="nump">237,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
        <td class="nump">5,809,000<span></span></td>
        <td class="nump">8,333,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
        <td class="nump">425,000<span></span></td>
        <td class="nump">396,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
        <td class="num">(2,392,000)<span></span></td>
        <td class="num">(202,000)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
        <td class="nump">211,000<span></span></td>
        <td class="nump">514,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_IncreaseDecreaseInClinicalLiabilities', window );">Accrued clinical liabilities</a></td>
        <td class="nump">2,757,000<span></span></td>
        <td class="nump">302,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued payroll and employee-related liabilities</a></td>
        <td class="nump">35,000<span></span></td>
        <td class="nump">454,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Other accrued expenses</a></td>
        <td class="nump">1,084,000<span></span></td>
        <td class="nump">70,000<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used for operating activities</a></td>
        <td class="num">(47,425,000)<span></span></td>
        <td class="num">(31,136,000)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_InvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
        <td class="num">(417,000)<span></span></td>
        <td class="num">(1,518,000)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used for investing activities</a></td>
        <td class="num">(417,000)<span></span></td>
        <td class="num">(1,518,000)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_FinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrant exercises</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">600,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Proceeds from purchases under the Employee Stock Purchase Plan</a></td>
        <td class="nump">19,000<span></span></td>
        <td class="nump">25,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock option exercises</a></td>
        <td class="nump">2,832,000<span></span></td>
        <td class="nump">1,120,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds from sale of common stock and pre-funded warrants</a></td>
        <td class="nump">58,916,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
        <td class="nump">61,767,000<span></span></td>
        <td class="nump">1,745,000<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase (decrease) in cash</a></td>
        <td class="nump">13,925,000<span></span></td>
        <td class="num">(30,909,000)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash at beginning of period</a></td>
        <td class="nump">72,287,000<span></span></td>
        <td class="nump">53,506,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash at end of period</a></td>
        <td class="nump">$ 86,212,000<span></span></td>
        <td class="nump">$ 22,597,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_AdjustmentsToReconcileNetLossToNetCashUsedForOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_ChangesInOperatingAssetsAndLiabilitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_FinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_FinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_IncreaseDecreaseInClinicalLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to clinical liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_IncreaseDecreaseInClinicalLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_InvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_InvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfDebtDiscountPremium</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders to acquire the entity's shares under incentive and share awards other than stock option exercises. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOrSaleOfEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (j)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromWarrantExercises</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 3 - Accounting Policies (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</a></td>
        <td class="text"><table id="TBL394" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellspacing="0" cellpadding="0" border="0">
      <tr id="TBL394.finRow.1">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.1.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.1.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6">
          <p id="PARA381" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b></b></font>
          </p>
          <p id="PARA382" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>As of September 30</b><b>,</b></font>
          </p>
        </td>
        <td id="TBL394.finRow.1.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL394.finRow.2">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.2.lead.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.2.amt.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA383" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2014</b></font>
          </p>
        </td>
        <td id="TBL394.finRow.2.trail.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.2.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.2.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA384" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2013</b></font>
          </p>
        </td>
        <td id="TBL394.finRow.2.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL394.finRow.3">
        <td>
          &#160;
        </td>
        <td id="TBL394.finRow.3.lead.B2">
          &#160;
        </td>
        <td id="TBL394.finRow.3.symb.B2">
          &#160;
        </td>
        <td id="TBL394.finRow.3.amt.B2">
          &#160;
        </td>
        <td id="TBL394.finRow.3.trail.B2">
          &#160;
        </td>
        <td id="TBL394.finRow.3.lead.B3">
          &#160;
        </td>
        <td id="TBL394.finRow.3.symb.B3">
          &#160;
        </td>
        <td id="TBL394.finRow.3.amt.B3">
          &#160;
        </td>
        <td id="TBL394.finRow.3.trail.B3">
          &#160;
        </td>
      </tr>
      <tr id="TBL394.finRow.4" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA385" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stock options outstanding</font>
          </p>
        </td>
        <td id="TBL394.finRow.4.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.4.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.4.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #cceeff">
          6,456
        </td>
        <td id="TBL394.finRow.4.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL394.finRow.4.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.4.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.4.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #cceeff">
          6,270
        </td>
        <td id="TBL394.finRow.4.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL394.finRow.5" style="BACKGROUND-COLOR: #ffffff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          <p id="PARA388" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrants outstanding</font>
          </p>
        </td>
        <td id="TBL394.finRow.5.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL394.finRow.5.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL394.finRow.5.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          4,108
        </td>
        <td id="TBL394.finRow.5.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL394.finRow.5.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL394.finRow.5.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL394.finRow.5.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          3,969
        </td>
        <td id="TBL394.finRow.5.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL394.finRow.6" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA391" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Common stock underlying convertible notes outstanding</font>
          </p>
        </td>
        <td id="TBL394.finRow.6.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.6.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.6.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 37.9pt; BACKGROUND-COLOR: #cceeff">
          6,578
        </td>
        <td id="TBL394.finRow.6.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL394.finRow.6.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.6.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.6.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 37.9pt; BACKGROUND-COLOR: #cceeff">
          6,198
        </td>
        <td id="TBL394.finRow.6.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EYDAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
        <td class="text"><p id="PARA365" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Use of Estimates</b></font>
    </p><br/><p id="PARA367" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis, including those related to clinical trial accruals, income taxes and stock-based compensation. We base our estimates on historical experience and on assumptions that we believe to be reasonable under the circumstances, the results of which form the basis of making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates under different assumptions or conditions.</font></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
        <td class="text"><p id="PARA369" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Cash</b></font>
    </p><br/><p id="PARA371" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We had cash of $86.2 million and $72.3 million at September 30, 2014 and December 31, 2013, respectively. We did not hold any cash equivalents or investment securities as of both dates. Our bank accounts have been placed under a control agreement in accordance with the Senior Secured Convertible Notes (see Note 4).</font></p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiquidityDisclosureTextBlock', window );">Liquidity Disclosure [Policy Text Block]</a></td>
        <td class="text"><p id="PARA371" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We had cash of $86.2 million and $72.3 million at September 30, 2014 and December 31, 2013, respectively.</font></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
        <td class="text"><p id="PARA373" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Earnings Per Share</b></font>
    </p><br/><p id="PARA375" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic earnings per share (&#8220;EPS&#8221;) is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration of common share equivalents. Diluted EPS is computed by dividing the net loss by the weighted-average number of common shares and common share equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, stock options, warrants and common stock underlying convertible notes are considered to be common stock equivalents and are only included in the calculation of diluted EPS when their effect is dilutive.</font>
    </p><br/><p id="PARA377" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Because we have incurred a net loss for all periods presented in the unaudited condensed statements of operations, outstanding stock options, warrants and common stock underlying convertible notes are not included in the computation of net loss per share because their effect would be anti-dilutive.</font>
    </p><br/><p id="PARA379" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table includes the number of outstanding stock options, warrants and common stock underlying convertible notes not included in the computation as of the dates shown below (in thousands):</font>
    </p><br/><table id="TBL394" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellspacing="0" cellpadding="0" border="0">
      <tr id="TBL394.finRow.1">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.1.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.1.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6">
          <p id="PARA381" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b></b></font>
          </p>
          <p id="PARA382" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>As of September 30</b><b>,</b></font>
          </p>
        </td>
        <td id="TBL394.finRow.1.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL394.finRow.2">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.2.lead.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.2.amt.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA383" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2014</b></font>
          </p>
        </td>
        <td id="TBL394.finRow.2.trail.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.2.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL394.finRow.2.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA384" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2013</b></font>
          </p>
        </td>
        <td id="TBL394.finRow.2.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL394.finRow.3">
        <td>
          &#160;
        </td>
        <td id="TBL394.finRow.3.lead.B2">
          &#160;
        </td>
        <td id="TBL394.finRow.3.symb.B2">
          &#160;
        </td>
        <td id="TBL394.finRow.3.amt.B2">
          &#160;
        </td>
        <td id="TBL394.finRow.3.trail.B2">
          &#160;
        </td>
        <td id="TBL394.finRow.3.lead.B3">
          &#160;
        </td>
        <td id="TBL394.finRow.3.symb.B3">
          &#160;
        </td>
        <td id="TBL394.finRow.3.amt.B3">
          &#160;
        </td>
        <td id="TBL394.finRow.3.trail.B3">
          &#160;
        </td>
      </tr>
      <tr id="TBL394.finRow.4" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA385" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stock options outstanding</font>
          </p>
        </td>
        <td id="TBL394.finRow.4.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.4.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.4.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #cceeff">
          6,456
        </td>
        <td id="TBL394.finRow.4.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL394.finRow.4.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.4.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.4.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #cceeff">
          6,270
        </td>
        <td id="TBL394.finRow.4.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL394.finRow.5" style="BACKGROUND-COLOR: #ffffff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          <p id="PARA388" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrants outstanding</font>
          </p>
        </td>
        <td id="TBL394.finRow.5.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL394.finRow.5.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL394.finRow.5.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          4,108
        </td>
        <td id="TBL394.finRow.5.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL394.finRow.5.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL394.finRow.5.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL394.finRow.5.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          3,969
        </td>
        <td id="TBL394.finRow.5.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL394.finRow.6" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA391" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Common stock underlying convertible notes outstanding</font>
          </p>
        </td>
        <td id="TBL394.finRow.6.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.6.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.6.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 37.9pt; BACKGROUND-COLOR: #cceeff">
          6,578
        </td>
        <td id="TBL394.finRow.6.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL394.finRow.6.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.6.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL394.finRow.6.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 37.9pt; BACKGROUND-COLOR: #cceeff">
          6,198
        </td>
        <td id="TBL394.finRow.6.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income, Policy [Policy Text Block]</a></td>
        <td class="text"><p id="PARA396" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Comprehensive Income (Loss)</b></font>
    </p><br/><p id="PARA398" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Our comprehensive net loss for all periods presented was comprised solely of our net loss and there were no other changes in equity from non-owner sources.</font></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
        <td class="text"><p id="PARA400" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Recent Accounting Pronouncements</b></font>
    </p><br/><p id="PARA402" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In August 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-15, <i>Presentation of Financial Statements &#8211; Going Concern (Subtopic 205-40)</i> (&#8220;ASU 2014-15&#8221;). ASU 2014-15 requires management to assess an entity&#8217;s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management&#8217;s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management&#8217;s plans, (5) require an express statement and other disclosures when substantial doubt is
      not alleviated, and (6) require an assessment for a period of one year after the date that the financial satements are issued (or available to be issued). The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early adoption is permitted. We plan to adopt the provisions on ASU 2014-15 in 2016. We do not expect the adoption of this ASU to have a material impact on our results of operations or financial condition.</font>
    </p><br/><p id="PARA404" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In June 2014, FASB issued ASU No. 2014-12, <i>Compensation &#8211; Stock Compensation (Topic 718)</i> (&#8220;ASU 2014-12&#8221;). ASU 2014-12 requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The amendments in ASU 2014-12 may either be applied (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earlier annual period presented in the financial statements and to all new or modified awards thereafter. We plan to adopt the provisions of ASU 2014-12 in the first quarter of 2016. We do not expect the adoption of this
      ASU to have a material impact on our results of operations or financial condition.</font>
    </p><br/><p id="PARA406" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In July 2013, the FASB issued ASU No.&#160;2013-11, <i>Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists</i> (&#8220;ASU 2013-11&#8221;). This update provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This guidance is effective prospectively for fiscal years, and interim periods within those years, beginning after December&#160;15, 2013, with an option for early adoption. We adopted this guidance in 2014 and it did not have a material impact on our financial condition, results of operations or related financial statement disclosures.</font></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 305<br><br> -SubTopic 10<br><br> -Section 05<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Financial Reporting Release (FRR)<br><br> -Number 203<br><br> -Paragraph 02-03<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerSharePolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiquidityDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiquidityDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6143-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6132-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6061-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UseOfEstimates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EEWAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 5 - Stockholders' Equity (Details) - Stock-based Compensation Expense (USD $)<br>In Thousands, except Per Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
        <td class="nump">$ 1,760<span></span></td>
        <td class="nump">$ 4,095<span></span></td>
        <td class="nump">$ 5,809<span></span></td>
        <td class="nump">$ 8,333<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare', window );">Impact on basic and diluted net loss per share (in Dollars per share)</a></td>
        <td class="nump">$ 0.06<span></span></td>
        <td class="nump">$ 0.27<span></span></td>
        <td class="nump">$ 0.23<span></span></td>
        <td class="nump">$ 0.54<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Research and Development Expense [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
        <td class="nump">715<span></span></td>
        <td class="nump">702<span></span></td>
        <td class="nump">2,423<span></span></td>
        <td class="nump">1,492<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">General and Administrative Expense [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
        <td class="nump">$ 1,045<span></span></td>
        <td class="nump">$ 3,393<span></span></td>
        <td class="nump">$ 3,386<span></span></td>
        <td class="nump">$ 6,841<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Impact on basic and diluted net loss per common share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_ImpactOnBasicAndDilutedNetLossPerCommonShareinDollarsPerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Note 3 - Accounting Policies (Details) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
        <td class="nump">$ 86,212,000<span></span></td>
        <td class="nump">$ 72,287,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash Equivalents, at Carrying Value</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Cash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EVDAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 5 - Stockholders' Equity (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_Note5StockholdersEquityTablesLineItems', window );"><strong>Note 5 - Stockholders' Equity (Tables) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</a></td>
        <td class="text"><table id="TBL490" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellspacing="0" cellpadding="0" border="0">
      <tr id="TBL490.finRow.1">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.1.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.1.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6">
          <p id="PARA460" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b></b></font>
          </p>
          <p id="PARA461" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Three Months Ended</b></font>
          </p>
          <p id="PARA462" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>September 30</b><b>,</b></font>
          </p>
        </td>
        <td id="TBL490.finRow.1.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.1.lead.D5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.1.amt.D5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6">
          <p id="PARA463" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b></b></font>
          </p>
          <p id="PARA464" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Nine</b> <b>Months Ended</b></font>
          </p>
          <p id="PARA465" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>September 30</b><b>,</b></font>
          </p>
        </td>
        <td id="TBL490.finRow.1.trail.D5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL490.finRow.2">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.lead.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.amt.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA466" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2014</b></font>
          </p>
        </td>
        <td id="TBL490.finRow.2.trail.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA467" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2013</b></font>
          </p>
        </td>
        <td id="TBL490.finRow.2.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA468" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2014</b></font>
          </p>
        </td>
        <td id="TBL490.finRow.2.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.lead.D5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
          <b>&#160;</b>
        </td>
        <td id="TBL490.finRow.2.amt.D5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA469" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>2013</b></font>
          </p>
        </td>
        <td id="TBL490.finRow.2.trail.D5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL490.finRow.3">
        <td>
          &#160;
        </td>
        <td id="TBL490.finRow.3.lead.B2">
          &#160;
        </td>
        <td id="TBL490.finRow.3.symb.B2">
          &#160;
        </td>
        <td id="TBL490.finRow.3.amt.B2">
          &#160;
        </td>
        <td id="TBL490.finRow.3.trail.B2">
          &#160;
        </td>
        <td id="TBL490.finRow.3.lead.B3">
          &#160;
        </td>
        <td id="TBL490.finRow.3.symb.B3">
          &#160;
        </td>
        <td id="TBL490.finRow.3.amt.B3">
          &#160;
        </td>
        <td id="TBL490.finRow.3.trail.B3">
          &#160;
        </td>
        <td id="TBL490.finRow.3.lead.B4">
          &#160;
        </td>
        <td id="TBL490.finRow.3.symb.B4">
          &#160;
        </td>
        <td id="TBL490.finRow.3.amt.B4">
          &#160;
        </td>
        <td id="TBL490.finRow.3.trail.B4">
          &#160;
        </td>
        <td id="TBL490.finRow.3.lead.B5">
          &#160;
        </td>
        <td id="TBL490.finRow.3.symb.B5">
          &#160;
        </td>
        <td id="TBL490.finRow.3.amt.B5">
          &#160;
        </td>
        <td id="TBL490.finRow.3.trail.B5">
          &#160;
        </td>
      </tr>
      <tr id="TBL490.finRow.4" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA470" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Research and development</font>
          </p>
        </td>
        <td id="TBL490.finRow.4.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.4.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.4.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          715
        </td>
        <td id="TBL490.finRow.4.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.4.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.4.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.4.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          702
        </td>
        <td id="TBL490.finRow.4.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.4.lead.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.4.symb.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.4.amt.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          2,423
        </td>
        <td id="TBL490.finRow.4.trail.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.4.lead.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.4.symb.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.4.amt.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          1,492
        </td>
        <td id="TBL490.finRow.4.trail.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL490.finRow.5" style="BACKGROUND-COLOR: #ffffff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          <p id="PARA475" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">General and administrative</font>
          </p>
        </td>
        <td id="TBL490.finRow.5.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          1,045
        </td>
        <td id="TBL490.finRow.5.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.5.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          3,393
        </td>
        <td id="TBL490.finRow.5.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.5.lead.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.symb.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.amt.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          3,386
        </td>
        <td id="TBL490.finRow.5.trail.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.5.lead.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.symb.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.5.amt.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 38.7pt; BACKGROUND-COLOR: #ffffff">
          6,841
        </td>
        <td id="TBL490.finRow.5.trail.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL490.finRow.6" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA480" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stock-based compensation expense included in operating expenses</font>
          </p>
        </td>
        <td id="TBL490.finRow.6.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.6.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.6.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          1,760
        </td>
        <td id="TBL490.finRow.6.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.6.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.6.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.6.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          4,095
        </td>
        <td id="TBL490.finRow.6.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.6.lead.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.6.symb.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.6.amt.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          5,809
        </td>
        <td id="TBL490.finRow.6.trail.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.6.lead.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.6.symb.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.6.amt.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          8,333
        </td>
        <td id="TBL490.finRow.6.trail.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL490.finRow.7" style="BACKGROUND-COLOR: #ffffff">
        <td style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.lead.B2" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.symb.B2" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.amt.B2" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.trail.B2" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.lead.B3" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.symb.B3" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.amt.B3" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.trail.B3" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.lead.B4" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.symb.B4" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.amt.B4" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.trail.B4" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.lead.B5" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.symb.B5" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.amt.B5" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL490.finRow.7.trail.B5" style="BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
      </tr>
      <tr id="TBL490.finRow.8" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
          <p id="PARA485" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Impact on basic and diluted net loss per share</font>
          </p>
        </td>
        <td id="TBL490.finRow.8.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.8.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.8.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          0.06
        </td>
        <td id="TBL490.finRow.8.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.8.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.8.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.8.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          0.27
        </td>
        <td id="TBL490.finRow.8.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.8.lead.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.8.symb.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.8.amt.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          0.23
        </td>
        <td id="TBL490.finRow.8.trail.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL490.finRow.8.lead.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL490.finRow.8.symb.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL490.finRow.8.amt.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          0.54
        </td>
        <td id="TBL490.finRow.8.trail.5" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Share-based Compensation, Activity [Table Text Block]</a></td>
        <td class="text"><table id="TBL558" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellspacing="0" cellpadding="0" border="0">
      <tr id="TBL558.finRow.1">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.lead.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.symb.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.amt.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.trail.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.lead.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.symb.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.amt.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.trail.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.1.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA522" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Weighted-</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.1.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL558.finRow.2">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.lead.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.symb.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.amt.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.trail.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.lead.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.symb.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.amt.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.trail.B3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.2.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA524" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Average</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.2.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL558.finRow.3">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.lead.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.symb.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.amt.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.trail.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA526" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Weighted-</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.3.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.3.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA527" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Remaining</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.3.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL558.finRow.4">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.lead.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.symb.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.amt.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.trail.B2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA529" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Average</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.4.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.4.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA530" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Contractual</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.4.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL558.finRow.5">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.5.lead.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.5.amt.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA532" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Shares</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.5.trail.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.5.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.5.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA533" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Exercise</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.5.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.5.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.5.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA534" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Term</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.5.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL558.finRow.6">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.6.lead.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.6.amt.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA536" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>(in thousands)</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.6.trail.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.6.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.6.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA537" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Price</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.6.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.6.lead.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL558.finRow.6.amt.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA538" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>(Years)</b></font>
          </p>
        </td>
        <td id="TBL558.finRow.6.trail.D4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL558.finRow.7" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA539" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance at January 1, 2014</font>
          </p>
        </td>
        <td id="TBL558.finRow.7.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.7.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.7.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          6,356
        </td>
        <td id="TBL558.finRow.7.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.7.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.7.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL558.finRow.7.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          8.22
        </td>
        <td id="TBL558.finRow.7.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.7.lead.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.7.symb.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.7.amt.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          8.14
        </td>
        <td id="TBL558.finRow.7.trail.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
      <tr id="TBL558.finRow.8" style="BACKGROUND-COLOR: #ffffff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff">
          <p id="PARA543" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</font>
          </p>
        </td>
        <td id="TBL558.finRow.8.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.8.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.8.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          1,631
        </td>
        <td id="TBL558.finRow.8.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.8.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.8.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          $
        </td>
        <td id="TBL558.finRow.8.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          9.95
        </td>
        <td id="TBL558.finRow.8.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.8.lead.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.8.symb.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.8.amt.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.8.trail.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
      </tr>
      <tr id="TBL558.finRow.9" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff">
          <p id="PARA546" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</font>
          </p>
        </td>
        <td id="TBL558.finRow.9.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.9.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.9.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          (719
        </td>
        <td id="TBL558.finRow.9.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          <p id="PARA548" style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</font>
          </p>
        </td>
        <td id="TBL558.finRow.9.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.9.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL558.finRow.9.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          6.29
        </td>
        <td id="TBL558.finRow.9.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.9.lead.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.9.symb.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.9.amt.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.9.trail.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
      </tr>
      <tr id="TBL558.finRow.10" style="BACKGROUND-COLOR: #ffffff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff">
          <p id="PARA550" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expired and forfeited</font>
          </p>
        </td>
        <td id="TBL558.finRow.10.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.10.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.10.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          (812
        </td>
        <td id="TBL558.finRow.10.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          <p id="PARA552" style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</font>
          </p>
        </td>
        <td id="TBL558.finRow.10.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.10.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          $
        </td>
        <td id="TBL558.finRow.10.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          9.82
        </td>
        <td id="TBL558.finRow.10.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.10.lead.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.10.symb.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.10.amt.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL558.finRow.10.trail.B4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
      </tr>
      <tr id="TBL558.finRow.11" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA554" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance at September 30, 2014</font>
          </p>
        </td>
        <td id="TBL558.finRow.11.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.11.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.11.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          6,456
        </td>
        <td id="TBL558.finRow.11.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.11.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.11.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          $
        </td>
        <td id="TBL558.finRow.11.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          8.67
        </td>
        <td id="TBL558.finRow.11.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL558.finRow.11.lead.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.11.symb.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL558.finRow.11.amt.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          8.18
        </td>
        <td id="TBL558.finRow.11.trail.4" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_Note5StockholdersEquityTablesLineItems', window );"><strong>Note 5 - Stockholders' Equity (Tables) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
        <td class="text"><table id="TBL512" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellspacing="0" cellpadding="0" border="0">
      <tr id="TBL512.finRow.1">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom">
          <em></em>
        </td>
        <td id="TBL512.finRow.1.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL512.finRow.1.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6">
          <p id="PARA497" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>September 30,</b></font>
          </p>
        </td>
        <td id="TBL512.finRow.1.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL512.finRow.2">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL512.finRow.2.lead.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL512.finRow.2.amt.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA498" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>20</b><b>14</b></font>
          </p>
        </td>
        <td id="TBL512.finRow.2.trail.D2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
        <td id="TBL512.finRow.2.lead.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">
          <b>&#160;</b>
        </td>
        <td id="TBL512.finRow.2.amt.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2">
          <p id="PARA499" style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>20</b><b>13</b></font>
          </p>
        </td>
        <td id="TBL512.finRow.2.trail.D3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px">
          <b>&#160;</b>
        </td>
      </tr>
      <tr id="TBL512.finRow.3" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA500" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</font>
          </p>
        </td>
        <td id="TBL512.finRow.3.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.3.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.3.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          2.0
        </td>
        <td id="TBL512.finRow.3.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          %
        </td>
        <td id="TBL512.finRow.3.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.3.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.3.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          1.0
        </td>
        <td id="TBL512.finRow.3.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          %
        </td>
      </tr>
      <tr id="TBL512.finRow.4" style="BACKGROUND-COLOR: #ffffff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          <p id="PARA503" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dividend yield</font>
          </p>
        </td>
        <td id="TBL512.finRow.4.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.4.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.4.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 19.55pt; BACKGROUND-COLOR: #ffffff">
          0.0
        </td>
        <td id="TBL512.finRow.4.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          %
        </td>
        <td id="TBL512.finRow.4.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.4.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.4.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 19.55pt; BACKGROUND-COLOR: #ffffff">
          0.0
        </td>
        <td id="TBL512.finRow.4.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          %
        </td>
      </tr>
      <tr id="TBL512.finRow.5" style="BACKGROUND-COLOR: #cceeff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          <p id="PARA506" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Volatility</font>
          </p>
        </td>
        <td id="TBL512.finRow.5.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.5.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.5.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          102.9
        </td>
        <td id="TBL512.finRow.5.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          %
        </td>
        <td id="TBL512.finRow.5.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.5.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
          &#160;
        </td>
        <td id="TBL512.finRow.5.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
          104.2
        </td>
        <td id="TBL512.finRow.5.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">
          %
        </td>
      </tr>
      <tr id="TBL512.finRow.6" style="BACKGROUND-COLOR: #ffffff">
        <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          <p id="PARA509" style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25">
            <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected life (years)</font>
          </p>
        </td>
        <td id="TBL512.finRow.6.lead.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.6.symb.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.6.amt.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">
          6.0
        </td>
        <td id="TBL512.finRow.6.trail.2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
        <td id="TBL512.finRow.6.lead.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.6.symb.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
          &#160;
        </td>
        <td id="TBL512.finRow.6.amt.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 54pt; BACKGROUND-COLOR: #ffffff">
          6.0
        </td>
        <td id="TBL512.finRow.6.trail.3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_Note5StockholdersEquityTablesLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_Note5StockholdersEquityTablesLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of share-based compensation plans that may be presented in a single table for outstanding, vested and expected to vest, and exercisable awards. The information that may be disclosed in this table may include, but is not limited to, number of shares, weighted average exercise price, weighted average remaining contractual life, and aggregate intrinsic value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EXJAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 1 - Business (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">45 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">0 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Jan. 13, 2014

</div>
          <div>Reverse Stock Split [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_Note1BusinessDetailsLineItems', window );"><strong>Note 1 - Business (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stockholders' Equity Note, Stock Split, Conversion Ratio</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
        <td class="num">$ (294,613,000)<span></span></td>
        <td class="num">$ (238,870,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet', window );">Proceeds from Issuance of Long-term Debt and Capital Securities, Net</a></td>
        <td class="nump">194,300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
        <td class="nump">$ 86,212,000<span></span></td>
        <td class="nump">$ 72,287,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_Note1BusinessDetailsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_Note1BusinessDetailsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Cash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with security instrument that either represents a creditor or an ownership relationship with the holder of the investment security with a maturity of beyond one year or normal operating cycle, if longer. Includes proceeds from (a) debt, (b) capital lease obligations, (c) mandatory redeemable capital securities, and (d) any combination of (a), (b), or (c).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Stock Split<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6525746<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EKGAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 3 - Accounting Policies (Details) - Equity Excluded From Calculation of Diluted Earnings Per Share<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Equity Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares excluded</a></td>
        <td class="nump">6,456<span></span></td>
        <td class="nump">6,270<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Warrant [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares excluded</a></td>
        <td class="nump">4,108<span></span></td>
        <td class="nump">3,969<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Convertible Debt Securities [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares excluded</a></td>
        <td class="nump">6,578<span></span></td>
        <td class="nump">6,198<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Antidilution<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Diluted Earnings Per Share<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Contingent Stock Agreement<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EIGAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 5 - Stockholders' Equity (Details) - Option Summary (USD $)<br>In Thousands, except Per Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_OptionSummaryAbstract', window );"><strong>Option Summary [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,356<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 8.22<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-Average Remaining Contractual Term</a></td>
        <td class="text">8 years 65 days<span></span></td>
        <td class="text">8 years 51 days<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
        <td class="nump">$ 9.95<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
        <td class="nump">1,631<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
        <td class="num">(719)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
        <td class="nump">$ 6.29<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Expired and forfeited</a></td>
        <td class="num">(812)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired and forfeited</a></td>
        <td class="nump">$ 9.82<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares</a></td>
        <td class="nump">6,456<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price</a></td>
        <td class="nump">$ 8.67<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-Average Remaining Contractual Term</a></td>
        <td class="text">8 years 65 days<span></span></td>
        <td class="text">8 years 51 days<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_OptionSummaryAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_OptionSummaryAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)-(4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price of options that were either forfeited or expired.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)-(4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options outstanding, including both vested and non-vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 1 - Business<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Business Description and Basis of Presentation [Text Block]</a></td>
        <td class="text"><p id="PARA337" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>1.&#160;&#160;&#160;&#160;&#160;Business</b></font>
    </p><br/><p id="PARA1519" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221;) is a biotechnology company using its proprietary technology and innovative efforts to develop products to address unmet medical needs. Our proprietary Biochronomer<sup style="vertical-align: baseline; position: relative; bottom:.33em;">&#174;</sup> polymer-based drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by extending the duration of action of known active ingredients. Our product development program also focuses on identifying new delivery methods and formulations utilizing known compounds that may expand or extend the therapeutic effort, or eliminate the drawbacks of current therapies.</font>
    </p><br/><p id="PARA1521" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our lead investigational product candidate, APF530, which we intend to market as SUSTOL<sup style="vertical-align: baseline; position: relative; bottom:.33em;">&#174;</sup> <sup style="vertical-align: baseline; position: relative; bottom:.33em;"></sup>(granisetron injection, extended release), subject to regulatory approval, is being developed for the prevention of both acute- and delayed-onset chemotherapy induced nausea and vomiting (&#8220;CINV&#8221;). In 2014, we initiated a Phase 3 clinical study with APF530 for the prevention of delayed-onset CINV in patients receiving highly emetogenic chemotherapy (&#8220;HEC study&#8221;). One of the most debilitating side effects of cancer chemotherapy, CINV is a leading cause of premature discontinuation of treatment. There is only one injectable 5-HT3 receptor antagonist approved for the prevention of delayed-onset CINV in patients receiving moderately
      emetogenic chemotherapy; none are approved for delayed-onset CINV in patients receiving highly emetogenic chemotherapy.</font>
    </p><br/><p id="PARA1523" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">SUSTOL contains the 5-HT3 receptor antagonist granisetron formulated in the Company's proprietary Biochronomer polymer-based drug delivery platform, which has been shown in clinical studies to maintain therapeutic drug levels of SUSTOL for up to five days with a single subcutaneous injection. Currently available intravenous and oral formulations of granisetron are approved only for the prevention of acute-onset CINV. Granisetron was selected for SUSTOL because it is widely prescribed by physicians based on a well-established record of safety and efficacy. We own the worldwide rights to SUSTOL.</font>
    </p><br/><p id="PARA1515" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In May 2009, we filed the original New Drug Application (&#8220;NDA&#8221;) with the U.S. Food and Drug Administration (&#8220;FDA&#8221;) seeking approval for SUSTOL for the prevention of acute-onset CINV in patients receiving both moderately and highly emetogenic chemotherapy and delayed-onset CINV in patients receiving moderately emetogenic chemotherapy. The FDA issued a Complete Response Letter (&#8220;CRL&#8221;) for the SUSTOL NDA in March 2010. In September 2012, we resubmitted our NDA for SUSTOL and, in March 2013, we received a second CRL, which identified several remaining issues that need to be addressed prior to approval of the SUSTOL NDA. We believe that we have substantially addressed those issues raised in the March 2013 CRL. We are targeting completing enrollment&#160;of our ongoing HEC study in the first quarter of 2015. We intend to include the results of the study in the resubmission of
      the SUSTOL NDA, which we anticipate filing shortly thereafter.&#160;</font>
    </p><br/><p id="PARA347" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our core Biochronomer technology, on which SUSTOL and our other product candidates are based, consists of bioerodible polymers designed to release drugs over a defined period of time. The results of over 100 <i>in vivo</i> and <i>in vitro</i> studies demonstrate that our Biochronomer technology is potentially applicable to a range of therapeutic areas, including prevention of CINV, pain management and control of inflammation, among others. We have also completed comprehensive animal and human toxicology studies that have established that our Biochronomer polymers are well tolerated. Furthermore, our Biochronomer technology can be designed to deliver drugs over periods varying from days to potentially multiple weeks. We are researching the potential use of our Biochronomer technology with other drugs for the clinical development of other drug candidates.</font>
    </p><br/><p id="PARA349" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In November 2013, we initiated a program to expand our pipeline of sustained-release products, including a new program targeting pain management. We selected HTX-011, a combination of local&#160;anesthetic bupivacaine and the anti-inflammatory meloxicam in a formulation utilizing our proprietary Biochronomer polymer-based drug delivery platform, as the lead product candidate for our&#160;pain management&#160;program. We are in the process of commencing a Phase 1 study in Europe to examine the product candidate in human candidates. As of 2012, approximately 25 million<sup style="vertical-align: baseline; position: relative; bottom:.33em;">1</sup> procedures associated with post-operative pain were conducted in the U.S. In addition, post-operative pain market sales were approximately $3.1&#160;billion<sup style="vertical-align: baseline; position: relative; bottom:.33em;">2</sup> in 2012.</font>
    </p><br/><p id="PARA1512" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In November 2014, we announced the initiation of a product development program for HTX-019. The investigational product HTX-019 is a proprietary intravenous formulation of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist used in combination with a 5-HT3 for the prevention of CINV. HTX-019 does not contain polysorbate 80. By eliminating the use of surfactant polysorbate 80, HTX-019 may reduce the hypersensitivity reactions observed with fosaprepitant formulations containing this component. At present, there is only one intravenous Nk<sub>1</sub> receptor antagonist approved in the U.S. for the prevention of CINV.</font>
    </p><br/><p id="PARA351" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In January 2014, we changed our name from A.P. Pharma, Inc. to Heron Therapeutics, Inc. Effective January&#160;13,&#160;2014, we effected a 1 - for - 20 reverse split of our outstanding common stock (&#8220;Reverse Stock Split&#8221;) (See Note 5). All historical share and per share amounts have been adjusted to reflect the Reverse Stock Split. All stock options, common stock underlying&#160;convertible notes and warrants outstanding were adjusted to give effect to the Reverse Stock Split.</font>
    </p><br/><p id="PARA353" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>Liquidity</b></font>
    </p><br/><p id="PARA355" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We have incurred significant operating losses and negative cash flows from operations and we have an accumulated deficit of $294.6 million as of September 30, 2014. Since 2011, we completed a total of five rounds of equity and/or debt financings, which provided us with cash of approximately $194.3 million, net of issuance costs, to fund operations (see Notes 4 and 5). As of September 30, 2014, we had cash on hand of $86.2 million.</font>
    </p><br/><p id="PARA1516" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We believe that our current working capital is sufficient to fund operations into 2015, including pursuing regulatory approval to market SUSTOL, and beginning human clinical studies relative to our HTX-011 and HTX-019 development programs. In the event we were to pursue clinical product development in other areas, potentially acquire other strategic assets, or begin to make significant investments in preparing for commercialization of SUSTOL, we would need to raise additional capital. If we are unable to obtain sufficient financing on acceptable terms or otherwise, we may be required to reduce or defer our activities.</font>
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureTextBlockAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Income Taxes<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
        <td class="text"><p id="PARA560" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><b>6. Income Taxes</b></font>
    </p><br/><p id="PARA562" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Deferred income tax assets and liabilities are recognized for temporary differences between financial statements and income tax carrying values using tax rates in effect for the years such differences are expected to reverse. Due to uncertainties surrounding our ability to generate future taxable income and consequently realize such deferred income tax assets, a full valuation allowance has been established. We continue to maintain a full valuation allowance against its deferred tax assets as of September&#160;30,&#160;2014.</font>
    </p><br/><p id="PARA564" style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">
      <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more likely than not to be sustained upon audit by the relevant tax authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. There have been no material changes in our unrecognized tax benefits since December&#160;31,&#160;2013 and as such, disclosures included in the Company&#8217;s 2013 Annual Report on Form&#160;10-K continue to be relevant for the period ended September 30, 2014.</font>
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Version>2.4.0.8</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>56</ContextCount>
  <ElementCount>123</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>20</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Disclosure - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Condensed Balance Sheets (Current Period Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Condensed Balance Sheets (Current Period Unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Condensed Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Condensed Statements of Operations (Unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Condensed Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Condensed Statements of Cash Flows (Unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Disclosure - Note 1 - Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/Note1Business</Role>
      <ShortName>Note 1 - Business</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Disclosure - Note 2 - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/Note2BasisofPresentation</Role>
      <ShortName>Note 2 - Basis of Presentation</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Disclosure - Note 3 - Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/Note3AccountingPolicies</Role>
      <ShortName>Note 3 - Accounting Policies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Note 4 - Convertible Notes to Related Parties</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://herontx.com/role/Note4ConvertibleNotestoRelatedParties</Role>
      <ShortName>Note 4 - Convertible Notes to Related Parties</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Note 5 - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/Note5StockholdersEquity</Role>
      <ShortName>Note 5 - Stockholders' Equity</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Note 6 - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/Note6IncomeTaxes</Role>
      <ShortName>Note 6 - Income Taxes</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Note 3 - Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/Note3AccountingPoliciesTables</Role>
      <ShortName>Note 3 - Accounting Policies (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Note 5 - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/Note5StockholdersEquityTables</Role>
      <ShortName>Note 5 - Stockholders' Equity (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Note 1 - Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/Note1BusinessDetails</Role>
      <ShortName>Note 1 - Business (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Note 3 - Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/Note3AccountingPoliciesDetails</Role>
      <ShortName>Note 3 - Accounting Policies (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Note 3 - Accounting Policies (Details) - Equity Excluded From Calculation of Diluted Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/EquityExcludedFromCalculationofDilutedEarningsPerShareTable</Role>
      <ShortName>Note 3 - Accounting Policies (Details) - Equity Excluded From Calculation of Diluted Earnings Per Share</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Note 4 - Convertible Notes to Related Parties (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://herontx.com/role/Note4ConvertibleNotestoRelatedPartiesDetails</Role>
      <ShortName>Note 4 - Convertible Notes to Related Parties (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Note 5 - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/Note5StockholdersEquityDetails</Role>
      <ShortName>Note 5 - Stockholders' Equity (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Note 5 - Stockholders' Equity (Details) - Stock-based Compensation Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/StockbasedCompensationExpenseTable</Role>
      <ShortName>Note 5 - Stockholders' Equity (Details) - Stock-based Compensation Expense</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Note 5 - Stockholders' Equity (Details) - Option Valuation Assumptions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/OptionValuationAssumptionsTable</Role>
      <ShortName>Note 5 - Stockholders' Equity (Details) - Option Valuation Assumptions</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Note 5 - Stockholders' Equity (Details) - Option Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://herontx.com/role/OptionSummaryTable</Role>
      <ShortName>Note 5 - Stockholders' Equity (Details) - Option Summary</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Element hrtx_ConvertibleNotesPayableRelatedPartiesCurrent had a mix of decimals attribute values: -3 0.</Log>
    <Log type="Info">Element us-gaap_ProceedsFromIssuanceOfCommonStock had a mix of decimals attribute values: -5 0.</Log>
    <Log type="Info">Element us-gaap_ProceedsFromIssuanceOrSaleOfEquity had a mix of decimals attribute values: -5 -3.</Log>
    <Log type="Info">Element us-gaap_ProceedsFromWarrantExercises had a mix of decimals attribute values: -5 -3.</Log>
    <Log type="Info">Element us-gaap_StockIssuedDuringPeriodSharesNewIssues had a mix of decimals attribute values: -5 0.</Log>
    <Log type="Info">'Monetary' elements on report '003 - Statement - Condensed Statements of Cash Flows (Unaudited)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '013 - Disclosure - Note 1 - Business (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '014 - Disclosure - Note 3 - Accounting Policies (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '016 - Disclosure - Note 4 - Convertible Notes to Related Parties (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '017 - Disclosure - Note 5 - Stockholders' Equity (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">Process Flow-Through: 001 - Statement - Condensed Balance Sheets (Current Period Unaudited)</Log>
    <Log type="Info">Process Flow-Through: 002 - Statement - Condensed Statements of Operations (Unaudited)</Log>
    <Log type="Info">Process Flow-Through: 003 - Statement - Condensed Statements of Cash Flows (Unaudited)</Log>
  </Logs>
  <InputFiles>
    <File>hrtx-20140930.xml</File>
    <File>hrtx-20140930.xsd</File>
    <File>hrtx-20140930_cal.xml</File>
    <File>hrtx-20140930_def.xml</File>
    <File>hrtx-20140930_lab.xml</File>
    <File>hrtx-20140930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EHLAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 5 - Stockholders' Equity (Details) - Option Valuation Assumptions (Employee Stock Option [Member])<br></strong></div>
        </th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems', window );"><strong>Note 5 - Stockholders' Equity (Details) - Option Valuation Assumptions [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
        <td class="nump">2.00%<span></span></td>
        <td class="nump">1.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
        <td class="nump">102.90%<span></span></td>
        <td class="nump">104.20%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (years)</a></td>
        <td class="text">6 years<span></span></td>
        <td class="text">6 years<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>hrtx_Note5StockholdersEquityDetailsOptionValuationAssumptionsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>hrtx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.D.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section D<br><br> -Subsection 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iv)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
